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Abstract
Surveys collecting data on food hypersensitivity were circulated online (and in person)
between November 2019 and October 2020. Participants included (a) adults aged 18
years and over, and (b) parents of children and adolescents under 18 years of age living
in the Ireland and Northern Ireland (NI). In total, 3,001 surveys from three food
hypersensitive groups were collected: 744 from people with a medically diagnosed food
allergy (MDFA), 1,035 with medically diagnosed coeliac disease (MDCD), and 1,222
from those reporting to have food intolerance and or suspected/undiagnosed food allergy
(FI). All data was self-reported for adults ≥18 years or parent-reported in the case of a
food hypersensitive child/adolescent <18 years, and an additional 1,113 control surveys
were collected from non-food hypersensitive individuals for data comparison purposes.
In summary, the total number of surveys collected in this study was 4,114.
Following analysis of the 744 surveys completed by MDFA respondents, peanuts (47%),
milk (36%), other nuts (35%), eggs (30%) and fruit (19% including 6% kiwi) were the
five most reported trigger foods, noted in Ireland and Northern Ireland. These allergens
were also the most associated with previous incidences of anaphylaxis among
respondents: peanuts (7%), other nuts (6%), eggs (4%), milk (3%), and fruit (2%
including 1% kiwi), highlighting the importance of these allergens among susceptible
populations. In addition, MDFA to kiwi (6%) was reported to be higher than that of
lupins (2%), sulphur dioxide and sulphites (2%), mustard (2%), celery (2%), and various
other non-declarable allergens under each of the different categories investigated (child,
adolescent, and adults). Notably, kiwi is currently not included in Appendix 2 to
Regulation (EU) No 1169/2011 – ‘Substances or products causing allergies or
intolerances’. The findings of this research suggest its inclusion warrants consideration.
Across the Island of Ireland (IoI), a total of 1,222 respondents reported having a food
intolerance and or suspected/undiagnosed food allergy (FI), and an additional 1,035
participants reported to have been MDCD. The two most prominent food intolerances
reported by the FI cohort were to milk (59%) and cereals containing gluten (45%). These
were followed by fruit (20% including 3% kiwi), eggs (10%), peanuts (9%) and other
nuts (6%).
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The socioeconomic cost of food hypersensitivity was calculated by examining direct and
indirect costs associated with each condition (MDFA, MDCD and FI) in Ireland and
Northern Ireland. Survey responses relating to an individual’s (for a food hypersensitive
adult) or households (for a food hypersensitive child/adolescent) expenditure were
reviewed. For the latter, costs were calculated for a family with just one FH child or
adolescent in this study, although many families consist of more than one. In more
general terms, only surveys where related questions were completed were included for
analysis. This gave a final total of 2,066 food hypersensitivity and 735 control surveys
for adults. These surveys consisted of 178/111 for adults with MDFA, 609/173 for adults
with MDCD, 536/459 for adults with FI, and 531/204 controls in Ireland and NI,
respectively. For parent-reported surveys, a total of 635 food hypersensitivity and 295
control surveys were analysed which consisted of 173/147 for children/adolescents with
MDFA, 148/60 for children/adolescents with MDCD, and 56/51 for children/adolescents
with FI, respectively (130/165 controls, respectively). Notably, no statistically significant
difference was found between genders on types of food allergies, regardless of food
hypersensitivity, examined in this study.
Direct costs consisting of healthcare related expenses (medical visits, associated travel,
hospital stays, medication, etc.) and total food costs per condition, were calculated for
food hypersensitive adults and parents of food hypersensitive children/adolescents in
Ireland and Northern Ireland. Moreover, indirect costs, based on lost time, missed days,
or lost earnings as a result of having a food hypersensitivity, were added to the direct
costs to give an overall estimate of the total socioeconomic costs associated with these
conditions.
Additional direct costs per annum associated with having a MDFA (calculated from the
survey data), were found to range from €1,115 (children/adolescents) to €1,325 (adults)
in Ireland, and €982 (adults) to €1,404 (children/adolescents) in Northern Ireland.
Similarly, additional direct costs per annum associated with MDCD were found to range
from €444 for adults (or €501 prior to claiming a tax rebate for gluten free food) to €903
for children/adolescents (or €993 prior to claiming a tax rebate for gluten free food) in
Ireland, and from €856 for adults to €1,871 for children/adolescents in NI. Lastly,
additional direct costs per annum associated with FI were found to range from €-128
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(children/adolescents) to €350 (adult) in Ireland, and from €337 (children/adolescents) to
€438 (adult) in NI.

Notably, direct costs were higher for all food hypersensitive

individuals in Ireland and NI compared to their controls, with the exception of the child
and adolescent FI cohort in Ireland. However, the sample number was small for this FI
group (n=56) due to challenges in findings parents of FI children and adolescents to
complete this survey, potentially impacting this figure. In more general terms, higher
direct costs as a result of additional healthcare and food related expenses were noted for
eleven (€337 - €1,871 p.a.) out of the twelve food hypersensitive groups investigated
across the IoI.
Indirect costs calculated in this study were smaller than direct costs and were found to
range from €96 to €730 for each of the ten cohorts who reported them; with the exceptions
being MDCD adult Ireland, and FI parental NI. The main driver for indirect costs was
found to be ‘missed days of work/school/college’, which tended to be higher in responses
from NI (€142 to €486), than the Ireland (€0 to €302).
Notably, the additional total cost (direct & indirect) associated with having a MDFA
ranged from €1,439 (children/adolescents) to €1,602 p.a. (adult) in Ireland, and €1,461
p.a. (adult) to €1,643p.a. (children/adolescents) in Northern Ireland. In addition, the final
figures calculated for all MDFA cohorts were found to be statistically significantly higher
(p-value<0.05) than those of the control groups. With regard to MDCD, the additional
total cost was calculated as €1,033 for children/adolescents (€1,123 prior to claiming a
tax rebate on gluten free food) in Ireland, and €1,586 for adults to €1,967 p.a. for
children/adolescents in Northern Ireland – all of which were found to be statistically
significantly higher (p-value<0.01) than controls. The additional total cost for the
MDCD adult Ireland cohort (n=609) was calculated as €438 (or € 495 prior to claiming
a tax rebate) p.a. but was not significant. The latter cohort reported less medical
expenses, than the other MDFA and MDCD groups, and zero additional ‘missed days’
compared to their control group (n=531). With regard to FI, higher additional total costs
were calculated (€504 and €656 p.a.) for adult respondents in Ireland and NI, than for
children/adolescents €70 and €66 p.a. counterparts, respectively. The main driver behind
the adult costs for FI were higher healthcare costs and ‘missed days’.
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In summary, health care related expenses were the main driver of costs associated with
food hypersensitivity in both Ireland and Northern Ireland. Total food costs, lost
earnings, and ‘missed days’ were independently statistically significant expenses (pvalue<0.05), in many of the cohorts examined. Out-of-pocket costs (mainly nonhealthcare) to individuals and households (parental survey), in each jurisdiction were
found to range from €499 to €1,141 p.a. for MDFA in Ireland, and €627 to €641 p.a. in
NI. While the equivalent for MDCD was found to range from €290 to €607 p.a. in Ireland
(€347 to €697 p.a. prior to claiming a tax rebate on gluten free foods, respectively), and
€1,121 to €1,178 p.a. in NI. In addition to out-of-pocket costs, respondents paid
additional healthcare costs in combination with the health service in each jurisdiction.
These shared healthcare costs ranged from €461 to €940 p.a. for MDFA in Ireland, and
€834 p.a. to €1,002 p.a. in NI, and €148 to €426 p.a. for MDCD in Ireland, and to €465
to €789 p.a. in NI. Notably, healthcare costs were on average ~40% higher for NI cohorts
examined, compared to those for Ireland in this study. These findings reveal the oftensubstantial additional expenses incurred by individuals with food hypersensitivity and
their families. These costs were more pronounced for MDFA and MDCD respondents
than for FI participants, although all conditions were associated with additional costs.
Intangible costs are defined as a loss of value or utility i.e., lost days, lost earnings, etc.
These costs can be difficult to measure in monetary terms, but health status values using
the EQ-5D (a set of standardised health-related quality of life questions) were examined.
Notably this study found that children under 18 years of age and adults with MDFA,
MDCD or FI had a statistically significantly lower quality of life compared to controls
(p-value<0.05). On closer examination of the data reported on the specific dimensions
of the EQ-5D, children and adults belonging to all three groups (MDFA, MDCD, and FI)
were found to have significantly higher levels of ‘pain and discomfort’ (<0.05) compared
to their control counterparts. Furthermore, adults from all cohorts and adolescents from
the MDFA and FI cohorts reported a statistically significantly higher level (p-value<0.05)
of ‘anxiety and depression’ compared to controls. These findings show how significant
the impact of food hypersensitivity can be on the Health-related Quality of Life (HRQoL)
of those affected. They also suggest an association between higher levels of ‘pain and
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discomfort’ and higher levels of ‘anxiety and depression’ in the adolescent and adult
cohorts specifically.
In total, 76 priority setting semi-structured interviews were conducted with 8 cohorts:
MDFA and MDCD adults and parents in both Ireland and Northern Ireland. The surveys
returned a wide selection of challenges. Interestingly, all MDFA and MDCD cohorts
prioritised ‘Public and Food Industry awareness and understanding of their/their child’s
condition’ as their number one challenge; with the exception of Northern Irish parents of
children/adolescents with MDFA in who ranked ‘Awareness and training in an
educational setting’ first and the former option third. All 8 cohorts recorded ‘Accessing
medical teams e.g., consultant’s specialist nurses etc. to treat your (or your child’s)
condition’ as the second most important priority. Notably, the provision of ‘Adrenaline
auto-injector in public places similar to AED’ (mirroring approaches currently in place
in countries like Canada) was the third highest priority for MDFA adults and parents.
Similarly, challenges with regard to ‘Awareness and training in an educational setting’
was the third highest priority of MDCD adults and parents, and the fourth highest for
their MDFA counterparts. Other important issues ranked, included cost and availability
of medication, access to counselling and dietetic services, and consideration to the
recognition of food allergy and coeliac disease as a disability (similar to measures in
place for severe food hypersensitivity in the US). An array of different strategies, ideas
and suggestions were proposed by participants to assist in combating these challenges.
Lastly, this study reviewed food hypersensitivity anonymised data from previously
published surveys and datasets for the IoI, including the collation of prevalence rates
reported for Ireland, the UK, Europe and elsewhere in the wider literature. In addition,
anonymised food hypersensitivity information was sought (2,513 institutions were
contacted) and collected from public and private organisations in Ireland and Northern
Ireland. More specifically this study reports percentages of food hypersensitivity, food
allergy and coeliac disease among 9,517 children in early years services, 3,233 school
children (primary and secondary) and 2,139 residences of nursing homes on the IoI.
Higher levels of all food hypersensitivity were reported in children in early years services
than in schools and nursing homes, with the exception of CD. The reported percentage
of CD was 1.5% in nursing homes (from a study cohort of 2,139 residents) for Ireland
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and NI combined, compared to 0.3-0.7% in the younger cohorts in this study. It is hoped
that the findings of this study will assist risk assessors, researchers, regulators, policy
makers and other stakeholders, in devising measures to improve the lives of food
hypersensitive consumers on the IoI.
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Chapter 1: Introduction and Literature Review
1.1 Introduction & Background
There is currently no ‘cure’ for a food hypersensitivity (FH). Management of this chronic
illness consists of strict avoidance of the “trigger” foods, and emergency medical
intervention if accidental consumption occurs (Allen et al., 2014, Crevel et al., 2008,
Helfe et al. 2007). While individuals with food allergy (FA) typically do not suffer the
symptoms of their disease on a daily basis, as with other chronic illnesses, the need for
constant vigilance regarding food places a heavy burden on them and their families
(Crevel et al., 2008, FSA, 2002, Miles, 2005). There are many studies highlighting the
negative impact of food allergies on the quality of life (QoL) of those affected, their
families, and caregivers (Sicherer, 2001, Cohen, 2004, Antolin-Amerigo, 2016). For
example, Primeau et al. (2000) reported significantly more daily disruption in the
activities of children with a peanut allergy than for children with rheumatological disease
(or other chronic illnesses examined). It is also notable that a study by the UK Food
Standards Agency (FSA) found that food allergies were more costly both in terms of
money and time (FSA, 2002; Jansson et al., 2014; Picarelli et al. 2014; Protudger et al.,
2015).

While societal costs associated with pediatric FA have been estimated to be in the region
of 25 billion dollars in the United States (Gupta et al., 2013), there is currently no
equivalent estimate available for Europe. A recent study (n=226) in Sweden (Protudger
et al., 2015), reported that total household costs (direct and indirect cost) were higher by
€3,961 for a child and €4,792 for an adolescent with FA. Another study examining annual
household costs associated with FA and carried out by the same research group (Jansson
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et al., 2014), found the costs to adults with FA to be significantly higher than the control
group (by €8,164) and the costs reported for children and adolescents (Protudger et al.,
2015). Intangible costs associated with perceptions of well-being were noted in both
studies Jansson et al. 2013; Jansson et al. 2014; Jansson et al. 2015; Protudjer et al. 2015;
Protudjer et al. 2016).

While these studies highlight the burden on individuals and the healthcare sector caused
by food allergy, they do not include hypersensitivity, such as coeliac disease and food
intolerance as a parameter in their research. In more specific terms, a review of existing
data/ literature (particularly with regard to prevalence rates), and the calculation of the
socio-economic costs associated with having food allergy, coeliac disease and food
intolerance (with consideration of gender, age, jurisdiction etc.) is warranted for the
island of Ireland (IoI).

1.1.1 Food Allergy and Food Hypersensitivity
Food allergy is defined as an adverse immunologic response to a food protein. Foodrelated allergic reactions are associated with a broad range of signs and symptoms that
may involve any body system, including the skin, gastrointestinal and respiratory tracts,
and cardiovascular system (Waserman et al. 2018). The most severe reaction is
anaphylaxis, which is defined as a serious allergic reaction (Waserman et al. 2018). Food
hypersensitivity is a broad term encompassing both food allergies and intolerances
(Johansson et al. 2001). While the prevalence of these conditions is not widely reported,
it is estimated that approximately 1.75 million people have been diagnosed with coeliac
disease (AOECS, 2015), and more than 7 million have been reported to suffer from food
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allergies (EAACI, 2015) in Europe alone. In Ireland, statistics show that approximately
5% of children and 3% of adults suffer from food allergies (INDI, 2019). While living
with a food hypersensitivity can of itself be challenging, it has been proposed that there
is a direct, and often significant, relationship between having such a condition and the
expenses incurred by the individuals and their families (Voodrouw et al. 2010; Fox et al.
2013; Jansson et al. 2014; Protudjer et al. 2015). Moreover, loss of productivity, missed
opportunities, and an overall unfavourable impact on QoL, have all been reported as
important intangible outcomes (Voodrouw et al. 2010; Jansson et al. 2013; Jansson et al.
2014; Jansson et al. 2015; Protudjer et al. 2015; Voordouw et al. 2016). The following is
a review of the socio-economic studies that endeavoured to cost food hypersensitivity in
Europe and elsewhere. Publications for children and adolescents, adults, and families
(where reported separately) are presented together. Finally, papers on the quality of life
of affected individuals are reviewed.

1.2. Socio-economic Costs of Food Hypersensitivity
Miles et al. (2005) developed a framework to measure the costs of having a food allergy,
which consisted of three categories, namely, direct costs, indirect costs and intangible
costs. The direct and indirect costs can be measured in monetary terms. In contrast,
intangible costs are difficult to quantify, as they are the costs associated with impaired
QoL as a consequence of having a condition such as a food allergy. For this reason,
intangible costs are often reported through self-reported health status and HRQoL
assessments. This framework can be adapted to examine the socio-economic costs
associated with other food hypersensitivities, including food intolerances and coeliac
disease.
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1.2.1 Direct costs
Direct costs can be defined as the cost to the health service and financial (out-of-pocket)
costs that individuals or their families incur as a result of having a food hypersensitivity.
More specifically direct costs are financial expenditures related to living with,
diagnosing, consulting or treating (e.g., medications, hospitalisation, use of emergency
services, etc.) the condition, and health insurance associated expenses. Moreover, they
include monetary out-goings, such as the cost of travel to visit medical/health care
professionals (including costs associated with hospital visits), and visits by medical
professionals to a patient’s home e.g., ambulance services (Miles et al. 2005). In addition,
the cost of health insurance, medication (including over-the-counter and prescribed
medicines), and outgoings associated with medical treatment not covered by insurance
(and thus paid for by the individual or their family) are included. Other possible
considerations include additional expenses associated with food, leisure activities
(including travel) and managing their condition (Miles et al. 2005; Voordouw et al. 2010;
Voordouw et al. 2016).

1.2.2 Indirect costs
Indirect financial costs associated with food hypersensitivity are not as readily
identifiable as direct costs. They can be defined as time impacts, and productivity &
earning associated losses which can include possible missed opportunities, as well as an
overall loss in human capital (Posnett and Jan, 1996, Miles et al. 2005). More specifically
this category covers aspects such as lost sick (or restricted) days, missed leisure time, or
an inability to perform domestic tasks as a result of illness. In fact, from a broader
perspective, family members may also need to be on hand to take care of an infirm
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individual, incurring their own personal monetary losses. Indirect costs may be accrued
by both the food hypersensitive individual themselves and their families. Time spent
obtaining medical treatment (consultations or admissions), visiting patients, shopping for
suitable foods, or even searching for information on health-related issues etc. would all
be considered indirect costs (Miles et al. 2005; Voordouw et al. 2010; Protudjer et al.
2015; Voordouw et al. 2016).
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1.2.3 Intangible costs
Intangible costs are defined as a loss of value or utility. These can be difficult to measure
in monetary terms but can be examined by reviewing the associated self-reported health
status. This includes aspects such as loss of welfare & well-being, pain/suffering,
inconvenience, or effects on QoL due to having a food hypersensitivity (Miles et al. 2005;
Voordouw et al. 2016). Intangible costs are typically examined via a HRQL assessment
(Miles et al. 2005) which focuses on an individual's perception of the overall effects of
the associated illness and its treatment. More specifically this includes aspects of
physical, psychological and social well-being and functioning.
Within the European Union’s project, “The Prevalence, Cost and Basis of Food Allergy
across Europe” (EuroPrevall), Fox et al. (2009) designed and validated a questionnaire
to measure the socio-economic costs of having a food allergy in the EU. This
questionnaire, termed the Food Allergy Socio-Economic Questionnaire (FA-ECOQ), has
been utilised in various European studies to determine the socio-economic costs of having
a food allergy in various EU countries (Voordouw et al. 2010; Fox et al. 2013; Cerecedo
et al. 2014; Jansson et al. 2014; Protudjer et al. 2015; Voordouw et al. 2016).

Fox et al. (2009) examined a wide range of scales used to measure economic welfare &
well-being in food allergy patients. This review was conducted to design a disease
specific questionnaire which best examined related intangible factors and their overall
impact. Notably, Fox et al. (2009) reviewed generic scales (which had been previously
used in the medical literature to examine disease associated intangible outcomes), to
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compare the attributes of cases and their control counterparts e.g. food allergic and nonfood allergic individuals. The generic scales that were included were:

i.

EuroQol 5-Dimension (EQ-5D) scale (EuroQol Group) to assess health status and
health-related quality of life across five non-disease specific dimensions

ii.

The five-point perceived health status scale (Benyamini and Idler, 1999) to
examine an individual’s health-related well-being

iii.

The Cantril ladder (Cantril, 1965) scale of subjective well-being measuring
feelings of happiness

iv.

The Income evaluation scale (Praag Van and Ferrer-I-Carbonell, 2004) to
measure an individual’s welfare associated with household income

In particular, the EQ-5D questionnaire (which consists of five ‘dimensions’ or questions
related to various aspects of health), has been used widely to assess health states and
health-related quality of life in comparable, but not food hypersensitivity-related, studies
(Møller et al. 2015; Quaranta et al. 2016; Rencz et al. 2016; Zrubka et al. 2017; Batóg et
al. 2018 and Prevolnik et al. 2019).

The economic costs associated with living with food allergies (including welfare, wellbeing & economic functioning), have been examined in a number of EU countries
including the UK, Sweden, Greece, Iceland, Poland, Spain, Czech Republic, France,
Italy, and the Netherlands (Miles et al. 2005; Voordouw et al. 2010; Fox et al. 2013;
Cerecedo et al. 2014; Jansson et al. 2014; Protudjer et al. 2015). Too date no such study
has been conducted on the IoI. More studies of this nature are required to obtain an
overview of food hypersensitivity related costs in the EU to assist affected individuals
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(and their families) and to determine associated governmental and regional costs.
Societal costs associated with pediatric food allergies have been estimated to be in the
order of 25 billion dollars annually in the United States of America (US) (Gupta et al.
2013). Moreover, the economic burden of illness due to food allergies and anaphylaxis
in the US was estimated to be in the region of half a billion dollars in 2007 (Patel et al.
2011). While there are currently no equivalent estimates available for the EU, the
European Academy of Allergy and Clinical Immunology (EAACI) have reported that
indirect costs associated with allergic disease (food related, and other sources) for adults
and children ranges from 55 to 151 billion euro per annum (EAACI, 2015).
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1.3 A Review of Studies on the Socio-economic Costs of Food Allergies
& Food Hypersensitivities
1.3.1 European studies
In this section, studies on the socio-economic costs of food allergies and other food
hypersensitivities in Europe were reviewed. Studies that reported costs in international
dollars1 or Pounds Sterling were converted to Euro for comparison (exchange-rates.org,
month,2019).

A pilot case-control study by Voordouw et al. (2010) used the FA-ECOQ (Fox et al.
2009) in the Netherlands (n = 99) and the UK (n = 91) to examine households with a food
allergic individual (adult or child) reporting to be self-diagnosed or clinician-diagnosed.
The data from these two countries was studied collectively against control samples (non
food allergic) and reported per household. The difference in annual direct costs per
household with a food allergic member (adult or children) compared to non-allergic
control households was estimated to be €1,088 (with costs of €8,984 and €7,896
respectively). Statistically significant differences in direct costs appeared to be primarily
related to those ‘obtaining health care’. In particular, medication (p < 0.01) and health
care (p < 0.05) related costs were significantly higher for households with food allergic
members compared to controls. Similarly, the annual difference in total indirect costs
(e.g., loss of earnings, costs due to an inability to perform domestic tasks due to ill health,

1

The international dollars (I$) (also known as the Geary–Khamis dollar) is an average unit of cost derived by adjusting exchange
rates between the US dollar and the local currency to compare values of different currencies based on purchasing power parity and
the average commodity prices within each country (Fox et al. 2013).
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etc.), were reported to be significantly higher among households (€2,571) with food
allergic members compared to controls (€9,269 and €6,698 respectively). Lastly,
intangible costs (i.e., self-reported health status and well-being) indicated lower overall
health status, lower self-perceived health status, and lower well-being2 for food allergic
individuals than controls.

A similar study by Fox et al., (2013) investigated the health service cost for food-allergic
Europeans across nine European countries (Greece, Iceland, Poland, Spain, Czech
Republic, France, Italy, The Netherlands and UK) collectively using the validated
questionnaire FA-ECOQ (Fox et al. 2009). The participants were recruited through
EuroPrevall in a case–control study in four countries (Greece, Iceland, Poland, Spain),
and a case only study in five countries (Czech Republic, France, Italy, The Netherlands
and UK). This study reported that food-allergic adults (n = 225, aged 20 – 54 years) and
children (n = 270, aged 7 - 11 years) (self-reported) in the case-control group had higher
health care costs than the control group, similar to findings reported by Voordouw et al.
(2010). The mean annual cost of health care for food allergic adults was estimated to be
I$2,016 (International dollars) equivalent to €1,794 based on a US dollar to euros
exchange rate in July 2019. This was I$927 (€825) more than the figure recorded for
those without food allergy (I$1,089/€969) in the European countries investigated.

2

The well-being of a food allergic individual can be described as the psychological impact of food allergy on the individual and their
household. This may include, for example, various limitations caused by health status, such as being unable to perform a job, or
restrictions on social life (Kahneman et al., 1999; Praag Van et al., 2004).
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Similarly, the mean annual cost of health care (I$2,197/€1955) reported for food allergic
children was I$1,334 (€1,187) more than the figure recorded for controls (I$863/€768)
on collective examination of the selected countries. Moreover, the mean annual cost of
health care for food allergic children (I$2,197/€1,955) was I$181 (€161) more than that
reported for food allergic adults (I$2,016/€1,794). While much variation exists between
individual healthcare systems in each of the nine European countries studied, this
calculation indicates overall higher health care related costs associated with food allergy
in children and adults (case-control group) in Greece, Iceland, Poland & Spain.

In this study, Fox et al. assessed whether the severity of symptoms had any impact on the
health care costs for allergic people in the two age ranges. Cases of possible and probable
food allergy were investigated, and the Mueller Clinical Severity Grading Scale (Muller,
1996) was used to categorise the severity of the reaction; if mild symptoms (e.g. skin
rashes) were reported, the severity was categorized as Grade 1; gastrointestinal symptoms
or angio-oedema were categorized as Grade 2; respiratory symptoms were categorized as
Grade 3. The most severe category was Grade 4 and included reported cardiovascular
symptoms and anaphylactic shock. They found that the costs of health care and the
severity of the symptoms of a food allergy were significantly related (P ≤ 0.0009). The
cost of health services for those reported to have a ‘moderate’ food allergy (category 3)
were likely to be 68% higher than for those with the ‘mildest’ symptoms (category 1)
while the costs for those with ‘severe’ food allergies (category 4) were predicted to be
twice that of those in category 1 (Fox et al. 2013).
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Another recent study in Sweden by Protudjer et al. (2015) investigated household costs
associated with ‘objectively’ diagnosed allergy to staple foods such as cows’ milk, hens’
egg, and wheat in children (0-12 years) and adolescents (13-17 years). This study
examined a cohort of outpatients (n = 144) from an allergy clinic who had a specialist
diagnosis of allergy to one (or more) of these staple foods. Notably, most food allergic
outpatients had parent-perceived and/or doctor-diagnosed allergies to foods other than
the staple foods examined. Protudjer et al. reported that mean total household costs (direct
plus indirect costs) were significantly (P < .05) higher by €3,961 for a food allergic child
(€20,819 and €16,858 respectively), and €4,792 for a food allergic adolescent (€23,468
and €18,676 respectively) (self-reported; n = 144), compared to non-allergic controls (age
and sex-matched; n = 150). It was noted that neither ‘concomitant allergic disorders’
(asthma, allergic rhinitis, allergic conjunctivitis, eczema), nor the number of offending
foods, significantly affected total household costs among children or adolescents. In fact,
overall indirect household costs did not differ between cases and controls amongst
adolescents. Some clinical factors such as food allergy severity, concomitant allergic
disorders, and the number of offending foods, were statistically associated with higher
indirect costs. Moreover, a history of anaphylaxis was significantly (P < 0.05) associated
with higher annual direct household costs (mean = €13,016), than no history of
anaphylaxis among children (mean = €10,044). When adolescents were examined, a
history of anaphylaxis was significantly (P < 0.05) associated with higher indirect costs
(mean = €11,915) compared to cost where anaphylaxis was not reported (mean = €7,159).
Protudjer et al. (2015) indicated that children and adolescents who had experienced
anaphylaxis were more likely to carry an adrenaline auto-injector (AAI) which was
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reported to be associated with ‘substantial’ out-of-pocket expenses. This study also
reported a significantly greater (P < 0.043) loss of earnings in households with food
allergic adolescents (but not children) than in control households (mean = €1,408 and
€544 respectively). Parents perceived their own well-being, as well as that of their child
and/or adolescent to be ‘poorer’, when compared with parents in households without food
allergy.

Jansson et al. (2014) investigated household costs among Swedish adults with
‘objectively’ diagnosed food allergies to cows’ milk, hens’ egg and/or wheat (n=81) who
had been recruited from an outpatient allergy clinic in Sweden. Other self-reported
allergies were reecorded in this survey which showed that self-reported allergy to peanut
and/or tree nuts was more prevalent among these food allergic adults compared to
controls (age and sex-matched; 61.7% vs 3.5%, respectively; P < 0.001). The mean
annual total household costs (direct plus indirect costs) were significantly higher (by
€8,164) for food allergic adults (n = 81), than the non-allergic control group (n = 85;
€23,856 and €15,692 respectively). It was also noted that the presence of concomitant
allergic disorders did not affect total costs and that the number of offending foods did not
significantly impact total costs similar to the findings of Protudjer et al. (2015) for
children and adolescents. However, a self-reported history of anaphylaxis was reported
to be associated with significantly higher costs (by €11,199), compared with no history
of anaphylaxis (€29,108 and €17,909, respectively). This included direct costs which
were significantly higher for cases with a self-reported history of anaphylaxis (€15 487
vs €9816; P < 0.05). The mean annual direct costs of healthcare (€237), medicines (€495)
and travel to healthcare professionals (€82) were reported to be significantly higher for
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those with food allergies, than non-allergic controls (€60 for healthcare costs, €199 for
medicines and €10 for travel to healthcare professionals). These results indicate that food
allergy severity may impact direct costs, notably healthcare and medication. Indirect
costs were also reported to be significantly higher (by €6,424) for households with food
allergic adults, compared to non-allergic controls (€12,822 and €6,398, respectively).
This included significantly higher indirect costs associated with time spent performing
domestic tasks due to a family member’s food allergy e.g. shopping, preparing food, etc.
When intangible costs were considered, adults with food allergy were reported to have
overall lower health status, self-perceived health status and perceptions of well-being,
than non-allergic controls. In summary, Jansson et al. (2014) suggests that food allergies
are often an unacknowledged resource burden on affected households.
A study by Cerecedo et al. (2014) examined an individual’s costs prior to and post
diagnosis using the double-blind placebo-controlled food challenge (DBPCFC) in Spain
and Poland as part of the EuroPrevall study. The validated questionnaire FA-ECOQ (Fox
et al. 2009) was distributed before and after the DBPCFC. Patients were invited to
participate on the first day of the DBPCFC (baseline) and were re-evaluated 6 months
later using the same instrument. Specifically, direct and indirect costs were compared
before and after the DBPCFC to detect possible differences between tolerant and reactive
patients (or parents of tolerant and reactive children). Costs were reported in international
dollars with 2007 as the benchmark year. Forty-two patients (31 food allergic children
(median age of 3 years) and 11 food allergic adults (median age of 35 years)) were
followed up after the DBPCFC and information on costs was collected before the
challenge and 6 months afterwards. The annual median total direct and indirect costs at
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baseline for the forty-two patients were I$3,289.8/€2,928 and I$5,094.4/€4,534,
respectively. Six months after the DBPCFC challenge, patients with a confirmed food
allergy were reported to have had significantly higher total costs (median increase of
I$813/€724) compared to the total cost spend in 2007 (the benchmark year), while
patients negative for food allergy recorded a median decrease in total costs (I$87.3/€78)
compared to the 2007 benchmark (P = .031). The amount of money spent on food 6
months after diagnosis was also significantly higher in those with a confirmed food
allergy (P = .040). It was noted that around 70% of the patients were diagnosed as allergic
to milk and egg. These two foodstuffs were also reported to be the most frequently ‘selfreported’ causes of food allergies in the EU based on the EuroPrevall cross-sectional
study (McBride et al. 2012). Milk and egg are present in many manufactured products
and allergic patients need to avoid foods that contain these ingredients even in trace
amounts.

In France, Flabbee et al. (2008) estimated the economic costs of anaphylaxis, including
direct medical expenses (such as treatment, hospitalisation, preventative and longterm
care measures) and indirect costs (absenteeism only) for 402 patients (children and
adults) with severe anaphylaxis – as documented by the Allergy Vigilance Network
(AVN). The global cost was estimated from the national data on hospital admissions for
anaphylaxis available for 2003, 2004 and 2005 using International Classification of
Diseases (ICD-10) codes for anaphylaxis. Of the 402 patients, 248 patients (96 children
and 152 adults) were reported to have experienced food anaphylaxis and 154 cases (17
children and 137 adults) were reported to have experienced drug-related anaphylaxis.
From this study, the mean direct cost was reported as €1,580 per patient and the mean
66

indirect cost (based on mean absenteeism of 3 work/classroom days) was €315. The mean
total cost was estimated to be €1,895 for food and drug-related anaphylaxis per patient
(€5,610 for the most severe) and €4,053 for Hymenoptera (wasps, bees, etc.) anaphylaxis.

Interestingly a study by Alanne et al. (2012) in Finland reports that having a food allergic
infant incurs a higher household cost than other allergic diseases, namely atopic
dermatitis and asthma (determined from birth to two years of age). In fact, they
determined that the mean total cost per infant was €4,348 with food allergy during the
first two years, €425 with atopic dermatitis, €1,858 with asthma, and €50 with healthy
infants. The reported mean total cost per infant with food allergy by the first year was
€1,791 and €2,556 by second year. The highest direct costs for food allergies were
reported to be associated with hospital outpatient care e.g., food challenges, infant
formulae for cow’s milk allergies, and indirect costs from travel. This study reported the
additional dietary cost for infants with food allergy compared to healthy infants was a
median of €778 (mean €2,041) inclusive of the Social Insurance Institution of Finland
reimbursement for part of the formulae costs for infants with cow’s milk allergy.

A subsequent study (Alanne, 2012) reported that hydrolysed formulas (for infants with
cow’s milk allergy) was the main factor for increased dietary costs incurred by the
families (n = 23) with more ‘severe’ allergy in Finland. Notably, the cohort examined
were not identified as either medically or self-diagnosed. The study reported that infants
who used hydrolysed formula (n = 12) had a higher daily dietary cost than those (n = 11)
who had used soy, oat, or rice-based alternatives or were breastfed at 12 months (€3.91
vs. €2.41 per day, respectively; p = 0.015). In addition, the society’s mean contribution
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(Social Insurance Institution of Finland) for using hydrolysed formula was €8.67 (SD
7.78) and €4.86 (SD 5.15) per allergic child at the ages of 12 and 24 months, respectively.

In the UK, Scott et al. (2019) estimated the resource use and associated costs for
individuals with peanut allergy compared to matched controls using the data from the UK
Clinical Practice Research Datalink and Hospital Episode Statistics. Individuals with
peanut allergy (n=15,483) were matched to two control cohorts: the first (simplematched) were matched 1:1 on year of birth, general practice, gender and registration
year (n=13,609, 87.9%). The second (atopy-matched) were matched on the same
characteristics plus presence/absence of an atopic condition (n=9,320, 60.2%). The
prescriptions and primary and secondary care contacts between cases and controls were
compared. They reported the total annual incremental health-care costs for peanutallergic individuals as £253/€293 (atopy-matched) and £333/€386 (simple-matched).
This study concluded that individuals with peanut allergy had increased health-care
contacts and consequently increased associated costs when compared to their control
counterparts.

In more general terms, a study by Voordouw et al. (2016) conducted in the Netherlands,
Poland and Spain (n = 1,558) examined socio-economic costs associated with food
hypersensitivity as opposed to having food allergies specifically (as examined in the
previous papers reviewed). Voordouw et al. reported that the average direct and indirect
costs calculated across all countries for families with food hypersensitivity (adults or
children) were not higher than for control households. This finding contrasts with
previous studies which examined direct and indirect costs associated with food allergies
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(as oppose to food hypersensitivities) in this review (Voordouw et al. 2010; Fox et al.
2013; Jansson et al. 2014; Protudjer et al. 2015). They noted that one of the reasons for
the lack of greater incurred costs in the case of food hypersensitive households might be
due to a restriction in food choices and related behaviours, including social and
recreational activities leading to less expenses when compared to a family without food
hypersensitivity (Cornelisse-Vermaat et al. 2008 and Voordouw et al. 2009). However,
Voordouw et al. does report higher costs for ‘time’ spent with, and travelling to visit,
health professionals by food hypersensitive members in all of the countries examined.
Similar to previous food allergy studies, they reported that intangible costs for food
hypersensitive individuals appear to be higher than controls and concluded the associated
‘lost opportunities’ were ‘substantial’. Food hypersensitive individuals were also more
likely to report restrictions concerning their job, giving up a job, changing job, restrictions
on leisure activities and social life, change of residence, and delayed family expansion,
compared to controls. In particular, Voordouw et al. proposed that having a food
hypersensitivity can influence, or limit, life choices associated with schooling,
employment, and family planning, possibly resulting in unfulfilled aspirations.

1.3.2 World-wide studies
A systematic review conducted by Bilaver et al. (2019) assessed the economic burden of
food allergies worldwide. Eleven papers were included in this global review (4 articles
from the US and 7 European articles). Four out of seven European articles were part of
the EuroPrevall project. These articles yielded household-level incremental costs of food
allergies using questionnaires that compared households with and without food allergic
members in Sweden, Greece, Iceland, Poland, and Spain. The generated costs were
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converted to US dollars (as set in 2018) and were converted to 2019 Euro (exchangerates.org) for comparison. The 7 articles that were not part of EuroPrevall all described
individual-level or societal-level costs (as opposed to household-level costs) of food
allergies. Summary of costs are outlined in Tables 3.3.2a to 3.3.2c for studies in European
countries and Tables 3.3.2d to 3.3.2f for the US. This review provided insights into the
economic effect of direct medical, out-of-pocket and opportunity costs to individuals and
their families with food allergies in the selected countries. Direct medical costs are
medical costs borne to the health care system. On the contrary, out-of-pocket costs, are
expenses associated with the burdens of disease that are not covered by insurance. Bilaver
et al. define out-of-pocket costs as all health care and non-health care-related costs borne
by patients, such as cost of travel to the physician or hospital, insurance co-payments (copaid by the insured person and the insurance company), cost of living, medications,
specialised foods, health insurance premiums, counselling, and special childcare
arrangements. They considered opportunity cost as the loss of potential earnings that
result from food allergy, for example decreased labour productivity, loss of leisure
activity, and increased time spent on any food allergy related household tasks.

Based on the Bilaver review, notable findings included that the mean annual direct
medical costs for an individual (US$2,081/€1,852) with food allergy were higher by
US$1,275/€1,134 than the mean annual direct medical costs calculated per household
with food allergy (US$806/€717). The mean out-of-pocket and opportunity costs for an
individual with food allergy were $1,874/€1,668 and $1,038/€924 respectively, while the
corresponding costs per food allergic household were $3,339/€2,972 and $4,881/€4,344
respectively. Moreover, household-level out-of-pocket costs were reported to be higher
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than medical costs (US$3,339/€2,972 compared to US$806/€717), with household-level
opportunity costs the most expensive (US$4,881/€4,344). It was noted that direct medical
costs are strongly influenced by the specific health care financing systems in place within
countries. For this reason, direct medical costs between the European and US studies
were difficult to compare directly. In more general terms, the cost associated with
‘special foods’ were among the largest proportion of out-of-pocket expenses reported in
both Swedish studies (Protudjer et al. 2015; Jansson et al. 2014) and a US study (Gupta
et al. 2013), highlighting it as an important factor for consideration as reviewed by
Bilaver et al. (2019).

In another study by Bilaver et al. (2016), the difference in the economic impact of food
allergy based on socioeconomic status was highlighted. They hypothesised that direct
medical and out-of-pocket costs of children with food allergy vary according to socioeconomic characteristics (household income, race and ethnicity). Households with food
allergic children in the lowest income group incurred 2.5 times the amount of emergency
department and hospitalisation costs than higher income strata ($1,021/€909 vs
$416/€370; P <0.05). Furthermore, expenses associated with specialist visits were
reported to be less in the lowest income group ($228/€203) than the highest income
cohorts ($311/€277; P <0.01). In terms of adjusted mean out-of-pocket costs, there was
a significant relationship between increasing family income and increasing out-of-pocket
medication. Low-income children had lower spending on specialty care and out-ofpocket expenses but incurred greater costs for emergency department visits and
hospitalisation. The low spendon specialist visits and key preventive measures suggest
that children in lower-income families may be at a higher risk for accidental ingestions
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and anaphylaxis because they have less access to specialty care, allergen-free foods, and
emergency medications such as epinephrine autoinjectors.
Gupta et al. (2013) reports that childhood food allergies in the US place a ‘considerable’
economic burden on families and society. In fact, the overall economic costs of childhood
food allergies (consisting of direct medical, out of pocket, opportunity costs, and lost
labour productivity) were estimated to be approximately $24.8 (€22.1) billion annually
(or $4,184/€3,724 per child per year). Direct medical costs to the US health care system
were estimated to contribute in the region of $4.3 (€3.8) billion annually (or $724/€644
per child per year). However, the majority of expenses were associated with lost labour
productivity (due to time spent on medical visits), out-of-pocket and opportunity costs,
which were collectively estimated to be in the region of $20.5 (€18.2) billion annually
(or $3,457/€3,077 per child per year). In more specific terms, lost labour productivity
and out-of-pocket costs were reported to be $0.77 (€0.69) billion annually (or $130/€116
per child per year) and $5.5 (€4.9) billion (or $931/€829 per child per year), respectively.
Notably, the highest reported cost of $14 (€12) billion (or $2,399/€2,135 per child per
year) was due to associated opportunity costs, such as a change/or loss of a job, as a result
of a child’s allergy.

Interestingly, caregivers reported a willingness to pay (WTP) of approximately $20.8
(€18.5) billion annually ($3,504/€3,119) per child per year) for an effective food allergy
treatment. These WTP estimates are remarkably similar to the total costs borne by
families associated with out-of-pocket expenses, lost labour productivity, and lost
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opportunity minus direct medical costs, suggesting possible avenues for future
exploration in this area.
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Summary tables based on studies of socio-economic costs of food allergies in Europe
Table 1.3.2a: Direct medical costs (borne by the health care system) of food allergy in European countries (adapted from Bilaver et al.
2019)
Direct Medical Costs per Patient with FA Per Year, 2018 US$ and 2019 Euro (converted)
Study

Primary

Private

Inpatient

ED

Hospital

Care

specialists &

Hospital

visits

Outpatient

Consultations

examination

Stays

$91.76/

$108.04/

NR

€81.67

€96.16

Medication

Travel

Infant

Disability

Costs

Formul
a

Allowance

$1,011.
38/

$238.28/

Total ($)

Total (€)

$2,309.32

€2,055.29

$3,542.98

€3,153.25

Country

Alanne et al.
2012

Finland

Care
NR

$627.50/

$47.36/

$185/

€558.48

€42.15

€164.65

Alanne et al.
2012

€212.07

€900.13

(first year of
life)
Finland

$7.40/

$158.35/

€6.59

€140.93

NR

NR

$741.45/

$47.36/

€659.89

€42.15

(second year
of life)

$187.95
/

$1,712.
30/

€167.28

€1,523.
95

$688.17/
€612.47

Flabbee et al.
2007
(children)

France

NR

NR

NR

NR

NR

NR

NR

NR

NR

$2,624.59

€2,335.89

Fox et
2013

Multiple
EU
countries

NR

NR

NR

NR

NR

NR

NR

NR

NR

Greece:
$153.41

Greece:
€136.53

Iceland:

Iceland:

(children)

al.
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̶ $112.01

̶ $99.71

Poland:
$1,654.58

Poland:
€1,472.58

Fox et
2013
(adults)

al.

Multiple
EU
countries

NR

NR

NR

NR

NR

NR

NR

NR

NR

Spain:
$1,199.24

Spain:
€1,067.32

Greece:
$253.24

Greece:
€225.38

Iceland:
$1,065.31

Iceland:
€948.13

Poland:
$2,208.55

Poland:
€1,965.61

Spain:
$233.76

Spain:
€208.05

*Abbreviations: ED, emergency department; NR, not reported. aDirect medical costs are those borne by the health care system associated with the prevention, diagnosis, and treatment of food allergies.
**All costs were converted to 2018 US dollars and 2019 Euro (1 US Dollar = €0.89, exchange-rates.org)
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Table 1.3.2b: Out-of-pocket costsa (costs borne by patient) of food allergy in European countries (adapted from Bilaver et al. 2019)
Out-of-pocket Costs, 2018 US$ and 2019 Euro (converted)**
Study

Country

Flabbee et
(children)

al.

2007

Cerecedo et al. 2014

Travel

Cost

Diet & food

Health
insurance

Total ($)

Total (€)

for visits

of living

France

NR

NR

NR

NR

NR

$2,342.45

€2,084.78

Spain and Poland

$3.29/

NR

$301.09/

$2,742.42/

NR

$4,005.33

€3,564.74

€267.97

€2,440.75
Included in cost
of living

$24.33/

$2,116.02

€1,883.26

Included in cost
of living

̶ $168.3/

$3,031.03

€2,697.62

Included in cost
of living

$85.77/

$4,204.18

€3,741.72

€2.93
Jansson et al. 2014

Medications
b

Sweden

Protudjer et al. 2015
(children 0-12 years old)

Sweden

Protudjer et al. 2015
(adolescents 13-17 years
old)

Sweden

$88.79/

$1,427.92/

$360.01/

€79.02

€1,270.85

€320.41

$56.70/

$2,702.48/

$423.03/

€50.46

€2,405.21

€376.50

$24.72/

$3,504.95/

$543.69/

€22.00

€3,119.41

€483.88

€21.65

-€149.79

€76.34

*Abbreviations: ED, emergency department; NR, not reported.
** All costs were converted to 2018 US dollars and 2019 Euro (1 US Dollar = €0.89, exchange-rates.org)
aThe

definition of out-of-pocket costs can vary to included or exclude healthcare expenses. In this instance ‘out-of-pocket’ costs include those borne by patient associated with the prevention, diagnosis, and treatment
of food allergies and all costs associated with protecting the child from exposure to allergens, including special childcare arrangements. This definition includes medication in this instance. Both articles by Alanne et al.
2012 are excluded from the table because they only present out-of-pocket costs related to infant’s diets during a very narrow period of infancy and early childhood.
b Includes

costs of food.
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Table 1.3.2c: Opportunity costs of food allergy in European countries (adapted from Bilaver et al. 2019)
Opportunity Costs, 2018 US$ and 2019 Euro (converted) *
Study

Alanne et al. 2012

Country

Total lost labour productivity and/or time
costs ($)

Total lost labour productivity and/or time
costs (€)

Finland

$141.96

€126.34

Finland

$134.92

€120.07

Spain and
Poland

$6,202.43

€5,520.16

(first year of life)
Alanne et al. 2012
(second year of life)
Cerecedo et al. 2014

* All costs were converted to 2018 US dollars and 2019 Euro (1 US Dollar = €0.89, exchange-rates.org)
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Summary Table based on Studies of Socio-Economic Costs of Food Allergies in the United States
Table 1.3.2d: Direct Medical Costs* (borne by the health care system) of food allergy in the US (adapted from Bilaver et al. 2019)
Direct Medical Costs per Patient with FA Per Year, 2018 US$ and 2019 Euro (converted)**
Study

Gupta
2013

et

Miller
2016

et

al.

al.

Country

Primary care
consultations

Private
specialists &
examination

Inpatient
hospital
stays

ED visits

Hospital
outpatient
care

Total ($)

Total (€)

USA

$103.25/

$212.11/

$352.39/

$144.77/

NR

$812.51

€723.13

€91.89

€188.78

€313.63

€128.85

NR

NR

NR

NR

NR

$1,113.7
4

€991.23

USA

Abbreviations: ED, emergency department; NR, not reported.
ˣ Hospital outpatient care, medication, travel costs, infant formula, disability allowance were not included in the costs analy sis
* Direct medical costs are those borne by the health care system associated with the prevention, diagnosis, and treatment of food allergies. The article by Bilaver et al. 2016 is excluded from the table because it focuses
on direct costs by race, ethnicity, and income and uses the same database as the articles by Gupta et al. 2013 The article by Patel et al. 2011 excluded from the table because individual-level direct medical costs
attributable to FA were not reported.
** All costs were converted to 2018 US dollars and 2019 Euro (1 US Dollar = €0.89, exchange-rates.org)
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Table 1.3.2e: Out-of-pocket costs* (costs borne by patient) of food allergy in the US (adapted from Bilaver et al. 2019)
Out-of-pocket Costs (individual-level), 2018 US$ and 2019 Euro (converted)**
Travel
(for
visits)

Medications

Diet and
food

Childcare,
schools,
camps,
and/or
counselling

Total ($)

Total (€)

$1,405.06

€1,250.50

Study

Country

Visits to
Physicians or
ED (including
co-payments)

Gupta et al. 2013

United States

$185.17/

$28.06/

$132.43/

$319.84/

$349.02/

€164.80

€24.97

€117.86

€284.66

€310.63

Abbreviations: ED, emergency department
* Out-of-pocket costs include those borne by patient associated with the prevention, diagnosis, and treatment of food allergies and all costs associated with protecting the child from exposure to allergens, including
special childcare arrangements. The article by Bilaver et al. 2016 is excluded from the table because it focuses on out-of-pocket costs by race, ethnicity, and income and uses the same database as the article by Gupta et
al. 2013.
** All costs were converted to 2018 US dollars and 2019 Euro (1 US Dollar = €0.89, exchange-rates.org)
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Table 1.3.2f: Opportunity costs of food allergy in the US (adapted from Bilaver et al., 2019)
Study

Gupta et al. 2013

Country

United
States

Opportunity Costs, 2018 US$ and 2019 Euro (converted)*
Total lost labour productivity and/or time
costs ($)

Total lost labour productivity and/or time
costs (€)

$2,838.18

€2,525.98

* All costs were converted to 2018 US dollars and 2019 Euro (1 US Dollar = €0.89, exchange-rates.org)
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1.4 Quality of Life of Food Allergic Individuals and their Family
Brazier et al. (2007) refers to HRQL as the impact of the health aspects of an individual’s
life on that person’s quality of life, or overall well-being. Contrary to direct and indirect
cost, intangible costs such as the loss of HQOL are typically not experienced in monetary
terms, however their influence can still be very pronounced in the lives of food allergic
individuals (Bollinger et al. 2006; Flokstra-De Blok et al. 2010; Jansson et al. 2013,
Jansson et al. 2015, DunnGalvin et al. 2015; Protudjer et al. 2016).The negative impact
of food allergies on the QoL of those affected and their families (Jansson et al. 2013;
Jansson et al. 2014; Protudjer et al. 2015; Jansson et al. 2015) should be considered.

1.4.1. Families studies
DunnGalvin et al. (2015) reviewed the literature (examining both quantitative and
qualitative research findings) to provide an in-depth picture of the impact of food allergy
on the concerns and everyday lives of children, teens, adults and parents. They proposed
that food allergy has a ‘strong’ impact on HRQL in terms of social, dietary, and
psychological factors. In particular, it was noted that food restrictions and avoidance
extend far beyond 'mealtimes', as food is such an integral part of daily life. More
specificically, social events have a different meaning for people with food allergy (and
are often experienced differently), sometimes giving rise to feelings of isolation or
exclusion. Moreover, food allergies were reported to compound existing psycho-social
stress in a household (e.g. normal developmental changes), potentially leading to adverse
effects on overall HRQL.

Flokstra-De Blok et al. (2010) compared the HRQL of food allergic adults (n = 72),
children (n = 79) and adolescents (n = 74) with the general population and other chronic
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diseases by using a generic HRQL questionnaire in the Netherlands. Food allergic
adolescents and adults were reported to have ‘impaired’ QoL and significantly lower
scores on ‘bodily pain’ (P = 0.020) when compared to the general population. In fact,
adults and adolescents with food allergies were reported to have ‘poorer’ overall health
and HRQL, than their non-food allergic counterparts. Moreover, adults with food allergy
reported poorer HRQL than that of adults with diabetes mellitus, but better HRQL than
adults with rheumatoid arthritis, asthma and irritable bowel syndrome.

Bollinger et al. (2006) conducted a study to evaluate the impact of food allergy on the
daily activities of food allergic children and their families in the US. Among 87 families,
more than 60% of caregivers reported that a child’s food allergy significantly affected
their meal preparation, while 41% of parents reported that their stress levels were
significantly affected. The causes were reported to be ‘cost’ (leading factor), correct
allergen labelling, and the potential for cross-contamination and accidental allergen
exposure outside of the home e.g. schools, parties, etc. In addition, Bollinger et al.
reported that 49% of parents indicated that their child’s food allergy impacted on the type
of social activities that each family could engage in. In more general terms, 34% of
respondents reported that their child’s attendance at school was affected, with 10% noting
that they would choose to home school their children as a result of their food allergy.

Following a world-wide literature review by Antolin-Amerigo et al. (2016), this research
group described the factors that may influence the quality of life of patients (children,
adolescents, and adults) with regard to food allergy. Sicherer, Noone & Muñoz‑Furlong,
(2001) noted that food allergic children with multiple food allergies (greater than two)
had lower QoL scores compared to those with one or two food allergies. Food allergies
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were also reported to affect the QoL scores for adolescents, resulting in social isolation,
depression, difficulties in school performance and leisure activities, along with the fear
of allergic reactions (Cumming et al. 2010; MacKenzie et al. 2010; Sommer et al. 2014).
Uncertainty and anxiety were reported to account for the greatest impact on HRQL in the
food-allergic adults reviewed (Flokstra‑de Blok et al. 2009; Goossens et al. 2014;
Antolin-Amerigo et al. 2015). In fact, Antolin-Amerigo et al. (2016) noted that the fact
that neither the time of onset nor the intensity of the allergic reaction is predictable, can
in itself significantly influence QoL. The constant threat of allergen exposure and the
need for vigilance in the avoidance of specific foods were reported as important
influencing factors (de Blok et al. 2007; Goossens et al. 2014).

1.4.2. Adult studies
Jansson et al. (2013), investigated HRQL in Swedish food allergic adults to at least one
staple food: cow’s milk, hen’s egg or wheat. The cohort involved (n = 79; 28 males, 51
females, mean age = 41 years) was recruited at an outpatient clinic where they had been
medically diagnosed with a food allergy. The respondents completed a disease-specific
food allergy quality of life survey FAQLQ-AF (EuroPrevall) containing a total of 29
questions which assesses HRQL in four areas: Allergen Avoidance and Dietary
Restrictions (AADR), Emotional Impact (EI), Risk of Accidental Exposure (RAE), and
Food Allergy-related Health (FAH). Out of the four areas examined, AADR had the
largest negative impact on HRQL, while health concerns associated with having a food
allergy (FAH) was reported as having the least impact. Notably, previous episodes of
anaphylaxis (and particularly the prescription of an AAI), was associated with an overall
‘low’ HRQL. Moreover, this paper proposes that both the severity of the food allergy
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and the presence of concomitant allergic disorders can have a ‘profound impact’ on
HRQL, for example asthma in combination with food allergy.

A further study by Jansson et al. in 2014 on food allergic adults (n = 81, and a control
group of n = 85) reported that food allergic adults in Sweden experienced overall lower
health status and self-perceived health status than their non-allergic counterparts. In fact,
adults with an allergy to at least one of the staple foods of cow’s milk, hen’s egg, or
wheat, reported significantly reduced and impaired HRQL (as determined by EQ-5D).

1.4.3. Children & adolescent studies
Jansson et al. (2015) investigated the factors that affect HRQL in households with a child
or adolescent with objectively diagnosed allergy, to at least one of the staple foods: cow’s
milk, hen’s egg or wheat. In this study, adolescents and parents of food allergic children
completed the FAQLQ. In total, 85 children (0-12 years) and 58 adolescents (13-17 years)
cases, as well as 94 children and 56 adolescents controls, participated. Dietary restrictions
(AADR) had the largest negative impact on HRQL experienced by the adolescents, while
concern for accidental exposure (AE) had the least. Children who had previous
anaphylaxis (p<0.001) and an AAI prescription (p<0.05) had a lower HRQL: this trend
was not observed in the adolescents. The variations in findings reported (between
children and adolescents) indicate that consideration should be given to the age of the
patient when managing patients with food allergies.

Protudjer et al. (2015) reported that food allergic children and adolescents (n = 144, a
control group of n = 150) in Sweden had a ‘poorer’ perception of their own well-being in
parent-reported studies than their peers without this condition. They also reported that
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food allergic children and adolescents experienced overall lower health status and selfperceived health status than their non-allergic counterparts (as determined by EQ-5D).

A later study by Protudjer et al. (2016) investigated the association between objectivelydiagnosed allergy to cow’s milk, hen’s egg and/or wheat and HRQL amongst adolescents
aged 13 – 17 years (n = 58) in Sweden using the disease-specific Food Allergy Quality
of Life questionnaire-Teenager form (FAQLQ‑TF) by EuroPrevall (18 females and 40
males). The food allergies impacted on the adolescents’ lifestyles and were associated
with poorer than average overall HRQL. The mean score for overall HRQL for
adolescents was 4.70/7.00 (based on the FAQLQ‑TF scale of 1-7, where 1 corresponds
to the best HRQL and 7 corresponds to worst HRQL (self-reported)). In particular, factors
such as ‘emerging independence’ and ‘the need for support’ (e.g., eating out, emotional
issues surrounding communication, and understanding/acknowledgment of food allergies
by others, etc.) were noted. Females were reported to have ‘clinically worse’ HRQL
compared to their male counterparts, however this was not reported to be statistically
significant (mean difference = 0.71; p < 0.07). HRQL tended to be lower amongst those
with multiple food allergies (three or more) or those with an AAI prescription.
Interestingly, the number and types of symptoms, including a history of anaphylaxis,
were not associated with a decrease in HRQL score.

1.5 The Socio-economic Costs of Coeliac Disease
Food intolerances also known as metabolic food disorders occur as the result of
genetically determined metabolic deficiencies that either affect the ability to metabolize
a specific substance in foods or heighten sensitivity to a particular foodborne chemical
(Taylor & Baumert, 2020). Non-coeliac gluten sensitivity is diagnosed in individuals
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who do not have coeliac disease or a wheat allergy; but who have intestinal symptoms,
extraintestinal symptoms, or both, related to ingestion of gluten-containing foods.
Notably, there are also symptomatic improvements on withdrawal of gluten containing
products from the diet (Leonard et al. 2017).

Coeliac disease (CD) is a chronic inflammatory intestinal disease caused by an
autoimmune response to gluten proteins, which occurs in genetically susceptible
individuals (Cappaci et al. 2018). Sources of gluten include wheat, barley and rye and
repeated consumption results in intestinal mucosal damage and other symptoms.
Management of the condition requires a strict life-long gluten-free (GF) diet. Notably,
coeliac disease can manifest at any age with a variety of symptoms (Caio et al. 2019).

An overall prevalence rate of 1% for coeliac disease has been suggested in EU
populations (Mustalahti et al. 2010 & Caio et al. 2019) and rates of 0.5-1% have been
reported in the Irish and UK populations (FSAI, 2015; Irish College of General
Practitioners (ICGP), 2015; Coeliac Society of Ireland (CSI), 2019; Coeliac UK, 2019).
In a systematic review and meta-analysis, Singh et al. (2018), reported that coeliac
disease had a global prevalence of 0.7% (n=138,792) when based on biopsy-confirmed
results, and up to 1.4% when based on serological test results (n=275,818). Prevalence
rates have been reported to be statistically significantly higher in females (Singh et al.
2018).

Picarelli et al. (2014) reported that each year of delay in coeliac disease diagnosis is
ultimately associated with higher medical care costs. The medical costs of laboratory tests
and medical surveys were collected from coeliac disease patients (n=28) in Italy and the
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US over a 3-year period prior to their receiving the ‘correct diagnosis’. The total prediagnosis expenditure was €408 in Italy and $8,748 (€7,786) in the US. The mean cost
proposed was €136 in Italy and $2,916 (€2,595) in the US for each year of delay in coeliac
disease diagnosis. This study is in agreement with another US study by Long et al. (2010),
who examined the impact of coeliac disease diagnosis on direct medical costs borne by
133 index cases versus 133 controls cases one year pre‐ and post‐diagnosis. The average
total costs were reduced by $1,764 (€1,570) in the year following diagnosis (pre‐ and
post-diagnosis costs of $5,023 (€4,470) and $3,259 (€2,901), respectivley; 95% CI of
difference $688 (€612) to $2,993 (€2,664)), highlighting the importance of a timely and
correct diagnosis of this condition.

Another study by Violato et al. (2012) reported higher health costs for coeliacs pre- and
post-diagnosis in an examination of 3,646 medically diagnosed coeliac disease (MDCD)
and 32,973 non-coeliac controls in UK primary care, as extracted from the General
Practice Research Database (GPRD) between 1987–2005. Contrary to reports by Picarelli
et al. (2014) and Long et al. (2010), Violato et al. reported that the average annual
healthcare costs per coeliac disease patient increased by £310 (€360) p.a. after diagnosis
(£340 (€394) pre-diagnosis versus £650 (€754) post-diagnosis). This calculation was
based on the average costs to the individual for a maximum of 10 years post diagnosis.
These differences were mainly driven by higher costs for tests and referrals (70% and
50%, respectively, compared with matched controls), while consultation and prescription
costs contributed to a lesser extent (less than 40% higher than for controls).

Similarly, Long et al. (2010) reported that MDCD individuals (n=153) in a US study
experienced higher out‐patient costs (mean difference of $1,457 (€1,297); P =0.016) and
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higher total costs (mean difference of $3,964 (€3,528); P = 0.053) than non-coeliacs
(n=153) when examined over a four year timeframe. These higher totals costs were
reported to be associated with out‐patient costs, radiological, laboratory service use and
office visits. In summary, higher costs (mainly attributed to healthcare) have been
associated with coeliac disease pre and post diagnosis (Long et al. 2010; Violato et al.
2012; Picarelli et al. 2014).

1.5.1 Availability and cost of gluten-free products
Previous studies have reported a lack of palatability regarding substitute GF products
which can affect adherence to a strict GF diet (Roma et al. 2010 and Crocker et al. 2018).
In addition, GF products have been reported to be significantly lower (p< 0.01) in protein
and higher in fat and fibre (p< 0.05) than their conventional counterparts. following a
review of 110 products available in UK supermarkets in 2017 (Allen & Orfila, 2018).
Similarly, Fry et al. (2018) observed higher levels of fat, sugar and salt in GF bread (and
some crackers) compared to standard foods in an examination of these macronutrients in
1,724 products in the UK.Allen & Orfila, (2018) reported that only 5% of GF bread
products in the UK were fortified with micronutritents such as calcium, iron, nicotinic
acid/nicotamide and thamin, and 28% with calcium and iron.Thompson (1999, 2000)
reported that only 9-23% of GF bread products in the United States were fortified with
thiamin, riboflavin, and niacin, and no fortification in US GF pasta products was
recordeid. These recent studies have demonstrated low intakes of micronutrients in the
diets of coeliacs (Kinsey et al., 2008; Wild et al., 2010; Ohlund et al. 2010 and Abenavoli
et al., 2015), which is of particular concern for growing children.
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In more general terms, many studies have demonstrated that adherence to a GF diet
significantly increases the cost of food for adherents, with prices often two to three times
greater than for similar non-gluten-free products (Lee et al. 2007, Burden et al. 2015;
Panagiotou and Kontogianni, 2017; Fry et al. 2018; Allen & Orfila, 2018; Hanci and
Jeanes, 2019; Lee et al. 2019).The cost to maintain a strict GF diet can be prohibitive,
with 33% of participants reporting cost as the reason for dietary non-compliance in a
study of several US cities (sample size unknown) in 2016 (Lee et al. 2019). One key
reason for the cost differenceis that naturally GF grains and flours (e.g., quinoa, millet,
teff, sorghum, buckwheat) currently available on the market are not as mainstream as
their gluten containing counterparts. For example, if we examine a staple food like bread,
Allen & Orfila, (2018) reported the average increase in the cost of GF bread alternatives
in the UK was 220-314% (white (+307%), brown (+314%) and seeded (+220%)). In
addition, the cost of GF pasta was found to be 70% higher than the cost of standard pasta.
GF products were significantly more expensive across all four product categories than
the standard equivalents. Two further UK studies (Burden et al. 2015; Hanci & Jeanes,
2019) reported GF products being up to 400% more expensive than their wheat-based
counterparts.

In addition to the higher cost of GF food, many reports discuss the limited availability of
GF products on the market. Notably, Allen & Orfila, (2018) reported GF foods are less
available and more expensive than gluten-containing products in the UK supermarkets.
A total of 110 products were used in the cost and nutritional analysis section of this study,
and significantly more ‘standard’ products were found to be available across all
categories. In fact, the mean number of standard products ranged from 23 to 62 per
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category, while the mean number of GF products available ranged from 4 to 11. There
was a significantly lower number of GF white breads, brown breads and pasta available
compared to standard alternatives (p ≤ 0.01). Therefore, the increased economic burden
of coeliac disease and the reduced availability of products may increase the likelihood of
some coeliacs being unable to comply with a GF diet.

1.5.2 Measures to address the cost of gluten free food
Designated schemes exist in some countries to assist coeliacs with the cost of GF foods.
For example, in Ireland and Canada, coeliacs receive tax deductions to subsidise the
additional cost of GF foods. In the UK, coeliacs are eligible to access GF core staples on
prescription. The National Health Service (NHS) spends about £195 (€226) per patient
per annum to cover the costs of prescribed foods (NICE, 2015). Cappaci et al. (2018)
noted there is suggestive evidence that the price paid by the NHS is higher than the shelf
price of the same GF products sold in supermarkets (Department of Health, 2017b). In
fact, in March 2017 the Department of Health launched a public consultation on whether
to end or reduce GF food prescriptions in England (Department of Health, 2017a) given
the increased availability of GF foods on the market. The cost of GF prescriptions in the
UK is estimated to be £25.7 (€29.8) million (2015 data).
In Italy, law no.123 from 2005 recognises coeliac disease as a ‘social disease’ and ensures
the free distribution of GF foods. Capuozzo et al. (2013) stated the pharmaceutical
service in Italy produced a booklet composed of 12 coupons corresponding to the months
of the year. The value in euro for each coupon varied according to the age and gender of
the patient, based on pre-determined expenditure patterns associated with an individual’s
demand for GF products. The value of each coupon for each age group was as follows:
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€45 for children aged 6 months to 1 year (both sexes), €62 for children aged 1–3.5 years
(both sexes), €94 for children aged >3.5–10 years (both sexes), and for those 10 years or
older the value of each coupon corresponds to €140 for males and €99 for females (most
likely as a result of higher consumption patterns among males). It was reported that
patients with coeliac disease can buy GF foods using these coupons in any Italian
pharmacy.

These subsidy schemes can be beneficial to coeliacs, given the reported higher costs
associated with GF products. From this perspective, they should be monitored to ensure
that they accurately reflect the expenditure incurred because of the disease and can
adequately support a GF diet where cost would otherwise be an obstacle.

1.5.3 Quality of life in coeliac disease
Many studies have reported a GF diet to be burdensome, restrictive and challenging to
adhere to which can cause difficulties in various aspects of daily life, including travelling,
shopping, and eating meals outside of the home (Sverker, Hensing & Hallert, 2005;
Whitaker et al. 2009; Shah et al., 2014; See et al. 2015; Black & Orfila, 2011). In fact,
Altobelli et al. 2013 reported frustrations felt by MDCD children and adolescents (n =
140) following a restrictive diet in an Italian study. Notably, nearly 20% of participants
reported feeling ‘different from others’ and ‘misunderstood’, as a result of their condition.

A survey by MacCulloch and Rashid (2014) evaluating GF diets in children and
adolescents, reported good adherence at home and in school, but low adherence at social
events. Significant barriers to good adherence were reported to be the availability of GF
products, appropriate labelling of food and the cost. Roma et al. (2010) reported that the
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main causes of non-adherence to GF diets in children (n=73) were poor palatability
(32%), issues dining outside home (17%), and poor availability of products (11%).
Furthermore, Wagner et al. (2008) reported that non-adherent adolescents had more
physical problems, a higher burden of illness, higher feelings of “ill-health” and more
family problems than their adherent counterparts.

Similarly, for adults (and as previously described), non-adherence to a GF diet can be
associated with higher costs of GF alternatives and a limited availability of suitable
products (Allen & Orfila, 2018; Lee et al. 2019), thereby affecting the individuals’ sense
of well-being and overall HRQoL.

Crocker et al. 2020 reported that healthcare

experiences can affect the HRQoL of adults (≥18 years) with coeliac disease). A cross‐
sectional postal survey was completed by 268 members of Coeliac UK in 2014. A
Coeliac disease Assessment Questionnaire (CDAQ) of 53 questions was used, and four
key healthcare associated areas were found to significantly impact the HRQoL of
coeliacs.

These were: information provision, general practioners’ knowledge,

communication with health professionals, and access to prescriptions (p-value<0.05).
Crocker et al. noted that, generally speaking, ‘poorer’ experiences of healthcare services
were related to a worse overall HRQoL. Therefore, improving services in these key areas,
may help to ameliorate the deleterious effects on HRQoL reported in this study.

In summary, coeliacs have been reported to have a reduced HRQoL as a result of their
condition (Ciacci and Zingone, 2015, Wagner et al. 2008; Crocker et al. 2020). In
particular, impacts have been recorded in interpersonal relationships, emotions, economic
difficulties and psychological effects (Martínez-Martinez et al. 2019, Crocker et al.
2020). Mechanisms to support coeliacs with regard to their healthcare requirements, and
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to address the cost and availability of GF foods, could greatly improve their quality of
life.
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1.6 Aims & Objectives
The aim of this study was to examine the socio-economic costs (direct, indirect, and
intangible) of food hypersensitivity on the IoI.

Definitions

Survey data was gathered from two target groups:
•

adults of 18 years of age or over who have a food hypersensitivity

•

parents of children and/or adolescents younger than 18 years of age who have a
food hypersensitivity.

Throughout the report, these are abbreviated to ‘adults’ and ‘children/adolescents’, unless
separate data are reported for ‘children’ (0-12 years) and ‘adolescents’ (13-17 years).

The food hypersensitivities investigated were:
•

Medically diagnosed food allergy (MDFA)

•

Medically diagnosed coeliac disease (MDCD)

•

Food intolerance/suspected or undiagnosed food allergies (FI)

The nounal or adjectival form of the term ‘food hypersensitivity’ is abbreviated to FH.
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Objectives
•

To calculate the direct and indirect costs associated with food hypersensitivity in
Ireland and Northern Ireland (NI).

•

To compare the costs associated with having different FH in both target groups
in Ireland and NI.

•

To investigate the overall quality of life (QoL), or intangible cost (non-monetary),
associated with food hypersensitivity in adults, and similarly for families
reporting to have a child/adolescent with one of these conditions

•

To examine available data on food hypersensitivity on the IoI, and to collect
related anonymised information from public and private institutions such as early
learning services (childcare facilities), schools (primary and secondary), and
nursing homes.

•

To carry out a review of the peer-reviewed scientific literature for prevalence
estimates for MDFA, MDCD and FI in Ireland, UK, Europe, and further afield.

•

To define the key areas of life impacted for adults and children/adolescents with
MDFA or MDCD.

•

To examine the challenges faced by adults and families of children/adolescents
with MDFA or MDCD and proffer possible recommendations or interventions.
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SECTION 2: METHODOLOGY
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Chapter 2: Study Methodologies
A comprehensive examination of the socio-economic cost of food hypersensitivity on the
IoI was undertaken (as described in the Project Aims & Objectives) under the following
headings:
•

Food Hypersensitivity Survey Design, Collection & General Analysis

•

Calculation of Socio-Economic Costs associated with Food Hypersensitivity on
the IoI (presented as Direct & Indirect Costs, and also as Healthcare and Out-ofPocket costs)

•

Calculation of the Socio-Economic Cost of Food Hypersensitivity on the IoI Intangible costs (EQ-5D) and effect on QoL

•

Completion of Priority Setting Interviews of Individuals reporting to be MDFA
or MDCD (and parents thereof) in Ireland and NI

•

Collection and Examination of Food Hypersensitivity Datasets in Public and
Private Institutions

•

Prevalence Rates for MDFA and MDCD on the Island of Ireland reported in the
Literature
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2.1 Methodology for Food Hypersensitivity Survey Design, Collection &
General Analysis
In this study, the age groups examined were adults aged ≥ 18 years, children aged 0 to 12
years, and adolescents aged 13 to 17 years. Costs were reported for adults (≥ 18 years)
and combined for children and adolescents (<18 years) due to the small number of
respondents for the adolescents group.

Surveys targeting adults (≥ 18 years) or parents of children/adolescents (< 18 years) with
food hypersensitivities were developed by our team (scientists, medics & health
economists) to be completed by respondents under the following headings:

1. Individuals with medically diagnosed food allergies - MDFA (as diagnosed by
a healthcare professional via any or all the following methods: skin-prick test,
blood tests, oral food challenge and trial elimination diet)
2. Individuals with medically diagnosed coeliac disease - MDCD (as diagnosed by
a healthcare professional via blood tests and/or gut biopsy)
3. Individuals with food intolerances or suspected/undiagnosed food allergies FI (not medically diagnosed)
4. Individuals with no known food sensitivities (i.e., control group). This survey
was launched independently as a ‘cost of living & health care’ survey and
contained corresponding questions to the other surveys.

Eight surveys were designed to accommodate groups 1-4 as outlined above from both an
individual adult perspective, and from the perspective of parents with affected
children/adolescents. These surveys are available in Appendix 9. The questions for the
surveys were designed based on the validated Food Allergy Economic Questionnaire
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(FA-ECOQ) developed by Europrevall (Fox et al. 2009), peer-reviewed papers (Miles et
al. 2005, Voordouw et al. 2010; Fox et al. 2013; Cerecedo et al. 2014; Jansson et al.
2014; Protudjer et al. 2015; Voordouw et al. 2016) and on discussion with the project
steering committee. The eight surveys proposed were reviewed by academics, medical
consultants, scientists, and stakeholders, including regulators and food hypersensitivity
patient representative groups. The agreed surveys were then piloted for the purposes of
validation with a test cohort of 104 individuals which included both food hypersensitive
and non-food hypersensitive adults, and parents of children/adolescents with food
hypersensitivity. All feedback was considered by the project team. The final surveys
were ethically approved by ethics committees in the Technological University Dublin
(TU Dublin) and Queen’s University Belfast (QUB).

The questionnaires had a

completion time of between 30 – 40 minutes and 10 – 15 minutes for each control survey.
They consisted of:
•

38 to 39 questions for respondents reporting to be MDFA (adults or parents)

•

31 to 32 questions for respondents reporting to be MDCD (adults or parents)

•

26 questions for respondents reporting to be FI (aduls or parents)

•

20 to 21 questions for the control (non-food hypersensitive) adult and parent
surveys

Notably, additional questions were added if for example an individual reporting to be
MDFA also indicated that they were MDCD, or had additional food intolerances etc., as
well as reporting to have MDFA. This was made possible by using a sophisticated
electronic platform (LimeSurvey) which not only added necessary questions where
relevant, but also redirected respondents if they were completing the wrong survey. For
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instance, if a food hypersensitive respondent started to complete the control survey they
would be automatically redirected to the correct and relevant survey; based on
information given in the initial line of questioning. Control study questionnaire (nonhypersensitive) were launched online, independent to the food hypersensitivity surveys
in Ireland and NI and titled a 'Cost of living and healthcare' (Appendix 9).

2.1.1 Methodology – survey distribution and collection
This survey set was available online on the LimeSurvey Platform via an electronic link.
The online surveys were launched in November 2019 and ran until October 2020, with
the focus on achieving target numbers for analysis in certain (low number) categories in
the final few months of this study, i.e. the parental surveys for children reporting to be
MDCD and FI. The Covid-19 pandemic began in Ireland and NI in early March 2020, at
which time additional wording was added to the surveys to request that respondents
completing cost questions did so from a pre-Covid perspective. This wording was
included to try to ensure that the pandemic (and possible associated changes in spending)
had minimum impact on the overall study.
A Facebook page called the ‘Food Hypersensitivity Study’ (and an associated TU Dublin
email address) were set-up to promote these surveys, distribute the link online, and serve
as a hub for respondent’s queries and questions. The survey link was forwarded to
stakeholders in Ireland and NI in order to circulate it widely. These stakeholders included
the Coeliac Society of Ireland, Gluten Free Ireland, Coeliac UK, Irish Allergy Support
Group, and Allergy Mums UK. The questionnaire was also promoted by Safefood on
their Facebook page and by intermittent paid advertising on Facebook. Similarly, the
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project team attended various public events to distribute (and collect) hard copies of the
surveys and circulate fliers to members of the public regarding this study. These events
included food hypersensitivity conferences, events, and meetings of associated support
groups (including a radio broadcast in January 2020) in Ireland and NI. No public events
were attended by the project team from March 2020 onwards, at which point all survey
promotion occurred online.

A total of 4,114 surveys were collected during this study (November 2019 to October
2020), as per Table 2.1a with 1,872 test surveys completed in Ireland (1,404 collected
from adults and 468 from parents (Table 2.1b). A corresponding set of 699 control
surveys (non-food hypersensitive) were collected in Ireland, from 557 adults and 142
parents. With regard to NI, a total of 1,129 test surveys were completed with 834
collected from adults and 295 from parents. In addition, 414 control surveys (non-food
hypersensitive) were collected in NI from 229 adults and 185 parents.
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Table 2.1a: Proposed study sample numbers and achieved study sample numbers in
a food hypersensitivity survey conducted between November 2019 and October 2020
in Ireland and NI

Cohorts to be examined

Original Proposed

Achieved

Survey

Survey Sample

Sample No.

Numbers

Children/Adolescents (< 18) reported as MDFA - Ireland

>125

258

Children/Adolescents (< 18) reported as MDFA - NI

>125

168

Total

>250

426

Adults ≥18) reported as MDFA – Ireland

>125

194

Adults (≥18) reported as MDFA - NI

>125

124

Total

>250

318

Children/Adolescents & Adults reported as MDCD - Ireland

>100

774

Children/Adolescents & Adults reported as MDCD - NI

>100

261

Total

>200

1,035

Children/Adolescents & Adults reported as FI - Ireland
Children/Adolescents & Adults reported as FI - NI
Total

This cohort was not
originally proposed for
inclusion

646
576
1,222

Control Group: Children/Adolescents - Ireland

>125

142

Control Group: Children/Adolescents - NI

>125

185

Total

>250

327

Control Group: Adults - Ireland

>125

557

Control Group: Adults - NI

>125

229

Total

>250

786

TOTAL

1,200

4,114

*MDFA: medically diagnosed food allergy, MDCD: medically diagnosed coeliac disease, FI: Food Intolerance or

Suspected/Undiagnosed food allergy.
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Table 2.1b: A detailed breakdown of the survey sample numbers of food
hypersensitive individuals (and parents thereof) collected between November 2019
and October 2020 in Ireland and NI (n=4,114)
Collected Survey Sample for Adults and Parental Surveys

N

Medically Diagnosed Food Allergy ADULT Surveys (MDFA) – Ireland

194

Medically Diagnosed Coeliac disease ADULT Surveys (MDCD) – Ireland

623

Food Intolerance & Suspected Food Allergies ADULT Surveys (FI), Ireland

587

ADULT Non-food hypersensitive controls, Ireland

557

Medically Diagnosed Food Allergy PARENTAL Surveys (MDFA) – Ireland

258

Medically Diagnosed Coeliac disease PARENTAL Surveys (MDCD) – Ireland

151

Food Intolerance & Suspected Food Allergies PARENTAL Surveys (FI),

59

PARENTAL Non-food hypersensitive controls, Ireland

142

Medically Diagnosed Food Allergy ADULT Surveys (MDFA) – NI

124

Medically Diagnosed Coeliac disease ADULT Surveys (MDCD) – NI

195

Food Intolerance & Suspected Food Allergies ADULT Surveys (FI) – NI

515

ADULT Non-food hypersensitive controls, NI

229

Medically Diagnosed Food Allergy PARENTAL Surveys (MDFA) – NI

168

Medically Diagnosed Coeliac disease PARENTAL Surveys (MDCD) – NI

66

Food Intolerance & Suspected Food Allergies PARENTAL Surveys (FI), NI

61

PARENTAL Non-food hypersensitive controls, NI

185

TOTAL

4,114

*MDFA: medically diagnosed food allergy, MDCD: medically diagnosed coeliac disease, FI: Food Intolerance or
Suspected/Undiagnosed food allergy.
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2.1.2 General analysis of the survey data
General analysis of the survey data was conducted on the 3,001 specific food
hypersensitive surveys collected during the course of this study. The findings of the
general analysis are presented in Chapter 3 of this report and also in Appendices 1-6.
These Appendices present specific information recorded on each survey group by
condition (MDFA, MDCD and FI) for Ireland and NI. Parental surveys and adult surveys
are also separated.

As the dataset collected is quite large, a highlights section

summarising the findings for each of the 6 survey groups has been included with the
associated figures and graphs in each of the relevant Appendices; as detailed in Table
2.1.2.

Table 2.1.2: Index of general analysis appendices, based on food hypersensitivity
survey data collected in Ireland and NI between November 2019 and October 2020
Food Hypersensitivity Survey Analysis
Appendix 1: MDFA Parental Surveys in Ireland and NI
Appendix 2: MDFA Adults Survey in Ireland and NI
Appendix 3: MDCD Parental Surveys in Ireland and NI
Appendix 4: MDCD Adults Survey in Ireland and NI
Appendix 5: FI Parental Survey in Ireland and NI
Appendix 6: FI Adults Survey in Ireland and NI
* MDFA: Medically Diagnosed Food Allergy, MDCD: Medically Diagnosed Coeliac disease, FI: Food Intolerances, Suspected, or
Non-Medically Diagnosed Food Allergy

2.1.3 Statistical analysis of the survey data
Statistical analysis was conducted on various findings of the study including differences
in gender. The statistical tests used include Pearson Chi-squared test, 2-sample t-test,
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Kruskal-Wallis rank sum test, and Pairwise Wilcoxon Rank Sum Tests with Benjamini
& Hochberg (1995) corrections for multiple testing.
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2.2 Calculation of Socio-Economic Costs associated with Food
Hypersensitivity on the Island of Ireland (Direct & Indirect Costs)
2.2.1. Summary of the calculation of direct & indirect costs
Socio-economic costs were calculated as either Direct or Indirect Costs (as per Table
2.2.1a) for i) adults (≥18 years) and ii) children and adolescents combined (<18 years)
for each food hypersensitivity examined (MDFA, MDCD and FI) in this study. Direct,
Indirect and total costs (direct and indirect) calculated based on the analysis of 4,114
surveys collected in Ireland and NI are reported in Chapter 3. Direct costs to the health
service associated with health care utilizations (e.g., visits to medical practitioners,
hospital stays) as well as costs incurred by the individual (e.g., travel costs, costs for
alternative therapies and medication costs) are detailed in Table 2.2.1a. Indirect costs
include loss of earnings associated with health care utilization, absences from
work/education and increases in the time spent food shopping. Non-medical out-ofpocket costs (borne by respondents) and healthcare costs (shared by respondents and the
health service) reported by food hypersensitive individuals and their families as a result
of their condition are detailed in Table 2.2.1b, and additional (incremental costs) are
presented in Table 4.1.2c and Table 4.2.2c.

The inclusion of surveys on cost analysis was based on the respondent completing
financial questions. If this information was incomplete or skipped, the survey was
removed from the overall dataset used for the analysis. The final number of surveys
which were viable for cost analysis was 3,731 as outlined in Table 2.2.2a. The costs
presented are the reported additional expenses incurred by food hypersensitive
individuals and their families as a result of their condition. No monetary value was
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calculated for intangible costs but the EQ-5D results, and an analysis of the QoL of those
affected (section 2.3.) are presented in Chapter 4.

Table 2.2.1a: Direct and indirect costs calculated for each food hypersensitivity
Direct Costs
Visits to GPs, Consultants/Specialists, Nurses, Nurses (Outpatient Clinic), Dieticians/Nutritionists,
Pharmacists, Physiotherapists, Other Health Professionals, Alternative Therapists
Travel costs associated with visits to GP, Consultant/Specialist, Nurses, Nurses (Outpatient Clinic),
Dieticians/Nutritionists, Pharmacists, Physiotherapists, Other Health Professionals, Alternative
Therapists
Outpatient attendance: Day unit
Emergency department attendance with or without subsequent admission to a ward
Ambulance (A&E); Ambulance (Hospital Admission)
Prescribed medicines; Over-the-counter medicines
Private Health Insurance
Food Cost
Indirect Costs
Time spent food shopping and preparing food
Days missed from Work/School/College
Lost Earning associated with healthcare visits
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Table 2.2.1b: Healthcare and out-of-pocket costs for each food hypersensitivity
Healthcare Costs* (incurred by respondents & the health service)
Visits to GPs, Consultants/Specialists, Nurses, Nurses (Outpatient Clinic), Dieticians/Nutritionists,
Pharmacists, Physiotherapists, Other Health Professionals
Outpatient attendance: Day unit
Emergency department attendance with or without subsequent admission to a ward
Ambulance (A&E); Ambulance (Hospital Admission)
Total prescribed medicines
Out-of-Pocket Costs** (incurred by respondents alone)
Visits to Other Alternative Therapists
Over-the-counter medicines
Private Health Insurance
Food Cost*
Travel costs associated with visits to GP, Consultant/Specialist, Nurses, Nurses (Outpatient Clinic),
Dieticians/Nutritionists, Pharmacists, Physiotherapists, Other Health Professionals, Alternative
Therapists
Time spent food shopping and preparing food
Days missed from Work/School/College
Lost Earning associated with healthcare visits
* A tax rebate for gluten free foods is available for MDCD individuals in Ireland. Respondents were asked if they claimed this taxrebate, and it was deducted from the overall cost to the respondent when reported (29% MDCD adults and 30% for MDCD
child/adolescents) to give an accurate reflection of food costs incurred as a result of this condition. However, the cost prior to this
deduction is also included in the text. In addition, certain gluten free foods are available on prescription in NI, these were not
captured as part of this study.

2.2.2 Detailed explanation of the calculation of direct & indirect costs
There is no common uniform database that covers unit costs in Ireland. Consequently,
information on unit costs comes from a variety of Irish data sources. Where necessary,
unit cost data obtained prior to 2019 were adjusted using an appropriate inflation index
(Central Statistics Office (CSO), 2020) to reflect costs for 2019. Labour costs were
calculated using consolidated salary scales available from the Health Service Executive
(HSE, 2019) for public-sector employees, with associated non-pay costs estimated
according to the methods outlined by the Health Information and Quality Authority
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(HIQA, 2019). Day unit and hospital admission costs were sourced from the HIPE dataset
(HIPE, 2018). GP and consultant visits, outpatient attendance, accident and emergency
and ambulance costs were sourced from previous Irish publications and were updated to
2019 figures (Connolly et al., 2014; Brick et al., 2015, Gannon et al., 2006).

Unit costs for NI were based on the 2018/2019 financial year. Staff costs, outpatient
attendance, day unit visits and hospital admission costs were obtained from Health
Resource Groups (HRG) unit cost schedules for 2018/2019 which can be found on the
Northern Ireland Department of Health website. An average for NI based on these was
used in this analysis. The average cost per GP visit was provided by the Information &
Analysis Directorate, Department of Health, Northern Ireland. In the absence of NI
specific data, the cost of an ambulance journey, consultant visit and the average cost per
hour of a pharmacist were sourced from Personal Social Services Research Unit data
(PSSRU, 2019) in England. Accident and emergency and minor injury unit attendance
costs were sourced from England NHS Reference Costs (NHS Reference Costs, 2019).

The survey elicited respondents use of health services, visits to alternative therapists, use
of prescribed and over-the-counter medications, their cost of living and their quality of
life as measured by the EQ5D-3L (The EuroQOL group, 1990). Medications were costed
based on information from the British National Formulary (https://bnf.nice.org.uk/) after
converting it to Euro.

The reported annual household medical insurance policy cost was divided by the
household size to obtain the cost per person. For the valuation of travel costs in both
Ireland and NI, a car was the assumed mode of transport, the methodology used was
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similar to Hanly et al., (2013) whereby the number of miles/kilometres travelled were
multiplied by the average cost per mile/kilometre for the year (Hanly et al., 2013; AA,
2019; HM Revenue and Customs, 2019).

The reported annual cost of gluten-free products was adjusted to account for any taxrelief claimed when reported by respondents. The annual cost for food shopping was
calculated based on respondents' reported weekly figures. Loss of earnings associated
with outpatient, day unit, emergency department and hospital admissions were directly
elicited from respondents. Time costs associated with shopping and preparation of food
and absences from work/college were valued, based on the national minimum wage in
2019 (€9.80 for Ireland (www.gov.ie) and £8.21 for NI (www.gov.uk).

The analysis considered respondents for whom complete information for the costing was
available: 2,361 and 1,370 individuals for Ireland and NI, respectively. Of these, 1,854
and 947 respectively were adults, in Ireland and NI respectively, while less responses
were obtained for the parental surveys with 507 and 423, respectively. The respondents
tended to be female (Table 2.2.2a), particularly in the MDFA group where the ration of
female:male responses was 167:15 in Ireland and 103:8 in NI. In the parental surveys,
the responses for adolescents (13 to 17 years) were less frequent than for children (0 to
12 years).
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Table 2.2.2a: Sample size for each group by jurisdiction used in the calculation of
direct and indirect costs for food hypersensitivity in Ireland and NI, based on
reported data from a survey run between November 2019 and October 2020
(n=3,731)
ADULTS
Control Adults

Ireland

NI

PARENTAL

Ireland

NI

531

204

Control
Parents

130

165

101

108

29

57

MDFA
Parental

173

147

8

MDFA Parental
- Aged 0 - 12
years

147

128

103

MDFA Parental
- Aged 13 - 17

26

19

173

MDCD
Parental

148

60

20

MDCD Parental
- Aged 0 -12

104

40

44

20

Control Parental
Aged 0 - 12

Control Adult - Male

70

23

Control Adult - Female

461

181

MDFA Adults

MDFA Adults - Male

MDFA Adults - Female
MDCD Adults
MDCD Adults - Male

178

15

163
609
110

111

Control Parental
Aged 13 -17

MDCD Adults - Female

499

153

MDCD Parental
- Aged 13 -17

FI Adults

536

459

FI Parental

56

51

32

MDFA Parental
- Aged 0 -12

44

37

488

426

MDFA Parental
- Aged 13 -17

12

14

1,854

947

TOTAL

507

423

FI Adults - Male

FI Adults -Female
TOTAL

48

*MDFA: medically diagnosed food allergy, MDCD: medically diagnosed coeliac disease, FI: Food Intolerance or
Suspected/Undiagnosed food allergy.
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Tables 2.2.2b. summarises the characteristics of the groups considered for Ireland. In the
adult sample, respondents with FI or MDFA tended to be younger than those in the
control or MDCD groups and were more likely to be female. Respondents in the control
group were less likely to report suffering from other long-term illnesses, health problems
or disabilities which limited daily activities. For the parental responses, we find that
responses for the MDFA and FI group tended to be younger than in the other groups. It
is also notable that the responses in the parental groups are more likely to be male than
in the corresponding adult groups. We again find that other long-term illnesses are less
prevalent in the control group than in the other groups.
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Table 2.2.2b: Characteristic of each group for Ireland used in the calculation of
direct and indirect costs for food hypersensitivity in Ireland, based on reported data
from a survey run between November 2019 and October 2020 (n=2,361)
Ireland
Average
Age (years)
Percentage
of Females
Average no.
of males
aged 18+
Average no.
of females
aged 18+
Average no.
of males
aged 13-17
Average no.
of females
aged 13-17
Average no.
of males
aged 0-12
Average no.
of females
aged 0-12
Percentage
with other
long-term
illness
Percentage
of Urban
Sample Size

Control
Adults

MDFA
Adults

MDCD
Adults

FI
Adults

Control
Parental

MDFA
Parental

MDCD
Parental

FI
Parental

41.45

31.20

47.28

32.08

8.35

7.00

9.99

7.50

87%

92%

82%

91%

55%

43%

63%

59%

1.12

1.09

1.03

1.13

0.98

0.95

1.11

1.07

1.35

1.75

1.30

1.70

1.13

1.07

1.16

1.25

0.14

0.12

0.11

0.11

0.12

0.14

0.30

0.11

0.19

0.19

0.13

0.12

0.18

0.19

0.37

0.21

0.48

0.13

0.24

0.18

0.96

0.95

0.65

0.73

0.48

0.24

0.23

0.13

0.91

0.80

0.91

0.79

10%

33%

34%

26%

5%

29%

25%

23%

47%

53%

45%

49%

45%

46%

41%

46%

531

178

609

536

130

173

148

56

MDFA: medically diagnosed food allergy, MDCD: medically diagnosed coeliac disease, FI: Food Intolerance or
Suspected/Undiagnosed food allergy
* ‘Other long-term illness’ and ‘Urban’ are based on the average of all responses with Yes =1 and No=0
** For each group, these show the mean for continuous variables (e.g., Age or number of male/female individuals in
each age group) of proportions for binary variables (e.g., Female, long-term illness and Urban)

Similarly, Table 2.2.c summarises the characteristics of the groups considered for NI
Among the adults, the age and gender pattern across groups was similar to that in Ireland,
although the control pool tended to be older than in Ireland and MDCD respondents
tended to be younger. In the parental survey, MDCD respondents tended to be the oldest
group, with the MDFA group the youngest group.
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The gender breakdowns were

relatively similar to those in Ireland. The rate of other long-term illnesses was higher
among the control pools (adult and parental) in NI than was the case for Ireland but the
rates in the other groups were quite similar between the jurisdictions, with the exception
of MDCD where respondents in NI were less likely to report suffering from other
illnesses.
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Table 2.2.2c: Characteristic of each group for Northern Ireland used in the
calculation of direct and indirect costs for food hypersensitivity in NI, based on
reported data from a survey run between November 2019 and October 2020
(n=1,370)
Northern
Ireland
Average Age
(years)
Percentage of
Females
Average no. of
males aged 18+
Average no. of
females aged
18+
Average no. of
males aged 1317
Averange no.
of females aged
13-17
Average no. of
males aged 012
Average no. of
females aged 012
Percentage
with
other
long-term
illness
Percentage of
Urban
Sample size

Control
Adults

MDFA
Adults

MDCD
Adults

FI
Adults

Control
Parental

MDFA
Parental

MDCD
Parental

FI
Parental

47.04

32.09

40.91

34.71

9.79

6.29

10.85

8.37

89%

93%

88%

93%

51%

44%

65%

53%

1.01

1.04

0.96

1.02

0.87

0.87

0.88

0.94

1.32

1.57

1.35

1.46

1.08

1.10

1.10

1.06

0.09

0.11

0.16

0.12

0.18

0.16

0.37

0.29

0.10

0.13

0.11

0.09

0.29

0.15

0.35

0.35

0.19

0.21

0.24

0.21

0.91

0.97

0.60

0.80

0.18

0.16

0.30

0.25

0.79

0.83

1.02

0.92

24%

32%

34%

30%

10%

21%

12%

20%

39%

43%

46%

46%

42%

42%

20%

41%

204

111

173

459

165

147

60

51

MDFA: medically diagnosed food allergy, MDCD: medically diagnosed coeliac disease, FI: Food Intolerance or
Suspected/Undiagnosed food allergy
* ‘Other long-term illness’ and ‘Urban’ are based on the average of all responses with Yes =1 and No=0
** For each group, these show the mean for continuous variables (e.g., Age or number of male/female individuals in
each age group) of proportions for binary variables (e.g., Female, long-term illness and Urban)
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2.2.3 Survey Selection for Costs Analysis and Data Cleaning
A total of 3,001 food hypersensitivity surveys and 1,113 control surveys were completed
during the course of this study (n=4,114). While data from all surveys were useable in
the general analysis section i.e., type of food hypersensitivity, associated foods etc.,
certain pertinent questions required responses for costs analysis. Careful examination of
each survey led to the selection of all suitable surveys for monetary cost calculations;
where these questions had not been omitted/skipped over. This reduced the overall
number of surveys that could be used in the calculation of direct and indirect costs by
condition for this study task.

Further examination of this cohort by the project team (including medics), led to the
removal of 3 outliers (3 additional surveys) from the overall cost analysis presented in
this report. These three respondents reported 40, 70 and 77 days in hospital in the last 12
months (at €904 per night in Ireland and £597/€663 in NI, HIPE, 2018; DoH (NI) Trust
Reference Costs 2018/2019). However, they reported no previous adverse reaction to
food e.g., anaphylaxis during this timeframe.

In addition, all three reported co-

morbidities (long-term illness not specified) and being on disability allowance. However,
tables with the inclusion of these 3 outliers are available to view in Appendix 7 (Table
7.A.5 & Table 7.A.7)

After careful examination a total of 2,701 food hypersensitivity questionnaires and 1,030
control surveys were deemed to be suitable for the calculation of direct and indirect costs
by condition (n=3,731) in this study – as per table 2.2.2a.
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2.2.4 Statistical analysis of direct, indirect and total costs
A linear regression model is estimated with the cost of interest as the dependent variable
(Y) and an indicator (D) for whether the individual is in the treated group (D=1) or the
control (D=0). The coefficient on this indicator represents the difference in mean costs
between the groups. By weighting the data using Entropy Balancing weights, we ensure
that the groups are comparable in terms of their characteristics. The coefficient therefore
represents the incremental cost for the treated group relative to the cost for a comparable
group of the controls. We also include the covariates in the regression models to account
for any residual confounding not controlled for by the entropy balancing. The standard
error and confidence interval can be recovered from the regression output and capture the
uncertainty of the incremental costs.
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2.3. Calculation of the Socio-Economic Cost of Food Hypersensitivity on
the Island of Ireland - Intangible costs and effect on QoL
The non-monetary cost was calculated when examining intangible costs or the effects of
food hypersensitivity on the QoL of food hypersensitive individuals and their families.
These aspects were examined by integrating the standard EQ-5D questionnaire in all
surveys. In addition, a specific food hypersensitivity question (designed as part of this
study) to examine the areas of life affected by MDFA, MDCD and FI, was included in
all surveys.

2.3.1. EQ-5D: standardised health-related quality of life questionnaire
Background to the EQ-5D
EQ-5D is a standardised health-related quality of life questionnaire developed by the
EuroQol Group, designed for self-completion by respondents. The EuroQol Group is a
network of international multidisciplinary researchers from Europe, North America,
Asia, Africa, Australia, and New Zealand (www.euroqol.org). EQ-5D consists of the
EQ-5D descriptive system that measures health-related quality of life and the EQ VAS
(a self-rating of overall health-related quality of life). EQ-5D is widely used in clinical
trials, observational studies, and other health surveys. This questionnaire is applicable to
a wide range of health conditions and treatments. It provides a simple descriptive profile
and a single index value for health status that can be used in the clinical and economic
evaluation of health care as well as in population health surveys.
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EQ-5D use in this food hypersensitivity survey study
Permission was sought and received from the EuroQol Group to include EQ-5D-3L for
adults (≥18 years) and EQ-5D-Y proxy version 1 for completion by parents of children
and adolescents in these surveys.

EQ-5D-3L for adults (≥18 years)
The EQ-5D descriptive system is comprised of 5 dimensions: mobility, self-care, usual
activities, pain/discomfort and anxiety/depression. Each dimension has 3 reporting
levels: no problems, some problems, or severe problems (Figure 2.3.1a). The respondents
were asked to indicate their health status by ticking the box against the most appropriate
statement in each of the 5 dimensions. A single index value of the health status for each
of the different food hypersensitive groups was calculated (as per EuroQol Group, 1990
and 2004) as well as an EQ VAS.
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Image Source: https://euroqol.org/wp-content/uploads/2016/10/Measuring_Self-Reported_Population_Health__An_International_Perspective_based_on_EQ-5D.pdf

Figure 2.3.1a: EQ-5D-3L for adults (≥18 years), as included in all food
hypersensitive and control surveys in this study
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The EQ VAS records the respondents self-rated health on a vertical, 20 cm visual
analogue scale where the endpoints are labelled ‘Best imaginable health state’ and ‘Worst
imaginable health state’ (Figure 2.3.1b). This information can be used as a quanlitative
measure of health outcome as judged by the individual respondents. In summary, the
following three parameters were examined from our survey results:

(i) Each of the 5 dimensions for each of the different food hypersensitive adult
groups (MDFA, MDCD, and FI) were compared against their control
counterparts.
(ii) A single index value of the health status was calculated for each of the different
food hypersensitive adult groups and their control counterparts, based on the
responses from participants on the 5 dimensions.
(iii) A self-rated health-related quality of life (EQ VAS) score was calculated for
each of the different food hypersensitive groups and the control group based on
adult participants rating of health status between 0 and 100.

EQ-5D-Y proxy version 1 (<18 years)
The EQ-5D-Y proxy version 1 was completed by parents of food hypersensitive children
(0-12 years) and adolescents (13-17 years) in the same way as EQ-5D-3L for adults (≥18
years). The proxy rating involved the respondents (parents) rating the health of their
child/adolescent. Results were reported for the same three parameters as for the EQ VAS
scoring.

121

2.3.2 Food hypersensitivity study question
In preparation for the release of the surveys to determine the socio-economic cost of food
hypersensitivity on the IoI, a question was prepared to highlight the key areas of life
affected by food hypersensitivity. This question was designed with the assistance of food
hypersensitive individuals and with reference to the literature. The areas of life selected
were amended and added too following the pilot study in which draft questionnaires were
completed by 104 individuals. The final question consisted of 25 options by which the
respondent could tick the areas affected within their life, or that of their child/adolescent,
as a result of their food hypersensitivity. The options included the following: cost, time,
the ability to eat out, social life, travel life, relationships, household tasks, social
activities/interactions, sports, public transport, childcare, their choice of job, and their
choice of school. The areas of life affected, as reported by the 4,114 main survey
respondents, are detailed by condition, jurisdiction (Ireland and NI) and status (whether
they completed the questionnaire as a food hypersensitive adult or as a parent of a food
hypersensitive child/adolescent).
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Image Source: https://euroqol.org/wp-content/uploads/2016/10/Measuring_Self-Reported_Population_Health__An_International_Perspective_based_on_EQ-5D.pdf

Figure 2.3.1b: Self-rated health-related quality of life (EQ VAS) as included in all
food hypersensitive and control surveys in this study
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2.3.3 Statistical analysis of EQ-5D
The following tests were used for statistical analysis of the EQ-5D data:

(i) 2-sample t-test

(ii) Kruskal-Wallis rank sum test was performed to test whether there was a difference in
the medians (location parameters) of the distributions of reported health status between
the Control, MDFA, MDCD and FI groups for children, adolescents and adults.

(iii) Pairwise Wilcoxon Rank Sum Tests with Benjamini & Hochberg (1995) corrections
for multiple testing were carried out to test for differences in reported health status
between controls and MDFA, MDCD and FI children, adolescents, and adults. Notably,
statistical analysis for self-reported and parent-reported health status was completed for
respondents who have no other health problems in addition to food hypersensitivity.
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2.4. Completion of Priority Setting Interviews of Individuals reporting
to be MDFA or MDCD (and parents thereof) in Ireland and NI
2.4.1 Priority setting interview study design
Food hypersensitivity surveys were completed by 744 MDFA and 1,035 MDCD adults
and parents as detailed in Chapter 2. Based on the findings of these surveys, including
feedback collected and reviewed from open questions requesting additional information
and opinion in the associated surveys, eight areas of concern were reported. Similar
feedback was recorded by MDFA and MDCD adults and parents allowing the same
headings to be used for the further examination of both affected groups (points 1 to 7),
with the exception of point No. 8 (on adrenaline autoinjector availability).

1. Awareness and training regarding food allergy/coeliac disease in an educational
setting
2. Public & food industry awareness and understanding of food allergy/coeliac
disease
3. Cost and availability of medication & supplements to treat food allergy/coeliac
disease
4. Accessing medical teams e.g., consultants, specialist nurses etc. to treat food
allergy/coeliac disease
5. Dietetic support for food allergy/coeliac disease
6. Counselling/psychological services for food hypersensitive individuals and their
families
7. Recognition of food allergy/coeliac disease as a ‘disability’
8. Adrenaline autoinjectors to be made available in all public spaces in case of
emergency (similar to automated external defibrillators, AED)
125

An interview plan was formulated to investigate perceived challenges or key issues for
food hypersensitive individuals, and also proposed solutions with regard to these
headings - with point 8 only under consideration by MDFA adults and parents. Priority
Setting Interviews were selected as a precise mechanism for ranking and comparing
feedback of the test groups based on similar studies reported in the literature (Aldiss et
al. 2019; Ghisoni, 2017; Jones, 2015; Wilson et al. 2009). A target schedule was proposed
which focused on arranging an equivalent number of interviews for MDFA and MDCD
individuals in Ireland and NI, with representation from both food hypersensitive adults
and parents of food hypersensitive children/adolescents (as per Table 2.4.2). This would
allow future comparisons between both jurisdictions, conditions (MDFA and MDCD),
and age groups (adult/parents). An ethical approval application was prepared and
completed prior to commencing phone interviews. This ethical application was approved
by the ethics committees of TU Dublin and QUB.
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Table 2.4.2: Priority Setting Interviews Sampling Plan based on Condition (MDFA
or MDCD) and Age Category (Adult or Parent of child/adolescent) in Ireland and
NI, conducted between August 2020 and November 2020
Priority Setting Interviews

Target
Interviews

Completed
Interviews

Target
Interviews

Ireland

Completed
Interviews
NI

Adults reporting to be MDFA

10

10

10

10

Adults reporting to be MDCD

10

10

10

10

Parents of children/adolescents
reporting to be MDFA

10

10

10

10

Parents of children/adolescents
reporting to be MDCD

5-10

10

5-10

6

TOTAL

35-40

40

35-40

36

2.4.2 Priority setting interview completion
Participants were invited to take part in the priority setting interviews by means of paid
advertisements on Facebook. Respondents were emailed a participant information leaflet
and a consent form to be completed prior to interview (Appendix 8). Each priority setting
interview lasted approximately 30 minutes and all researchers involved in the field work
(n=3) received prior interview training. All interviewers completed a survey-style
questionnaire (semi-structured interview) to record details of the discussion throughout
the phone call. More details in Appendix 8. The interviewees answers were transcribed
for future reference, but the interviews were not recorded. Moreover, this survey focused
on i) key issues and ii) possible solutions with regard to the associated 7/8 areas of
concern.

Post interview, participants were requested to complete a short online

anonymous survey which included ranking the topics discussed from most important to
least important (Appendix 8).
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A total of the 76 phone interviews - 40 in Ireland and 36 in NI - were completed (Table
2.4.3) between July and December 2020. All interviewees were adults (18 years of age
and above) and reported to have MDFA or MDCD themselves or be a parent of a
child/adolescent (<18 years) with either condition. All participants reported to be resident
in Ireland or NI at the time of interview. All recorded data was anonymised and
participants received a gratuity for their assistance with this project task.
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Table 2.4.3: Priority setting interviews sampling plan based on condition (MDFA or
MDCD) and age category (adult or parent of child/adolescent reporting to have
either condition) in Ireland and NI, conducted between August 2020 and November
2020
Priority Setting Interviews conducted
Age Profile & Gender Information
in Ireland & NI

Adults reporting to be MDFA – Ireland

Ten adults from Ireland participated in this interview
process. All participants were females, with 70% (n=7) of
these females aged between 21-29 and 30% (n=3) aged
between 30-39 years.

Adults reporting to be MDFA – NI

Ten adults from NI participated in this interview process. All
participants were females with 50% (n=5) aged between 2129 and 50% (n=5) aged between 30-39 years.

Adults reporting to be MDCD – Ireland

Ten adults from Ireland participated in this interview
process. Seventy percent (n=7) of participants were female
and 30% (n=3) were male. The age profile was as follows:
21-29 years (30%, n=3), 30-39 years (20%, n=2), 40-49
(20%, n=2), 50-59 (20%, n=2), 60+ (10%, n=1).

Adults reporting to be MDCD – NI

Ten adults were interviewed from NI: 80% were female
(n=8) and 20% male (n=2). The age profile was as follows:
21-29 years (10%, n=1), 30-39 years (30%, n=3), 40-49
(20%, n=2), 50-59 (20%, n=2), 60+ (20%, n=2).

Parents of children/adolescents
reporting to be MDFA – Ireland

Ten parents of children/adolescents (7 female and 3 male,
≤17 years) from Ireland reporting to have MDFA
children/adolescents were interviewed. Twenty percent
(n=2) of children were between 0-5 years, 60% (n=6)
between 6-12 years, and 20% (n=2) were adolescents
between 13-17 years.

Parents of children/adolescents
reporting to be MDFA- NI

Ten parents of children/adolescents (7 female and 3 male,
≤17 years) from NI reporting to have MDFA children were
interviewed. Sixty percent (n=6) of these children were
between 0-5 years, 20% (n=2) between 6-12 years, and 20%
were adolescents (n=2) between 13-17 years.

Parents of children/adolescents
reporting to be MDCD – Ireland

Ten parents (8 female and 2 male, <18 years) from Ireland
reporting to have MDCD children/adolescents were
interviewed. Forty percent (n=4) of these children were
between 6-12 years of age and 60% (n=6) were adolescents
between 13-17 years.

Parents of children/adolescents
reporting to be MDCD – NI

Six parents from Ireland reporting to have MDCD
children/adolescents (4 female and 2 male, <18 years) were
interviewed. Eighty three percent (n=5) of these children
were between 6-12 years and 17% (n=1) were adolescents
between 13-17 years.

*MDFA: medically diagnosed food allergy, MDCD: medically diagnosed coeliac disease
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2.4.3. Priority setting interview results overview with regard to gender and age
A target of 10 interviews was agreed for each target group listed in Table 2.1.2. However
an exception of 5-10 interviews was set for parents of children reporting to have MDCD
(10 achieved in Ireland and 6 in NI); as this cohort was the most difficult to locate. A
breakdown by gender revealed that 35 females (88%) and 5 males (12%) completed the
priority setting interviews for the ‘adults’ group. There were 26 females (72%) and 10
male children (28%) represented in the parental MDFA and MDCD interviews (Figure
2.4.3).

Figure 2.4.3: Breakdown of the number of adult participant or children/adolescents
(parental interview) reported as having MDFA or MDCD by gender, who completed
the priority setting phone interviews conducted between August 2020 and
November 2020 (n=76)
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2.5 Collection and Examination of Datasets in Public and Private
Institutions
This task targeted existing databases of information on food hypersensitivity in Early
Years Service (EYS) providers childcare facilities, primary and secondary schools, and
nursing homes. Surveys were sent via email to target institutions in Ireland and NI.
These questionnaires were designed to collect information on i) gender, ii) age range, and
iii) associated trigger foods (where applicable) of hypersensitive children and elderly
adults. Additional information on carrying an adrenaline autoinjector, or having
experienced previous adverse reactions to food on-site, was requested. Notably these
surveys sought information on all of the individuals in attendance at, or residing within,
these institutions/facilities i.e., one completed survey could contain relevant information
on several hundred individuals.
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2.5.1. Survey of Early Year Services (EYS) Providers in Ireland and NI
There are approximately 1,300 EYS providers in Ireland. The contacts details of
registered EYS are provided by Tusla on their website by county, and 800 of these
facilities were contacted at random across all counties in Ireland3. In total, 95 nurseries
and 480 pre-schools are registered with the Department of Education in NI4. A random
sample of 342 were contacted and were also requested to complete the food
hypersensitivity survey with anonymous information on attendees in their services.
•
•

3
4

https://www.tusla.ie/services/preschool-services/list-of-pre-school-services-bycounty/
http://apps.education-ni.gov.uk/appinstitutes/default.aspx

https://www.education.ie/en/Publications/Statistics/Data-on-Individual-Schools/
http://apps.education-ni.gov.uk/appinstitutes/default.aspx
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2.5.2. Survey of primary & secondary school in Ireland and NI
There are currently a total of 3,926 schools under the remit of the Department of
Education and Skills in Ireland. They consist of 3,106 primary schools, 134 special
schools and 722 post-primary schools. With the exception of nursery and pre-school
facilities, there are 983 schools under the remit of the Department of Education in NI.
These consist of 801 primary schools, 40 special schools, 130 secondary schools, and 12
preparatory schools.

Twenty schools (10 primary and 10 secondary) were randomly selected from every
county in Ireland and NI. However, for the more heavily populated counties such Dublin,
Cork, Galway, Limerick, and Antrim, up to 40 schools were targeted (20 primary and 20
secondary). In total 600 schools were contacted in Ireland, and 136 schools in NI via
email; and were requested to provide anonymous food hypersensitivity information on
all of the pupils attending their facilities. Contacted schools and their details were found
via the Department of Education and Skills website for Ireland, and for the Department
of Education website for NI.
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2.5.3. Survey of nursing homes in Ireland and NI
According to Nursing homes Ireland (NHI), there are over 400 nursing homes in Ireland
providing care for over 25,000 people. All the 432 organisations listed on the NHI
website in 2019 were contacted via email regarding completion of the food
hypersensitivity study5. The number of nursing home facilities in NI could not be
confirmed, however an online directory (carehome.co.uk) of nursing homes in NI was
used to find contact details for this study6. A total of 212 nursing homes were contacted
in NI using this website. All of these facilities were requested to provide anonymous
food hypersensitivity information on their residents.

2.5.4. Collection of food hypersensitivity surveys from public and private
institutions
A follow-up (reminder) email was sent to EYS, Schools and Nursing Homes
approximately one month after the initial questionnaire email. Many surveys were
completed with regard to the specific number of individuals in each organisation with a
food hypersensitivity, but not all respondents gave further details regarding trigger foods
or the carriage of adrenaline autoinjectors etc., as requested. Response rates and their
breakdown per county are provided for EYS, Schools and Nursing Homes.

The

percentage of reported food hypersensitivities (FA, CD and FI) are presented in Tables
6.1.1a, 6.2.1 and 6.3.1. Where possible, information regarding gender is included for this

5
6

https://nhi.ie/find-a-nursing-home/
https://www.carehome.co.uk
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data.

Information on associated trigger foods and adrenaline autoinjectors is also

included if reported, as were records of any previous incidences of adverse reactions to
food on-site. The total number of organisations who participated in this survey was 214
and the total number of individuals represented was 14,889 throughout the IoI. It is worth
noting that schools (particularly secondary) were less likely than nursing homes and EYS
providers to have a record of a mild food hypersensitivity, particularly when food is not
always provided on-site.
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2.5.5. Examination of food hypersensitivity datasets on the island of Ireland
During the course of this study, databases were sought with information on food
hypersensitivity for the IoI. The percentages of reported food hypersensitivity, the
breakdown by age and gender, and the associated trigger foods (where available) are
reported.

Statistical analysis conducted on the food hypersensitivity datasets included:
•

Growing up in Ireland studies were statistically analysed by the 2-sample test for
equality of proportions with continuity correction

•

HIPE 2 data was statistically analysed by Pearson Chi-squared test

A summary of the databases reviewed are as follows and are presented in Chapter 6,
Section 6.5:

6.5.1 Self-reported food hypersensitivity data from registered students (19,929
students) attending TU Dublin (2018-2019): This dataset includes the self-reported
food hypersensitivity data (often including the trigger food) by gender for 19,929 students
registered in the academic year 2018/2019

6.5.2 The Growing up in Ireland study from the Economic & Social Research
Institute (ERSI): This includes the percentage of reported food hypersensitivity on a
cohort of 11,134 infants when they are 9 months old, 3 years old (n=9,783) and 5 years
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old, between 2008-20137. The gender of each of the food hypersensitive cohorts (wave
1, 2, and 3) is also examined.

6.5.3 Central Statistics Office (CSO) survey for 5,348 secondary school students
from 155 secondary schools (2015): This includes the breakdown of specific food
allergies within this cohort8.

6.5.4 Dining out: The challenge for those with a Food Allergy or Food Intolerance
in the Republic of Ireland and Northern Ireland (2013): This includes information of
trigger foods associated with food hypersensitivity for 241 individuals in Ireland and 111
in NI9,10.

Available at the following links:

https://www.safefood.net/getmedia/62903d02-8532-4659-a7e6-59ba365ec00f/Finalreport-Ireland-Jan2015.aspx?ext=.pdf

https://www.safefood.net/getmedia/3f1e9d08-a448-47c9-bfbb-0305513ef6b7/Finalreport-NI-Jan2015.aspx?ext=.pdf

7

https://www.growingup.ie/about-growing-up-in-ireland/
www.censusatschool.ie
9
https://www.safefood.net/getmedia/62903d02-8532-4659-a7e6-59ba365ec00f/Final-report-ROIJan2015.aspx?ext=.pdf
10
https://www.safefood.net/getmedia/3f1e9d08-a448-47c9-bfbb-0305513ef6b7/Final-report-NIJan2015.aspx?ext=.pdf
8
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6.5.5 FSAI Food Allergy Survey (2011): The FSAI conducted an online food allergy
and intolerance survey in Ireland (n=509) as part of their Monitoring & Surveillance
Series Food Allergens & Labelling Survey”, Dublin, Ireland. Associated food allergens
are reported. Available at:

https://www.fsai.ie/resources_publications/allergen_labelling_2011.html.html

6.5.6a Irish Hospital Inpatients Enquiry (HIPE 1) data for Ireland: Information on
the predominant food associated with food anaphylaxis between 1995 to 2004.

6.5.6b Irish Hospital Inpatients Enquiry (HIPE 2) data for Ireland: HIPE 2 is a
dataset of the number of individuals discharged from hospital as a result of food
anaphylaxis (principal diagnosis) between 2008 and 2018. Figures on hospital discharge
numbers, associated age categories and gender are reviewed.

6.5.7 Data from a study on the Incidence and Prevalence of Coeliac disease in the
UK (per Region) Over Two Decades (1990-2011): Population-Based Study: This
study provides information on the prevalence of coeliac disease (per 100,000 population)
in NI, England, Scotland & Wales in 2011. This data is also examined with regard to
gender and age of individuals diagnosed with coeliac disease11.

6.5.8 Coeliac Society of Ireland Dataset of 2,899 individuals reporting to have
medically diagnosed coeliac disease in 2019: The Coeliac Society of Ireland 2019
dataset includes information on 2,899 members (by gender) reported to be medically

11

https://journals.lww.com/ajg/Fulltext/2014/05000/Incidence_and_Prevalence_of_Celiac_Disease_and.22.aspx
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diagnosed with coeliac disease. This information was also available by age category:
infants and young children (0 to 3 years), children (4 to 12 years), adolescents (13 to 17
years), adults (18 to 64 years) and adults (>65 years).
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2.6. Prevalence Rates for MDFA and MDCD reported in the Literature
An internet search was conducted to find reported prevalence values for MDFA and
MDCD in the published literature and from known institutions.

This review was

conducted on PubMed, Science Direct, Wiley Online Library and Google Scholar.
Tables 6.6a to 6.6i were prepared giving consideration to previous published prevalence
figures by EAACI in 2014. A total of 130 peer-reviewed papers were included ranging
from 1973 to 2021, as well as data reported by 26 institutions on food hypersensitivity.
The prevalence values for MFDA in children/adolescents are outlined in Table 6.6a, with
data for peanuts, eggs, and milk allergy presented in Table 6.6b, and data for other food
groups in Table 6.6c. The food allergy prevalence values for children/adolescents and
adults (where all ages were reported together) are included in Table 6.6d, food allergy
prevalence values for adults only in Table 6.6e, and food allergy in adults by different
food groups in Table 6.6f.

In addition, to peer-reviewed papers, prevalence data for children, adolescents and adults
from food allergy studies reported by certain worldwide institutions are presented in
Tables 6.6g to 6.6h. The prevalence values reported for coeliac disease in children,
adolescents, and adults from peer-reviewed papers and certain institutions are presented
in Table 6.6i.
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Chapter 3: Results for the General Analysis of Food Hypersensitivity
Survey Data
Six food hypersensitivity surveys targeting (a) adults and (b) parents of children with:
•

medically diagnosed food allergy (MDFA),

•

medically diagnosed coeliac disease (MDCD) and

•

food intolerance and suspected/diagnosed food allergy (FI),

were released in Ireland and NI in November 2019 and ran until October 2020. A total
of 3,001 specific food hypersensitive surveys were collected during the course of this
study, and an additional 1,013 surveys from non-food hypersensitive controls (total
n=4,114). More detailed information on these specific surveys per cohort is available in
Table 2.1b.

A large amount of data was gathered from each of the surveys. A detailed breakdown of
this data is available in Appendices 1-6. A summary of each of the six datasets is
presented in this chapter as well as a review of some of the key findings with regard to
trigger foods, age and gender.
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3.1 Summary information on children & adolescents with MDFA from
parental surveys conducted in Ireland and Northern Ireland
3.1.1a. Summary of the Medically Diagnosed Food Allergy (MDFA) parental survey
in Ireland
This group consisted of the responses from 258 parents of children and adolescents
reported as having MDFA in a parental survey in Ireland. The overall gender breakdown
was 57% (n=148) male parents and 43% (n=110) female parents. Forty-three percent
(n=111) of children were reported to be in the < 5 years of age category (28% males &
15% females), and 84% (n=218) were reported to be < 12 years (50% males & 34%
females). The remaining 16% (n=40) were adolescents aged between 13-17 years (7%
males & 8% females) (Figure 3.1.1a).

All of the children and adolescents in this study were required to have been medically
diagnosed with a food allergy by at least one of the HSE/NHS recognised diagnostic test
methods by a recognised healthcare professional: 80% (n=206) of parents reported their
child/adolescent to have had a confirmatory blood test, 79% (n=205) a positive skin prick
test, 39% (n=101) reported diagnosis by food oral challenge, and 25% (n=64) via trial
elimination diet. With regard to the number of tests used to make a diagnosis, 21% of
parents (n=54) reported diagnosis by one of the HSE/NHS tests, 41% (n=106) by 2 tests,
30% (n=78) by 3 tests, and 8% (n=20) by all 4 tests. Approximately 1 in 10 (9.5%; n=25)
parents reported their child to have had an anaphylactic reaction over the 12 months prior
to completing this survey, with 9% (n=24) reporting 1 episode, and 0.4% (n=1) reporting
2 episodes. More details on this cohort are available in Appendix 1.
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*Associated number of children and adolescents reported by their parents to have MDFA: <1 year = 4 males & 3 females; 1 – 5
years = 67 males & 37 females; 6 – 12 years = 58 males & 49 females; 13 – 17 years = 19 males & 21 females

Figure 3.1.1a: Percentage breakdown of children and adolescents, by gender and
age, who were reported to have MDFA in the parental survey conducted in Ireland
between November 2019 and June 2020 (children/adolescents <18 years; n = 258)

3.1.1b Summary of the Medically Diagnosed Food Allergy (MDFA) parental survey
in Northern Ireland:
This group consisted of responses from 168 parents of children and adolescents reported
as MFDA in a parental survey in NI. The overall gender breakdown of the responding
parents was 58% (n=97) males and 42% (n=71) females. Notably, 52% (n=88) of
children were reported to be < 5 years of age (29% males & 24% females) and 87%
(n=145) to be < 12 years (50% males & 36% females); with approx. 13% (n=23) of
adolescents in the 13-17 years age category (8% males & 6% females) (Figure 3.1.1b).

With regard to the tests used for diagnosis of MDFA, 58% (n=97) of parents reported
their child/adolescent to have had a confirmatory blood test and 71% (n=120) a positive
skin prick test. Forty-four percent (n=74) reported diagnosis via trial elimination diet and
38% (n=64) by oral food challenge. In addition, 26% (n=43) reported diagnosis by one
of these tests, 46% (n=78) by 2 tests, 19% (n=32) by 3 tests, and 9% (n=15) by all 4 tests.
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Lastly, 10% (n=17) of parents surveyed reported their child to have had an anaphylactic
reaction over the 12 months prior to completing this survey; with 7% (n=11) reporting 1
episode and 4% (n=6) reporting 2 episodes. More details on this cohort are available in
Appendix 1.
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*Associated number of children and adolescents reported by their parents to have MDFA: <1 year = 6 males & 5 females; 1 – 5
years = 42 males & 35 females; 6 – 12 years = 36 males & 21 females; 13 – 17 years = 13 males & 10 females

Figure 3.1.1b: Percentage breakdown of children and adolescents, by gender and
age, who were reported to have MDFA in the parental survey conducted in NI
between November 2019 and June 2020 (children/adolescents <18 years, n = 168)
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3.1.2 Summary Information on Adults reported to have MDFA in a
survey conducted in Ireland and NI
3.1.2a Summary of the Medically Diagnosed Food Allergy (MDFA) adult survey in
Ireland
This group consisted of responses from 194 adult participants (≥18 years) surveyed in
Ireland. The overall gender breakdown was 91% (n=178) female, and 9% male (n=16).
Just over half of all respondents (54%, n=105), were in the 18-29 years age category
(51% females & 3% males), 77% (n=150) were aged between 18-39 years (females 72%
& males 5%), and 23% (n=44) were aged > 40 years (19% females and 4% males) (Figure
3.1.2a).

With regard to the frequency of tests used in the medical diagnosis of food allergy, 71%
(n=137) reported having had a confirmatory blood test, 60% (n=116) a positive skin prick
test, 46% (n=90) were diagnosed via trial elimination diet and 26% (n=51) by food oral
challenge. In addition, 34% (n=66) were diagnosed by 1 test, 36% (n=70) by 2 tests,
23% (n=44) by 3 tests, and 7% (n=14) by all 4 tests. With regard to serious allergic
reactions, 9.5% (n=18) of all respondents reported to have had an anaphylactic reaction
over the 12-months prior to completing this survey, with 5% (n=9) reporting 1 episode,
1.5% (n=3) reporting 2 episodes, and 2% (n=4) reporting 3 episodes. More details on this
cohort are available in Appendix 2.
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*Associated number of individuals who reported their age group: 18 – 29 years = 99 females & 6 males; 30 – 39 years = 41 females
& 4 males; 40 – 49 years = 19 females & 3 males; 50 – 59 years = 14 females & 2 males; ≥ 60 years = 5 females & 1 male

Figure 3.1.2a: Percentage breakdown of adults, by gender and age, who reported to
be MDFA in a survey conducted in Ireland between November 2019 and June 2020
(≥18 years, n = 194)

3.1.2b Summary of the Medically Diagnosed Food Allergy (MDFA) adult survey in
Northern Ireland
This group consisted of responses from 124 adult participants (≥18 years) surveyed in
NI. The overall gender breakdown was 92% (n=114) female and 8% male (n=10). Just
over half (56%, n=69) of all respondents were in the 18-29 years category (52% females
& 4% males), 76% (n=94) were 18-39 years (females 70.5% & males 5.5%); and 24%
(n=30) were > 40 years (21.5% female and 2.5% male) (Figure 3.1.2b).

When the frequency of tests used in the diagnosis of MDFA were examined, 77% (n=96)
reported to having had a confirmatory blood test, 54% (n=67) a positive skin prick test,
35% (n=44) were diagnosed by trial elimination diet, and 26% (n=32) by food oral
challenge. Notably, 37% (n=46) were diagnosed by 1 diagnostic tests, 38% (n=47) by 2
tests, 21% (n=26) by 3 tests, and 4% (n=5) by all 4 tests. Finally, 13% (n=15) of
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respondents reported to have had an anaphylactic reaction over the 12 months prior to
completing this survey, with 8% (n=10) reporting 1 episode, 2% (n=2) reporting two
episodes, and 3% (n=3) reporting an anaphylactic reaction on 3 or more occasions.
Notably, 1 individual reported 7 instances of anaphylaxis over this period. More details
on this cohort are available in Appendix 2.
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Figure 3.1.2b: Percentage breakdown of adults, by gender and age, who reported to
be MDFA in a survey conducted in NI between November 2019 and June 2020 (≥18
years, n = 124)
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3.1.3 Summary Information on Children & Adolescents who were
reported to be MDCD in a parental survey conducted in Ireland and NI
3.1.3a Summary of the Medically Diagnosed Coeliac Disease (MDCD) parental
survey in Ireland
This group consisted of responses from 151 parents of children and adolescents (<18
years) reported as having MDCD in a parental survey in Ireland. The overall gender
breakdown of children and adolescents was 63% (n=95) females and 37% (n=56) males.
Only 12% (n=18) of children were reported to be in the < 5 years age category (8%
females & 4% males), and 71% (n=107) being < 12 years (48% females & 23% males).
The other 29% (n=44) were adolescents aged 13-17 years (15% females & 14% males)
(Figure 3.1.3a).

All of the children and adolescents in this study were required to have been positively
diagnosed by at least one of the HSE/NHS recognised diagnostic test methods and by a
healthcare professional. Ninety-three percent (n=140) of parents reported their child as
having had a confirmatory blood test and 66% (n=99) a gastrointestinal endoscopy and
biopsy. Forty percent (n=61) were reported to be diagnosed by 1 diagnostic test and 60%
(n=90) by both tests. More details on this cohort are available in Appendix 3.
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Figure 3.1.3a: Percentage breakdown of children and adolescents, by gender and
age, who were reported to have MDCD in parental a survey in Ireland conducted
between November 2019 and October 2020 (<18 years, n = 151)

3.1.3b Summary of the Medically Diagnosed Coeliac disease (MDCD) parental
survey in Northern Ireland
This group consisted of responses from 66 parents of children and adolescents (<18
years) reported as having MDCD in a parental survey in NI. The overall gender
breakdown was 67% (n=44) female and 33% (n=22) male. Notably, only 9% (n=6) of
children were reported to be < 5 years of age (8% females & 1% males) and 65% (n=43)
were reported to be < 12 years of age (26% females & 16% males). The other 35%
(n=23) were adolescents in the 13-17 years age category (females 18% & males 17%)
(Figure 3.1.3b).

With regard to diagnosis, 92% (n=61) were diagnosed by a confirmatory blood test and
42% (n=28) by gastrointestinal endoscopy and biopsy. Sixty-two percent (n=41) were
diagnosed by 1 test and 38% (n=25) by both tests. More details on this cohort are
available in Appendix 3.
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Figure 3.1.3b: Percentage breakdown by parents of children and adolescents, by
gender and age, who were reported to have MDCD in a parental survey conducted
in NI between November 2019 and October 2020 (<18 years, n = 66)
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3.1.4 Summary information on adults who were reported to be MDCD
in a parental survey conducted in Ireland and NI
3.1.4a Summary of the Medically Diagnosed Coeliac disease (MDCD) adult survey
in Ireland
This group consisted of responses from 623 adults surveyed in Ireland reporting to have
MDCD. The overall gender breakdown was 82% (n=511) female and 18% male (n=112).
Only 17% (n=106) of respondents were in the 18-29 years category (16% females & 1%
males). An additional 17% (n=105) of all respondents were aged between 30-39 years
(15% females & 2% males), with 66% (n=412) being > 40 years (51% females & 15%
males) (Figure 3.1.4a).
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With regard to the frequency of tests used in the diagnosis of coeliac disease, 47%
(n=509) had a confirmatory blood test and 53% (n=570) a gastrointestinal endoscopy and
biopsy. Twenty-seven percent (n=168) were diagnosed with 1 of these tests and 73%
(n=455) by both of these tests. More details on this cohort are available in Appendix 4.
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Figure 3.1.4a: Percentage breakdown of adults, by gender and age, who reported to
be MDCD in a survey conducted in Ireland between November 2019 and June 2020
(≥18 years, n = 623)

3.1.4b Summary of the Medically Diagnosed Coeliac disease (MDCD) adult survey
n Northern Ireland
This group consisted of responses from 195 adults surveyed in NI reporting to have
MDCD. The overall breakdown of this group was 88% (n=171) female and 13% male
(n=24). A third (33%) of all respondents (n=63) were in the 18-29 years age category
(30% females & 3% males), and 16% (n=31) were aged 30-39 years (females 13% &
males 3%), with 52% (n=101) aged > 40 years (45% females and 7% males) (Figure
3.1.4b).
153

With regard to the tests used in the diagnosis of coeliac disease, 85% (n=166) had a
confirmatory blood test and 90% (n=175) a gastrointestinal endoscopy and biopsy. A
quarter (25%, n=49) of all respondents were diagnosed by 1 test and 75% (n=146) by
both of these tests. More details on this cohort are available in Appendix 4.
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Figure 3.1.4b: Percentage breakdown of adults, by gender and age, who reported to
be MDCD in a survey conducted in NI between November 2019 and June 2020 (≥18
years, n = 195)
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3.1.5 Summary Information on children & adolescents who were
reported to have a Food Intolerance or Suspected/Undiagnosed Food
Allergy (FI) in a parental survey conducted in Ireland and NI
3.1.5a Summary of the Food Intolerance or Suspected/Undiagnosed Food Allergy
(FI) parental survey in Ireland
This group consisted of responses from 59 parents of children and adolescents (<18
years) reported as FI in a parental survey in Ireland. The overall gender breakdown was
56% (n=33) females and 44% (n=26) males. Forty-two percent (n=25) of children were
in the < 5 years category (17% females & 25% males), while 80% (n=47) were < 12 years
(41% females & 39% males), and 20% (n=12) of adolescents were 13-17 years (15%
females & 5% males) (Figure 3.1.5a). More details on this cohort are available in
Appendix 5.
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Figure 3.1.5a: Percentage breakdown of children and adolescents, by gender and
age, who were reported to have FI in the parental survey conducted in Ireland
between November 2019 and June 2020 (<18 years, n = 59)
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3.1.5b Summary of the Food Intolerance or Suspected/Undiagnosed Food Allergy
(FI) parental survey in Northern Ireland
This group consisted of responses from 61 parents of children and adolescents (<18
years) reported as FI in a parental survey in NI. The overall gender breakdown was 52%
(n=32) females and 48% (n=29) males. Notably, 39% (n=24) of children were < 5 years
of age (18% females & 21.5% males), 73% (n=44) were < 12 years (females 36% &
males 36.5%), and 27% (n=17) of adolescents were 13-17 years (16% females & 11.5%
males) (Figure 3.1.5b). More details on this cohort are available in Appendix 5.
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Figure 3.1.5b: Percentage breakdown of children and adolescents, by gender and
age, who were reported to have FI in the parental survey conducted in NI between
November 2019 and June 2020 (<18 years, n = 61)
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3.1.6 Summary Information on adults who reported to be FI in a survey
conducted in Ireland and NI
3.1.6a Summary of the Food Intolerance or Suspected/Undiagnosed Food Allergy
(FI) Adult survey in Ireland
This group consisted of responses from 587 Adults (>18 years) reported as FI in a survey
in Ireland. The overall gender breakdown was 91% (n=537) female and 9% male (n=50).
Over half of all respondents (53%, n=113) were in the 18-29 years category (49% females
& 4% males). Seventy-three percent (n=228) of all respondents were aged 18-39 years
(females 67% & males 6%), with 27% (n=159) being > 40 years (24% females & 3%
males) (Figure 3.1.6a). More details on this cohort are available in Appendix 6.
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Figure 3.1.6a: Percentage breakdown of adults, by gender and age, who reported to
be FI in a survey conducted in Ireland between November 2019 and June 2020 (≥18
years, n = 587)
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3.1.6b Summary of the Food Intolerance or Suspected/Undiagnosed Food Allergy
(FI) in adults in Northern Ireland
This group consisted of responses from 515 adults (>18 years) reported as FI in a survey
in NI. The overall gender breakdown was 93% female (n=479) and 7% male (n=36).
44% (n=229) of respondents were in the 18-29 years age category (41% females & 3%
males). In fact, 68% (n=349) of respondents were aged 18-39 years (females 63% &
males 5%), with 32% (n=166) being > 40 years (30% females & 2% males) (Figure
3.1.6b). More details on this cohort are available in Appendix 6.
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Figure 3.1.6b: Percentage breakdown of adults, by gender and age, who reported to
be FI in a survey conducted in NI between November 2019 and June 2020 (≥18
years, n = 515)
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3.2. A review of Trigger foods, Gender and Age Category associated
with reported Medically Diagnosed Food Allergy (MDFA)
3.2.1. Reported Medically Diagnosed Food Allergies (MDFA) for the children &
adolescents (parental survey) in Ireland (n=258) and NI (n=168)
Peanuts (52%), milk (45%), eggs (42%) and ‘other nuts’ (37%) were the four most
reported MDFA in children (<12 years; n=363) in Ireland (n=218) and NI (n=145) (Table
3.2.1). In fact, the prevalence of allergy to these four foods was significantly greater (at
the 5% significance level) than all other MDFA reported in the child cohorts Ireland. The
5th most reported MDFA in this age group was to fruit at 15% (kiwi 4% and other fruit
11%), followed closely by soybeans (11%) and fish (10%), respectively (Figure 3.2.1).
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Table 3.2.1: The five most reported MDFA among children (<12 years, n=363),
adolescents (13-17 years, n=63) and adults (≥18 years, n=318) reported in a food
hypersensitivity survey conducted in Ireland and NI between November 2019 and
October 2020
MDFA Children
Prevalence

(Males & Females)
(n=363)

MDFA
Adolescents
(Males &
Females)

MDFA Adults
(Males & Females)
(n=318)

(n=63)
1st

Peanuts (52%)

Peanuts (57%)

Peanuts (39%)

2nd

Milk (45%)

Other Nuts (43%)

Other nuts (31%)

3rd

Eggs (42%)

Eggs (29%)

Milk (29%)

4th

Other Nuts (37%)

Milk (24%)

Fruit*(23%)

5th

Fruit (15%)

Fish/Fruit* (14%)

Eggs (17%)

*Fruit: consists of kiwi and other fruits (Children: 4% kiwi & 11% other fruits; Adolescents: 6% kiwi & 8% other fruits;
Adults: 8% kiwi & 15% other fruits)

Similarly, peanuts (57%), other nuts (43%), eggs (29%), and milk (24%), were the four
most reported MDFA for adolescents (13-17 years) in both cohorts (Ireland n=40 and NI
n=23) (Table 3.2.1). Notably, milk allergy moved from the second most reported MDFA
in children to fourth place for adolescents. In fact, an overall percentage decrease is noted
in MDFA to milk (45% on average) in children compared to adolescents (24% on
average). MDFA to milk was found to be significantly lower in adolescents (13-17 years)
and adults (>18 years) than in children (p-value <0.001).

Egg allergy remained the third most reported MDFA in adolescents (as in children), but
the mean percentage is lower in adolescents (29% on average) than in children (42% on
average). Similarly, allergy to ‘other nuts’ moved from the fourth most reported MDFA
in children (37% on average) into second place for adolescents (43% on average).
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3.2.2 Reported Medically Diagnosed Food Allergies (MDFA) among adults selfreported by survey in Ireland (n=194) and NI (n=124)
Similar to the data collected on MDFA in children and adolescents, peanuts (39%), other
nuts (31%), milk (29%) and eggs (17%), were the most common MDFAs reported by all
adults (Ireland and NI, n=318) (Table 3.2.3c). However, fruits (including 8% kiwi)
ranked as the 4th most prevalent food allergies among adults. These were followed by
eggs (17%) in 5th place and crustaceans (13%) in 6th place. A lower percentage of milk
(29%) and egg (17%) allergy was noted in adults (Figure 3.2.2) compared to children
(45% and 42%, respectively), and these differences were statistically significant (p-value
<0.05).

Notably, an increase in prevalence was noted for several foods in adults (in particular
cereals containing gluten, fruits, crustaceans and molluscs) when compared to those
reported for children and adolescents. For example, MDFA to cereals containing gluten
was reported as 3% in children, 6% in adolescents and 7% for adults who participated in
this study. While MDFA to fruit (kiwi and other fruits) was 15% (4% kiwi) in children,
14% (6% kiwi) in adolescents and 23% (8% kiwi) in adults. MDFA to crustaceans and
molluscs was at 3%, 5% and 13% and 2%, 5% and 9% in children, adolescents and adults,
respectively.

The prevalence of peanuts, other nuts, eggs and milk allergy were (independently)
significantly lower (p-value <0.05) among the adult cohorts (n=318) compared to
children (n=363). The only significant (p-value <0.05) increase in allergy prevalence
compared to adolescents was recorded for cereals containing gluten.
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The prevalence of kiwi was found to be higher in adults (8%) than in children (4%) (not
statistically significantly). While kiwi is not one of the 14 allergens currently listed in
Regulation EU No. 1169/2011, the reported percentage of MDFA to kiwi was found to
be higher among MDFA children, adolescents, and adults, than for many of the foods
causing allergies or intolerances on that list (Figure 3.2.1 and 3.2.2). For example, if we
examine all adults in this study reporting to be MDFA (Ireland and NI, n=318), kiwi
allergy (8%) was reported to be equally as common as fish allergy (8%) and frequently
more common than that for soybeans (5%), sesame seeds (5%), celery (4%), mustard
(3%), sulphites and SO2 (3%), and lupin (2%). That said, the difference in the reported
prevalence of MDFA to kiwi was only found to be statistically significant (p-value <0.05)
when compared to lupin (2%).
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Figure 3.2.1. Breakdown of medically diagnosed food allergies (MDFA) in a food
hypersensitivity study by survey, conducted between November 2019 and October
2020. Children (≤ 12 years, Ireland (n=218), NI (n=145), IoI (n=363)) & adolescents
(13-17 years, Ireland (n=40), NI (n=23), IoI (n=63)
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Figure 3.2.2. Breakdown of medically diagnosed food allergies (MDFA) in adults (>
18 years, n=318) in a food hypersensitivity survey conducted between November
2019 and October 2020. Ireland (n=194), NI (n=124), IoI (n=318)
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3.2.3 Gender breakdown of reported Medically Diagnosed Food Allergy (MDFA) in
children, adolescents and adults (n=744) from the Food Hypersensitivity Survey
Data
When the parental MDFA surveys were examined in this study, a slightly higher
statistically insignificant percentage of male children (57% in Ireland, and 58% in NI)
were reported with this condition. Interestingly, there was consistency between the
genders with regard to the trigger foods reported by the parents (Figure 3.2.3a). A
prevalence ranking of trigger foods in male and female MDFA children can be seen in
Table 3.2.3a.

Table 3.2.3a: The five most reported MDFA among children (<12 years, n=363) by
gender (parent-reported) in a food hypersensitivity survey conducted between
November 2019 and October 2020 in Ireland and NI
Prevalence
Ranking

Female
Children
reporting to be
MDFA (n=149)

1st

Peanuts (51%)

Peanuts (52%)

Peanuts (52%)

2nd

Milk (45%)

Milk (45%)

Milk (45%)

3rd

Eggs (39%)

Eggs (43%)

Eggs (42%)

4th

Other
(34%)

Other Nuts** (39%)

Other Nuts** (37%)

5th

Fruit* (16%)

Fruit* (13%)

Fruit* (15%)

Nuts**

Male Children
reporting to be
MDFA (n=214)

MDFA Children
(Males & Females)
(n=363)

*Fruit: consists of kiwi and other fruits (Female Children: 5% kiwi & 11% other fruits; Male Children: 3% kiwi & 10% other fruits;
All MDFA Children (Female & Male): 4% kiwi & 11% other fruits)
**Other Nuts and Other nuts: see Appendix 1 for a detailed breakdown

Similar prevalence percentages emerged when data for all children (<12 years, n=363)
was examined for each of the 14 regulated food allergens; the largest difference for any
MDFA between the genders in this age group being just 5% (Figure 3.2.3a). MDFA to
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sulphur dioxide and sulphites, and celery were absent in male children and present at very
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Figure 3.2.3a. Gender breakdown of medically diagnosed food allergy (MDFA) in
IoI children (≤ 12 years, females = 149, males = 214) and adolescents (13-17 years,
females = 31, males = 32); parent-reported in a food hypersensitivity survey
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A similar prevalence ranking order was also noted in the reported percentages of MDFA
to specific foods in the female and male adolescents examined i.e., peanuts, other nuts,
eggs and milk, respectively (Table 3.2.3b). However, the sample size for adolescents
(n=63) is not as large as that for children (n=363), and the similarities in percentages
between the genders were not as evident in this age category. This adolescent sample
size was smaller probably because it spanned just five years (13-17 years), compared to
12 years for the child cohorts (0-12 years).

Table 3.2.3b: The five most reported MDFA among Adolescents (13-17 years, n=63)
by Gender (parent-reported) in a food hypersensitivity survey conducted between
November 2019 and October 2020 in Ireland and NI
Prevalence
Ranking

Female
Adolescents
reporting to be
MDFA (n=31)

Male Adolescents
reporting to be
MDFA (n=32)

MDFA Adolescents
(Males & Females)
(n=63)

1st

Peanuts (48%)

Peanuts (66%)

Peanuts (57%)

2nd

Other Nuts**
(42%)

Other Nuts** (44%)

Other Nuts** (43%)

3rd

Milk (29%)

Eggs (31%)

Eggs (29%)

4th

Eggs (26%)

Milk (19%)

Milk (24%)

5th

Fruit* (16%)

Fish/Soybeans (16%)

Fish/Fruit* (14%)

*Fruit: consists of kiwi and other fruits (Female Adolescents: 6% kiwi & 10% other fruits; All MDFA Adolescents (Female & Male):
6% kiwi & 8% other fruits)
**Other Nuts: see Appendix 1 for a breakdown of other nuts
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When reported MDFA in adults is reviewed, peanuts were (once again) the most reported
MDFA (average 39 %; Table 3.2.3c). While a large sample size was obtained for female
adults (n=292), challenges in acquiring a representative adult male MDFA cohort in this
study (n=26) made comparisons between genders in this age category difficult. However,
the emergence of crustaceans is notable in the top five most reported MDFA in females
(13%) and males (46%) (Figure 3.2.3b), and the 6th most reported MDFA in adults
overall.

Table 3.2.3c: The five most self-reported MDFA among Adults (>18 years, n=318),
in a food hypersensitivity survey conducted between November 2019 and October
2020 in Ireland and NI.
Prevalence
Ranking

Female Adults
reporting to be
MDFA (n=292)

Male Adults
reporting to be
MDFA (n=26)

MDFA Adults (Males
& Females) (n=318)

1st

Peanuts (38%)

Peanuts (50%)

2nd

Other Nuts** (30%)/
Milk (30%)

Crustaceans (46%) Other Nuts** (31%)

3rd

Fruit* (24%)

4th

Eggs (17%)

5th

Crustaceans (13%)

Other
nuts** Milk (29%)
(38%)
Eggs (15%)/ Milk Fruit* (23%)
(15%)
Fruit* (12%)
Eggs (17%)

Peanuts (39%)

*Fruit: consists of kiwi and other fruits (Female Adults: 8% kiwi & 16% other fruits; Male Adults: 4% kiwi & 8% other fruits; All
MDFA Adults (Female & Male): 8% kiwi & 15% other fruits)
**Other Nuts: see Appendix 2 for a breakdown of other nuts
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Figure 3.2.3b Gender breakdown of medically diagnosed food allergy (MDFA) in
IoI adults (> 18 years, females = 292, males = 26), in a food hypersensitivity survey
conducted between November 2019 and October 2020
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3.2.4. Overall Study Findings on Reported Medically Diagnosed Food Allergy
(MDFA) from the Food Hypersensitivity Surveys
When all of the reported MDFA were examined for all of the respondents (adult and
parental), the main trigger foods reported were peanuts (47%), milk (36%), other nuts
(35%), and eggs (30%) (Table 3.2.4). In addition, when the percentage of foods reported
to be associated with anaphylactic episodes were examined, the same 4 foods were once
again noted. The order of these 4 allergens was however different with peanuts (7%) and
other nuts (6%) being the most reported trigger foods.

Interestingly, our data indicates that kiwi associated anaphylaxis was reported to occur in
1% all respondents (n=744). Notably this dataset suggests that the percentage rate of
anaphylaxis for kiwi (1%) is comparable to crustaceans (1%), sesame seeds (1%),
molluscs (1%) and lupins (1%). However, unlike these foods, kiwi is currently regulated
under EU Regulation EU No. 1169/2011.
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Table 3.2.4: Percentages of the ten most reported MDFA for ‘All
Respondents’(n=744) in Ireland and NI, based on adult self-reported and parentreported data from a survey run between November 2019 and October 2020
Most
Reported
(Rank)

% Reported MDFA to
various food from All
Respondents** (n=744)

% Reported food allergens
associated with anaphylactic
reactions from All
Respondents** (n=744)

1st

Peanuts 47%

Peanuts 7%

2nd

Milk 36%

Other Nuts* 6%

3rd

Other Nuts* 35%

Eggs 4%

4th

Eggs 30%

Milk 3%

5th

Fruit* 19% (6% of which kiwi) Fruit* 2% (1% of which kiwi)

6th

Fish 10%

Fish 2%

7th

Crustaceans 8%

Crustaceans 1%

8th

Soybeans 8%

Sesame seeds 1%

9th

Sesame seeds 7%

Molluscs 1%

10th

Cereals containing gluten, 5%

Lupins 1%

* The full breakdown of ‘Other nuts’ and ‘Fruit’ is available in Appendix 1 and Appendix 2
** ‘All Respondents (n= 744) reporting to be MDFA included the parental surveys of Children (≤12 years, n=363) and Adolescents
(13-17 years, n=63), and the Adults survey (≥18 years n=318)

Finally, when all respondents (n=744) were queried regarding the number of foods to
which they (or their child/adolescent) have been medically diagnosed as allergic, 43%
reported 1 food, 24% reported 2 foods and 14% indicated 3 foods (Figure 3.2.4). While
most respondents (n=318, 43%) reported to have a MDFA to just 1 food, a small
proportion (n=19, 2.5%) of the sample group reported having an MDFA to >10 foods.
Notably, 25% (n=188) of 744 respondents reporting to be MDFA also indicated that they
had additional food hypersensitivities, with 24% (n=175) reporting to have FI, with
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another 0.5% (n=4) reporting to have MDCD, and another 1% (n=9) to have both FI and
MDCD. More data on these cohorts is available in Appendices 1 and 2.

8 MDFA 9 MDFA
1%
0.5%
6 MDFA
≥10 MDFA
7
MDFA
2.5%
2.5%
0.5%

5 MDFA
4%
4 MDFA
8%

1 MDFA
43%
3 MDFA
14%

2 MDFA
24%

318 respondents reported having 1 MDFA; 177 reported having 2; 103 reported having 3; 62 reported having 4; 26 reported having
5; 19 reported having 6; 8 reported having 7; 7 reported having 8, 4 reported having 9, and 19 respondents reported having >10
MDFAs

Figure 3.2.4: Average number of MDFA to different foods per respondent, reported
as a percentage of ‘All Respondents’ (n=744) reporting to have this condition in
Ireland and NI, based on adult self-reported and parent-reported data from a
survey run between November 2019 and October 2020
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3.3. A Review of Gender and Age Category associated with reported
Medically Diagnosed Coeliac Disease (MDCD) in the Food
Hypersensitivity Surveys
Coeliac disease (CD) is an autoimmune condition characterised by a specific serological
and histological profile triggered by gluten ingestion in genetically predisposed
individuals (Fasano & Catassi, 2012). Gluten is the general term for alcohol soluble
proteins present in various cereals, including wheat, rye, barley, spelt, and kamut. The
predominant gender reported in the parental MDCD survey groups in Ireland and NI was
female (64%), as opposed to male (36%). This resulted in a 64:36 or 1.6:1 ratio of
females to males in the children and adolescents studied. Similarly, a larger number of
female respondents completed the MDCD adult survey (83%).

A large dataset of adult MDCD respondents were examined in this study (n=623) in
Ireland and NI (n=195). However, the project team found it challenging to find parents
of children and adolescents with MDCD to complete the parental MDCD surveys
(n=217).
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3.4. A review of Trigger foods and Age Category associated with
reported Food Intolerance and/or Suspected or undiagnosed food
allergy (FI) in the Food Hypersensitivity Surveys
A total of 1,222 participants in Ireland and NI who completed the food hypersensitivity
survey reported that they or their child had a food intolerance and/or a suspected or
undiagnosed food allergy (FI) Ireland. This consisted of 120 parents and 1,102 adults.
The parental group was smaller due to a lower uptake of these surveys, and the reported
associated FI trigger foods for Ireland (n=59) and NI (n=60) are presented together here
(Figure 3.4.a). Notably the most reported trigger foods associated with FI were milk
(59%), cereals containing gluten (20%), fruits (kiwi 1% & other fruits 12%), and eggs
(6%).
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*Associated number of Children and Adolescents who suffer from food intolerances to these foodstuffs: Milk = 81 individuals; Cereals
containing gluten = 42; Fruits = 27 (of which 2 are kiwi); Eggs = 12; Soybeans = 6; Meat and poultry = 6; Other nuts = 5; Vegetables=5;
Peanuts = 4; Fish = 4; Sulphur dioxide and sulphites = 2; Honey=2; Crustaceans = 1; Celery(n=1); Other foods=15,
Breakdown of foods in unspecified groups:
- Fruits (n=27): Citrus fruits (Oranges, n=7; Lemon, n=1); Strawberries (n=3); Tomatoes (n=3); Kiwi (n=2); Fruits (unspecified, n=2);
Berries (n=1); Banana (n=1); Coconut (n=1); Grapes (n=1); Melon (n=1); Pineapple (n=1); Apples (n=1); Apricot (n=1); Watermelon
(n=1)
- Other Nuts (n=5): Nuts (unspecified, n=4); Almonds (n=1)
- Vegetables (n=5): Green pepper (n=1); Potatoes (n=1); Peas (n=1); Carrot (n=1); Garlic (n=1)
- Other Foods (n=15) = Sulphites/Sulphur dioxide (n=2); Honey (n=2); Sweets (n=2); Sugar (n=2); Crustaceans (n=1); Coffee (n=1);
Buckwheat (n=1); Chia seeds (n=1); Yeast (n=1); Food Colouring (n=1)

Figure 3.4a: Food Intolerances and/or undiagnosed/suspected food allergy (FI)*
indicated by parents of children and adolescents (<18 years) reported in a parental
survey conducted between November 2019 and June 2020 in Ireland and NI (n=120)

180

A large dataset of FI associated trigger foods was collected for adults (n=1,102) in Ireland
and NI, so the data is presented separately in Figure 3.4b and 3.4c. The top four most
reported foods in Ireland and NI were the same as those reported for children previously
(Figure 3.4a); with the exception of the inclusion of peanuts in joint fourth place with
eggs. Milk was the most reported trigger food (58%) for FI in adults, followed by cereals
containing gluten (46%), Fruit (3% kiwi & 17% other fruit), eggs (10%) and peanuts

Percentage

(9%).
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*Associated number of individuals who suffer from food intolerance to these foodstuffs: Milk = 333 individuals; Cereals containing
gluten = 259; Other Foods = 142; Other Fruits = 99; Peanut = 63; Sulphur dioxide and sulphites = 54; Eggs = 53; Crustaceans = 40;
Other nuts = 41; Soy beans = 38; Molluscs = 28; Fish = 28; Meat and poultry = 30; Celery = 17 individuals; Kiwi = 15; Sesame seeds
= 14; Mustard = 10; Lupins = 9
Breakdown of foods in unspecified groups:-Other nuts (n=51) = Nuts (*Unspecified, n=13); All tree nuts (n=7); Almonds (n=7);
Cashew nuts (n=7); Hazelnuts (n=7); Walnut (n=4); Pine Nut (n=3); Pistachio (n=3)
-Other fruits (n=99) = Fruits (*Unspecified, n=18); Citrus fruit (*Unspecified, n=4; Orange, n=15; Grapefruit, n=2; Lemon, n=1;
Nectarine, n=1); Apple (n=18); Berries (*Unspecified, n=1; Strawberry, n=11; Cranberry, n=2; Blackcurrant, n=1; Pomegranate, n=1;
Raspberry, n=1); Tomato (n=15); Banana (n=14); Pineapple (n=6); Pear (n=4); Avocado (n=2); Cherry (n=2); Coconut (n=2); Plum
(n=2); Grape (n=1); Mango (n=1); Passion fruit (n=1); Passion fruit (n=1); Peach (n=1)
-Other Foods (n=142); For further details please see Appendix 6 of this report

Figure 3.4b: Food intolerances and/or undiagnosed/suspected food allergy (FI)*
indicated by adults in a survey conducted between November 2019 and June 2020
in Ireland (≥18 years, n = 587)
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*Associated number of individuals who suffer from food intolerance to these foodstuffs: Milk = 306; Cereals containing gluten = 245;
Other Foods = 125; Other Fruits = 84; Eggs = 58; Peanut = 40; Meat and poultry = 36; Other nuts = 33; Crustaceans = 26; Fish = 25;
Sulphur dioxide and sulphites = 22; Molluscs = 23; Soy beans = 21; Kiwi = 17; Celery = 18; Sesame seeds = 11; Mustard = 6; Lu pins
=4
Breakdown of foods in unspecified groups:-Other nuts (n=36) = Nuts (unspecified, n=12); All tree nuts (n=5); Almond (n=8); Hazelnut
(n=4); Brazil nut (n=2); Cashew nut (n=2); Walnut (n=2); Pine nuts (n=1)
-Other fruits (n=99) = Fruit (unspecified, n=7); Citrus fruits (unspecified, n=9; Orange, n=15; Lime, n=1); Banana (n=16); Ber ries
(*Unspecified, n=3; Strawberry, n=7; Raspberry, n=4; Blackcurrant, n=1; Cranberry, n=1); Tomatoes (n=15); Apple (n=9); Grapes
(n=5); Melon (n=3); Coconut (n=2); Mango (n=2); Peach (n=2); Pineapple (n=2); Avocado (n=1); Dragon fruit (n=1); Passionfruit
(n=1); Pear (n=1)
-Other Foods (n=125); For further details please see Appendix 6 of this report

Figure 3.4c: Food intolerances and/or undiagnosed/suspected food allergy (FI)*
indicated by adults in a survey conducted between November 2019 and June 2020
in NI (≥18 years, n = 515)
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3.4.1 Overview of Trigger Foods on Food Intolerance and/or Suspected,
Undiagnosed food allergy (FI) from the Food Hypersensitivity Surveys
The ‘top ten’ most reported food intolerances for all FI survey participants (adult and
parental) are presented in Table 3.4.1. This table contains 8 foods that were also in the
top ten most reported foods associated with MDFA, with sulphites/SO2 and meat &
poultry included for FI; and fish and sesame seeds included for MDFA. One of the most
notable differences in the top ten FI and MDFA trigger foods is that peanut FI (9%) and
other nut FI (6%) ranked fifth and sixth (respectively) (Table 3.4.1) compared to first
(peanuts, 47%) and third (35% other nuts) in the case of MDFA (Table 3.2.4). In fact,
the two most reported trigger foods associated with FI were found to be milk and cereals
containing gluten. Milk was associated with 59% of FI in the 1,222 respondents surveyed
in this study, and it was also the second most reported MDFA (36%, Table 3.2.4). Cereals
containing gluten ranked second place at 45% for FI and ranked sixth at 14% for MDFA.
The percentage of fruit FI was approximately the same as that reported for fruit MDFA
(20% and 19%, respectively). However, kiwi FI was 3%, while MDFA to kiwi was 6%.
Similarly, FI to egg was 10%, while MDFA to egg was 30%. A large overlap in specific
trigger foods associated with FI and MDFA was observed. In fact, all of the FI trigger
foods mentioned in Tables 3.4.1 are regarded as food allergens under EU food law, with
the exception of ‘meat & poultry’ and kiwi (as part of ‘fruit’).
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Table 3.4.1: Percentages of the ten most reported FI for ‘All Respondents’
(n=1,222**) in Ireland and NI based on adult self-reported and parent-reported
data from a survey run between November 2019 and October 2020
Most Reported

% of Reported FI to various food from All
Respondents**

(Rank)

(n=1,222)

1st

Milk 59%

2nd

Cereals containing gluten 45%

3rd

Fruit* 20% (3% of which kiwi)

4th

Eggs 10%

5th

Peanuts 9%

6th

Other nuts* 6%

7th

Sulphur dioxide and sulphites 6%

8th

Meat or poultry 6%

9th

Crustaceans 5%

10th

Soybeans 5%

* The full breakdown of ‘Other nuts’ and ‘Fruit’ is available in Appendix 5 and Appendix 6
** ‘All Respondents (n= 1,222) reporting to be FI included in the parental surveys of Children and Adolescents (<18 years, n= 120),
and the Adult surveys (>18 years n=1,102)
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Chapter 4: Results for the Calculation of the Socioeconomic Cost of
Food Hypersensitivity in Ireland & NI
Many studies have been conducted around the world to try to determine the socioeconomic costs associated with food allergy and other food hypersensitivities. Published
reports have included costing data (either collectively or singly) for the following
countries: the UK, Sweden, Greece, Iceland, Poland, the Czech Republic, France, Italy,
Finland, the Netherlands, and the USA. This is the first study to examine the direct and
indirect costs associated with MDFA, MDCD and FI in Ireland, and NI. In addition, this
chapter will review intangible costs (non-monetary costs) and their impact on QoL
associated with these conditions; but unlike direct and indirect costs these will not be
examined in terms of their monetary impacts.
In this study, the age groups examined were adults aged ≥ 18 years, children aged 0 to 12
years, adolescents aged 13 to 17 years. Costs were reported for adults and combined for
children and adolescents due to small number of respondents for the adolescents group.

The incremental cost is the estimated excess cost for a group with the condition (MDFA,
etc) relative to the costs observed for a similar cohort of individuals without that condition
(i.e., the reweighted controls). All costs reported were incremental costs associated with
each of the conditions examined. Incremental costs were reported as an individual cost
for adults or household costs with a child/adolescent with a food hypersensitivity. No
statistical comparison was made for the incremental costs calculated for each condition
based on jurisdiction as these were two separate data sets and could not readily be
compared given the reweighting of the associated controls.
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Total costs are the sum of direct and indirect costs. These costs were self-reported data
for individual FH adults or parent-reported for households with an FH child or adolescent.
Intangible costs were non-monetary costs. Direct costs to the health services associated
with health care utilizations (e.g., visits to medical practitioners, hospital stays) as well
as costs incurred by the individual (e.g., travel costs, costs for alternative therapies and
medication costs) are detailed in Table 2.2.1a. Indirect costs include loss of earnings
associated with health care utilization, absences from work/education and increases in
the time spent food shopping. In addition, this data is also presented as healthcare and
out-of-pocket costs incurred by individuals and their families as a result of their FH are
detailed in Table 2.2.1b, Table 4.1.2c and Table 4.2.2c.
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4.1. Results for the calculation of Socio-Economic Costs associated with
Food Hypersensitivity on the Island of Ireland: ADULTS
4.1.1 Overview of the adult food hypersensitivity (self-reported) dataset for Ireland
and NI
In section 4.1, we compared 178 and 111 responses for adults with MDFA; 609 and 173
responses for adults with MDCD; 536 and 459 adults with FI in Ireland and NI,
respectively, to 531 and 204 controls in Ireland and NI. All costs presented are the mean
values calculated from self-reported survey data and are the additional or extra
(incremental) costs per annum (p.a.) associated with each condition for individual adults.
No statistically significant difference was found between gender in the cohorts examined.
Tables 4.1.2a and 4.1.2b show a summary of the breakdown of direct, indirect and total
(direct plus indirect) costs under selected headings in Ireland and NI. Statistical analysis
was conducted by comparing costs reported for each of the 6 adult food hypersensitive
cohorts with those of their comparative (non-food hypersensitive) control groups. The
control groups have been reweighted so that they are in turn similar to each of the groups
of interest, as described in the methodology (Chapter 2, section 2.2). A more detailed
breakdown of adult costs is available in Table 7.A.1 and 7.A.2; Appendix 7 (Costs in
Euro and Pounds Sterling). Figure 4.1.2a provides a visual comparison of the incremental
(additional) direct, indirect and total costs p.a. for each food hypersensitive adult group
(MDFA, MDCD and FI) relative to the corresponding reweighted controls in Ireland and
NI.
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4.1.2 Examination of Additional (Incremental) Monetary Costs associated with
Food Hypersensitivity in Adults in Ireland and NI: Direct and Indirect Costs
Medically diagnosed food allergy (MDFA)
Direct costs calculated in this study included medical visits, travel to appointments,
hospital stays, cost of medication, private health insurance, and food costs. Higher direct
costs were associated with adult MDFA (self-reported) in Ireland (€1,325 p.a. pvalue<0.01) and NI (€982 p.a.), when compared with controls (Tables 4.1.2a and 4.1.2b).
The direct costs were significant (p-value<0.01) for this cohort in Ireland.

When the MDFA adult group (n=178) was compared with the corresponding control
group (n=531) in Ireland, medical visits (mean cost €178 p.a., p-value<0.05), and
especially GP visits (mean cost €71 p.a., p-value<0.01), were found to be significantly
higher than controls (Table 4.1.2a and Table 7.A.1; Appendix 7). Travel to medical
appointments (mean cost €71 p.a. p-value<0.01), and in particular travel to GP surgeries
(€58 p.a., p-value<0.01), were also found to be significantly higher (p-value<0.01), than
controls.

A similar trend was observed in NI with regard to significantly higher costs compared to
controls, including medical visits (mean cost €326 p.a. p-value<0.05; Table 4.1.2b), GP
visits (mean cost €56 p.a., p-value<0.01), travel to GP surgeries (mean cost €141 p.a., pvalue<0.05), and travel to hospital day units (€126 p.a. p-value<0.01) (Table 7.A.1;
Appendix 7). Notably, all of these costs were found to be significantly higher for those
with MDFA (n=111) than for their corresponding controls (n=204) in NI.

With regard to medications (prescription and over the counter), costs were found to be
significantly higher in Ireland and NI (mean cost €52 and €19 p.a., respectively, p188

value<0.01) than for controls, with visits to pharmacists being significantly higher in
Ireland only (mean cost €15 p.a., p-value<0.05) (Table 7.A.1; Appendix 7).

The total cost of hospital stays and visits was higher for MDFA adults in Ireland (mean
cost €291 p.a.), and NI (mean cost €500 p.a.), than for controls, although neither increase
was statistically significant. Similarly, a higher cost was associated with attending the
emergency department with subsequent admission to a ward for Irish adults with MDFA
(mean cost €371 p.a.) and NI (mean cost €134 p.a.) compared to controls, although not
statistically significantly (p-value<0.05).
Total food costs were significantly higher for MDFA adults in Ireland (mean cost €724
p.a., p-value<0.01), but not significantly higher in NI (mean cost €25 p.a.). Indirect costs
such as time lost, days missed, loss of earning, etc., were all higher for the MDFA adult
cohorts in NI (€479 p.a., p-value<0.01), but not in Ireland (mean cost €277 p.a.),
compared to controls.

Overall, a slightly higher figure (+9%) was calculated for total costs associated with adult
MDFA in Ireland (€1,602 p.a., p-value<0.01) compared to NI (€1,461 p.a., pvalue<0.05).

Both figures were statistically higher than controls, highlighting the

additional costs associated with this condition in both jurisdictions. These total costs
were also broken down into ‘out-of-pocket’ (mainly non-health) or healthcare costs
(Table 2.2.1b). Notably, ‘out-of-pocket’ costs made up 71% of the total cost in Ireland
(€1,141 p.a.) and 43% in NI (€627 p.a.) (Table 4.1.2c); and were borne by MDFA adults
alone. Healthcare costs made up the remaining 29% of the total cost in Ireland (€461
p.a.) and 57% (€834 p.a.) in NI (Table 4.1.2c). These additional healthcare costs
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(although shared with the health service in each jurisdiction), would also have increased
the yearly condition related expenditure of MDFA adults.

Medically diagnosed coeliac disease
Direct costs for adults reporting to have MDCD were €444 (€501 p.a. prior to claiming
the gluten free food tax rebate) in Ireland compared €856 p.a. in NI (Tables 4.1.2a and
4.1.2b). Notably, the direct costs where significantly higher (p<0.01) for the MDCD
adult group in NI (n=173) when compared to controls (n=204); this was not however the
case in Ireland (MDCD group n= 609, control group n=531). For Ireland, visits to GPs,
pharmacists, dieticians, alternative therapists, prescribed medicines, travel to GP, and
medical appointments, were all significantly higher (p<0.05) than controls, but the
associated costs were reasonably low (mean costs €31, €9, €14, €8, €36, and €44 p.a.,
respectively; Table 7.A.1; Appendix 7). Notably, private health insurance was a factor
for Irish adults with MDCD (mean cost €95 p.a., p-value<0.01), but not in NI. Visits to
GP surgeries, dieticians and prescribed medicine were all found to be significantly higher
(p-value<0.01) for those with MDCD in NI (mean costs €50, €26, and €6, respectively).
However, the data suggests that costs associated with medical visits (€296 p.a., pvalue<0.01), and the total cost of hospital visits and stays (€165 p.a.) were the main
drivers in the overall higher costs for MDCD adults in NI compared to Ireland. In
addition, food costs were a factor in the overall direct costs, with reported costs of €164
p.a. (€221 p.a. prior to claiming the tax rebate for gluten free foods) in Ireland, and €370
in NI. Notably, food costs were only found to be significantly higher (p<0.05) in NI.

There was a difference in indirect costs between Ireland and NI. In fact, indirect costs
were found to be largely negligible (cost €-6 p.a.; with very little difference) in Ireland,
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compared to a statistically significant €730 p.a. (p-value<0.01) in NI. A higher cost
associated with preparing food (€203p.a), and days missed from work, school, or college,
(€486 p.a.) was reported in NI (Table 7.A.1), with an average of 6.7 missed days p.a. in
NI compared to 0 days in Ireland. The higher direct and indirect costs reported in NI
resulted in a significant total cost of €1,586 p.a. (p-value<0.01); similar to the total cost
reported for MDFA adults in NI (€1,461 p.a. p<0.05). In contrast, the total cost for
MDCD adults was found to be €438 p.a. (or €495 p.a. prior to claiming a tax rebate for
gluten free foods) in Ireland.
These total costs were also broken down into ‘out-of-pocket’ (mainly non-health) or
healthcare costs. In fact, 71% (€1,121 p.a.) of the total cost was reported to be borne
alone by MDCD adults in NI and 66% (mean cost €290) in Ireland, in the form of ‘outof-pocket’ costs (Table 4.1.2c). The remaining 29% and 34% (respectively), were
calculated as health care costs associated with MDCD. While the latter costs are shared
with the health service in each jurisdiction, they would still have increased the yearly
expenditure of MDCD adults, as a results of their condition.

Food intolerance / suspected food allergy
The mean direct costs reported for adult FI (n=536) in Ireland (mean cost €350 p.a.) were
found to be similar, although slightly lower, than the equivalent chohort (n=459) in NI
(€438 p.a.) (Tables 4.1.2a and 4.1.2b).

Notably, neither cohort was found to be

statistically significant. In Ireland, the total cost of medical appointments, hospital stays,
food, and travel to appointments were found to be higher for FI adults (€79, €95, €82,
€71 p.a., respectively) with just the last cost being statistically significant (p-value<0.01).
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Similarly, the total cost of medical appointments, hospital stays, and travel to
appointments were found to be higher for FI adults in NI (€189, €91, €178, respectively);
the higher cost for hospital stays was not statistically significant (p-value<0.01). Food
costs were not reported as an additional expense for FI adults in NI, when compared to
controls. Indirect costs were similar but statistically insignificant for Ireland (€154 p.a.)
and NI (€218 p.a.). The total cost for FI adults was €504 p.a. in Ireland and 23% higher
(€656 p.a.) in NI; this was found to be statistically significant (p-value<0.05). When the
breakdown of these total costs was examined with regard to ‘out-of-pocket’ (mainly nonhealth) and healthcare costs. FI adults were found to incur 69% (€349 p.a.) of the total
cost in Ireland, alone as ‘out-of-pocket’ costs. While their NI counterparts bore 60%
(€395 p.a.) of the total cost alone as ‘out-of-pocket’ costs. The remaining 31 and 40%
(respectively), were healthcare costs shared by respondents and the health service in each
jurisdiction. A barchart of total additional costs (direct plus indirect) by condition in
Ireland and NI for adults is presented in Figure 4.1.2b for ease of comparison.
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Table 4.1.2a: Direct, Indirect and Total Costs (Direct + Indirect) associated with adult (≥18 years) food hypersensitivity (selfreported): MDFA (n=178), MDCD (n=609) and FI (n=536) compared to non-food hypersensitive controls (n=531) in Ireland (Nov
2019 – Oct 2020)
Ireland MDFA Adults (n=178)

Ireland MDCD Adults (n=609)

Ireland FI Adults (n=536)

Cost in Euro per annum

Cost in Euro per annum

Cost in Euro per annum

Total Cost of Medical Visits

178*

78

79

Total Cost of Travel to Medical Visits

71**

44**

71**

Total Cost of Hospital Visits & Stays

291

76

95

Total Cost of Medication

52**

-13

1

Private Health Insurance

9

95**

22

Total Healthcare Costs

601

280

268

724**

164/221

82

1,325**

444/501

350

Ireland MDFA Adults (n=178)

Ireland MDCD Adults(n=609)

Ireland FI Adults (n=536)

Cost in Euro per annum

Cost in Euro per annum

Cost in Euro per annum

Time spent Food shopping

57

-23

-17

Time spent Preparing food

-5

6

71

222

0

104

3

11

-4

277

-6

154

1,602**

438/495

504

COMPONENTS OF DIRECT COSTS

Total Food Cost
TOTAL DIRECT COSTS

COMPONENTS OF INDIRECT COSTS

Days missed from Work/School/College
Lost Earning associated with healthcare visits
TOTAL INDIRECT COSTS
TOTAL DIRECT & INDIRECT COSTS
*p <0.05 and ** p <0.01 are statistically significant

 Costs excluding/including a tax rebate on gluten-free foods reported as claimed by 29% of MDCD adults in Ireland
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Table 4.1.2b: Direct, Indirect and Total Cost (Direct + Indirect) associated with adult (≥18 years) food hypersensitivity (selfreported): MDFA (n=111), MDCD (n=173) and FI (n=459) compared to non-food hypersensitive controls (n=204) in Northern
Ireland (Nov 2019 – Oct 2020)
NI MDFA Adults (n=111)

NI MDCD Adults (n=173)

NI FI Adults (n=459)

Cost in Euro per annum

Cost in Euro per annum

Cost in Euro per annum

Total Cost of Medical Visits

326*

296**

189**

Total Cost of Travel to Medical Visits

111

43

178**

Total Cost of Hospital Visits & Stays

500

165

91

Total Cost of Medication

19**

6

10**

Private Health Insurance

1

-24

-10

Total Healthcare Costs

957

486

458

Total Food Cost

25

370*

-20

TOTAL DIRECT COSTS

982

856**

438

NI MDFA Adults (n=111)

NI MDCD Adults (n=173)

NI FI Adults (n=459)

Cost in Euro per annum

Cost in Euro per annum

Cost in Euro per annum

Time spent Food shopping

36

15

-41

Time spent Preparing food

59

203

-31

Days missed from Work/School/College

384

486*

267**

0

26*

23*

479*

730**

218

1,461*

1,586**

656

COMPONENTS OF DIRECT COSTS

COMPONENTS OF INDIRECT COSTS

Lost Earning associated with healthcare visits
TOTAL INDIRECT COSTS
TOTAL DIRECT & INDIRECT COSTS
*p <0.05 and **p <0.01 are statistically significant
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-*p <0.05 and **p <0.01 are statistically significant

 Costs excluding/including a tax rebate on gluten-free foods reported as claimed by 29% of MDCD adults in Ireland

Figure 4.1.2a: Additional Mean Direct, Indirect & Total Costs (euro per annum) for adults with food hypersensitivity (self-reported)
based on cost data collected from an online survey conducted between November 2019 to October 2020 in Ireland (n=1,323) and
Northern Ireland (n=743)
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Mean Direct & Indirect Costs for Adults with Food Hypersensitivity (self-reported) in Ireland
& NI

* p <0.05 and **p <0.01 are statistically significant

 Costs excluding/including a tax rebate on gluten-free foods reported as claimed by 29% of MDCD adults of Ireland
Adult Sample Sizes: MDFA Ireland=178, MDFA NI=111, MDCD Ireland=609, MDCD NI=173, FI Ireland=536, FI NI=459, Control
Group Ireland=531 and NI=204

Figure 4.1.2b. Additional Mean Total (Direct + Indirect) costs (euro per annum) for
adults with food hypersensitivity (self-reported) based on cost data collected from
an online survey conducted between November 2019 and October 2020 in Ireland
(n=1,323) and Northern Ireland (n=743)
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Table 4.1.2c: Additional (incremental) Healthcare and out-of-pocket costs (mainly
non-healthcare) in euro (€) associated with adult (≥18 years) food hypersensitivity
(self-reported) in Ireland and Northern Ireland: MDFA (n=178; n=111); MDCD
(n=609; n=173); FI (n=536; n=459), compared to non-food hypersensitive controls
(n=531; n=204), respectively (November 2019 – October 2020)
Ireland

NI

MDFA Adults

Ireland

NI

MDCD Adults

Ireland

NI

FI Adults

Incremental Cost in Euro (€)
Healthcare Costs
(borne by respondents
& the health service)
Out-of-Pocket Costs
(borne by respondents
alone)
Total Cost

461

834
(57%)

148
(34%)

465
(29%)

155
(31%)

261
(40%)

(71%)

627
(43%)

290
(66%)

1,121
(71%)

349
(69%)

395
(60%)

1,602

1,461

438

1,586

504

656

Number in group

178

111

609

173

536

459

Number in comparison
group

531

204

531

204

531

204

(29%)
1,141

* Table 2.2.1b lists the components of (a) Healthcare costs and (b) Out-of-pocket costs for each food hypersensitivity. These are
described in depth in Tables 7.A.1 (Euro) and 7.A.2 (Sterling) in Appendix 7. MDCD figures for Ireland are reported after the tax
rebate on gluten free food had been subtracted.
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4.2. Results for the calculation of Socio-Economic Costs associated with
Food Hypersensitivity on the Island of Ireland: CHILDREN AND
ADOLESCENTS
4.2.1 Overview of the parental food hypersensitivity (self-reported) dataset for
Ireland and NI
In section 4.2. we compared 173 and 147 responses from the parental surveys for children
and adolescents with MDFA, 148 and 60 responses for MDCD, and 56 and 51 responses
for FI to 130 and 165 controls in Ireland and NI, respectively. Notably these groups have
been reweighted so that they are in turn similar to each of these groups, as described in
the methodology as per chapter 2. Given the small number of adolescents for many
groups (Table 2.2.2a) we do not include the figures for this group separately, and instead
present children and adolescents together. Costs were calculated for a family with just
one FH child or adolescent in this study, although many families have more than one. No
statistically significant difference was found between gender in the cohorts examined.
Tables 4.2.2a and 4.2.2b show a summary of the breakdown of direct and indirect costs,
and total costs under selected headings in Ireland and NI.

Statistical analysis was conducted by comparing costs reported for each of the 6 parental
test groups with their comparative (non-food hypersensitive) control groups. More
detailed tables of these costs for children and adolescents in euro and in pounds sterling
are available in Appendix 7 (Table 7.A.3 in euro and 7.A.4 in pounds sterling).

As a visual guide, Figure 4.2.2a displays the mean and confidence intervals for the direct,
indirect, and total incremental costs for each food hypersensitive group (FI, MDCD,
MDFA) for the parental surveys in Ireland and NI respectively. In addition, a barchart
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of total additional costs (direct and indirect) by condition and jurisdiction for the parents
of children/adolescents with MDFA is presented in Figure 4.2.2b, for ease of comparison.

4.2.2. Examination of Additional (Incremental) Monetary Costs associated with
Food Hypersensitivity in Children and Adolescents reported by parents in Ireland
and NI: Direct & Indirect Costs
Medically diagnosed food allergy
Direct costs associated with MDFA children and adolescents were reported as a mean
cost of €1,115 p.a. in Ireland (n=173) compared to €1,404 p.a. in NI (n=147) (Tables
4.2.2a and 4.2.2b). Both of these costs were significantly higher (p value <0.01) than that
of their corresponding controls (Ireland n=130, NI n=165, respectively).

The cost of medical appointments reported by parents of children/adolescents with
MDFA was found to be significantly higher for families affected by MDFA in Ireland
(mean cost €386, p value<0.01) and NI (mean cost €391, p value<0.01) (Tables 4.2.2a
and 4.2.2b). In Ireland, this was comprised of increased costs associated with visits to
GP surgeries, consultants/specialists, pharmacists, and dieticians (mean cost €76, €131,
€148 and €17, respectively), all of which were found to be significantly higher (p
value<0.01) than the control group (Table 7.A.3; Appendix 7). Similarly, increased costs
associated with visits to GPs, consultants/specialists, pharmacists, dieticians and travel
costs (mean cost €85, €118, €102, €59 and €286 respectively; p value<0.01) were noted
for families of MDFA children and adolescents (parent-reported) living in NI.
Comparable costs for hospital visits were reported in Ireland (mean cost of €542 p.a.) and
NI (mean cost of €595 p.a.), both of which were significant (p value<0.01 and <0.05,
respectively) when compared to controls (Tables 4.2.2a and 4.2.2b). These mainly
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comprised of outpatient, day units and emergency department attendance (without, and
with subsequent admission to hospital in Ireland: mean cost €82, €175, €130 (p value
<0.05) and €150, respectively). This was the same as in NI: mean cost €128, €195, €66
(p value<0.05), and €193, respectively (Table 7.A.3; Appendix 7).

Other increased costs for families affected by MDFA children and adolescents were the
total cost of medication and private health insurance in both Ireland (mean cost €93, p
value<0.01 and €85, respectively) and NI (mean cost €34 and €33, respectively; p
value<0.01). Food costs for families of children and adolescents with MDFA were not
found to be significantly higher compared to controls in Ireland (mean cost €-14 p.a.;
with very little difference) or NI (mean cost €64 p.a.).

With regard to indirect costs, families of MDFA children and adolescents incurred
additional comparable costs in Ireland (mean cost €324) and NI (mean cost €239).
However, neither were found to be significantly higher compared to controls (Tables
4.2.2a and 4.2.2b). That said, 'days missed' and 'lost earnings' were significant (p
value<0.01) when examined independently for Ireland (mean cost €302 and €170,
respectively). The former was also significant in NI (€142, p value<0.05), but not the
latter (€56 p.a.). Similar to indirect costs calculated for MDFA adults, these figures are
lower than those reported for children and adolescents in Sweden (mean cost €1,876 p.a.
and €1,900 p.a., respectively).

The total mean additional cost (direct + indirect costs) incurred by parents of MDFA
children and adolescents in this study was calculated at €1,439 p.a. in Ireland and €1,643
p.a. in NI (Tables 4.2.2a and 4.2.2b). Both of these figures were significantly higher (p
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value<0.1) than controls highlighting the cumulative additional costs associated with this
condition.
Total costs were also examined as ‘out-of-pocket’ (mainly non-health) and healthcare
costs. Notably 35% (€499 p.a.) of the total cost was reported to be borne alone by
households of MDFA children and adolescents in Ireland, in the form of ‘out-of-pocket’
costs, and 39% (€641 p.a.) in NI – as per table 4.2.2c. The remaining 65% and 61%
(respectively) were deemed as healthcare costs. While these latter costs are shared with
the health service in each jurisdiction, they still add to the financial burden on families
with a MDFA child/adolescent.

Medically diagnosed coeliac disease
With regard to food hypersensitivity related expenses reported by parents with MDCD
children/adolescents, significant direct costs were calculated in Ireland (mean cost €903;
p-value <0.01; n=148) and NI (mean cost €1,871 p.a.; p-value<0.01; n=60); when
compared with the corresponding control groups (Ireland: n=130; NI: n=165) (Tables
4.2.2a and 4.2.2b).
Notably the direct cost associated with having a MDCD child in Ireland, was €993 p.a.,
prior to the subtraction of tax-relief granted for gluten free food purchases. For Ireland,
the cost of medical visits was found to be a statistically significant expense for families
(mean cost €253 p.a.; p-value<0.01), particularly consultant/specialist appointments
(mean cost €117 p.a.; p-value<0.01). Notably, a higher figure for medical visits was
reported by parents of MDCD children and adolescents in NI (mean cost €503; pvalue<0.01) than for Ireland (Table 7.A.3; Appendix 7). This was driven by visits to GP
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surgeries (mean cost €45 p.a.), consultant/specialist appointments (mean cost €147 p.a.),
and visits to pharmacists (mean cost €206 p.a.) in NI; all of which were found to be
statistically significant (p-value<0.01) for these families when compared to controls.

In addition, travel to medical appointments and hospital stays were reported to be higher
for parents of MDCD children and adolescents in NI (mean cost €414 and 298 p.a.,
respectively; p-value <0.05) than in Ireland (mean cost €14 and 167 p.a., respectively).

While costs associated with private health insurance were higher in Ireland (mean cost
€189 p.a.; p-value <0.01) than NI (mean cost €48; p-value<0.05), the costs of medication
were comparable (mean cost Ireland €23 p.a.; p-value<0.05 and NI €59 p.a.; pvalue<0.01).

Food costs for MDCD children and adolescents were significantly higher in both Ireland
at a cost €257 p.a, (p-value<0.01, or €347 prior to the subtraction of a tax rebate for gluten
free food purchases), and in NI at €549 p.a.; (p-value<0.01) (Tables 4.2.2a and 4.2.2b).
Notably, food costs for MDCD children and adolescents in the ROI and NI were a
significant household cost, but not for their MDFA or FI counterparts.
Indirect costs were higher for the MDCD cohorts in Ireland (mean cost €130 p.a.) and NI
(mean cost €96 p.a.) when compared to controls, but not significantly so. The main driver
was 'days missed from work/school/college' particularly in NI where it was a significant
cost (cost €406 p.a.; p-value <0.05), compared to Ireland where it was not (€115 p.a.). In
fact, an average of 5.6 missed days p.a. was reported by the parents of
children/adolescents with MDCD questioned in NI, compared to 1.5 days in Ireland.
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The overall total additional cost was however significant in both Ireland at €1,033 (pvalue <0.01, or €1,123 prior to the subtraction of a tax rebate for gluten free food
purchases) and NI (€1,967; p-value <0.01); highlighting the additional expenses incurred
by this condition.
Total costs were also examined as ‘out-of-pocket’ (mainly non-health) and healthcare
costs. Notably, 59%, €607 p.a. (or €697 p.a., prior to claiming the gluten free food tax
rebate) of the total cost was reported to be borne alone by households of MDCD children
and adolescents in Ireland in the form of ‘out-of-pocket’ costs, and 60%, €1,178 p.a. in
the NI – as per table 4.2.2c. The remaining 41% and 40%, respectively, were healthcare
costs incurred by the respondents and health service in each jurisdiction. While annual
reported ‘out-of-pocket’ costs were high (particularly in NI), these additional healthcare
costs would also have increased the yearly expenditure of families of MDCD children
and adolescents.

Food intolerance / suspected food allergy
Out of all of the surveys conducted this study, the FI questionnaire for children and
adolescents had the lowest number of respondents with 56 surveys in Ireland and 51 in
NI. Despite several online promotion attempts during the course of this project; this
questionnaire had the lowest level of uptake of all the survey target groups.

Direct Costs were not found to statistically significant for children and adolescents
reported in the FI category (Ireland: €-128; with very little difference, NI: €337 p.a.).,
compared to their MDFA and MDCD counterparts in Ireland and NI. The higher cost
for NI was mainly driven by medical visits, including travel to medical appointments
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(€208; p-value<0.01 and €74 p.a.; p-value<0.05), compared to Ireland (€73 and €9 p.a.,
respectively). Variation also occurred in the total indirect costs between Ireland and NI
groups, none of which were found to be statistically significant (€198 and €-271 p.a. with
very little difference for NI, respectively).
The total cost for FI children and adolescents were found to be similar for Ireland at €70
p.a. and NI at €66 p.a., none of which were found to be statistically significant. This
contrasts with their MDFA and MDCD counterparts in Ireland and NI, for which the cost
of having a child with either condition was found to be a significant additional financial
burden on their households.
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Table 4.2.2a: Direct, Indirect and Total Cost (Direct & Indirect) associated with children/adolescents (<18 years) with food
hypersensitivity (parent-reported): MDFA (n=173), MDCD (n=148) and FI (n=56) compared to non-food hypersensitive controls
(n=130) in Ireland (November 2019 – October 2020)
Ireland MDFA CHILD & ADOLESCENT
(n=173)

Ireland MDCD CHILD & ADOLESCENT
(n=148)

Ireland FI CHILD &
ADOLESCENT(n=56)

Cost in Euro per annum

Cost in Euro per annum

Cost in Euro per annum

386**

253**

73

Total Cost of Travel to Medical Visits

23

14

9

Total Cost of Hospital Visits & Stays

542**

167

-106

Total Cost of Medication

93**

23*

24**

Private Health Insurance

85

189**

32

Total Healthcare Costs

1,129

646/646

32

-14

257**/347

-160

1,115**

903**/993

-128

Ireland MDFA CHILD & ADOLESCENT
(n=173)

Ireland MDCD CHILD & ADOLESCENT
(n=148)

Ireland FI CHILD& ADOLESCENT
(n=56)

Cost in Euro per annum

Cost in Euro per annum

Cost in Euro per annum

Time spent Food shopping

-29

64

59

Time spent Preparing food

-119

-83

18

Days missed from Work/School/College

302**

115 (-29, 259)

98

Lost Earning associated with healthcare visits

170**

34 (-8, 75)

23

324

130

198

1,439**

1,033**/1,123

70

COMPONENTS OF DIRECT COSTS
Total Cost of Medical Visits

Total Food Cost
TOTAL DIRECT COSTS

COMPONENTS OF INDIRECT COSTS

TOTAL INDIRECT COSTS
TOTAL DIRECT & INDIRECT COSTS

*p <0.05 and **p <0.01 are statistically significant
Costs excluding/including a tax rebate on gluten-free foods claimed by 30% of parents of MDCD children/adolescents in Ireland
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Table 4.2.2b: Direct, Indirect and Total Cost (Direct & Indirect) associated with children/adolescents (<18 years) with food
hypersensitivity (parent-reported): MDFA (n=147), MDCD (n=60) and FI (n=51) compared to non-food hypersensitive controls
(n=165) in Northern Ireland (November 2019 – October 2020)
NI MDFA CHILD & ADOLESCENT
(n=147)

NI MDCD CHILD & ADOLESCENT
(n=60)

NI FI CHILD & ADOLESCENT
(n=51)

Cost in Euro per annum

Cost in Euro per annum

Cost in Euro per annum

Total Cost of Medical Visits

391**

503**

208**

Total Cost of Travel to Medical Visits

286**

414*

74*

Total Cost of Hospital Visits & Stays

595*

298*

-18

Total Cost of Medication

34**

59**

10

Private Health Insurance

33**

48*

16*

Total Healthcare Costs

1,339

1,322

290

65

549**

47

1,404**

1,871**

337

NI MDFA CHILD & ADOLESCENT
(n=147)

NI MDCD CHILD & ADOLESCENT
(n=60)

NI FI CHILD & ADOLESCENT
(n=51)

Cost in Euro per annum

Cost in Euro per annum

Cost in Euro per annum

Time spent Food shopping

-61

8

-71

Time spent Preparing food

102

-325*

-382**

Days missed from Work/School/College

142*

406*

167

Lost Earning associated with healthcare visits

56

7

15

TOTAL INDIRECT COSTS

239

96

-271

1,643**

1,967**

66

COMPONENTS OF DIRECT COSTS

Total Food Cost
TOTAL DIRECT COSTS

COMPONENTS OF INDIRECT COSTS

TOTAL DIRECT & INDIRECT COSTS
*p <0.05 and **p <0.01 are statistically significant
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-*p <0.05 and **p <0.01 are statistically significant
Costs excluding/including a tax rebate on gluten-free foods claimed by 30% of parents of MDCD children/adolescents in Ireland

Figure 4.2.2a: Additional Mean Direct, Indirect & Total Costs (euro per annum) for food hypersensitive children/adolescents
(parent-reported) based on cost data collected from an online survey conducted between November 2019 and October 2020 in Ireland
(n=377) and Northern Ireland (n=258)
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2500
1967**

Mean Euro Per Annum

2000
1643**
1500

1439**
1033**/1123

1000

500
70

66

0
Child MDFA Child MDFA NI Child MDCD Child MDCD NI Child FI ROI
ROI
ROI

Child FI NI

Mean Direct & Indirect Costs assoicated with Children/Adolescents with Food
Hypersensitivity in Ireland & NI
* p <0.05 and **p <0.01 are statistically significant

 Costs excluding/including a tax rebate on gluten-free foods claimed by 30% of parents of MDCD children/adolescents in Ireland
Children/Adolescent Sample Sizes: MDFA Ireland=173, MDFA NI=147, MDCD Ireland=148, MDCD NI=60, FI Ireland=56, FI NI=51,
Control Groups Ireland=130 and NI=165

Figure 4.2.2b: Additional Mean Direct & Indirect Costs (euro per annum) for
families with a food hypersensitivity child or adolescent (parent-reported), based on
cost data collected from an online survey conducted between November 2019 to
October in Ireland (n=377) and NI (n=258)
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Table 4.2.2c: Additional (incremental) healthcare and out-of-pocket costs in euro
(€) associated with children/adolescents (<18 years) with food hypersensitivity
(parent-reported) in Ireland and Northern Ireland: MDFA (n=173; n=147); MDCD
(n=148; n=60); FI (n=56; n=51) compared to non-food hypersensitive controls
(n=130; n=165), respectively (November 2019 – October 2020)
Ireland

NI

Ireland

MDFA Parental

NI

MDCD Parental

Ireland

NI

FI Parental

Incremental Cost in Euro (€)
Healthcare Costs
(borne by
respondents
& the health
service)

940
(65%)

1,002
(61%)

426
(41%)

789
(40%)

-39
(26%)

176
(62%)

Out-of-Pocket Costs
(borne by
respondents alone)

499
(35%)

641
(39%)

607
(59%)

1,178
(60%)

109
(74%)

-110
(38%)

Total Cost

1,439

1,643

1,033

1,967

70

66

Number in group

173

147

148

60

56

51

Number in
comparison group

130

165

130

165

130

165

* Table 2.2.1b lists the components of (a) Healthcare costs and (b) Out-of-pocket costs for each food hypersensitivity. These are
described in depth in Tables 7.A.3 (Euro) and 7.A.4 (Sterling) in Appendix 7. MDCD figures for Ireland are reported after the tax
rebate on gluten free food had been subtracted.
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4.3. Examination of the Factors Contributing to Additional Costs for
those with Food Hypersensitivity
This study examined data provided by 2,066 adults with food hypersensitivity (selfreported) against information collected from a separate control survey of non-food
hypersensitive adults (n=735) in Ireland and NI. Similarly, reported costs associated with
having a food hypersensitive child or adolescent from 635 parental surveys were
examined in comparison to data from parents of non-food hypersensitive child/adolescent
(n=295). A total of 12 test groups were studied, consisting of 3 different food
hypersensitivities (MDFA, MDCD and FI), in the adult and parents of child/adolescent
cohorts in both Ireland and NI.
Higher total costs of additional condition-related expenses (€66 up to €1,643 p.a.) were
calculated for the 12 food hypersensitive cohorts examined. The yearly out-of-pocket
costs (mainly non healthcare) borne by individuals and households alone, ranged from
negative to up to €1,178 p.a. (Table 4.1.2c & 4.2.2c), depending on the condition
examined. While healthcare costs (shared by the respondents and health service) were
reported as high as €940 p.a in Ireland and €1,002 p.a. in NI, for some sample groups.
Notably, healthcare costs were consistently the main driver of food hypersensitivity
related expenses for individuals and households in this study (sections 4.1. and 4.2; Table
7.A.1 and 7.A.3; Appendix 7).
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4.3.1 Additional healthcare costs for food hypersensitive consumers on the Island of
Ireland
If all the healthcare elements examined (medical visits, hospital visits/stays, associated
travel, medication and insurance) are combined into one figure per test group, certain
trends are observed (Figure 4.3a and Figure 4.3b).

Individuals with MDFA

(child/adolescent and adult) had higher healthcare related outgoings in Ireland (€601 to
€1,129 p.a.) and NI (€957 to €1,339 p.a.) than other food hypersensitive groups. This
was followed by MDCD, who reported the next highest healthcare related costs for
Ireland (€280 to €646 p.a.) and NI (€486 to €1,322 p.a.). FI had the lowest set of
healthcare related costs for Ireland (€32 to €268 p.a.) and also for NI (€290 to €458 p.a.).

The second observation noted, is that healthcare costs were higher for all of the NI test
groups, in comparison to their Ireland counterparts (Figure 4.3a and Figure 4.3b). In fact,
healthcare costs were reported to be approximately 40% higher in NI for all of the food
hypersensitive adult groups, than in Ireland.

Similarly, they were reported to be

approximately 39% higher by all parental groups of food hypersensitive children and
adolescents. This difference was found to range from costs of €190 p.a. (Adult, FI) up
to €676 p.a. (Children & Adolescent, MDCD) when the two jurisdictions were compared.
The result being higher healthcare costs, for MDCD individuals/households in NI
(although shared with the health service), compared to Ireland, in many instances (Table
4.1.2c & 4.2.2c).

One additional finding regarding private healthcare can be seen in Tables 7.A.1 and 7.A.3
in Appendix 7. Higher additional private health insurance related costs were noted for
the families of food hypersensitive children/adolescents in Ireland (€32 to €189 p.a.),
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compared to the same group in NI (€16 to €48 p.a.). A similar observation was made
regarding private health insurance costs for food hypersensitive adult respondents in
Ireland (mean cost €9 to €95 p.a.), compared to NI (mean cost €-24 to €1 p.a.) (sections
4.1 and 4.2).

4.3.2 Additional food costs for food hypersensitive consumers on the Island of
Ireland
With regard to food related expenses (shopping, eating out, take-aways, etc.), all of the
adult respondents in both jurisdictions were found to have higher mean total food costs
than their control counterparts (range €82 to €724 p.a.), with the exception of FI in NI
(mean cost €-20 p.a.). Similarly, the mean additional food costs ranged from €47 to €549
p.a. for the parental groups, with the exception of MDFA and FI in Ireland (mean cost €14 and €-160 p.a., with very little difference, respectively). If we examine food costs by
condition, additional food costs were consistently high (and often significant p<0.05) for
MDCD respondents on the Island of Ireland. However, MDCD food costs were reported
as higher for individuals/households in NI at €370 to €549 p.a, than for Ireland at €164
to €257 p.a. (or €221 to €347 p.a. prior to claiming tax relief on gluten free food),
respectively.

Tax relief on gluten-free foods is available in Ireland and was considered, when reported,
in the final calculated figure by survey respondents (30% of parental and 29% adult of
MDCD survey respondents claimed tax-relief when asked). It is worth noting, that
certain gluten-free food products are currently free-of-charge for coeliac individuals in
NI on prescription, but would not have been included in their final food costs for NI.
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Lastly, food costs were also reported to be high for the MDFA adult group in the ROI
(€724 p.a. p<0.01), but not for the other test groups examined.
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Adult FI NI

Mean Healthcare Costs for Adults with Food Hypersensitivity (self-reported) in
Ireland & NI

Adult Sample Sizes: MDFA Ireland=178, MDFA NI=111, MDCD Ireland=609, MDCD NI=173, FI Ireland=536, FI NI=459, Control
Group Ireland=531 and NI=204
A statistical analysis for incremental costs for each condition between Ireland and NI was not carried out as these data sets are separate
and cannot readily be compared given the reweighting of controls.
 Costs excluding/including a tax rebate on gluten-free foods claimed by 29% of MDCD adults in Ireland

Figure 4.3a Additional mean healthcare costs (euro per annum) for adults with food
hypersensitivity based on cost data collected from an online survey conducted
between November 2019 and October 2020 in Ireland (n=1,323) and Northern
Ireland (n=743)
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Mean Healthcare Costs for Children reported with Food Hypersensitivity in
Ireland & NI
Children/Adolescent Sample Sizes: MDFA Ireland=173, MDFA NI=147, MDCD Ireland=148, MDCD NI=60, FI Ireland=56, FI NI=51,
Control Groups Ireland=130 and NI=165
A statistical analysis for incremental costs for each condition between Ireland and NI was not carried out as these data sets are
separate and cannot readily be compared given the reweighting of controls.
 Costs excluding/including a tax rebate on gluten-free foods claimed by 30% of parents of MDCD children/adolescents in Ireland

Figure 4.3b: Additional Mean Healthcare Costs (euro per annum) for
children/adolescents with food hypersensitivity (parent-reported) based on cost
data collected from an online survey conducted between November 2019 and
October 2020 in Ireland (n=377) and Northern Ireland (n=258)
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4.3.3 Additional indirect costs for food hypersensitive consumers on the Island of
Ireland
A large amount of variation was reported in indirect costs across the test groups; where
they were in some cases negligible and in others a significant cost. This variation was
often associated with responses for ‘time spent preparing food’. The main driver of
indirect cost was associated with ‘days missed from work/school/college’. These costs
tended to higher in responses from NI (€142 to €486), than in Ireland (€0 to €302). In
more general terms, indirect costs were found to contribute to the overall total cost (€96
to €730 p.a.) of food hypersensitivity for all groups, with the exception of adult MDCD
in Irelandand child/adolescents FI in NI (sections 4.1. and 4.2). While a higher overall
cost was attributed to indirect costs in most instances, they were only found to be a
statistically significant for MDFA and MDCD adults in NI (€479 p<0.05, and €730
p<0.01).

4.3.4 Additional Out-of-Pocket costs for food hypersensitive consumers on the
Island of Ireland
All of the parameters examined in this study were found to contribute to increases in the
overall cost of food hypersensitivity in Ireland and NI. Most notable was the contribution
of health care related expenses (Figures 4.3a and 4.3b), although total food costs, lost
earnings, and lost days of work/college/schools (among other aspects) were significant
in some of the cohorts studied. Out-of-pocket costs (as opposed to healthcare costs) borne
alone by individuals and households (parental survey), were found to range from €499 to
€1,141 p.a. for MDFA in Ireland, and €627 to €641 p.a. in NI (Table 4.1.2c & 4.2.2c).
While the equivalent for MDCD was found to range from €290 to €607 p.a. in Ireland
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(€347 to €697 p.a. prior to claiming a tax rebate on gluten free foods), and €1,121 to
€1,178 p.a. in NI.

In addition, respondents shared in an unknown amount of healthcare cost with their health
service provider (€461 to €940 p.a. for MDFA in Ireland, and €834 p.a to €1,002 p.a. in
NI, and €148 to €426 p.a. for MDCD in Ireland, and to €465 to €789 p.a. in NI), adding
to their annual burden of expense. These figures highlight the high additional costs
associated with diagnosis of either condition for individuals and families. Condition
associated out-of-pocket costs were also noted for three of the FI cohorts, to a lesser
amount (€109 to €395 p.a.), than others examined in this study. Out-of pocket costs were
not reported for the FI parental NI group.
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4.4 Examination of Intangible
Hypersensitivity in Ireland and NI

Costs

associated

with

Food

Intangible costs were examined for adults aged ≥ 18 years, children aged 0 to 12 years
and adolescents aged 13 to 17 years. Intangible costs are defined as a loss of value or
utility. This can be difficult to measure in monetary terms but can be examined through
self-reported health status. Intangible costs are typically examined via a health-related
quality of life (HRQL) assessment (Miles et al. 2005) which focuses on an individual’s
perception of the overall effects of the associated illness and its treatment. More
specifically this includes aspects of physical, psychological, and social well‐being and
functioning. For the purposes of this study, the EQ-5D questionnaire (sections 4.4.1 4.4.3) and a specific food hypersensitivity intangible question (section 4.4.4.) included in
all surveys, are presented here.

4.4.1. EQ-5D Questionnaire: Examination of the 5 Dimensions
EQ-5D is a standardised health-related quality of life questionnaire. The five dimensions
examined in EQ-5D relate to various aspects of health and have been widely used to
assess health states and health-related quality of life for different conditions in many
countries including Ireland (e.g., 0.60 for patients on hemodialysis, 0.59 for individuals
with multiple sclerosis, and 0.49 for rheumatoid arthritis etc., Adams et al. (2010),
Lowney et al. (2015), MSS (2015). However, it is notable that the EQ-5D questions have
not been designed specifically to examine food hypersensitivity but are instead a
mechanism to assist in measuring the overall impact of a disease or illness on an
individual’s QoL.
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From this perspective, dimensions such as ‘mobility’ and the ability of a food
hypersensitive person to complete their ‘usual activities’ unhindered or ‘look after him
or herself’, while included as part of the EQ-5D questionnaire were unlikely to be affected
by food hypersensitivity. Pearson Chi-squared was used to compare differences between
the control and food hypersensitive groups and no patterns or significant differences were
noted between groups with regard to the 3 aforementioned dimensions. However,
significant differences were noted between the food hypersensitive groups and the control
group with regard to the 2 dimensions of the EQ-5D: ‘having pain or discomfort’ and
‘having anxiety and depression’ (Figures 4.4.1a and 4.4.1b).

From data reported in the parental study, children belonging to all three groups (MDFA,
MDCD, and FI) on the Iol (n=223, n=116, n=73, respectively) were found to have
significantly higher levels of pain and discomfort (p<0.05) compared to controls (n=212)
(Figure 4.4.1a). Similarly, adults belonging to all three food hypersensitive groups
(MDFA, MDCD, and FI) on the IoI (n=194, n=528, n=767, respectively) were found to
have a significantly higher level (p-value <0.05) of pain and discomfort compared to
controls (n=669). With regard to adolescents, a significant difference was only found for
the FI group (and not MDFA and MDCD) for this dimension. However, it should be
noted that the sample size of this group (n=14) was smaller than others examined which
may have had a bearing on this result. These findings strongly suggest a relationship
between food hypersensitivity and higher levels of pain and discomfort in the daily lives
of those affected.
With regard to the last dimension, ‘feeling worried or sad’ (Figure 4.4.1b), no significant
difference was found between child MDFA, MDCD and FI and their corresponding
218

controls (n=223, n=116, n=73, and n=212, respectively). In contrast, MDFA and FI
adolescents were found to have significantly higher levels of anxiety and depression
(<0.05) than their controls. While adolescents with MDCD did have a higher level of
sadness and anxiety when compared to their corresponding control group, this was not
found to be statistically significant. Notably, a significantly higher level of anxiety and
depression (p<0.05) was found for adults in all three of the food hypersensitive groups
compared to controls (n=194, n=528, n=767, and n=669 respectively). These findings
suggest an increased level of anxiety and depression associated with having a food
hypersensitivity in the adult and adolescent groups examined. However, it was noted that
the levels of anxiety and depression were higher for MDFA and FI. This finding may be
underpinned by a greater ability of those with MDCD to manage and control their
condition, compared to those with MDFA or FI.
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* a versus b, c versus d, and e versus f are significantly different (p value <0.05)

Figure 4.4.1a: Self-reported and parent-reported health status associated with food
hypersensitivity in children (n=412), adolescents (n=98), adults (n=1,489) and nonfood hypersensitive controls (n=962) on the Island of Ireland under the EQ-5D
dimension of ‘Pain and Discomfort’
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*a versus b, and c versus d are significantly different (p value <0.05)

Figure 4.4.1b: Self-reported and parent-reported health status associated with food
hypersensitivity in children (n=412), adolescents (n=98), adults (n=1,489) and nonfood hypersensitive controls (n=962) on the island of Ireland under the EQ-5D
dimension of ‘Feeling worried, sad or unhappy’
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4.4.2. EQ-5D Questionnaire: Examination EQ-5D Single Index Value
A single index value of the health status of each food hypersensitive and control group
was calculated by averaging values for each of the 5 dimensions of the EQ-5D reported
by children and adolescents (parental survey) and adults. These figures are presented and
statistically analysed using a 2-sample t-test in Table 4.4.2. It is noteworthy that these
data are unweighted and are therefore not comparable with the costing data previously
reported in Section 4.1 and 4.2.

When the Irish parental surveys were examined, the mean value for the control group
was found to be 0.90, while the three food hypersensitive cohorts were all found to be
lower (0.79 to 0.83) (Table 4.4.2), but not statistically significant (p <0.05). With regard
to the parental surveys in NI, the control group for children and adolescents was found to
be 0.89, while the three food hypersensitive cohorts were found to be 0.76 to 0.84. The
index values reported for MDFA (0.80) and FI (0.76) were found to be significantly lower
(p <0.05) than controls in NI. The same trend was also observed for the IoI with index
values for MDFA (0.82) and FI (0.78) being significantly lower (p <0.05) than controls
(0.90). On all three occasions (Ireland, NI and IoI), MDCD was found to have a lower
index value than the control group, but not significantly so (p <0.05).

When Irish adult groups were examined (Table 4.4.2), a significantly lower health status
were reported for MDFA (0.78) and FI (0.77) compared to the control (0.89). With regard
to the adult groups in NI, the index score for MDFA (0.75) was found to be lower
compared to the control (0.79), but not statistically significant (p <0.05). The index values
reported for FI (0.74) was found to be significantly lower (p <0.05) than the control group
(0.79) in NI.
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The overall IoI index figure showed a significant difference (p-value 0.05) between the
three adult food hypersensitive cohorts (0.76 to 0.82) and the control group (0.84). These
results highlight the significant impact of food hypersensitivity on the reported health
status of susceptible adults on the IoI.
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Table 4.4.2: EQ-5D utility index of parent-reported health status of children/adolescents and self-reported health status of adults in
a survey conducted between November 2019 and June 2020 in Ireland (n=2,361) and NI (n=1,370)
EQ-5D-3L Index scores for Children and Adolescents, and Adults
Ireland
Control

MDFA

MDCD

FI

Control

MDFA

MDCD

FI

Children & Adol.

Children & Adol.

Children & Adol.

Children & Adol.

Adults

Adults

Adults

Adults

Sample Size

130

173

148

56

531

178

609

536

Mean Value

0.90

0.83

0.86

0.79

0.89a

0.78b

0.84

0.77b

Standard deviation

0.19

0.25

0.21

0.22

0.16

0.25

0.19

0.23

Health Status

NI
Control

MDFA

MDCD

FI

Control

MDFA

MDCD

FI

Children & Adol.

Children & Adol.

Children & Adol.

Children & Adol.

Adults

Adults

Adults

Adults

Sample Size

165

147

60

51

204

111

173

459

Mean Value

0.89c

0.80d

0.84

0.76d

0.79e

0.75

0.79

0.74f

Standard deviation

0.18

0.25

0.19

0.24

0.26

0.29

0.25

0.27

Health Status

Island of Ireland
Control

MDFA

MDCD

FI

Control

MDFA

MDCD

FI

Children & Adol.

Children & Adol.

Children & Adol.

Children & Adol.

Adults

Adults

Adults

Adults

Sample Size

295

320

208

107

735

289

782

995

Mean Value

0.90g

0.82h

0.85

0.78h

0.84i

0.77j

0.82j

0.76j

Standard deviation

0.19

0.25

0.20

0.23

0.21

0.27

0.22

0.25

Health Status

*The following relationships are statistically significant (p-value <0.05); a versus b, c versus d, e versus f, g versus h, i versus j
** Adol. – adolescents
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4.4.3. EQ-5D Questionnaire: Examination Mean Overall Health Status Score (EQ
VAS)
A second mechanism of measuring overall health status (other than the calculation of a
single index value based on 5 dimensions as per section 4.4.2), is by asking respondents
and parents of food hypersensitive children to rate their own perceived status. The mean
overall health status score (or EQ VAS) records the respondents self-rated health on a
vertical 20 cm visual analogue scale, where the endpoints are labelled ‘Best imaginable
health state’ and ‘Worst imaginable health state’ (Figure 2.3b). This information can be
used as a quantitative measure of health outcome as judged by individual respondents.

The mean overall health status score of children and adolescents who were reported as
MDFA, MDCD, and FI in surveys completed by their parents, was significantly lower
(p<0.05) for all food hypersensitive groups in Ireland (score 79 – 84, control group score
89), NI (score 81 - 87, control group score 91) and for the IoI (score 80 - 84, control group
score 90) (Table 4.4.3). In other words, parents reported a significantly lower overall
health status for their food hypersensitive child/ adolescent (p-value <0.05) than those
recorded by parents of non-hypersensitive children/adolescents (control group). This
finding is in agreement with observations regarding lower health status noted in section
4.4.2 (EQ-5D single index value). However, on this occasion children and adolescents
reported as MDCD also had a significantly lower health status than their control
counterparts, like the MDFA and FI groups.

Interestingly, while a significantly lower health status was reported for all of the food
hypersensitive cohorts in Ireland with regard to their calculated EQ-5D single index value
(section 4.4.2), only FI (score 75) was found to be significantly lower (p-value <0.05)
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than the control group (score 80) with regard to the Irish EQ-VAS. Figures for MDFA
(score 77) and MDCD (score 79) were lower than the control group but not significantly
so. Similarly, the three food hypersensitive cohorts (score 77) were found to have lower
EQ-VAS scores than the control group for NI (score 80), but not significantly so.
However, when an average of these figures was taken for the overall IoI, both MDFA
(score 77) and FI (score 76) were found to have a significantly lower EQ-VAS score than
the control group (score 80). These finding once again highlight the impact of MDFA
and FI on the overall health status of affected adults on the IoI. The mean reported overall
health status for MDCD adults (score 79) was also lower than the control group (score
80), but not significantly so.
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Table 4.4.3: Parent-reported health status of children/adolescents and self-reported health status of adults in a survey conducted
between November 2019 and June 2020 in Ireland (n=1,743) and NI (n=1,015)
Parent-reported (Children and Adolescents) and Self-reported (Adults) health status (out of 100)
Ireland
Control

MDFA

MDCD

FI

Control

MDFA

MDCD

FI

Child/Adolescent

Child/Adolescent

Child/Adolescent

Child/Adolescent

Adults

Adults

Adults

Adults

Sample Size

124

124

111

40

475

105

376

388

Mean Value

89a

81b

84b

79b

80g

77

79

75h

13..1

14.6

12.6

15.3

13.4

15.6

14.8

15.6

Health Status

Standard deviation

NI
Control

MDFA

MDCD

FI

Control

MDFA

MDCD

FI

Child/Adolescent

Child/Adolescent

Child/Adolescent

Child/Adolescent

Adults

Adults

Adults

Adults

Sample Size

142

115

50

42

151

73

114

328

Mean Value

91c

87d

86d

81d

80

77

77

77

Standard deviation

10.8

11.3

10.8

12.0

14.7

15.1

14.1

14.9

Health Status

Island of Ireland
Control

MDFA

MDCD

FI

Control

MDFA

MDCD

FI

Child/Adolescent

Child/Adolescent

Child/Adolescent

Child/Adolescent

Adults

Adults

Adults

Adults

Sample Size

266

239

161

82

626

178

490

716

Mean Value

90e

84f

84f

80f

80i

77j

79

76j

Standard deviation

11.6

14.0

12.3

13.6

13.7

15.4

14.7

15.3

Health Status

*The following relationships are statistically significant (p-value <0.05); a versus b, c versus d, e versus f, g versus h, i versus j
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4.4.4. Examination of areas of life affected by food hypersensitivity
In preparation for the release of the surveys to determine the socio-economic cost of food
hypersensitivity on the IoI, a specific question was prepared to help highlight key areas
of life affected by having a food hypersensitivity, both for the individuals affected and
their families. This question was designed with the assistance of food hypersensitive
individuals and with reference to the literature. The options included the following: cost,
time, ability to eat out, social life, travel life, relationships, household tasks, social
activities/interactions, sports, public transport, childcare, choice of job, and schools,
among others. The reported areas of life affected, by the 3,001 food hypersensitive
survey respondents are detailed by condition, jurisdiction and status (whether they
completed the questionnaire as an adult or as a parent) in Tables in Appendix 7. A
summary of the top five most important areas by condition and age category for the IoI
are included in Table 4.4.4.
The previous examination of the EQ-5D results revealed that areas such as ‘pain and
discomfort’ and ‘feeling worried, sad or unhappy’ were significantly worse for many of
the food hypersensitive survey participants than the control respondents. This question
regarding areas of life affected by food hypersensitivity, adds additional detail to this
dataset, and some interesting trends were observed. Notably, ‘the ability to eat out’ (74%
to 86%) was the most recorded parameter affecting QoL of all MDFA respondents (Table
4.4.4), thereby elucidating the impact of the many challenges associated with this activity
as a result of having a food allergy. This was also closely linked to other important
concerns reported by those with MDFA and their families (top 5 most reported) such as
the ‘assumption of being a fussy eater’, difficulties with regard to ‘children’s parties’ and
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‘travel’. Other predominant areas included the ‘cost of food shopping’ and ‘the effect on
the diet of the whole family’, highlighting the impact of food hypersensitivity on family
life.

In addition, 75% of participants of the parental survey reported that food

hypersensitivity had a notable effect on their adolescents’ emotional well-being.

The most reported parameter affecting QoL in those with MDCD (96-98%), FI (68-88%)
and their families, was the ‘cost of food shopping’, highlighting the importance of this
issue for individuals living with these conditions. This was followed by ‘ability to eat
out’ which was consistently the second most reported aspect for all the MDCD cohorts
examined (82-95%), and the second/third most reported issue for the FI respondents (6275%). Related areas such as ‘children parties’, ‘travel’, ‘assumption of being a fussy
eater’ and also ‘poor treatment in restaurants’ were also noted in the ‘top 5’. In addition,
‘time spent food shopping’ (extended time associated with reading food labels for
instance) is reported in the ‘top 5’ for two of the MDCD groups (62-81%), and all three
of the FI groups (46-59%). Lastly, the overall impact of food hypersensitivity on
emotional well-being was recorded as an important issue for children with FI (parental
survey) and adults with FI in this study.

One interesting aspect of these results is the consistency of the findings between cohorts
with the same conditions (Table 4.4.4). Overall, these results highlight key issues which
could be addressed to help improve the lives of those affected by food hypersensitivity,
and the lives of their families.
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Table 4.4.4: Areas of life affected for food hypersensitive adults (self-reported) and children/adolescents (parent-reported) on the IoI
(n = 3,001) following an online survey November 2019 to October 2020
CHILDREN WITH MDFA (n=363)
•
•
•
•
•

Ability to eat out (82%)
Children’s parties (78%)
Affects the diet of all the family (77%)
Cost of food shopping (70%)
Time for food shopping (70%)

ADOLESCENTS WITH MDFA (n=63)
•
•
•
•
•

CHILDREN WITH MDCD (n=150)
•
•
•
•
•

Cost of food shopping (98%)
Ability to eat out (95%)
Affects the diet of all the family (81%)
Children’s parties (79%)
Travel (73%)

Cost of food shopping (84%)
Ability to eat out (71%)
Affects the diet of all the family (67%)
Time spent food shopping (59%)
Emotions (56%)

•
•
•
•
•

ADOLESCENTS WITH MDCD (n=67)
•
•
•
•
•

CHILDREN WITH FI (n=91)
•
•
•
•
•

Ability to eat out (86%)
Affects the diet of all the family (78%)
Travel (75%)
Emotions (72%)
Children’s parties (64%)

ADULTS WITH MDFA (n=318)

Cost of food shopping (98%)
Ability to eat out (91%)
Time spent food shopping (81%)
Affects the diet of all the family (74%)
Travel (70%)

Ability to Eat Out (74%)
Assumption of being a fussy eater (72%)
Affects the diet of the family (68%)
Cost of food shopping (64%)
Poor Treatment in Restaurants (58%)
ADULTS WITH MDCD (n=818)

•
•
•
•
•

Cost of food shopping (96%)
Ability to Eat Out (82%)
Assumption of being a fussy eater (65%)
Time spent Food Shopping (62%)
Poor Treatment in Restaurants (61%)

ADOLESCENTS WITH FI (n=29)
•
•
•
•
•

Cost of food shopping (88%)
Affects the diet of all the family (75%)
Ability to eat out (62%)
Time spent food shopping (50%)
Assumption of being a fussy eater (44%)

ADULTS WITH FI (n=1,102)
• Cost of food shopping (68%)
• Assumption of being a fussy eater (62%)
• Ability to eat out (54%)
• Time spent food shopping (46%)
• Emotions (42%)

*MDFA: Medically Diagnosed Food Allergy; MDCD: Medically Diagnosed Coeliac Disease; FI: Food Intolerance or Suspected/Undiagnosed Food Allergy
** A more detailed breakdown of this data is available in Appendix 7
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Chapter 5: Results for the Priority Setting Interviews with Adults and
Parents of Children/Adolescents with MDFA or MDCD
A total of 76 phone interviews were completed during which time participants discussed
eight items of interest which emerged from the initial survey results for this study. These
areas, where selected based on the survey findings (Chapter 3, and Appendices 1-6) and
included headings such as perceived awareness (and recognition) of a particular
condition, associated costs, available supports and specifics such as adrenaline
autoinjector availability for individuals with MDFA. This report presents the findings
from these interviews, including the positive and negative experiences of participants in
Ireland and NI, for each of the areas discussed. In addition, it includes potential solutions
to these challenges as proposed by the cohort of participants interviewed.

5.1 Priority Setting Interview Results: Priority Ranking and Interview
Responses for Ireland and NI
Participants openly shared their opinions and provided informative insights into their
real-life experiences under each of the topics discussed. Both positives and negative
perspectives were discussed, and participants proposed strategies for addressing the
issues encountered under each of the selected headings. A large volume of data was
gathered during this exercise and interesting observations and suggestions (often
common to MDFA and MDCD) emerged. This information is presented under each
individual heading in the Tables 5.2.1 to 5.3.6. Information on the interviewees is
provided in Table 2.4b and in section 5.1.1.
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5.1.1 Trigger Foods
Adults and parents of children and adolescents reporting to be MDFA in Ireland (n=20)
and NI (n=20), provided information on the trigger foods associated with their condition.

The top 5 most reported food allergies among the adults reporting to have MDFA in
Ireland and NI (n=20) were: other nuts (n=11), peanuts (n=9), milk (n=3), fruits (n=3)
and cereals containing gluten (n=2) (Figure 5.1.1a). Additional food intolerances or
suspected/non-medically diagnosed food allergies were also reported (n=10, 50%) by the
adult participants (Figure 5.1.1c).

Other Nuts

55%

Percentage

Peanuts

45%

Milk

15%

Fruits

15%

Cereals containing gluten

10%

Crustaceans

10%

Sesame seeds

5%

Fish

5%

Other Foods

5%

0%

10%

20%

30%

40%

50%

60%

MDFA Adults
*Associated number of individuals who reported MDFA to these foodstuffs: Other Nuts = 11 individuals; Peanuts = 9 individuals ;
Milk = 3 individuals; Fruits = 3 individuals; Cereals containing gluten = 2 individuals; Crustaceans = 2 individuals; Sesame seeds =
1 individual; Fish = 1 individual; Other Foods = 1 individual. Breakdown of MDFA to: Other Nuts = Nuts (unspecified) (n=9),
Cashew nuts (n=1), Pine nuts (n=1); Fruits = Kiwi (n=2) & Strawberries (n=1); Cereals containing gluten = Wheat (n=2); Other Foods
= Grass seeds (n=1)

Figure 5.1.1a: Trigger foods indicated by adults reporting to have MDFA* in
Ireland and NI (≥18 years, n = 20)
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The top 5 most reported food allergies among the children and adolescents reported as
having MDFA in Ireland and NI (n=20) were other nuts (n=16), peanuts (n=9), eggs
(n=9), milk (n=8) and soya beans (n=3) (Figure 5.1.1b). Additional food intolerances or
suspected/non-medically diagnosed food allergies were reported (n=8, 40%) by the
parents of children and adolescents (Figure 5.1.1c).

Other Nuts

80%

Peanuts

45%

Eggs

45%

Percentage

Milk

40%

Soybeans

15%

Cereals containing gluten

5%

Fish

5%

Crustaceans

5%

Fruits

5%

Other Foods

5%

0%

20%

40%

60%

80%

100%

MDFA Children and Adolescents
*Associated number of parents of children and adolescents who reported their child’s MFDA to these foodstuffs: Other Nuts = 16
individuals; Peanuts = 9 individuals; Eggs = 9 individuals; Milk = 8 individuals; Soybeans = 3 individuals; Cereals containing gluten = 1
individual; Fish = 1 individual; Crustaceans = 1 individual; Fruits = 1 individual; Other Foods = 1 individual . Breakdown of MDFA to:
Other Nuts = Nuts (unspecified) (n=11), Hazelnuts (n=2), Macadamia nuts (n=1), Walnuts (n=1), Pecan nut (n=1); Cereals containing
gluten = Wheat (n=1); Fruits = Kiwi (n=1); Other foods = Rice (n=1)

Figure 5.1.1b: Trigger foods indicated by parents of children and adolescents with
MDFA* in Ireland and NI (< 18 years, n = 20)
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60%
50%
50%

Percentage

40%

40%
30%
20%
10%

0%
Adults

Children and Adolescents

Additional Food Intolerances

*Associated number of adults who reported additional FI to these foodstuffs: Other Nuts = 2 individuals; Milk = 1 individual; Cereals
containing gluten = 2 individuals; Fish = 1 individual; Soybeans = 1 individual; Molluscs = 1 individual; Fruits = 1 individual; Other
Foods = 4 individuals
**Breakdown of additional FI to: Other nuts = Nuts (unspecified) (n=2); Fruits = Lemon (n=1); Other Foods = Meat (n=2); Legumes
(n=1); Peas (n=1); Oats (n=1); Food additives (n=1)
ˣAssociated number of parents of children and adolescents who reported their child’s additional FI to these foodstuffs: Eggs = 3
individuals; Milk = 1 individual; Fish = 1 individual; Cereals containing gluten = 1 individual; Fruits = 2 individuals; Other Foods =
2 individuals. ˣˣBreakdown of additional FI to: Fruits = Oranges (n=1); Apricots (n=1); Berries (n=1); Other Foods = Beans (n=1);
Food additives (n=2)

Figure 5.1.1c: Additional food intolerances or suspected/non-medically diagnosed
food allergies indicated by adults* (≥18 years, n=20) and parents of children and
adolescents (<18 years, n=20) with MDFA in Ireland and NI
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5.2.1 Priority Setting Interview Ranking for Adults and Children/Adolescents
reported to MDFA in Ireland
Adults and parents of children and adolescents reported as having MDFA interviewed in
Ireland (n=20) were requested to rank each of the topics discussed in order of priority,
with 1 being the most important topic and 8 being the least. Similarly, they were asked
to rank which were the easiest challenges to solve, with 1 being the easiest to solve and
8 being the most difficulty.
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Table 5.2.1: Priority setting interviews ranking of adults (>18 years), and parents of
children/adolescents with MDFA (<18 years) in Ireland (n=20): Priority ranking of
importance 1-8 (most to least) and Ease of ability to solve 1-8 (easiest to most
difficult)
Priority

Ease
8 Points considered: Adults reporting to be MDFA (n=10), Ireland

Rank

to solve

1

Public & food industry awareness and understanding of your (or your child’s)
condition

3

2

Accessing medical teams e.g., consultants, specialist nurses etc. to treat your (or
your child’s) condition

4

3

Adrenaline auto-injector to be available in all public spaces in case of
emergency (similar to automated external defibrillator, AED

5

4

Cost and availability of medication & supplements to treat your (or your child’s)
condition

1

5

Awareness and training regarding your (or your child’s) condition in an
educational setting

2

6

Dietetic support for your (or your child's) condition

7

7

Counselling/psychological services for sufferers and their families

8

8

Recognition of your (or your child’s) condition as a ‘disability’

6

Priority

8 Points considered: Parents of Child & Adoles. reported as MDFA (n=10),
Ireland

Ease

1

Public & food industry awareness and understanding of your (or your child’s)
condition

2

2

Accessing medical teams e.g., consultants, specialist nurses etc. to treat your (or
your child’s) condition

6

3

Adrenaline auto-injector to be available in all public spaces in case of
emergency (similar to automated external defibrillator, AED

4

4

Awareness and training regarding your (or your child’s) condition in an
educational setting

1

5

Counselling/psychological services for sufferers and their families

8

6

Cost and availability of medication & supplements to treat your (or your child’s)
condition

5

7

Dietetic support for your (or your child's) condition

3

8

Recognition of your (or your child’s) condition as a ‘disability’

7

Rank

* MDFA- Medically Diagnosed Food Allergy
** Child – Children, Adoles. – Adolescents
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to solve

5.2.2 Priority Setting Interview ranking for adults and children/adolescents
reported as MDCD in Ireland
Adults and parents of children and adolescents reported as having MDCD interviewed in
Ireland (n=20) were requested to rank each of the topics discussed in order of priority,
with 1 being the most important topic and 8 being the least. Similarly, they were asked
to rank which were the easiest challenges to solve, with 1 being the easiest to solve and
8 being the most difficulty.
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Table 5.2.2: Priority setting interviews ranking of adults (>18 years), and parents of
children and adolescents reporting to MDCD (<18 years) in Ireland (n=20): Priority
ranking of importance 1-8 (most to least) and Ease of ability to solve 1-8 (easiest to
most difficult)
Priority

Ease
7 Points considered: Adults reporting to be MDCD (n=10), Ireland

Rank

to solve

1

Public & food industry awareness and understanding of your (or your child’s)
condition

1

2

Accessing medical teams e.g. consultants, specialist nurses etc. to treat your (or
your child’s) condition

7

3

Cost and availability of medication & supplements to treat your (or your child’s)
condition

3

4

Dietetic support for your (or your child's) condition

6

5

Awareness and training regarding your (or your child’s) condition in an
educational setting

2

6

Counselling/psychological services for sufferers and their families

5

7

Recognition of your (or your child’s) condition as a ‘disability’

4

Priority

7 Points considered: Parents of Children/Adolescents with MDCD in
Ireland (n=10)

Ease

1

Public & food industry awareness and understanding of your (or your child’s)
condition

6

2

Accessing medical teams e.g. consultants, specialist nurses etc. to treat your (or
your child’s) condition

4

3

Dietetic support for your (or your child's) condition

2

4

Awareness and training regarding your (or your child’s) condition in an
educational setting

1

5

Counselling/psychological services for individualssufferers and their families

3

6

Cost and availability of medication & supplements to treat your (or your child’s)
condition

5

7

Recognition of your (or your child’s) condition as a ‘disability’

7

Rank

* MDCD- Medically Diagnosed Coeliac Disease
** Child – Children, Adoles. – Adolescents
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to solve

Table 5.2.3: Summary of priority setting interview findings for Irish adults with MDFA (n ≤ 10)
KEY ISSUES

PROPOSED STRATEGIES

PRIORITY 1:

Opinions were obtained from 10 participants:

Strategies were proposed by 10 participants:

Public & food industry
awareness
and
understanding of your
condition

•

•

•

•

80% (n=8) were not confident about awareness and understanding of
food allergy within the restaurant / catering sector. Although
participants noted that some establishments are highly reliable (e.g.,
franchise restaurants were mentioned by one participant), they were
concerned about the inability of staff in other establishments to
answer questions on food allergens and guarantee that a meal is
allergen free. Consequently, food allergy sufferers adopt a
cautionary approach to dining out, i.e., they only consume trusted
meals in trusted establishments.
60% (n=6) of participants mentioned their concern regarding crosscontamination. Although pre-packed foods are seen by many allergy
sufferers as a safer option, 40% (n=4) raised issues regarding
labelling (e.g., inaccurate/unclear labelling and overuse of the
precautionary wording ‘may contain ….’). One participant noted that
it can take several hours to complete food shopping because of the
time required to read labels.
60% (n=6) suggested that awareness of food allergy is poor amongst
the non-sufferers

PRIORITY 2:

Opinions were obtained from 10 participants:

Accessing medical teams
e.g. consultants, specialist
nurses etc. to treat your
condition

•
•

80% (n=8) referred to difficulty accessing appointments with
specialists / consultants.
Participants noted that GPs are not equipped to diagnose food
allergies and thus referral to a specialist / consultant is required. One
participant waited nine months to see a specialist / consultant.
Another took part in a medical research trial in the UK, thereby
avoiding the Irish waiting lists.
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•
•

70% (n=7) proposed improved education and training (i.e.,
professional training, work-place training).
60% (n=6) proposed more public awareness campaigns (using
traditional and social media channels).
20% (n=2) proposed stricter controls in food establishments (e.g.,
avoidance of cross contamination).

Strategies were proposed by 9 participants (1 respondent did not
propose any strategies):
•

•

77% (n=7) proposed greater access to medical support for both
initial and follow-up appointments, where possible. Additional
proposals from participants included: more engagement from GP
with regard to care, understanding and management of their
condition, where possible
11% (n=1) suggested the establishment of a helpline for newly
diagnosed patients.

•

20% (n=2) had a positive experience in terms of medical access.

PRIORITY 3:

Opinions were obtained from 10 participants:

Adrenaline auto-injector
to be available in all
public spaces in case of
emergency (similar to
automated
external
defibrillator, AED)

•

PRIORITY 4:

Opinions were obtained from 10 participants:

Cost and availability of
medication
&
supplements to treat your
conditioN

70% (n=7) agreed that Adrenaline auto-injector should be available
in all public places.
10% (n=1) stated that Adrenaline auto-injector should be available
in schools only and not other public places.

•

•
•

•

•

60% (n=6) commented on the high cost of Adrenaline autoinjector and other medications for the treatment of food allergies.
60% (n=6) suggested that this was compounded by the short
shelf-life of adrenaline auto-injector which need to be replaced
frequently – thereby increasing the cost.
50% (n=5) noted that the cost of Adrenaline auto-injector and
other medications such as inhalers and antihistamines are
covered under the Drug Payment Scheme / Medical Card
Scheme. Participants were very appreciative of these schemes.
30% (n=3) commented on the high-cost of ‘free-from …’ foods
in supermarkets compared to conventional foods.

Strategies were proposed by 9 participants (1 respondent did not propose
any strategies):
•

55% (n=5) stated that Adrenaline auto-injector should be located
in public places such as shopping centres, premises serving food
and public transport. 11% of participants (n=1) stated that
Adrenaline auto-injector should be located in First Aid boxes and
their location should be identified through a service such as
Google Maps.
•
33% (n=3) suggested that training should be provided (to the
public) on the administration of Adrenaline auto-injector.
Strategies were proposed by 9 participants (1 respondent did not
propose any strategies):
•

•

•
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77% (n=7) proposed additional financial support to reduce the
cost of medication for allergy sufferers. In particular, many felt
that Adrenaline auto-injector should be available free of
charge.
22% (n=2) proposed strategies to address the short shelf-life
of Adrenaline auto-injector. These included:
o Manufacturers to consider reformulation to extend shelflife (e.g., preservative content).
o Medical Board to undertake market review of Adrenaline
autoinjector shelf-life in other countries & to utilise this
information for the Irish market.
o Pharmacies to establish an alert system to identify when
an Adrenaline autoinjector is approaching the end of its
shelf-life (this will assist timely re-ordering).
22% (n=2) of participants proposed price control on ‘free-from
….’ foods.

PRIORITY 5:
Awareness and training
regarding your condition
in an educational setting

Responses were obtained from 8 participants regarding second level
schools (2 respondents did not specify any issues):
•

62% (n=5) commented that food allergy awareness was poor, and
that policies and procedures were not strict enough to deal with
food allergens within school environments. In addition, these
participants highlighted that teachers and educators are not
trained in this regard, and are may not even be aware of the
location of Adrenaline auto-injector in a school.
•
37% (n=3) advised that schools had good awareness and
management of allergies. In one school allergy forms were
provided to parents at the beginning of each year to collate
information on food allergies. However, this information was
often not shared or reviewed by new teachers and substitute
teachers within these schools.
Responses were obtained from 3 participants regarding third level
institutes:
•
•

66% (n=2) advised of poor food allergy awareness (e.g.,
leaflets/posters for students and educators), policies or training.
33% (n=1) highlighted the lack of an ‘allergen free zone’ to allow
students to eat in a safe environment. On a more positive note,
one participant commented on a recent visit to a university where
food allergen leaflets were available and a nut ban policy in place.

PRIORITY 6:

Opinions were obtained from 10 participants:

Dietetic support for your
condition

Information, knowledge and support from dietician post diagnosis
•
•

60% (n=6) were not referred to a dietitian.
20% (n=2) specifically stated that were referred to a dietitian.
Mixed feedback was provided on the supports obtained.
•
For the remaining 20% (n=2) of participants, it was not clear if
they were / were not referred to a dietitian.
Support on suitable foods and brands
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Strategies were proposed by 6 participants for primary level (4
respondent did not propose any strategies):
•

50% (n=3) proposed greater awareness and information
campaigns on food allergies (e.g., training, leaflets, posters)
for inclusion in an educational setting. These should be
directed at parents of non-FA sufferers, students and teachers.
•
50% (n=3) proposed stricter policies and procedures within
schools, and ideally, all staff should complete food allergen
training (including training on Adrenaline auto-injector
administration); all new teachers and substitute teachers
should be aware of children in their class with food allergies
(in particular those carrying Adrenaline auto-injector); parents
should be informed of allergens which are not permitted within
the school and the school menu should be shared in advance
with parents.
•
17% (n=1) proposed greater availability and range of allergen
free foods in school canteens.
Strategies were proposed by 3 participants for third level:
•
•

66% (n=2) proposed stricter policies and procedures on the
prohibition of eating in lecture halls
33% (n=1) proposed greater awareness within the educational
setting of allergen free zones.

Strategies were proposed by 9 participants (1 respondent did not propose
any strategies):
•

100% (n=9) proposed that adults with medically diagnosed
food allergies should, ideally, have immediate access to a
dietitian post-diagnosis. One participant noted that group
sessions with a dietitian should be considered if individual
appointments are not possible.

•

PRIORITY 7:
Counselling/psychological
services for sufferers and
their families

Opinions were obtained from 10 participants:
•

•

PRIORITY 8:
Recognition of condition
as a 'disability'?

30% (n=3) commented on the support provided:
o
Two participants received literature (leaflets / books) on
food allergens. Another participant noted that the advice
provided was not child-friendly.

100% (n=10) believe access to these services are important.
Some participants noted that a food allergy diagnosis is a life
changing event which is stressful not only for the patient but also
for their family and possibly even friends. This stress may be
exacerbated by long waiting lists for appointments with allergy
specialists. A number of participants noted that access to
counselling/psychological services should be made available
immediately after diagnosis.
20% (n=2) commented on existing services for allergy sufferers.
One participant noted that many support groups exist in the
community. Another participant raised concern over online
support groups because they are not supported by the medical
community.

Opinions were obtained from 10 participants:
•
•

•

50% (n=5) were ‘unsure’. One participant stated that recognition
as a disability could depend on the severity of the condition.
30% (n=3) agree. Key points of rationale: i) a medically
diagnosed food allergy is a life changing event, ii) allergies, such
as nut allergies, negatively impact employment prospects and iii)
although a medically diagnosed allergy is not a ‘physical
disability’, it is a ‘body malfunction’.
20% (n=2) disagree. Key points of rationale: i) its recognition as
a disability would undermine conditions that are more serious
and ii) it is a manageable condition (however, the participant
acknowledged that the severity varies per individual)
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•

33% (n=3) proposed improved resources. Relevant topics
included information on food allergies, diet plans and recipes.
Resources should also be developed specifically for children.

Strategies were proposed by 9 participants (1 respondent did not
propose any strategies):
•

•
•

100% (n=9) proposed that access to counselling /
psychological services should be made available as soon as
possible after diagnosis.
11% (n=1) proposed that group counselling sessions should be
available if private individual sessions are not feasible.
11% (n=1) proposed the establishment of a helpline.

Strategies were proposed by 4 participants (6 respondents did not
propose any strategies):
•
•

25% (n=1) suggested recognition of food allergies as a
disability (due to its life changing nature).
75% (n=3) suggested more education and awareness
campaigns to improve understanding of food allergies in all
settings, combined with greater availability of gluten free food
as an alternative to disability status.

Table 5.2.4: Summary of priority setting interview finding for Irish parents of children/adolescents with MDFA (n ≤ 10)

PRIORITY 1:
Public & food industry
awareness
and
understanding of your
condition

KEY ISSUES

PROPOSED STRATEGIES

Opinions were obtained from 10 participants:

Strategies were proposed by 10 participants:

•

•

•
•

PRIORITY 2:
Accessing medical teams
e.g. consultants, specialist
nurses etc. to treat your
condition

100% (n=10) commented on food industry awareness of allergies
o 60% (n=6) are not confident about awareness and
understanding of food allergy within the food industry
(including the restaurant/catering sector).
o 50% (n=5) noted that awareness and understanding of food
allergy within the food industry has improved over the years.
o 30% (n=3) stated that they adopt a cautionary approach to
dining out, i.e., they only consume trusted meals in certain
establishments.
60% (n=6) raised concern over the provision of allergen
information on food labels and food menus. Key concerns
included over-use of precautionary ‘may contain’
statements/labels on labels of pre-packed foods (this protects the
manufacturer but limits consumer choice); no precautionary
information on food menus (this gives a false sense of security to
consumers) and lack of specificity for some allergens (e.g., nut
species).
50% (n=5) raised concerns over cross contamination and of
these, 40% (n=4) stated that they only purchase pre-packed foods
30% (n=3) commented on public awareness of food allergies and
suggested that this was sometimes poor.

Opinions were obtained from 10 participants:
•

•
•
•

•

70% (n=7) proposed more public awareness campaigns.
60% (n=6) proposed improved education and training for the
food industry.
10% (n=1) proposed the implementation of policies in schools
to prohibit students from bringing allergens to school (i.e., to
reduce the risk of cross contamination for food allergy
sufferers).
10% (n=1) proposed that allergen information should be an
integral part of the online shopping experience and customers
should have the ability to filter products based on
presence/absence of food allergens.

Strategies were proposed by 10 participants:

100% (n=10) referred to challenges accessing specialists /
consultants i.e. often lengthy waiting lists. However private
appointment were noted as more rapid but were associated with
additional cost
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•

90% (n=9) focused on greater access to medical specialists and
treatment. Proposals included:
o Ideally, more expedited access to a specialist post
diagnosis

PRIORITY 3:
Adrenaline auto-injector
to be available in all
public spaces in case of
emergency (similar to
automated
external
defibrillator, AED)

Opinions were obtained from 10 participants:
•

100% (n=10) supported the concept of availability of Adrenaline
auto-injector in public spaces. However, 30% (n=3) provided
caveats:
o Such as Adrenaline auto-injector should only be available in
specific locations (i.e., strategic locations such as those not
easily accessible to the ambulance services) and sufferers
should be made aware of these locations.
o Another agreed but suggested that it may not be practicable
to provide Adrenaline auto-injector in all public locations
because stolen and expired Adrenaline auto-injector would
need to replaced.
o It was also noted that the availability of Adrenaline autoinjector in all public locations could possibly discourage
sufferers from carrying their own Adrenaline autoinjector.

PRIORITY 4:

Opinions were obtained from 10 participants:

Awareness and training
regarding your condition
in an educational setting

Parents of children and adolescents attending primary school advised of
mixed experiences in relation to awareness of food allergies in school.
•

o From this perspective, it was suggested more specialists
should be provided where possible
o A query regarding outsourcing of tests, if necessary (and
if capacity is not available to conduct tests on-site).
•
10% (n=1) proposed better education and support for parents.
Strategies were proposed by 5 participants (5 respondents did not
propose any strategies):
•

•

40% (n=2) stated that Adrenaline auto-injector should be
located in public spaces, premises serving food and in
designated locations (i.e., within 50 meters of premises
serving food). One of these participants stated that Adrenaline
autoinjector locations should be made available to the public.
40% (n=2) suggested that awareness and training on the
administration of Adrenaline auto-injector should increase.

Strategies were proposed by 10 participants:

60% (n=6) reported poor allergen management and lack of
awareness of food allergies in the classroom from teachers and
other students. In one case the parent advised that when the
teacher brings in treats, they do not always check if they are nut
free, so the child with allergies is left out. Three participants felt
that the obligation was on parents to educate teachers about food
allergies and the administration of Adrenaline auto-injector. One
of these participants noted that parents meet with the school
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•

80% (n=8) focused on the need for greater awareness and
training on food allergies for both staff and students. Topics
included food allergy management, symptoms of food
allergies and anaphylaxis, what to do in the case of emergency,
how to administer an Adrenaline autoinjector and the link
between allergies and other conditions (such as asthma and
eczema). One participant proposed that anaphylaxis training
should be provided by the government (rather than other
charities or informal groups/networks). The importance of

•

PRIORITY 5:
Counselling/psychological
services for sufferers and
their families

Opinions were obtained from 10 participants:
•

•

PRIORITY 6:
Cost and availability of
medication
&
supplements to treat your
conditioN

annually to discuss changes to medication, allergy plans and
training of staff on how to use the different types of Adrenaline
auto-injector.
30% (n=3) reported positive experiences such as good
awareness, procedures and enforcement of a ‘nut-free’ policy in
schools (e.g., one school requiring medical form to be completed
at the start of entry into the school and for school trips).

100% (n=10) noted the importance of the availability of these
services, particularly for older children as they become more
aware of their allergy and its management. Specific comments
were raised around the psychological distress caused by
anaphylaxis and the use of Adrenaline auto-injector.
60% (n=6) stated that they have not accessed or are not aware of
existing counselling/psychological services for children and
adolescents with medically diagnosed food allergies.

Opinions were obtained from 10 participants:
•

90% (n=9) focused on the cost of products and the supports
currently available via the Drug Payment Scheme / Medical Card
Scheme. Whilst there was general consensus that these schemes
are extremely helpful, four participants noted that certain
products (e.g., liquid antihistamines, eczema creams, food
supplements) are not covered under one or both of these schemes
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•

practical and engaging training was highlighted (e.g., real life
stories, colourful posters, videos etc).
60% (n=6) focused on food allergy policies, procedures and
guidelines within schools. Three participants highlighted that
direction on the management of food allergies in educational
settings should come from the Department of Education.
Other actions were proposed by several participants, these
included - distribution of the school allergy policy and canteen
menus to all parents; clear labelling of allergens in the canteen;
school to be provided with an annual update of each child’s
allergy medication; teachers to take greater responsibility for
food allergies and a dedicated allergy nurse to be assigned to
a number of schools/region.

Strategies were proposed by 6 participants (4 respondents did not
propose any strategies):
•

•

100% (n=6) proposed that counselling/psychological services
should be available to children and adolescents with medically
diagnosed food allergies. In particular, these services should
be available when the child is diagnosed, when the child starts
school and after an anaphylaxis incident.
16.6% (n=1) proposed support groups on social media or
support systems from schools to help manage and get
information about their condition.

Strategies were proposed by 9 participants (1 respondent did not
propose any strategies):
•

88% (n=8) focused on the need for greater financial support
for the purchase of medication and allergen-free foods. It was
suggested that: i) Adrenaline auto-injector should be provided
free of charge (because it is a life-saving product), ii) Products
such as antihistamines and skin allergy creams should be

•

•

PRIORITY 7:
Dietetic support for your
condition

and this has a significant financial impact for the families of
sufferers.
40% (n=4) focused on the short shelf-life of Adrenaline autoinjector. The financial impact on families of sufferers was
discussed(as Adrenaline auto-injector need to be replenished
frequently),
40% (n=4) focused on ‘free-from …..’ foods for allergy sufferers.
It was acknowledged that many foods available in the
supermarket do not contain allergens; however, an additional
cost is associated with foods specifically labelled as ‘freefrom….’. It was noted that tax credits are available to coeliac
sufferers for the purchase of ‘gluten-free’ foods & that similar
supports should be available for other allergen sufferers.

Opinions were obtained from 9 participants. (1 respondent did not
specify any issues):

•

Strategies were proposed by 10 participants.
•

Information, knowledge and support from dietician post diagnosis
•
•

44% (n=4) stated that their child had no access to a dietitian.
55% (n=5) stated that their child had access to a dietitian; but
mixed views were expressed on the service provided, with two
participants suggesting that the advice was minimal
Support on suitable foods and brands

•

•

PRIORITY 8:
Recognition of condition
as a 'disability'?

20% (n=2) commented positively on the supports available
regarding suitable foods and brands. Both participants received
information; however, one participant claimed that minimal
information was provided on ‘living with food allergies’.
Opinions were obtained from 10 participants:
•

40% (n=4) agreed. It was noted that recognition of medically
diagnosed food allergies as a disability may be beneficial for
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available on the DPS, iii) Tax credits should be available for
the purchase of ‘free-from ….’ foods, iv) long term illness
card should be issued for individuals with medically
diagnosed food allergies.
33% (n=3) focused on issues relating to the availability of
Adrenaline auto-injector. It was noted that: i) Similar brands
should be available across all pharmacies, ii) Adrenaline autoinjector should be available in public places in case of
emergency, iii) Efforts should be made to increase the shelflife of Adrenaline auto-injector, if possible

70% (n=7) proposed that children and adolescents with a
medically diagnosed food allergies should have improved
access to a dietitian. Immediate access to a dietitian post
diagnosis and regular follow-up appointments were deemed
important.
40% (n=4) of participants specifically mentioned that need for
additional information and resources. Relevant topics include
food allergy management, understanding food labels
(particularly regarding the listing of nuts) and information on
appropriate intake of vitamins and minerals.

Strategies were proposed by 4 participants (6 respondents did not
propose any strategies):
•

100% (n=4) Agreed that MFDA should be considered a
disability

•

•

advocacy purposes, i.e., to highlight the condition and influence
strict protocols in public/educational/food industry settings.
40% (n=4) disagreed. It was noted that carers are not required for
this condition (however, that financial support would be
beneficial for the purchase of ‘free-from’ foods).
20% (n=2) were ‘unsure’. However, they noted that this may help
to: i) provide financial support for individuals with anaphylaxis
and ii) remove the label of ‘fussy eater’ from children with
medically diagnosed allergies.

247

•

75% (n=3) suggested that increased focus education and
awareness on food allergies should be also be considered

Table 5.2.5: Summary of priority setting interview findings for Irish adults with MDCD (n ≤ 10)

PRIORITY 1:
Public & food industry
awareness
and
understanding of your
condition

KEY ISSUES

PROPOSED STRATEGIES

Opinions were provided by 10 participants:

Strategies were proposed by 10 participants:

•

•

•

PRIORITY 2:
Accessing medical teams
e.g. consultants, specialist
nurses etc. to treat your
condition

80% (n=8) commented on food industry awareness of coeliac
disease. Regarding the restaurant/catering sector, establishments
with poor knowledge of coeliac disease and gluten free foods are
not trusted. Participants noted that within establishments, staff
vary in their understanding (i.e., waiting staff typically have a
poorer understanding compared to chefs). Thus, the importance
of accurate and effective communication from customers to
waiting staff to chefs (& vice versa) was stressed. One participant
noted that whilst some restaurant’s offer good and safe places to
eat, others instill a feeling of embarrassment when the coeliac
sufferer requests specific information.
70% (n=7) commented on public awareness of coeliac disease.
There was a consensus that the public are aware of this disease;
however, it was suggested that there was poor accuracy in their
understanding. Some see it is a ‘dietary fad’, ‘healthy option’ or
‘lifestyle choice’
60% (n=6) raised concern over cross contamination and the
majority have a preference for pre-packed foods (as the risk of
cross contamination is perceived to be lower than loose foods).

Opinions were obtained from 10 participants:
•

40% (n=4) noted poor access to medical teams. Participants
stated that public patients encounter lengthy delays in securing
initial appointments with specialists / consultants (one participant
waited 2.5 years for an appointment). Challenges are also
encountered with follow-up appointments.
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•
•

•
•
•

90% (n=9) proposed improved education and training for the
food industry.
40% (n=4) proposed improvements in the provision of
accurate information on the gluten status of foods (i.e., on
menu, clearer labels, in-store etc.).
30% (n=3) proposed more public awareness campaigns.
20% (n=2) proposed improvements in the availability of
gluten free foods.
10% (n=1) proposed the use of technology (e.g., Apps) to
improved communication between waiting staff and chefs.

Strategies were proposed by 9 participants (1 respondent did not
propose any strategies):
•
•

55% (n=5) proposed greater access to medical teams.
44% (n=4) proposed education and information strategies to
improve awareness of coeliac disease and its symptoms. Two
participants specifically mentioned that a more proactive
approach to screening for this disease (via blood tests) should
be considered

•

•
•

PRIORITY 3:
Cost and availability of
medication
&
supplements to treat your
condition

30% (n=3) seemed content with their access to medical teams.
One participant had urgent symptoms, and this expedited their
initial appointment.
20% (n=2) specifically stated that they progressed with private
appointments and were happy with the overall process.
10% (n=1) referred to lack of information on coeliac disease and
its management.

Opinions were obtained from 10 participants:
•

•

•

90% (n=9) mentioned the high cost of products (e.g., gluten free
foods, food supplements) required by coeliacs. This can place a
significant financial burden on families. One participant
reporting bulk purchasing vitamins to make them affordable
(e.g., availing of 3 for 2 offers).
20% (n=2) commented on the process for claiming tax relief on
medical expenses. Both participants noted that this process was
cumbersome and is not optimal,
10% (n=1) commented on challenges sourcing ‘gluten-free’
medications.

PRIORITY 4:

Opinions were obtained from 10 participants:

Dietetic support for your
condition

Information, knowledge and support from dietician post diagnosis

Strategies were proposed by 8 participants (2 respondents did not
propose any strategies):
•

•

Strategies were proposed by 10 participants:
•

All ten participants commented on the information, knowledge and support
from dietitians post diagnosis. The following are the key points:•
•
•

100% (n=8) proposed additional financial support for those
with medically diagnosed coeliac disease. These included: i)
availability of ‘gluten-free’ food products on prescription to
enable reimbursement; ii) flat tax rebate for the purchase of
gluten-free products / food supplements, iii) free medical tests
(e.g., routine check-ups, routine screening and blood tests) for
individuals on lower incomes.
12% (n=1) proposed clearer labelling of medications to
declare its gluten status (i.e., contains gluten / gluten-free)

60% (n=6) had access to a dietitian at some stage. The situation
was unclear for the remaining 40% (n=4) of participants.
60% (n=6) mentioned the importance of access to a dietitian at
the time of diagnosis.
20% (n=2) noted that they had to ‘push hard’ for both initial and
follow-up appointments.
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•

100% (n=10) proposed that adults with coeliac disease should
have access to a dietitian. Immediate access post diagnosis was
identified as important by the majority of participants, to
ensure coeliac sufferers learn more about the disease and its
management.
50% (n=5) proposed greater availability of information and
resources. Relevant topics include support on coeliac disease,
complications associated with coeliac disease, list of gluten
free foods, gluten free recipes, dietary advice on the nutrients
list and measures to avoid cross contamination.

•

20% (n=2) noted that the information provided by dietitians is
very generic. One of these participants reported that although this
information is good for the initial appointment, more specific
information is required for follow-up appointments.
•
20% (n=2) suggested that self-education is necessary.
Support on suitable foods and brands
Three out of ten participants (30%) commented on the support provided
regarding suitable foods and brands:
•
•

PRIORITY 5:
Awareness and training
regarding your condition
in an educational setting

One participant was complimentary of the resources provided by
the Coeliac Society of Ireland.
Another interviewee stated that the dietitian provided support on
understanding/reading food labels and identification of the gluten
status of foods.

Opinions were provided by 8 participants (2 respondents did not
specify any issues):
•

87% (n=7) advised of poor awareness with many taking
responsibility for bringing their own food to the school or
university each day. These sufferers commented that food
handlers within the canteens of these educational setting lacked
awareness of coeliac disease, difference between gluten
intolerant and coeliac disease and awareness of gluten-free
requirements. It was noted that schools seem to be more aware
of food allergies compared to coeliac disease. This includes the
lack of knowledge and awareness about coeliac disease itself, its
severity, and the high risks of potential cross contamination of
gluten during food preparation and serving. In some cases,
participants advised that while the mandatory listing of food
allergens is provided, participants do not eat food provided by
the canteen due to the fear of foods being labelled incorrectly.
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Strategies were proposed by 8 participants (2 respondents did not
propose any strategies):
•

•
•

75% (n=6) focused on the need for greater awareness of
coeliac disease by the public and within the educational
systems (i.e., staff, students and parents). Awareness
campaigns should be delivered via social media and traditional
media routes (posters, TV adverts etc). Regarding the
educational system, it was proposed that education on coeliac
disease and food allergies should form part of the primary
school curriculum. One further participant proposed
campaigns for food handlers specifically highlighting the
impact of cross contamination.
37% (n=3) proposed greater availability of gluten-free options.
12% (n=1) proposed greater availability of allergy-free zones
for people with food allergies/sensitivities.

•

•

PRIORITY 6:
Counselling/psychological
services for sufferers and
their families

Opinions were obtained from 9 participants (1 respondent did not
specify any issues):
•

•

•
•

PRIORITY 7:
Recognition of condition
as a 'disability'?

One participant noted that gluten-free food and meals for coeliac
sufferers were not provided at school events and meetings thus
indicating the lack of recognition of the disease by organisers.
With regard to work settings, one participant indicated the need
to explain the seriousness of coeliac disease to co- workers and
the risks of cross contamination e.g., why the same toaster could
not be used by a person with coeliac disease.

55% (n=5) stated that counselling/psychological services are
either ‘not necessary for everyone’ or ‘are not for them’. One of
these participants expressed concern about attending such
services and suggested that there is a social stigma associated
with a gluten-free diet.
22% (n=2) stated that they have not attended or are not aware of
any existing counselling/psychological services for adults with
coeliac disease.
11% (n=1) currently attends a local support group and has
benefited greatly from this.
11% (n=1) spoke about the psychological problems when first
diagnosed.

Opinions were obtained from 9 participants (1 respondent did not
specify any issues):
•

•

56% (n=5) disagree. Key points of rationale: i) coeliac disease is
manageable and does not impact a person's life in the same way
as a physical disability and ii) its recognition as a medical
condition / auto-immune condition would be more accurate.
22% (n=2) agree. Key points of rationale: i) the disease has longterm health and socio-economic impacts (e.g., diagnosis may
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Strategies were proposed by 7 participants (3 respondents did not
propose any strategies):
•

100% (n=7) proposed that access to counselling /
psychological services should be available to people that need
them. Ideally, relevant contact details would be provided at
the time of diagnosis.

Strategies were proposed by 3 participants (7 respondents did not
propose any strategies):
•

•

66% (n=2) stated that education and awareness campaigns
should be considered, which recognise the impact (health,
social, emotional) of coeliac disease on sufferers
33% (n=1) suggested that ideally there should be easier access
to support services such as medical cards, once diagnosed.

•

•

negatively impact employment prospects) and ii) the disease is
particularly challenging during flare-ups.
22% (n=2) were ‘unsure’. Key points of rationale: i) recognition
of coeliac disease as a disability should depend on the severity of
the illness, ii) the disease is manageable; however, difficulties are
encountered when first diagnosed and iiI) there are social
challenges (e.g. lack of toilet facilities).
11% (n=1) said that is should be recognised as an auto-immune
disease
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Table 5.2.6: Summary of priority setting interview findings for Irish parents of children/adolescents with MDCD (n ≤ 10)
KEY ISSUES

PROPOSED STRATEGIES

PRIORITY 1:

Opinions were provided by 10 participants:

Public & food industry
awareness
and
understanding of your
condition

•

Strategies were proposed by 8 participants (2 respondents did not
propose any strategies):

•

•

•

90% (n=9) commented on food industry awareness of coeliac disease.
Regarding restaurants and catering establishments mixed views were
expressed (some establishments are good; some are poor, and some
are improving). Two participants noted that they only eat in trusted
restaurants and another two participants noted that if going to a new
restaurant they would always check in advance about the availability
of gluten-free food. Regarding the broader food sector, two
participants noted that the availability of gluten-free food has
increased in supermarkets; however, one participant noted that lack of
availability at sporting and other outdoor events.
60% (n=6) identified cross-contamination as a major concern. Two
participants noted that fruit and vegetables are the only loose food (i.e.,
non-pre-packed) they will purchase. A number of participants
mentioned poor practices by the food sector, e.g., the removal of
bread/grains from the plate of a coeliac child without any
understanding of the risk of cross contamination.
50% (n=5) commented on public awareness of coeliac disease. The
majority (n=4) stated that public awareness is very poor. Only one
participant noted that awareness is higher in Ireland than in other
countries.
30% (n=3) commented on allergen labelling. One participant trusts
food labelled as ‘gluten-free’, another participant would like to see
precautionary labelling (may contain statements) become mandatory,
another participant stated that allergen labelling is not easy to access.

PRIORITY 2:

Opinions were obtained from 10 participants:

Accessing medical teams
e.g. consultants, specialist

•

50% (n=5) indicated that their child had difficulties accessing medical
teams.
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•
•
•
•

50% (n=4) proposed great education and awareness of coeliac
disease within the food sector.
37% (n=3) proposed stricter measures within establishments to
ensure no cross contamination.
25% (n=2) focused on greater availability of gluten free foods.
25% (n=2) proposed better labelling to identify all foods that do not
contain gluten and the standardisation of this labelling.

Strategies were proposed by 7 participants (3 respondents did not
propose any strategies):

o

nurses etc. to treat your
condition
•
•
•

PRIORITY 3:
Dietetic support for your
condition

One participant a three years for an appointment with an
immunologist to confirm diagnosis. Another participant referred
to current delays on account of COVID-19.
30% (n=3) noted no issues with access to medical teams.
20% (n=2) referred to lack of expertise and collaboration between
health care professionals.
10% (n=1)of participants noted that they felt there was a lack of
collaboration between health professionals when dealing with their
child’s condition.

Opinions were obtained from 9 participants (1 respondent did not
specify any issues):
Information, knowledge and support from dietician post diagnosis
•

•

55% (n=5) stated that their child had access to a dietitian post
diagnosis. The consensus was generally positive regarding the initial
appointment and the information provided. Regarding follow-up
appointments, two participants noted that a third appointment was not
necessary as adequate information on management of the condition
was obtained at that stage.
44% (n=4) stated that their child had no access / poor access to a
dietitian post diagnosis. One participant noted that parents needed to
‘push hard’ to obtain dietetic support. Another participant noted that
self-education is essential (this participant was particularly concerned
about the link between coeliac disease and eating disorders).

Support on suitable foods and brands
•
•

33% (n=3) commented on the support available regarding suitable
foods and brands. Mixed views were expressed:
Two participants received adequate information; whilst one
participant claimed that the information provided was poor.
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•
•

57% (n=4) proposed improved medical access for initial diagnosis
and follow up appointments, if possible
28% (n=2) suggested they would like greater input from their GP
regarding management and treatment of their condition
14% (n=1) suggested that they would like treatment of coeliac
disease to be personalised for each individual

Strategies were proposed by 10 participants:
100% (n=10) proposed that children and adolescents with coeliac
disease should have access to a dietitian. Immediate access to a
dietitian post diagnosis would be preferable, and regular follow-up
appointments were deemed important.

PRIORITY 4:

Opinions were provided by 10 participants:

Strategies were proposed by 10 participants:

Awareness and training
regarding your condition
in an educational setting

•

•

•

•

PRIORITY 5:

90% (n=9) commented on awareness of coeliac disease within
educational settings.
o 66% (n=6) noted a lack of awareness and understanding within
educational settings i.e., the differences between food allergies,
food intolerances and coeliac disease are not always understood
o 33% (n=3) noted a greater level of awareness. One participant
noted that at pre-school level their child was provided with a
specific plate (easily identifiable coloured plate) for their own
use only (to minimise the risk of cross contamination). Others
reported that If treats are provided by teachers, gluten-free treats
are always provided.
80% (n=8) commented on provisions available within educational
settings for students with coeliac disease. In primary schools, many
students bring their own lunch to school. Lack of canteen facilities
appears to be a factor. In secondary schools, canteen facilities are more
common; however, all canteens do not provide coeliac options. In
schools where canteen facilities provide coeliac options, participants
reported mixed standards. One participant noted an incident where
their child was either served gluten containing (or cross-contaminated)
food.
40% (n=4) commented on awareness amongst peers and parents of
peers, and a general acceptance amongst peers of this condition. For
instance, parents of peers were reported to be mindful of coeliac
disease when organising parties or events at school. However, one
participant noted that their child is often excluded from events as it
could be considered troublesome to cater for a child with coeliac
disease.

Opinions were obtained from 10 participants:

•

100% (n=10) proposed greater education and awareness for school
staff and students. Topics proposed include greater understanding
of gluten containing foods; impact of the disease (physical and
social); risk managements strategies (avoidance of cross
contamination) and labelling. Both the Coeliac Society of Ireland
and the Department of Education were identified as potential
partners for this education and awareness.
10% (n=1) proposed that food menu should clearly indicate the
gluten-free status of foods.
10% (n=1) propose that schools should be obliged to meet the
dietary needs of students on school trips. Information on dietary
requirements could be captured on the consent form used for the
school trip.

Strategies were proposed by 7 participants (3 respondents did not
propose any strategies):
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Counselling/psychological
services for sufferers and
their families

• 70% (n=7) noted that these services are particularly important for older
children as they become more aware of their condition and its
management but strive to ‘fit in’ with their peers.
• 50% (n=5) stated that they have not accessed or are not aware of existing
counselling/psychological services for children/adolescents with coeliac
disease.

PRIORITY 6:

Opinions were obtained from 10 participants:

Cost and availability of
medication
&
supplements to treat your
condition

• 60% (n=6) focused on the cost of gluten-free foods. There was
consensus that products positioned as ‘gluten-free’ are very expensive
compared to their conventional counterparts (i.e., products not
positioned as ‘gluten-free’). However, it was noted that many
conventional products do not contain gluten and are reasonably priced
alternatives when identified
• 30% (n=3) focused on the high cost of food supplements (Vitamin D)
and/or probiotics.
• 20% (n=2) noted difficulties sourcing gluten-free Vitamin D and
medications.

100% (n=7) proposed that counselling/psychological services
should be available to children and adolescents with coeliac
disease.

Strategies were proposed by 8 participants (2 respondents did not
propose any strategies):
•
•

•

•

•

PRIORITY 7:
Recognition of condition
as a 'disability'?

Opinions were obtained from 8 participants (2 respondent did not
specify any issues):
• 50% (n=4) disagreed with this idea. Participants noted that coeliac
disease is a medical condition, not a disability.
• 38% (n=3) were ‘unsure’. One participant noted that this would depend
on the definition of a disability; and suggested that coeliac disease can
be managed by diet (& thus differs from other disabilities).
• 12% (n=1) agreed. This participant noted that it would be a way to
increase awareness of the disease.
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50% (n=4) focused on price control for gluten-free foods.
25% (n=2) focused on labelling of foods and medication, and
suggested that, every product which does not contain gluten should
be labelled as gluten-free.
25% (n=2) focused on tax rebates: Rather than using a receiptbased system for tax rebates, the government should consider
issuing a flat refund.
12% (n=1) focused on packaging. Gluten-free foods are typically
packaged in small quantities; larger pack sizes should be available
(this would be helpful from both a cost and packaging perspective)
12% (n=1) focused on further research to identify an effective
treatment (or the possibility of a future cure) for coeliac disease.

Strategies were proposed by 2 participants (8 respondents did not
propose any strategies):
•

One participant agreed with the implementation of disability status
for the condition
Another suggested instead that the focus should remain on
government driven support of improved standards in the food
sector.

5.3.1 Priority Setting Interview Ranking for Adults and Children/Adolescents
reported as having MDFA in NI
Adults and parents of children and adolescents reported as having MDFA interviewed in
the NI (n=20) were requested to rank each of the topics discussed in order of priority,
with 1 being the most important topic and 8 being the least. Similarly, they were asked
to rank which were the easiest challenges to solve, with 1 being the easiest to solve and
8 being the most difficulty.
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Table 5.3.1: Priority setting interviews ranking of adults (>18 years), and parents of
children and adolescents reported as having MDFA (<18 years) in NI (n=20):
Priority ranking of importance 1-8 (most to least) and Ease of ability to solve 1-8
(easiest to most difficult)
Priority
Rank
1

8 Points considered: Northern Irish adults with MDFA (n=10)
Public & food industry awareness and understanding of your (or your child’s) condition

Ease
to solve
2

2

Accessing medical teams e.g. consultants, specialist nurses etc. to treat your (or your
child’s) condition

7

3

Awareness and training regarding your (or your child’s) condition in an educational
setting

1

4

Adrenaline auto-injector to be available in all public spaces in case of emergency (similar
to automated external defibrillator, AED)

5

5

Cost and availability of medication & supplements to treat your (or your child’s) condition

3

6

Dietetic support for your (or your child's) condition

8

7

Recognition of your (or your child’s) condition as a ‘disability’

4

8

Counselling/psychological services for sufferers and their families

6

Priority
Rank
1

8 Points considered: Northern Irish parents of children/adolescents with MDFA
(n=10)
Awareness and training regarding your (or your child’s) condition in an educational
setting

Ease
to solve
1

2

Accessing medical teams e.g. consultants, specialist nurses etc. to treat your (or your
child’s) condition

5

3

Public & food industry awareness and understanding of your (or your child’s) condition

2

4

Adrenaline auto-injector to be available in all public spaces in case of emergency (similar
to automated external defibrillator, AED)

6

5

Dietetic support for your (or your child's) condition

7

6

Counselling/psychological services for sufferers and their families

8

7

Cost and availability of medication & supplements to treat your (or your child’s) condition

3

8

Recognition of your (or your child’s) condition as a ‘disability’

4

* MDFA- Medically Diagnosed Food Allergy
** Child – Children, Adoles. – Adolescents
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5.3.2 Priority setting interview ranking for adults, and children and adolescents,
reported as MDCD, NI
Adults and parents of children and adolescents reported as having MDCD, interviewed
in the NI (n=16) were requested to rank each of the topics discussed in order of priority,
with 1 being the most important topic and 8 being the least. Similarly, they were asked
to rank which were the easiest challenges to solve, with 1 being the easiest to solve and
8 being the most difficulty.
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Table 5.3.2: Priority setting interviews ranking of adults (>18 years), and parents of
children and adolescents reported as MDCD (<18 years) in NI (n=16): Priority
ranking of importance 1-8 (most to least) and Ease of ability to solve 1-8 (easiest to
most difficult)
Ease

Rank

7 Points considered: Northern Irish adults with MDCD
(n=10)

1

Public & food industry awareness and understanding of your (or your child’s) condition

1

2

Accessing medical teams e.g. consultants, specialist nurses etc. to treat your (or your
child’s) condition

7

3

Cost and availability of medication & supplements to treat your (or your child’s)
condition

3

4

Dietetic support for your (or your child's) condition

6

5

Awareness and training regarding your (or your child’s) condition in an educational
setting

2

6

Counselling/psychological services for sufferers and their families

5

7

Recognition of your (or your child’s) condition as a ‘disability’

4

Priority
Rank

7 Points considered: Northern Irish
children/adolescents with MDCD (n=6)

1

Public & food industry awareness and understanding of your (or your child’s) condition

6

2

Accessing medical teams e.g. consultants, specialist nurses etc. to treat your (or your
child’s) condition

4

3

Dietetic support for your (or your child's) condition

2

4

Awareness and training regarding your (or your child’s) condition in an educational
setting

1

5

Counselling/psychological services for sufferers and their families

3

6

Cost and availability of medication & supplements to treat your (or your child’s)
condition

5

7

Recognition of your (or your child’s) condition as a ‘disability’

7

Priority

* MDCD- Medically Diagnosed Coeliac Disease
** Child – Children, Adoles. – Adolescents
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parents

of

to solve

Ease
to solve

Table 5.3.3: Summary of priority setting interview findings for Northern Irish adults with MDFA (n ≤ 10)
Key Issues

Proposed Strategies

PRIORITY 1:

Opinions were provided by 10 participants:

Strategies were proposed by 10 participants:

Public & food industry
awareness
and
understanding
of
your
child’s condition

•

•
•

•

•

•

90% (n=9) commented on food industry awareness of food allergies.
These comments ranged from ‘not very confident in restaurants…’ to
‘restaurants go to extraordinary lengths…’. One participant noted
differences in allergy awareness between franchise and independent
restaurants (the suggestion being that franchise were better).
Furthermore, within establishments, many participants noted a lack of
awareness amongst waiting staff. Seven participants noted that they adopt
a cautionary approach to dining out, i.e., they only consume trusted meals
in trusted establishments.
70% (n=7) commented on the risk of cross contamination. Three
participants noted that tend to purchase pre-packed products (as they
consider the risk of cross contamination to be lower). Two participants
specifically mentioned bakeries and noted that although allergen
information is always available on site (e.g., in a folder), staff are not
always equipped to answer questions.
70% (n=7) commented on public awareness of food allergies. Five
participants noted that awareness is poor / could improve; whilst two
participants noted that awareness is moderate / good.
40% (n=4) commented on labelling. Frustration was expressed about the
over-use of precautionary ‘may contain’ statements/labels and in
particular the lack of specificity for some allergens (e.g. nut species).

PRIORITY 2:

Opinions were obtained from 10 participants:

Accessing medical teams e.g.
consultants, specialist nurses
etc. to treat your condition

•

70% (n=7) focused on diagnosis. There were mixed views:
o five participants noted speedy diagnosis (two participants attributed
this to the severity of their symptoms)
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•

60% (n=6) proposed campaigns to increase public awareness.
50% (n=5) proposed campaigns /training to increase
awareness in the food industry. One participant noted that
allergen training should be mandatory for all food handlers.
Another participant suggested that training should address all
allergens, not only the 14 EU allergens.
50% (n=5) focused on the provision of allergen information
to consumers. Participants are looking for more accurate and
complete information. Suggestions included reduction in the
use of precautionary statements (‘may contain ….’) and the
provision of more clearer allergen information on both food
labels and food menus.

Strategies were proposed by 9 participants (1 respondent did
not propose any strategies).
•

100% (n=9) would like to greater access to medical treatment.
To this end, two participants suggested increasing the number
of allergy specialists in NI

o
•

PRIORITY 3:
Awareness and training
regarding your condition in
an educational setting

two participants noted lengthy delays in their diagnosis (one
participant reported that it took them many years to be diagnosed)
70% (n=7) focused on difficulties securing follow-up appointments. One
participant referred to the impact caused by COVID-19 in this regard.

7 participants commented on allergy awareness within educational
settings (3 respondents did not specify any issues):

Strategies were proposed by 8 participants (2 respondents did
not propose any strategies):

•

•

•

71% (n=5) advised that most schools had poor awareness and training on
food allergies. These interviewees noted most school canteens could not
guarantee nut free food and the canteen environment was not free of
allergens. As a result, some children brought their own lunch to school as
they could not eat in the school canteen.
28% (n=2) advised of good awareness, allergen management and training
within schools and in some cases a lack of training and awareness within
the third level educational institutes.

•

•

PRIORITY 4:

Opinions were obtained from 10 participants:

Adrenaline auto-injector to
be available in all public
spaces in case of emergency
(similar
to
automated
external defibrillator, AED)

•

•

100% (n=10) stated that they would like to see Adrenaline auto-injector
available in public spaces such as shopping centres, premises serving
food, chemists, play centres and public transport.
10% (n=1) elaborated that there should be an allergy emergency box with
Adrenaline auto-injector, antihistamines and inhaler in public places,
similar to an AED box. This emergency box should be accessed with a
key by trained personnel (similar to the AED box).

PRIORITY 5:

Opinions were raised by 10 participants:

Cost and availability of
medication & supplements to
treat your condition

•

90% (n=9) commented on the medications (antihistamines and
Adrenaline auto-injector) under this heading. Regarding cost, no issues
were raised. Participants noted that these products are available free of
charge by the NHS (however, one participant noted that antihistamines
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75% (n=6) proposed enhanced awareness and education of
food allergies. Proposed topics include greater awareness of
symptoms and severity of food allergies, food allergy
management and administration of an Adrenaline
autoinjector.
12% (n=1) proposed that Adrenaline auto-injector should be
stored in the teacher’s room or locker rather than the main
office cabinet (to ensure quicker access if needed).
12% (n=1) proposed improved listing of ingredients (and
allergens) on food menus

Strategies were proposed by 7 participants (3 respondents did
not propose any strategies).
•

•

85% (n=6) stated that Adrenaline auto-injector should be
located in public spaces and all premises serving food. One
person noted that the location of Adrenaline auto-injector
should be identified via an App.
14% (n=1) stated that awareness should be increased in the
administration of Adrenaline auto-injector.

Strategies were proposed by 8 participants (2 respondents did
not propose any strategies).
•

37% (n=3) proposed greater availability of ‘free from …’
foods and food supplements, where possible. One of these

•

are purchased over the counter, but they are affordable). Another
interviewee reported issues with the availability of Adrenaline autoinjector in pharmacies (i.e., allergy sufferers often need to visit multiple
pharmacies before securing their prescription).
50% (n=5) commented on the high cost of foods positioned as ‘free-from
….’. One participant noted that many conventional products (i.e.,
products not lablelled as ‘free-from...’) do not contain allergens and are
reasonably priced alternatives. However, consumers must spend time
reviewing labels to identify these products.

•

•

interviewee suggested the additional inclusion of food
supplements on prescription.
37% (n=3) proposed strategies relating to Adrenaline autoinjector, i.e., longer shelf-lives would be prefereable and the
establishment of a system to address availability challenges
in pharmacies.
25% (n=2) proposed consideration of price control on ‘freefrom …’ foods

PRIORITY 6:

Opinions were obtained from 10 participants:

Strategies were proposed by 10 participants:

Dietetic support for your
condition

Information, knowledge and support from dietician post diagnosis

•

•

40% (n=4) were referred to a dietitian post diagnosis. Poor feedback was
provided on these referrals:
o One participant was simply advised to obtain a medical ID bracelet
to inform others of their nut allergy.
o One participant commented on poor information at initial
consultation and a lack of follow-up.
o One participant noted that each consultation was with a student
dietitians. From a patient perspective this was very unsatisfactory
because: i) each appointment was conducted by a different student
and ii) the students continually referred to their supervisor for
advice.
o One participant commented on inconsistency in advice from
medical professions (e.g., avoidance of all nuts versus avoidance of
peanuts).
Support on suitable foods and brands
50% (n=5) provided comment:
•

All five participants noted that the support provided was poor. One
participant noted that he/she had to conduct their own research regarding
their condition
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•

60% (n=6) proposed that greater dietetic support should be
available for adults with medically diagnosed food allergies.
50% (n=5) proposed that availability of resources (e.g.,
leaflets, books, apps) should be improved. Resources should
focus on: how to read food labels, how to administer an
Adrenaline autoinjector, information on overall diet and
general information on how to live with a food allergy.

PRIORITY 7:

Opinions were obtained from 10 participants:

Recognition of condition as a
'disability'?

•

•

•

50% (n=5) disagree with this idea. They suggested that medically
diagnosed food allergies were manageable and they do not impact a
person's life in the same way as other disabilities.
30% (n=3) were ‘unsure’. Participants stated that recognition could be
helpful in certain circumstances, e.g., severe cases and to support time
away from work due to illness.
20% (n=2) agree. One participant stated that recognition as a disability
would help protect allergy sufferers from discrimination in the
workplace.

PRIORITY 8:

Opinions were obtained from 10 participants:

Counselling/psychological
services for sufferers and
their families

•

•
•

60% (n=6) stated that they have not accessed or are not aware of existing
counselling/psychological services for adults with medically diagnosed
food allergies.
30% (n=3) stated that support services should be provided.
10% (n=1) do not believe that counselling/psychological services are
required; however, they believed greater work needs to be done ‘outside
the home’ (i.e., public, food industry etc)
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Strategies were proposed by 2 participants (8 respondents did
not propose any strategies):
•

Put in place measures to recognise medically diagnosed food
allergies as a disability.

Strategies were proposed by 9 participants (1 respondent did
not propose any strategies):
•

100% (n=9) proposed that access to counselling /
psychological services should be available to people that need
them.

Table 5.3.4: Summary of priority setting interview finding for Northern Irish parents of children/adolescents with MDFA (n ≤ 10)

PRIORITY 1:
Awareness
and
training
regarding your condition in an
educational setting

Key Issues

Proposed Strategies

Opinions were provided by 9 participants (1 respondent did not
specify any issues):

Strategies were proposed by 6 participants (4 respondents did
not propose any strategies):

•

•

•

66% (n=6) provided positive comments on the awareness and
management of food allergies in schools. Generally, school are
proactive, they have solid policies in place, and they have
implemented innovative ways to increase awareness. Positive
experiences included the provision of separate meals / treats for
children and adolescents with food allergies; the display of
children’s photographs with details of their allergy in the school
canteen; the training of teachers on food allergies and the
administration of Adrenaline auto-injector; interaction with the
community school nurse and the development of a health care plan
including food allergy management for each child/adolescent.
33% (n=3) reported more negative experiences regarding the
awareness and management of food allergies in schools. In some
schools the teachers were not trained on the use of Adrenaline autoinjector and one participant suggested (in their experience)
awareness of food allergies was greater in primary schools than
secondary schools. In addition, generally, there was more focus on
nuts allergies compared with other allergies.
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•

100% (n=6) proposed enhanced awareness and education on
food allergies. Proposed strategies included food allergy
awareness days (students to be actively involved); training on
Adrenaline autoinjector administration for school staff;
allergy updates for school staff, parents and students via
digital (website, social media accounts, mobile apps) and
traditional (workshops, leaflets etc) means.
16% (n=1) proposed the implementation and enforcement of
an allergen-free policy. The school should ask parents to
ensure their children bring none of a selected list of allergens
to school.

PRIORITY 2:

Opinions were obtained from 10 participants:

Accessing medical teams e.g.
consultants, specialist nurses etc.
to treat your child’s condition

•

•

70% (n=7) referred to delays in securing initial appointments with
specialists / consultants, and also follow-up appointments. The
overall process was reported to be more efficient for private patients.
30% (n=3) suggested a lack of support at GP level regarding
management of this condition, with participant often referring to
support groups for advice

Strategies were proposed by 9 participants (1 respondent did
not propose any strategies):
• 77% (n=7) proposed greater access to medical treatment,
where possible. Suggestions included:
o Ideally an increase the number of allergy specialists
recruited
o Ideally an increase the number of allergy facilities (these
should be provided in all local hospitals), where possible
• 33% (n=3) proposed greater awareness, information,
education and supports, in particular for newly diagnosed
patients, would be very helpful

PRIORITY 3:

Responses were provided by 10 participants:

Strategies were proposed by 10 participants.

Public
&
food
industry
awareness and understanding of
your child’s condition

•

•

•

•

90% (n=9) commented on food industry awareness of food allergies.
Almost all participants (n=8) said that they speak to staff about the
food allergy when ordering food in restaurants/catering
establishments; however, most participants noted a general lack of
awareness amongst waiting staff. One participant noted differences
in allergy awareness between large chains and independent
restaurants (chains are better). Three participants noted that they
adopt a cautionary approach to dining out, i.e., they only consume
trusted meals in trusted establishments, or they rarely dine out.
70% (n=7) commented on public awareness of food allergies. Five
participants noted that awareness is poor; whilst two participants
suggested that awareness is improving.
40% (n=4) commented on food labels. Three participants suggested
the overuse of the precautionary ‘may contain ….’ statement; whilst
another participant suggested that further clarity should be provided
on statements such as ‘not suitable for individuals with nut allergy’.
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•
•

70% (n=7) proposed campaigns /training to increase
awareness in the food industry.
60% (n=6) proposed campaigns to increase public awareness
of food allergies.
50% (n=5) focused on the provision of allergen information
to consumers. Participants are looking for more accurate and
complete information. Suggestions included reduction in the
use of precautionary statements (‘may contain ….’) and the
provision of more complete allergen information on both food
labels and food menus.

PRIORITY 4:

Opinions were obtained from 10 participants:

Strategies were proposed by 10 participants

Adrenaline auto-injector to be
available in all public spaces in
case of emergency (similar to
automated external defibrillator,
AED)

•

•
•

•

90% (n=9) of participants stated that ideally Adrenaline autoinjector should be available in all public spaces. One participant was
not sure, and suggested that Adrenaline auto-injector should be in
kept in safe places to ensure correct use and to avoid accidental
injection or misuse.
20% (n=2) of participants suggestion that this provision could
coincide with training on the administration of Adrenaline autoinjector.

PRIORITY 5:

Opinions were obtained from 10 participants:

Dietetic support for your child's
condition

Information, knowledge and support from dietician post diagnosis
All ten participants commented on the information, knowledge and
support from dietitians post diagnosis:
•

90% (n=9) noted that their child had access to a dietitian post
diagnosis. Four participants were very positive about their
experience, i.e., the dietitian was very accessible and useful
information was provided. The other five participants commented
on the lack of follow-up appointments and relevant information.
• 10% (n=1) noted that their child received no dietetic support.
Support on suitable foods and brands
•

50% (n=5) commented on the support available regarding suitable
foods and brands. Mixed views were expressed. Three participants
received information; whilst one participant would have liked more
information and support.

PRIORITY 6:

Opinions were obtained from 10 participants:

Counselling/psychological
services for sufferers and their
families

•

80% (n=8) specifically stated that access to these services for
children and adolescents with medically diagnosed food allergies
would be beneficial. These services are particularly important to
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90% (n=9) of participants agreed with this proposal
50% (n=5) of participants stated that ,in addition, awareness
and training on the administration of Adrenaline auto-injector
should also be more widely available

Strategies were proposed by 5 participants (5 respondents did
not propose any strategies):
• 60% (n=3) proposed that ideally children and adolescents with
medically diagnosed food allergies should have improved
access to a dietitian.
• 60% (n=3) proposed that additional information and resources
should be made available, where possible. Relevant topics
included information on reading food labels (particularly
regarding the listing of fish and nuts), menu ideas and recipe
cards.
• 20% (n=1) proposed that after initial diagnosis children and
adolescents should ideally be tested for other food allergies
(as children/adolescents with one allergy are more than likely
to have multiple allergies).

Strategies were proposed by 6 participants (4 respondents did
not propose any strategies):
•

100% (n=6) proposed that support services should be
available to children and adolescents (and parents of children

•
•

ease anxiety and support the child in their understanding and
management of the allergy.
40% (n=4) stated that they are not aware of the existence of services
/ services were not provided to them.
20% (n=2) commented on use of existing services. One participant
spoke positively about their child's experience with a counselling
service. Another participant joined a support group to help manage
their childs allergy.

PRIORITY 7:

Opinions were raised by 10 participants:

Cost
and
availability
of
medication & supplements to
treat your child’s condition

•

•

100% (n=10) focused on the financial support available for the
purchase of medication and other products for children and
adolescents with medically diagnosed food allergies. It was noted
that Adrenaline auto-injector, antihistamines, infant formula and
supplements are available free of charge on prescription. No issues
were raised.
30% (n=3) focused on the cost of foods positioned as ‘free-from…’.
Two participants noted the high cost; whilst one participant was
comfortable with the cost. Another interviewee noted that many
conventional products (i.e., products not positioned as ‘free-from...’)
do not contain allergens and are reasonably priced alternatives.
However, consumers must spend time reviewing labels to identify
these products.

PRIORITY 8:

Opinions were obtained from 10 participants:

Recognition of condition as a
'disability'?

•
•

•

and adolescents) with food allergies. The psychological
impact of a food allergy was noted by many participants.

Strategies were proposed by 4 participants (6 respondents did
not propose any strategies):
•

50% (n=2) proposed price reduction/control for ‘freefrom….’ foods (greater pack size was proposed as a potential
strategy)
25% (n=1) proposed the establishment of a pharmacy/GP
alert system to notify patients when their Adrenaline
autoinjector is nearing expiry and to remind them to order a
new one. This may minimise problems with Adrenaline autoinjector being ‘out of stock’ when needed by patients.
25% (n=1) proposed that medicines should be available in
sachets (rather than bottles) to support patients who need to
carry their medication throughout the day.

•

•

Strategies were proposed by 10 participants:

50% (n=5) of participants disagreed.
40% (n=4) of participants were ‘unsure’. It was noted that this would
depend on the severity of the illness and would need to be assessed
on a case-by-case basis.
10% (n=1) of participants agreed. This participant noted that it
would be a useful diagnosis for some people (but also mentioned
that it may need to be based on severity).
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•
•

50% (n=5) of participants agreed with consideration of
MDFA as a disability.
50% (n=5) of participants believed that other strategies
should be considered, rather than disability status
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Table 5.3.5: Summary of priority setting interview findings for Northern Irish adults with MDCD (n ≤ 10)
Key Issues

Proposed Strategies

PRIORITY 1:

Opinions were provided by 10 participants:

Strategies were proposed by 10 participants:

Public & food industry awareness
and understanding of your child’s
condition

•

•

•
•

100% (n=10) commented on food industry awareness/knowledge of
coeliac disease. Regarding restaurants / catering establishments,
participants noted considerable variation in awareness/knowledge
between establishments. In addition, one participant was critical of
many establishments that provide gluten-free options to
accommodate a trend rather than accommodate individuals with
medically diagnosed coeliac disease (the participant was concerned
about the prevention of cross contamination in these establishments).
In terms of the broader food industry, four participants commented
on the availability of gluten free products (mixed views were
expressed) and another two participants commented on the possibly
unnecessary addition of gluten to many products. One participant
highlighted challenges at airports and on flights.
70% (n=7) commented on public awareness of coeliac disease and
suggest that awareness among non-sufferers was often poor.
50% (n=5) commented on food information. Regarding food
labelling, participants noted inaccuracies on labels (e.g., ‘glutenfree’ products sometimes contain ingredients with gluten) and overuse of precautionary statements.
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•

•

•

80% (n=8) suggested that greater awareness and education
of coeliac disease amongst the public and the food industry
would be advantageous. Greater awareness in the travel
industry (airports and airlines) was specifically mentioned.
30% (n=3) proposed greater availability of foods where
possible, i.e., more food establishments to cater for coeliacs,
more gluten-free options in catering establishments and
supermarkets, and better positioning and labelling of
gluten-free products within retail premises.
10% (n=1) proposed that food labelling should be more
standardised and specific, where possible, and that use of
precautionary terminology ‘may contain …’ should be
reduced.
10% (n=1) proposed that coeliac sufferers should be
encouraged to contact food manufacturers to inform them
of labelling errors.

PRIORITY 2:

Opinions were obtained from 10 participants:

Accessing medical teams e.g.
consultants, specialist nurses etc. to
treat your condition

•

•

60% (n=6) focused on follow-up appointments. Mixed feedback was
provided. Three participants reported positively on the health
services received. While the other three participants mentioned
delays and challenges in securing appointments.
50% (n=5) focused on their diagnosis. Mixed feedback was
provided. Three participants noted a speedy diagnosis and an
efficient process. On the other hand, two participants referred to
challenges with initial inaccurate diagnoses (one participant reported
that they were inaccurately diagnosed with shingles; whilst the other
participant initially received a negative coeliac result)

PRIORITY 3:

Opinions were raised by 10 participants:

Cost and availability of medication
& supplements to treat your
condition

•

•

70% (n=7) commented on the high cost of gluten-free products. In
NI, certain gluten-free products (i.e., staple products) are available
free on prescription. Any gluten-free product not prescribed by the
GP must be purchased by the coeliac sufferer. There was also
discussion regarding the high cost of gluten free products.
20% (n=2) of participants commented on food supplements.
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Strategies were proposed by 6 participants (4 respondents
did not propose any strategies).
•
•
•

33% (n=2) suggested that greater access to medical services
would be preferable.
33% (n=2) proposed greater awareness of coeliac disease,
its symptoms and associated problems would be helpful
33% (n=2) proposed improvements in diagnosis, where
possible. One participant suggested a more consistent
approach to diagnosis should be established. Another
participant proposed that diagnostic services should be
improved for children, and suggested difficulties
experienced with testing methods such as biopsies.

Strategies were proposed by 8 participants (2 respondents
did not propose any strategies):
•
•
•

75% (n=6) proposed that efforts should be taken to reduce
the cost of gluten-free foods, where possible
25% (n=2) noted that products prescribed on prescription
should continue to be provided free of charge.
12.5% (n=1) suggested that clear recommendation on
appropriate supplements should be provided to coeliac
sufferers.

PRIORITY 4:

Opinions were obtained from 10 participants:

Dietetic support for your condition

Information, knowledge and support from dietician post diagnosis
•

•

60% (n=6) were critical of the support received.
o One participant felt that he/she had to explain coeliac disease
to a dietitian whilst in hospital for an operation.
o Another participant noted that the dietitian advised him/her to
conduct their own research on the disease.
o Another participant reported that the dietitian would read
information from published literature and was unable to
answer any questions outside of this literature.
o Another participant noted that the dietitian focused on body
weight and avoided topics such as intolerance and intake of
vitamins and minerals.
40% (n=4) were more positive regarding the support received. Three
of these participants mentioned follow-up appointments. One
participant noted that he/she also attends support groups.

Strategies were proposed by 6 participants (4 respondents
did not propose any strategies):
•

•

66% (n=4) proposed that adults with coeliac disease should
have improved access to a dietitian, where possible.
Immediate access to a dietitian post diagnosis and regular
follow-up appointments were deemed as preferable.
66% (n=4) proposed greater availability of information and
resources. Relevant topics include support on coeliac
disease and gluten free diet.

Support on suitable foods and brands
20% (n=2) of participants commented on the support provided. These
comments were positive i.e., the dietitian advised to avoid gluten and
provided a list of recommended foods.

PRIORITY 5:

Opinions were provided by 10 participants:

Awareness and training regarding
your condition in an educational
setting

•

90% (n=9) noted very poor awareness of coeliac disease within
educational settings. Participants noted poor knowledge of the
disease, its symptoms, the seriousness of the condition and the
differentiation between gluten intolerance and coeliac disease.
Furthermore, coeliac disease is more often recognised as an allergy
rather than an autoimmune disease. Three participants noted that
canteens often do not cater for students with coeliac disease.
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Strategies were proposed by 9 participants (1 respondent
did not propose any strategies):
•

100% (n=9) proposed greater education and awareness,
where possible. Proposed topics included general
awareness about the disease and its severity, and
recognition of coeliac disease as a medical condition. It was
noted that improved awareness will assist with earlier
diagnosis.

•

PRIORITY 6:
Counselling/psychological services
for sufferers and their families

20% (n=2) noted that the awareness of coeliac disease has improved
in recent years.

•

33% (n=3) proposed, ideally, the provision of greater
availability of gluten free foods in schools and universities
for students with coeliac disease.

Opinions were obtained from 8 participants (2 respondents did not
specify any issues):

Strategies were proposed by 4 participants (6 respondents
did not propose any strategies).

•

•

•

•

62% (n=5) of participants stated that counselling services could be
very beneficial for certain cohorts, e.g., children, parents of newly
diagnosed children, young people and people struggling to accept /
manage their diagnosis.
62% (n=5) of participants stated that they have not accessed or are
not aware of existing counselling/psychological services for adults
with coeliac disease.
37% (n=3) of participants suggested that they do not need
counselling services.

PRIORITY 7:

Opinions were obtained from 10 participants:

Recognition of condition as a
'disability'?

•

•

70% (n=7) disagree with this concept. Key points of rationale: i)
coeliac disease is manageable and does not impact a person's life in
the same way as a physical disability and ii) recognition as a medical
condition would be more accurate reflection of this condition.
30% (n=3) agree. It was stated that coeliac disease, as it has a daily
impact on life and therefore this recognition is warranted.
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100% (n=4) proposed that access to support services should
be made available to people that need them, where possible

Strategies were proposed by 3 participants (7 respondents
did not propose any strategies):
• 100% (n=3) agreed with consideration of recognition of their
condition as a disability

Table 5.3.6: Summary of priority setting interview findings for Northern Irish parents of children/adolescents with MDCD (n ≤ 6)
Key Issues

Proposed Strategies

PRIORITY 1:

Opinions were provided by 6 participants:

Strategies were proposed by 6 participants:

Public & food industry
awareness and understanding
of your child’s condition

•

•

•

•
•

83% (n=5) commented on awareness of coeliac disease in restaurants
and catering establishments.
o 66% (n=4) adopt a cautionary approach to dining out, i.e., they
only consume trusted meals in trusted establishments.
o 66% (n=4) commented on the lack of knowledge amongst staff.
Two participants noted that when asked about food allergens, staff
will hand over a large document/folder and are unable to provide
additional verbal answers.
o 50% (n=3) were very critical of the selection of gluten-free food
available for children and adolescents and noted that it is often
necessary to order gluten-free meals from the adults’ menu.
66% (n=4) suggested that public awareness of coeliac disease is often
poor; however, one participant also reported that in their opinion it is
improving.
33% (n=2) suggested on a positive note, that the availability of glutenfree products is increasing in supermarkets.
33% (n=2) commented on precautionary statements on food labels &
noted that they will not purchase any product carrying a ‘may contain
….’ label.

PRIORITY 2:

Opinions were obtained from 6 participants:

Accessing medical teams e.g.
consultants, specialist nurses
etc. to treat your child’s
condition

•

•

83% (n=5) referred to diagnosis. Two participants noted that the
diagnosis process was efficient; however, three participants noted
specific challenges, i.e. with appointments and diagnosis
33% (n=2) noted difficulties accessing medical teams. One participant
noted that there is no continuity in consultants assigned to assess his/her
child..
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•

•

66% (n=4) proposed the promotion of greater education and
awareness of coeliac disease throughout the public and the
food industry
50% (n=3) highlighted the need for greater choice and
availability of gluten-free foods for children and
adolescents with coeliac disease, where possible
33% (n=2) proposed clearer information on the gluten-free
status of foods. Ideally clear and highly visible labelling
indicating gluten-free.

Strategies were proposed by 4 participants (2 respondents
did not propose any strategies):
•

•

75% (n=3) proposed improving access to medical teams,
where possible, or providing possible financial supports to
assist patients in affording to go of privately
25% (n=1) proposed the establishment of a consistent
approach for the assessment of coeliac disease.

PRIORITY 3:
Dietetic support
child's condition

Opinions were obtained from 6 participants:
for

your

Information, knowledge and support from dietician post diagnosis
•

•

83% (n=5) noted that their children had access to a dietitian post
diagnosis. Two participants were very positive about their experience,
i.e., there is good access and support was provided. Three participants
suggested that the waiting lists were long, and the advice provided
somewhat generic.
16% (n=1) noted that their child had no access to a dietitian.

Strategies were proposed by 2 participants (4 respondents
did not propose any strategies):
• 100% (n=2) proposed that children and adolescents with
coeliac disease should have improved access to a dietitian,
where possible
• 50% (n=1) proposed that information resources should be
less generic and should focus more on individual needs.

Support on suitable foods and brands
•

Two participants commented on the support available regarding suitable
foods and brands, one suggested it was quite ‘basic’, while the other
reported it to be very good.

PRIORITY 4:

Opinions were provided by 6 participants:

Awareness
and
training
regarding your condition in an
educational setting

•

•

66% (n=4) suggested that they have experienced poor awareness of
coeliac disease within education settings, and an insufficient availability
of gluten free options for children and adolescents with coeliac disease.
One participant noted that their child (who has severe coeliac disease),
often cannot attend school trips as the provision of gluten free food is
not guaranteed.
33% (n=2) noted very good awareness of coeliac disease within
educational settings. In one secondary school, a separate desk and gluten
free products are provided for the student during home economics class.
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Strategies were proposed by 4 participants (2 respondents
did not propose any strategies:
•
•

•
•

100% (n=4) proposed increased education and awareness
about coeliac disease, where possible
25% (n=1) proposed the provision of ‘kid-friendly’ gluten
information on food labels to enable children identify the
foods they can consume / must avoid.
25% (n=1) proposed greater availability of gluten free foods
on the school menu, where possible
25% (n=1) proposed the implementation of strict measures
to avoid cross contamination.

With the other interviewee commenting that awareness among teachers
and peers was good.

PRIORITY 5:

Opinions were obtained from 6 participants:

Counselling/psychological
services for sufferers and their
families

•

66% (n=4) stated that support services should be available for children
and adolescents with coeliac disease. Support services would be
beneficial for newly diagnosed children (particularly older children).
One of these participants noted that a support group rather than a
counselling service would suffice.
• 66% (n=4) stated that they have not accessed or are not aware of existing
counselling/psychological services for children and adolescents with
coeliac disease.
50% (n=3) specifically spoke about the impact of diagnosis on the young
child. In two cases, the children progressed well; however, one participant
spoke about the anxiety for their child.

PRIORITY 6:

Opinions were obtained from 6 participants:

Cost and availability of
medication & supplements to
treat your child’s condition

•

•
•

83% (n=5) focused on the cost and availability of gluten-free products.
Certain gluten-free products (i.e., staple products) are available free of
charge on prescription. All other gluten-free products must be
purchased. Respondents suggested that these products were often costly.
On a positive note, respondents reported that the range of gluten-free
products is increasing in supermarkets.
16% (n=1) noted the lack of recommendations on appropriate
supplements for children and adolescents with coeliac disease
16% (n=1) noted the lack of gluten-free medications.

276

Strategies were proposed by 4 participants (2 respondents
did not propose any strategies):
• 100% (n=4) proposed that support services should be
available to children and adolescents (and parents/families
of children and adolescents) with coeliac disease, where
possible

Strategies were proposed by 4 participants (2 respondents
did not propose any strategies):
•

•

100% (n=4) proposed that efforts should be taken to reduce
the cost of gluten free food, where possible. One participant
suggested that special offers such as ‘buy one get one free’
of gluten free products would be helpful
25% (n=1) noted that products prescribed on prescription
should continue to be provided free of charge.

PRIORITY 7:

Opinions were obtained from 6 participants:

Strategies were proposed by 6 participants

Recognition of condition as a
'disability'?

•

•
•

•
•

50% (n=3) agreed. It was noted that this disease has a significant impact
on the life of sufferers and for this reason should be recognised as a
disability.
33% (n=2) disagreed. However, one participant noted that the disease
should be recognised in some way.
17% (n=1) of participants were ‘unsure’.
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50% (n=3) agreed that this proposal should be considered
50% (n=3) disagreed or were unsure of this proposal and
would prefer consideration of other strategies

5.4 Priority Setting Interview Results: Overall Findings
Eight cohorts were interviewed by phone in this study. These consisted of the following
four groups of respondents in each jurisdiction:
•

Adults with MDFA (self-reported) in Ireland (n=10) and NI (n=10),

•

Parents of children/adolescents with MDFA in Ireland (n=10) and NI (n=10).

•

Adults with MDCD (self-reported) in Ireland (n=10) and NI (n=10)

•

Parents of children/adolescents with MDCD in Ireland (n=10) and NI (n=6)

A priority ranking table for each of the eight cohorts is presented in Tables 5.2.1, 5.2.2,
5.3.1 & 5.3.2, and summary versions of all interviewees’ priorities as per condition
(MDFA or MDCD) and ease of ability to solve are presented in Figures 5.4.1a - 5.4.3b.
All of the examined groups prioritised ‘Public and Food Industry awareness and
understanding of their/their child’s condition’ as their number one; with the exception of
parents of children/adolescents with MDFA in NI who ranked ‘Awareness and training
in an educational setting’ first and the former option third. Interestingly, this topic
(Public and Food Industry awareness etc.) was ranked as the overall second easiest area
to achieve a solution for, on the ‘ease to solve’ scale (Figures 5.4.1b and 5.4.3b).

Tables 5.2.3, 5.2.4 and 5.3.3, 5.3.4 detail concern by food hypersensitive individuals with
regard to knowledge, training and awareness of food allergens, coupled with a fear of
cross-contamination when eating out. In addition, issues regarding whether allergen
information is ‘accurate’ or ‘complete’ were raised, particularly by NI MDFA
interviewees. Notably, verbal communication of allergen information is acceptable in
catering establishments in NI compared to a mandatory requirement for a written
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declarations in such food businesses in Ireland. All of the aforementioned factors
contributed to a range of outcomes, with some respondents eating only in trusted or
franchised food businesses, to others who limited their diet to pre-packaged foods (only)
when outside the home.
While an improvement was noted with regard to allergen awareness when ‘eating-out’ in
recent years (possibly as a result of allergen labelling requirements on non-pre-packaged
or loose foods which came into force in 2014), respondents felt more could be done by
this sector.

One additional recurring theme noted by respondents was the overuse/misuse of
precautionary allergen labelling (PAL). This point was noted by many of the MDFA
cohorts who felt strongly that this issue limited the availability and choice of the food
products that they could consume. Participants were keen for measures to be put in place
to reduce the unnecessary use of this ‘tag line’ on food labels. Lastly respondents noted
a general lack of public awareness and understanding, particularly with regard to the
symptoms, potential severity, and management of food hypersensitivity.
Respondents proposed many strategies to achieve improvements in the area of ‘Public
and Food Industry awareness and understanding’. These included enhanced education
and training regarding food allergens and their management in the food industry. The
mechanism by which this could be achieved was mostly public awareness campaigns and
included elements such as professional and workplace training to ensure the safety of
susceptible co-workers. Many respondents noted that they would like to see improved
allergen labelling on menus and stricter measures in catering establishments to prevent
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possible cross-contamination. The use of technology for effective communication of
allergen information between waiting staff and kitchen staff (i.e. chefs) was also
suggested. Coeliac disease interviewees noted that they were very keen to see a greater
availability and range of clearly labelled gluten-free products in the shops.

With regard to the priority list, it was interesting to see that all 8 cohorts recorded
‘Accessing medical teams e.g. consultant’s specialist nurses etc. to treat your (or your
child’s) condition’ as the second most important priority (Figure 5.4.3a).

Many

interviewees noted difficulties in securing medical appointments with specialists for
diagnosis (overall 64%) and also follow-up appointments. This was more pronounced
for MDFA interviewees (range of 70% to 100% per group) than for MDCD interviewees
(range 33% to 60% per group) in Ireland (Tables 5.2.3 - 5.2.6). Moreover, the percent of
individual’s who reported challenges in this area were higher for MDFA adults and
parents thereof (80% and 100%, respectively) in Ireland than in NI (70% and 70%,
respectively). Interviewees were keen to have improved access to specialists and more
timely appointments and suggested the hiring of further consultants to assist with related
medical services in Ireland and in NI. In addition, they proposed further engagement and
support from GPs with regard to management options and understanding their diagnosis.
Cost of visitation, coupled with access to information were also reported as a challenge.
Notably, one respondent suggested the creation of a helpline for newly diagnosed MDFA
individuals to support and inform individuals with relevant information.
The provision of ‘Adrenaline auto-injector in public places similar to AED (automated
external defibrillator)’ was the third highest priority for MDFA interviewees in Ireland
(Table 5.2.1) and the fourth highest priority for their counterparts in NI (Table 5.3.1).
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This concept was only proposed to MDFA adults and parents of child/adolescent with
MDFA as an option on their priority lists and was not included for MDCD interviewees.
There was strong support (90% overall, with an additional 8% unsure) for placing
adrenaline auto-injector in strategic public places so that they could be accessed in an
emergency (Tables 5.2.3, 5.2.4 and 5.3.3, 5.3.4). In Ireland, 80% of adult interviewees
(10% advocating for school placement only) and 100% of the parents agreed with this
proposal. Similarly in NI, 100% of adult interviewees and 90% of the parents were
interested in this idea. It was suggested that such a proposal would most likely require
an increase in training on the administration of adrenaline auto-injector and improved
public awareness. Another suggestion was that an ‘app’ could be considered to show the
location of this medication.

The next most important priority noted by both food hypersensitive groups was
‘Awareness and training regarding their condition in an educational setting’. This was
the third most important priority for MDCD respondents (Figure 5.4.2a), and the fourth
most important for MDFA respondents (as adrenaline autoinjector availability ranked
third) (Figure 5.4.1a). The majority of the MDFA and MDCD cohorts interviewed (range
from 60-71% for MDFA cohorts and 66-90% for MDCD cohorts, respectively) reported
a lack of awareness, education, training and understanding of their condition in
educational settings (primary, secondary and third level) (Tables 5.2.3 to 5.2.6 and 5.3.3
to 5.3.4). There was however one exception, 66% of the MDFA parent cohort in NI
reported a positive experience (only 33% negative) with schools regarding the treatment
of their food hypersensitive child. They reported separate meals and suitable treats for
their children, clear identification (photographs and allergen details) of their child in the
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school canteen, teachers trained on food allergies and the administration of adrenaline
auto-injector, coupled with the development of a health care plan (with food allergen
management) in many cases.

While there was general consensus that improvements had been made with regards to the
treatment of food hypersensitivities in an educational setting in recent years, the number
of interviewees reporting positive comments was noticeably lower (ranged from 28-37%
for the MDFA cohort and 0-33% for the MDCD cohort) than those reporting negative
experiences (with the exception of the MDFA parent cohort in NI). Issues reported by
adults and parents in Ireland and NI included a general lack of understanding, awareness
and training of school staff. Misunderstandings regarding the medical nature of these
conditions and the potential severity of food hypersensitivity were noted, so too was a
lack of training on adrenaline autoinjector administration and anaphylaxis.

Other concerns raised included:
•

a lack of recognition of food allergens other than nuts,

•

a lack of clear food allergen labelling on canteen menus,

•

a lack of confidence in the allergen management systems and staff awareness in
school canteens,

•

a lack of availability of foods suitable for individuals with the condition
(particularly gluten-free products for MDCD individuals)

•

exclusion of children/adolescents from school trips as a result of their dietary
requirements.
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There was general agreement among the MDFA and MDCD cohorts in both jurisdictions
that public and educator focused awareness campaigns were necessary to increase the
level of understanding of these conditions. One interviewee even suggested a dedicated
awareness day to be included in the school calendar (for teachers and students) for this
purpose. In addition, both groups proposed the need for clearer allergen labelling on
school menus (which would ideally be available in advance of the school day), coupled
with strict enforcement of allergen policies. MDCD interviewees consistently reported a
lack of availability of gluten-free foods and proposed the provision of an expanded range
of GF products for students. One interviewee proposed that allergen food labelling could
be made more child friendly in school canteens.
The next point prioritised by interviewees was the ‘Cost and availability of medication
and supplements’. This area was reported as the fifth most important issue for MDFA
and MDCD interviewees as per Figures 5.4.1a, 5.4.2a and 5.4.3a. The MDFA cohorts in
Ireland pay €114 per month (CI, 2021) for medication under the Drugs Payment Scheme,
unless eligible for a medical card. The majority of MDFA adults (60%) and MDFA
parents (88%) reported that they found the cost of medication high, and noted that
additional non-prescription medication like eczema creams, antihistamines, etc., still had
to be bought over the counter. The cost of suitable foods, particularly the additional
expenses associated with products labelled ‘free from…’, was noted.

For MDFA

interviewees in NI, both adults (90%) and parents (100%) reported no issue with regard
to the cost of medication as it is currently free-of-charge under the NHS in NI. However,
similar to Ireland, over-the-counter medication such as antihistamines still have to be
paid for by individuals. While a difference in medication costs between each jurisdiction
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was evident, both groups proposed that they would like to see increased availability of
‘free from’ foods at a lower cost. In addition, research into the possibility of prolonging
the shelf-life of adrenaline auto-injector, was suggested by several individuals as a
potential future cost saving measure, if achievable.

For MDCD cohorts, discussion regarding cost was mainly focused on food and
supplements (as opposed to medication). This was raised by 60-100% of the MDCD
groups in Ireland and 70-83% of the corresponding groups in NI (Tables 5.2.5, 5.2.6, and
5.3.5 to 5.3.6). MDCD respondents (adults and parents) in Ireland would like to see
certain GF food products available on prescription. Similarly, a reduction in cost, price
control, or further tax relief were also proposed. These suggestions were generally in
agreement with the interviewees from NI. However, certain GF products are currently
free-of-charge for coeliacs in NI on prescription, and several interviewees noted that they
would like this financial support to continue. Interviewees from both jurisdictions noted
the lack of availability of GF medicines on the market. In addition, they indicated (range
25 to 40%) a wish to see clear and prominent markings on all GF food products in
supermarkets i.e., statements saying ‘Gluten Free’; so that they were clearly identifiable
to consumers.
‘Dietetic Support’ was prioritised as the fourth most important issue for the MDCD
cohorts and the seventh for MDFA interviewees (Figures 5.4.1a and 5.4.2a). There were
mixed reports of access to dietetic services across all groups interviewed. The two
exceptions were positive reports for parents of children/adolescents in NI where 90% of
MDFA interviewees and 83% of MDCD interviewees reported having good access to
these services post diagnosis (compared to 55% and 55% in Ireland, respectively). There
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was general agreement across all interviewees that services should be available for
MDFA (ranged from 60-100%) and MDCD individuals (ranged from 75%-100%) post
diagnosis, with follow-up appointments available. Notably a ‘lack of resources and
supports’ was a common theme documented across all groups.

The following

suggestions were proposed by interviewees (Table 5.4.1) to be available in electronic,
leaflet or booklet format.
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Table 5.4.1: Additional supporting resources suggested by MDFA and MDCD
respondents (adults and parents) to assist sufferers with living with their food
hypersensitivity in Ireland and NI, based on information given in priority setting
interviews conducted between August and December 2020 (n=76)
MDFA Respondents

MDCD Respondents

Recommendations on nutritional
supplementation

Recommendations on nutritional
supplementation, particularly what food
supplements to take

Resources on how to understand food
labels, and how to read them

Resources on how to understand food
labels, and how to read them

Resources on practical measures to
prevent cross-contamination

Resources on practical measures to
prevent cross-contamination

Information on food allergy lifestyle
management

An index of Gluten Free (GF) Food on
the market

Diet Plans /Recipes/ Recipe Cards

Suggested GF Recipes

Resources specifically for children

Information on disease complications

* MDFA: Medically Diagnosed Food Allergy, MDCD: Medically Diagnosed Coeliac disease

With regard to ‘Counselling/psychological services for food hypersensitive individuals
and their families, both MDFA and MDCD interviewees indicated that this area was their
6th priority (Figures 5.4.1a, 5.4.2a, and 5.4.3a). Between 40% and 66% of respondents
reported that they currently have no access to such services, however, it is unclear if the
remaining respondents are actually accessing them. There was strong agreement among
all cohorts interviewed (100% of each, with the exception of the MDFA Adult group in
NI (75%)) that such services should be available, particularly after the initial diagnosis.
Interviewees discussed anxiety associated with having a food hypersensitivity in their
comments, particularly for children and adolescents who are trying to ‘fit-in’ with their
peers. In addition, MDFA interviewees commented on the psychological impact of
incidences of anaphylaxis and having to carry an adrenaline autoinjector on a daily basis.
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The benefits of support groups were discussed by many interviewees, although the lack
of assured medical advice from healthcare professionals in these settings was raised. A
helpline for food hypersensitivity was also proposed: so too was a buddy system for food
hypersensitive children in a school environment.
The last priority for both MDFA (ranked 8th) and MDCD groups (ranked 7th) was
‘recognition of their condition as a disability’ (Figures 5.4.1a and 5.4.2a). Neither of
these conditions is currently recognised as a disability in Ireland or NI.

While disability status ranked the lowest priority for MDFA interviewees in Ireland and
NI, it is worth noting that 25% of interviewees believed that their (or their
child’s/adolescent’s) condition should be considered as a disability (Tables 5.2.3, 5.2.4,
5.3.3 and 5.3.4). The argument in favour of such a move was that it gives recognition to
food hypersensitive individuals and helps them lobby for stricter rules in a number of
settings (public, educational, food sector, etc.). In addition, it also provides protection
for MDFA individuals against discrimination in the workplace or other environments.
An additional 35% of interviewees were ‘unsure’ and a possible decision based on
severity was suggested. A further 45% disagreed with this proposal and did not believe
MDFA required this status. 21% of MDCD interviewees believed that their or their
child/adolescent’s condition should be considered a disability. One argument proposed
was the long-term health implications and socio-economic effects of this condition.
Thirty percent of interviewees were, however, ‘unsure’ and also suggested consideration
on a case-by-case basis depending on severity. 49% of interviewees disagreed with the
concept of MDCD being given disability status.
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5.4.1 Priority setting interview ranking for ‘all respondents’ reporting to have
MDFA

* ‘All Respondents’ including adults and parents of children and adolescents reporting to be MDFA (n=40) in Ireland and NI

Figure 5.4.1a: Prioritisation of topics in order of importance by All Respondents*
reporting to be MDFA on the IoI (n=40): Priority ranking of importance 1-8 (most
to least)

* ‘All Respondents’ including adults and parents of children and adolescents reporting to be MDFA (n=40) in Ireland and NI

Figure 5.4.1b: Prioritisation of topics in terms of level of ease/difficulty in addressing
the issues in each topic by All Respondents* reporting to be MDFA in the IoI (n=40):
Priority ranking of ease of ability to Solve 1-8 (easiest to most difficult)
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5.4.2 Priority setting interview ranking for ‘All Respondents’ reporting to have
MDCD

* ‘All Respondents’ including adults and parents of children and adolescents reporting to be MDCD (n=36) in Ireland and NI

Figure 5.4.2a: Prioritisation of topics in order of importance by All Respondents*
reporting to be MDCD in the IoI (n=36): Priority ranking of importance 1-8 (most
to least)

* ‘All Respondents’ including adults and parents of children and adolescents reporting to be MDCD (n=36) in Ireland and NI

Figure 5.4.2b: Prioritisation of topics in terms of level of ease/difficulty in addressing
the issues in each topic by All Respondents* reporting to be MDCD in the IoI
(n=36): Priority ranking of ease of ability to Solve 1-8 (easiest to most difficult)
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5.4.3 Priority setting interview ranking for ‘All Respondents’ MDFA versus MDCD

* ‘All Respondents’ including adults and parents of children and adolescents (n= 76) reporting to be MDFA (n=40) and MDCD
(n=36) in Ireland and NI

Figure 5.4.3a: Prioritisation of topics in order of importance by All Respondents*
reporting to be MDFA and MDCD on the IoI (n=76): Priority ranking of
importance 1-8 (most to least)

* ‘All Respondents’ including adults and parents of children and adolescents (n= 76) reporting to be MDFA (n=40) and MDCD
(n=36) in Ireland and NI

Figure 5.4.3b: Prioritisation of topics in terms of level of ease/difficulty in addressing
the issues in each topic by All Respondents* reporting to be MDFA and MDCD on
the IoI (n=76): Priority ranking of ease of ability to solve 1-8 (easiest to most
difficult)
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Chapter 6: Results for the Food Hypersensitivity Datasets & Peerreviewed Published Prevalence Values
6.1 Collection and Examination of Datasets on Food Hypersensitivity in
Public and Private Institutions
This task targeted existing databases of information on food hypersensitivity in Early
Years Service (EYS) providers (childcare facilities), primary and secondary schools, and
nursing homes. The method used is described in section 2.5. In brief, surveys were sent
via email to target Institutions in Ireland and NI. These questionnaires were designed to
collect information on the i) gender, ii) age range, and iii) associated trigger foods (where
applicable) of hypersensitive children and elderly adults. Additional information on
whether the sufferers carried an adrenaline autoinjector, or previous instances of adverse
reactions to food (on-site) were requested. A follow-up (reminder) email was sent to
EYS, Schools and Nursing Homes approximately one month after the initial
questionnaire email. Many surveys were completed with regard to the specific number
of individuals in each organisation with a food hypersensitivity, but not all respondents
gave further details regarding trigger foods or the carriage of adrenaline auto-injector etc.
as requested. The sample size (no. of completed surveys) consisted of 164 EYS providers
(145 in Ireland and 19 in NI) representing 9,517 children: 15 schools (12 in Ireland and
3 in NI) representing 3,233 children/adolescents, and 35 nursing homes (28 in Ireland
and 7 in NI) representing 2,139 residents. Notably these surveys sought information on
all of the individuals in attendance, or residing, within these institutions/facilities, so a
single completed survey could contain relevant information on several hundred
individuals.
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6.1.1 Reported percentages of food hypersensitivity in Early Years Services (EYS)
in Ireland & NI
A survey targeting Early Learning Service (EYS) providers in Ireland (n=800) and NI
(n=342) was conducted between July and December of 2019. The aim of this task was
to collate information on food hypersensitivity in children attending childcare and preschool (approx. age range 1-5 years). Completion of this survey by county is presented
in Figures 6.1.1a and b. This survey was completed in all the counties in Ireland (in
particular Dublin 27%, Galway 12% and Cork 10%) and NI.

Reported Food

Hypersensitivity percentages associated with each gender (where recorded on survey),
and specific trigger foods (where relevant) are presented in Figure 6.1.1c and Table
6.1.1b.

One hundred and forty-five EYS completed (or partially completed) a survey about food
hypersensitivity in their charges out of total of 800 EYS providers contacted in Ireland.
The responses contained information on 8,499 children. A total of 560 (6.6%) children
were reported to have a food hypersensitivity (Table 6.1.1a). These included 284
individuals (3.3%) who had a food allergy (FA), 26 (0.30%) had coeliac disease (CD),
and 250 (2.9%) had FI.

Nineteen EYS completed (or partially completed) a survey about food hypersensitivity
in their charges out of total of 342 EYS contacted in NI. The responses contained
information on 1,018 children. A total of 86 (8.5%) children were reported to have a
food hypersensitivity in Ireland (Table 6.1.1a). These included 33 individuals (3.2%)
who had a food allergy (FA), 5 (0.5%) had coeliac disease (CD), and 48 (4.7%) had FI.
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A wide range of 'trigger foods' were reported and are presented in Figure 6.1.1c and Table
6.1.1d. Nuts, eggs, dairy, sesame seeds and wheat were the five most reported food
allergens on the IoI from the 164 EYS responses collected in this survey. Of the 317
children reported as having a FA, 17% (n=55) were recorded as carrying an adrenaline
autoinjector. In addition, 11% (41 in Ireland, and 14 in NI) of the EYS respondents
indicated they previously had an adverse reaction (severity unspecified) to food on-site.

Not ReportedCarlow Cavan
Clare
1%
3% 2% Cork
Wicklow 6%
8%
10%
Westmeath
2%
Sligo 2%
Roscommon 3%
Offaly 1%
Monaghan 1%

Donegal
1%

Meath 2%
Mayo 2%
Louth 2%
Longford 1%
Limerick 2%
Leitrim 2%
Laois 2%
Kilkenny
1% Kildare
Kerry
6%
4%

Dublin
27%

Galway
12%

*Carlow =1, Cavan=4, Clare=3, Cork=15, Donegal =2, Dublin=35, Galway=17, Kerry=6, Kildare =9. Kilkenny=1, Laois=4,
Leitrim=3, Limerick=2, Longford=2, Louth=3, Mayo=3, Meath=6, Monaghan=1, Offaly=1, Roscommon=3, Sligo =2, Westmeath=2,
Wicklow=12, Not reported=8
**137 respondents indicated a county, 8 respondents did not.

Figure 6.1.1a: Breakdown of completion rate of the food hypersensitivity survey in
Early Learning Services by county in Ireland (n=145), following online circulation
to schools between July and December 2019
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Antrim
33.3%
Armagh
33.3%

Tyrone
32%

Derry
5%
Fermanagh
5%

Down
33.3%

*Antrim=2, Armagh=2, Down=7, Fermanagh =1, Derry=1, Tyrone=6

Figure 6.1.1b: Breakdown of completion rate of the food hypersensitivity survey in
Early Year Services by county in NI (n=19), following online circulation to schools
between July and December 2019
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Table 6.1.1a: Breakdown of reported food hypersensitivity in children enrolled in
Early Years Services in Ireland (EYS n=145; 8,499 individuals) and NI (EYS n=19;
1,018 individuals). Online survey July and December 2019.
Early Years Services Survey Results

Ireland

NI

Ireland & NI

EYS Contacted regarding this Survey

800

342

1,142

EYS who Completed Survey (% of total)

145 (18%)

19 (6%)

164 (14%)

No. of Children Represented in Completed
Surveys

8,499

1,018

9,517

EYS: Females (% of total)

4,055(48%)

425(42%)

5,120 (44%)

EYS: Males (% of total)

4,444 (52%)

442 (43%)

4,740 (40.5%)

Reported Food Hypersensitivity EYS (% of
children)

560 (6.6%)

86 (8.5%)

646 (6.8%)

EYS: Females reported FH (% of FH total)

109 (20%)

26 (2.6%)

135 (1.2%)

EYS: Males reported with FH (% of FH total)

114 (20%)

35 (3.5%)

149 (1.3%)

EYS: Gender Unknown with FH (% of FH total)

337 (60%)

25 (2.5%)

362 (3.1%)

Reported Food Allergy (FA) in EYS (% of
children)

284 (3.3%)

33 (3.2%)

317 (3.3%)

EYS: Females reported FA (% of FA total)

46 (16%)

9 (0.9%)

55 (0.5 %)

EYS: Males reported with FA (% of FA total)

63 (22%)

13 (1.3%)

76 (0.7%)

EYS: Gender Unknown with FA (% of FA total)

175 (62%

11 (1.1 %)

186 (1.6%)

Reported Coeliac disease (CD) in EYS (% of
children)

26 (0.30)

5 (0.5%)

31 (0.33%)

EYS: Females reported CD (% of total)

3 (12%%)

3 (0.3%)

7 (0.1%)

EYS: Males reported with CD (% of total)

6 (23%)

1 (0.1%)

7 (0.1%)

EYS: Gender Unknown with CD (% of total)

17 (65%)

1 (0.1%)

18 (0.2%)

Reported Food Intolerance (FI) in EYS (% of
total)

250 (2.9%)

48 (4.7%)

298 (3.1%)

EYS: Females reported FI (% of total)

60 (24%)

14 (1.4%)

74 (0.6%)

EYS: Males reported with FI (% of total)

45 (18%)

21 (2.1%)

66 (0.6%)

EYS: Gender Unknown with FI (% of total)

145 (58%)

13 (1.3%)

158 (1.4%)

* FA: Food Allergy, CD: Coeliac disease, FI: Food Intolerance or Suspected/Undiagnosed Food Allergies (FI)
** Food Hypersensitivity includes FA, CD and FI

295

45
40

39

36

Reported Food Allergy (FA)
Reported Food Intolerance or Suspected/Undiagnosed Food Allergy (FI)

32

35
30

26

25
18

20
15

12

10
5

10

8

6

5

5
1

4

2 3

2

2

21 1

4

1

3

2

2

0

* Ireland:
Medically Diagnosed Food Allergy: Nuts (unspecified)=30 plus 8 reports of peanut allergy =38, Dairy =29, Eggs=31, Sesame
Seeds=8, Wheat=6, Chickpeas=5, Soya =4, Kiwi=4, Fish =3, Chicken=2, Oranges=2, Coconut =2, Strawberries =1, Apples =1
Food Intolerance: Nuts (unspecified)=10 plus 2 reports of peanut allergy =12, Dairy =12, Eggs=9, Wheat=14, Soya=1, Kiwi=2,
Coconut=1, Strawberries=3, Apples=3, Bananas=2, Sweetcorn=2
** Northern Ireland:
Medically Diagnosed Food Allergy: Nuts (unspecified)=1, Dairy =7, Eggs=1, Soya=1
Food Intolerance: Dairy=14, Eggs=1, Wheat=4, Strawberries=1

Figure 6.1.1c: The predominant trigger foods reported by Early Year Service
respondents in Ireland and NI, for 75 food allergic children (242 unknown, n=317)
and for 132 food intolerant children (with the exception of coeliac disease sufferers)
(166 unknown, n=298) reported in an online survey conducted between July to
December 2019
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Table 6.1.1b: Other foods reported by Early Year Service respondents in Ireland
and NI, for 75 food allergic food allergic Children (242 unknown, n=317) and for
132 Food Intolerant Children (with the exception of coeliac disease sufferers) (166
unknown, n=298) reported in an online survey conducted between July to December
2019
Additional

Additional

Food Allergies Reported

Food Intolerances Reported

Shellfish, Pork, Figs
Rice, Garlic, Sultanas
Bananas, Turkey
Food Colouring (unspecified)

Fruit (unspecified), Grapefruit
Watermelon, Red Pepper
Cauliflower, Potato, Oats
Sweet potato, Kidney Beans
Asparatame, Sweetener (unspecified)

*These foods are reported allergens not captured in Figure 6.1.1c (above). Each of these foods was reported just once in the surveys
circulated to EYS.

Yes, Previous
Adverse
Reaction to
Food
11%

Didn't answer
the question
30%

No, Previous
Adverse
Reaction to
Food
59%

*EYS in Ireland (n=145): 17 facilities reported ‘Yes’, 79 facilities reported ‘No’, and 49 facilities did not answer the question.
**EYS in NI (n=19): 1 facility reported ‘Yes’, 17 facilities reported ‘No’, and 1 facility did not answer the question.

Figure 6.1.1d: Percentage of Early Year Services (n=164) that reported a previous
incident of an adverse reaction (severity not specified) to food on-site, reported in
an online survey conducted between July to December 2019
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Food Allergic EYS
Children with adrenaline
autoinjectors
17%

Food Allergic EYS Children
without adrenaline
autoinjectors
83%

*55 children were reported to have adrenaline auto-injector: 41 from Ireland and 14 from NI

Figure 6.1.1e: Percentage of children attending Early Learning Services (EYS)
reported with a food allergy (n=317), who carry an adrenaline autoinjector (n=55),
based on data collected from an online survey conducted between July to December
2019
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6.2 Reported Percentages of Food Hypersensitivity in Primary &
Secondary Schools in Ireland & NI
A survey targeting primary and secondary schools in Ireland (n=600) and NI (n=136)
was conducted between July and December of 2019. The aim of this study was to collate
information on food hypersensitivity in children and adolescents attending primary
school (approx. age range 4-12 year) and secondary school (approx. age range 12 to 18
years). Completion of this survey by county is presented in Figures 6.2.1a and 6.2.1b.
Reported food hypersensitivity percentages associated with each gender, and specific
trigger foods (where relevant), are presented in Figures 6.2.1c and 6.2.1d.

Eight primary schools and 4 secondary schools, out of total of 600 school contacted in
Ireland, completed (or partially completed) a survey on food hypersensitivity in their
student population. The responses collected from these participating schools consisted
of information on 1,349 students attending primary school and 1,090 adolescents
attending secondary school in Ireland. A total of 56 (4.2%) primary school children were
reported as having a food hypersensitivity by the survey respondents in Ireland (Table
6.2.1). These included 30 individuals (2.2%) who were reported as having FA, 11 (0.8%)
with CD, and 15 (1.1%) with FI. With regard to secondary school students in Ireland, a
total of 42 (3.9%) were reported as having a food hypersensitivity (Table 6.2.1). These
included 29 individuals (2.7%) who were reported as having FA, 3 (0.3%) with coeliac
disease (CDCD, and 10 (0.9%) with FI.

One primary school, 1 secondary school, and 1 school with both a primary and secondary
school on-site in NI, completed the survey on food hypersensitivity in their student
population. This accounted for 3 schools out of total of 136 school contacted in NI. The
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information collected from these participating schools consisted of information on 794
students in NI. A total of 13 (9%) primary school children were reported as having a
food hypersensitivity (Table 6.2.1). These included 5 individuals (3.5%) with FA, 0 (0%)
with CD, and 8 (5.5%) with FI. With regard to secondary school students in NI, a total
of 15 (2.3%) were reported as having a food hypersensitivity (Table 6.2.1). These
included 12 individuals (1.9%) with FA, 1 (0.2%) with CD, and 2 (0.2%) with FI.

Trigger foods associated with the reported food allergies and intolerances are presented
in Figures 6.2.1c and 6.2.1d. Nuts, dairy, eggs, and soya were the four most reported
food allergens in primary schools on the IoI (n=10), with nuts, eggs, dairy, and kiwi being
the main food allergens in secondary schools (n=6). Of the 35 children reported as having
a FA in primary schools, 43% (15 children in Ireland only) were noted to carry an
adrenaline autoinjector, and 20% (2 children in Ireland and 6 in NI) out of 41 FA
adolescents were attending second level (Figures 6.2.1g and 6.2.1h).

When the

respondent schools were asked about previous incidences of adverse reactions to food
on-site (severity not specified), 20% of primary schools (2 in Ireland) and 33% of
secondary schools (2 in Ireland) reported they had experienced this (Figures 6.2.1e Figure
6.2.1f)
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Monaghan
Sligo 8.3%
8.3%

Dublin
8.3%
Laois
17%

Cavan
8.3%
Westmeath
8.3%
Limerick
8.3%
Roscommon
8.3%

Offaly
17%
Kerry
8.3%

*8 Primary Schools responded to the survey in Ireland: Offaly=2, Laois=1, Monaghan =1, Dublin=1, Kerry=1, Cavan=1, Sligo=1,
**4 Secondary Schools responded to the survey in Ireland: Laois=1, Roscommon =1, Limerick=1, Westmeath=1

Figure 6.2.1a: Breakdown of completion rate of the food hypersensitivity survey in
schools by county in Ireland (n=12), following online circulation to schools between
July and December 2019

Fermanagh
33.3%

Tyrone
33.3%

Down
33.3%
*3 Schools responded to the survey in NI: a Primary School in Fermanagh, a Secondary School in Tyrone and a Mixed Level Schoo l
(Primary and Secondary on-site) in Co. Down

Figure 6.2.1b: Breakdown of completion rate of the food hypersensitivity survey in
schools by county in NI (n=3), following online circulation to schools between July
and December 2019
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Table 6.2.1: Breakdown of reported food hypersensitivity in children/adolescents
attending schools (n=12) in Ireland (2.439 individuals), and schools (n=3) in NI (794
individuals), based on responses from online survey circulated to schools between
July and December 2019
Ireland

NI

Ireland & NI

600

136

736

303

68

371

297

68

365

No. of Schools who Completed Survey (% of total)

12 (2%)

3 (2.2%)

15 (2.0%)

Primary Schools who Completed Survey (% of total)

8 (2.6%)

1 (1.5%)

9 (2.4%)

School with Mixed Primary & Secondary on-site (% of
total)

0 (0%)

1 (0.7%)

1 (0.1%)

4 (1.3%)

1 (1.5%)

5 (1.4%)

No. of Students Represented in Completed Surveys

2,439

794

3,233

Primary Students Represented in Completed Surveys

1,349

29

1,378

Schools with Mixed Primary & Secondary on-site

0

233

233

Secondary Students Represented in Completed Surveys

1,090

532

1,622

Primary Schools: Females (% of total)

741 (12%)

13 (0.1%)

754 (14%)

Primary Schools: Males (% of total)

608 (10%)

16 (2%)

624 (12%)

Mixed Primary & Secondary on-site: Females

0 (0%)

58 (7%)

58 (1%)

Mixed Primary & Secondary on-site: Males (% of total)

0 (0%)

175 (22%)

175 (3%)

Secondary Schools: Females (% of total)

388 (16%)

268 (34%)

656 (20%)

Secondary Schools: Males (% of total)

702 (29%)

264 (33%)

966 (30%)

Reported Food Hypersensitivity Primary (% of
primary)

56 (4.2%)

13 (9%)

69 (4.6%)

42 (3.9%)

15 (2.3%)

57 (3.5%)

11 (0.8%)

2 (1.4%)

13 (0.9%)

School Survey Results
Total No. School Contacted regarding this Survey
Primary Schools
Secondary Schools

Secondary Schools who Completed Survey (% of total)

(% of total)

Reported Food Hypersensitivity Secondary
(% of secondary)
Primary Schools: Females reported FH
(% of primary)
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Primary Schools: Males reported with FH

11 (0.8%)

10 (7%)

21 (1.4%)

34 (2.5%)

1 (0.7%)

35 (2.3%)

0 (0%)

3 (0.5%)

3 (0.05%)

13 (0.3%)

12 (1.9%)

25 (0.4%)

29 (0.6%)

0 (0%)

29 (0.5%)

30 (2.2%)

5 (3.5%)

35 (2.3%)

29 (2.7%)

12 (1.9%)

41 (2.5%)

Primary Schools: Females reported FA (% of total)

8 (0.6)

1 (0.7%)

9 (0.6 %)

Primary Schools: Males reported with FA (% of total)

10 (0.7)

3 (2.1%)

13 (0.9%)

Primary Schools Gender Unknown with FA (% of total)

12 (0.8)

1 (0.7 %)

13 (0.9%)

Secondary Schools: Females reported FA (% of total)

0 (0%)

1 (0.2 %)

1 (%)

Secondary Schools: Males reported with FA (% of total)

12 (0.2%)

11 (1.7 %)

23(%)

Secondary Schools: Gender Unknown with FA (% total)

17 (0.3%)

0 (%)

17(%)

Reported Coeliac disease in Primary (CD (% of total)

11 (0.8%)

0 (0%)

11 (0.7%)

Reported Coeliac disease in Secondary (CD) (% of
total)

3 (0.3%)

1 (0.2%)

4 (0.3%)

Primary Schools: Females reported CD (% of total)

1 (0.07%)

0 (0%)

1 (0.1%)

Primary Schools: Males reported with CD (% of total)

0 (0%)

0 (0%)

0 (0%)

Primary Schools Gender Unknown with CD (% of total)

10 (0.7%)

0 (0%)

10 (0.7%)

Secondary Schools: Females reported CD (% of total)

0 (0%)

1 (0.2%)

1 (0.02%)

Secondary Schools: Males reported with CD (% of total)

0 (0%)

0 (0%)

0 (0%)

Secondary Schools: Gender Unknown with CD (% total)

3 (100%)

0 (0%)

3 (0.05%)

Reported Food Intolerance in Primary (FI) (% of
total)

15 (1.1%)

8 (5.5%)

23 (1.5%)

10 (0.9%)

2 (0.2%)

12 (0.7%)

Primary Schools Females reported FI (% of total)

2 (0.2%)

0 (0%)

2 (0.1%)

Primary Schools: Males reported with FI (% of total)

1 (0.07%)

7 (7%)

8 (0.5%)

(% of primary)
Primary Schools Gender Unknown with FH
(% of primary)
Secondary Schools: Females reported FH
(% of secondary)
Secondary School: Males reported with FH
(% of secondary)
Secondary Schools: Gender Unknown with FH
(% of second.)
Reported Food Allergy in Primary (FA) (% of
primary)
Reported Food Allergy in Secondary (FA) (% of
secondary)

Reported Food Intolerance in Secondary (FI) (% of
total)

303

Primary Schools Gender Unknown with FI (% of total)

12 (0.9%)

1 (0.7%)

13 (0.9%)

Secondary Schools: Females reported FI (% of total)

0 (0%)

1 (0.2%)

1 (0.02%)

Secondary Schools: Males reported with FI (% of total)

1 (0.02%)

1 (0.2%)

2 (0.04%)

Secondary Schools: Gender Unknown with FI (% total)

9 (0.2%)

0 (0%)

9 (0.2%)

* FA: Food Allergy, CD: Coeliac disease, FI: Food Intolerance or Suspected/Undiagnosed Food Allergies (FI)
** Food Hypersensitivity includes FA, CD and FI

18

17

16

Reported Food Allergy (FA)

14
Reported Food Intolerance or suspected undiagnosed food allergy (FI)

12
10

8

8
6
3

4
2

0

3
1

2

2

1

0

1

0

1

0

0

1

0

1

0

* Ireland:
Medically Diagnosed Food Allergy: Nuts (unspecified)=16, Dairy =1, Eggs=1, Sesame Seeds=1
Food Intolerance: Dairy=2, Eggs=1
** Northern Ireland:
Medically Diagnosed Food Allergy: Nuts (unspecified)=1, Dairy =2, Eggs=2, Soya=2 Tomatoes = 1, Wheat =1
Food Intolerance: Dairy=6, Soya=2, Grapes =1, Strawberries =1

Figure 6.2.1c: Trigger foods reported for primary school children in Ireland and
NI, for 20 food intolerant individuals (with the exception of coeliac disease) (3
unknown, n=23) and 22 food allergic individuals (13 unknown, n=35) reported in an
online survey conducted between July to December 2019
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12
10
10

Food Allergy

8

Food Intolerance

8
6
4

4

4
2

2

2

1 1
0

0

0

1

1
0

0

1
0

1
0

1
0

1
0

1
0

0

0

* Ireland:
Medically Diagnosed Food Allergy: Nuts (unspecified)=3, Eggs=6, Dairy =4, kiwi=2, Fruit (Unspecified)=1, shellfish=1, chicken=1,
mustard=1
Food Intolerance: wheat=2, Dairy=1
** Northern Ireland:
Medically Diagnosed Food Allergy: Nuts (unspecified)=7, Eggs=2, Kiwi =2, Oranges=1, Fish (unspecified) =1, Prawns=1
Food Intolerance: Dairy=1, Orange=1, Blackcurrant=1

Figure 6.2.1d: Trigger foods reported for secondary school children in Ireland and
NI, for 2 food intolerant individuals (with the exception of coeliac disease) (10
unknown, n=12) and 24 food allergic individuals (17 unknown, n=41) reported in an
online survey conducted between July to December 2019
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Didn't answer theSALES
question
10%

Yes, Previous
Adverse Reaction
to Food
20%

No, Previous
Adverse Reaction
to Food
70%

*Primary Schools in Ireland (n=8): 2 schools reported ‘Yes’, 5 schools reported ‘No’, and 1 school did not answer the questio n.
**Primary Schools in NI (n=2- one of which was mixed primary and secondary): 2 schools reported ‘No’

Figure 6.2.1e: Percentage of primary schools (n=10) that reported a previous
incident of an adverse reaction (severity not specified) to food on-site, reported in
an online survey conducted between July to December 2019
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Didn't answer
the question
25%

Yes, Previous
Adverse
Reaction to
Food
33%

No, Previous
Adverse
Reaction to
Food
25%
*Secondary Schools in Ireland (n=4): 2 schools reported ‘Yes’, 1 school reported ‘No’, and 1 school did not answer the question.
**Secondary Schools in NI (n=2- one of which was mixed primary and secondary): 2 schools reported ‘No’

Figure 6.2.1f Percentage of secondary schools (n=6) that reported a previous
incident of an adverse reaction (severity not specified) to food on-site, reported in
an online survey conducted between July to December 2019

Food Allergic Primary School
Students with adrenaline
autoinjectors
43%

Food Allergic Primary
School Students
without adrenaline
autoinjectors
57%

*15 food allergic primary school students were reported to carry adrenaline auto-injector, all of which were from Ireland and 0 in NI.
The total number of students reported with food allergies in Ireland was 30 and the NI was 5.

Figure 6.2.1g: Percentage of primary students reported with a food allergy (n=35)
to carry an adrenaline autoinjector (n=15), based on data collected from an online
survey conducted between July to December 2019
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Food Allergic Secondary School
Students with adrenaline
autoinjectors
20%

Food Allergic Secondary
School Students without
adrenaline autoinjectors
80%

*2 food allergic secondary school students in Ireland, and 6 in NI, were reported to carry adrenaline auto-injector. The total number
of secondary student’s reported to have food allergies in Ireland was 29 and in NI was 12.

Figure 6.2.1h: Percentage of secondary students reported with a food allergy (n=41)
to carry an adrenaline autoinjector (n=8), based on data collected from an online
survey conducted between July to December 2019
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6.3 Reported Percentages of Food Hypersensitivity in Nursing Homes in
Ireland & NI
A survey targeting all the Nursing Homes in Ireland (n=423) and NI (n=212) was
conducted between July and December of 2019. The aim of this study was to collate
information on food hypersensitivity in adults residing in these facilities (age range 49103, predominantly 70 - 95 years old). Completion of this survey by county is presented
in Figures 6.3.1a and 6.3.1b. Reported food hypersensitivity percentages associated with
each gender and specific trigger foods (where relevant) are presented in Figure 6.3.1c.

Twenty-eight nursing homes representing 1,973 residents out of 423 contacted in Ireland,
completed (or partially completed) a survey on food hypersensitivity in Ireland (Table
6.3.1). A total of 122 (6.2%) residents were reported to have a food hypersensitivity by
the facilities who responded. These included 43 individuals (2.2%) with FA, 31 (1.6%)
with CD and 54 (2.4%) with FI. Three nursing homes in Ireland (9%) reported residents
having previously had adverse reactions to food (severity not specified) on their premises;
18 nursing homes reported none, and 7 did not answer the question (Figure 6.3.1d). Ten
nursing homes in Ireland (29%) reported having an adrenaline autoinjector available in
their facilities in case of emergencies, 7 nursing homes didn’t have one, 3 didn't know,
and 8 didn’t answer the question (Figure 6.3.1e).

Seven nursing homes representing 166 residents, out of 212 contacted in NI, completed
(or partially completed) a survey on food hypersensitivity (Figure 6.3.1). A total of 5
(3%) residents were reported to have a food hypersensitivity by the facilities who
responded. These included 2 individuals (1.2%) who with FA, 2 (1.2%) with CD, and 1
(0.6%) with FI. Only a small number of trigger foods were reported for this cohort, but
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the allergens noted were nuts, dairy and eggs (Figure 6.3.1c). Five nursing homes (71%)
reported residences having previously had adverse reactions to food (severity not
specified) on their premises, while the other 2 nursing homes did not answer the question
(Figure 6.3.1d). Three nursing homes (43%) reported to have an adrenaline autoinjector
available in their facilities in case of emergencies, while 2 nursing homes reported none,
and 2 did not answer the question (Figure 6.3.1e).

Donegal Cavan
Wicklow 4%
4%
4%
Tipperary
4%
Cork
4%
Limerick
4%

Dublin
38%

Kildare
7%
Louth
7%

Kerry
11%

Galway
13%

*28 Nursing Homes responded to the survey in Ireland: Dublin=11, Galway=4, Kerry=3, Louth=2, Kildare =2, Limerick=1, Cork=1,
Tipperary=1, Wicklow=1, Donegal =1, Cavan =1

Figure 6.3.1a: Breakdown of completion rate of the food hypersensitivity survey in
nursing homes by county in Ireland (n=28), following online circulation to nursing
homes between July and December 2019

310

Antrim
15%

Tyrone
57%

Down
28%

*7 Nursing Homes responded to the survey in NI: Tyrone=4, Antrim=2 Down =1

Figure 6.3.1b: Breakdown of completion rate of the food hypersensitivity survey in
nursing homes by county in NI (n=7), following online circulation to nursing homes
between July and December 2019
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Table 6.3.1 Breakdown of reported food hypersensitivity in nursing homes (n=28)
in Ireland (1,973 individuals), and nursing homes (n=7) in NI (166 individuals),
based on an online survey circulated to nursing homes between July and December
2019
Nursing Homes Residence Survey Results

Ireland

NI

Ireland
NI

Nursing Homes Contacted regarding this Survey

423

212

635

No. of Nursing Homes who Completed Survey (% of
total)

28 (7%)

7 (3%)

35 (6%)

No. of Residence Represented in Completed Surveys

1,973

166

2,139

Females Residence (% of total)

1,118 (57%)

127 (77%)

1,245 (58%)

Male Residence (% of total)

610 (31%)

39 (23%)

649 (30%)

Gender Unknown (% of total)

245 (12%)

0 (0%)

245 (12%)

Reported Food Hypersensitivity: (% of total)

122 (6.2%)

5 (3%)

127 (5.9%)

Females Residence reported with FH (% of total)

17 (0.9%)

2 (1.2%)

19 (0.9%)

Males Residence reported with FH (% of total)

8 (0.4%)

3 (1.8%)

11 (0.5%)

Gender Unknown with reported FH (% of total)

97 (4.9%)

0 (0%)

97 (4.5%)

Reported Food Allergy (FA) (% of total)

43 (2.2%)

2 (1.2%)

45 (2.1%)

Females Residence reported with FA (% of total)

4 (0.2%)

1 (0.6%)

5 (0.25)

Male Residence reported with FA (% of total)

0 (0%)

1 (0.6%)

1 (0.05%)

Gender Unknown with reported FA (% of total)

39 (2%)

0 (0%)

39 (1.8%)

Reported Coeliac disease (CD) (% of total)

31 (1.6%)

2 (1.2%)

33 (1.5%)

Females Residence reported with CD (% of total)

10 (0.5%)

1 (0.6%)

11 (0.5%)

Male Residence reported with CD (% of total)

4 (0.2%)

1 (0.6%)

5 (0.2%)

Gender Unknown with reported CD (% of total)

17 (0.9%)

0 (0%)

17 (0.8)

Reported Food Intoler. or Suspected Food Allergy
(FI)

48 (2.4%)

1 (0.6%)

49 (2.3%)

Females Residence reported with FI (% of total)

3 (0.2%)

0 (0%)

3 (0.1%)

Male Residence reported with FI (% of total)

4 (0.2%)

1 (0.6%)

5 (0.2%)

Gender Unknown with reported FI (% of total)

41 (2%)

0 (0%)

41 (2%)

* FA: Food Allergy, CD: Coeliac disease, FI: Food Intolerance or Suspected/Undiagnosed Food Allergies (FI)
**Food Hypersensitivity includes FA, CD and FI
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Reported Food Allergy (FA)
Reported Food Intolerance or Suspected/Undiagnosed Food Allergy (FI)
* Ireland:
Medically Diagnosed Food Allergy: Strawberries =1, Grapes =1, Mushrooms =1, Eggs =1
Food Intolerance or Suspected/Undiagnosed Food Allergy: Beef =4, Pork=3, Lamb=2, Strawberry =1, Seafood (not specified) =1,
Food Additives =1(not specified)
** Northern Ireland:
Medically Diagnosed Food Allergy – Nuts (Unspecified) =1, Dairy =1:
Food Intolerance or Suspected/Undiagnosed Food Allergy: Gluten =1

Figure 6.3.1c Trigger foods reported for residence of nursing homes in Ireland and
NI? for 12 food intolerant individuals (with the exception of coeliac disease) (36
unknown, n=48) and 4 medically diagnosed individuals (39 unknown, n=43) in as
survey conducted between July to December 2019
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Yes, Previous
Adverse
Reaction to
Food
23%

Didn't answer
the question
26%

No, Previous
Adverse
Reaction to
Food
51%
* 3 nursing homes in Ireland reported that residences had previously had adverse reactions to food on-site, 18 respondents reported
none, and 7 did not answer the question
** 5 nursing homes in NI reported that residences had previously had adverse reactions to food on-site, and the other 2 nursing homes
did not answer the question.

Figure 6.3.1d: Percentage of reported incidence of adverse reactions to food
(severity not specified) occurring in nursing home facilities in Ireland (n=28) and NI
(n=7) based on an online survey conducted between July to December 2019

Didn't answer the
question
23%

Adrenaline
autoinjectors
available on-site
37%

Don't know
14%

No adrenaline
autoinjectors
available on-site
26%

* 10 nursing homes in Ireland reported having an adrenaline autoinjector available in their facilities in case of emergencies, 7
respondents reported none; 3 didn't know, 8 did not answer the question.
** 3 nursing homes in NI reported having an adrenaline autoinjector available in their facilities in case of emergencies, 2 respondents
reported none; 2 didn’t know

Figure 6.3.1e: Percentage of reported availability of adrenaline auto-injector in
nursing home facilities in Ireland (n=28) and NI (n=7) based on an online survey
conducted between July to December 2019
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6.4 Overview of Reported Percentages of Food Hypersensitivity in EYS,
Schools & Nursing Homes
An overview of the reported percentages of food hypersensitivity by organisational
category and condition is presented in Figure 6.4. It should be noted however, that this
data is self-reported (based on the respondents' knowledge and information) and therefore
may not necessarily reflect all of the food hypersensitivities of all of the 14,889
individuals from the 214 organisations that are represented in this survey. In particular
this may be true for schools who do not serve food on a daily basis, and therefore may
not have any record of a child/adolescents mild or non-life-threatening food
hypersensitivity, as opposed to a severe food allergy. In addition, the nature of this data
i.e., resident versus attendee (and the varying amounts of personal data retained on any
individual in one organisation compared to another) make it difficult to directly compare
between the four organisational datasets. That said, this chapter presents a 'snap-shot' of
some of the food hypersensitivity information currently stored in public and private
organisations in Ireland and NI and does provides data with regard to trends associated
with these conditions.
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8%

Percentage Reported

6.8%
5.9%

6%

4.6%
4%

3.5%

3.3%

3.1%
2.3% 2.5% 2.1%

2.3%
1.5%

2%
0.3%

0.7%

1.5%

0.3%

0.2%

0%
FH

FA

CD

FI

Conditions examined in this study
Early Years Services (~1-5 years old)

Primary Schools (~5-12 years old)

Secondary Schools (~12 to 18 years old)

Nursing Homes (~70-95 years old)

* Surveys were collected from145 EYS in Ireland and 19 EYS in NI; 8 primary schools and 4 secondary schools in Ireland and 1
primary school, 1 secondary and 1 mixed primary and secondary school in NI, 28 nursing homes in NI and 7 in Ireland.

Figure 6.4. Reported percentages of food hypersensitivity in 14,889 individuals in
214 organisations on the IoI based on an online survey circulated to nursing homes
between July and December 2019

For instance, higher levels of all food hypersensitivity were reported in children in EYS
than in schools and nursing homes, with the exception of CD. A lower percentage of FI
(0.2%-1.5%) leading to a lower overall reported percentage of food hypersensitivity (3.54.6%) was reported for primary school and secondary school children and adolescents.
This finding could potentially be a result of the under-reporting of milder food
hypersensitivity in schools where packed lunches are in the norm and no food is served.

Food hypersensitivity was found to range from 3.5-6.8% (FA from 2.1-3.3%, CD from
0.3-1.5%, and FI 0.2-3.1%) in the cohorts examined in this study. In addition, 17-43%
of food allergic groups were noted to carry an adrenaline autoinjector. More specifically,
an average of 20% of EYS children and school goers combined carried them, while 37%
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of nursing homes reported having an adrenaline autoinjector on-site. Approximately 11%
of EYS, 20% of primary schools, 23% of nursing homes, and 33% secondary schools
reported a previous incidence of an adverse reaction to food on their premises (30
organisations, 14% of all surveyed). The severity of these reported episodes was not
queried within the context of the surveys. However, some respondents detailed severe
reaction and the use of adrenaline auto-injector in some of these incidences in their
answers, indicating the probable severity of these reactions.
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6.5 Examination of Food Hypersensitivity Datasets on the Island of
Ireland
During this course of this study, databases were sought with information on Food
Hypersensitivity for the IoI, and relevant figures were analysed. Percentages of reported
food hypersensitivity in datasets acquired, breakdown by age and gender, and associated
trigger foods (where available) are reported. A summary of the databases reviewed are
as follows:
•

6.5.1 Self-reported food allergy/hypersensitivity data from registered
students (19,929 students) attending TU Dublin (2018-2019): This dataset
includes the self-reported food allergy/hypersensitivity data (often including the
trigger food) by gender for 19,929 students registered in the academic year
2018/2019

•

6.5.2 The Growing up in Ireland study from the Economic & Social Research
Institute (ERSI): This includes the percentage of reported food hypersensitivity
on a cohort of 11,134 infants when they are 9 months old, 3 years old (n=9,783)
and 5 years old, between 2008-2013.

The gender of each of the food

hypersensitive cohorts (wave 1, 2, and 3) is also examined. Available at:
https://www.growingup.ie/about-growing-up-in-ireland/
•

6.5.3 Central Statistics Office (CSO) survey for 5,348 secondary school
students from 155 secondary schools (2015): This includes the breakdown of
specific food allergies within this cohort. Available at: www.censusatschool.ie

•

6.5.4 Dining out: The challenge for those with a Food Allergy or Food
Intolerance in the Republic of Ireland and Northern Ireland (2013). This
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includes information of trigger foods associated with food hypersensitivity for
241 individuals in Ireland and 111 in NI. Available at the following links:
•

https://www.safefood.net/getmedia/62903d02-8532-4659-a7e6-59ba365ec00f/Final-report-IRELANDJan2015.aspx?ext=.pdf

•

https://www.safefood.net/getmedia/3f1e9d08-a448-47c9-bfbb-0305513ef6b7/Final-report-NIJan2015.aspx?ext=.pdf

•

6.5.5 FSAI Food Allergy Survey (2011): The FSAI conducted an online food
allergy and intolerance survey in Ireland (n=509) as part of their Monitoring &
Surveillance Series Food Allergens & Labelling Survey”. Dublin, Ireland.
Associated

food

allergens

are

reported.

Available

at:

https://www.fsai.ie/resources_publications/allergen_labelling_2011.html.html
•

6.5.6a Irish Hospital Inpatients Enquiry (HIPE 1) data for Ireland:
Information on the predominant food associated with food anaphylaxis between
1995 to 2004.

•

6.5.6b Irish Hospital Inpatients Enquiry (HIPE 2) data for Ireland: HIPE 2
is a dataset of the number of individuals discharged from hospital as a result of
food anaphylaxis (principal diagnosis) between 2008 and 2018. Figures on
hospital discharge numbers, associated age categories and gender are reviewed.

•

6.5.7 Data from a study on the Incidence and Prevalence of Coeliac disease
in the UK (per Region) Over Two Decades (1990-2011): Population-Based
Study: This study provides information on the prevalence of Coeliac disease (per
100,000 population) in Northern Ireland, England, Scotland & Wales in 2011.
This data is also examined with regard to gender and age of individuals diagnosed
with coeliac disease.
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Available at:
https://journals.lww.com/ajg/Fulltext/2014/05000/Incidence_and_Prevalence_of
_Celiac_Disease_and.22.aspx
•

6.5.8 Coeliac Society of Ireland Dataset of 2,899 individuals reporting to have
medically diagnosed coeliac disease in 2019: The Coeliac Society of Ireland
2019 dataset includes information on 2,899 members (by gender) reported to be
medically diagnosed with coeliac disease. This information was also available
by age category: infants and young children (0 to 3 years), children (4 to 12 years),
adolescents (13 to 17 years), adults (18 to 64 years) and adults (>65 years).

•

6.5.9 Prevalence Values reported in the Literature
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6.5.1 Self-reported food allergy/hypersensitivity data from registered students
(19,929 students) attending TU Dublin (2018-2019)
Gender breakdown of students with a food allergy
The database was acquired for the academic year 2018-2019 and consists of anonymised
food hypersensitivity information on 19,929 students (11,818 males and 8,111 females)
who were registered in TU Dublin at this time. Students were asked to give information
regarding any ‘food allergies’ they may have on their registration form. However, no
other option was included to record other food hypersensitivities such as a food
intolerance, so this information may have also been recorded under the ‘food allergy’
heading.

For this reason, the data presented will be reported as % food

allergy/hypersensitivity. For the academic year in question, 313 students (161 males and
152 females) or 1.57% reported to have a food allergy/hypersensitivity on their registered
form (Figure 6.5.1a). Out of this group 65 or 0.33% of these students reported to carry
Adrenaline autoinjector. There was no age breakdown reported for this dataset.

Male
Female

1%

1%

Figure 6.5.1a: Percentage of students, by gender, who reported to have Food
Allergy/ Hypersensitivity (n=313) when registering with TU Dublin in the academic
year 2018-2019
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When trigger foods were examined, nuts (n=121, 39%), cereals containing gluten (n=71,
23%), crustaceans (n=48), eggs (n=41), and milk (n=35) were the five most reported
allergens among the food hypersensitive student cohort (n=313) – as per Figure 6.5.1b
and Table 6.5.1a. All of these allergens are covered under the 14 EU food allergens in
EU food law (as per Regulation (EU) No. 1169/2011).

Percentage of students with food
allergy/hypersensitivity

45%
40%

39%

35%
30%
25%
20%

15%
10%

23%
15%

13%

11%

9%

7%

7%

5%

2%

2%

2%

1%

1%

1%

0%

Food Allergens

Figure 6.5.1b: Percentage of students who reported a food allergy/hypersensitivity
(n=313) to any of the 14 EU allergens when registering with TU Dublin in the
academic year 2018-2019

322

Table 6.5.1a: Percentage of students who reported to have a food
allergy/hypersensitivity (n=313) to any of 14 EU allergens when registering with TU
Dublin in the academic year 2018-2019 (n=19,929)

EU
14
Food
allergens
(Regulation (EU)
No. 1169/2011)

No. of students
who reported
FA/FH. to
foodstuffs
(n=313)

FA/FH. (n=313)

% of all
students with
reported
FA/FH
(n=19,929)

Nuts

121

39%

1%

Cereals containing
gluten

71

23%

0.4%

Crustaceans

48

15%

0.2%

Eggs

41

13%

0.2%

Milk

35

11%

0.2%

Molluscs

27

9%

0.1%

Fish

23

7%

0.1%

Peanuts

22

7%

0.1%

Sesame

7

2%

0.04%

Lupin

5

2%

0.03%

Soybeans

5

2%

0.03%

Mustard

4

1%

0.02%

Celery

4

1%

0.02%

Sulphur Dioxide
& sulphites

3

1%

0.02%

*FA: Food Allergy, FH Food Hypersensitivity
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% of students
with reported

Outside of the 14 EU allergens, fruit unspecified (15%, n=48, Figure 6.5.1c), and other
foods (5%, n=17, Figure 6.5.1d); vegetables (2%, n=6), herbs and spices (1%, n=4), meat
(0.3%, n=1), poultry (0.3%, n=1), yeast (0.3%, n=1), food additives (unspecified) (0.3%,
n=1), oats (0.3%, n=1), sugar (0.3%, n=1) and chocolate (0.3%, n=1) were reported by
food allergic/hypersensitive cohort. Notably 7% (n=21) of these students and 0.1% of all
students reported an allergy/hypersensitivity to kiwi (Figure 6.5.1c); 3% to pineapple
(0.04% of all students) and 2% to apples or citrus fruit (0.03% of all students).

25

21

Total number of students
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1

0

Food Allergy/Hypersensitivity to Fruits

Figure 6.5.1c: Number of students who reported to have a food
allergy/hypersensitivity (n=313) to fruit (n=48) when registering with TU Dublin in
the academic year 2018-2019 (n=19,929)
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Food Allergy/Hypersensitivity to Other Foods

Figure 6.5.1d: Number of students who reported to have a food
allergy/hypersensitivity (n=313) to other foods (n=17) when registering with TU
Dublin in the academic year 2018-2019 (n=19,929)
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6.5.2 The Growing up in Ireland study from the Economic & Social Research
Institute, ESRI (2008 -2013)
The Growing Up in Ireland Study was a Government-funded study of children jointly
carried out by the Economic & Social Research Institute (ESRI) and Trinity College
Dublin. It was managed by the Department of Children, Equality, Disability, Integration
and Youth (formerly Department of Children and Youth Affairs) in association with the
Central Statistics Office. Details available at: https://www.growingup.ie/about-growingup-in-ireland/

The study started in 2006 and followed the progress of two groups of children: 8,500 9year-olds (Child Cohort/Cohort ’98) and 11,134, 9-month-olds (Infant Cohort/Cohort
’08). Notably parents of the latter infant cohort were asked a question regarding ‘food or
digestive allergy (or food intolerance)’ in each of their three surveys. In fact, different
questions were proposed on each of the three occasions (waves) these parents were
surveyed.
Wave 1: “Has a medical professional ever told you that baby has “digestive allergies”
(e.g., lactose intolerant)"?
Wave 2: “Any kind of food or digestive allergy?”
Wave 3: “Any kind of food or digestive allergy or food intolerance?”

Given the slightly confusing description included in these survey questions (particularly
the question and example for wave 1), the data will henceforth be described in terms of
food hypersensitivity, instead of food allergy. The same cohort was questioned on three
occasions between 2008 and 2013 in wave 1, 2, and 3 as per Figure 6.5.2a. A summary
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of the data collected for these infants/children with regard to food hypersensitivity in each
of three waves is included here. The gender of each group of infants/children reported to
have food hypersensitivity was statistically analysed by 2-sample test. No information
regarding associated trigger foods was reported from these surveys.

Wave 1 (Sept. 2008 -April 2009)
9 months olds: 11,134 children
https://www.ucd.ie/issda/data/guiinfant/guiinfantwave1/

Wave 2 (Dec. 2010 – July 2011)
3 years old: 9,793 children
https://www.ucd.ie/issda/data/guiinfant/guiinfantwave2/

Wave 3 (Mar -Sept. 2013)
5 years old: 9,001 children
https://www.ucd.ie/issda/data/guiinfant/guiinfantwave3/

Figure 6.5.2a: Outline of the infant subgroup and source link of the Growing up in
Ireland Study conducted in three waves on the same set of children between 2008
and 2013 (n=11, 134, n=9,793, n=9,001 children) by the ESRI
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Wave 1: Parental Survey of 9-month-old Infants (Sept 2008 – April 2009)
In wave 1, the parents of infants (11,134 participants) were surveyed when their children
were 9 months old. A total of 433 (3.9%) of these participants answered yes to the
question “has a medical professional ever told you that baby has “digestive allergies”
(e.g., lactose intolerant)". The gender breakdown of the infants who were reported to
have a food hypersensitivity was 238 (55%) males, and 195 (45%) females (as shown in
Figure 6.5.2b). Although the percentage of male infants who were reported to have food
hypersensitivity was higher than for females, no significant difference was found between
the genders on this occasion (p value = 0.11).

Male
Female

45%
55%

Figure 6.5.2b Percentage breakdown of infants by gender (aged 9 months) whose
parents (n=433) reported that they had food hypersensitivity (“digestive allergies
e.g., lactose intolerance”) in the Growing Up in Ireland study (Sept. 2008- April 2009)
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Wave 2: Parental Survey of 3-year-old Children (Dec. 2010 – July 2011)
In wave 2, parents of infants who completed wave 1 were surveyed, when their child
reached 3 years of age (9,793 participants). A total of 151 (1.3%) parents answered ‘yes’
to their child having “Any kind of food or digestive allergy” (as per Figure 6.5.2c). The
food hypersensitive children consisted of 92 males (61%) and 59 females (39%).
Notably, boys were statistically significantly more likely to have food hypersensitivity
than girls on this occasion (p-value =0.01).

Male
Female
39%

61%

Figure 6.5.2c Percentage breakdown of children by gender (aged 3 years old) whose
parents (n=151) reported that they had food hypersensitivity (“any kind of food or
digestive allergies”) in the Growing Up in Ireland study (Dec. 2010 – July 2011)
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Wave 3: Parental Survey of 5-year-old Children (Mar -Sept. 2013)
In wave 3, the parents of children (9,001 participants) from wave 1 and wave 2 were
surveyed when their child reached 5 years of age. A total of 165 participants (1.8%),
reported their child as having “any kind food or digestive allergy, or food intolerance”
Figure 6.5.2d. The gender breakdown of this food hypersensitive group consisted of 89
(54%) males and 76 (46%) females. While the figure for male infants with food
hypersensitivity was slightly higher (54%) than for females, this was not found to be
statistically significant (p-value = 0.5) on this occasion.

Male
Female

46%
54%

Figure 6.5.2d: Percentage breakdown of children by gender aged 5 years who were
reported to have food hypersensitivity “any kind of food or digestive allergy, or food
intolerance” by their parents (n=165) in the Growing Up in Ireland study (Mar -Sept
2013)
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6.5.3 Central Statistics Office Survey (CSO) 5,348 students attending 155 secondary
schools
In 2009, the Professional Development Service for Teachers (PDST), the CSO, Project
Maths and the National Council for Curriculum and Assessment (NCCA) collaborated to
set-up the Irish website (www.censusatschool.ie). From this, 5,348 (1.5%) of an
estimated 368,000 secondary school students completed the Phase 14 questionnaire of
the ‘CensusAtSchool’ survey between September 2014 and August 2015. Details
available at:

https://www.cso.ie/en/interactivezone/censusatschoolsreleases/censusatschool2015/

The questionnaire covered a variety of topics ranging from how often students
participated in family activities each week to the number of text messages they sent daily.
One of the questions asked students what foods they were allergic too. The percentage
of adolescents with food allergies (or possibly hypersensitivity) was not reported, just
associated trigger foods. The age range of participants was 12 - 18 years.

Trigger Foods:
The most reported ‘food allergy’/hypersensitivity was peanuts (22%), followed by milk
(19%), eggs (13%) and gluten (12%). Over half (51%) of students indicated that the
associated trigger food was not one of the allergens listed on the questionnaire. Notably
19% of the individuals surveyed reported to have multi-food allergies, to more than one
food.
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Figure 6.5.3: Percentage of survey respondents who reported to be ‘allergic’ to these
foodstuffs and other foods from Irish secondary school students in Ireland (n=5,348)
(CSO, 2015)
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6.5.4 Dining Out: The Challenge for those with a Food Allergy or Food Intolerance
(Ireland and NI Studies, 2013)
A joint-survey was conducted on an all-island basis by Safefood in Ireland and a
Safefood-FSA-NI partnership in NI between January to February 2013.

Details available at the following links:
•

https://www.safefood.net/getmedia/62903d02-8532-4659-a7e659ba365ec00f/Final-report-Ireland-Jan2015.aspx?ext=.pdf

•

https://www.safefood.net/getmedia/3f1e9d08-a448-47c9-bfbb0305513ef6b7/Final-report-NI-Jan2015.aspx?ext=.pdf

The purpose of the survey was to examine the experiences and opinions of food
hypersensitive consumers with regard to eating out in catering establishments such as
restaurants, hotels, cafes, etc. The survey was circulated electronically to the membership
bases of ‘Anaphylaxis Ireland’ and ‘Allergy NI’. Notably, this study was limited to
members of these two organisations, and as such does not capture opinion of food
hypersensitive non-members.

In summary, a total of 241 valid responses were collected in Ireland. Overall, 45% of
survey responses were completed by parent/guardians/carers of food hypersensitive
children (0 – 12-year-olds). This number increases to 73% when food hypersensitive
adolescents/young adults (13 – 20-year-olds) are included. In total, 97% of the
respondents reported that their ‘food allergy or food intolerance had been medically
diagnosed’. In terms of prevalence, the top five most reported food allergies were peanut
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(71%), tree-nuts (59%), eggs (41%), crustaceans (21%) and milk (19%) (Figure 6.5.4a).
The respondents also reported hypersensitivity to other foods (non-regulated food
allergens in EU food law), such as fruit, vegetables, and meat. Notably, food
hypersensitivity to kiwi (10%) was reported to be more prevalent than some EU regulated
food allergens: soya bean (6%), cereals with gluten (5%) mustard (3%), lupin (2%),
sulphur dioxide (1%) and celery (no % reported).

A total of 111 valid responses were collected for NI in the same study. Overall, 69% of
the survey responses were completed by parent/guardians/carers of food hypersensitive
children (0 – 12-year-olds). This number increases to 86% when food hypersensitive
adolescents/young adults (13 – 20-year-olds) are included. In this cohort, 99% of the
respondents reported that their ‘food allergy or food intolerance had been medically
diagnosed’. In terms of prevalence, the top five reported food allergens were peanut
(68%), tree-nuts (66%), eggs (41%), milk (30%) and sesame seeds (14%) (Figure 6.5.4b).
The other foods (non-regulated food allergens in EU food law) that respondents reported
to be food hypersensitive too, were mostly varieties of fruit and vegetables, and types of
meat. Notably, food hypersensitivity to kiwi (10%) was reported to be more prevalent
than some EU regulated food allergens: soya bean (9%), fish (8%), crustaceans (5%),
celery (4 %), sulphur dioxide (4%), lupin (2%) and mustard (1%).
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Figure 6.5.4a: Percentage of survey respondents who reported to be
allergic/intolerant to the 14 food allergens identified in Appendix II of the EU FIC
and non-regulated food allergens in the Safefood “Dining Out” Study in Ireland in
2013 (n=241)
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Figure 6.5.4b: Percentage of survey respondents who reported to be
allergic/intolerant to the 14 food allergens identified in Appendix II of the EU FIC
and non-regulated food allergens in the Safefood “Dining Out” Study in Northern
Ireland in 2013 (n=111)
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6.5.5 FSAI Food Allergy Survey 2011
The FSAI carried out an electronic survey in 2011 in order to provide an estimate of the
Irish population living with the food allergies and intolerances as specified in EU Food
legislation. This survey was open to the public, and members of Anaphylaxis Ireland and
the Coeliac Society of Ireland were informed of this study. A total of 509 responses
consisting of 67% (n=339) females and 33% (n=170) males were gathered, while 85%
(n=434) of respondents claimed to have been medically diagnosed. The most reported
allergies in this cohort were to cereals containing gluten, peanuts, eggs, and tree nuts
(Figure 6.5.5)

*Source: FSAI, 2019,2011

https://www.fsai.ie/resources_publications/allergen_labelling_2011.html.html
https://www.fsai.ie/WorkArea/DownloadAsset.aspx?id=17186

Figure 6.5.5 FSAI electronic food allergy and intolerance survey in 2011 (n=509)
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6.5.6a. Irish Hospital Inpatients Enquiry (HIPE 1) data for Ireland: Foods
associated with anaphylaxis which resulted in hospital admissions between 1995 and
2004
The Irish Hospital Enquiry (HIPE1) is a database of hospital admissions between 1995
and 2004 associated with food anaphylaxis for Ireland. These data suggest that peanuts,
fish, eggs, tree nuts, milk and crustaceans were the most predominant food allergies
which resulted in hospital admissions during this time (as per figure 6.5.6a). However,
it has been suggested by the medical community during the course of this study, and by
other published sources (FSAI, 2019), that there is a lack of confidence with regard to
the overall reliability of this data. However, HIPE 1 does indicate general trends among
the food allergy sufferers in the Irish population which can be considered.

*Image Source: FSAI, 2019
https://www.fsai.ie/WorkArea/DownloadAsset.aspx?id=17186

Figure 6.5.6a: Foods reported to be associated anaphylaxis related hospital
admissions between 1995-2004
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6.5.6b. Irish Hospital Inpatients Enquiry (HIPE 2) data for Ireland: recorded
number of hospital discharges for 2008 and 2018 due to food related anaphylaxis
The record of the Irish Hospital Inpatients Enquiry (HIPE 2) data for 2008-2018 provides
a general indication of the number of hospitalisations (Figure 6.5.6b) in Ireland where
food-related anaphylaxis was the principal diagnosis (n=807). The data presented are
based on patient discharge records from January 2008 to December 2018 from the Health
Service Executive (HSE) in Ireland. While there is a general query over the reliability of
this data (as previously mentioned for HIPE 1), information on hospital discharge
numbers (Figure 6.5.6b), age categories, (Figure 6.5.6c) and associated gender (Figure
6.5.6d), are presented here.
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*Source: HSE- HIPE Discharge data for Food associated anaphylaxis
Figure 6.5.6b: Total number of hospitalisations in Ireland due to food related
anaphylaxis recorded by the Health Service Executive (HSE) between 2008 and
2018 (n=807)
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When age categories were reviewed, it was noted that 30% of all food anaphylaxis
admissions were in the 0-4 years age group, and 43% were between 0-9 years of age
(Figure 6.5.6c). The 0-4 years age category was significantly higher (p-value<0.01) than
all the other age categories examined, with the exception of 5-9 years. This finding
suggests that children, four years and younger, are more likely to be admitted to hospital
as a result of food anaphylaxis than older children (9+ years), adolescents, or adults.
Similarly, the 5-9 years age group was found to be significantly higher (p-value<0.01)
than the 20+ years age groups.

Differences in gender were also noticeable in this dataset, with a higher percentage of
boys admitted to hospital as a result of food anaphylaxis than girls, in the 0-14 years age
groups (33% to 39%) - as per Figure 6.5.6d. The male to female admission ratios were
similar in the 15-24 years age categories, however from 25+ years the percentage of
female admissions reported were higher (57-63%), than those of their male adult
counterparts.
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Figure 6.5.6c: Total number of individuals reported (n=807) by age group who were
admitted to hospital in Ireland as a result of food anaphylaxis (principal diagnosis)
between 2008-2018
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20-24 years: 25 males, 27 females; 25-29 years: 14 males, 22 males; 30-34 years: 16 males, 23 females; 35-39 years: 14 males, 21
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**Source: HSE- HIPE Discharge data for Food associated anaphylaxis

Figure 6.5.6d: Total number of individuals reported (n=807) by age group and
gender who were admitted to hospital in Ireland as a result of food anaphylaxis
(principal diagnosis) between 2008-2018
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6.5.7 Data from a study on the Incidence and Prevalence of Coeliac Disease in the
UK (per Region) Over Two Decades (1990-2011): Population-Based Study
A study conducted by West et al., (2014) identified individuals with coeliac disease in
the ‘Clinical Practice Research Datalink’.

Details available at:
•

https://journals.lww.com/ajg/Fulltext/2014/05000/Incidence_and_Prevalence_of
_Celiac_Disease_and.22.aspx

This study reported an ‘overall point prevalence’ of coeliac disease of 0.24% across the
entire population of the United Kingdom in 2011, based on a figure of 10,872 individuals
reported to have coeliac disease. In other words, this study suggests that 1 in every 420
people in the UK had coeliac disease in 2011. If examined by gender, females (n= 7,210;
0.32%) were twice as likely as males (n=3,662; 0.16%) to be diagnosed with this
condition in 2011(Figure 6.5.7a).

Male

Female
0.16%

0.32%

Figure 6.5.7a: Prevalence of coeliac disease per gender in the United Kingdom
(n=10,872), as reported by West et al., (2014)
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Interestingly, the data suggested a direct relationship between the prevalence of coeliac
disease and age. From the perspective, the lowest prevalence rate of coeliac disease was
reported in the <5 years age group (0.03%), while the highest was reported in the 70+
years age group (0.38%) (Figure 6.5.7b).
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Figure
6.5.7b: Prevalence of coeliac disease by age group in the United Kingdom (n=
10,872), as reported by West et al., (2014)

In addition, it was noted that there were large regional variations in the reported
prevalence of coeliac disease. For example, a prevalence rate of 0.16% (n=905; 95% CI
0.15% to 0.17%) was reported for London compared to 0.39% (0.36% to 0.42%) for
Northern Ireland. Notably, this data suggested that Northern Ireland had the largest
prevalence of coeliac disease (0.39%), when compared to other regions of the UK (0.160.28%). (Figure 6.5.7c). The possible reason/s for these differences was not discussed in
this paper.
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Figure 6.5.7c: Point prevalence of coeliac disease per region in the United Kingdom
(2011) (n=10,872), as reported by West et al., (2014)
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6.5.8 Coeliac Society of Ireland Dataset of 2,899 individuals reporting to have
medically diagnosed coeliac disease in 2019
The Coeliac Society of Ireland provides (CSI) support and information to people with
gluten intolerance and who have been medically diagnosed with coeliac disease in Ireland
and strives to create awareness of this condition. Their aim is to improve the quality of
life of individuals with coeliac disease and their families (Coeliac Society of Ireland,
2020) Website: https://coeliac.ie/

In 2019, CSI estimated that they had 3,688 active members, of which 2,899 individuals
(children, adolescents and adults) reported to have been medically diagnosed with coeliac
disease (MDCD). The overall gender breakdown of these MDCD members was 28%
(n=809) males and 72% (n=2,090) females (Figure 6.5.8a).

Male
28%

Female

72%

Figure 6.5.8a: Percentage of members of the Coeliac Society of Ireland reporting
(or reported as – for children/adolescents) medically diagnosed with coeliac disease
(MDCD), by Gender, in 2019 (n=2,899)
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When this MDCD membership dataset (self-reported) was examined by age group, most
(62%) were found to be in adults 18 to 64 years of age (n=1,796). An additional 12%
were children/adolescents 0-17 years of age (n=337, many parent reported), and 26%
were >65 years of age (n=766). A further breakdown by age category of members
reporting to be MDCD (or a parent reporting their child/adolescents to be MDCD) is
presented in Figure 6.5.8b.
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*Associated number of individuals who reported to be 0 – 3 years: 18 males and 28 females; 4 – 12 years: 51 males and 110 females;
13 – 17 years: 45 males and 85 females; 18 – 64 years: 442 males and 1,354 females; >60 years: 253 males and 513 females

Figure 6.5.8b: Percentage of Individuals reporting (or reported as – for
children/adolescents) medically diagnosed with coeliac disease (MDCD) by Gender
and Age, who were members of the Coeliac Society of Ireland in 2019 (n=2,899)
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6.6 Prevalence Values for MDFA and MDCD reported in the Literature
Prevalence values published in the literature for food allergy and coeliac disease are
presented in Table 6.6a to 6.6i. A total of 130 peer-reviewed papers have been included
ranging from 1973 to 2021, and figures reported by 26 pertinent institutions on food
hypersensitivity. The prevalence values for food allergy for children and adolescents (<18
years) are outlined in Table 6.6a, with MFDA associated peanuts, eggs, and milk allergy
(<18 years) specifically presented in Table 6.6b, and other food groups (<18 years) in
Table 6.6c. The food allergy prevalence values for child, adolescents and adults (where
all ages were reported together) are included in Table 6.6d, food allergy prevalence values
for adults only (≥18 years) in Table 6.6e, and food allergy in adults by different food
groups in Table 6.6f.

In addition, to peer-reviewed papers, prevalence figures for children, adolescents and
adults from food allergy studies reported by certain world-wide institutions are presented
in Table 6.6g to 6.6h. Lastly, the prevalence values reported for coeliac disease in
children, adolescents, and adults from peer-reviewed papers and certain institutions are
presented in Table 6.6i.

These data elucidate the wide range of prevalence values

reported in the literature. This large variation in figures was more pronounced for
MDFA, than MDCD, and is most likely the result of differences in study parameters,
geographical locations, and sample group characteristics (age, gender etc.).

346

Table 6.6a: Peer-reviewed prevalence figures from food allergy studies for children & adolescents (<18 years) from the 52 published
papers between the years 2000 and 2020
Prevalence of food allergies to a range of foodstuffs: children & adolescents ( <18 years of age)
Reference

Country/Region

Number of
participants

Age group

Frequency of food allergies

Diagnosed*/Selfreported

Penard-Morand et al. 2005

France

7,781

9 to 11 years

0.1%

Diagnosed

Kaya et al. 2013

Turkey

10,096

Children

0.2%

Diagnosed

Dubakiene et al.2012

Lithuania

1,558

6 to 12 months

0.3%

Diagnosed

Goncalves et al. 2016

Brazil

3,301

Preschool Children

0.4%

Diagnosed

Grundy et al. 2002

UK

1,273

3 to 4 years

0.6%

Diagnosed

Orhan et al. 2009

Turkey

2,739

6 to 9 years

0.7%

Diagnosed

Venter et al. 2008; Dean et al.
2007; Venter et al. 2006

UK

969

3 years

0.8%

Diagnosed

Nwaru et al. 2014

Europe

105 studies

0 to 18 years

0.9%

Diagnosed

Mahabir et al. 2013

Ireland

8,318

primary school children

1.2%

Not indicated

Eller et al. 2009, Kjaer et al.
2008, Johnke et al. 2006

Denmark

562

6 years

1.2%

Diagnosed

Venter et al. 2006

UK

798

6 years

0.4 - 1.3%

Diagnosed

Caffarelli et al.2011

Italy

625

5 to 14 years

1.6%

Self-reported

Kristinsdottir et al. 2011

Iceland

1,341

1 year

1.9%

Diagnosed

Goncalves et al. 2016

Brazil

596

Infants

1.9%

Diagnosed

Pereira et al. 2005

UK

1,532

11 & 15 years

1.8-2.3%

Diagnosed

Osterballe et al. 2005

Denmark

898

<18 years

At 3 years: 2.3%

Diagnosed
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Bingol et al. 2016

Turkey

1,377

0 to 1 years

2.4%

Diagnosed

MacGiobuin et al. 2017

Ireland

3,203

pre-school children

3%

Not indicated

Prescott et al. 2020

Sweden

Preschool 3 to 5 years

3.2%

Diagnosed

Kurulaaratchy et al. 2005,
Arshad et al. 2001, Tariq et al.
2000

UK

1,456

4 years

3.5%

Diagnosed

Pyrhönen et al. 2009, 2011

Finland

3,899

0 to 4 years

By 4 years: 3.3%

Diagnosed

Peters et al. 2017

Australia

4,291

0 to 4 years

At 4 years: 3.8%

Diagnosed

Krause et al. 2002

Greenland

1,068

5 to 18 years

4.1%

Diagnosed

Kim et al. 2017

Korea

29,842

6 to 16 years

4.1%

Self-reported

Prescott et al. 2014

Germany

739

Infants

4.2%

Diagnosed

Ronchetti et al. 2008

Italy

380

9 & 13 years

4.2%

Diagnosed

Sasaki et al. 2018

United States of America

5,016

10 to 14 years

4.5%

Diagnosed

Kelleher et al. 2016

Ireland

1,355

0 to 2 years

At 2 years: 4.5% (positive food
challenge or clinical reaction)

Diagnosed

Leung et al. 2009

Hong Kong

3,677

2 to 7 years

4.6%

Diagnosed

Rance et al. 2005

France

2,716

Mean age 8.9 years

4.7%

Self-reported

Steinke et al. 2007

Europe

40,426

<18 years

5%

Self-reported

Prescott et al. 2019

Cape Town

212

14 to 18 years

5.4%

Diagnosed

Sasaki et al. 2018

United States of America

4,800

10 to 14 years

5.5%

Self-reported

Prescott et al. 2015

Turkey

3,500

6 to 9 years

5.7%

Self-reported

Clarke et al. 2020

Canada

Children

~ 6%

Diagnosed

Kelleher et al. 2016

Ireland

0 to 2 years

At 2 years: 6.3% (skin prick test)

Diagnosed

1,355
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Kvenshagen et al. 2009

Norway

609

2 years

6.8%

Diagnosed

Lee et al. 2013

Korea

27,679

4 to 18 years

6.8%

Diagnosed

Sollier et al. 2012

Canada

2,198

Children

7.1%

Self-reported

Perkin et al. 2016

UK

1,303

3 months to 6 months

By 1 to 3 years: 7.1%

Diagnosed

Gupta et al. 2018

United States of America

38,408

Children

7.6%

Self Reported

Bedolla et al. 2019

Mexico

1,992

15 to 18 years

7.8%

Self Reported

Gupta et al. 2011

US

38,480

0 to 17 years

8%

Not indicated

Leung et al. 2009

Hong Kong

3,677

2 to 7 Years

8.1%

Self-reported

Prescott et al. 2016

Poland

8,825

Children

8.3%

Self-reported

Prescott et al. 2017

Columbia

3,099

1 to 8 years

10%

Self-reported

Ontiveros et al. 2016

Mexico

1,049

5 to 13 years

10%

Self-reported

Peters et al. 2017

Australia

5,276

0 to 4 years

At 1 year: 11%

Diagnosed

Schnabel et al. 2010

Germany

1,082

6 years

11.7%

Diagnosed

Prescott et al. 2018

Columbia

3,099

9 to 16 years

12%

Self-reported

Östblom et al. 2008a, 2008b,
2008c and Almqvist et al. 2005

Sweden

4,089

4 to 8 years

At 8 years 13.8%

Diagnosed

Sandin et al. 2005

Sweden & Estonia

770

10 to 11 years

13.9%

Diagnosed

Prescott et al. 2013

Germany

1,570

Infants

14.5%

Self-reported

Nwaru et al. 2014

Europe

105 studies

0 to 18 years

5.9% Pooled-point prevalence

Self-reported

Frongia et al. 2005

Italy

4,602

1 to 2 years

7.8% Lifetime prevalence

Self-reported

Majkowska-Wojciechowska et
al. 2009

Poland

2,148

7 to 10 years

41% Lifetime prevalence

Self-reported
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Pyziak & Kamer 2011

Poland

83

6 to 7 years

Frequencies not given

Self-reported
diagnosed

Colver et al.2005

UK and Ireland

13,028,933

<16 years

Frequencies not given

Diagnosed

Fox et al. 2009

UK

33 cases, 310 controls

< 4 years

Frequencies not given

Diagnosed

*Diagnosed through one or more of the following tests:
a) Specific IgE (slgE) immunoglobulin test
b) Skin prick test
c) Oral food challenge
d) Double blind placebo-controlled food challenge
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Table 6.6b: Peer-reviewed prevalence figures from food allergy studies for children & adolescents (<18 years) by peanuts, eggs & milk
from the 41 published papers between the years 2000 and 2020
Prevalence of peanut allergic children & adolescents ( <18 years of age)
Country/Region

Number
participants

Age group

Frequency of food allergies

Diagnosed*/Selfreported

Kaya et al. 2013

Turkey

10,096

Children

0.05% peanut allergy

Diagnosed

Roberts et al. 2005 and Lack et al.
2003

UK

12,090

0 to 7 years

0.2% peanut allergy

Diagnosed

Venter et al. 2010

UK

3,382

3 to 4 years

0.3% peanut allergy

Diagnosed

Du Toit et al. 2008

UK and Israel

8,826

4 to 18 years

0.4% peanut allergy

Diagnosed

Ho et al.2012

Hong Kong

7,393

<14 years

0.3% - 0.5% peanut allergy

Diagnosed

Nicolaou et al. 2010

UK

1,085

8 years

0.7% peanut allergy

Diagnosed

Kim et al. 2017

Korea

29,842

6 to 16 years

0.22% peanut allergy

Self-reported

Hourihane et al. 2007

UK

1,125

4 to 15 years

1.4% peanut allergy

Diagnosed

Grundy et al. 2002

UK

1,246

3 to 4 years

1.5% peanut allergy

Diagnosed

Soller et al. 2012

Canada

2,198

Children

1.7% peanut allergy

Self-reported

Kelleher et al. 2016

Ireland

1,355

0 to 2 years

At 2 years: 1.8% peanut allergy (positive food
challenge or clinical reaction)

Diagnosed

Peters et al. 2017

Australia

4,291

0 to 4 years

At 4 years: 1.9% peanut allergy

Diagnosed

Gupta et al. 2018

United
America

38,408

Children

2.2% peanut allergy

Self-reported

Kelleher et al. 2016

Ireland

1,355

0 to 2 years

At 2 years: 2.6% peanut allergy (skin prick
test)

Diagnosed

Reference

States

of

of

351

Sasaki et al. 2018

United
America

States

of

Sasaki et al. 2018

United
America

States

of

Osborne et al. 2011

5,016

10 to 14 years

2.7% peanut allergy

Diagnosed

4,800

10 to 14 years

2.8% peanut allergy

Self-reported

Australia

2,848

1 year

3% peanut allergy

Diagnosed

Peters et al. 2017

Australia

5,276

0 to 4 years

At 1 year: 3.1% peanut allergy

Diagnosed

Simons et al. 2020

Canada

2,669

at 3 years

3.8% peanut allergy

Self-reported

von Hertzen et al. 2006

Finland

413 children,

Peanut allergic children 8.2%
7 to 16 years

409 mothers

Diagnosed
& mothers 10.1%

Niggemann et al. 2011

Germany

17,641

0 to 17 years

10.9% peanut allergy

Diagnosed

Bergmann et al. 2016

Germany

12,988

Children

10.9% peanut allergy

Diagnosed

Prevalence of egg allergic children & adolescents ( <18 years of age)
Country/Region

Number of participants

Age group

Frequency of food allergies

Diagnosed*/Selfreported

Brazil

3,301

Preschool
Children

0.2% egg allergy

Diagnosed

Eggesbø et al. 2003, 2001a &
2001b

Norway

3,754

2.5 years

0.3% egg allergy

Diagnosed

Krause et al. 2002

Greenland

5 to 18 years

0.4% egg allergy

Diagnosed

Kurulaaratchy et al. 2005, Arshad
et al. 2001, Tariq et al. 2000

UK

4 years

At 4 years; 0.8% egg allergy

Diagnosed

Goncalves et al. 2016

Brazil

596

Infants

0.8% egg allergy

Diagnosed

Gupta et al. 2018

United
America

38,408

Children

0.9% egg allergy

Self-reported

Matricardi et al. 2007

Germany

1,314

2 to 10 years

At 10 years: 0.9% egg allergy

Diagnosed

Reference
Goncalves et al. 2016

States

Of

352

Kim et al. 2017

Korea

29,842

6 to 16 years

0.21% egg allergy

Self-reported

Xepapdaki et al. 2016

Europe

9,336

0 to 2 years

By 2 years; 1.2% egg allergy

Diagnosed

Peters et al. 2017

Australia

4,291

0 to 4 years

At 4 years: 1.2% egg allergy

Diagnosed

Grundy et al. 2002

UK

3 to 4 years

1.4% egg allergy

Diagnosed

Du Toit et al. 2008

UK

4 to 18 years

1.5% egg allergy

Self-reported

Osterballe et al. 2005

Denmark

3 years

1.6% egg allergy

Diagnosed

Dubakiene et al. 2012

Lithuania

6 to 12 months

0.1-1.7% egg allergy

Diagnosed

Kucukosmanoglu et al. 2008

Turkey

1,015

8 to 18 months

1.9% egg allergy

Diagnosed

Julge et al. 2001, Vasar et al. 2000

Estonia

298

5 years

0 - 2.4% egg allergy

Diagnosed

Kelleher et al. 2016

Ireland

1,355

0 to 2 years

At 2 years: 2.9% egg allergy (positive food
challenge or clinical reaction)

Diagnosed

Kelleher et al. 2016

Ireland

1,355

0 to 2 years

At 2 years: 3.9% egg allergy (skin prick test)

Diagnosed

Osborne et al. 2011

Australia

2,848

1 year

8.9% raw allergy

Diagnosed

Peters et al. 2017

Australia

5,276

0 to 4 years

At 1 year: 9.5% egg allergy

Diagnosed

486

Prevalence of milk allergic children & adolescents ( <18 years of age)
Country/Region

Number of participants

Age group

Frequency of food allergies

Diagnosed*/Selfreported

Kim et al. 2017

Korea

29,842

6 to 16 years

0.18% milk allergy

Self-reported

Eggesbø et al. 2003, 2001a &
2001b

Norway

3,754

2.5 years

0.4% milk allergy

Diagnosed

Krause et al. 2002

Greenland

5 to 18 years

0.5% milk allergy

Diagnosed

Schoemaker, et al. 2015

Europe

0 to 2 years

0.5% milk allergy

Diagnosed

Grundy et al. 2002

UK

3 to 4 years

0.7% milk allergy

Diagnosed

Reference

9,336

353

Bedolla et al. 2019

Mexico

1,992

Munblit et al. 2020

15 to 18 years

1% milk allergy

Self-reported

Infants

~1% milk allergy (food oral challenge)

Diagnosed

Kelleher et al. 2016

Ireland

1,355

0 to 2 years

At 2 years: 1% milk allergy (skin prick test)

Diagnosed

Kelleher et al. 2016

Ireland

1,355

0 to 2 years

At 2 years: 1% milk allergy (positive food
challenge or clinical reaction)

Diagnosed

Matricardi et al. 2007

Germany

1,314

2 to 10 years

At 10 years: 1% milk allergy

Diagnosed

Simons et al.2020

Canada

2,669

At 3 years

1.12% milk allergy

Self-reported

Peters et al. 2017

Australia

5,276

0 to 4 years

At 1 year: 1.5% milk allergy

Diagnosed

Dubakiene et al.2012

Lithuania

6 to 12 months

0.1-1.7% milk allergy

Diagnosed

Gupta et al. 2018

United
America

Children

1.9% milk allergy

Self-reported

Du Toit et al. 2008

UK

4 to 18 years

2.2% milk allergy

Self-reported

Høst et al. 2002

Denmark

15 years

2.2% milk allergy

Diagnosed

States

of

38,408

1,749

*Diagnosed through one or more of the following tests:
a) Specific IgE (slgE) immunoglobulin test
b) Skin prick test
c) Oral food challenge
d) Double blind placebo-controlled food challenge

354

Table 6.6c: Peer-reviewed prevalence figures from food allergy studies for children & adolescents (<18 years) for different food groups
(other than peanut, egg and milk) from the 15 published papers between the years 1996 and 2019
Other specific food allergies in children & adolescents ( <18 years of age)
Country/Region
Number
Reference
participants
Ireland
1,355
Kelleher et al. 2016

of

Age group

Frequency of food allergies

0 to 2 years

Diagnosed*/Selfreported
Diagnosed

Kelleher et al. 2016

Ireland

1,355

0 to 2 years

Peters et al. 2017
Peters et al. 2017

Australia
Australia
United
States
America
Canada
Australia
Ireland
Greenland
Germany
Ireland
Greenland
Lithuania
Germany
Canada
United
States
America
Mexico
United States
Ireland

4,291
5,276
38,408

0 to 4 years
0 to 4 years
Children

At 2 years: 0.1% sesame allergy (skin prick
test)
At 2 years: 0.1% sesame allergy (positive food
challenge or clinical reaction)
At 4 years: 0.4% sesame allergy
At 1 year: 0.6% sesame allergy
0.2% sesame allergy

2,198
2,848
1,355

Children
1 year
0 to 2 years
5 to 18 years
2 to 10 years
0 to 2 years
5 to 18 years
6 to 12 months
2 to 10 years
Children
Children

0.23% sesame allergy
0.8% sesame allergy
At 2 years: 0.2% soya allergy (skin prick test)
1.2 % soy allergy
At 10 years: 6.1% soy allergy
At 2 years: 0.6% wheat allergy (skin prick test)
0.7% wheat allergy
0.1-1.5% wheat allergy
At 10 years: 8.8% wheat
0.55% shellfish
1.3% shellfish

Self-reported
Diagnosed
Diagnosed
Diagnosed
Diagnosed
Diagnosed
Diagnosed
Diagnosed
Diagnosed
Self-reported
Self-reported

1,355

15 to 18 years
Children
0 to 2 years

Self-reported
Diagnosed
Diagnosed

1,355
10,096
5,276

0 to 2 years
Children
1 to 6 years

2.3% shrimp
1.3% Shellfish
At 2 years: 0.2% cod allergy (positive food
challenge or clinical reaction)
At 2 years: 0.6% cod allergy (skin prick test)
0.05% tree nut allergy
At 1 year: 0.1% treenut allergy

Gupta et al. 2018
Soller et al. 2012
Osborne et al. 2011
Kelleher et al. 2016
Krause et al. 2002
Matricardi et al. 2007
Kelleher et al. 2016
Krause et al. 2002
Dubakiene et al.2012
Matricardi et al. 2007
Soller et al. 2012
Gupta et al. 2018
Bedolla et al. 2019
Wang et al. 2020
Kelleher et al. 2016
Kelleher et al. 2016
Kaya et al. 2013
McWilliam et al. 2019

Ireland
Turkey
Australia

Of

1,314
1,355

of

1,314
2,198
38,408
1,992

355

Diagnosed
Diagnosed
Diagnosed
Self-reported

Diagnosed
Diagnosed
Self-reported

Kim et al. 2017
Tariq et al. 1996
Gupta et al. 2018
Sasaki et al. 2018
Sasaki et al. 2018
McWilliam et al. 2019
Kelleher et al. 2016
Kelleher et al. 2016
Kelleher et al. 2016
Kelleher et al. 2016

Korea
UK
United
America
Australia
Australia
Australia
Ireland

29,842
1,218
38,408

6 to 16 years
At 4 years
Children

0.32% tree nut allergy
1.2% tree nut allergy
1.2% tree nut allergy

Self-reported
Diagnosed
Self-reported

5,016
4,800
5,276
1,355

10 to 14 years
10 to 14 years
1 to 6 years
0 to 2 years

Diagnosed
Self-reported
Diagnosed
Diagnosed

Ireland

1,355

0 to 2 years

Ireland

1,355

0 to 2 years

Ireland

1,355

0 to 2 years

2.3% tree nut allergy
2.3% tree nut allergy
At 6 years: 3.3% tree nut allergy
At 2 years: 0.1% cashew nut allergy (positive
food challenge or clinical reaction)
At 2 years: 0.1% cashew nut allergy (skin
prick test)
At 2 years: 0.2% hazelnut allergy (skin prick
test)
At 2 years: 0.2% hazelnut allergy (positive
food challenge or clinical reaction)

States

of

*Diagnosed through one or more of the following tests:
a) Specific IgE (slgE) immunoglobulin test
b) Skin prick test
c) Oral food challenge
d) Double blind placebo-controlled food challenge

356

Diagnosed
Diagnosed
Diagnosed

Table 6.6d: Peer-reviewed prevalence figures from food allergy studies for children, adolescents and adults (all ages) where data is
presented together from the 14 published papers between the years 2001 and 2021
Prevalence of food allergies to a range of foodstuffs: adults & children together
Country/Region
Number of
Reference
participants
Flokstra-de Blok et al. 2011
The Netherlands
2,284
Kanny et al. 2001
France
31,110
Soost et al. 2009 and Zuberbier et al. Germany
4,093
2004, Roehr et al. 2004
Rona et al. 2007
World-wide
51 studies
Marklund et al. 2004,
Sweden
1,488
Moonesinghe et al. 2016
World-wide
61 studies
World-wide
51 studies
Rona et al. 2007
Moonesinghe et al. 2016
Rona et al. 2007
Sicherer et al.2010
Rona et al. 2007
Rona et al. 2007
Hsicherer et al. 2003
Zuidmeer et al. 2008
Marrugo et al. 2008 Althumiri et
al.2021
Althumiri et al.2021

World-wide
World-wide
United
States
America
World-wide
World-wide
United
States
America
World-wide
Columbia
Saudi Arabia

Age group

Frequency of food allergies

Diagnosed*/Selfreported
Self-reported
Self-reported
Diagnosed

11 to 20 years
≤ 60 years
0 to 79 ages

2.1%
3.5%
Children 4.2%; Adults: 2.9%

All ages
13 to 21 years
All ages
All ages

Self-reported
Self-reported
Diagnosed
Self-reported

of

61 studies
51 studies
13534

All ages
All ages
all ages

3% to 35%
18.7%
0% to 0.3% fish allergy
0% - 2% peanut and fish allergy
(together)
0% to 0.9% shellfish allergy
0% to 10% shellfish allergy
0.1% sesame allergy

of

51 studies
51 studies
13493

All ages
All ages
All ages

0.2% to 7% egg allergy
1.2% to 17% milk allergy
1.04% peanut allergy

Self-reported
Self-reported
Self-reported

33 studies
3099

All ages
1 to 83 years

1.4% allergy to vegetables
14.9%

Diagnosed
Self-reported

6,239

18-90 years old

19.7%

Self-reported

*Diagnosed through one or more of the following tests:
a) Specific IgE (slgE) immunoglobulin test
b) Skin prick test
c) Oral food challenge
d) Double blind placebo-controlled food challenge

357

Diagnosed
Self-reported
Self-reported

Table 6.6e: Peer-reviewed prevalence figures from food allergy studies adults (>18 years) from the 12 published papers between the
years 2001 and 2019
Prevalence of food allergies to a range of foodstuffs: Adults ≥18 years of age
Country/Region
Number of
Reference
participants
Gelincik et al. 2008
Turkey
11,816
Lyons et al. 2019
Athens
EuroPrevall Study
Woods et al. 2002
Australia
1,140
Lyons et al. 2019
Reyjavik, Iceland
EuroPrevall Study
Denmark
843
Osterballe et al. 2009
Lyons et al. 2019
Lyons et al. 2019
Osterballe et al. 2005
Mossakowska et al. 2008
Lyons et al. 2019
Johansson et al. 2005
Falcaõ et al. 2004,
Lyons et al. 2019
Soller et al. 2012
Isolauri et al. 2004
Bant et al. 2008,
Burney et al. 2010; Woods et al.
2001,
Schäfer et al. 2001,

Utrecht, Netherlands
Lodz, Poland
Denmark
Poland
Madrid, Spain
Sweden & Norway
Portugal
Zurich, Germany
Canada
Finland
Poland
Europe, US, Australia &
New Zealand
Germany

Age group

Frequency of food allergies
0.1%
0.3%
1.3%
1.4%
1.8%

EuroPrevall Study
EuroPrevall Study
936
301
EuroPrevall Study
1502
659
EuroPrevall Study
7,469
400
156

>18 years
Adults
20 to 45 years
Adults
Mean age 22
years
Adults
Adults
Adults
>100 years old
Adults
Adults
> 39 years
Adults
Adults
67 (& other ages)
18 to 27 years

Diagnosed*/Selfreported
Diagnosed
Self-reported
Diagnosed
Self-reported
Diagnosed

2.1%
2.8%
3.2%
3.3%
3.3%
3.6%
5.2%
5.6%
6.6%
At 67 years: 9%
11%

Self-reported
Self-reported
Diagnosed
Self-reported
Self-reported
Diagnosed
Self-reported
Self-reported
Self-reported
Diagnosed
Diagnosed

17,280

20 to 44 years

12.3%

Diagnosed

1,537

25 to 74 years

16.8%

Diagnosed

*Diagnosed through one or more of the following tests:
a) Specific IgE (slgE) immunoglobulin test
b) Skin prick test
c) Oral food challenge
d) Double blind placebo-controlled food challenge

358

Table 6.6f: Peer-reviewed prevalence figures from food allergy studies adults (>18 years) by food group from the 9 published papers
between the years 2001 and 2019
Specific food allergies: adults ( >18 years of age)
Reference
Burney et al. 2010; Woods et al. 2001,
Falcaõ et al. 2004,
Bergmann et al. 2016
Falcaõ et al. 2004,
Burney et al. 2010; Woods et al. 2001,
Bergmann et al. 2016
Gupta et al. 2019
Burney et al. 2010; Woods et al. 2001,
Bergmann et al. 2016
Osterballe et al. 2005
Soller et al 2012
Gupta et al. 2019
Osterballe et al. 2005
Osterballe et al. 2005
Soller et al. 2012
Thalayasingam and Lee, 2015
Sicherer et al. 2004
Gupta et al. 2019
Soller et al. 2012

Country/Region
Europe, US, Australia &
New Zealand
Portugal
Germany
Portugal
Europe, US, Australia &
New Zealand
Germany
USA
Europe, US, Australia &
New Zealand
Germany
Denmark
Canada
USA
Denmark
Denmark
Canada
World-wide
USA
USA
Canada

Number
participants

Age group

Frequency of food allergies

20 to 44 years

0.2% egg allergy

Diagnosed*/Selfreported
Diagnosed

> 39 years
Adults
> 39 years
20 to 44 years

0.6% egg allergy
1.6% egg allergy
0.3% milk allergy
0.7% milk allergy

Self-reported
Diagnosed
Self-reported
Diagnosed

7,025
40,443

Adults
Adults
20 to 44 years

1.6% milk protein allergy
1.9% milk allergy
3.4% wheat allergy

Diagnosed
Self-reported
Diagnosed

7,025
936
7,469
40,443
936
936
7,469

Adults
Adults
Adults
Adults
Adults
Adults
Adults

14,948
40,443
7,469

Adults
Adults
Adults

5.6% wheat flour allergy
0.4% peanut allergy
0.78% peanut allergy
1.8% peanut allergy
0.2% cod fish allergy
0.3% shrimp allergy
1.9% shellfish
~ 0.5 - 5% fish and shellfish
2.3% seafood allergy (fish & shellfish)
2.9% shellfish allergy
0.07% sesame allergy

Diagnosed
Diagnosed
Self-reported
Self-reported
Diagnosed
Diagnosed
Self-reported
Not indicated
Self-reported
Self-reported
Self-reported

7,025

of

*Diagnosed through one or more of the following tests:
a) Specific IgE (slgE) immunoglobulin test
b) Skin prick test
c) Oral food challenge
d) Double blind placebo-controlled food challenge

359

Table 6.6g: Reported prevalence figures from food allergy studies and other reports for children & adolescents (<18 years), and adults
(≥18 years) from the 17 published papers and institutions between the years 2006 and 2019
Reported prevalence of food allergies in Ireland & the UK: Children & Adolescents ( <18 years of age)
Reference
Country/Region
Irish Food Allery Network (IFAN), 2019

UK

The Irish Times (2018a)
Ireland
HSE, 2013
Ireland
Irish Health, 2016
Ireland
The Lancet, 2011
UK
Irish Nutrition & Dietetic Institute (INDI), 2019
Ireland
Irish Food Allery Network (IFAN), 2019
Ireland
Institute of Food Research (IFR), 2006
UK
Safefood, 2016
Ireland
Irish Nurses and Midwives Organisation (INMO),2010
UK
Reported prevalence of peanut allergies in Ireland & the UK: Children & Adolescents ( <18 years of age)
Reference
Country/Region
The Irish Times (2018b)
Ireland
The Lancet, 2011
UK
Allergy Ireland, 2019
Ireland
Reported prevalence of egg allergies in Ireland & the UK: Children & Adolescents ( <18 years of age)
Country/Region
Reference
University of Portsmouth, 2013
Ireland
Reported prevalence of milk allergies in Ireland & the UK: Children & Adolescents ( <18 years of age)
Reference
Country/Region
Irish Nurses and Midwives Organisation (INMO),2010
University of Portsmouth, 2013
Irish Health, 2016

UK
Ireland
Ireland

360

Points of
information
pre-school
children
2-year-olds

Infants

Frequency of food
allergies
3 - 6%

Diagnosed/Selfreported
Not Indicated

2%
4%
4%
5%
5%
5 - 6%
5 - 7%
5 - 8%
6 - 8%

Not Indicated
Diagnosed
Diagnosed
Not Indicated
Not Indicated
Not Indicated
Not Indicated
Not Indicated
Not Indicated

Points
information

of

Frequency
of
allergies
2% peanut allergy
2% nut allergy
2% nut allergy

food

Diagnosed/Selfreported
Diagnosed
Not Indicated
Not Indicated

Points
information
At 4 years

of

Frequency
of
allergies
2% egg allergy

food

Diagnosed/Selfreported
Self-reported

Points
information
<1 year
At 4 years

of

Frequency
of
allergies
2.5% milk allergy
2.7% milk allergy
<3% milk allergy

food

Diagnosed/Selfreported
Not Indicated
Self-reported
Not Indicated

Reported prevalence on other specific food allergies in children & adolescents in Ireland & the UK ( <18 years of age)
Reference
Country/Region
Points
information
University of Portsmouth, 2013
Ireland
At 4 years
University of Portsmouth, 2013
Ireland
At 4 years
University of Portsmouth, 2013
Ireland
At 4 years
University of Portsmouth, 2013
Ireland
At 4 years
University of Portsmouth, 2013
Ireland
At 4 years
Reported prevalence data of food allergies children & adults (All Ages) in Ireland & the Ireland
At 4 years
UK
Reference
Country/Region
Points
information
Irish Food Allery Network (IFAN), 2019
UK
The Association of UK Dietitians (BDA), 2015
UK
Reported prevalence of food allergies in Ireland & the UK : Adults ( >18 years of age)
Country/Region
Points
Reference
information
Safefood, 2016
Ireland
Institute of Food Research (IFR), 2006
UK
Irish Nutrition & Dietetic Institute INDI, 2019
Ireland
Food Safety Authority of Ireland (FSAI), 2016
Ireland
Singh, 2018 (study currently unpublished)
Ireland
17-36 years
*Diagnosed through one or more of the following tests:
a) Specific IgE (slgE) immunoglobulin test
b) Skin prick test
c) Oral food challenge
d) Double blind placebo-controlled food challenge

361

of

Frequency
of
allergies
0.7% additives
1.3% yoghurt
2% dairy products
3.3% sweets
4.7% colourings
6% soft drinks

food

Diagnosed/Selfreported
Self-reported
Self-reported
Self-reported
Self-reported
Self-reported
Self-reported

of

Frequency
allergies
1 - 2%
1 - 10%

of

food

Diagnosed/Selfreported
Not Indicated
Not Indicated

of

Frequency
allergies
1 - 2%
1 - 2%
3%
3%
7.6%

of

food

Diagnosed/Selfreported
Not Indicated
Not Indicated
Not Indicated
Not Indicated
Diagnosed

Table 6.6h: Reported prevalence figures of food allergy from world-wide institutions for children & adolescent (<18 years), and adults
(≥18 years) from the 7 institutions between the years 1997 and 2015
Reported prevalence data of food allergies world-wide: General population
Reference
Country/Region
EFSA, 2014
Europe
EUFIC, 2013
Europe
EUFIC, 2013
Europe
FDA, 2008
US
Reported prevalence data of food allergies world-wide: Children & adolescents ( <18 years of age)
Reference
Country/Region
WHO, 2006
World-wide
EAACI, 2015
Europe
CDC, 2013
US
WAO, 2013
World-wide
FDA, 2008
US
Reported prevalence of milk allergies world-wide: Children & adolescents ( <18 years of age)
Reference
Country/Region
European Commission, 1997
Europe
Reported prevalence data of food allergies world-wide: Children & adults
Reference
Country/Region
Europe, the USA,
EFSA, 2014
Australia/New Zealand
Reported prevalence of milk allergies world-wide: Children & adults
Reference
Country/Region
European Commission, 1997
Europe
Reported prevalence data of food allergy World-wide: adults ( >18 years of age)
Reference
Country/Region
WAO, 2013
World-wide
WHO, 2006
World-wide
*Diagnosed through one or more of the following tests:
a) Specific IgE (slgE) immunoglobulin test
b) Skin prick test
c) Oral food challenge

362

Points of information

Frequency of food allergies
1%
1 - 11%
3 - 38%
4%

Diagnosed/Self-reported
Diagnosed
Diagnosed
Self-reported
Not indicated

Points of information

Frequency of food allergies
4 - 6%
4 -7%
6%
5 - 8%
6%

Diagnosed/Self-reported
Not indicated
Not indicated
Self-reported
Not indicated
Not indicated

Points of information
Infants

Frequency of food allergies
1-3% cow's milk

Diagnosed/Self-reported
Diagnosed

Points of information

Frequency of food allergies

Diagnosed/Self-reported

3%

Diagnosed

Points of information

Frequency of food allergies
<1%

Diagnosed/Self-reported
Diagnosed

Points of information

Frequency of food allergies
1 - 2%
1 - 3%

Diagnosed/Self-reported
Not indicated
Not indicated

d) Double blind placebo-controlled food challenge

363

Table 6.6i: Reported prevalence figures from coeliac disease studies and other reports, for children & adolescent (<18 years), and adults
(≥18 years) from the 28 published papers and other institutions between the years 1973 and 2019
Reported prevalence of coeliac disease: General population
Reference
Country/Region
Food Safety Authority of Ireland (FSAI), 2015
Ireland
Irish College of General Practitioners, 2015
Ireland
Gujral et al. 2012
World-wide
Dr. Schär Institute, 2019
UK
Lionetti et al. 2015
Europe
Coeliac Society of Ireland, 2019
Ireland
Irish Health, 2018a
Ireland
Health Service Executive (HSE), 2018
Ireland
Irish Nutrition & Dietetic Institute (INDI),2019
Ireland
Coeliac UK, 2019
UK
Irish Health, 2018b
Europe
Coeliac disease Foundation, 2019
UK
Reported prevalence of coeliac disease: Children & adolescents ( <18 years of age)
Reference
Country/Region
Mylotte et al. 1973
Ireland
Johnson et al. 1997
Northern Ireland
Coeliac UK, 2019
UK
Coeliac UK, 2019
Europe
Ashtari et al. 2019
Asia Pacific Region
Gatti et al. 2020
Italy
Reported Prevalence data of coeliac disease: Adults ( >18 years of age)
Reference
Country/Region
Mylotte et al. 1973
Ireland
Mustalahti et al. 2010
Finland
Mustalahti et al. 2010
Germany
Mustalahti et al. 2010
Italy
Kratzer et al. 2013
Germany
Leja et al. 2015
Latvia

Frequency of coeliac disease
0.5 - 1%
0.5 - 1%
0.5 - 1%
~ 1%
~ 1%
1%
1%
1%
1%
1%
1%
~ 1%
Frequency of coeliac disease
0.16%
0.8%
1%
3%
0.32 - 1.41%
1.58%
Frequency of coeliac disease
0.33%
2.4%
0.3%
0.7%
0.4%
0.35 - 0.49%

364

Ashtari et al.2019
Asia pacific region
Dobru et al. 2003
Romania
Reported Prevalence data of coeliac disease worldwide: Adults & children
Reference
Country/Region
Rewers, 2005
Europe & US
Mustalahti et al. 2010
Europe
Altobelli et al. 2014
Europe
Singh et al. 2018
Worldwide
Singh et al. 2018
Worldwide
Singh et al. 2018
South America
Singh et al. 2018
Africa and North America
Singh et al. 2018
Asia
Singh et al. 2018
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0.35%
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0.7%
1%
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0.39%
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Chapter 7: Discussion
7.1 Food Hypersensitivity Surveys on the Island of Ireland
Following the analysis of 744 surveys completed by MDFA respondents (and parents
thereof), peanuts (47%), milk (36%), other nuts (35%), eggs (30%) and fruit (19%, 6%
of which was kiwi) were the five most reported trigger foods on the IoI. Similarly, the
same allergens were the most reported trigger foods associated with incidences of
anaphylaxis on the IoI: peanuts (7%), other nuts (6%), eggs (4%), milk (3%), and fruit
(2%, 1% of which was kiwi). These findings are in agreement with similar studies
conducted in Ireland and NI (FSAI, 2011; Safefood, 2013a; Safefood, 2013b; Colver,
2005; McClain et al. 2014; Kelleher et al. (2016); MacGiobuin, 2017).

With regard to MDFA in children, these findings are in agreement with a previous
Safefood study conducted in 2013, which indicated that the most reported food allergies
in children between 0-12 years (n=107 in Ireland; n=77 in NI) were peanut, eggs, milk
and ‘treenuts’. In addition, many Irish and UK sources have highlighted peanuts, milk,
eggs and nuts as the most prevalent allergies affecting infants and young children in both
countries (Colver, 2005; McClain et al. 2014; Kelleher et al. (2016); MacGiobuin, 2017;
IFAN, 2019).

With regard to egg allergy, egg allergy remained the third most reported MDFA in
adolescents and children. While many children are reported to outgrow allergies to milk
and eggs (EFSA,2014), (a trend supported by the reported percentages of MDFA in this
study), this is not as common for allergies to peanuts, tree nuts, fish or shellfish (FSAI,
2011). Notably, the European Food Safety Authority have previously reported that 75%
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of allergic reactions in children have been attributed to eggs, peanuts, milk, other nuts
and fish (EFSA, 2014).

With regard to age category, milk allergy was more prominent (45%) among children
examined, than for adolescent (24%) and adult groups (29%), while MDFA to cereals
containing gluten (7%), fruit (23%, 8% of which was to kiwi), crustaceans (13%) and
molluscs (9%) were more pronounced in MDFA adults surveyed than in adolescents or
children. These results are in agreement with other studies in the literature that report
similar findings (Ben-Shoshan et al., 2010, Burney et al., 2010, McGowan and Keet,
2013, Kamdar et al., 2015 and Moonesinghe et al., 2016). When differences in gender
with regard to reported MDFA associated trigger foods were examined, strong
similarities were evident between male and female children and adolescents (Tables
3.2.3a, 3.2.3b and Figure 3.2.3a). Notably, the widest difference in the percentage of
MDFA to various trigger foods (‘tree nuts’ and soybeans) between male and female
children was 5%; with many trigger foods (peanuts, milk, fish, sesame seeds and
crustaceans) reported as the same percentage for each gender or with only a 1 or 2%
difference in this age category.

When the parental MDFA surveys were examined in this study, a slightly higher
percentage of male children (57% in Ireland, and 58% in NI) were reported with this
condition. Food allergy has previously been documented to be more common in male
children (Ford et al. 2003; Ben-Shoshan et al. 2012), possibly as a result of differences
in immune response regulation between the genders (DunnGalvin et al. 2006).
Moreover, a review of hospital admissions for severe allergic reactions in children
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between 1998 and 2000 in the UK and Ireland suggested that 65% of these admissions
were male (Clover, 2005).

A total of 1,222 respondents (adults and parents of children/adolescents reporting to have
food intolerance and or suspected/undiagnosed food allergy) completed the FI survey.
Milk (59%) and cereals containing gluten (45%) were reported as the most prominent FI
trigger foods among the non-coeliac respondents surveyed, highlighting the importance
of milk and gluten containing foods as a cause of food hypersensitivity on the IoI.
Another notable difference between the top ten trigger foods associated with FI versus
those associated with MDFA in this study, was that peanut (9%) and ‘other nut’ (6%)
ranked fifth and sixth (respectively) for all FI participants, compared to first (peanuts,
47%) and third (35% other nuts) for all MDFA respondents.

In addition, 1,035 respondents (adults and parents of children/adolescents reporting to be
medically diagnosed with coeliac disease) completed the MDCD survey. The
predominant gender reported in the parental MDCD survey groups in Ireland and NI was
female (64%), as opposed to male (36%). However, these high percentages could be a
reflection of a greater willingness to engage in online surveys among the female adult
population as noted in other survey cohorts in this study. That said, coeliac disease has
been previously reported as predominant in females (Caio et al. 2019; Volta et al. 2014;
Fasano, & Catassi, 2012), with actual serological screening reporting a 60:40 or 1.5:1
ratio between female and male coeliacs (Choung et al. 2015).

A large dataset of adult MDCD respondents were examined in this study (n=623) in
Ireland and NI (n=195). However, the project team found it challenging to find parents
of children and adolescents with MDCD to complete the parental MDCD surveys
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(n=217). This suggests an overall lower prevalence, or more likely a lower level of
diagnosis, of this disease in younger populations (Volta et al. 2014; Fassano and Casassi,
2005). Coeliac disease is reported to occur at any age from early childhood to old age
with two suggested peaks of onset: one shortly after weaning with gluten in the first 2
years of life, and the other in the second or third decades of life (Fassano, 2003).
Moreover, the diagnosis of coeliac disease can be challenging since symptoms may vary
significantly from patient to patient. Notably 5% (n=11) of the parental participants and
9% of the adults surveyed reported additional food intolerances in combination with
MDCD (Appendices 3 and 4).

In more general terms, kiwi fruit was found to be a prominent trigger food associated
with MDFA (6%, with 1% reporting previous incidences of anaphylaxis) and FI (3%) in
this study. Food hypersensitivity to kiwi is commonly reported in the EU (Mattila et al.
2003; Lucas et al. 2004; Bublin et al. 2010; Bublin et al. 2011; Le et al. 2013; Burney et
al. 2014). In fact, MDFA to kiwi was reported at comparable or higher levels than some
food allergens currently covered under EU food law (Regulation EU No. 1169/2011). In
addition, a recent publication by Lyons et al. (2020) is also in agreement with this
observation regarding kiwi allergy. They reviewed food hypersensitivity in 6 European
cities and reported higher rates of probable food allergy to kiwi than to fish (with the
exception of Athens), soybeans, sesame seed, celery (with the exception of Lodz), and
mustard seed. The incidence of probable food allergy to kiwi was also reported to be
higher than for wheat in all but one city (Reykjavik), where the incidence was reported
as equal (Lyons et al., 2020a). This study highlights the importance of this particular
food allergen among sensitive populations in Europe.
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For example, if we examine all adults in this study reporting to have MDFA (n=318),
kiwi allergy (8%) was reported to be as common as fish allergy (8%), and more common
than for soybeans (5%), sesame seeds (5%), celery (4%), mustard (3%), sulphites and
SO2 (3%), and lupins (2%). This in agreement with two previous Safefood studies
(Safefood, 2013a, Safefood, 2013b) which describe kiwi hypersensitivity (as opposed to
self-reported MDFA in this study) to be 10% in Ireland (n=259) and 10% in NI (n=123).
Both the previous Safefood studies (2013a, 2013b) reported kiwi food hypersensitivity to
be more prevalent than hypersensitivity to soybeans (6% Ireland, 9% NI), celery (0%
Ireland, 4% NI), mustard (3% Ireland, 1% NI), lupin (2% Ireland, 2% NI), sulphites and
SO2 (1% Ireland, 4% NI), and higher than fish (8%), crustaceans (5%) and molluscs (4%)
in NI only. In addition, a higher prevalence of kiwi allergy, compared to allergies to foods
currently included on the EU list of 14, has been reported in other European studies
(Rancé et al. 2005; Lyons et al. 2020) suggesting further research and possible
consideration of kiwi as a candidate food for allergen labelling regulations.

In summary, this study elucidates the most prominent food hypersensitivity by condition
and age category in the respondents surveyed. This study is not only a repository of selfreported (and parent-reported) food hypersensitivity data (3,001 detailed surveys) among
the populations of Ireland and NI but can also be interrogated further by researchers to
improve our understanding and examine specific characteristics of these diseases.
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7.2 Socioeconomic Cost of Food Hypersensitivity on the Island of
Ireland
The socioeconomic cost of food hypersensitivity was calculated by examining direct and
indirect costs associated with each condition (MDFA, MDCD and FI) in Ireland and NI.
To this end, survey questions relating to individuals (for adults) or household (for
children/adolescents <18 years old) expenditure were reviewed. In total, 2,066 food
hypersensitivity and 735 control (non-food hypersensitive respondents) completed
surveys were used. Direct costs consisting of healthcare related expenses (medical visits,
associated travel, hospital stays, medication, etc.) and total food costs per condition were
calculated for adults and parents of children/adolescents with food hypersensitivity in the
Ireland and NI. In addition, indirect costs, based on lost time, missed days, or lost
earnings (as a result of having a food hypersensitivity) were added to direct costs to give
an overall total cost figure per condition.
Additional direct costs per annum associated with having MDFA ranged from €1,115
(<18 years) to €1,325 (adults) in Ireland, and €982 (adults) to €1,404 (<18 years) in NI.
The range of direct costs were similar to those reported in other studies in which the direct
costs of food allergy for individuals were calculated. These include a mean cost of €1,088
p.a. for the UK and the Netherlands (average of adult and child costs; n=126) by
Voordouw et al. 2010, and a mean cost of €1,740 p.a. for a food allergic adult (n=81)
living in Sweden (Jansson et al. 2014).

Direct costs associated with MDFA children and adolescents were reported as a mean
cost of €1,115 p.a. in Ireland (n=173) compared to €1,404 p.a. in NI (n=147). These
figures are lower than the direct costs reported for food allergic children (n=84) and
adolescents (n=60) in a study in Sweden (€2,085 and 2,892 p.a. respectively). However,
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they are similar to those reported by Fox et al. (2013) for mean healthcare costs for food
allergic children (n=270) (approximately €1,334 p.a. or I$1,134) in Greece, Iceland,
Poland and Spain, and those reported by Voordouw et al. 2010 for food allergic
individuals in the UK and the Netherlands (mean of €1,088 p.a., average of adult and
children).

Similarly, additional direct costs per annum associated with MDCD were found to range
from €444/501 (adult/adult prior to claiming a tax rebate for gluten free food) to €903/993
(<18 years/<18 years without tax rebate) in Ireland, and from €856 (adult) to €1,871 (<18
years) in NI. Lastly, additional direct costs per annum associated with FI were found to
range from €-128 (<18 years) to €350 (adult) in Ireland, and from €337 (<18 years) to
€438 (adult) in NI.

Notably, direct costs were higher for all food hypersensitive individuals in Ireland and
NI compared to controls, with the exception of the child and adolescent FI cohort in
Ireland. However, the sample number was small for this FI group (n=56) due to
challenges in findings parents of children/adolescents with FI to complete this survey,
potentially impacting this figure.

In more general terms, higher direct costs as a result of additional healthcare and food
related expenses were noted for eleven (€337 - €1,871 p.a.) out of the twelve food
hypersensitive groups. These overall findings are in agreement with many published
studies which report higher costs associated with medication, healthcare, and travel to
see medical professionals, as a result of having a food allergy (Voordouw et al. 2010;
Fox et al. 2013; Jansson et al. 2014; Cerecedo et al. 2014; Protudjer et al. 2015), coeliac
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disease (Long et al. 2010; Violato et al. 2012; Picarelli et al. 2014; Cappaci et al. 2018;
Lee et al. 2019; Hanci and Jeanes, 2019), but not specifically for food intolerance.
Indirect costs calculated were smaller than direct costs and were found to range from €96
to €730 for each of the ten cohorts who reported them; with the exceptions being MDCD
adult Ireland, and FI parental NI. The main driver for indirect costs was found to be
‘missed days of work/school/college’, which tended to be higher in responses from NI
(€142 to €486), than the Ireland (€0 to €302). Similar to the findings of this study, indirect
costs have been reported in the literature to generally be a contributor to the total cost of
food hypersensitivity (Voordouw et al. 2010; Fox et al. 2013; Jansson et al. 2014;
Cerecedo et al. 2014; Protudjer et al. 2015).
Indirect costs were all higher for the MDFA adult cohorts in NI (€479 p.a., p-value<0.01),
but not in Ireland (mean cost €277 p.a.), compared to controls. Notably, higher indirect
costs (approx. €2,500 to €6,500 p.a.) associated with MDFA have been reported for some
other child and adults’ groups (Voordouw et al. 2010; Jansson et al. 2014; Protudjer et
al. 2015) from other countries (the UK & the Netherlands collectively, Sweden), than
were reported in this study. The reason for these differences is unknown but could be the
variations of cost of living between countries, regions, or economic model.

When the total additional costs for MDFA were examined, they found to range from
€1,439 (<18 years) to €1,602 p.a. (adult) in Ireland, and €1,461 p.a. (adult) to €1,643p.a.
(<18 years) in NI. In addition, the final figures calculated for all of the MDFA groups
were found to be statistically significantly higher (p-value<0.05).

Similarly, high

additional total cost figures were also reported for MDCD, with €1,033/1,123 (<18
years/<18 years without tax rebate ) calculated in Ireland, and €1,507 (adult) to €1,967
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p.a. (<18 years) in NI – all of which were found to be statistically significantly (pvalue<0.01)
The additional total cost for MDCD adult Ireland cohort (n=609) was calculated as €438
(or € 495 without tax rebate) p.a., but was not significant. The latter cohort reported less
medical expenses, than the other MDFA and MDCD groups, and zero additional ‘missed
days’ compared to the control group (n=531). With regard to FI, higher additional total
costs were calculated (€504 and €656 p.a.) for adult respondents in Ireland and NI, than
for children/adolescents €70 and €66 p.a. counterparts, respectively. The main driver
behind the adult costs for FI were higher healthcare costs and ‘missed days’.

In summary, a higher total cost (direct and indirect costs) was reported for all of the food
hypersensitive groups examined. These were comparable to some of the total costs
figures previously reported for food allergy in the literature which ranged from €1,791 to
€23,468 p.a. (Flabbee et al. 2008; Voordouw et al. 2010; Alanne et al. 2012; Fox et al.
2013; Gupta et al. 2013; Jansson et al. 2014; Cerecedo et al. 2014; Protudjer et al. 2015;
Bilaver et al. 2019), and for coeliac disease from €226 to €4,470 p.a. (Long et al. 2010;
Violato et al. 2012; Picarelli et al. 2014; NICE, 2015). Notably, no studies examining the
socio-economic cost of non-coeliac gluten sensitivity or food intolerance were found,
suggesting that this is the first study of its kind. In more general terms, health care related
expenses were the main driver of costs for food hypersensitive individuals in Ireland and
NI, although total food costs, lost earnings, and lost days at work/college/schools were in
themselves (independently) statistically significant expenses (p-value<0.05) in many of
the cohorts studied.
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Out-of-pocket costs are borne alone by individuals and households (parental survey) were
found to range from €499 to €1,141 p.a. for MDFA in Ireland, and €627 to €641 p.a. in
NI. While the equivalent for MDCD was found to range from €290 to €607 p.a. in Ireland
(€347 to €697 p.a. prior to claiming a tax rebate on gluten free foods), and €1,121 to
€1,178 p.a. in NI. In addition, respondents incurred healthcare costs in conjunction with
(or shared with) their healthcare provider (cumulative cost: €461 to €940 p.a. for MDFA
in Ireland, and €834 p.a to €1,002 p.a. in NI, and €148 to €426 p.a. for MDCD in Ireland,
and to €465 to €789 p.a. in NI). These findings reveal the often-substantial additional
expenses incurred by individuals with food hypersensitivity and their families. These
costs were more pronounced for MDFA and MDCD participants than for FI participants,
although all conditions were associated with additional costs. From this perspective
measures should be considered to assist food hypersensitive individuals in bearing these
additional expenses.

Intangible costs were also investigated in the non-monetary terms in this survey.
Intangible costs can be examined through self-reported health status. This includes
aspects such as loss of welfare & well-being, pain/suffering, inconvenience or effects on
QoL due to having a food hypersensitivity in this instance (Miles et al. 2005; Voordouw
et al. 2016). Intangible costs are typically examined via a health-related quality of life
(HRQL) assessment (Miles et al. 2005) which focuses on an individual’s perception of
the overall effects of the associated illness and its treatment. More specifically this
includes aspects of physical, psychological, and social well‐being and functioning.

Intangible costs were examined by using a set of standardised HRQoL questions called
the EQ-5D. The five dimensions examined in EQ-5D relate to various aspects of health
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and have been widely used to assess health states and health-related quality of life for
different conditions in many countries including Ireland (e.g., 0.60 for patients on
hemodialysis, 0.59 for individuals with multiple sclerosis, and 0.49 for rheumatoid
arthritis etc., Adams et al. (2010), Lowney et al. (2015), MSS (2015). From this
perspective, dimensions such as ‘mobility’ and the ability of a food hypersensitive person
to complete their ‘usual activities’ unhindered or ‘look after him or herself’, while
included as part of the EQ-5D questionnaire were unlikely to be affected by food
hypersensitivity.

Notably this study found that children, adolescents and adults with any form of food
hypersensitivity had a statistically significantly lower quality of life, than their control
counterparts (p-value<0.05). On closer examination of the data reported on the specific
dimensions of the EQ-5D, children and adults belonging to all three groups (MDFA,
MDCD, and FI) were found to have significantly higher levels of ‘pain and discomfort’
(<0.05) compared to controls. Furthermore, adults from all food hypersensitivity cohorts,
and adolescents from the MDFA and FI cohorts, reported a statistically significantly
higher level (p-value<0.05) of ‘anxiety and depression’ than controls.

These findings highlight the often significant impact of food hypersensitivity on the
HRQoL of sufferers. This observation is in general agreement with similar studies in the
literature (Fong et al. 2017; Shaker et al. 2017; Du Toit et al., 2016; Greenhawt, 2016;
Walker et al. 2015), and notably two studies in Swedish children and adults using the
same EQ-5D model as used in this study (Protudjer et al 2015; Jansson et al. 2013), In
addition, there is evidence to suggest that the recent Covid-19 pandemic has further
exasperated the effect of food hypersensitivity on the quality of life of sufferers (Protudjer
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et al., 2019). Unexpected challenges associated with food shopping and delays in food
allergy testing and therapy were some of the reasons cited, highlighting additional
problems arising as a result of the pandemic. Notably (while not examined in this study),
a ‘poorer’ quality of life and higher levels of anxiety have also been reported for
caregivers of children with food hypersensitivity; highlighting the wider effect of a
diagnosis (DunnGalvin 2020; Ascaster, 2020; Birdi et al. 2016) and the need for
supporting measures to assist sufferers and their families.

A further specific intangible question on the food hypersensitivity surveys, regarding
areas of life affected by food hypersensitivity, adds additional detail to these findings.
Notably, ‘the ability to eat out’ was the most cited parameter affecting QoL by MDFA
respondents (74% to 86%). The most reported parameter affecting QoL in MDCD
sufferers (96-98%) and FI respondents (68-88%) and their families, was the ‘cost of food
shopping’. Both of the aforementioned challenges have been previously reported in the
literature for MDFA (DunnGalvin et al. 2015; Jansson et al. 2013; Jansson et al. 2015)
and MDCD sufferers (MacCulloch and Rashid, 2014; Altobelli et al. 2013; Black &
Orfila, 2011; Roma et al. 2010).
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7.3 Priority Setting Interviews with Adults and Parents of
Children/Adolescents with MDFA or MDCD
A complementary study, consisting of 76 priority setting phone interviews of MDFA and
MDCD sufferers, was also organised. These interviews investigated a wide range of key
challenges (based on the findings and feedback from open questions in the food
hypersensitivity surveys) in semi-structured style interviews and considered measures
that could be taken to ameliorate them.
Interestingly, all MDFA and MDCD groups examined prioritised ‘Public and Food
Industry awareness and understanding of their/their child’s condition’ as their number
one challenge, with the exception of parents of sufferers of MDFA in NI who ranked
‘Awareness and training in an educational setting’ first and the former option third.
Issues mainly pertained to problems with eating out, and a perception of inadequate
training and awareness in the food sector (as previously reported by Gruenfeldova et al.
2019; FSAI, 2017; EFSA, 2014), coupled with the overuse/misuse of precautionary
allergen labelling.
While an improvement was noted with regard to allergen awareness when ‘eating-out’ in
recent years (possibly as a result of allergen labelling requirements on non-pre-packaged
or loose foods which came into force in 2014), respondents felt more could be done by
this sector. This is supported by a previous FSAI audit of 50 food businesses that found
that while 68% of these outlets complied with the obligation to have a written allergen
declaration, the majority required some form of corrective action due to incomplete or
inaccurate allergen labelling (FSAI, 2017). In addition, a recent study by Gruenfeldova
et al. (2019) on food safety, knowledge, awareness and practices in Ireland, found that
only 16% of respondents (food handlers) were able to list all 14 allergens in EU food law.
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In addition, only 51% of the survey respondents were able to name 7 or more food
allergens. When these figures (regarding the lack of compliance and knowledge) are
considered in the context of the reported prevalence of food allergy and coeliac disease
(approximately 3-5% and 1% of the population, respectively), it is clear that a greater
awareness and compliance is required by the food services sector in this regard (IFAN,
2019; INDI, 2019; Mustalahti et al. 2010, Altobelli et al. 2014, MacGiobuin et al. 2017
& CSI, 2019).
Respondents proposed many strategies to achieve improvements in the area of ‘Public
and Food Industry awareness and understanding’. One of these strategies is the use of
technology for effective communication of allergen information between waiting staff
and kitchen staff (i.e. chefs). This raises the possibility that such software could also be
used as a quick reference for waiting staff of all ingredients (including trace or
‘compound’ ingredients in pre-bought products e.g., sauces, stocks, etc.) in dishes on the
menu. This system could be an effective tool to assist with allergen management and
communication in food businesses, assuming it was well maintained and frequently
updated. Similarly, additional filters in online shopping sites were suggested to reduce
the time that food hypersensitive individuals are required to spend reading labels while
shopping. For instance, a button/tab could be selected to eliminate all products containing
nuts, or dairy etc., as an ingredient on their label. In addition, there is a possibility that
this software could notify users of any allergen related product recalls (or RASFF) in
place on a particular food product at a given time when shopping. That said, this software
would only be effective if properly managed and kept up to date.
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One interviewee proposed that allergen food labelling could be made more child friendly
in school canteens. This concept could be explored to a greater degree and include
symbols or colour-coding to assist children/adolescents to make quick and safe decision
regarding suitable foods in an educational setting. In addition, the provision of allergenfree zones for students to eat their meals in (canteen food or packed lunches) was strongly
supported by both sets (MDFA and MDCD) of interviewees. Moreover, MDCD
interviewees indicated a wish to see clear and prominent markings on all GF food
products in supermarkets i.e., statements saying ‘Gluten Free’; so that they were clearly
identifiable to consumers. Interestingly, this was also a recommendation of a recent Bord
Bia study (Bord Bia, 2017).

Many solutions were suggested in Chapter 5 to improve allergen management systems.
In addition, a clinically validated tiered risk assessment approach to PAL is being
considered at EU level in order to develop systems of transparency regarding food
labelling (DunnGalvin, et al. 2019; Reese et al. 2015). The potential impact of a
regulatory requirement for food companies to conduct a risk assessment of the potential
for allergen cross-contamination, in order to warrant the use of such labels on prepackaged foods, has been discussed elsewhere (DunnGalvin et al. 2019).

Targeted measures to address these two issues would benefit sufferers of food
hypersensitivity on the IoI. Similarly, challenges with regard to awareness and training
in food hypersensitivity in educational settings, was the overall third highest priority of
MDCD participants interviewed (and parents thereof), and the overall fourth highest for
their MDFA counterparts.

381

Many suggestions to alleviate the day-to-day challenges have been proffered by
respondents. Notably guidance has been issued to educators in NI (DoE, NI, 2018), but
not Ireland to assist in policy creation and management. In this regard, a similar
standardised approach involving the formulation of guidance with stakeholders, is worth
investigating at departmental level in Ireland. This would assist both parents and
educators in co-managing students’ needs in this regard.

It is worth noting that there is currently no legal or formal requirement for the acquisition
of adrenaline autoinjector training in Irish childcare and educational environments
(IFAN, 2017). Similarly, there is no legal requirement for this responsibility to be
undertaken by educators in NI, however guidance on the use of AAIs in schools from the
Department of Education in NI (DoE, NI, 2018) is available to assist in policy creation
and management. Notably, this document includes instructions for teachers who have
‘shown willingness to assist in the administration of medication’ if required in NI. To
the best of our knowledge, there is no similar guidance available in Ireland.
All cohorts examined reported ‘Accessing medical teams e.g., consultant’s specialist
nurses etc. to treat your (or your child’s) condition’ as the second most important priority.
Challenges associated with accessing dietetic and counselling services are also reported
in this study. From this perspective, the development of clinical pathways with improved
access to medical services, could greatly support sufferers diagnosed with these
conditions. Greater difficulties with regard to accessing medical treatment and dealing
with food hypersensitivity during the current Covid-19 pandemic have been reported
(Cianferoni and Voto, 2020; D’Auria, et al. 2020; Mack et al. 2020); highlighting the
importance of having well established clinical pathways for sufferers.
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Notably, the provision of ‘Adrenaline auto-injector in public places similar to AED’ was
the overall third highest priority for MDFA adults and parents of sufferers (90% approval,
with an additional 8% unsure). It was suggested that such a proposal would most likely
require an increase in training on the administration of adrenaline auto-injector and
improved public awareness. Another suggestion was that an ‘app’ could be considered
to show the location of this medication. This idea could be further developed. For
instance, the app could release a code to a registered sufferer to access such a device from
a secure facility in the case of an emergency. Notably, provision of adrenaline autoinjector in public places is a system available in parts of Canada (Allergicliving, 2015),
and a petition was sent to the UK parliament with 13,098 signatures in 2019 (UK
Parliament, 2019). The feasibility of introducing such a measure in Ireland and NI
warrants further research.

Other important issues ranked, included the cost and availability of medication, access to
counselling and dietetic services, and consideration that food allergy and coeliac disease
could be recognised as disabilities (similar to measures currently in place for severe food
hypersensitivity in the US). Neither of these conditions is currently recognised as a
disability in Ireland or NI.

Notably, MDFA and MDCD can be considered a disability in the US (if severe enough)
under the ‘Americans with Disabilities Act’ (AAFA, 2019). This Act defines a person
with a disability as “a physical or mental impairment that substantially limits one or
more major life activities of such individual, a record of such an impairment or, being
regarded as having such an impairment” (ADA National Network, 2020).
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The results of this study reflect the complexity of challenges which sufferers of food
hypersensitivity encounter daily. While progress had been made in this broader area of
allergen awareness and management, these data reflect the need for additional measures
to reduce the impact of this disease on the lives of sufferers and their families.
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7.4 Food Hypersensitivity Datasets & Peer-reviewed Published
Prevalence Values
This study reviewed food hypersensitivity anonymised data from previously published
surveys and datasets for the Island of Ireland, including the collation of prevalence rates
reported for Ireland, the UK, Europe and elsewhere in the wider literature. In addition,
anonymised food hypersensitivity information was sought (2,513 institutions were
contacted) and collected from public and private organisations in Ireland and Northern
Ireland.

More specifically this study reports percentages of food hypersensitivity, food allergy
and coeliac disease among 9,517 children in early years services, 3,233 school children
(primary and secondary) and 2,139 residences of nursing homes on the Island of Ireland.
Higher levels of all food hypersensitivity were reported in children in early years services
than in schools and nursing homes, with the exception of CD. This is in agreement with
published studies that reported higher levels of FA and FI in pre-school children than in
their older counterparts (Lyons et al. 2020b, De Martinis et al. 2019). In addition, the
low level of CD reported in this early years services cohort is not unexpected as this
condition is generally diagnosed later in life (Price & Howard, 2017). Notably, the
reported percentage of CD was 1.5% in nursing homes (from a study cohort of 2,139
residents) for Ireland and NI combined, compared to 0.3-0.7% in the younger cohorts in
this study. CD is typically reported at 1% in adults in Ireland (CSI, 2019).

It is expected that these data will contribute to the general body of knowledge of food
hypersensitivity data publicly available for the Island of Ireland. It is hoped that the
findings of this study will assist risk assessors, researchers, regulators, policy makers and
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other stakeholders, in devising measures to improve the lives of food hypersensitive
consumers on the IoI.
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Chapter 8: Conclusions
This study provides evidence of the socio-economic costs associated with food
hypersensitivity on the IoI. Statistically significantly higher total costs were found for
seven out of the eight MDFA and MDCD study groups examined, highlighting the
financial burden typically associated with these conditions. Healthcare related expenses
were found to be the main driver of costs, although total food costs, and loss time/days
were also found to be significant for many of the groups examined. Similarly, additional
total costs reported by FI sufferers were found to be higher than those of non-sufferers
but (unlike most MDFA and MDCD groups) not significantly so. Measures to address
expenses incurred by sufferers could greatly ameliorate costs associated with these
conditions.

In addition, evidence of intangible costs (non-monetary) and the overall effect of food
hypersensitivity on health-related quality of life (HRQoL) of sufferers was examined.
Notably, intangible costs were found to be significant for all food hypersensitivities
studied (MDFA, MDCD and FI) for all age groups (child, adolescent and adult) using the
standardised EQ-5D model. The deleterious effect on HRQoL associated with having a
food allergy, was particularly pronounced with regard to the dimensions of ‘pain and
discomfort’ and ‘anxiety and depression’. These findings further highlight the physical
and psychological stresses associated with these conditions, and the need for focused
measures to support sufferers of food hypersensitivity in this regard.

To this end, challenges and associated solutions were reviewed in the priority setting
interviews, completed as part of the study. Notably, public and food industry awareness
and training was the overall number one priority for both MDCD and MDFA, indicating
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that this area should be targeted for improvement, where possible. Other areas included
improved access to medical teams, consideration to making adrenaline auto-injector
available in public places, and increased awareness of food hypersensitivity in
educational settings. It is the project team’s aspiration that this study will serve as
evidence of the need for targeted improvements and supports in the areas affecting the
lives of sufferers of food hypersensitivity, and for continued research into the areas
highlighted in this study.
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Chapter 9: Recommendations, and Added Value and Anticipated
Benefits of Research
9.1 Key Project Recommendations
•

Due consideration should be given to the relative prevalence of medically
diagnosed and suspect allergy to kiwi fruit, and possible intolerance to kiwi fruit,
by the regulatory authorities on the IoI.

•

Those who suspect they have a food intolerance or a suspected/undiagnosed food
allergy should seek a proper diagnosis either with a qualified medical practitioner
or a registered dietitian.

•

Assistance with healthcare costs (and consideration with regard to the most
effective mechanisms for doing so) should be offered to those with a medically
diagnosed food allergy (MDFA) in Ireland and Northern Ireland.

•

Provision of a greater range of more suitably priced gluten free foods, with
additional financial supports (e.g., vouchers or the provision of certain gluten-free
foods on prescription, etc.) to parents of medically diagnosed coeliac disease
(MDCD) children up to 18 years of age in Ireland.

•

Availability of a wider range of gluten-free products, particularly on prescription
in Northern Ireland, and/or the provision of tax rebates or vouchers for consumers
with MDCD in Northern Ireland.

•

Further examination of the health-related intangible costs associated with food
hypersensitivity, as elucidated in this report should be considered, as well as
avenues for addressing them.

•

More measures should be developed to promote food industry awareness of food
hypersensitivity. This would include an increased focus on food allergens and
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the prevention of cross-contamination within current food safety training
programmes, and compliance with labelling on non-prepackaged/loose foods.
•

Investigation into mechanisms to prevent misuse/over-use of precautionary
allergen labelling (i.e., “may contain” labelling) in the food manufacturing sector
should be considered, as well as an exploration of a possible partnership approach
with industry and other key stakeholders to address this issue.

•

The development of healthcare pathways (improved access to medical teams,
including dietetic support and counselling) for individuals with food
hypersensitivity should be considered.

•

Further research is needed into the feasibility, effectiveness, and costeffectiveness of providing adrenaline autoinjectors in controlled environments
(similar to Automated External Defibrillators) such as in schools and Early
Learning and Care facilities in Ireland and Northern Ireland.

•

National guidance on the management of food hypersensitivity in educational
settings should be developed in Ireland by the Department of Education in
conjunction with relevant stakeholders (this is already available in Northern
Ireland). This should include advice on the formulation of food allergy polices,
individual emergency plans, staff allergen awareness training, storage and use of
adrenaline autoinjectors, recommendations regarding school activities, trips, etc.

•

The promotion of public awareness of food hypersensitivities, and the provision
of public guidance around the administration of adrenaline autoinjectors, should
continue.

•

Nationwide surveys (e.g., TILDA, Healthy Ireland, Growing-up in Ireland, etc.),
should include clearly defined food hypersensitivity-related questions developed
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in consultation with appropriate stakeholders. This will assist the continuing
collection of data on these conditions in Ireland and Northern Ireland.
•

Further research into measures to improve food allergen management and the
quality of life of food hypersensitive consumers on the IoI is recommended.
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9.2 Added Value & Anticipated Benefits of Research
•

This study provides data on the additional monetary costs (direct and indirect)
associated with food hypersensitivity (MDFA, MDCD, and FI) for
children/adolescents and adults.

These data can be used to assist in the

development of policy, guidance, assistance and supports in this area.
•

In addition, this report provides evidence of intangible costs (non-monetary)
associated with food hypersensitivity (MDFA, MDCD, and FI); separately for
children, adolescents and adults. Notably, this impact was particularly evident
with regard to ‘pain and discomfort’ and ‘anxiety/depression’. These findings
highlight the need for measures to assist sufferers with regard to the deleterious
effects associated with having food hypersensitivity on HRQoL. Similarly, it is
hoped that these findings will inform policy, supports, guidance and further
research in this area.

•

Furthermore, the results of the priority setting workshop highlights key areas that
can be targeted, and potentials solutions for consideration. These data, coupled
with the study recommendations, provide information to assist stakeholders and
policy makers in the formulation of interventions in this area.

•

In more general terms, this study provides detailed (anonymised) information on
3,001 food hypersensitive individuals on the IoI. This data is presented clearly in
six detailed Appendices and is a repository which can be further investigation (for
other trends, relationships, observations etc.) by researchers. In addition, the suite
of food hypersensitive and controls surveys developed during the course of the
study can be used at a future date (i.e. ten, twenty years from now) to compare
data (i.e. changes in costs, potential changes in trigger foods due to dietary
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changes etc.) over a given frame. From this perspective, direct comparisons can
also be made with other countries, if the same surveys are used. These data, and
developed surveys, may be valuable instruments to further investigate food
hypersensitivity on the IoI - presently and in the future.
•

Finally, the collation of Irish datasets, prevalence rates, and the collection of
information on food hypersensitivity from 9,517 children in early years services,
3,233 school children (primary and secondary) and 2,139 residences in nursing
homes on the IoI, will add to existing publicly available datasets. These data will
also help to build a picture of the prevalence rates of food hypersensitivity on the
IoI; thereby assisting scientists, researchers, policy makers and other stakeholders
in understanding these conditions and their rate of occurrence on the IoI.
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APPENDICES
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Appendix 1 - MDFA Parental Surveys
General analysis and summary information of children & adolescents (< 18 years of
age) who were reported to be MDFA in the parental survey conducted between
November 2019 and June 2020, in both Ireland and NI
1.1 Main findings of the parental survey of children and adolescents with MDFA in
Ireland (258 respondents)
1. Background information on the respondents:
•

43% (n=111) of children were reported to be in the < 5 years category (28% males
& 15% females). More specifically, 84% (n=218) were reported to be < 12 years
(50% males & 34% females); with approximately 16% (n=40) of adolescents
reported to be in the 13-17 years category (7% males and 8% females).

•

The gender breakdown of children and adolescents reported as MDFA was 57%
(n=148) males and 43% (n=110) females as indicated in the parental surveys.

•

The majority 87.5% (n=226) of children and adolescents reported as MDFA in
the parental survey had their status recorded as Irish, and approximately 0.5%
(n=1) were originally from Britain and approximately 0.5% (n=1) from Northern
Irish. An additional 11.5% (n=30) noted that they were originally from elsewhere
but were currently residing in Ireland.

•

Approximately 47.5% (n=122) of parents of MDFA sufferers reported obtaining
a third level qualification as their highest qualification, while approximately 7%
(n=19) reported that they had completed a second level qualification.

An

additional 45.5% (n=117) of respondents did not specify their educational
background.
•

39% (n=101) of parents of MDFA sufferers reported: to be working either fulltime (including self-employed) or part-time, with 15% (n=39) not working, and
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approximately 0.5% (n=1) in education.

An additional 45.5% (n=117) not

specifying their working status.
•

The majority of respondents reported to be living in an urban setting 32% (n=82),
compared to 23% (n=59) in a rural area; with an additional 45% (n=117) not
specifying their geographical location.

•

22% (n=58) of the parents of MDFA sufferers indicated that they were earning
between <€1,000 and €3,500 (as combined household income) per month and
approximately 28% (n=72) >€3,501 (as combined household income) after tax
deductions; with 50% (n=128) not specifying their combined monthly income.

•

74% (n=190) of the parents of children and adolescents reported as MDFA,
indicated that their child had no additional long-term illness, health problems, or
disabilities (other than food allergy or intolerance), and approximately 26%
(n=68) indicated to the contrary.

•

36% (n=93) of the parents of children and adolescents reported as MDFA
indicated that their child does have a private medical insurance policy, with 24%
(n=62) reporting not to have one. An additional 40% (n=103) did not specify
whether their child had a private medical insurance or not.

2. Food Hypersensitivity information on the respondents:
•

Peanuts (61%, n=134), other nuts (49%, n=107), eggs (45%, n=99), milk (35%,
n=77) and fish (11%, n=25) were the most common food allergens associated
with MDFA for children (n=218) reported by this cohort (see Figure 1.A.17 for
the breakdown of other nuts°).

396

•

Fruits (15%, n=34; consisting of kiwi, n=5 and other fruits, n=29), cereals
containing gluten (9%, n=20), and soybeans (8%, n=18) were the most common
additional FIs in children (n=218) reported by this cohort (see Table 1.A.1 for the
breakdown of other fruits˟).

•

Peanuts (60%, n=24), other nuts (50%, n=20), eggs (35%, n=14) and milk (25%,
n=10) were the most common food allergens associated with MDFA for
adolescents (n=40) reported by this cohort (see Figure 1.A.18 for the breakdown
of other nuts°).

•

Fruits (13%, n=5; consisting of kiwi, n=1 and other fruits, n=4) and eggs (8%,
n=3) were the most common additional FI in adolescents (n=40) reported by this
cohort (see Table 1.A.2 for the breakdown of other fruits˟).

•

4.6% (n=12) of children and adolescents were reported to have additional food
hypersensitivities as well as being confirmed as MDFA to certain food/s. This
consisted of 2.3% (n=6) of the examined cohort reporting to have additional FI
and 2.3% (n=6) reporting to have food intolerance and MDCD.

3. Information regarding Diagnosis of MDFA on the respondents:
•

90% (n=232) reported being diagnosed with MDFA, <1-5 years, 9% (n=23)
between 6-12 years, and 1% (n=3) between 13-17 years. However, this result
needs to be considered in line with the age demographic of the children and
adolescents. The average age of the respondent in this study was found to be 7
years for females and 7 years for males.

•

All of the children and adolescents in this study were required to have been
positively diagnosed by at least one of the HSE/NHS recognised methods of
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testing1 by a healthcare professional, as a specific inclusion criteria. However,
with regard to the number of tests per individual, 21% (n=54) reported to be
diagnosed as MDFA by one of HSE/NHS recognised tests 1, 41% (n=106) by 2
tests, 30% (n=78) by 3 tests, and 8% (n=20) by 4 tests, respectively.
•

With regard to the frequency of tests used in the diagnosis of MDFA, 80%
(n=206) reported to have had a confirmatory blood test and 79% (n=205) a
positive skin prick test. While 39% (n=101) reported diagnosis by food oral
challenge and 25% (n=64) via trial elimination diet.

•

71% (n=184) of the parents of children and adolescents reported as MDFA,
indicated that their child had been diagnosed by one healthcare professional, 24%
(n=62) by 2, approximately 4.5% (n=11) by 3, while approximately 0.5% (n=1)
reported as diagnosed with a MDFA by a healthcare professional, did not specify
the exact number of healthcare professional involved in their diagnosis.

•

Whether the child’s diagnosis occurred once or on multi occasions, testing and
diagnosis were reported to have been completed by medical consultant by 75%
(n=194) of respondents, medical doctors during a hospital admission by 30%
(n=78), family doctors (GP) by 27% (n=69) and 1% (n=3) reported to be
diagnosed by a dietitian, in addition to being diagnosed by family doctor and
medical consultant, or dietitian only.

•

Approximately 26.5% (n=68) of the parents of children and adolescents reported
as MDFA, indicated that their child had IgE-mediated food allergy, 10% (n=26)
mixed IgE and non-IgE-mediated food allergy, approximately 5.5% (n=14) had
non-IgE-mediated food allergy, while 58% (n=150) of respondents did not
specify classification of their child’s food allergy.
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•

Peanuts (17%, n=43), other nuts (14%, n=37) and eggs (11%, n=29) were the
most common food allergens associated with IgE-mediated food allergy reported
by this cohort (Table 1.A.7).

•

14% (n=36) of parents of MDFA sufferers reported that at least one other
household member has MDFA. Notably, 12% (n=32) reported it to be 2 additional
household members, and 2% (n=6) reported it to be 3 additional household
members; with 8% (n=20) not answering the question.

4. Information regarding medication, history of anaphylaxis over a 12-month
timeframe and reported food allergens associated with anaphylactic
reactions
•

Parents of MDFA sufferers reported that their child was prescribed with the
following medications as a result of their MDFA; 81% (n=210) adrenaline
(epinephrine) auto-injectors, with 74% (n=190) antihistamines, 24% (n=61)
corticosteroids, and 6% (n=19) ‘other medications’ (including inhalers,
prescribed milk formula and acid reflux medications).

•

Approximately 9.5% (n=25) of parents of MDFA sufferers reported their child to
have had anaphylactic reactions over the 12-months prior to completing this
survey, with 9% (n=24) reporting 1 episode, and 0.4% (n=1) reporting 2 times.

•

Peanuts (7%, n=18), other nuts (7%, n=17), eggs (5%, n=13) and milk (2%, n=6)
were the most common food allergens associated with anaphylactic reactions over
the 12-months reported by this cohort (Table 1.A.9).

1 HSE/NHS

recognised tests for the diagnosis of food allergy: Skin prick testing, Blood tests, Trial elimination diet and Food oral
challenge: https://www.hse.ie/eng/health/az/a/allergy,-food/diagnosing-food-allergy-.html; https://www.nhs.uk/conditions/foodallergy/diagnosis/
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1.2 Main findings of the parental survey of children and adolescents with MDFA in
Northern Ireland (168 respondents)
1. Background information on the respondents:
•

52% (n=88) of children reported to be in the < 5 years category (29% males &
24% females). More specifically, 87% (n=145) were reported to be < 12 years
(50% males & 36% females) with approximately 13% (n=23) of adolescents
reported to be in the 13-17 years category (8% males and 6% females).

•

The gender breakdown of children and adolescents reporting as MDFA was 58%
(n=97) males and 42% (n=71) females; as indicated in the parental surveys.

•

The majority 50% (n=84) of children and adolescents reported as MDFA in the
parental survey had their status recorded as Northern Irish, and approximately
26% (n=43) as Irish and 20% (n=34) were originally from Britain. An additional
4% (n=7) noted that they were originally from elsewhere but were currently
residing in NI.

•

60% (n=100) of parents of MDFA sufferers reported obtaining a third level
qualification as their highest qualification, while approximately 13% (n=23)
reported that they had completed a second level qualification. An additional 27%
(n=45) of respondents did not specify their educational background.

•

58% (n=97) of parents of MDFA sufferers reported: to be working either fulltime (including self-employed) or part-time, approximately 14% (n=24) not to be
working, and 1% (n=2) in education. An additional 27% (n=45) not specifying
their working status.

•

The majority of respondents reported to be living in an urban setting 44% (n=74)
compared to 30% (n=50) in the rural area; with an additional 26% (n=44) not
specifying their geographical location.
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•

39% (n=65) of the parents of MDFA sufferers indicated that they were earning
between <€1,000 and €3,500 (as combined household income) per month and
approximately 27% (n=45) >€3,501 (as combined household income) after tax
deductions; with 34% (n=58) not specifying their combined monthly income.

•

76% (n=128) of the parents of children and adolescents reported as MDFA,
indicated that their child had no additional long-term illness, health problems, or
disabilities (other than food allergy or intolerance), and approximately 23%
(n=39) indicated to the contrary; with 1% (n=1) did not answer this question.

•

16% (n=27) of the parents of children and adolescents reported as MDFA
indicated that their child does have a private medical insurance policy, with 64%
(n=107) reporting not to have one. An additional 20% (n=34) did not specify
whether their child had a private medical insurance or not.

2. Food Hypersensitivity information on the respondents:
•

Milk (60%, n=87), peanuts (37%, n=53), eggs (36%, n=52), other nuts (19%,
n=28) and soybeans (14%, n=20) were the most common food allergens
associated with MDFA for children (n=145) reported by this cohort (see Figure
1.A.19 for the breakdown of other nuts°).

•

Cereals containing gluten (13%, n=19), soybeans (8%, n=11), eggs (7%, n=10),
milk (6%, n=8) and fruits (6%, n=9 consisting of kiwi n=2 & other fruits, n=7)
were the most common additional food intolerances, suspected, or non-MDFA
for children (n=145) reported by this cohort (see Table 1.A.3 for the breakdown
of other fruits˟).

•

Peanuts (52%, n=12), other nuts (30%, n=7), milk (22%, n=5) and eggs (17%,
n=4) were the most common food allergens associated with MDFA for
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adolescents (n=23) reported by this cohort (see Figure 1.A.20 for the breakdown
of other nuts°).
•

Cereals containing gluten (13%, n=3), fruits (18%, n=4 consisting of kiwi n=2 &
other fruits, n=2) and milk (9%, n=2) were the most common additional food
intolerances, suspected, or non-MDFA for adolescents (n=23) reported by this
cohort (Table 1.A.4 for the breakdown of other fruits˟).

•

20% (n=34) of children and adolescents were reported to have additional food
intolerances, and/or suspected, or undiagnosed food allergy as well as being
confirmed as MDFA to certain food/s.

3. Information regarding Diagnosis of MDFA on the respondents:
•

91% (n=154) reported being diagnosed with MDFA, <1-5 years, 7% (n=11)
between 6-12 years, and 2% (n=3) between 13-17 years. However, this result
needs to be considered in line with the age demographic of the children and
adolescents. The average age of the respondent in this study was found to be 6
years for females and 6 years for males.

•

All of the children and adolescents in the study were required to have been
positively diagnosed by at least one of the HSE/NHS recognised methods of
testing1 by a healthcare professional, as a specific inclusion criteria. However,
with regard to the number of tests per individual, 26% (n=43) reported to be
diagnosed as MDFA by one of HSE/NHS recognised tests1, 46% (n=78) by 2
tests, 19% (n=32) by 3 tests, and 9% (n=15) by 4 tests, respectively.

•

With regard to the frequency of tests used in the diagnosis of MDFA, 58% (n=97)
reported to having had a confirmatory blood test and 71% (n=120) a positive skin
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prick test. While 44% (n=74) reported diagnosis via trial elimination diet and 38%
(n=64) by food oral challenge.
•

65% (n=109) of the parents of children and adolescents reported as MDFA,
indicated that their child had been diagnosed by one healthcare professional, 27%
(n=45) by 2, 7% (n=11) by 3, while 1% (n=3) reported as diagnosed with a MDFA
by a healthcare professional, did not specify the exact number of healthcare
professional involved in their diagnosis.

•

Whether the child’s diagnosis occurred once or on multi occasions, testing and
diagnosis were reported to have been completed by medical consultant by 71%
(n=120) of respondents, family doctors (GP) by 33% (n=56), and medical doctors
during a hospital admission by 27% (n=45). In addition, 4% (n=6) reported to be
diagnosed by health visitors, and 4% (n=6) reported to be diagnosed by a dietitian,
in addition to being diagnosed by family doctor, medical consultant, or either by
dietitian or health visitor only.

•

17% (n=29) of the parents of children and adolescents reported as MDFA,
indicated that their child had IgE-mediated food allergy, 15% (n=26) mixed IgE
and non-IgE-mediated food allergy, 13% (n=21) had non-IgE-mediated food
allergy, while 55% (n=92) of respondents did not specify classification of their
child’s food allergy.

•

Peanuts (10%, n=16), eggs (6%, n=10) and other nuts (5%, n=9) were the most
common food allergens associated with IgE-mediated food allergy reported by
this cohort (Table 1.A.8).

•

17% (n=29) of parents of MDFA sufferers reported that at least one other
household member has MDFA. Notably, 16% (n=27) reported it to be 2 additional
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household members, and 1% (n=2) reported it to be ≥3 additional household
members; with 6% (n=10) not answering the question.

4. Information regarding medication, history of anaphylaxis over a 12-month
timeframe and reported food allergens associated with anaphylactic
reactions:
•

Parents of MDFA sufferers reported that their child was prescribed with the
following medications as a result of their MDFA; 74% (n=124) antihistamines,
with 52% (n=88) adrenaline (epinephrine) auto-injectors, 13% (n=22)
corticosteroids, and 9% (n=15) ‘other medications’ (including inhalers,
prescribed milk formula, acid reflux medications and nausea medications).

•

10% (n=17) of parents of MDFA sufferers reported their child to have had
anaphylactic reactions over the 12-months prior to completing this survey, with
7% (n=11) reporting 1 episode, and 4% (n=6) reporting 2 times.

•

Eggs (7%, n=11), peanuts (5%, n=9), milk (4%, n=6) and other nuts (4%, n=6)
were the most common food allergens associated with anaphylactic reactions over
the 12-months reported by this cohort (Table 1.A.10).

1 HSE/NHS

recognised tests for the diagnosis of food allergy: Skin prick testing, Blood tests, Trial elimination diet and Food oral
challenge: https://www.hse.ie/eng/health/az/a/allergy,-food/diagnosing-food-allergy-.html; https://www.nhs.uk/conditions/foodallergy/diagnosis/
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Age and gender of children & adolescents who were reported to have MDFA in the
parental survey in Ireland(n=258) and NI (n=168)
30%

Percentage of children (male)

26%

Percentage

25%

Percentage of children (female)

23%

19%

20%
14%

15%
10%
5%

8%

7%
2%

1%

0%
below 1 year

1-5

6-12

13-17

Age Group
*Associated number of children and adolescents reported by parents to have MDFA by their age group: below 1 year: 4 males & 3
females; 1 – 5 years: 67 males & 37 females; 6 – 12 years: 58 males & 49 females; 13 – 17 years: 19 males & 21 females

Figure 1.A.1: Percentage breakdown of children and adolescents, by gender and
age, who were reported to have MDFA in the parental survey conducted between
November 2019 and June 2020, in Ireland (<18 years, n = 258)
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0%
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1-5

6-12
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Age Group
*Associated number of children and adolescents reported by parents to have MDFA by their age group: below 1 year: 6 males & 5
females; 1 – 5 years: 42 males & 35 females; 6 – 12 years: 36 males & 21 females; 13 – 17 years: 13 males & 10 females

Figure 1.A.2: Percentage breakdown of children and adolescents, by gender and
age, who were reported to have MDFA in the parental survey conducted between
November 2019 and June 2020, in NI (<18 years, n = 168)
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Ethnicity (or cultural background) reported by parents of children and adolescents
suffering from MDFA in Ireland (n=258) and NI (n=168)
0.5%
5%
0.5%
0.5%

Irish

6%

British

Northern Irish
Any other White background
Any other Asian background
Other (including mixed
background)

87.5%
*Associated number of parents who reported their child’s ethnicity (or cultural background): Irish = 226 individuals; British = 1
individual; Northern Irish = 1 individual; Any other White background = 13 individuals; Any other Asian background = 1
individual; Other (including mixed background) = 16 individuals

Figure 1.A.3: Ethnicity (or cultural background) indicated by parents reporting
their child to have MDFA in a survey conducted between November 2019 and June
2020, in Ireland (<18 years, n = 258)
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Other (including mixed background)
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20%

*Associated number of parents who reported their child’s ethnicity (or cultural background): Irish = 43 individuals; British = 34
individuals; Northern Irish = 84 individuals; Any other White background = 1 individual; African = 1 individual; Other (inclu ding
mixed background) = 5 individuals

Figure 1.A.4: Ethnicity (or cultural background) indicated by parents reporting
their child to have MDFA in a survey conducted between November 2019 and June
2020, in NI (<18 years, n = 168)

407

Highest level of education indicated by parents of children and adolescents reported
as having MDFA in Ireland(n=258) and NI (n=168)
Percentage of Parent/Guardian
Percentage of Spouse/Partner
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Highest level of education
*Number of parents who reported their highest-level education: Parent/Guardian: Postgraduate/Higher degree = 59 individuals;
Diploma/Certificate = 32 individuals; Primary/Bachelor’s degree: 31 individuals; ˢLeaving Certificate or similar (includes Advanced
Levels/General Certificate of Education Advanced) = 13 individuals; ˣJunior Certificate or similar (includes
Intermediate/Group/Ordinary Levels/General Certificate of Secondary Education or equivalent) = 6 individuals; *Unspecified (did
not answer) = 117 individuals
**Spouse/Partner: Postgraduate/Higher degree = 52 individuals; Diploma/Certificate = 23 individuals; Primary/Bachelor’s degree:
20 individuals; ˢLeaving Certificate or similar (includes Advanced Levels/General Certificate of Education Advanced) = 16
individuals; ˣJunior Certificate or similar (includes Intermediate/Group/Ordinary Levels/General Certificate of Secondary Education
or equivalent) = 10 individuals; Primary Education or less = 1 individual; *Unspecified (did not answer) = 136 individuals

Figure 1.A.5: Highest level of education indicated by parents who reported their
child/adolescent to have MDFA in a survey conducted between November 2019 and
June 2020, in Ireland (<18years, n = 258)
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degree

Postgraduate/Higher
degree

Diploma/Certificate Leaving Certificate or
similarˢ

Junior Certificate or
similarˣ

Primary Education or
less

Unspecified*

Highest level of education
*Number of parents who reported their highest-level education: Parent/Guardian: Primary/Bachelor’s degree = 47 individuals;
Postgraduate/Higher degree = 33 individuals; Diploma/Certificate = 20 individuals; ˢLeaving Certificate or similar (includes
Advanced Levels/General Certificate of Education Advanced) = 16 individuals; ˣJunior Certificate or similar (includes
Intermediate/Group/Ordinary Levels/General Certificate of Secondary Education or equivalent) = 7 individuals; *Unspecified (did
not answer) = 45 individuals
**Spouse/Partner: Parent/Guardian: Primary/Bachelor’s degree = 29 individuals; Postgraduate/Higher degree = 22 individuals;
Diploma/Certificate = 15 individuals; ˢLeaving Certificate or similar (includes Advanced Levels/General Certificate of Education
Advanced) = 14 individuals; ˣJunior Certificate or similar (includes Intermediate/Group/Ordinary Levels/General Certificate of
Secondary Education or equivalent) = 19 individuals; Primary Education or less = 3 individuals *Unspecified (did not answer) = 66
individuals

Figure 1.A.6: Highest level of education indicated by parents who reported their
child/adolescent to have MDFA in a survey conducted between November 2019 and
June 2020, in NI (<18 years, n = 168)
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Employment status indicated by parents of children and adolescents reported as
having MDFA in Ireland(n=258) and NI (n=168)
Percentage of Parent/Guardian
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2% 0.5% 0.5% 0.5%

0%
Full-time

Part-time

Self-employed

On disability
allowance

Student

Unspecified

Employment Status

*Associated number of parents who reported their employment status: Parent/Guardian: Full-time = 57 individuals; Part-time = 36
individuals; Homemaker = 24 individuals; Unemployed = 10 individuals; Self-employed = 8 individuals; On disability allowance =
5 individuals; Student = 1 individual; *Unspecified (did not answer) = 117 individuals
**Spouse/Partner: Full-time = 97 individuals; Part-time = 9 individuals; Homemaker = 1 individuals; Unemployed = 2 individuals;
Self-employed = 12 individuals; On disability allowance = 2 individuals; Student = 1 individual; *Unspecified (did not answer) =
134 individuals

Figure 1.A.7: Employment status recorded by parents who reported their
child/adolescent to have MDFA in a survey conducted between November 2019 and
June 2020, in Ireland (<18 years, n = 258)
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Employment Status
*Associated number of parents who reported their employment status: Parent/Guardian: Part-time = 52 individuals; Full-time = 39
individuals; Homemaker = 14 individuals; Self-employed = 6 individual; Unemployed = 7 individuals; Student = 2 individuals;
Retired = 1 individuals; Volunteer = 2 individuals; *Unspecified (did not answer) = 45 individuals
**Spouse/Partner: Spouse/Partner: Part-time = 1 individuals; Full-time = 77 individuals; Homemaker = 1 individuals; Selfemployed = 17 individual; Unemployed = 2 individuals; Student = 2 individuals; On disability allowance = 1 individuals;
*Unspecified (did not answer) = 67 individuals

Figure 1.A.8: Employment status recorded by parents who reported their
child/adolescent to have MDFA in a survey conducted between November 2019 and
June 2020, in NI (<18 years, n = 168)
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Geographical location indicated by parents reporting their child/adolescent to have
MDFA in Ireland(n=258) and NI (n=168)
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35%
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23%
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0%
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Unspecified*

Geographical location
*Associated number of parents who reported their living settlement: Urban = 82 individuals; Rural = 59 individuals; *Unspecified
(did not answer) = 117 individuals

Figure 1.A.9: Percentage of parents of children and adolescents reported with
MDFA in a survey conducted between November 2019 and June 2020, living in
Urban and Rural settings in Ireland (<18 years, n = 258)
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Geographical Location
*Associated number of parents who reported their living settlement: Urban = 74 individuals; Rural = 50 individuals; *Unspecified
(did not answer) = 44 individuals

Figure 1.A.10: Percentage of parents of children and adolescents reported with
MDFA in a survey conducted between November 2019 and June 2020, living in
Urban and Rural settings in NI (<18 years, n = 168)

413

Combined Monthly income range (after tax deductions) recorded by parents of
children with MDFA in Ireland (n=258) and NI (n=168)
60%
50%

Percentage

50%
40%
28%

30%

22%
20%
10%
0%
Under 1,000 to 3,500

3,501 to 8,0001 or more

Unspecified*

Combined Household Income Per Month
*Associated number of parents who reported their combined monthly income range (after tax deductions): Under 1,000 to 3,500 =
58 individuals; 3,501 to 8,0001 or more = 72 individuals; *Unspecified (did not answer) = 128 individuals

Figure 1.A.11: Percentage of combined monthly income range (after tax deductions)
earned by both Parents reporting their child to have MDFA in a survey conducted
between November 2019 and June 2020, in Ireland (< 18 years, n = 258)
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Combined Household Income Per Month
*Associated number of parents who reported their combined monthly income range (after tax deductions): Under 1,000 to 3,500 =
65 individuals; 3,501 to 8,0001 or more = 45 individuals; *Unspecified (did not answer) = 58 individuals

Figure 1.A.12: Percentage of combined monthly income range (after tax deductions)
earned by both Parents reporting their child to have MDFA in a survey conducted
between November 2019 and June 2020, in the NI (< 18 years, n = 168)
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Additional long-term illness, health problems, or disabilities other than food allergy
or intolerance of children and adolescents indicated by parents of children and
adolescents reported with MDFA in Ireland(n=258) and NI (n=168)
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74%

70%
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Percentage
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40%
26%

30%
20%

10%
0%

No

Yes

Long-term illness, health problems, or disabilities
*Associated number of children and adolescents whose parents indicated additional long-term illness, health problems, or
disabilities other than food allergy or intolerance: No = 190 individuals; Yes = 68 individuals

Figure 1.A.13: Percentage of parents who reported additional long-term illness,
health problems, or disabilities (other than food allergy or intolerance) in their
child/adolescent in a survey conducted between November 2019 and June 2020, in
Ireland (<18 years, n = 258)
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Long-term illness, health problems, or disabilities other than food
allergy or intolerance
*Associated number of children and adolescents whose parents indicated additional long-term illness, health problems, or
disabilities other than food allergy or intolerance: No = 128 individuals; Yes = 39 individuals: Unspecified = 1 individual

Figure 1.A.14: Percentage of parents who reported additional long-term illness,
health problems, or disabilities (other than food allergy or intolerance) in their
child/adolescent in a survey conducted between November 2019 and June 2020, in
NI (<18 years, n = 168)
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Confirmation of Private medical insurance indicated by parents of children and
adolescents reported with MDFA in Ireland(n=258) and NI (n=168)
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Private Medical Insurance
*Associated number of parents who reported to have a private medical insurance for their child/adolescent: Yes = 93 individuals;
No = 62 individuals; *Unspecified (did not answer): 103 individuals.

Figure 1.A.15: Percentage of parents reporting their child/adolescent to have MDFA
who indicated that they pay for private medical insurance in a survey conducted
between November 2019 and June 2020, in Ireland (<18 years, n = 258)

70%

64%

60%
50%

Percentage

40%
30%
16%

20%

20%

10%
0%
No

Yes

Unspecified*

Private Medical Insurance
*Associated number of parents who reported to have a private medical insurance for their child/adolescent: No = 107 individuals;
Yes = 27 individuals; *Unspecified (did not answer) = 34 individuals

Figure 1.A.16: Percentage of parents reporting their child/adolescent to have MDFA
who indicated that they pay for private medical insurance in a survey conducted
between November 2019 and June 2020, in NI (<18 years, n = 168)
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Reported MDFA indicated by parents of children reported with MDFA in Ireland (n=218)
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MDFA in Children in Ireland
*Associated number of children who suffer from food allergies to these foodstuffs: Peanuts = 134 individuals; Other nuts = 10 7
individuals; Eggs = 99 individuals; Milk = 77 individuals; Fish = 25 individuals; Sesame seeds = 22 individuals; Soybeans = 19
individuals; Crustaceans = 9 individuals; Cereals containing gluten = 7 individuals; Molluscs = 6 individuals; Lupins = 7
individuals; Sulphur dioxide & sulphites = 4 individuals; Mustard = 2 individuals; Celery = 1 individuals; Meat or poultry = 4
individuals; Kiwi = 11 individuals; Other Fruits = 22 individuals; Other Foods = 17 individuals
**Breakdown of MDFA to:
°Other Nuts (n=107) = All tree nuts (n=33); Nuts (unspecified, n=20), Cashews (n=27); Pistachio nuts (n=17); Almonds (n=5);
Walnuts (n=19); Hazelnuts (n=22); Pecan nuts (n=11); Brazil nuts (n=6)
˟Other Fruits (n=22) = Fruits (unspecified, n=8); Bananas (n=4); Coconut (n=3); Apples (n=2); Strawberries (n=2); Stone fruits (n=1);
Citrus fruits (n=1); Watermelon (n=1); Melon (n=1); Grapes (n=1)
˟˟Other Foods (n=17) = Potatoes (n=1), Sweet potatoes (n=1); Peas (n=7); Chickpeas (n=4); Lentils (n=3); Beans (n=2); Oats (n=2 );
Pumpkin seeds (n=2); Sunflower seeds (n=2); Cinnamon (n=1); Food additives (n=1)

Figure 1.A.17: MDFA indicated by parents reporting their child to have MDFA in
a survey conducted between November 2019 and June 2020, in Ireland (0 to 12
years, n=218)
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Reported Additional FI indicated by parents of children reported with MDFA in
Ireland (n=218)
Table 1.A.1: Additional FI indicated by parents reporting their child to have MDFA
in a survey conducted between November 2019 and June 2020, in Ireland (0 to 12
years, n=218)
Additional Food Intolerances, Suspected, or NonMDFA

Children (n=218)

Children (%)

Other Fruits˟

29

13%

Cereals containing gluten

20

9%

Soybeans

18

8%

Milk

16

7%

Meat or poultry

14

6%

Fish

13

6%

Sesame seeds

13

6%

Sulphur dioxide and sulphites

13

6%

Eggs

12

6%

Other Foods˟˟

12

6%

Celery

11

5%

Crustaceans

11

5%

Molluscs

10

5%

Lupins

9

4%

Mustard

9

4%

Peanuts

9

4%

Kiwi

5

2%

Other Nuts°

3

1%

*Breakdown of additional food intolerances, suspected, or non-MDFA to:
°Other nuts (n=3) = Nuts (unspecified, n=2), Hazelnuts (n=1); Almonds (n=1)
˟Other Fruits (n=29) = Fruits (unspecified, n=9); Bananas (n=5); Tomatoes (n=5); Oranges (n=5); Coconut (n=4); Apples (n=3);
Pears (n=2); Strawberries (n=1); Raspberries (n=1); Berries (n=1); Melon (n=1); Corn (n=1); Watermelon (n=1); Mangoes (n=1);
Citrus fruits (n=1); Lemon (n=1)
˟˟Other Foods (n=12) = Mushrooms (n=1); Food additives (food colouring, sweeteners; n=2); Legumes (n=3); Peas (n=2); Potatoes
(n=1); Sweet potatoes (n=2); Broccoli (n=1); Carrots (n=1); Rapeseed oil (n=1); Palm kernel (n=1); Sweets (n=1); Caramel (n=1)
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Reported MDFA indicated by parents of adolescents reported with MDFA in
Ireland (n=40)
Peanuts
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MDFA in Adolescents in Ireland
*Associated number of adolescents who suffer from food allergies to these foodstuffs Peanuts = 24 individuals; Other nuts = 20
individuals; Eggs = 14 individuals; Milk = 10 individuals; Fish = 5 individuals; Cereals containing gluten = 4 individuals; Sesame
seeds = 1 individual; Soy beans = 3 individuals; Crustaceans = 1 individual; Molluscs = none; Lupins = none; Sulphur dioxide &
sulphites = none; Mustard = 1 individual; Celery = 1 individual; Meat or poultry = none; Kiwi = 1 individual; Other Fruits = 4
individuals; Other Foods = 2 individuals
**Breakdown of MDFA to:
°Other nuts (n=20) = Nuts (unspecified, n=4); Walnuts (n=4); Almonds (n=2); Cashews (n=3); Hazelnuts (n=8); All tree nuts (n=1);
Pistachio nuts (n=1); Pecan nuts (n=2); Brazil nuts (n=1)
˟Other fruits (n=4) = Pineapples (n=2); Strawberries (n=2); Apples (n=1); Banana (n=1); Pears (n=1); Peach (n=1); Apricot (n=1);
Nectarines (n=1); Citrus (unspecified, n=1)
˟˟Other foods (n=2) = Paprika (n=1); Peas (n=1)

Figure 1.A.18: MDFA indicated by parents reporting their child to have MDFA in
a survey conducted between November 2019 and June 2020, in Ireland (13 to 17
years, n=40)
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Reported Additional FI indicated by parents of adolescents reported with MDFA in
Ireland (n=40)
Table 1.A.2: Additional Food Intolerances, Suspected, or Non-MDFA indicated by
parents reporting their child to have MDFA in a survey conducted between
November 2019 and June 2020, in Ireland (13 to 17 years, n=40)
Additional Food Intolerances, Suspected, or NonMDFA

Adolescents (n=40)

Adolescents
(%)

Other Fruits˟

4

10%

Eggs

3

8%

Crustaceans

2

5%

Milk

2

5%

Molluscs

2

5%

Sulphur dioxide and sulphites

2

5%

Cereals containing gluten

2

5%

Kiwi

1

3%

Other Nuts°

1

3%

Celery

0

0%

Fish

0

0%

Other Foods

0

0%

Lupins

0

0%

Meat or poultry

0

0%

Mustard

0

0%

Peanuts

0

0%

Sesame seeds

0

0%

Soybeans

0

0%

*Breakdown of additional food intolerances, suspected, or non-MDFA to:
°Other Nuts (n=1) = All tree nuts (n=1)
˟Other Fruits (n=4) = Apples (n=3); Avocados (n=1)
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Percentage

Reported MDFA indicated by parents of children reported with MDFA in NI
(n=145)
Peanuts
Other Nuts
Eggs
Milk
Fish
Sesame seeds
Soy beans
Crustaceans
Cereals containing gluten
Molluscs
Lupins
Sulphur dioxide and sulphites
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Celery
Meat or poultry
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Other Fruits
Other Foods

37%
19%
36%
60%
9%
4%
14%
1%
3%
1%
3%
2%
2%
2%
2%
2%
12%
9%
0%

10%

20%

30%

40%

50%

60%

70%

MDFA in Children in NI
*Associated number of children who suffer from food allergies to these foodstuffs: Peanuts = 53 individuals; Other nuts = 28
individuals; Eggs = 52 individuals; Milk = 87 individuals; Fish = 13 individuals; Sesame seeds = 6 individuals; Soybeans = 20
individuals; Crustaceans = 2 individuals; Cereals containing gluten = 5 individuals; Molluscs = 2 individuals; Lupins = 4
individuals; Sulphur dioxide & sulphites = 3 individuals; Mustard = 3 individuals; Celery = 3 individuals; Meat or poultry = 3
individuals; Kiwi = 3 individuals; Other Fruits = 17 individuals; Other Foods = 13 individuals
**Breakdown of MDFA to:
°Other nuts (n=28) = Walnuts (n=9); Hazelnuts (n=9); All tree nuts (n=8); Cashews (n=6); Pistachio nuts (n=5); Nuts (unspecified,
n=4); Almonds (n=4); Pecan nuts (n=4); Brazil nuts (n=4); Macadamia nuts (n=1)
˟Other Fruits (n=17) = Coconut (n=5); Tomatoes (n=4); Corn (n=2); Pineapples (n=2); Peach (n=2); Bananas (n=2); Pears (n=2);
Strawberries (n=2); Blackberries (n=1); Raspberries (n=1); Berries (n=1); Citrus (n=1); Grapes (n=1); Melon (n=1); Fruit (unspecified,
n=1)
˟˟Other Foods (n=13) = Legumes (n=3); Rice (n=3); Pepper (n=3); Garlic (n=2); Onion (n=1); Oats (n=2); Beans (n=1); Sorbitol
(n=1); Potatoes (n=1); Sweet potatoes (n=1); Chickpeas (n=1); Peas (n=1); Rapeseed oil (n=1); Food additives (saccharin, n=1); Citric
acid (n=1)

Figure 1.A.19: MDFA indicated by parents reporting their child to have MDFA in
a survey conducted between November 2019 and June 2020, in NI (0 to 12 years,
n=145)
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Reported Additional FI indicated by parents of children reported with MDFA in NI
(n=145)

Table 1.A.3: Additional FI indicated by parents reporting their child to have MDFA
in a survey conducted between November 2019 and June 2020, in NI (0 to 12 years,
n=145)
Additional Food Intolerances, Suspected, or NonMDFA

Children
(n=145)

Children (%)

Cereals containing gluten

19

13%

Soybeans

11

8%

Eggs

10

7%

Milk

8

6%

Other Fruits˟

7

5%

Peanuts

5

3%

Meat or poultry

4

3%

Sesame seeds

4

3%

Molluscs

3

2%

Other Nuts°

3

2%

Other Foods˟˟

3

2%

Celery

2

1%

Crustaceans

2

1%

Fish

2

1%

Kiwi

2

1%

Lupins

2

1%

Mustard

2

1%

Sulphur dioxide and sulphites

1

1%

*Breakdown of additional food intolerances, suspected, or non-MDFA to:
°Other nuts (n=3) = Nuts (unspecified, n=3)
˟Other Fruits (n=7) = Bananas (n=2); Strawberries (n=2); Oranges (n=1); Corn (n=1); Raspberries (n=1); Coconut (n=1)
˟˟Other Foods (n=3) = Broccoli (n=1); Legumes (n=1)
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Percentage

Reported MDFA indicated by parents of adolescents reported with MDFA in NI (n=23)
Peanuts
Other Nuts
Eggs
Milk
Fish
Cereals containing gluten
Sesame seeds
Soy beans
Crustaceans
Molluscs
Lupins
Sulphur dioxide and sulphites
Mustard
Celery
Meat or poultry
Kiwi
Other Fruits
Other Foods

52%
30%

17%
22%
17%
13%
9%
9%

13%

4%
13%
4%
4%
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10%

20%
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40%

50%

60%

MDFA in Adolescents in NI
*Associated number of adolescents who suffer from food allergies to these foodstuffs: Peanuts = 12 individuals; Other nuts = 7
individuals; Eggs = 4 individuals; Milk = 5 individuals; Fish = 4 individuals; Cereals containing gluten = none; Sesame seeds = 3
individuals; Soybeans = 2 individuals; Crustaceans = 2 individuals; Molluscs = 3 individuals; Lupins = none; Sulphur dioxide &
sulphites = none; Mustard = none; Celery = 1 individual; Meat or poultry = none; Kiwi = 3 individuals; Other Fruits = 1 indiv idual;
Other Foods = 1 individual
**Breakdown of MDFA to:
°Other nuts (n=7) = All tree nuts (n=4); Nuts (unspecified, n=2), Cashews (n=1); Hazelnuts (n=1); Almonds (n=1); Brazil nuts (n=1);
Pine nuts (n=1); Pistachio nuts (n=1)
˟Other fruits (n=1) = Strawberry (n=1)
˟˟Other foods (n=1) = Chillies (n=1)

Figure 1.A.20: MDFA indicated by parents reporting their child to have MDFA in
a survey conducted between November 2019 and June 2020, in NI (13 to 17 years,
n=23)
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Reported Additional FI indicated by parents of adolescents reported with MDFA in
NI (n=23)
Table 1.A.4: Additional FI indicated by parents reporting their child to have MDFA
in a survey conducted between November 2019 and June 2020, in NI (13 to 17 years,
n=23)
Additional Food Intolerances, Suspected, or NonMDFA

Adolescents
(n=23)

Adolescents
(%)

Cereals containing gluten

3

13%

Other Fruits˟

2

9%

Kiwi

2

9%

Milk

2

9%

Other Nuts°

2

9%

Soybeans

2

9%

Celery

1

4%

Eggs

1

4%

Fish

1

4%

Other Foods˟˟

1

4%

Lupins

1

4%

Meat or poultry

1

4%

Mustard

1

4%

Sesame seeds

1

4%

Sulphur dioxide and sulphites

1

4%

Crustaceans

0

0%

Molluscs

0

0%

Peanuts

0

0%

*Breakdown of additional food intolerances, suspected, or non-MDFA to:
°Other Nuts (n=2) = All tree nuts (n=1); Hazelnuts (n=1)
˟Other Fruits (n=2) = Pineapple (n=1); Apple (n=1)
˟˟Other Foods (n=1) = Legumes (n-1); Lentils (n=1)
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Additional Food Hypersensitivities indicated by parents of children and adolescents
reported with MDFA in Ireland (n=258) and NI (n=168)
Table 1.A.5: Additional food hypersensitivities recorded by parents reporting their
child/adolescent to have MDFA in a survey conducted between November 2019 and
June 2020, in Ireland (<18 years, n = 258)
Additional food hypersensitivities

N

%

Food Intolerance

6

2.3%

Medically diagnosed coeliac disease & Food Intolerance

6

2.3%

Total

12

4.6%

Table 1.A.6: Additional food hypersensitivities recorded by parents reporting their
child/adolescent to have MDFA in a survey conducted between November 2019 and
June 2020, in NI (<18 years, n = 168)
Additional food hypersensitivities

N

%

Food Intolerance

34

20%
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Age category of as indicated by parents of children and adolescents reported with
MDFA in Ireland (n=258) and NI (n=168)
70%
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6-12

13-17

Reported age when diagnosed with food allergy
*Associated number of parents who reported their child to be MDFA at the following age groups: Below 1 year = 69 individuals; 1
– 5 years = 163 individuals; 6 – 12 years = 23 individuals; 13 – 17 years = 3 individuals

Figure 1.A.21: Age category of diagnosis (by a medical professional) indicated by
parents reporting their child/adolescent to have MDFA in a survey conducted
between November 2019 and June 2020, in Ireland (< 18 years, n = 258)
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Reported age when diagnosed with food allergy
*Associated number of parents who reported their child to be MDFA at the following age groups: Below 1 year = 71 individuals; 1
– 5 years = 83 individuals; 6 – 12 years = 11 individuals; 13 – 17 years = 3 individuals

Figure 1.A.22: Age category of diagnosis (by a medical professional) indicated by
parents reporting their child/adolescent to have MDFA in a survey conducted
between November 2019 and June 2020, in NI (< 18 years, n = 168)
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Food allergy testing indicated by parents of children and adolescents reported with
MDFA in Ireland(n=258)
1 test

8%

2 tests

21%

3 tests
4 tests
30%

41%

*Associated number of parents who reported single and multiple number of food allergy tests carried out on their child: 1 test = 54
individuals; 2 tests = 106 individuals; 3 tests = 78 individuals; 4 tests = 20 individuals

Figure 1.A.23: Percentage of reported number of food allergy tests indicated by
parents reporting their child/adolescent to have MDFA in a survey conducted
between November 2019 and June 2020, in Ireland (< 18 years, n = 258)
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Food Allergy Tests
*HSE/NHS approved testfor MDFA (1-4): Blood test = 206 individuals (80%); Skin prick test = 205 individuals (79%); Food oral
challenge = 101 individuals (39%); Trial elimination diet = 64 individuals (25%)
**Many sufferers were diagnosed by more than one test as per Figure 1.A.23

Figure 1.A.24: Frequency of food allergy test used for diagnosis* (HSE/NHS
recommended tests) of MDFA, reported by parents of children and adolescents
suffering from MDFA in a survey conducted between November 2019 and June
2020, in Ireland (< 18 years, n = 258)
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Food allergy testing indicated by parents of children and adolescents reported with
MDFA in NI (n=168)
1 test
9%
2 tests
26%
3 tests
19%

4 tests

46%
*Associated number of parents who reported single and multiple number of food allergy tests carried out on their child: 1 test = 43
individuals; 2 tests = 78 individuals; 3 tests = 32 individuals; 4 tests = 15 individuals

Number of Children & Adolescents

Figure 1.A.25: Percentage of reported number of food allergy tests indicated by
parents reporting their child/adolescent to have MDFA in a survey conducted
between November 2019 and June 2020, in NI (< 18 years, n = 168)
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*HSE/NHS approved test for MDFA (1-4): Blood test = 97 individuals (58%); Skin prick test = 120 individuals (71%); Trial
elimination diet = 74 individuals (44%); Food oral challenge = 64 individuals (38%)
**Many sufferers were diagnosed by more than one test as per Figure 1.A.25

Figure 1.A.26: Frequency of food allergy test used for diagnosis* (HSE/NHS
recommended tests) of MDFA, reported by parents of children and adolescents
suffering from MDFA in a survey conducted between November 2019 and June
2020, in NI (< 18 years, n = 168)
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Healthcare professional diagnosis indicated by parents of children and adolescents
reported with MDFA in Ireland (n = 258)
4.5% 0.5%

1 healthcare professional
2 healthcare professionals

24%

3 healthcare professionals
Unspecified*

71%

*Associated number of parents of children who reported the number of healthcare professionals which diagnosed the child’s foo d
allergies:
1 healthcare professional= 184 individuals; 2 healthcare professionals = 62 individuals; 3 healthcare professionals = 11 individuals;
*Unspecified (No. of individuals who did not specify which healthcare professional) = 1 individual

Figure 1.A.27: Percentage of reported number of healthcare professionals involved
in food allergy diagnosis* of children and adolescents with MDFA in a survey
conducted between November 2019 and June 2020, in Ireland (< 18 years, n = 258)
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*Associated number of parents of children who reported the number of healthcare professionals involved in their child’s food
allergies diagnosis; by healthcare professionals or following/during hospital admission or attendance: Consultant out-patient clinic =
194 individuals (75%); Following/during hospital admission = 78 individuals (30%); Family doctor (GP) = 69 individuals (27%);
Dietitian = 3 individuals (1%);
**Many sufferers were diagnosed by more than one healthcare professional as per Figure 1.A.27

Figure 1.A.28: Healthcare professionals involved in diagnosis of children and
adolescents with MDFA reported by parents in a survey conducted between
November 2019 and June 2020, in Ireland (< 18 years, n = 258)
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Healthcare professional diagnosis indicated by parents of children and adolescents
reported with MDFA in NI (n=168)
7%

1%
1 healthcare professional
2 healthcare professionals
3 healthcare professionals

27%

Unspecified*

65%

*Associated number of parents of children who reported the number of healthcare professionals which diagnosed the child’s foo d
allergies:
1 healthcare professional= 109 individuals; 2 healthcare professionals = 45 individuals; 3 healthcare professionals =11 individuals;
*Unspecified (No. of individuals who did not specify which healthcare professional) = 3 individuals

Figure 1.A.29: Percentage of reported number of healthcare professionals involved
in food allergy diagnosis* of children and adolescents with MDFA in a survey
conducted between November 2019 and June 2020, in NI (< 18 years, n = 168)
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*Associated number of parents of children who reported the number of healthcare professionals involved in their child’s food
allergies diagnosis; by healthcare professionals or following/during hospital admission or attendance: Consultant out-patient clinic =
120 individuals (71%); Family doctor (GP) = 56 individuals (33%); Following/during hospital admission = 45 individuals (27%);
Health Visitor = 6 individuals (4%); Dietitian = 6 individuals (4%)
**Many sufferers were diagnosed by more than one healthcare professional as per Figure 1.A.29

Figure 1.A.30: Healthcare professionals involved in diagnosis of children and
adolescents with MDFA reported by parents in a survey conducted between
November 2019 and June 2020, in NI (< 18 years, n = 168)
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Food allergy classification as indicated by parents of children and adolescents
reported with MDFA in Ireland(n=258) and NI (n=168)
IgE-mediated
Mixed IgE and non-IgE-mediated
26.5%

Non-IgE-mediated

Unspecified*

58%
10%

5.5%

*Associated number of parents of children who reported their child’s classification of food allergy diagnosis: IgE-mediated = 68
individuals; Mixed IgE and non-IgE-mediated = 26 individuals; Non-IgE-mediated = 14 individuals; *Unspecified (did not answer)
= 150 individuals

Figure 1.A.31: Food allergy classification as indicated by parents reporting their
child/adolescent to have MDFA in a survey conducted between November 2019 and
June 2020, in Ireland (< 18 years, n = 258)

IgE-mediated
17%
Mixed IgE and non-IgEmediated
Non-IgE-mediated
15%

Unspecified*

55%

13%

*Associated number of parents of children who reported their child’s classification of food allergy diagnosis: IgE-mediated = 29
individuals; Mixed IgE and non-IgE-mediated = 26 individuals; Non-IgE-mediated = 21 individuals; *Unspecified (did not answer)
= 92 individuals

Figure 1.A.32: Food allergy classification as indicated by parents reporting their
child/adolescent to have MDFA in a survey conducted between November 2019 and
June 2020, in NI (< 18 years, n = 168)
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Reported food allergens associated with food allergy classification as indicated by
parents of children and adolescents reported with MDFA in Ireland(n=258)
Table 1.A.7: Reported food allergens associated with each classification as indicated
by parents reporting their child/adolescent to have MDFA in a survey conducted
between November 2019 and June 2020, in Ireland (<18 years, n = 258)
Food allergens
associated with
food
allergy
classification

IgEmediated

%

Non-IgEmediated

%

Mixed IgE
and nonIgEmediated

%

Unspecified

%

Peanuts

43

17%

1

0.4%

18

7%

96

37%

Other nuts

37

14%

0

0%

13

5%

77

30%

Eggs

29

11%

2

1%

20

8%

62

24%

Milk

22

9%

13

5%

23

9%

29

11%

Sesame seeds

8

3%

0

0%

3

1%

12

5%

Other Fruits

8

3%

0

0%

9

3%

9

3%

Fish

6

2%

0

0%

5

2%

19

7%

Other Foods

5

2%

0

0%

3

1%

11

4%

Cereals*

2

1%

0

0%

5

2%

8

3%

Lupins

2

1%

0

0%

1

0.4%

4

2%

Kiwi

2

1%

0

0%

3

1%

7

3%

Soybeans

1

0.4%

2

1%

10

4%

9

3%

Meat or poultry

1

0.4%

1

0.4%

1

0.4%

1

0.4%

Mustard

1

0.4%

0

0%

1

0.4%

0

0%

Celery

1

0.4%

0

0%

1

0.4%

0

0%

Crustaceans

0

0%

0

0%

3

1%

7

3%

Molluscs

0

0%

0

0%

2

1%

4

2%

*Cereals containing gluten
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Reported food allergens associated with food allergy classification as indicated by
parents of children and adolescents reported with MDFA in NI (n=168)
Table 1.A.8: Reported food allergens associated with each classification as indicated
by parents reporting their child/adolescent to have MDFA in a survey conducted
between November 2019 and June 2020, in NI (<18 years, n = 168)
Food allergens
associated with
food
allergy
classification

IgEmediated

%

Non-IgEmediated

%

Mixed IgE
and NonIgEmediated

%

Unspecified

%

Peanuts

16

10%

0

0%

8

5%

41

24%

Eggs

10

6%

7

4%

16

10%

23

14%

Other nuts

9

5%

0

0%

4

2%

22

13%

Milk

9

5%

20

12%

21

13%

42

25%

Kiwi

4

2%

2

1%

0

0%

1

0.6%

Fish

3

2%

2

1%

4

2%

8

5%

Sesame seeds

2

1%

0

0%

2

1%

5

3%

Other Fruits

2

1%

2

1%

7

4%

7

4%

Soybeans

1

0.6%

8

5%

8

5%

5

3%

Other Foods

0

0%

3

2%

3

2%

8

5%

Cereals

0

0%

3

2%

5

3%

6

4%

Lupins

0

0%

1

0.6%

2

1%

1

0.6%

Mustard

0

0%

1

0.6%

2

1%

0

0%

Celery

0

0%

1

0.6%

2

1%

1

0.6%

Crustaceans

0

0%

1

0.6%

1

0.6%

2

1%

Molluscs

0

0%

1

0.6%

2

1%

2

1%

Meat or poultry

0

0%

2

1%

1

0.6%

1

0.6%

*Cereals containing gluten
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Number of additional household members with MDFA indicated by parents of
children and adolescents who were reported to have MDFA in Ireland(n=258) and
NI (n=168)
2%

8%
1 household member
2 household members

12%

3 household members
Unspecified*

78%

*Associated number of parents who reported number of household members with MDFA: 1 household member (the
child/adolescent reported to be MDFA) = 200 individuals; 2 household members = 32 individuals; 3 plus household members = 6
individuals; *Unspecified (did not answer) = 20 individuals

Figure 1.A.33: Additional household members recorded as suffering with MDFA in
a survey conducted between November 2019 and June 2020, in Ireland (< 18 years,
n = 258)

1 household member

1% 6%

2 household members
16%
3 household members
Unspecified*

77%

*Associated number of parents who reported number of household members with MDFA: 1 household member (the
child/adolescent reported to be MDFA) = 129 individuals; 2 household members = 27 individuals; 3 household members = 2
individuals; *Unspecified (did not answer) = 10 individuals

Figure 1.A.34: Additional household members recorded as suffering with MDFA in
a survey conducted between November 2019 and June 2020, in NI (< 18 years, n =
168)
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Prescribed medications indicated by parents of children and adolescents with
MDFA in Ireland(n=258) and NI (n=168)
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adolescents
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Other*

Prescribed medications
*Other = Inhaler (n=11); Prescribed milk formula (n=4); Acid reflux medication (n=2)
**Associated number of parents of children who reported their child’s prescribed medications for MDFA: Adrenaline (epinephrine)
auto-injectors = 210 individuals (81%); Antihistamines = 190 individuals (74%); CorticosteRoIds (prescribed to treat symptoms of
food allergy) = 61 individuals (24%), Other* = 19 individuals (6%)

Number of Children &
Adolescents

Figure 1.A.35: Prescribed medications indicated by parents reporting their
child/adolescent to have MDFA in a survey conducted between November 2019 and
June 2020, in Ireland (< 18 years, n = 258)
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injectors
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allergy)

15
Other*

Prescribed medications
*Other = Inhaler (n=6); Prescribed milk formula (n=5); Acid reflux medication (n=2); Nausea medication (n=2)
**Associated number of parents of children who reported their child’s prescribed medications for MDFA: Antihistamines = 124
individuals (74%); Adrenaline (epinephrine) auto-injectors = 88 individuals (52%); CorticosteRoIds (prescribed to treat symptoms
of food allergy) = 22 individuals (13%), Other* = 15 individuals (9%)

Figure 1.A.36: Prescribed medications indicated by parents reporting their
child/adolescent to have MDFA in a survey conducted between November 2019 and
June 2020, in NI (< 18 years, n = 168)
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Number of Children and Adolescents

Reported Anaphylactic reactions over a 12-month timeframe as indicated by
parents of children and adolescents reported with MDFA in Ireland(n=258) and NI
(n=168)
30
25

1 time
24
2 times

20
Unspecified no. of anaphylactic
reactions

15
10
5

1

1

2 times

Unspecified no. of
anaphylactic reactions

0
1 time

Reported number of anaphylactic reactions
*Associated number of parents of children who reported an anaphylactic episode experienced by their child as a result of a fo od
allergen/s in the last 12 months: 1 time = 24 individuals (9%); 2 times = 1 individual (0.4%); History of anaphylaxis reported, but
exact number of incidence of the last 12 months not recorded by the respondent = 1 individual (0.4%)

Figure 1.A.37: No. of anaphylactic reactions over a 12-month timeframe (last 12months) as indicated by parents reporting their child/adolescent to have MDFA in
a survey conducted between November 2019 and June 2020 in Ireland (< 18 years,
n = 258)
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*Associated number of parents of children who reported an anaphylactic episode experienced by their child as a result of a food
allergen/s in the last 12 months: 1 time = 11 individuals (7%); 2 times = 6 individuals (4%); History of anaphylaxis reported, but
exact number of incidences of the last 12 months not recorded by the respondent = 1 individual (0.6%)

Figure 1.A.38: No. of anaphylactic reactions over a 12-month timeframe (last 12months) as indicated by parents reporting their child/adolescent to have MDFA in
a survey conducted between November 2019 and June 2020 in NI (< 18 years, n =
168)

437

Reported food allergens associated with anaphylactic reactions over a 12-month
timeframe as indicated by parents of children and adolescents reported with MDFA
in Ireland (n=258) and NI (n=168)
Table 1.A.9: Reported food allergens associated with anaphylactic reactions over a
12-month timeframe (last 12-months) as indicated by parents reporting their
child/adolescent to have MDFA in a survey conducted between November 2019 and
June 2020 in Ireland (<18 years, n = 258)
Reported food allergens
anaphylactic reactions

associated

with

Ireland Parental
(n=258)

Parental (%)

Peanuts

18

7%

Other nuts°

17

7%

Eggs

13

5%

Milk

6

2%

Lupins

6

2.3%

Fish

5

2%

Sesame seeds

4

1.6%

Cereals containing gluten

2

1%

Soybeans

2

0.8%

Mustard

1

0.4%

Celery

1

0.4%

Crustaceans

1

0.4%

Molluscs

1

0.4%

Sulphur dioxide and sulphites

1

0.4%

Other Fruits ˟

3

1.2%

Kiwi

1

0.4%

Meat or poultry

1

0.4%

Other Foods

2

1%

°Other Nuts (n=17) = Nuts (unspecified, n=8); Hazelnuts (n=5); Walnuts (n=5); Cashews (n=4); Brazil nuts (n=3); ; Pecan nuts
(n=2); Almonds (n=1); Pistachios (n=1)
ˣOther Fruits (n=3) = Coconut (n=1); Stone fruit (n=1)
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Table 1.A.10: Reported food allergens associated with anaphylactic reactions over
a 12-month timeframe (last 12-months) as indicated by parents reporting their
child/adolescent to have MDFA in a survey conducted between November 2019 and
June 2020 in NI (<18 years, n = 168)
Reported food allergens associated with anaphylactic
reactions

NI Parental
(n=168)

Parental
(%)

Eggs

11

7%

Peanuts

9

5%

Milk

6

4%

Other nuts°

6

4%

Sesame seeds

4

2%

Fish

4

2%

Soybeans

3

1.8%

Mustard

1

0.6%

Celery

1

0.6%

Crustaceans

1

0.6%

Molluscs

1

0.6%

Lupins

2

1%

Cereals containing gluten

1

0.6%

Other Fruits˟

3

1.8%

°Other Nuts (n=6) = All nuts (n=2); Cashews (n=3); Hazelnuts (n=3); Pistachio (n=2), Almonds (n=2); Brazil nuts (n=2); Walnuts
(n=1); Pecan nuts (n=1); Macadamia nuts (n=1); Pinenuts (n=1)
ˣOther Fruits (n=3) = Corn (n=1); Tomatoes (n=1); Strawberries (n=1)
ˣˣOther Foods (n=2) = Peas (n=1); Chillies (n=1)
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Appendix 2: MDFA Adult Surveys
General analysis and summary information of adults (≥18 years of age) who
reported to be MDFA in a survey conducted between November 2019 and June
2020, in Ireland and NI
2.1 Main findings of the survey of adults with MDFA in Ireland (194 respondents)
1. Background information on the respondents:
•

54% (n=105) of all respondents reported to be in the 18-29 years category (51%
females & 3% males). In fact, 77% (n=150) of all respondents reported to be
aged between 18-39 years (females 72% & males 5%), with 23% (n=44) being ≥
40 years (19% females and 4% males).

•

Approximately 91% (n=178) of respondents reported to be female and 9% male
(n=16) of the respondents reporting to be medically diagnosed with a food allergy
(MDFA) inIreland.

•

The majority 77% (n=149) of the MDFA respondents reported to be Irish, 4.5%
(n=9) to be British (originally from Britain), 0.5% (n=1) originally from Northern
Irish and 18% from originally from elsewhere but are currently residing in
Ireland.

•

Approximately 51% (n=99) of the adults reported to be MDFA reported a third
level qualification as their highest qualification, and approximately 18% (n=34)
reported to have completed a second level qualification; with 31% (n=61) not
specifying their educational background.

•

41% (n=79) reported to be working either full-time (including self-employed) or
part-time, approximately 10.5% (n=21) not to be working, 17.5% (n=34) in
education; with 31% (n=60) not specifying their working status.
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•

The majority of respondents reported to be living in an urban setting 45% (n=88)
compared to 24% (n=46) in the rural area; with 31% (n=60) not specifying their
geographical location.

•

39% (n=76) of MDFA adults reported to be earning between <€1,000 and €3,500
(as an individual) per month, and approximately 6% (n=11) >€3,501, after tax
deductions; with 55% (n=107) not specifying their monthly income.

•

64% (n=124) of MDFA adults reported to have no additional long-term illness,
health problems, or disabilities other than food allergy or intolerance; with 36%
(n=70) indicating to the contrary.

•

43% (n=84) of MDFA adults reported to have a private medical insurance, with
33% (n=63) indicating they do not have a private medical insurance; with 24%
(n=47) did not specify whether they have private medical insurance.

2. Food Hypersensitivity information on the respondents:
•

Peanuts (36%, n=70), milk (34%, n=65), other nuts (24%, n=47), crustaceans
(19%, n=36), and eggs (18%, n= 34) were the most common food allergens
associated with MDFA reported by this cohort (see Figure 2.A.17 for the
breakdown of other nuts°).

•

Cereals containing gluten (34%, n=66), milk (19%, n=37), fruits (29%, n=29;
consisting of kiwi, n=6 and other fruits, n=23) and other foods (8%, n=16) were
the most common additional food intolerances, suspected, or non-medically
diagnosed food allergies reported by this cohort (see Table 2.A.1 for the
breakdown of other fruits˟ and other foods˟˟).
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•

49.5% (n=96) of all respondents reported to have additional food
hypersensitivities as well as being confirmed as MDFA to certain food/s. This
consisted of 47% (n=91) of the examined cohort reporting to have additional food
intolerances, and/or suspected, or undiagnosed food allergy, 1.5% (n=3) reporting
to have food intolerance and medically diagnosed coeliac disease, and 1% (n=2)
who reported to have medically diagnosed coeliac disease.

3. Information regarding Diagnosis of MDFA on the respondents:
•

81% (n=157) reported being diagnosed with MDFA before the age of 29 years of
age, however this result needs to be considered in line with the age demographic
of the respondents. The average age of the respondent in this study was found to
be 32 years for females and 31 years for males.

•

All of the respondents in the study were required to have been positively
diagnosed by at least one of the HSE/NHS recognised methods of testing1 by a
healthcare professional, as a specific inclusion criteria. However, with regard to
the number of tests per individual, 34% (n=66) reported to be diagnosed as MDFA
by one of HSE/NHS recognised tests1, 36% (n=70) by 2 tests, 23% (n=44) by 3
tests, and 7% (n=14) by 4 tests, respectively.

•

With regard to the frequency of tests used in the diagnosis of MDFA, 71%
(n=137) reported to having had a confirmatory blood test and 60% (n=116) a
positive skin prick test. While 46% (n=90) reported diagnosis via trial elimination
diet and 26% (n=51) by food oral challenge.

•

70% (n=135) of individuals reporting to be MDFA indicated that they had been
diagnosed by one healthcare professional, 19% (n=37) by 2, 7% (n=14) by 3. An
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additional, 4% (n=8) who reported to be diagnosed with a MDFA by a healthcare
professional, did not specify the exact number of healthcare professional involved
in their diagnosis.
•

Whether the survey respondent’s diagnosis occurred once or on multi occasions,
testing and diagnosis were reported to have been completed by medical consultant
by 55% (n=107) of respondents, family doctors (GP) by 52% (n=101), medical
doctors during a hospital admission by 21% (n=41) and 1% (n=2) reported to be
diagnosed by a dietitian only.

•

12% (n=24) of the adults who reported to be MDFA indicated they have IgEmediated food allergy, 6% (n=11) mixed IgE and non-IgE-mediated food allergy,
4% (n=8) have non-IgE-mediated food allergy, while 78% (n=151) did not
specify their food allergy classification.

•

Peanuts (7%, n=13), other nuts (4%, n=8) and crustaceans (4%, n=8) were the
most common food allergens associated with IgE-mediated food allergy reported
by this cohort (Table 2.A.5).

•

16% (n=31) of MDFA respondents reported that at least one other household
member has medically diagnosed food allergies. Notably, 11% (n=22) reported it
to be 2 additional household members, and 5% (n=9) reported it to be ≥3
additional household members; with 42% (n=82) not answering the question.

4. Information regarding medication, history of anaphylaxis over a 12-month
timeframe and reported food allergens associated with anaphylactic
reactions:
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•

Respondents reported that they were prescribed the following medications as a
result of their MDFA 59% (n=115) antihistamines, with 41% (n=79) adrenaline
(epinephrine) auto-injectors, 27% (n=53) corticosteroids, and 4% (n=8) ‘other
medications’ (including antispasmodics, inhalers, nasal sprays, asthma
medications, pharmacy creams, anti-vomiting medications, probiotics and
diarrhoea medications).

•

9.5% (n=18) of all respondents reported to have had anaphylactic reactions over
the 12-months prior to completing this survey, with 5% (n=9) reporting 1 episode,
and 5% (n=9) greater than >2 times. Notably, 1 individual reported 10 episodes,
and another 12 episodes over this period.

•

Peanuts (7%, n=13), other nuts (5%, n=10), crustaceans (5%, n=9) and molluscs
(4%, n=8) were the most common food allergens associated with anaphylactic
reactions over the 12-months reported by this cohort (Table 2.A.7).

1

HSE/NHS recognised tests for the diagnosis of food allergy: Skin prick testing, Blood tests, Trial elimination diet and Food oral
challenge: https://www.hse.ie/eng/health/az/a/allergy,-food/diagnosing-food-allergy-.html; https://www.nhs.uk/conditions/foodallergy/diagnosis/
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2.2 Main findings of the survey of adults with MDFA in Northern Ireland (124
respondents)
1. Background information on the respondents:
•

56% (n=69) of all respondents reported to be in the 18-29 years category (52%
females & 4% males). In fact, 76% (n=94) of all respondents reported to be aged
between 18-39 years (females 70.5% & males 5.5%), with 24% (n=30) being ≥
40 years (21.5% female and 2.5% male).

•

92% (n=114) of respondents reported to be female and 8% male (n=10) of the
respondents reporting to be medically diagnosed with a food allergy (MDFA) in
NI.

•

The majority 49% (n=61) of the MDFA respondents reported to be Northern Irish,
20% (n=25) to be British (originally from Britain), 24% (n=30) to be Irish, and
7% (n=8) originally from elsewhere but are currently residing in NI.

•

52% (n=65) of the MDFA respondents reported a third level qualification as their
highest qualification, and 18% (n=22) reported to have completed a second level
qualification; with 30% (n=37) not specifying their educational background.

•

44% (n=54) reported to be working either full-time (including self-employed) or
part-time, approximately 8% (n=11) not to be working, 18% (n=22) in education;
with 30% (n=37) not specifying their working status.

•

The majority of respondents reported to be living in an urban setting 44% (n=55)
compared to 30% (n=37) in the rural area; with an additional 26% (n=32) not
specifying their geographical location.

•

47% (n=58) of MDFA adults reported to be earning between <€1,000 and €3,500
(as an individual) per month and approximately 6% (n=8) >€3,501 (as an
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individual) after tax deductions; with 47% (n=58) not specifying their monthly
income.
•

69% (n=85) of MDFA adults reported to have no additional long-term illness,
health problems, or disabilities other than food allergy or intolerance; with
approximately 31% (n=39) indicating to the contrary.

•

18% (n=22) of MDFA adults reported to have a private medical insurance, with
61% (n=76) indicating they do not have a private medical insurance; with 21%
(n=26) did not specify whether they have private medical insurance.

2. Food Hypersensitivity information on the respondents:
•

Peanuts (44%, n=55), other nuts (40%, n=50), fruits (28%, n=35; consisting of
kiwi, n=8 and other fruits, n=27), eggs (15%, n=19) and milk (21%, n=26) were
the most common food allergens associated with MDFA reported by this cohort
(see Figure 2.A.18 for the breakdown of other nuts °and other fruits˟).

•

Cereals containing gluten (27%, n=34), milk (16%, n=20), fruits (9%, n=11,
consisting of kiwi n=1 & other fruits, n=10) and other foods (7%, n=9) were the
most common additional food intolerances, suspected, or non-medically
diagnosed food allergies reported by this cohort (see Table 2.A.2 for the
breakdown of other fruits˟ and other foods˟˟).

•

37% (n=46) of all respondents reported to have additional food hypersensitivities,
as well as being confirmed as MDFA to certain food/s. This consisted of 35%
(n=44) of the examined cohort reporting to have additional food intolerances,
and/or suspected, or undiagnosed food allergy and 2% (n=2) who reported to have
medically diagnosed coeliac disease.
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3. Information regarding diagnosis of MDFA in the respondents:
•

74% (n=92) reported being diagnosed with MDFA before the age of 29 years of
age, however this result needs to be considered in line with the age demographic
of the respondents. The average age of the respondent in this study was found to
be 32 years for females and 30 years for males.

•

All of the respondents in the study were required to have been positively
diagnosed by at least one of the HSE/NHS recognised methods of testing1 by a
healthcare professional, as a specific inclusion criteria. However, with regard to
the number of tests per individual, 37% (n=46) reported to be diagnosed as MDFA
by one of HSE/NHS recognised tests, 38% (n=47) by 2 tests, 21% (n=26) by 3
tests, and 4% (n=5) by 4 tests, respectively.

•

With regard to the frequency of tests used in the diagnosis of MDFA, 77% (n=96)
reported to having had a confirmatory blood test and 54% (n=67) a positive skin
prick test. While 35% (n=44) reported diagnosis via trial elimination diet and 26%
(n=32) by food oral challenge.

•

70% (n=87) of individuals reporting to be MDFA indicated that they had been
diagnosed by one healthcare professional, 24% (n=30) by 2, 4% (n=5) by 3. An
additional, 2% (n=2) who reported to be diagnosed with a MDFA by a healthcare
professional, did not specify the exact number of healthcare professional involved
in their diagnosis.

•

Whether the survey respondent’s diagnosis occurred once or on multi occasions,
testing and diagnosis were reported to have been completed by medical consultant
by 48% (n=59) of respondents, family doctors (GP) by 45% (n=56), medical
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doctors during a hospital admission by 37% (n=46) and 1% (n=1) reported to be
diagnosed by a dietitian only.
•

8% (n=10) of the adults who reported to be MDFA indicated they have IgEmediated food allergy, 4% (n=5) mixed IgE and non-IgE-mediated food allergy,
2% (n=3) have non-IgE-mediated food allergy, while 86% (n=106) did not
specify their food allergy classification.

•

Other nuts (5%, n=6), peanuts (4%, n=5) and milk (2%, n=3) were the most
common food allergens associated with IgE-mediated food allergy reported by
this cohort (Table 2.A.6).

•

14% (n=18) of MDFA respondents reported that at least one other household
member has medically diagnosed food allergies. Notably, 11% (n=14) reported it
to be 2 additional household members, and 3% (n=4) reported it to be 3 additional
household members; with 36% (n=45) not answering the question.

4. Information regarding medication, history of anaphylaxis over a 12-month
timeframe and reported food allergens associated with anaphylactic
reactions:
•

Respondents reported that they were prescribed the following medications as a
result of their MDFA 64% (n=79) antihistamines, with 48% (n=60) adrenaline
(epinephrine) auto-injectors, 10% (n=13) corticosteroids, and 2% (n=3) ‘other
medications’ (including acid reflux medications, diarrhoea medications,
antispasmodics and inhalers).

•

13% (n=15) of all respondents reported to have had anaphylactic reactions over
the 12-months prior to completing this survey, with 8% (n=10) reporting 1
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episode, 2% (n=2) two episodes, and 3% (n=3) greater than >3 times. Notably, 1
individual reported 7 episodes over this period.
•

Peanuts (10%, n=12), other nuts (8%, n=10), other fruits (4%, n=5) and kiwi (2%,
n=3) were the most common food allergens associated with anaphylactic
reactions over the 12-months reported by this cohort (Table 2.A8).

1

HSE/NHS recognised tests for the diagnosis of food allergy: Skin prick testing, Blood tests, Trial elimination diet and Food oral
challenge: https://www.hse.ie/eng/health/az/a/allergy,-food/diagnosing-food-allergy-.html; https://www.nhs.uk/conditions/foodallergy/diagnosis/
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Age and gender reported by adults reporting to have Medically Diagnosed Food
Allergies (MDFA) in Ireland (n=194) and NI (n=124)
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10%
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2%
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1%

0%
18 - 29

30 - 39

40 - 49

50 - 59

≥ 60

Age Group
*Associated number of individuals who reported their age group: 18 – 29 years: 99 females & 6 males; 30 – 39 years: 41 females &
4 males; 40 – 49 years: 19 females & 3 males; 50 – 59 years: 14 females & 2 males; ≥ 60 years: 5 females & 1 male

Figure 2.A.1: Percentage breakdown of adults, by gender and age, who reported to
be MDFA in a survey conducted between November 2019 and June 2020, in Ireland
(≥18 years, n = 194)
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Age group
*Associated number of individuals who reported their age group: 18 – 29 years: 64 females & 5 males; 30 – 39 years: 23 females &
2 males; 40 – 49 years: 12 females & 2 males; 50 – 59 years: 11 females & 1 males; ≥ 60 years: 4 females

Figure 2.A.2: Percentage breakdown of adults, by gender and age, who reported to
be MDFA in a survey conducted between November 2019 and June 2020, in NI (≥18
years, n = 124)
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Ethnicity (or cultural background) of adults reporting to have Medically Diagnosed
Food Allergies (MDFA) in Ireland (n=194) and NI (n=124)
3%

3%
Irish
British
Northern Irish
Any other White background
Any other Asian background

12%
0.5%
4.5%

77%

*Associated number of individuals who reported their ethnicity (or cultural background): Irish = 149 individuals; British = 9
individuals; Northern Irish = 1 individual; Any other White background = 23 individuals; Any other Asian background = 6 individuals;
Other (including mixed background) = 6 individuals

Figure 2.A.3: Ethnicity (or cultural background) indicated by adults reporting to be
MDFA in a survey conducted between November 2019 and June 2020, in Ireland
(≥18 years, n = 194)

3%1% 3%

Northern Irish
British

Irish

24%

Any other White Background
49%

Any other Asian Background
Other

20%
*Associated number of individuals who reported their ethnicity (or cultural background): Northern Irish = 61 individuals; British =
25 individuals; Irish = 30 individuals; Any other White background = 3 individuals; Any other Asian background = 1 individual;
Other (including mixed background) = 4 individuals

Figure 2.A.4: Ethnicity (or cultural background) indicated by adults reporting to be
MDFA in a survey conducted between November 2019 and June 2020, in NI (≥18
years, n = 124)
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Highest level of education indicated by adults reporting to have Medically
Diagnosed Food Allergies (MDFA) in Ireland (n=194) and NI (n=124)
35%

31%
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Percenatge

25%

20%

21%

18.5%
15%
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12%

10%
2.5%

5%
0%

Postgraduate/Higher Primary/Bachelor's Leaving Certificate or Diploma/Certificate Junior Certificate or
similarˢ
similarˣ
degree
degree

Unspecified*

Highest level of Education
*Associated number of individuals who reported their highest-level education: Postgraduate/Higher degree = 40 individuals;
Primary/Bachelor’s degree: 36 individuals; ˢLeaving Certificate or similar (includes Advanced Levels/General Certificate of
Education Advanced) = 29 individuals; Diploma/Certificate = 23 individuals; ˣJunior Certificate or similar (includes
Intermediate/Group/Ordinary Levels/General Certificate of Secondary Education or equivalent) = 5 individuals; *Unspecified (did
not answer) = 61 individuals

Figure 2.A.5: Highest level of education indicated by adults who reported to be
MDFA in a survey conducted between November 2019 and June 2020, in Ireland
(≥18 years, n = 194)
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Primary/Bachelor's Postgraduate/Higher Diploma/Certificate Leaving Certificate or Junior Certificate or
similarˢ
similarˣ
degree
degree

Unspecified*

Highest level of Education
*Associated number of individuals who reported their highest-level education: Primary/Bachelor’s degree = 29
individuals; Postgraduate/Higher degree = 18 individuals; Diploma/Certificate = 18 individuals; ˢLeaving Certificate
or similar (includes Advanced Levels/General Certificate of Education Advanced) = 17 individuals; ˣJunior Certificate
or similar (includes Intermediate/Group/Ordinary Levels/General Certificate of Secondary Education or equivalent) =
5 individuals; *Unspecified (did not answer) = 37 individuals

Figure 2.A.6: Highest level of education indicated by adults who reported to be
MDFA in a survey conducted between November 2019 and June 2020, in NI (≥18
years, n = 124)
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Employment status indicated by adults reporting to have Medically Diagnosed Food
Allergies (MDFA) in Ireland (n=194) and NI (n=124)
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allowance
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Employment Status
*Associated number of individuals who reported their employment status: Full-time = 51 individuals; Student = 34 individuals; Parttime = 21 individuals; Self-employed = 7 individuals; Unemployed = 8 individuals; On disability allowance = 6 individuals;
Homemaker = 4 individuals; Retired = 3 individuals; *Unspecified (did not answer) = 60 individuals

Figure 2.A.7: Employment status recorded by adults who reported to be MDFA in
a survey conducted between November 2019 and June 2020, in Ireland (≥18 years,
n = 194)
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Employment Status
*Associated number of individuals who reported their employment status: Full-time = 40 individuals; Student = 22 individuals; Parttime = 13 individuals; On disability allowance = 3 individuals; Homemaker = 3 individuals; Retired = 3 individuals; Unemployed =
2 individuals; Self-employed = 1 individual; *Unspecified (did not answer) = 37 individuals

Figure 2.A.8: Employment status recorded by adults who reported to be MDFA in
a survey conducted between November 2019 and June 2020, in NI (≥18 years, n =
124)
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Geographical location indicated by adults reporting to have Medically Diagnosed
Food Allergies (MDFA) in Ireland (n=194) and NI (n=124)
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Geographical location
*Associated number of individuals who reported their living settlement: Urban = 88 individuals; Rural = 46 individuals; *Unspecified
(did not answer) = 60 individuals

Figure 2.A.9: Percentage of adults reporting to have MDFA in a survey conducted
between November 2019 and June 2020, living in urban and rural setting in Ireland
(≥18 years, n = 194)
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*Associated number of individuals who reported their living settlement: Urban = 55 individuals; Rural = 37 individuals; *Unspecified
(did not answer) = 32 individuals

Figure 2.A.10: Percentage of adults reporting to have MDFA in a survey conducted
between November 2019 and June 2020, living in urban and rural setting in NI (≥18
years, n = 124)
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Monthly income range as an individual (after tax deductions) recorded by adults
reporting to have Medically Diagnosed Food Allergies (MDFA) in Ireland (n=194)
and NI (n=124)
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Unspecified*

Income range per month
*Associated number of individuals who reported their monthly income range (after tax deductions): Under 1,000 to 3,500 = 76
individuals; 3,501 to 8,0001 or more = 11 individuals; *Unspecified (did not answer) = 107 individuals

Figure 2.A.11: Percentage of monthly income range (after tax deductions) earned
by adults reporting to have MDFA in a survey conducted between November 2019
and June 2020, in Ireland (≥18 years, n = 194)
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Income range per month
*Associated number of individuals who reported their monthly income range (after tax deductions): Under 1,000 to 3,500 = 58
individuals; 3,501 to 8,0001 or more = 8 individuals; *Unspecified (did not answer) = 58 individuals

Figure 2.A.12: Percentage of monthly income range (after tax deductions) earned
by adults reporting to have MDFA in a survey conducted between November 2019
and June 2020, in the NI (≥18 years, n = 124)
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Additional long-term illness, health problems, or disabilities other than food allergy
or intolerance indicated by adults reporting to have Medically Diagnosed Food
Allergies (MDFA) in Ireland (n=194) and NI (n=124)
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10%
0%
No

Yes

Long-term illness, health problems, or disabilities other than food allergy or
intolerance
*Associated number of individuals who reported to have additional long-term illness, health problems, or disabilities other than food
allergy or intolerance: No = 124 individuals; Yes = 70 individuals

Figure 2.A.13: Percentage of adults who reported to have MDFA and have
additional long-term illness, health problems, or disabilities (other than food allergy
or intolerance) in a survey conducted between November 2019 and June 2020, in
Ireland (≥18 years, n = 194)
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*Associated number of individuals who reported to have additional long-term illness, health problems, or disabilities other than food
allergy or intolerance: No = 85 individuals; Yes = 39 individuals

Figure 2.A.14: Percentage of adults who reported to have MDFA and have
additional long-term illness, health problems, or disabilities (other than food allergy
or intolerance) in a survey conducted between November 2019 and June 2020, in NI
(≥18 years, n = 124)
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Private medical insurance recorded by adults reporting to have Medically
Diagnosed Food Allergies (MDFA) in Ireland (n=194) and NI (n=124)
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Private Medical Insurance
*Associated number of individuals who reported to have a private medical insurance: Yes = 84 individuals; No = 63 individuals ;
*Unspecified (did no answer): 47 individuals.

Figure 2.A.15: Percentage of adults reporting to have MDFA who indicated that
they pay for private medical insurance in a survey conducted between November
2019 and June 2020, in Ireland (≥18 years, n = 194)
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*Associated number of individuals who reported to have a private medical insurance: No = 76 individuals; Yes = 22 individuals;
*Unspecified (did not answer) = 26 individuals

Figure 2.A.16: Percentage of adults reporting to have MDFA who indicated that
they pay for private medical insurance in a survey conducted between November
2019 and June 2020, in NI (≥18 years, n = 124)
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Percentage

Reported Medically Diagnosed Food Allergies indicated by adults reporting to have
Medically Diagnosed Food Allergies (MDFA) in Ireland (n=194)
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*Associated number of individuals who reported medically diagnosed to these foodstuffs: Peanuts = 70 individuals; Other nuts = 47
individuals; Eggs = 34 individuals; Milk = 65 individuals; Fish = 20 individuals; Sesame seeds = 10 individuals; Soy beans = 10
individuals; Crustaceans = 36 individuals; Molluscs = 26 individuals; Cereals containing gluten = 16 individuals; Lupins = 2
individuals; Sulphur dioxide & sulphites = 4 individuals; Mustard = 6 individuals; Celery = 9 individuals; Meat or poultry = 4
individuals; Kiwi = 16 individuals; Other Fruits = 22 individuals; Other Foods = 19 individuals
**Breakdown of medically diagnosed food allergies to:
°Other nuts (n=47) = All tree nuts (n=22); Nuts (unspecified, n=9), Walnuts (n=5), Cashews (n=5); Hazelnuts (n=4); Brazil nut s
(n=3); Pine nuts (n=2)
˟Other fruits (n=22) = Citrus (oranges (n=3) and lemons (n=1), n=4); Pineapple (n=4); Fruit (unspecified, n=3); Apple (n=2);
Strawberries (n=1); Peach (n=1); Tomatoes (n=1); Berries (n=1); Blueberries (n=1); Raspberries (n=1); Grapes (n=1); Butternut
squash (n=1); Corn (n=1); Cucumber (n=1); Stone fruits (n=1)
˟˟Other foods (n=19) = Peas (n=5); Yeast (n=4); Garlic (n=3); Food Additives (n=3); Onion (n=1); Mushrooms (n=1); Chili (n=1);
Caffeine (n=1); Pumpkin seeds (n=1); Rhubarb (n=1); Potatoes (n=1); Marrow skin (n=1); Kale (n=1); Chickpeas (n=1); Carrots
(n=1); Beans (n=1); Lentils (n=1); Paprika (n=1); Peppers (n=1); Alcohol (n=1); Rice (n=1); Black tea (n=1); Green tea (n=1)

Figure 2.A.17: Medically diagnosed food allergies indicated by adults reporting to
be MDFA in a survey conducted between November 2019 and June 2020, in Ireland
(≥18 years, n = 194)
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Percentage

Reported Medically Diagnosed Food Allergies indicated by Adults reporting to have
Medically Diagnosed Food Allergies (MDFA) in NI (n=124)
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*Associated number of individuals who reported medically diagnosed to these foodstuffs: Peanuts = 55 individuals; Other nuts = 50
individuals; Eggs = 19 individuals; Milk = 26 individuals; Fish = 7 individuals; Sesame seeds = 7 individuals; Soy beans = 5
individuals; Crustaceans = 6 individuals; Molluscs = 3 individuals; Cereals containing gluten = 6 individuals; Lupins = 4 individuals;
Sulphur dioxide & sulphites = 4 individuals; Mustard = 3 individuals; Celery = 3 individuals; Meat or poultry = 5 individuals; Kiwi
= 8 individuals; Other Fruits = 27 individuals; Other Foods = 15 individuals
**Breakdown of medically diagnosed food allergies to:
°Other Nuts (n=50) = All tree nuts (n=28); Hazelnuts (n=12); Almonds (n=10); Walnuts (n=7); Nuts (unspecified, n=6); Pistachio
nuts (n=6); Cashew nuts (n=4); Brazil nuts (n=4); Pecan nuts (n=2); Pine nuts (n=1)
˟Other fruits (n=27) = Citrus (unspecified, n= 2, Oranges = n=7 & Grapefruit = n=1, n=10); Pineapple (n=6); Bananas (n=5); Fruit
(unspecified, n=3); Apples (n=3); Pears (n=2); Tomatoes (n=2); Strawberries (n=2); Corn (n=1); Cranberry (n=1); Dragon fruit (n=1);
Melon (n=1); Plums (n=1); Raspberries (n=1); Cherries (n=1); Peach (n=1); Papaya (n=1); Coconut (n=1)
˟˟Other foods (n=15) = Pulses (n=6); Potatoes (n=3); Onions (n=2); Rhubarb (n=1); Cilantro (n=1); Yeast (n=1); Garlic (n=1);
Peppers (n=2); Chilli (n=1); Leeks (n=1); Liquorice (n=1); Rapeseed oil (n=1); Honey (n=1); Mushroom (n=1); Curry 1

Figure 2.A.18: Medically diagnosed food allergies indicated by adults reporting to
be MDFA in a survey conducted between November 2019 and June 2020, in NI (≥18
years, n = 124)
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Reported Additional Food Intolerances, Suspected or Non-medically diagnosed
food allergies indicated by adults reporting to have Medically Diagnosed Food
Allergies (MDFA) in Ireland (n=194)
Table 2.A.1: Additional Food Intolerances, Suspected, or Non-medically diagnosed
food allergies indicated by adults reporting to be MDFA in a survey conducted
between November 2019 and June 2020, in Ireland (≥18 years, n = 194)
Additional Food Intolerances, Suspected, or Nonmedically diagnosed food allergies

Adults (n=194)

Adults (%)

Cereals containing gluten

66

34%

Milk

37

19%

Other Fruits˟

23

12%

Other Foods˟˟

16

8%

Other Nuts°

13

7%

Eggs

10

5%

Peanuts

8

4%

Crustaceans

7

4%

Meat or poultry

7

4%

Soybeans

6

3%

Kiwi

6

3%

Sulphur dioxide and sulphites

5

3%

Fish

4

2%

Molluscs

3

2%

Mustard

2

1%

Sesame seeds

1

1%

Celery

1

1%

Lupins

0

0%

*Breakdown of additional food intolerances, suspected, or non-medically diagnosed food allergies to:
°Other Nuts = All tree nuts (n=2); Nuts (unspecified, n=4); Walnuts (n=3); Cashews (n=2); Hazelnuts (n=2); Brazil nuts (n=1); Pine
nuts (n=2); Pistachio nuts (n=1); Pecan nuts (n=1)
˟Other Fruits (n=23) = Apple (n=5); Bananas (n=3); Fruit (Unspecified) (n=2); Strawberries (n=2); Peach (n=2);
Citrus (unspecified (n=1) and Oranges (n=1), n=2); Pineapple (n=2); Berries (n=2); Grapes (n=2); Plums (n=2);
Coconut (n=1); Tomatoes (n=1); Avocado (n=1); Cherries (n=1); Jackfruit (n=1); Mangoes (n=1); Melon (n=1);
Pears (n=1)
˟˟Other Foods (n=16) = Onion (n=7); Garlic (n=4); Food Additives (n=3); Mushrooms (n=1); Chili (n=1); Caffeine (n=1); Bell
Peppers (n=1); Sweet potatoes (n=1); Turmeric (n=1); Vegetables (n=1); Sunflower seeds (n=1); Coriander (n=1); Honey (n=1);
Radishes (n=1)
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Reported Additional Food Intolerances, Suspected or Non-medically diagnosed
food allergies indicated by adults reporting to have Medically Diagnosed Food
Allergies (MDFA) in NI (n=124)
Table 2.A.2: Additional Food Intolerances, Suspected or Non-medically diagnosed
food allergies indicated by adults reporting to be MDFA in a survey conducted
between November 2019 and June 2020, in NI (≥18 years, n = 124)
Additional Food Intolerances, Suspected, or Nonmedically diagnosed food allergies

Adults (n=124)

Adults (%)

Cereals containing gluten

34

27%

Milk

20

16%

Other Fruits˟

10

8%

Other Foods ˟˟

9

7%

Eggs

7

6%

Soybeans

6

5%

Other Nuts°

5

4%

Sesame seeds

5

4%

Meat or poultry

5

4%

Peanuts

4

3%

Fish

3

2%

Sulphur dioxide and sulphites

3

2%

Mustard

3

2%

Celery

3

2%

Crustaceans

2

2%

Molluscs

2

2%

Lupins

1

1%

Kiwi

1

1%

*Breakdown of additional food intolerances, suspected, or non-medically diagnosed food allergies to:
Other Nuts (n=5) = Nuts (unspecified, n=3); All tree nuts (n=2); Hazelnuts (n=1); Walnuts (n=1); Cashew nuts (n=1); Pecan nut s
(n=1)
˟Other Fruits (n=10) = Citrus (unspecified n=1 and Nectarines (n=1), n=2); All fruit (n=1); Tomatoes (n=2); Corn (n=2); Bananas
(n=1); Pineapple (n=1); Cranberries (n=1); Peaches (n=1); Peppers (n=1); Berries (n=1); Coconut (n=1); Grapes (n=1); Mango (n =1)
˟˟Other Foods (n=9) = Pulses (n=2); Onions (n=2); Oats (n=1); Chilli (n=1); Honey (n=1); Lettuces (n=1);
Mint (n=1); Mushrooms (n=1); Alcohol(n=1); Aspartame (n=1); Sugar (n=1)
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Additional Food Hypersensitivities reported by adults reporting to have Medically
Diagnosed Food Allergies (MDFA) in Ireland (n=194) and NI (n=124)
Table 2.A.3: Additional food hypersensitivities recorded by adults reporting to be
MDFA in a survey conducted between November 2019 and June 2020, in Ireland
(n=194)
Additional food hypersensitivities

N

%

Food Intolerance

91

47%

Medically diagnosed coeliac disease & Food Intolerance

3

1.5%

Medically diagnosed coeliac disease only

2

1%

Total

96

49.5%

Table 2.A.4: Additional food hypersensitivities recorded by adults reporting to be
MDFA in a survey conducted between November 2019 and June 2020, in NI (n=124)
Additional food hypersensitivities

N

%

Food Intolerance

44

35%

Medically diagnosed coeliac disease only

2

2%

Total

46

37%
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Age category of diagnosis indicated by adults reporting to have Medically
Diagnosed Food Allergies (MDFA) in Ireland (n=194) and NI (n=124)
30%
25%

25%

Percenatge

25%

20%
14%

15%

15%
10%

10%
5%

6%
2.5%

2%

0.5%

0%
below 1
year

1-5

6-12
13-17
18 - 29 30 - 39 40 - 49
Reported age when diagnosed with food allergy

50 - 59

> 60

*Associated number of individuals who reported to be diagnosed with a food allergy at the following age groups: Below 1 year = 3
individuals; 1 – 5 years = 49 individuals; 6 – 12 years = 27 individuals; 13 – 17 years = 29 individuals; 18 – 29 years = 49 individuals;
30 – 39 years = 19 individuals; 40 – 49 years = 12 individuals; 50 – 59 years = 5 individuals; 60 and above = 1 individual

Figure 2.A.19: Age category of diagnosis (by a medical professional) indicated by
adults reporting to be MDFA in a survey study conducted between November 2019
and June 2020, in Ireland (≥18 years, n = 194)
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25%
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20%

18%

21%

19%

16%

15%
11%
10%
5%

5%

4%

4%
2%

0%
below 1
year

1-5

6-12
13-17
18-29
30-39
40-49
Reported age when diagnosed with food allergy

50-59

60 and
above

*Associated number of individuals who reported to be diagnosed with a food allergy at the following age groups: Below 1 year = 6
individuals; 1 – 5 years = 22 individuals; 6 – 12 years = 24 individuals; 13 – 17 years = 14 individuals; 18 – 29 years = 26 individuals;
30 – 39 years = 20 individuals; 40 – 49 years = 5 individuals; 50 – 59 years = 5 individuals; 60 and above = 2 individuals

Figure 2.A.20: Age category of diagnosis (by a medical professional) indicated by
adults reporting to be MDFA in a survey study conducted between November 2019
and June 2020, in NI (≥18 years, n = 124)
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Food allergy testing recorded by adults reporting to have Medically Diagnosed Food
Allergies (MDFA) in Ireland (n=194) and NI (n=124)
7%

1 test
2 tests
34%

23%

3 tests
4 tests

36%
*Associated number of individuals who reported single and multiple number of food allergy tests: 1 test = 66 individuals; 2 tests =
70 individuals; 3 tests = 44 individuals; 4 tests = 14 individuals

Figure 2.A.21: Percentage of reported number of food allergy tests by adults
reporting to be MDFA in a survey study conducted between November 2019 and
June 2020, in Ireland (≥18 years, n = 194)
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Food Allergy Tests
*HSE/NHS approved test for MDFA (1-4): Blood test = 137 individuals (71%); Skin prick test = 116 individuals (60%); Trial
elimination diet = 90 individuals (46%); Food oral challenge = 51 individuals (26%)
**Many sufferers were diagnosed by more than one test as per Figure 2.A.21

Figure 2.A.22: Frequency of food allergy test used for diagnosis* (HSE/NHS
recommended tests) of MDFA, reported by adult sufferers in a survey conducted
between November 2019 and June 2020, in Ireland (≥18 years, n = 194)

4%

1 test
2 tests

21%

3 tests
37%

4 tests

38%
*Associated number of individuals who reported single and multiple number of food allergy tests: 1 test = 46 individuals; 2 tests =
47 individuals; 3 tests = 26 individuals; 4 tests = 5 individuals

Figure 2.A.23: Percentage of reported number of food allergy tests by adults
reporting to be MDFA in a survey study conducted between November 2019 and
June 2020, in NI (≥18 years, n = 124)
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Food Allergy Tests
*HSE/NHS approved test for MDFA (1-4): Blood test = 96 individuals (77%); Skin prick test = 67 individuals (54%); Trial
elimination diet = 44 individuals (35%); Food oral challenge = 32 individuals (26%)
**Many sufferers were diagnosed by more than one test as per Figure2.A.23

Figure 2.A.24: Frequency of food allergy test used for diagnosis* (HSE/NHS
recommended tests) of MDFA, reported by adult sufferers in a survey conducted
between November 2019 and June 2020, in NI (≥18 years, n = 124)
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Healthcare professional diagnosis indicated by adults reporting to have Medically
Diagnosed Food Allergies (MDFA) (≥18 years) in Ireland (n = 194) and NI (n=124)
4%
7%

1 healthcare professional
2 healthcare professionals
3 healthcare professionals
Unspecified*

19%

70%

*Associated number of individuals who reported number of healthcare professionals which diagnosed their food allergies: 1
healthcare professional= 135 individuals; 2 healthcare professionals = 37 individuals; 3 healthcare professionals = 14 individuals;
*No. of individuals who did not specify which healthcare professional= 8 individuals

Figure 2.A.25: Percentage of reported number of healthcare professionals involved
in food allergy diagnosis* by Adult MDFA sufferers in a survey conducted between
November 2019 and June 2020, in Ireland (≥18 years, n = 194)
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*Associated number of individuals who reported food allergy diagnosis by healthcare professionals or following/during hospital
admission or attendance: Consultant out-patient clinic = 107 individuals (55%); Family doctor (GP) = 101 individuals (52%);
Following/during hospital admission = 41 individuals (21%); Dietitian = 2 individuals (1%)
**Many sufferers were diagnosed by more than one healthcare professional as per Figure 2.A.25

Figure 2.A.26: Healthcare professionals involved in diagnosis of MDFA reported by
Adults sufferers in a survey conducted between November 2019 and June 2020, in
Ireland (≥18 years, n = 194)
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1 healthcare professional

4% 2%

2 healthcare professionals
3 healthcare professionals

Unspecified*

24%

70%

*Associated number of individuals who reported number of healthcare professionals which diagnosed their food allergies: 1
healthcare professional= 87 individuals; 2 healthcare professionals = 30 individuals; 3 healthcare professionals =5 individuals; *No.
of individuals who did not specify which healthcare professional= 2 individuals

Figure 2.A.27: Percentage of reported number of healthcare professionals involved
in food allergy diagnosis* by Adult MDFA sufferers in a survey conducted between
November 2019 and June 2020, in NI (≥18 years, n = 124)
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Healthcare Professionals
*Associated number of individuals who reported food allergy diagnosis by healthcare professionals or following/during hospita l
admission or attendance: Consultant out-patient clinic = 59 individuals (48%); Family doctor (GP) = 56 individuals (45%);
Following/during hospital admission = 46 individuals (37%); Dietitian = 1 individual (1%)
**Many sufferers were diagnosed by more than one healthcare professional as per Figure 2.A.27

Figure 2.A.28: Healthcare professionals involved in diagnosis of MDFA reported by
adult sufferers in a survey conducted between November 2019 and June 2020, in NI
(≥18 years, n = 124)
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Food allergy classification as indicated by adults reporting to have Medically
Diagnosed Food Allergies (MDFA) in Ireland(n=194) and NI (n=124)
12%

IgE-mediated
Mixed IgE and non-IgE-mediated
6%

Non-IgE-mediated
4%

Unspecified*

78%

*Associated number of individuals who reported the classification of food allergy diagnosis: IgE-mediated = 24 individuals; Mixed
IgE and non-IgE-mediated = 11 individuals; Non-IgE-mediated = 8 individuals; *Unspecified (did not answer) = 151 individuals

Figure 2.A.29: Food allergy classification as indicated by adults reporting to be
MDFA in a survey conducted between November 2019 and June 2020, in Ireland
(≥18 years, n = 194)

IgE-mediated

8%
4%

Mixed IgE and non-IgE-mediated
2%

Non-IgE-mediated
Unspecified*

86%

*Associated number of individuals who reported the classification of food allergy diagnosis; IgE-mediated = 10 individuals; Mixed
IgE and non-IgE-mediated = 5 individuals; Non-IgE-mediated = 3 individuals; *Unspecified (did not answer) = 106 individuals

Figure 2.A.30: Food allergy classification as indicated by adults reporting to be
MDFA in a survey conducted between November 2019 and June 2020, in NI (≥18
years, n = 124)
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Reported food allergens associated with food allergy classification as indicated by
adults reporting to have Medically Diagnosed Food Allergies (MDFA) in Ireland
(n=194) and NI (n=124)
Table 2.A.5: Reported food allergens associated with each classification as indicated
by adults reporting to be MDFA in a survey conducted between November 2019 and
June 2020, in Ireland (≥18 years, n = 194)
Food
allergens
associated
with
food
allergy
classification

IgEmediated

%

Non-IgEmediated

%

Mixed IgE
and NonIgEmediated

%

Unspecified

%

Peanuts

13

7%

1

0.5%

5

3%

51

26%

Other Nuts

8

4%

1

0.5%

5

3%

33

17%

Crustaceans

8

4%

1

0.5%

4

2%

23

12%

Cereals*

8

4%

3

1.5%

4

2%

33

17%

Milk

6

3%

2

1%

5

3%

52

27%

Molluscs

6

3%

0

0%

4

2%

15

8%

Eggs

5

3%

0

0%

2

1%

27

14%

Sesame seeds

4

2%

0

0%

0

0%

6

3%

Other Fruits

3

1.5%

2

1%

1

0.5%

16

8%

Fish

3

1.5%

0

0%

1

0.5%

16

8%

Mustard

3

1.5%

0

0%

0

0%

3

2%

Kiwi

2

1%

0

0%

0

0%

14

7%

Other Foods

2

1%

1

0.5%

1

0.5%

15

8%

Soybeans

1

0.5%

1

0.5%

2

1%

6

3%

Lupins

1

0.5%

0

0.0%

0

0%

1

1%

Celery

0

0%

2

1%

0

0%

7

4%

Meat/ poultry

0

0%

0

0%

0

0%

4

2%

*Cereals containing gluten
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Table 2.A.6: Reported food allergens associated with each classification as indicated
by adults reporting to be MDFA in a survey conducted between November 2019 and
June 2020, in NI (≥18 years, n = 124)
Reported food
allergens
associated with
food
allergy
classification

IgEmediated
(n=10)

%

Non-IgEmediated
(n=3)

%

Mixed IgE
and
NonIgEmediated
(n=5)

%

Unspecified
(n=106)

%

Other Nuts

6

5%

1

1%

3

2%

40

32%

Peanuts

5

4%

1

1%

2

2%

47

38%

Milk

3

2%

0

0%

3

2%

20

16%

Crustaceans

2

4%

1

1%

0

0%

3

2%

Sesame seeds

2

2%

0

0%

0

0%

5

4%

Kiwi

2

2%

0

0%

0

0%

6

5%

Other Foods

2

2%

0

0%

0

0%

13

10%

Mustard

1

1%

0

0%

0

0%

2

2%

Other Fruits

1

1%

0

0%

0

0%

25

20%

Cereals

0

0%

1

1%

0

0%

24

19%

Molluscs

0

0%

1

0%

0

0%

2

2%

Eggs

0

0%

0

0%

0

0%

18

15%

Fish

0

0%

0

0%

0

0%

7

6%

Soybeans

0

0%

1

1%

1

1%

3

2%

Lupins

0

0%

0

0%

0

0%

4

3%

Celery

0

0%

0

0%

0

0%

3

2%

Meat/poultry

0

0%

0

0%

0

0%

5

4%

*Cereals containing gluten
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Number of additional household members with medically diagnosed food allergies
reported by adults reporting to have Medically Diagnosed Food Allergies (MDFA)
in Ireland (n=194) and NI (n=124)
1 household member
2 household members
3 plus household members

42%

42%

5%

Unspecified*

11%

*Associated number of individuals who reported number of household members with medically diagnosed food allergies: 1 household
member (the survey respondent) = 81 individuals; 2 household members = 22 individuals; 3 plus household members = 9 individua ls;
*Unspecified (did not answer) = 82 individuals

Figure 2.A.31: Additional household members recorded as suffering with MDFA
(other than the Adult survey respondent reporting to be MDFA) in a survey
conducted between November 2019 and June 2020, in Ireland (≥18 years, n = 194)

1 household member
2 household members
3 household members

36%

Unspecified*
50%

3%
11%
*Associated number of individuals who reported number of household members with medically diagnosed food allergies: 1 household
member (the survey respondent) = 61 individuals; 2 household members = 14 individuals; 3 household members = 4 individuals;
*Unspecified (did not answer) = 45 individuals

Figure 2.A.32: Additional household members recorded as suffering with MDFA
(other than the Adult survey respondent reporting to be MDFA) in a survey
conducted between November 2019 and June 2020, in NI (≥18 years, n = 124)
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Prescribed medications recorded by adults reporting to have Medically Diagnosed
Food Allergies (MDFA) (≥18 years) in Ireland (n = 194) and NI (n=124)
140

Number of adults

120

115

100

79

80

53

60
40

20

8

0

Antihistamines

Adrenaline (epinephrine)
auto-injectors

Corticosteroids
(prescribed to treat
symptoms of food
allergy)

Other*

Prescribed medications

*Other = Antispasmodics (n=2); Inhalers (n=2); Asthma medications (n=2); Nasal sprays (n=1); Pharmacy creams (n=1); Antivomiting medications (n=1) Probiotics (n=1); Diarrhoea medications (n=1)
**Associated number of individuals who reported prescribed medications for food allergy/ies: Antihistamines = 115 individuals
(59%); Adrenaline (epinephrine) auto-injectors = 79 individuals (41%); Corticosteroids (prescribed to treat symptoms of food allergy)
= 53 individuals (27%), Other* = 8 individuals (4%)

Number of adults

Figure 2.A.33: Prescribed medications indicated by adults reporting to be MDFA in
a survey conducted between November 2019 and June 2020, in Ireland (≥18 years,
n = 194)
90
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(epinephrine) autoinjectors
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(prescribed to treat
symptoms of food
allergy)
Prescribed medications

Other*

*Other = Acid reflux medications (n=1); Diarrhoea medications (n=1); Antispasmodics (n=1); Inhalers (n=1)
**Associated number of individuals who reported prescribed medications for food allergy/ies: Antihistamines = 79 individuals (64%);
Adrenaline (epinephrine) auto-injectors = 60 individuals (48%); Corticosteroids (prescribed to treat symptoms of food allergy) = 13
individuals (10%), Other* = 3 individuals (2%)

Figure 2.A.34: Prescribed medications indicated by adults reporting to be MDFA in
a survey conducted between November 2019 and June 2020, in NI (≥18 years, n =
124)
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Reported Anaphylactic reactions over a 12-month timeframe reported by adults
reporting to have Medically Diagnosed Food Allergies (MDFA) (≥18 years) in
Ireland (n=194) and NI (n=124)
10

1 time

9

9

2 - 3 times

Number of adults

8

7

7

10 - 12 times

6
5
4

3

3

2

2
1
0

1 time

2 - 3 times

10 - 12 times

Unspecified no. of
anaphylactic reactions

Reported number of anaphylactic reactions
*Associated number of individuals who reported an anaphylactic episode as a result of a food allergen/s in the last 12 months: 1 time
= 9 individuals (5%); 2 times = 3 individuals (1.5%); 3 times = 4 individuals (2%); 10 times = 1 individual (0.5%); 12 times = 1
individual (0.5%); History of anaphylaxis reported, but exact number of incidences of the last 12 months not recorded by the
respondent = 3 individuals (1.5%)

Figure 2.A.35: No. of anaphylactic reactions reported by Adult MDFA sufferers
over a 12-month timeframe (last 12-months) in a survey conducted between
November 2019 and June 2020 in Ireland (≥18 years, n = 194)
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*Associated number of individuals who reported an anaphylactic episode as a result of a food allergen/s in the last 12 months: 1 time
= 10 individuals (8%); 2 times = 2 individuals (2%); 3 times = 1 individual (1%); 4 times = 1 individual (1%); 7 times = 1 individual
(1%); History of anaphylaxis reported, but exact number of incidences of the last 12 months not recorded by the respondent = 2
individuals (2%)

Figure 2.A.36: No. of anaphylactic reactions reported by Adult MDFA sufferers
over a 12-month timeframe (last 12-months) in a survey conducted between
November 2019 and June 2020 in NI (≥18 years, n = 124)
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Reported food allergens associated with anaphylactic reactions over a 12-month
timeframe as indicated by adults reporting to have Medically Diagnosed Food
Allergies (MDFA) (≥18 years) in Ireland (n=194) and NI (n=124)
Table 2.A.7: Reported food allergens associated with anaphylactic reactions over a
12-month timeframe (last 12-months) as indicated by Adult MDFA sufferers in a
survey conducted between November 2019 and June 2020 in the ROI (≥18 years, n
= 194)
Reported food allergens associated with anaphylactic
reactions

Adults
(n=194)

Adults
(%)

Peanuts

13

7%

Other Nuts°

10

5%

Crustaceans

9

5%

Molluscs

8

4%

Eggs

7

4%

Milk

6

3%

Cereals containing gluten

4

2%

Sesame seeds

3

1.5%

Fish

2

1%

Soybeans

1

0.5%

Mustard

1

0.5%

Celery

1

0.5%

Lupins

1

0.5%

Kiwi

1

0.5%

Other Fruits ˟

1

0.5%

Other Foods ˟˟

3

1.5%

°Other Nuts (n=10) = All nuts (n=7), Hazelnuts (n=1), Almonds (n=1), Cashews (n=2), Walnuts (n=2)
˟Other Fruits (n=1) = Tomatoes (n=1), Oranges (n=1), Strawberries (n=1)
˟˟Other Foods (n=3) = Peas (n-1), Chickpeas (n=1), Pumpkin seeds (n=1)
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Table 2.A.8: Reported food allergens associated with anaphylactic reactions over a
12-month timeframe (last 12-months) as indicated by Adult MDFA sufferers in a
survey conducted between November 2019 and June 2020 in NI (≥18 years, n = 124)
Adults
(n=124)

Reported food allergens associated with anaphylactic

Adults (%)

reactions
Peanuts

12

10%

Other Nuts°

10

8%

Other Fruits ˟

5

4%

Kiwi

3

2%

Cereals containing gluten

2

1.6%

Crustaceans

2

1.6%

Milk

1

0.8%

Eggs

1

0.8%

Fish

1

0.8%

Celery

1

0.8%

Lupins

1

0.8%

Sulphur dioxide and sulphites

1

0.8%

°Other Nuts (n=10) = All nuts (n=8), Hazelnuts (n=2)
˟Other Fruits (n=5) = Fruit (unspecified, n=2), Apples (n=2), Pineapples (n=2), Papaya (n=1), Coconut (n=1), Oranges (n=1), Melon
(n=1), Banana (n=1), Dragon Fruit (n=1)
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Appendix 3: MDCD Parental Surveys
General analysis and summary information of children & adolescents (< 18 years of
age) who were reported to be MDCD in the parental survey conducted between
November 2019 and June 2020, in both Irelandand NI
3.1 Main findings of the parental survey of children and adolescents with MDCD in
Ireland (151 respondents)
1. Background information on the respondents:
•

12% (n=18) of children were reported to be in the < 5 years category (8% females
& 4% males). More specifically, 71% (n=107) were reported to be < 12 years
(48% females & 23% males); with 29% (n=44) of adolescents reported to be in
the 13-17 years category (15% females and 14% males).

•

The gender breakdown of children and adolescents reported as MDCD in
Irelandwas 63% (n=95) females and 37% males (n=56); as indicated in the
parental surveys.

•

The majority 95% (n=142) of children and adolescents reported as MDCD in the
parental survey had their status recorded as Irish, approximately 0.5% British
(n=1), Approximately 4.5% (n=8) were from elsewhere, but currently residing in
Ireland.

•

Approximately 61% (n=93) of parents of MDCD sufferers reported obtaining a
third level qualification as their highest qualification, and 8% (n=12) reported to
have completed a second level qualification, with 31% (n=46) not specifying their
educational background.

•

54% (n=82) of parents of MDCD sufferers reported to be working either full-time
(including self-employed) and part time, with 15% (n=22) not working, and 31%
(n=47) not specifying their working status.
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•

The majority of respondents reported to be living in an urban setting 40% (n=61)
compared to 31% (n=47) in the rural area; with an additional 29% (n=43) not
specifying their geographical location.

•

21% (n=31) of the parents of MDCD sufferers indicated that they were earning
between <€1,000 and €3,500 (as combined household income) per month and
42% (n=64) >€3,501 (as combined household income) after tax deductions; with
37% (n=56) not specifying their combined monthly income.

•

75% (n=114) of the parents of children and adolescents reported as MDCD,
indicated that their child had no additional long-term illness, health problems, or
disabilities other than food hypersensitivity and approximately 25% (n=37)
indicated to the contrary.

•

61% (n=92) of the parents of children and adolescents reported as MDCD
indicated that their child does have a private medical insurance policy, with 19%
(n=29) reporting not to have one. An additional 20% (n=30) did not specify
whether their child had a private medical insurance or not.

2. Food Hypersensitivity information on the respondents:
•

Milk (1%, n=2), peanuts (1%, n=1), soybeans (1%, n=1) and other foods (1%,
n=1) were the most common additional food intolerances, suspected, or nonmedically diagnosed food allergies for children and adolescents reported by this
cohort.

•

3% (n=5) of children and adolescents reported to have additional food
hypersensitivities including other food intolerances as well as being confirmed as
MDCD.
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3. Information regarding Diagnosis of MDCD in the children and adolescents:
•

44% (n=66) reported being diagnosed with MDCD between 1-5 years, 48%
(n=72) between 6-12 years and 8% (n=13) between 13-17 years. However, this
result needs to be considered in line with the age demographic of the children and
adolescents. The average age of the respondent in this study was found to be 10
years for females and 10 years for males.

•

All of the children and adolescents in the study were required to have been
positively diagnosed by at least one of the HSE/NHS recognised methods of
testing2 by a healthcare professional, as a specific inclusion criteria. However,
with regard to the number of tests per individual, 40% (n=61) reported to be
diagnosed as MDCD by one of HSE recognised tests, 60% (n=90) by 2 tests, and
1% (n=1) did not specify what test.

•

With regard to the frequency of tests used in the diagnosis of MDCD, 93%
(n=140) reported to having had a confirmatory blood test and 66% (n=99) had
gastrointestinal endoscopy & biopsy.

•

67% (n=101) of the parents of children and adolescents reported as MDCD,
indicated that their child had been diagnosed by 1 healthcare professional, 28%
(n=43) by 2 healthcare professionals, 5% (n=7) by 3 healthcare professionals.

•

Whether the child’s diagnosis occurred once or on multi occasions, testing and
diagnosis were reported to have been completed by medical consultant by 65%
(n=98), family doctors (GP) by 46% (n=70), and medical doctors during a hospital
admission 26% (n=39).
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•

14% (n=21) of parents of MDFA sufferers reported that at least one other
household member has medically diagnosed coeliac disease. Notably, 12%
(n=18) reported it to be 2 additional household members, and 2% (n=3) reported
it to be ≥3 additional household members; with 11% (n=16) not answering the
question.

4. Information regarding medication over a 12-month timeframe, tax relief
claim on gluten products and annual cost on gluten-free products
•

Parents of the MDCD sufferers reported their child was prescribed with the
following medications as a result of their MDCD: 1% (n=2) Corticosteroids, 41%
(n=64) prescribed vitamins & supplements, and 8% (n=12) prescribed ‘other
medications’ including laxatives (n=3); antibiotics, thyroid medications, IBS
medication, analgesics, antiemetic and heartburn tablets.

•

35% (n=53) of parents of children and adolescents reported to be MDCD
indicated they claimed tax relief on gluten free products, with 44% (n=66) did not
claim tax relief, and 21% (n=32) did not specify whether they claim tax relief on
gluten free products.

•

The average annual household cost on gluten-free products were reported to be
€1,346 (n=117).

2

HSE/NHS recognised tests for the diagnosis of coeliac disease: Blood tests and Biopsy: https://www2.hse.ie/conditions/coeliacdisease/diagnosis/; https://www.nhs.uk/conditions/coeliac-disease/diagnosis/
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3.2 Main findings of the parental survey of children and adolescents with MDCD in
Northern Ireland (66 respondents)
1. Background information on the respondents:
•

9% (n=6) of children were reported to be in the < 5 years category (8% females
& 1% males). More specifically, 65% (n=43) were reported to be < 12 years (26%
females & 16% males), with 35% (n=23) of adolescents reported to be in the 1317 years category (females 18% & males 17%).

•

The gender breakdown of children and adolescents reported as MDCD was 67%
(n=44) females and 33% (n=22) males; as indicated in the parental surveys.

•

The majority 53% (n=35) of children and adolescents reported as MDCD in the
parental survey had their status recorded as Northern Irish, 21% (n=14) to be Irish,
21% (n=14) to be British, and 5% (n=3) to be from other background.

•

46% (n=30) of parents of MDCD sufferers reported obtaining a third level
qualification as their highest qualification, and 18% (n=12) reported to have
completed a second level qualification, with 36% (n=24) not specifying their
educational background.

•

52% (n=34) of parents of MDCD sufferers reported to be working either full-time
(including self-employed) and part time, with 12% (n=8) not working, and 36%
(n=24) not specifying their working status.

•

The majority of respondents reported to be living in a rural setting 46% (n=30)
compared to 21% (n=14) in an urban area; with an additional 33% (n=22) not
specifying their geographical location.

•

36% (n=24) of the parents of MDCD sufferers indicated that they were earning
between <€1,000 and €3,500 (as combined household income) per month and
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26% (n=17) earning >€3,501 after (as combined household income) tax
deductions; with 38% (n=25) not specifying their combined monthly income.
•

83% (n=55) of the parents of children and adolescents reported as MDCD,
indicated that their child had no additional long-term illness, health problems, or
disabilities other than food hypersensitivity, and approximately 17% (n=11)
indicated to the contrary.

•

12% (n=8) of the parents of children and adolescents reported as MDCD indicated
that their child does have a private medical insurance policy, with 64% (n=42)
reporting not to have one. An additional 24% (n=16) did not specify whether their
child had a private medical insurance or not.

2. Food Hypersensitivity information on the respondents:
•

Milk (9%, n=6), other foods (1%, n=2), crustaceans (2%, n=1) and fish (2%, n=1)
were the most common additional food intolerances, suspected, or non-medically
diagnosed food allergies for children and adolescents reported by this cohort.

•

9% (n=6) of children and adolescents reported to have additional food
hypersensitivities including other food intolerances as well as being confirmed as
MDCD.
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3. Information regarding Diagnosis of MDCD in the respondents:
•

47% (n=31) reported being diagnosed with MDCD, <1-5 years, 45% (n=30)
between 6-12 years, and 8% (n=5) between 13-17 years. However, this result
needs to be considered in line with the age demographic of children and
adolescents. The average age of the respondent in this study was found to be 11
years for females and 11 years for males.

•

All of the children and adolescents in the study were required to have been
positively diagnosed by at least one of the HSE/NHS recognised methods of
testing2 by a healthcare professional, as a specific inclusion criteria. However,
with regard to the number of tests per individual, 61% (n=40) reported to be
diagnosed as MDCD by one of HSE recognised tests, 38% (n=25) by 2 tests, and
1% (n=1) unspecified* (did not answer).

•

With regard to the frequency of tests used in the diagnosis of MDCD, 92% (n=61)
reported to having had a confirmatory blood test and 42% (n=28) had
gastrointestinal endoscopy & biopsy.

•

71% (n=47) of the parents of children and adolescents reported as MDCD,
indicated that they had been diagnosed by 1 healthcare professional, 26% (n=17)
by 2 healthcare professionals, 5% (n=7) by 3 healthcare professionals.

•

Whether the child’s diagnosis occurred once or on multi occasions, all testing and
diagnosis were reported to have been completed by medical consultant by 80%
(n=53) of respondents, family doctors (GP) by 38% (n=25) and medical doctors
during a hospital admission 14% (n=9).

•

17% (n=11) of parents of MDCD sufferers reported that at least one other
household member has medically diagnosed coeliac disease. Notably, 14% (n=9)
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reported it to be 2 additional household members, and 3% (n=2) reported it to be
≥3 additional household members; with 10% (n=7) not answering the question.

4. Information regarding medication over a 12-month timeframe and annual
cost on gluten-free products
•

Parents of the MDCD sufferers reported their child was prescribed with the
following medications as a result of their MDCD: 6% (n=4) Corticosteroids, 41%
(n=20) prescribed vitamins and supplements, and 4% (n=12) prescribed ‘other
medications’ including antiemetic, antihistamines and laxatives.

•

The average annual household cost on gluten-free products were reported to be
£1,285 (n=51).

2

HSE/NHS recognised tests for the diagnosis of coeliac disease: Blood tests and Biopsy: https://www2.hse.ie/conditions/coeliac disease/diagnosis/; https://www.nhs.uk/conditions/coeliac-disease/diagnosis/
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Age and Gender of Children & Adolescents who were reported to have Medically
Diagnosed Coeliac Disease (MDCD) in the parental survey in Ireland (n=151) and
NI (n=66)
45%

Percentage of children (female)

40%

40%

Percentage of children (male)

35%

Percentage

30%
25%

19%

20%

15%

14%

15%
7%

10%
5%

4%
1%

0%
below 1

1-5

6-12

13 -17

Age group
*Associated number of children and adolescents reported by parents to have MDCD by their age group: below 1 year: 1 female & 0
males; 1-5 years: 11 females & 6 males; 6-12 years: 60 females & 29 males; 13-17 years: 23 females & 21 males

Figure 3.A.1: Percentage breakdown of children and adolescents, by gender and
age, who were reported to have MDCD in the parental survey conducted between
November 2019 and October 2020, in Ireland (<18 years, n = 151)
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45%

41%

Percentage of children (female)

40%

Percentage

35%

Percentage of children (male)

30%
25%
18%

20%

17%

15%

15%
8%

10%
5%

1%

0%
below 1

1 to 5

6 to 12

13 -17

Age group
*Associated number of Children and Adolescents reported by parents to have MDCD by their age group: below 1 years: 0 females
& 1 male; 1-5 years: 5 females & 0 males; 6-12 years: 27 females & 10 males; 13-17 years: 12 females & 11 males

Figure 3.A.2: Percentage breakdown by parents of children and adolescents, by
gender and age, who were reported to have MDCD in the parental survey conducted
between November 2019 and October 2020, in NI (<18 years, n = 66)
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Ethnicity (or cultural background) reported by parents of children and adolescents
suffering from Medically Diagnosed Coeliac Disease (MDCD) in Ireland (n=151)
and NI (n=66)
0.5% 2%

Irish
British
Any other White background
African
Other including mixed backround

0.5% 2%

95%
* Associated number of parents who reported their child’s ethnicity (or cultural background): Irish =142 individuals; British = 1
individuals; Any other White background = 4 individuals; African = 1 Individual; Other = 3 individuals.

Figure 3.A.3: Ethnicity (or cultural background) indicated by parents reporting
their child to have MDCD in a survey conducted between November 2019 and
October 2020, in Ireland (<18 years, n = 151)

Irish

5%

British

21%

Northern Irish
Other including mixed backround

53%

21%

*Associated number of parents who reported their child’s ethnicity (or cultural background): Irish = 14 individuals; British = 14
individuals; Northern Irish = 35 individuals; other = 3 individuals.

Figure 3.A.4: Ethnicity (or cultural background) indicated by parents of children
and adolescents reporting to have MDCD in a survey conducted between November
2019 and October 2020, in NI (<18 years, n = 66)
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Highest level of education indicated by parents of children and adolescents reported
as having Medically Diagnosed Coeliac Disease (MDCD) in Ireland (n=151) and NI
(n=66)
40%
35%

Parent/guardian
34%
32%

Spouse/partner

30%

Percentage

30%
25%
21%

20%

18%

18%
14%

15%

11%
10%

9%
7%
5%

5%

2%

0%

Highest level of education
*Number of parents who reported their highest-level education: Parent/Guardian; Postgraduate/Higher degree = 52 individuals;
Primary/Bachelor’s degree: 27 individuals; Diploma/Certificate = 14 individual; ˢLeaving Certificate or similar (includes Advanced
Levels/General Certificate of Education Advanced) = 11 individuals;; ˣJunior Certificate or similar (includes
Intermediate/Group/Ordinary Levels/General Certificate of Secondary Education or equivalent) = 1 individuals; *Unspecified (did
not answer) = 46 individuals
**Spouse/Partner; Primary/Bachelor’s degree: 32 individuals; Postgraduate/Higher degree = 27 individuals; ; Diploma/Certificate =
21 individual ˢLeaving Certificate or similar (includes Advanced Levels/General Certificate of Education Advanced) = 16
individuals; ˣJunior Certificate or similar (includes Intermediate/Group/Ordinary Levels/General Certificate of Secondary Education
or equivalent) = 7 individuals; *Unspecified (did not answer) = 48 individuals.

Figure 3.A 5: Highest level of education indicated by parents who reported their
child/adolescent to have MDCD in a survey conducted between November 2019 and
October 2020, in Ireland (<18 years, n = 151)
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50%

Parent/guardian

45%

Spouse/partner

44%

40%

36%

Percentage

35%

30%
25%

21%

20%

20%
15%

10%

9%

11%

12%

13%

11%
6%

11%
5%

5%
0%
Postgraduate/Higher
degree

Primary/Bachelor's
degree

Leaving Certificate or
similarˢ

Junior Certificate or
similarˣ

Diploma/Certificate

Unspecified*

Highest level of education
*Associated number of parents who reported their highest-level education: Parent/guardian; Postgraduate/Higher degree = 14
individuals; Primary/Bachelor’s degree = 13 individuals; leaving Certificate or similar (includes Advanced Levels/General
Certificate of Education Advanced) = 8 individuals; junior Certificate or similar (includes Intermediate/Group/Ordinary
Levels/General Certificate of Secondary Education or equivalent) = 4 individuals; Diploma/Certificate = 3 individuals; ;
*Unspecified (did not answer) = 24 individuals.
**Spouse/Partner) leaving Certificate or similar (includes Advanced Levels/General Certificate of Education Advanced) = 9
individuals; Primary/Bachelor’s degree = 7 individuals; Diploma/Certificate = 7 individuals; junior Certificate or similar (includes
Intermediate/Group/Ordinary Levels/General Certificate of Secondary Education or equivalent) = 7 individuals;
Postgraduate/Higher degree = 6 individuals; Primary education or less = 1 individual; *Unspecified (did not answer) = 29
individuals.

Figure 3.A 6: Highest level of education indicated by parents of children and
adolescents reported to have MDCD in a survey conducted between November 2019
and October 2020, in NI (<18 years, n=66)
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Employment status indicated by parents of children and adolescents reported as
having Medically Diagnosed coeliac disease (MDCD) in Ireland (n=151) and NI
(n=66)
60%

Parent/guardian

50%

Spouse/partner

50%

Percentage

40%
31%

32%

31%

30%
20%

16%

15%

14%
7%

10%

3%

1%
0%
Full-time

Unspecified*

Part-time

Homemaker

Self employed

Employment status
*Associated number of parents who reported their employment status: Parent/guardian ; Full-time = 47 individuals; Part-time = 24
individuals; Homemaker = 22 individuals; Self-employed = 11 individuals; Unspecified* (did not answer) = 47 individuals;
Spouse/Partner; Full-time = 75 individuals; Self-employed = 21 individuals; Homemaker = 5 individuals; Part-time = 2 individuals;
*Unspecified (did not answer) = 48 individuals.

Figure 3.A.7: Employment status recorded by parents who reported their
child/adolescent to have MDCD in a survey conducted between November 2019 and
October 2020, in Ireland (<18 years, n = 151)
Parent/guardian

Percentage

50%
45%
40%
35%
30%
25%
20%
15%
10%
5%
0%

44%

Spouse/partner
36%
26%

24%

25%

25%

10%
2%
part-time

2%
full time

homemaker

2%

2%

On disability
allowance

2%
self employed

Unspecified*

Employment status
*Associated number of parents who reported their employment status: Parent/guardian; Part-time = 17 individuals; Full-time = 16
individuals; ; Homemaker = 7 individuals; On disability allowance = 1 individual; Self-employed = 1 individuals; *Unspecified (did
not answer) = 24 individuals; Spouse/Partner; Full-time = 17 individuals; Self-employed = 17 individuals; Part-time = 1 individuals;
On disability allowance = 1 individuals; Homemaker = 1 individuals; *Unspecified (did not answer) = 29 individuals

Figure 3.A 8: Employment status recorded by Parents of children reported as
having MDCD in a survey conducted between November 2019 and October 2020, in
NI (<18 years, n = 66)
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Geographical location indicated by parents reporting their child/adolescent to have
Medically Diagnosed Coeliac Disease (MDCD) in Ireland (n=151) and NI (n=66)
45%

40%

40%

Percentage

35%

31%

30%

29%

25%
20%
15%

10%
5%
0%
Urban

Rural
Geographical location

Unspecified*

*Associated number of parents who reported their living settlement: Urban = 61 individuals; Rural = 47 individuals; *Unspecified
(did not answer) = 43 individuals

Figure 3.A 9: Percentage of parents of children and adolescents reported with
MDCD in a survey conducted between November 2019 and October 2020, living in
Urban and Rural settings in Ireland (<18 years, n = 151)

50%

46%

45%
40%
33%

Percentage

35%
30%
25%

21%

20%
15%
10%
5%
0%
urban

rural

unspecified*

Geographical location
*Associated number of parents who reported their living settlement: Urban = 14 individuals; Rural = 30 individuals; *Unspecified
(did not answer) = 22 individuals

Figure 3.A.10: Percentage of parents of children and adolescents with MDCD in a
survey conducted between November 2019 and October 2020, living in Urban and
Rural settings in NI (<18 years, n = 66)
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Combined Monthly income range (after tax deductions) recorded by parents of
children with Medically Diagnosed Coeliac Disease (MDCD) in Ireland (n=151) and
NI (n=66)
45%

42%

40%

37%

35%

Percentage

30%
25%

21%

20%
15%
10%
5%
0%

3,501 to 8,001 or more

Under 1,000 to 3,500
Combined Income per month

Unspecified*

*Associated number of parents who reported their combined monthly income range (after tax deductions): 3,501 to 8,0001 or more =
64 individuals; Under 1,000 to 3,500 = 31 individuals; *Unspecified (did not answer) = 56 individuals

Figure 3.A 11: Percentage of combined monthly income range (after tax deductions)
earned by both Parents reporting their child to have MDCD in a survey conducted
between November 2019 and October 2020, in Ireland (<18 years, n = 151)

40%

38%

36%

35%

Percentage

30%

26%

25%

20%
15%
10%
5%
0%
Under 1,000 to 3,500

3,501 to 8,001 or more

Unspecified*

Combined income range per month
*Associated number of parents who reported their combined monthly income range (after tax deductions): Under 1,000 to 3,500 = 24
individuals; 3,501 to 8,0001 or more = 17 individuals; *Unspecified (did not answer) = 25 individuals

Figure 3.A 12: Percentage of combined monthly income range (after tax deductions)
earned by both parents reporting their child to have MDCD in a survey conducted
between November 2019 and October 2020, in the NI (<18 years, n = 66)
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Additional long-term illness, health problems, or disabilities other than food
hypersensitivity indicated by parents of children and adolescents reported with
Medically Diagnosed Coeliac Disease (MDCD) in Ireland (n=151) and NI (n=66)
80%

75%

70%

Percentage

60%
50%
40%
30%

25%

20%
10%
0%
No
Yes
Long-term illness, health problems/disabilities other than food hypersensitivity
*Associated number of children and adolescents whose parents indicated additional long-term illness, health problems, or disabilities
other than food hypersensitivity: No = 114 individuals; Yes = 37 individuals

Figure 3.A 13: Percentage of parents who reported additional long-term illness,
health problems, or disabilities (other than food hypersensitivity) in their
child/adolescent in a survey conducted between November 2019 and October 2020,
in Ireland (<18 years, n = 151)

90%

83%

80%
70%

Percentage

60%
50%
40%
30%

17%

20%
10%
0%
No

Yes

Long term ilness, health problems, or disabilities other than food hypersensitivity
*Associated number of children and adolescents whose parents reported additional long-term illness, health problems, or disabilities
other than food hypersensitivity: No = 55 individuals; Yes = 11 individuals

Figure 3.A 14: Percentage of parents who reported additional long-term illness,
health problems, or disabilities (other than food hypersensitivity) in their
child/adolescent in a survey conducted between November 2019 and October 2020,
in NI (<18 years, n = 66)
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Confirmation of private medical insurance indicated by parents of children and
adolescents reported with Medically Diagnosed Coeliac Disease (MDCD) in Ireland
(n=151) and NI (n=66)
70%
61%
60%

Percentage

50%
40%
30%
19%

20%

No
Private Medical Insurance

Unspecified*

20%

10%
0%
Yes

*Associated number of parents who reported to have a private medical insurance for their child/adolescent: Yes = 92 individuals; No
= 29 individuals; **Unspecified* (did not answer): 30 individuals.

Figure 3.A 15: Percentage of parents reporting their child/adolescent to have
MDCD who indicated that they pay for private medical insurance in a survey
conducted between November 2019 and October 2020, in Ireland (<18 years, n =
151)
70%

64%

60%

Percentage

50%
40%

30%

24%

20%

12%

10%
0%
No

Yes

Unspecified*

Private Medical Insurance
*Associated number of parents who reported to have a private medical insurance for their child/adolescent: No = 42 individuals; Yes
= 8 individuals; **Unspecified* (did not answer) = 16 individuals

Figure 3.A 16: Percentage of parents reporting their child/adolescent to have
MDCD who indicated that they pay for private medical insurance in a survey
conducted between November 2019 and October 2020, in NI (<18 years, n = 66)
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Reported Additional Food Intolerances, Suspected or Non-medically diagnosed
food allergies indicated by parents of children and adolescents reported with
Medically Diagnosed Coeliac Disease (MDCD) in Ireland (n=151)
Milk

1%

Percentage

Other Foods

1%

Soy beans

1%

Peanuts

1%
0%

0%

0%

1%

1%

1%

1%

Food itolerances, Suspected, or Non-medically diagnosed food allergies
*Associated number of children and adolescents who suffer from food intolerances to these foodstuffs: Peanuts = 1 individual; Milk
= 2 individuals; Soybeans = 1 individual; Other Foods = 1 individual
**Breakdown of food intolerance to: Other foods (unspecified, n=1)

Figure 3.A 17: Reported additional food intolerances indicated by parents reporting
their child/adolescent to have MDCD in a survey conducted between November
2019 and October 2020, in Ireland (<18 years, n = 151)

Reported Additional Food Intolerances, Suspected or Non-medically diagnosed
food allergies indicated by parents of children and adolescents reported with
Medically Diagnosed Coeliac Disease (MDCD) in NI (n=66)

Percentage

Milk

9%

Other Foods

3%

Crustaceans

2%

Fish

2%
0%

2%

4%

6%

8%

10%

Food intolerances, Suspected, or Non-medically diagnsoed food allergies
*Associated number of children and adolescents who suffer from food intolerances to these foodstuffs: Milk = 6 individuals;
Crustaceans = 1 individual; Fish = 1 individual; Other Foods = 2 individuals
**Breakdown of food intolerance to: Other foods (n=2); rice (n=1); chickpeas (n=1)

Figure 3.A.18: Reported additional food intolerances indicated by parents reporting
their child/adolescent to have MDCD in a survey conducted between November
2019 and October 2020, in NI (<18 years, n = 66)
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Additional Food Hypersensitivities indicated by parents of children and adolescents
reported with Medically Diagnosed Coeliac Disease (MDCD) in Ireland (n=151) and
NI (n=66)
Table 3.A.1: Additional (other) food hypersensitivities recorded by parents
reporting their child/adolescent to have MDCD in a survey conducted between
November 2019 and October 2020, in Ireland (n=151)
Additional food hypersensitivities

N

Medically diagnosed coeliac disease & Other Food Intolerance

5

%
3%

Table 3.A.2 Additional (other) food hypersensitivities recorded by parents reporting
their child/adolescent to have MDCD in a survey conducted between November
2019 and October 2020, in NI (n=66)
Additional food hypersensitivities

N

Medically diagnosed coeliac disease & Other Food Intolerance

6
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%
9%

Age category of diagnosis as indicated by parents of children and adolescents
reported with medically diagnosed coeliac disease (MDCD) in Ireland (n=151) and
NI (n=66)
60%
48%

50%

44%

Percentage

40%
30%
20%
8%

10%
0%
below 1 year

1-5

6-12

13-17

Reported age when diagnosed with coeliac disease
*Associated number of parents who reported their child to be medically diagnosed with coeliac disease at the following age groups:
1 – 5 years = 66 individuals; 6 – 12 years = 72 individuals; 13 – 17 years = 13 individuals

Figure 3.A.19: Age category of diagnosis (by a medical professional) indicated by
parents reporting their child/adolescent to have MDCD in a survey conducted
between November 2019 and October 2020, in Ireland (<18 years, n = 151)
50%

45%

45%
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40%

Percentage

35%

30%
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20%
15%
8%

10%

5%

2%

0%
below 1 year

1-5

6-12

13-17

Reported age when diagnosed with coeliac disease
*Associated number of Parents who reported their child to be diagnosed with medically coeliac disease at the following age groups:
Below 1 year = 1 individuals; 1 – 5 years = 30 individuals; 6 – 12 years = 30 individuals; 13 – 17 years = 5 individuals

Figure 3.A.20: Age category of diagnosis (by a medical professional) indicated by
parents reporting their child/adolescent to have MDCD in a survey conducted
between November 2019 and October 2020, in NI (<18 years, n = 66)
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Coeliac Disease Tests indicated by parents of children and adolescents reported with
Medically Diagnosed Coeliac Disease (MDCD) in Ireland (n=151)
1 Test
2 Tests

40%

60%

*Associated number of parents who reported single and multiple number of coeliac tests carried out on their child: 1 test = 61
individual; 2 tests = 90 individuals

Figure 3.A.21: Percentage of reported number of Coeliac disease diagnosis tests
indicated by parents reporting their child/adolescent to have MDCD in a survey
conducted between November 2019 and October 2020, in Ireland (<18 years, n =
151)
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Number of children and adolescents
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140
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100
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Blood tests

Gastrointestinal endoscopy & biopsy
Tests for coeliac disease

*HSE/NHS approved test for MDCD (1-2): Blood tests = 140 individuals (93%); Gastrointestinal endoscopy & biopsy = 99
individuals (66%)
**Many sufferers were diagnosed by more than one test as per figure 3.A.21

Figure 3.A.22: Frequency of coeliac disease test used for diagnosis* (HSE/NHS
recommended tests) of MDCD, reported by parents of children and adolescents
suffering from MDCD in a survey conducted between November 2019 and October
2020, in Ireland (<18 years, n = 151)
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Coeliac Disease Tests reported by parents of children and adolescents reported with
Medically Diagnosed Coeliac Disease (MDCD) in NI (n=66)
1 test
2 tests

38%

62%

*Associated number of parents who reported single and multiple number of coeliac tests carried out on their child: 1 test = 41
individuals; 2 tests = 25 individuals

Figure 3.A.23: Percentage of reported number of coeliac disease diagnosis tests
indicated by parents reporting their child/adolescent to have MDCD in a survey
conducted between November 2019 and October 2020, in NI (<18 years, n = 66)
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Gastrointestinal endoscopy & biopsy

Tests for coeliac disease
*HSE/NHS approved test for MDCD (1-2): Blood tests = 62 individuals (94%); Gastrointestinal endoscopy & biopsy = 28 individuals
(42%).
**Many sufferers were diagnosed by more than one test as per figure 3.A.23

Figure 3.A.24: Frequency of coeliac disease test used for diagnosis* (HSE/NHS
recommended tests) of MDCD, reported by parents reporting their child/adolescent
to have MDCD in a survey conducted between November 2019 and October 2020,
in NI (<18 years, n = 66)
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Healthcare professional diagnosis indicated by parents of children and adolescents
reported with Medically Diagnosed Coeliac Disease (MDCD) in Ireland (n = 151)
5%

1 healthcare professional
2 healthcare professionals
3 healthcare professionals

28%

67%

*Associated number of parents of children who reported the number of healthcare professionals which diagnosed the child’s coe liac
disease: 1 healthcare professional= 101 individuals; 2 healthcare professionals = 43 individuals; 3 healthcare professionals = 7
individuals

Figure 3.A.25: Percentage of reported number of healthcare professionals involved
in coeliac disease diagnosis* of children and adolescents with MDCD in a survey
conducted between November 2019 and October 2020, in Ireland (<18 years, n =
151)
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Healthcare Professional
*Associated number of parents of children who reported the number of healthcare professionals which diagnosed their child’s c oeliac
disease; Coeliac Disease by healthcare professionals or following/during hospital admission or attendance: Consultant, out-patient
clinic = 98 Individuals; Family doctor (GP) = 70 individuals; Following/during hospital admission = 39 individuals.
**Many sufferers were diagnosed by more than one healthcare professional as per Figure 3.A,25

Figure 3.A.26: Healthcare professionals involved in diagnosis of children and
adolescents with MDCD reported by parents in a survey conducted between
November 2019 and October 2020, in Ireland (<18 years, n = 151)
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Healthcare professional diagnosis indicated by parents of children and adolescents
reported with Medically Diagnosed Coeliac Disease (MDCD) in NI (n=66)
3%

1 healthcare professional
2 healthcare professionals

26%

3 healthcare professionals

71%

Associated number of parents of children who reported the number of healthcare professionals which diagnosed their child’s co eliac
disease: 1 healthcare professional= 47 individuals; 2 healthcare professionals = 17 individuals; 3 healthcare professionals = 2
individuals

Figure 3.A.27: Percentage of reported number of healthcare professionals involved
in Coeliac disease diagnosis* by Parents of children and adolescents reported as
suffering from MDCD in a survey conducted between November 2019 and October
2020, in NI (<18 years, n=66)
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*Associated number of parents of children who reported the number of healthcare professionals involved in their child’s coeliac
disease diagnosis; Coeliac Disease by healthcare professionals or following/during hospital admission or attendance: Consultant outpatient clinic = 53 individuals; Family doctor (GP) = 25 individuals; Following/during hospital admission = 9 individuals.
**Many sufferers were diagnosed by more than one healthcare professional as per figure 3.A.27.

Figure 3.A.28: Healthcare professionals involved in diagnosis of MDCD reported by
Parents of children and adolescents reported as suffering from MDCD in a survey
conducted between November 2019 and October 2020, in NI (<18 years, n = 66)
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Number of additional household members with Medically Diagnosed Coeliac
Disease (MDCD) indicated by parents of children and adolescents who were
reported to have MDCD disease in Ireland (n=151) and NI (n=66)
11%

1 household member

2%

2 household members
3 plus household members

12%

Unspecified*

75%

*Associated number of parents who reported number of household members with MDCD: 1 household member (the child/adolescent
reported to be MDCD) = 114 individuals; 2 household members = 18 individuals; 3 plus household members = 3 individuals;
*Unspecified (did not answer) = 16 individuals

Figure 3.A. 29: Additional household members recorded as suffering with MDCD
in a survey conducted between November 2019 and October 2020, in Ireland (<18
years, n=151)

1 household member

10%
3%

2 household members
3 plus household members
Unspecified*

14%

73%

*Associated number of parents who reported number of household members with MDCD: 1 household member (the child/adolescent
reported to be MDCD) = 48 individuals; 2 household members = 9 individuals; 3 plus household members = 2 individuals;
*Unspecified (did not answer) = 7 individuals

Figure 3.A.30: Additional household members recorded as suffering with MDCD in
a survey conducted between November 2019 and October 2020, in NI (<18 years, n
= 66)
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Prescribed medications indicated by parents of children and adolescents with
Medically Diagnosed Coeliac Disease (MDCD) in Ireland (n = 151) and NI (n=66)
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Other*

Prescribed Medications

Corticosteroids (prescribed to
treat symptoms of coeliac disease

*Other medications (n=12) including, laxatives (n=3); antibiotics (n=2); thyroid medications (n=2); IBS medications (n=1); analgesics
(n=1); antiemetic (n=1), heartburn tablets (n=1). unspecified medication (n=1)
**Associated number of parents of children who reported their child’s prescribed medications for MDCD: Prescribed vitamins an d
supplements = 64 individuals (42%); Corticosteroids = 2 individuals (1%); Other* = 12 individuals (8%).

Figure 3.A.31: Prescribed medications indicated by parents reporting their
child/adolescent to have MDCD in a survey conducted between November 2019 and
October 2020, in Ireland (<18 years, n = 151)
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Other*
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*Other medications (n=3) including, Antiemetic (n=1); Antihistamines (n=1); Laxatives (n=1).
** Associated number of parents of children who reported their child’s prescribed medications for MDCD: Vitamins and supplements
= 20 individuals (30%); Corticosteroids = 4 individuals (6%); Other* = 3 individuals (5%)

Figure 3.A.32: Prescribed medications indicated by parents reporting their
child/adolescent to have MDCD in a survey conducted between November 2019 and
October 2020, in NI (<18 years, n = 66)
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Tax relief claims on Gluten Free Products indicated by parents of children and
adolescents reported with Medically Diagnosed Coeliac Disease (MDCD) in Ireland
only (n=151)
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Unspecified*

Tax relief claims
*Associated number of parents who Claimed tax on gluten free products: Yes = 53 individuals; No = 66 individuals; Unspecified *=32
individuals

Figure 3.A.33: Tax relief claims made on gluten free products indicated by parents
of children and adolescents with MDCD in a survey conducted between November
2019 and October 2020, in Ireland (<18 years, n = 151)
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Appendix 4: MDCD Adult Surveys
General analysis and summary information of adults (≥ 18 years of age) who
reported being MDCD in a survey conducted between November 2019 and June
2020, in both Ireland and NI
4.1 Main findings of the survey of adults with MDCD in Ireland (623 respondents)
1. Background information on the respondents:
•

17% (n=106) of all respondents reported to be in the 18-29 years category (16%
females & 1% males). In fact, 17% (n=105) of all respondents reported to be
aged between 30-39 years (15% females & 2% males), with 66% (n=412) being
> 40 years (51% females and 15% males).

•

82% (n=511) of respondents reported to be female and 18% male (n=112) of the
respondents reporting to be medically diagnosed with Coeliac disease (MDCD)
in Ireland.

•

Approximately 93% (n=581) of the MDCD respondents reported to be Irish, 2%
(n=13) to be British (originally from Britain), Approximately 4.2% (n=26) to be
from another white background, approximately 0.2% (n=1) originally from
Africa, 0.2% (n=1) from other Asian background, and 0.2% (n=1) from
elsewhere.

•

52% (n=231) of the MDCD respondents reported a third level qualification as
their highest qualification, and 18% (n=110) reported to have completed a second
level qualification; and 2% (n=7) reported to have completed primary education,
with 28% (n=175) not specifying their educational background.

•

Approximately 44.5% (n=276) reported to be working either full-time (including
self-employed) and part time. Approximately 21.3% (n=130) not to be working,
512

4% (n=28) in education; with approximately 30.2% (n=189) not specifying their
working status.
•

The majority of respondents reported to be living in an urban setting 44% (n=273)
compared to 28% (n=175) in the rural area; with an additional 28% (n=175) not
specifying their geographical location.

•

48% (n=58) of MDCD adults reported to be earning between <€1,000 and €3,500
(as an individual) per month and 10% (n=59) >€3,501 (as an individual) after tax
deductions; with 42% (n=264) not specifying their monthly income.

•

65% (n=408) of MDCD adults reported to have no additional long-term illness,
health problems, or disabilities other than food hypersensitivity; with
approximately 35% (n=215) indicating to the contrary.

•

59% (n=369) of MDCD adults reported to have a private medical insurance, with
21% (n=132) indicating they do not have a private medical insurance; with 20%
(n=122) did not specify whether they have private medical insurance.
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2. Food Hypersensitivity information based on the respondents:
•

Milk (6%, n=40), other foods (2%, n=15) and fruits including kiwi (2%, n=12)
were the most common additional food intolerances, suspected, or non-medically
diagnosed food allergies reported by this cohort.

•

8.5% (n=53) of all respondents reported to have other food intolerances, as well
as being confirmed with MDCD.

3. Information regarding Diagnosis of MDCD in the respondents:
•

37.5% (n=229) reported being diagnosed with MDCD before the age of 29 years
of age, however this result needs to be considered in line with the age
demographic of the respondents. The average age of the respondent in this study
was found to be 42 years for females and 43 years for males.

•

All of the respondents in the study were required to have been positively
diagnosed by at least one of the HSE/NHS recognised methods of testing2 by a
healthcare professional, as a specific inclusion criteria. However, with regard to
the number of tests per individual, 27% (n=168) reported to be diagnosed as
MDCD by one of HSE/NHS recognised tests, and 73% (n=455) by 2 tests.

•

With regard to the frequency of tests used in the diagnosis of MDCD, 47%
(n=509) reported to having had a confirmatory blood test and 53% (n=570) a
Gastrointestinal endoscopy & biopsy.

•

75% (n=470) of individuals reporting to be MDCD indicated that they had been
diagnosed by one healthcare professional, 23% (n=141) by 2, 1% (n=6) by 3. And
1% (n=5) did not specify their diagnosis.
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•

Whether the survey respondent’s diagnosis occurred once or on multi occasions,
testing and diagnosis were reported to have been completed by medical consultant
by 55% (n=345), family doctors (GP), 43% (n=267), and medical doctors during
a hospital admission by 26% (n=162).

•

10% (n=61) of MDCD respondents reported that at least one other household
member has medically diagnosed coeliac disease. Notably, 8% (n=48) reported it
to be 2 additional household members, and 2% (n=13) reported it to be ≥3
additional household members; with 32% (n=200) not answering the question.

4. Information regarding medication over a 12-month timeframe, tax relief
claims on gluten-free products and annual cost on gluten-free products:
•

Respondents reported that they were prescribed the following medications as a
result of their MDCD: 5% (n=32) Corticosteroids, 41% (n=258) prescribed
vitamins &supplements, and 5% (n=31) prescribed ‘other medications’ (including
acid reflux medications, antihistamines, laxatives, antidepressants, antibiotics,
probiotics, thyroid medications, analgesics, IBS medication and heart tablets).

•

48% (n=296) of all respondents reported to have claimed tax relief on gluten free
products, with 32% (n=202) did not claim tax relief, and 20% (n=125) did not
specify whether they claimed tax relief on gluten free products.

•

The average annual individual cost on gluten-free products were reported to be
€1,032 (n=483).

2

HSE/NHS recognised tests for coeliac disease: Blood tests and Biopsy: https://www2.hse.ie/conditions/coeliac-disease/diagnosis/;
https://www.nhs.uk/conditions/coeliac-disease/diagnosis/
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4.2 Main findings of the survey of adults with MDCD in Northern Ireland (195
respondents)
1. Background information on the respondents:
•

33% (n=63) of all respondents reported to be in the 18-29 years category (30%
females & 3% males). In fact, 16% (n=31) of all respondents reported to be aged
between 30-39 years (females 13% & males 3%), with 52% (n=101) being > 40
years (45% females and 7% males).

•

88% (n=171) of respondents reported to be female and 13% male (n=24) of the
respondents reporting to be medically diagnosed with Coeliac disease (MDCD)
in NI.

•

The majority 43% (n=84) of the MDCD respondents reported to be Northern
Irish, 33% (n=64) to be Irish, 21% (n=41) to be British (originally from Britain).
3% (n=6) from another white background.

•

47% (n=92) of the MDCD respondents reported a third level qualification as their
highest qualification, and 25% (n=49) reported a second level qualification; and
2% (n=3) reported to have completed primary education, with 26% (n=50) not
specifying their educational background.

•

42.5% (n=87) reported to be working either full-time (including self-employed)
and part time. 16.5% (n=32) not to be working, 12% (n=20) in education with
29% (n=56) not specifying their working status.

•

The majority of respondents reported to be living in an urban setting 46% (n=90)
compared to 28% (n=55) in the rural area; with an additional 26% (n=50 not
specifying their geographical location.
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•

52% (n=102) of MDCD adults reported to be earning between <€1,000 and
€3,500 (as an individual) per month and 7% (n=14) >€3,501 (as an individual)
after tax deductions; with 41% (n=79) not specifying their monthly income.

•

63% (n=123) of MDCD adults reported to have no additional long-term illness,
health problems, or disabilities other than food hypersensitivity; with 37% (n=72)
indicating to the contrary.

•

69% (n=135) of MDCD adults reported to have a private medical insurance, with
11% (n=22) indicating they do not have a private medical insurance; with 20%
(n=38) did not specify whether they have private medical insurance.

2. Food Hypersensitivity information on the respondents:
•

Milk (6%, n=12) and other foods (4%, n=8) were the most common additional
food intolerances, suspected, or non-medically diagnosed food allergies reported
by this cohort.

•

Approximately 10% (n=19) of all respondents reported to have other food
intolerances as well as being confirmed with MDCD.
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3. Information regarding Diagnosis of MDCD in the respondents:
•

50% (n=98) reported being diagnosed with MDCD before the age of 29 years of
age, however this result needs to be considered in line with the age demographic
of the respondents. The average age of the respondent in this study was found to
be 42 years for females and 43 years for males.

•

All of the respondents in the study were required to have been positively
diagnosed by at least one of the HSE/NHS recognised methods of testing2 by a
healthcare professional, as a specific inclusion criteria. However, with regard to
the number of tests per individual, 25% (n=49) reported to be diagnosed as
MDCD by one of HSE/NHS recognised tests, 75% (n=146) by 2 tests.

•

With regard to the frequency of tests used in the diagnosis of MDCD, 85%
(n=166) reported to having had a confirmatory blood test and 90% (n=175) a
Gastrointestinal endoscopy & biopsy,

•

71% (n=138) of individuals reporting to be MDCD indicated that they had been
diagnosed by one healthcare professional, 27.5% (n=54) by 2, 0.5% (n=1) by 3.
1% (n=1) did not specify the specific number of healthcare professional/s
involved in their diagnosis.

•

Whether the survey respondent’s diagnosis occurred once or on multi occasions,
testing and diagnosis were reported to have been completed by medical consultant
by 65% (n=126) of respondents, family doctors (GP) by 47% (n=91), medical
doctors during a hospital admission by 16% (n=32).

•

86% (n=168) of MDCD respondents reported that at least one other household
member has medically diagnosed coeliac disease. Notably, 30% (n=59) reported
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it to be 2 additional household members, and 56% (n=109) reported it to be ≥3
additional household members; with 4% (n=7) not answering the question.

4. Information regarding medication over a 12-month timeframe and annual
cost on gluten-free products:
•

Respondents reported that they were prescribed the following medications as a
result of their MDCD: 6% (n=12) Corticosteroids, 45% (n=88) prescribed
vitamins and supplements, and 2% (n=4) prescribed ‘other medications’
including heartburn tablets, IBS medication and probiotics.

•

The average annual individual cost on gluten-free products were reported to be
£754 (n=156).

2

HSE/NHS recognised tests for coeliac disease: Blood tests and Biopsy: https://www2.hse.ie/conditions/coeliac-disease/diagnosis/;
https://www.nhs.uk/conditions/coeliac-disease/diagnosis/
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Age and gender reported by adults reporting to have Medically Diagnosed Coeliac
Disease (MDCD) in Ireland (n=623) and NI (n=195)
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18%
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16%

16%

15%
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5%

18 - 29

3%

2%

1%
30 - 39

40 - 49

50 - 59

≥ 60

Age group
*Associated number of individuals who reported their age group: 18 – 29 years: 100 females & 6 males; 30 – 39 years: 93 females
& 12 males; 40 – 49 years: 107 females & 20 males; 50 – 59 years: 100 females & 28 males; ≥ 60 years: 111 females & 46 males

Figure 4.A.1: Percentage breakdown of adults, by gender and age, who reported to
be MDCD in a survey conducted between November 2019 and June 2020, in Ireland
(≥18 years, n = 623)
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Age Group
*Associated number of individuals who reported their age group: 18 – 29 years: 58 females & 5 males; 30 – 39 years: 26 females &
5 males; 40 – 49 years: 31 females & 6 males; 50 – 59 years: 25 females & 2 males; ≥ 60 years: 31 females & 6 males.

Figure 4.A.2: Percentage breakdown of adults, by gender and age, who reported to
be MDCD in a survey conducted between November 2019 and June 2020, in NI (≥18
years, n = 195)
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Ethnicity (or cultural background) reported by adults reporting to have Medically
Diagnosed Coeliac Disease (MDCD) in the ROI (n=623) and NI (n=195)
1%
2% 4%

Irish
British
Any other White background
Other

93%
*Associated number of individuals who reported their ethnicity (or cultural background): Irish = 581 individuals; British = 13
individuals; Any other White background = 26 individuals; Other = African (n=1); Any other Asian background (n=1); Mixed
background (n=1)

Figure 4.A.3: Ethnicity (or cultural background) indicated by adults reporting to be
MDCD in a survey conducted between November 2019 and June 2020, in Ireland
(≥18 years, n = 623)

3%
Northern irish

21%

Irish
British
43%

Any other White background

33%
*Associated number of individuals who reported their ethnicity (or cultural background): Northern Irish = 84 individuals; Irish = 64
individuals; British = 41 individuals; Any other White background = 6 individuals

Figure 4.A.4: Ethnicity (or cultural background) indicated by adults reporting to be
MDCD in a survey conducted between November 2019 and June 2020, in NI (≥18
years, n = 195)
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Highest level of education reported by adults reporting to have Medically Diagnosed
Coeliac Disease (MDCD) in Ireland (n=623) and NI (n=195)
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18%
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degree

Leaving Certificate or
similarˢ

Junior Certificate or
similarˣ

Primary Education or
less

Unspecified*

Highest level of education
*Associated number of individuals who reported their highest-level education: Postgraduate/Higher degree = 114 individuals;
Diploma/Certificate = 115 individuals; Primary/Bachelor’s degree: 102 individuals; ˢLeaving Certificate or similar (includes
Advanced Levels/General Certificate of Education Advanced) = 72 individuals; ˣJunior Certificate or similar (includes
Intermediate/Group/Ordinary Levels/General Certificate of Secondary Education or equivalent) = 38 individuals; Primary education
or less = 7 individuals; *Unspecified (did not answer) = 175 individuals.

Figure 4.A.5: Highest level of education indicated by adults who reported to be
MDCD in a survey conducted between November 2019 and June 2020, in Ireland
(≥18 years, n = 623)
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Highest level of education
*Associated number of individuals who reported their highest-level education: Primary/Bachelor’s degree = 43 individuals; leaving
Certificate or similar (includes Advanced Levels/General Certificate of Education Advanced) = 31 individuals; Postgraduate/Higher
degree = 25 individuals; Diploma/Certificate = 25 individuals; Primary education or less = 3 individuals; junior Certificate or
similar (includes Intermediate/Group/Ordinary Levels/General Certificate of Secondary Education or equivalent) = 18 individuals;
*Unspecified (did not answer) = 50 individuals

Figure 4.A.6: Highest level of education indicated by adults who reported to be
MDCD in a survey conducted between November 2019 and June 2020, in NI (≥18
years, n = 195)
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Employment status reported by adults reporting to have Medically Diagnosed
Coeliac Disease (MDCD) in Ireland (n=623) and NI (n=195)
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allowance
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Unspecified*

Employment Status
*Associated number of individuals who reported their employment status: Full-time = 197 individuals; Retired = 81 individuals; Parttime = 48 individuals; Self-employed = 31 individuals; Student = 28 individuals; Homemaker = 27 individuals; On disability
allowance = 12 individuals; Unemployed = 8 individuals; Volunteer = 2 individuals *Unspecified (did not answer) = 189 individ uals.

Figure 4.A.7: Employment status recorded by adults who reported to be MDCD in
a survey conducted between November 2019 and June 2020, in Ireland (≥18 years,
n = 623)
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Employment Status
*Associated number of individuals who reported their employment status: Full-time = 56 individuals; Part-time = 24 individuals;
Student = 20 individuals; ; Retired = 17 individuals; On disability allowance = 9 individuals; Self-employed = 7 individuals;
Homemaker = 4 individuals; Unemployed = 2 individuals; *Unspecified (did not answer) = 56 individuals.

Figure 4.A.8: Employment status recorded by adults who reported to be MDCD in
a survey conducted between November 2019 and June 2020, in NI (≥18 years, n =
195)
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Geographical location indicated by adults reporting to have Medically Diagnosed
Coeliac Disease (MDCD) in Ireland (n=623) and NI (n=195)
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*Associated number of individuals who reported their living settlement: Urban = 273 individuals; Rural = 175 individuals;
*Unspecified (did not answer) = 175 individuals

Figure 4.A.9: Percentage of adults reporting to have MDCD in a survey conducted
between November 2019 and June 2020, living in urban and rural setting in Ireland
(≥18 years, n = 623)
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*Associated number of individuals who reported their living settlement: Urban = 90 individuals; Rural = 55 individuals;
*Unspecified (did not answer) = 50 individuals

Figure 4.A.10: Percentage of adults reporting to have MDCD in a survey conducted
between November 2019 and June 2020, living in urban and rural setting in NI (≥18
years, n = 124)
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Monthly income range as an individual (after tax deductions) recorded by adults
reporting to have Medically Diagnosed Coeliac Disease (MDCD) in Ireland (n=623)
and NI (n=195)
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3,501 to 8,001 or more

Unspecified*

Income range per month
*Associated number of individuals who reported their monthly income range (after tax deductions): Under 1,000 to 3,500 = 300
individuals; 3,501 to 8,0001 or more = 59 individuals; *Unspecified (did not answer) = 264 individuals

Figure 4.A.11: Percentage of monthly income range (after tax deductions) earned
by adults reporting to have MDCD in a survey conducted between November 2019
and June 2020, in Ireland (≥18 years, n = 623)

60%

52%

50%
41%

Percentage

40%
30%
20%
7%

10%
0%
Under 1,000 to 3,500

3,501 to 8,001 or more

Unspecified*

Income Range Per Month
*Associated number of individuals who reported their monthly income range (after tax deductions): Under 1,000 to 3,500 = 102
individuals; 3,501 to 8,0001 or more = 14 individuals; *Unspecified (did not answer) = 79 individuals

Figure 4.A.12: Percentage of monthly income range (after tax deductions) earned
by adults reporting to have MDCD in a survey conducted between November 2019
and June 2020, in NI (≥18 years, n = 195)
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Additional long-term illness, health problems, or disabilities other than food
hypersensitivity indicated by adults reporting to have Medically Diagnosed Coeliac
Disease (MDCD) in Ireland (n=623) and NI (n=195)
70%

65%

60%

Percentage

50%
40%

35%

30%
20%
10%
0%
No
Yes
Long term illness, health problems, or disabilities other than food hypersensitivity

*Associated number of individuals who reported to have additional long-term illness, health problems, or disabilities other than food
hypersensitivity: No = 408 individuals; Yes = 215 individuals

Figure 4.A.13: Percentage of adults who reported to have MDCD and have
additional long-term illness, health problems, or disabilities (other than food
hypersensitivity) in a survey conducted between November 2019 and June 2020, in
Ireland (≥18 years, n = 623)
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*Associated number of individuals who reported to have additional long-term illness, health problems, or disabilities other than food
hypersensitivity: No = 123 individuals; Yes = 72 individuals

Figure 4.A.14: Percentage of adults who reported to have MDCD and have
additional long-term illness, health problems, or disabilities (other than food
hypersensitivity) in a survey conducted between November 2019 and June 2020, in
NI (≥18 years, n = 195)
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Private medical insurance reported by adults reporting to have Medically
Diagnosed Coeliac Disease (MDCD) in Ireland (n=623) and NI (n=195)
70%
60%

59%

Percentage

50%
40%
30%

21%

20%

20%

10%
0%
Yes

No
Private Medical Insurance

Unspecified*

*Associated number of individuals who reported to have a private medical insurance: Yes = 369 individuals; No = 132individuals;
*Unspecified (did not answer): 122 individuals.

Figure 4.A.15: Percentage of adults reporting to have MDCD who indicated that
they pay for private medical insurance in a survey conducted between November
2019 and June 2020, in Ireland (≥18 years, n = 623)

80%
70%

69%

60%

Percentage

50%
40%
30%

20%

20%

11%

10%

0%
Yes

No
Private/additional medical insurance

Unspecified*

*Associated number of individuals who reported to have a private medical insurance: Yes = 135 individuals; No = 22 individuals;
*Unspecified (did not answer) = 38 individuals

Figure 4.A.16: Percentage of adults reporting to have MDCD who indicated that
they pay for private medical insurance in a survey conducted between November
2019 and June 2020, in NI (≥18 years, n = 195)
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Percentage

Reported Additional Food Intolerances, Suspected, or Non-medically diagnosed
food allergies indicated by adults reporting to have Medically Diagnosed Coeliac
Disease (MDCD) in Ireland (n=623)
Milk
Other Foods
Other Fruits
Sulphur dioxide and sulphites
Eggs
Soy beans
Other nuts
Molluscs
Celery
Crustaceans
Meat or poultry
Sesame seeds
Fish
Peanuts
Kiwi
Mustard
Lupins
0.0%

6%
2%
2%
1%
1%
1%
1%
1%
1%
1%
0.5%
0.3%
0.3%
0.3%
0.2%
0.2%
0.2%
1.0%

2.0%

3.0%

4.0%

5.0%

6.0%

Food Intolerances, Suspected, or Non-medically diagnosed food allergies
*Associated number of individuals who suffer from food intolerances to these foodstuffs: Milk = 40 individuals; Other Foods = 15
individuals;
Other Fruits = 11 individuals; Sulphur dioxide & sulphites = 9 individuals; Eggs = 7 individuals; Soy beans = 6 individuals; Other
nuts = 7
individuals; Molluscs = 5 individuals; Celery = 4 individuals; Crustaceans = 4 individuals; Meat or poultry = 3 individuals; Sesame
seeds = 2
individuals; Fish = 2 individuals; Peanuts = 2 individuals; Kiwi = 1 individuals; Mustard = 1 individuals; Lupins = 1 individuals.
**Breakdown of food intolerance to:
ͦOther Nuts (n=7); Nuts (unspecified, n=1); Walnuts (n=1); Cashews (n=3); Hazelnuts (n=2); Brazil nuts (n=1); Pistachio nuts (n=1);
almond nuts (n=1)
˟Other fruits (n=11) = Apple (n=4); Fruit (Unspecified n=2); Peach (n=2); plum (n=1);
Oranges (n=3), n=2); Pineapple (n=1); Berries (n=1); mango (n=1); papaya (n=1); raspberry (n=1)
Coconut (n=1); Tomatoes (n=2)
˟˟Other foods (n=15) = Onion (n=6); Garlic (n=5); Food Additives (n=1); Mushrooms (n=1); Bell Peppers (n=1); Vegetables (n=2);
cinnamon (n=1); peas (n=4); pulses (n=1); beans (n=1); potatoes (n=1)

Figure 4.A.17: Reported additional Food Intolerances, Suspected, or Non-medically
diagnosed food allergies indicated by adults reporting to be MDCD in a survey
conducted between November 2019 and June 2020, in Ireland (≥18 years, n = (623)
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7.0%

Reported Additional Food Intolerances, Suspected, or Non-medically diagnosed
food allergies indicated by adults reporting to have Medically Diagnosed Coeliac
Disease (MDCD) in NI (n=195)
Milk
Other Foods
Sulphur dioxide and sulphites
Soy beans
Meat or poultry
Peanuts
Other Fruits
Kiwi
Celery
Mustard
Lupins
Molluscs
Crustaceans
Other nuts
Sesame seeds
Fish
Eggs

6%
4%
2%
2%

Percentage

1%
1%
1%
0.5%
0.5%
0.5%
0.5%
0.5%
0.5%
0.5%

0%

1%

2%

3%

4%

5%

6%

7%

Food Intolerances, Suspected, or Non-medically diagnosed food allergies
*Associated number of individuals who suffer from food intolerances to these foodstuffs: Milk = 12 individuals; Other Foods = 8
individuals; Sulphur dioxide & sulphites = 3 individuals; Soy beans = 3 individuals; Meat or poultry = 2 individuals; Peanuts = 2
individuals; Other Fruits = 2 individual; Kiwi = 1 individuals; Celery = 1 individuals; Mustard = 1 individuals; Lupins = 1
individuals; Molluscs = 1 individuals; Crustaceans = 1 individuals; Other nuts = 1 individuals; Sesame seeds = 0 individuals; Fish =
0 individuals; Eggs = 0 individuals.
**Breakdown of food intolerance to:
ͦOther Nuts (n=1) = All tree nuts (n=3); Nuts (unspecified, n=1)
˟Other fruits (n=0) Kiwi (n=1) = Apple (n=0); Bananas (n=1); Fruit (Unspecified) (n=2)
˟˟Other foods (n=16) = Onion (n=2); Food Additives (n=1); Chili (n=1); paprika (n=1); rapeseed (n=1); soy milk (n=1); Caffeine
(n=1); Potatoes (n=1)

Figure 4.A.18: Reported additional food Intolerances, Suspected, or Non-medically
diagnosed food allergies indicated by adults reporting to be MDCD in a survey
conducted between November 2019 and June 2020, in NI (≥18 years, n = 195)
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Additional Food Hypersensitivities reported by adults reporting to have Medically
Diagnosed Coeliac Disease (MDCD) in Ireland (n=623) and NI (n=195)
Table 4.A.1: Additional (other) food hypersensitivities recorded by adults reporting
to be MDCD in a survey conducted between November 2019 and June 2020, in
Ireland (n=623)
Additional food hypersensitivities

N

%

Other Food Intolerance/s, Suspected, or Non-medically diagnosed food allergy/ies

53

8.5

Table 4.A.2: Additional (other) food hypersensitivities recorded by adults reporting
to be MDCD in a survey conducted between November 2019 and June 2020, in NI
(n=195)
Additional food hypersensitivities

N

%

Other Food Intolerance/s, Suspected, or Non-medically diagnosed food allergy/ies

19

9.7
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Age category of diagnosis reported by adults reporting to have Medically Diagnosed
Coeliac Disease (MDCD) sufferers in Ireland (n=623) and NI (n=195)
30.0%
24.5%

25.0%

Percentage

21%

21%

20.0%
15.0%

12%
9%

10.0%
5%

5.0%

3.5%

3.5%

6-12

13-17

0.5%
0.0%
below 1
year

1-5

18 - 29

30 - 39

40 - 49

50 - 59

> 60

Reported age when diagnosed with coeliac disease

*Associated number of individuals who reported to be medically diagnosed with coeliac disease at the following age groups: Below
1 year = 3 individuals; 1 – 5 years = 30 individuals; 6 – 12 years = 22 individuals; 13 – 17 years = 22 individuals; 18 – 29 years =
152 individuals; 30 – 39 years = 129 individuals; 40 – 49 years = 130 individuals; 50 – 59 years = 77 individuals; 60 and above = 58
individuals

Figure 4.A.19: Age category of diagnosis (by a medical professional) indicated by
adults reporting to be MDCD in a survey study conducted between November 2019
and June 2020, in Ireland (≥18 years, n = 623)
33%

35%
30%

Percentage

25%

22%

20%
14%

15%

10%

10%

10%
5%

3%

3%

1-5

6-12

4%

1%

0%
below 1
year

13-17

18 - 29

30 - 39

40 - 49

50 - 59

> 60

Reported age when diagnosed with ceoliac disease

*Associated number of individuals who reported to be medically diagnosed with coeliac disease at the following age groups: Below
1 year = 1 individuals; 1 – 5 years = 6 individuals; 6 – 12 years = 6 individuals; 13 – 17 years = 20 individuals; 18 – 29 years = 65
individuals; 30 – 39 years = 42 individuals; 40 – 49 years = 28 individuals; 50 – 59 years = 20 individuals; 60 and above = 7 individuals

Figure 4.A.20: Age category of diagnosis (by a medical professional) indicated by
adults reporting to be MDCD in a survey study conducted between November 2019
and June 2020, in NI (≥18 years, n = 195)
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Coeliac Disease Tests indicated by adults reporting to have Medically Diagnosed
Coeliac Disease (MDCD) in Ireland (n=623)
1 test
2 Tests
27%

73%

*Associated number of individuals who reported single and multiple number of coeliac tests: 1 test = 168 individuals; 2 tests = 455
individuals.

Number of Adults

Figure 4.A.21: Percentage of reported number of coeliac disease tests by adults
reporting to be MDCD in a survey study conducted between November 2019 and
June 2020, in Ireland (≥18 years, n = 623)

580
570
560
550
540
530
520
510
500
490
480
470

570

509

Gastrointestinal endoscopy and biopsy
Blood test
Tests for coeliac disease
HSE/NHS approved test for MDCD (1-2): Gastrointestinal endoscopy & biopsy = 570 individuals (53%); Blood test = 509 individuals
(47%);
*Many sufferers were diagnosed by more than one test as per Figure 4.A.21

Figure 4.A.22: Frequency of coeliac disease test used for diagnosis* (HSE/NHS
recommended tests) of MDCD, reported by adult sufferers in a survey conducted
between November 2019 and June 2020, in Ireland (≥18 years, n = 623)
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Coeliac Disease Tests indicated by adults reporting to have Medically Diagnosed
Coeliac Disease (MDCD) in NI (n=195)
1 Test

25%

2 Tests

75%

*Associated number of individuals who reported single and multiple number of coeliac tests: 1 test = 49 individuals; 2 tests = 146
individuals.

Figure 4.A.23: Percentage of reported number of coeliac disease tests by adults
reporting to be MDCD in a survey study conducted between November 2019 and
June 2020, in NI (≥18 years, n = 195)

176

175

174

Number of adults

172

170
168

166

166
164
162
160
Gastrointestinal endocopy & biopsy

Blood test

Coeliac disease tests
*HSE/NHS approved test for MDCD (1-2): Gastrointestinal endoscopy & biopsy = 175 individuals (51%); Blood test = 166
individuals (49%);
*Many sufferers were diagnosed by more than one test as per Figure 4.A.23

Figure 4.A.24: Frequency of coeliac disease test used for diagnosis* (HSE/NHS
recommended tests) of MDCD, reported by adult sufferers in a survey conducted
between November 2019 and June 2020, in NI (≥18 years, n = 195)
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Healthcare professional diagnosis indicated by adults reporting to have Medically
Diagnosed Coeliac Disease (MDCD) (≥18 years) in Ireland (n = 623)
1%1%
1 healthcare professional

23%

2 healthcare professionals
3 healthcare professionals
Unspecified*

75%
*Associated number of individuals who reported the number of healthcare professionals which diagnosed their coeliac disease: 1
healthcare professional= 470 individuals; 2 healthcare professionals = 141 individuals; 3 healthcare professionals = 6 individuals;
Other = 1 individual; Unspecified = *No. of individuals who did not specify which healthcare professional= 5 individuals

Figure 4.A.25: Percentage of reported number of healthcare professionals involved
in coeliac disease diagnosis* by adult MDCD sufferers in a survey conducted
between November 2019 and June 2020, in Ireland (≥18 years, n = 623)

400
350

345

Number of Adults

300

267

250
200

162

150
100

50
0
Consultant out-patient clinic

Family doctor (GP)
Healthcare Professionals

Following/during hospital
admission

*Associated number of individuals who reported the number of healthcare professionals which diagnosed their coeliac disease; Coeliac
Disease by healthcare professionals or following/during hospital admission or attendance: Consultant, out-patient clinic = 345
Individuals (55%); Family doctor (GP) = 267 individuals (43%); Following/during hospital admission = 162 individuals (26%).
*Many sufferers were diagnosed by more than one healthcare professional as per Figure 4.A.25

Figure 4.A.26: Healthcare professionals involved in diagnosis of MDCD reported by
adults sufferers in a survey conducted between November 2019 and June 2020, in
Ireland (≥18 years, n = 623)
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Healthcare professional diagnosis indicated by adults reporting have Medically
Diagnosed Coeliac Disease (MDCD) (≥18 years) in NI (n=195)
1 healthcare professional
0.5% 1%

2 healthcare professionals
3 healthcare professionals

27.5%

Unspecified*

71%

*Associated number of individuals who reported the number of healthcare professionals which diagnosed their coeliac disease: 1
healthcare professional= 138 individuals; 2 healthcare professionals = 54 individuals; 3 healthcare professionals =1 individu al; other
= 1 individual; *No. of individuals who did not specify which healthcare professional= 1 individual

Figure 4.A.27: Percentage of reported number of healthcare professionals involved
in coeliac disease diagnosis* by Adult MDCD sufferers in a survey conducted
between November 2019 and June 2020, in NI (≥18 years, n = 195)

140

126

Number of adults

120
91

100
80
60

32

40
20
0
Consultant out-patient clinic

Family doctor (GP)

Following/during hospital
admission

Healthcare Professionals
*Associated number of individuals who reported the number of healthcare professionals which diagnosed their coeliac disease;
Coeliac Disease by healthcare professionals or following/during hospital admission or attendance: Consultant out-patient clinic
=126 individuals (65%); Family doctor (GP) = 91 individuals (47%); Following/during hospital admission = 32 individuals (16%)
*Many sufferers were diagnosed by more than one healthcare professional as per Figure 4.A.27.

Figure 4.A.28: Healthcare professionals involved in diagnosis of MDCD reported by
adult sufferers in a survey conducted between November 2019 and June 2020, in NI
(≥18 years, n = 195)
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Number of additional household members with medically diagnosed coeliac disease,
reported by adults reporting to have Medically Diagnosed Coeliac Disease (MDCD)
in Ireland (n=623) and NI (n=195)
1 household member
2 household members

32%

3 plus household members
Unspecified*

58%
2%
8%

*Associated number of individuals who reported number of household members with medically diagnosed coeliac disease: 1
household member (the survey respondent) = 362 individuals; 2 household members = 48 individuals; 3 plus household members =
13 individuals; *Unspecified (did not answer) = 200 individuals

Figure 4.A.29: Additional household members recorded as suffering with MDCD
(other than the adult survey respondent reporting to be MDCD) in a survey
conducted between November 2019 and June 2020, in Ireland (≥18 years, n = 623)

4%

10%
1 household member
2 household members
3 plus household
members
30%

56%

*Associated number of individuals who reported number of household members with medically diagnosed coeliac disease: 1
household member (the survey respondent) = 20 individuals; 2 household members = 59 individuals; 3 plus household members =
109 individuals; *Unspecified (did not answer) = 7 individuals.

Figure 4.A.30: Additional household members recorded as suffering with MDCD in
a survey conducted between November 2019 and June 2020, in NI (≥18 years, n =
195)
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Prescribed medications recorded by adults reporting to have Medically Diagnosed
Coeliac Disease (MDCD) (≥18 years) in Ireland (n = 623) and NI (n=195)
300

258

250

Number of Adults

200
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100
32

31

Corticosteroids (prescribed to
treat symptoms of coeliac
disease

Other*

50
0
Prescribed vitamins and
supplements

Perscribed Medications
*Other = Antihistamines (n=3); Heartburn tablets (n=7); Analgesics (n=1); Laxatives (n=2);
Thyroid medication (n=3); Probiotics (n=3); IBS relief medication (n=7); Heart tablets (n=1); Antidepressants (n=2); Antibiotics
(n=2).
-Associated number of individuals who reported prescribed medications for MDCD: Corticosteroids = 32 individuals (5%); Prescribed
vitamins and supplements = 258 (41%); Other* = 31 individuals (5%)

Number of adults

Figure 4.A.31: Prescribed medications indicated by adults reporting to be MDCD
in a survey conducted between November 2019 and June 2020, in Ireland (≥18 years,
n = 623)
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4
Prescribed vitamins and
supplements

Corticosteroids (prescribed to
treat symptoms of coeliac disease

Other*

Prescribed Medications
*Other = Heartburn tablets (n=1); IBS medication (n=2); Probiotics (n=1).
Associated number of individuals who reported prescribed medications for MDCD: Corticosteroids = 12 individuals (6%); Vitamins
and supplements = 88 individuals (45; Other* = 4 individuals (2%)

Figure 4.A.32: Prescribed medications indicated by adults reporting to be MDCD
in a survey conducted between November 2019 and June 2020, in NI (≥18 years, n
= 195)
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Tax relief claims made on gluten free products reported by adults reporting to have
Medically Diagnosed Coeliac Disease (MDCD) (≥18 years) in Irelandonly (n = 623)
60%

Percentage

50%

48%

40%

32%
30%

20%
20%
10%
0%

Yes

No

Unspecified*

Tax Relief Claim
*Associated number of individuals who claimed tax on gluten free products: Yes = 296 individuals; No = 202 individuals;
Unspecified* =125 individuals

Figure 4.A.33: Tax relief claims made on gluten free products indicated by adults
reporting to be MDCD in a survey conducted between November 2019 and June
2020, in Ireland (≥18 years, n = 623)
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Appendix 5: FI Parental Surveys
General analysis and summary information of children & adolescents (< 18 years of
age) who were reported to have a FI in a parental survey conducted between
November 2019 and June 2020, in Ireland and NI
5.1 Main findings of the parental survey of children and adolescents with FI in
Ireland (59 respondents)
1. Background information on the respondents:
•

42% (n=25) of children were reported to be in the < 5 years category (17%
females & 25% males). More specifically, 80% (n=47) were reported to be < 12
years (41% females & 39% males); with 20% (n=12) of adolescents reported to
be in the 13-17 years category (15% females and 5% males).

•

The gender breakdown of children and adolescents reported as FI was 56% (n=33)
females and 44% (n=26) males; as indicated in the parental surveys.

•

The majority 81% (n=48) of children and adolescents reporting to have FI
reported to be Irish and 2% (n=1) to be British (originally from Britain); with 17%
(n=10) originally from elsewhere, but are currently residing in Ireland.

•

70% (n=41) of the parents of FI sufferers reported a third level qualification as
their highest qualification and 10% (n=6) reported to have completed a second
level qualification; with 20% (n=12) not specifying their educational background.

•

Approximately 50% (n=29) of the parents of FI sufferers reported to be employed
either full-time (including self-employed) or part-time, 3% (n=2) in education;
27% (n=16) not to be working; with 20% (n=12) not specifying their working
status.
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•

The majority of respondents reported to be living in an urban setting 46% (n=27)
compared to 34% (n=20) in the rural area; with an additional 20% (n=12) not
specifying their geographical location.

•

37% (n=22) of parents of children and adolescents reporting to have FI indicated
to be earning between <€1,000 and €3,500 (as combined household income) per
month and approximately 32% (n=19) >€3,501 (as combined household income)
after tax deductions; with 31% (n=18) not specifying their combined monthly
income.

•

76% (n=45) of parents of children and adolescents reporting to have FI indicated
that their child has no additional long-term illness, health problems, or disabilities
other than food allergy or intolerance and approximately 24% (n=14) indicating
to the contrary.

•

43% (n=254) of parents of children and adolescents reporting to have FI indicated
that their child does not have a private medical insurance, with 36% (n=210)
indicating they do have a private medical insurance; with 21% (n=123) did not
specify whether they have private medical insurance.
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2. Food Hypersensitivity information on the respondents:
•

Milk (59%, n=35), cereals containing gluten (41%, n=24), other foods (17%,
n=10), other fruits (17%, n=10) and eggs (8%, n=5) were the most common food
allergens associated with FI reported by this cohort.

•

51% (n=30) of children and adolescents were reported to have additional gluten
sensitivities. This consisted of 24% (n=14) of the examined cohort reporting to
have gluten/non-coeliac gluten sensitivity, 17% (n=10) reported to have
suspected wheat allergy and 10% (n=6) reported to have suspected coeliac
disease.

•

25% (n=25) of parents of FI sufferers reported that at least one other household
member has food intolerance. Notably, 17% (n=10) reported that figure to be 2
additional household members, and 8% (n=5) reported it to be ≥3 additional
household members; with 19% (n=11) not answering the question.
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5.2 Main findings of the parental survey of children and adolescents with FI in
Northern Ireland (61 respondents)
1. Background information on the respondents:
•

39% (n=24) of children were reported to be in the < 5 years category (18%
females & 21.5% males). More specifically, 73% (n=44) were reported to be <
12 years (females 36% & males 36.5%); with 27% (n=17) of adolescents reported
to be in the 13-17 years category (16% females and 11.5% males).

•

The gender breakdown of children and adolescents reported as FI was 52% (n=32)
females and 48% (n=29) males; as indicated in the parental surveys.

•

39% (n=24) of children and adolescents reporting to have FI reported to be
Northern Irish, 33% (n=20) to be British (originally from Britain) and 23% (n=14)
to be Irish; with 5% (n=3) originally from elsewhere, but are currently residing in
NI.

•

51% (n=31) of the parents of FI sufferers reported a third level qualification as
their highest qualification and 19% (n=12) reported to have completed a second
level; with 30% (n=18) not specifying their educational background.

•

54% (n=33) of the parents of FI sufferers reported to be employed either full-time
(including self-employed) or part-time, 5% (n=3) in education; approximately
11% (n=7) not to be working; with 30% (n=18) not specifying their working
status.

•

The majority of respondents reported to be living in an urban setting 38% (n=23)
compared to 36% (n=22) in the rural area; with an additional 26% (n=16) not
specifying their geographical location.

•

48% (n=29) of parents of children and adolescents reporting to have FI indicated
to be earning between <€1,000 and €3,500 (as combined household income) per
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month and approximately 18% (n=11) >€3,501 (as combined household income)
after tax deductions; with 34% (n=21) not specifying their combined monthly
income.
•

80% (n=49) of parents of children and adolescents reporting to have FI indicated
that their child has no additional long-term illness, health problems, or disabilities
other than food allergy or intolerance and approximately 20% (n=12) indicating
to the contrary.

•

67% (n=41) of parents of children and adolescents reporting to have FI indicated
that their child does not have a private medical insurance, with 8% (n=5)
indicating they do have a private medical insurance; with 25% (n=15) did not
specify whether they have private medical insurance.

2. Food Hypersensitivity information on the respondents:
•

Milk (75%, n=46), cereals containing gluten (30%, n=18), other foods (18%,
n=11), fruits (21%, n=13, consisting of kiwi n=2 & other fruits˟, n=11) and eggs
(11%, n= 7) were the most common food allergens associated with FI reported by
this cohort.

•

57% (n=35) of children and adolescents were reported to have additional gluten
sensitivities. This consisted of 26% (n=16) of the examined cohort reporting to
have gluten/non-coeliac gluten sensitivity, 18% (n=11) reported to have
suspected coeliac disease and 13% (n=08) reported to have suspected wheat
allergy.

•

23% (n=14) of parents of FI sufferers reported that at least one other household
member has food intolerance. Notably, 16% (n=10) reported that figure to be 2
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additional household members, and 7% (n=4) reported it to be ≥3 additional
household members; with 16% (n=10) not answering the question.
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Age and Gender of Children & Adolescents who were reported to have Food
Intolerance (FI) in the parental survey in Ireland(n=59) and NI (n=61)
Percentage of children (female)
Percentage of children (male)

30%
24%

Percentage

25%
20%

17%
14%

15%

15%

8%

10%
5%

14%

5%

3%

0%

below 1 year

1-5

Age Group

6-12

13-17

*Associated number of children and adolescents reported by parents to have FI by their age group: below 1 year: 2 females & 5 males;
1 – 5 years: 8 females & 10 males; 6 – 12 years: 14 females & 8 males; 13 -17 years: 9 females & 3 male

Figure 5.A.1: Percentage breakdown of children and adolescents, by gender and
age, who were reported to have FI in the parental survey conducted between
November 2019 and June 2020, in Ireland (<18 years, n = 59)

Percentage of children (female)
20%

18%

18%

Percentage

16%

15%

Percentage of children (male)
16%

15%
11.5%

10%

5%

3.5%
2%

0%
below 1 year
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*Associated number of children and adolescents reported by parents to have FI by their age group: below 1 year: 1 female & 2 males;
1 – 5 years: 10 females & 11 males; 6 – 12 years: 11 females & 9 males; 13 -17 years: 10 females & 7 males

Figure 5.A.2: Percentage breakdown of children and adolescents, by gender and
age, who were reported to have FI in the parental survey conducted between
November 2019 and June 2020, in NI (<18 years, n = 61)
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Ethnicity (or cultural background) reported by parents of children and adolescents
suffering from Food Intolerance (FI) in Ireland (n=59) and NI (n=61)
3%

2%
Irish

12%

British
Any other White background
2%

Any other Asian background
Other

81%
*Associated number of parents who reported their child’s ethnicity (or cultural background): Irish = 48 individuals; British = 1
individual; Any other White background = 7 individuals; Any other Asian background = 2 individuals; Other (including mixed
background) = 1 individual

Figure 5.A.3: Ethnicity (or cultural background) indicated by parents reporting
their child to have of FI in a survey conducted between November 2019 and June
2020, in Ireland (<18 years, n = 59)
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3% 2%
Nothern Irish
Irish
British
39%
33%

Any other White background
Other

23%
*Associated number of parents who reported their child’s ethnicity (or cultural background): Northern Irish = 24 individuals; Irish =
14 individuals; British = 20 individuals; Any other White background = 2 individuals; Other (including mixed background) = 1
individual

Figure 5.A.4: Ethnicity (or cultural background) indicated by parents reporting
their child to have of FI in a survey conducted between November 2019 and June
2020, in NI (<18 years, n = 61)
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Highest level of education indicated by parents of children and adolescents reported
as having Food Intolerance (FI) in Ireland (n=59) and NI (n=61)
Percentage of Parent/Guardian

35%

Percentage of Spouse/Partner

31%

32%

30%

Percentage

20%

24%

22%

25%

20%
17%

15%

14%

15%
10%

10%

8%

7%

5%
0%
Primary/Bachelor's Postgraduate/Higher Diploma/Certificate Leaving Certificate or Junior Certificate or
similarˢ
similarˣ
degree
degree

Unspecified*

Highest level of education
*Associated number of parents who reported their highest-level education: Parent/Guardian: Primary/Bachelor’s degree = 18
individuals; Postgraduate/Higher degree = 13 individuals; Diploma/Certificate = 10 individuals; ˢLeaving Certificate or similar
(includes Advanced Levels/General Certificate of Education Advanced) = 6 individuals; ; ˣJunior Certificate or similar (includes
Intermediate/Group/Ordinary Levels/General Certificate of Secondary Education or equivalent) = 4 individuals; *Unspecified (did
not answer) = 12 individuals
**Spouse/Partner: Diploma/Certificate = 14 individuals; Primary/Bachelor’s degree = 9 individuals; ˢLeaving Certificate or similar
(includes Advanced Levels/General Certificate of Education Advanced) = 8 individuals; Postgraduate/Higher degree = 5
individuals; ˣJunior Certificate or similar (includes Intermediate/Group/Ordinary Levels/General Certificate of Secondary Education
or equivalent) = 4 individuals; *Unspecified (did not answer) = 19 individuals

Figure 5.A.5: Highest level of education indicated by parents who reported their
child/adolescent to have FI in a survey conducted between November 2019 and June
2020, in Ireland (<18 years, n = 59)
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Highest level of education
*Associated number of parents who reported their highest-level education: Parent/Guardian: Primary/Bachelor’s degree = 12
individuals; Postgraduate/Higher degree = 11 individuals; Diploma/Certificate = 8 individuals; ˣJunior Certificate or similar (includes
Intermediate/Group/Ordinary Levels/General Certificate of Secondary Education or equivalent) = 7 individuals; ˢLeaving Certificate
or similar (includes Advanced Levels/General Certificate of Education Advanced) = 5 individuals; *Unspecified (did not answer) =
18 individuals
**Spouse/Partner: Diploma/Certificate = 10 individuals; ˣJunior Certificate or similar (includes Intermediate/Group/Ordinary
Levels/General Certificate of Secondary Education or equivalent) = 8 individuals; Primary/Bachelor’s degree = 6 individuals; ˢLeaving
Certificate or similar (includes Advanced Levels/General Certificate of Education Advanced) = 5 individuals; Postgraduate/Higher
degree = 3 individuals; Primary Education or less = 1 individual; *Unspecified (did not answer) = 28 individuals

Figure 5.A.6 Highest level of education indicated by parents who reported their
child/adolescent to have FI in a survey conducted between November 2019 and June
2020, in NI (<18 years, n = 61)
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Employment status indicated by parents of children and adolescents reported as
having Food Intolerance (FI) in Ireland (n=59) and NI (n=61)
60%

Percentage of Parent/Guardian
48%
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Percentage of Spouse/Partner
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3%
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0%
Full-time

Homemaker

Part-time

Unemployed

On disability
allowance

Student

Self employed

Unspecified*

Employment Status
*Associated number of parents who reported their employment status: Parent/Guardian: Full-time = 24 individuals; Homemaker = 9
individuals; Part-time = 4 individuals; Unemployed = 4 individuals; On disability allowance = 3 individuals; Student = 2 individuals;
Self employed = 1 individuals; *Unspecified (did not answer) = 12 individuals
**Spouse/Partner: Full-time = 28 individuals; Self-employed = 5 individuals; Part-time = 2 individuals; Unemployed = 2 individuals;
Student = 2 individuals; *Unspecified (did not answer) = 20 individuals

Figure 5.A.7: Employment status recorded by parents who reported their
child/adolescent to have FI in a survey conducted between November 2019 and June
2020, in Ireland (<18 years, n = 59)
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Employment Staus
*Associated number of parents who reported their employment status: Parent/Guardian: Part-time = 17 individuals; Full-time = 13
individuals; Self-employed = 3 individuals; Student = 3 individuals; Unemployed = 2 individuals; On disability allowance = 2
individuals; Homemaker = 2 individuals; Volunteer = 1 individual; *Unspecified (did not answer) = 18 individuals
**Spouse/Partner: Full-time = 21 individuals; Self-employed = 8 individuals; Unemployed = 3 individuals; Part-time = 2 individuals;
Student = 1 individual; *Unspecified (did not answer) = 26 individuals

Figure 5.A.8: Employment status recorded by parents who reported their
child/adolescent to have FI in a survey conducted between November 2019 and June
2020, in NI (<18 years, n = 61)
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Geographical location indicated by parents reporting their child/adolescent to have
Food Intolerance (FI) in Ireland (n=59) and NI (n=61)
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Geographical Location
*Associated number of parents who reported their living settlement: Urban = 27 individuals; Rural = 20 individuals; *Unspecified
(did not answer) = 12 individuals

Figure 5.A.9: Percentage of parents of children and adolescents reported with FI
sufferers in a survey conducted between November 2019 and June 2020, living in
urban and rural setting in Ireland (<18 years, n = 59)
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Geographical Location
*Associated number of parents who reported their living settlement: Urban = 23 individuals; Rural = 22 individuals; *Unspecified
(did not answer) = 16 individuals

Figure 5.A.10: Percentage of parents of children and adolescents reported with FI
sufferers in a survey conducted between November 2019 and June 2020, living in
urban and rural setting in NI (<18 years, n = 61)
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Combined monthly income range (after tax deductions) recorded by parents of
children with Food Intolerance (FI) in Ireland (n=59) and NI (n=61)
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37%
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Percentage
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15%
10%
5%
0%
Under 1,000 to 3,500

3,501 to 8,0001 or more

Unspecified*

Combined Income Per Month
*Associated number of parents who reported their combined monthly income range (after tax deductions): Under 1,000 to 3,500 = 22
individuals; 3,501 to 8,0001 or more = 19 individuals; *Unspecified (did not answer) = 18 individuals

Figure 5.A.11: Percentage of combined monthly income range (after tax deductions)
earned by both parents reporting to have FI in a survey conducted between
November 2019 and June 2020, in Ireland (<18 years, n = 59)
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3,501 to 8,0001 or more
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Combined Income Per Month
*Associated number of parents who reported their combined monthly income range (after tax deductions): Under 1,000 to 3,500 = 29
individuals; 3,501 to 8,0001 or more = 11 individuals; *Unspecified (did not answer) = 21 individuals

Figure 5.A.12 Percentage of combined monthly income range (after tax deductions)
earned by both parents reporting to have FI in a survey conducted between
November 2019 and June 2020, in the NI (<18 years, n = 61)
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Additional long-term illness, health problems, or disabilities other than food allergy
or intolerance indicated by parents of children and adolescents reported with Food
Intolerance (FI) in Ireland (n=59) and NI (n=61)
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24%

20%

10%
0%
No

Yes

Long-term illness, health problems, or disabilities other than food allergy or
intolerance
*Associated number of children and adolescents whose parents indicated additional long-term illness, health problems, or disabilities
other than food allergy or intolerance: No = 45 individuals; Yes = 14 individuals

Figure 5.A.13: Percentage of parents who reported additional long-term illness,
health problems, or disabilities (other than food allergy or intolerance) in their
child/adolescent in a survey conducted between November 2019 and June 2020, in
Ireland (<18 years, n = 59)
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* Associated number of children and adolescents whose parents indicated additional long-term illness, health problems, or disabilities
other than food allergy or intolerance: No = 49 individuals; Yes = 12 individuals

Figure 5.A.14: Percentage of parents who reported additional long-term illness,
health problems, or disabilities (other than food allergy or intolerance) in their
child/adolescent in a survey conducted between November 2019 and June 2020, in
NI (<18 years, n = 61)
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Confirmation of Private medical insurance indicated by parents of children and
adolescents reported with Food Intolerance (FI) in Ireland (n=59) and NI (n=61)
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Private Medical Insurance
*Associated number of parents who reported to have a private medical insurance for their child/adolescent: No = 28 individuals; Yes
= 24 individuals; *Unspecified (did not answer): 7 individuals.

Figure 5.A.15: Percentage of parents reporting their child/adolescent to have FI who
indicated that they pay for private medical insurance in a survey conducted between
November 2019 and June 2020, in Ireland (<18 years, n = 59)
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Private Medical Insurance
* Associated number of parents who reported to have a private medical insurance for their child/adolescent: No = 41 individuals; Yes
= 5 individuals; *Unspecified (did not answer) = 15 individuals

Figure 5.A.16: Percentage of parents reporting their child/adolescent to have FI who
indicated that they pay for private medical insurance in a survey conducted between
November 2019 and June 2020, in NI (<18 years, n = 61)
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Reported Food Intolerances, Suspected or Non-medically diagnosed food allergies
indicated by parents of children and adolescents reported with Food Intolerance
(FI) in Ireland (n=59)
Milk

59%

Percentage

Cereals containing gluten

41%
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Other Fruits

17%
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40%

50%

60%

70%

Food intolerances, Suspected or Non-medically diagnosed food allergies
*Associated number of children and adolescents who suffer from food intolerances to these foodstuffs: Milk = 35 individuals; Cereals
containing gluten = 24 individuals; Other Foods = 10 individuals; Other Fruits = 10 individuals; Eggs = 5 individuals; Meat and
poultry = 3 individuals; Fish = 3 individuals; Other nuts = 2 individuals; Peanuts = 2 individuals; Sulphur dioxide and sulph ites = 1
individuals; Crustaceans = 1 individuals; Soybeans = 1 individuals
**Breakdown of food intolerances to:
°Other Nuts (n=2) = Nuts (unspecified, n=2)
˟Other Fruits (n=13) = Fruits (unspecified, n=2); Orange (n=3); Strawberries (n=3); Tomatoes (n=2); Apples (n=1); Apricot (n=1 );
Watermelon (n=1)
˟˟Other Foods (n=10) = Carrot (n=1); Garlic (n=1); Honey (n=1); Chocolate (n=1); Coffee (n=1); Soft drinks (n=1); Sweets (n=1);
Sugar (n=1)

Figure 5.A.17: Food intolerances indicated by parents reporting their
child/adolescent to have FI in a survey conducted between November 2019 and June
2020, in Ireland (<18 years, n = 59)
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Percentage

Reported Food Intolerances, Suspected or Non-medically diagnosed food allergies
indicated by parents of children and adolescents reported with Food Intolerance
(FI) in NI (n=61)
Milk
Cereals containing gluten
Other Foods
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Food intolerances, Suspected, or Non-medically diagnosed food allergies
*Associated number of children and adolescents who suffer from food intolerances to these foodstuffs: Milk = 46 individuals; Cereals
containing gluten = 18 individuals; Other Foods = 11 individuals; Other Fruits = 11 individuals; Eggs = 7 individuals; Soybea ns = 5
individuals; Meat or poultry = 3 individuals; Other nuts = 3 individuals; Kiwi = 2 individuals; Peanuts = 2 individuals; Celery = 1
individual; Sulphur dioxide and sulphites = 1 individual; Fish = 1 individual
**Breakdown of food intolerance to:
°Other nuts (n=3) = Nuts (unspecified, n=2); Almonds (n=1)
˟Other fruits (n=20) = Citrus fruits (Oranges, n=4; Lemon, n=1); Berries (n=1); Banana (n=1); Coconut (n=1); Grapes (n=1); Melon
(n=1); Pineapple (n=1); Tomatoes (n=1)
˟˟Other foods (n=) = Buckwheat (n=1); Chia seeds (n=1); Green pepper (n=1); Potatoes (n=1); Honey (n=1); Sweets (n=1); Chocolate
(n=1); Peas (n=1); Sugar (n=1); Food Colouring (n=1); Yeast (n=1)

Figure 5.A.18: Food intolerances indicated by parents reporting their
child/adolescent to have FI in a survey conducted between November 2019 and June
2020, in NI (<18 years, n = 61)
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Additional gluten sensitivities reported by parents of children and adolescents
reported with Food Intolerance (FI) in Ireland (n=59) and NI (n=61)
Number of children and adolescents

16
14
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10
8
6
6

4
2
0
Gluten sensitivity/non-coeliac gluten
sensitivity

Suspected wheat allergy (not
medically diagnosed

Suspected coeliac disease (not
medically diagnosed

Additional gluten sensitivities
*Associated number of children and adolescents who suffer from gluten sensitivities: Gluten sensitivity/non-coeliac gluten sensitivity
= 14 individuals (24%); Suspected wheat allergy (not medically diagnosed) = 10 individuals (17%); Suspected coeliac disease (not
medically diagnosed) = 6 individuals (10%)

Figure 5.A.19: Additional gluten sensitivities recorded by parents reporting their
child/adolescent to have FI in a survey conducted between November 2019 and June
2020, in Ireland (<18 years, n=59)
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Additional gluten sensitivities
*Associated number of children and adolescents who suffer from gluten sensitivities: Gluten sensitivity/non-coeliac gluten sensitivity
= 16 individuals (26%); Suspected coeliac disease (not medically diagnosed) = 11 individuals (18%); Suspected wheat allergy (not
medically diagnosed) = 8 individuals (13%)

Figure 5.A.20: Additional gluten sensitivities recorded by parents reporting their
child/adolescent to have FI in a survey conducted between November 2019 and June
2020, in NI (<18 years, n=61)
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Number of additional household members with Food Intolerance (FI) indicated by
Parents of children and adolescents reported with FI in Ireland (n=59) and NI
(n=61)
19%
1 household member
2 household members
3 plus household members
Unspecified*
8%
56%

17%

*Associated number of parents who reported additional household members with food intolerance: 1 household member (the
child/adolescent reported to be FI) = 33 individuals; 2 household members = 10 individuals; 3 plus household members = 5
individuals; *Unspecified (did not mention) = 11 individuals

Figure 5.A.21: Additional household members recorded as suffering with FI (other
than the children and adolescents reporting to be FI) in a survey conducted between
November 2019 and June 2020, in Ireland (<18 years, n = 59)
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16%
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2 household members
3 plus household members

7%

Unspecified*

61%

16%

* Associated number of parents who reported additional household members with food intolerance: 1 household member (the
child/adolescent reported to be FI) = 37 individuals; 2 household members = 10 individuals; 3 plus household members = 4
individuals; *Unspecified (did not mention) = 10 individuals

Figure 5.A.22: Additional household members recorded as suffering with FI (other
than the children and adolescents reporting to be FI) in a survey conducted between
November 2019 and June 2020, in NI (<18 years, n = 61)
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Appendix 6: FI Adult Surveys
General analysis and summary information of adults (≥ 18 years of age) who
reported having a FI in a survey conducted between November 2019 and June 2020,
in both Ireland and NI
6.1 Main findings of the survey of adults with FI in Ireland (587 respondents)
1. Background information on the respondents:
•

53% (n=113) of all respondents reported to be in the 18-29 years category (49%
females & 4% males). In fact, 73% (n=228) of all respondents reported to be
aged between 18-39 years (females 67% & males 6%), with 27% (n=159) being
> 40 years (24% females and 3% males).

•

91% (n=537) of respondents reported to be female and 9% male (n=50) of the
respondents reporting to have a food intolerance (FI) in the Ireland.

•

The majority 81% (n=476) of the FI respondents reported to be Irish, 0.2% (n=1)
to be Irish Traveller, 3% (n=20) to be British (originally from Britain), 1% (n=3)
to be Northern Irish, and 14.8% (n=87) originally from elsewhere, but are
currently residing in Ireland

•

50% (n=293) of the FI respondents reported a third level qualification as their
highest qualification, and 21% (n=126) reported to have completed a second level
qualification and 0.5% of the FI respondents reported to have completed Primary
Education or less; with 28.5% (n=167) not specifying their educational
background.

•

43% (n=251) reported to be employed either full-time (including self-employed)
or part-time, approximately 17% (n=99) in education; 8% (n=47) not to be
working, with 32% (n=190) not specifying their working status.
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•

The majority of respondents reported to be living in an urban setting 44% (n=55)
compared to 30% (n=37) in the rural area; with an additional 26% (n=32) not
specifying their geographical location

•

The majority of respondents reported to be living in an urban setting 47% (n=278)
compared to 24% (n=142) in the rural area; with an additional 29% (n=167) not
specifying their geographical location.

•

47% (n=276) of FI adults reported to be earning between <€1,000 and €3,500 (as
an individual) per month and approximately 4% (n=22) >€3,501 (as an
individual) after tax deductions; with 49% (n=289) not specifying their monthly
income.

•

72% (n=424) of FI adults reported to have no additional long-term illness, health
problems, or disabilities other than food allergy or intolerance and approximately
27% (n=161) indicating to the contrary; with 1% (n=2) not specifying their
condition.

•

43% (n=254) of FI adults reported do not have a private medical insurance, with
36% (n=210) indicating they do have a private medical insurance; with 21%
(n=123) did not specify whether they have private medical insurance.

2. Food Hypersensitivity information on the respondents:
•

Milk (57%, n=333), cereals containing gluten (44%, n=259), other foods (24%,
n=142), fruits (20%, n=114, consisting of kiwi n=15 & other fruits˟, n=99) and
peanuts (11%, n=63) were the most common food allergens associated with FI
reported by this cohort.
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•

Onion (n=33), garlic (n=20), mushroom (n=12), yeast (n=10), pepper (n=9),
legumes (n=9), food additives (n=8), potatoes (n=7), cabbage (n=7) and broccoli
(n=6) were the most reported food intolerances for Other foods category as
indicated by this cohort.

•

70% (n=411) of all respondents were reported to have additional gluten
sensitivities. This consisted of 36% (n=211) of the examined cohort reporting to
have gluten/non-coeliac gluten sensitivity, 22% (n=131) reported to have
suspected wheat allergy and 12% (n=69) reported to have suspected coeliac
disease.

•

20% (n=119) of all respondents reported that at least one other household member
has food intolerance. Notably, 14% (n=82) reported it to be 2 additional
household members, and 6% (n=37) reported it to be ≥3 additional household
members; with 39% (n=231) not answering the question.
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6.2 Main findings of the survey of adults with FI in Northern Ireland (515
respondents)
1. Background information on the respondents:
•

44% (n=229) of all respondents reported to be in the 18-29 years category (41%
females & 3% males). In fact, 68% (n=349) of all respondents reported to be
aged between 18-39 years (females 63% & males 5%), with 32% (n=166) being
> 40 years (30% females and 2% males).

•

93% (n=479) of respondents reported to be female and 7% male (n=36) of the
respondents reporting to have a food intolerance (FI) in NI.

•

The majority 50% (n=259) of the FI respondents reported to be Northern Irish,
26% (n=136) to be Irish and approximately 19% (n=96) to be British (originally
from Britain); with approximately 5% (n=24) originally from elsewhere but are
currently residing in NI.

•

48% (n=248) of the FI respondents reported a third level qualification as their
highest qualification, and 18% (n=96) reported to have completed a second level
qualification and 1%(n=3) of the FI respondents reported to have completed
Primary Education or less; with 33% (n=168) not specifying their educational
background.

•

45.5% (n=233) reported to be employed either full-time (including selfemployed) or part-time, approximately 11% (n=57) in education; 11% (n=57) not
to be working, with 32.5% (n=168) not specifying their working status.

•

The majority of respondents reported to be living in an urban setting 43% (n=222)
compared to 24% (n=125) in the rural area; with an additional 33% (n=168) not
specifying their geographical location.
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•

48% (n=247) of FI adults reported to be earning between <€1,000 and €3,500 (as
an individual) per month and approximately 5% (n=27) >€3,501 (as an
individual) after tax deductions; with 47% (n=241) not specifying their monthly
income.

•

70% (n=361) of FI adults reported to have no additional long-term illness, health
problems, or disabilities other than food allergy or intolerance and approximately
29% (n=152) indicating to the contrary; with 1% (n=2) not specifying their
condition.

•

67% (n=343) of FI adults reported do not have a private medical insurance, with
11% (n=59) indicating they do have a private medical insurance; with 22%
(n=113) did not specify whether they have private medical insurance.

2. Food Hypersensitivity information on the respondents:
•

Milk (59%, n=306), cereals containing gluten (48%, n=245), other foods (24%,
n=125), fruits (19%, n=101, consisting of kiwi n=17 & other fruits˟, n=84) and
eggs (11%, n=58) were the most common food allergens associated with FI
reported by this cohort.

•

Onion (n=22), garlic (n=22), food additives (n=13), pepper (n=11), potatoes
(n=10); mushroom (n=10), legumes (n=9), yeast (n=8), cocoa (n=7) and gravy
(n=7) were the most reported food intolerances for other foods category as
indicated by this cohort.

•

70% (n=360) of all respondents were reported to have additional gluten
sensitivities. This consisted of 36% (n=183) of the examined cohort reporting to
have gluten/non-coeliac gluten sensitivity, 23% (n=118) reported to have
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suspected wheat allergy and 11% (n=59) reported to have suspected coeliac
disease.
•

17% (n=90) of all respondents reported that at least one other household member
has food intolerance. Notably, 14% (n=72) reported it to be 2 additional
household members, and 3% (n=18) reported it to be ≥3 additional household
members; with 35% (n=178) not answering the question.
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Age and gender reported by adults reporting to have Food Intolerance (FI) in
Ireland (n=587) and NI (n=515)
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Age Group
*Associated number of individuals who reported their age group: 18 – 29 years: 290 females & 23 males; 30 – 39 years: 106 females
& 9 males; 40 – 49 years: 64 females & 8 males; 50 – 59 years: 49 females & 4 males; ≥ 60 years: 28 females & 6 males

Figure 6.A.1: Percentage breakdown of adults, by gender and age, who reported to
be FI in a survey conducted between November 2019 and June 2020, in Ireland (≥18
years, n = 587)
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*Associated number of individuals who reported their age group: 18 – 29 years: 213 females & 16 males; 30 – 39 years: 111 females
& 9 males; 40 – 49 years: 77 females & 6 males; 50 – 59 years: 46 females & 4 males; ≥ 60 years: 32 females & 1 male

Figure 6.A.2: Percentage breakdown of adults, by gender and age, who reported to
be FI in a survey conducted between November 2019 and June 2020, in NI (≥18
years, n = 515)
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Ethnicity (or cultural background) reported by adults reporting to have Food
Intolerance (FI) in Ireland (n=587) and NI (n=515)
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Any other White background
Any other Asian background
African
Chinese
Other

81%

*Associated number of individuals who reported their ethnicity (or cultural background): Irish = 476 individuals; British = 20
individuals; Northern Irish = 3 individuals; Any other White background = 53 individuals; Irish Traveller = 1 individual; African =
4 individuals; Chinese = 1 individual; Any other Asian background = 20 individuals; Other (including mixed background) = 9
individuals

Figure 6.A.3: Ethnicity (or cultural background) indicated by adults reporting to be
FI in a survey conducted between November 2019 and June 2020, in Ireland (≥18
years, n = 587)
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50%
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26%

*Associated number of individuals who reported their ethnicity (or cultural background): Northern Irish = 259 individuals; Ir ish =
136 individuals British = 96 individuals; Any other White background = 12 individuals; African = 1 individual; Chinese = 4
individuals; Any other Asian background = 4 individuals; Mixed background = 2 individuals; Other (including mixed background) =
1 individual

Figure 6.A.4: Ethnicity (or cultural background) indicated by adults reporting to be
FI in a survey conducted between November 2019 and June 2020, in NI (≥18 years,
n = 515)
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Highest level of education reported by adults reporting to have Food Intolerance
(FI) in Ireland (n=587) and NI (n=515)
30%
25%

28.5%
23%

Percentage

20%

17.5%
14.5%

15%

12%

10%
4%

5%

0.5%
0%
Primary/Bachelor's
degree

Leaving Certificate or Postgraduate/Higher
similarˢ
degree

Diploma/Certificate

Junior Certificate or
similarˣ

Primary Education or
less

Unspecified*

Highest level of Education
*Associated number of individuals who reported their highest-level education: Primary/Bachelor’s degree: 137 individuals; ˢLeaving
Certificate or similar (includes Advanced Levels/General Certificate of Education Advanced) = 103 individuals; Postgraduate/Higher
degree = 85 individuals; Diploma/Certificate = 71 individuals; ˣJunior Certificate or similar (includes Intermediate/Group/Ordinary
Levels/General Certificate of Secondary Education or equivalent) = 23 individuals; Primary Education or less = 1 individual;
*Unspecified (did not answer) = 167 individuals

Figure 6.A.5: Highest level of education indicated by adults who reported to be FI
in a survey conducted between November 2019 and June 2020, in Ireland (≥18 years,
n = 587)
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1%
0%
Primary/Bachelor's Leaving Certificate or Postgraduate/Higher Diploma/Certificate
similarˢ
degree
degree

Junior Certificate or Primary Education or
similarˣ
less

Unspecified*

Highest level of Education
*Associated number of individuals who reported their highest-level education: Primary/Bachelor’s degree = 115 individuals; ˢLeaving
Certificate or similar (includes Advanced Levels/General Certificate of Education Advanced) = 74 individuals; Postgraduate/Higher
degree = 71 individuals; Diploma/Certificate = 62 individuals; ˣJunior Certificate or similar (includes Intermediate/Group/Ordinary
Levels/General Certificate of Secondary Education or equivalent) =22 individuals; Primary Education or less = 3 individual;
*Unspecified (did not answer) = 168 individuals

Figure 6.A.6: Highest level of education indicated by adults who reported to be FI
in a survey conducted between November 2019 and June 2020, in NI (≥18 years, n
= 515)
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Employment status reported by adults reporting to have Food Intolerance (FI) in
Ireland (n=587) and NI (n=515)
32%

35%
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26%
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0.5%

0%
Full-time

Student

Part-time Unemployed

Self
On disability Homemaker
employed allowance

Retired

Volunteer Unspecified*

Employment Satus
*Associated number of individuals who reported their employment status: Full-time = 150 individuals; Student = 99 individuals; Parttime = 77 individuals; Unemployed = 22 individuals; Self-employed = 13 individuals; Homemaker = 13 individuals; On disability
allowance = 11 individuals; Retired = 8 individuals; Volunteer = 4; *Unspecified (did not answer) = 190 individuals

Figure 6.A.7: Employment status recorded by adults who reported to be FI in a
survey conducted between November 2019 and June 2020, in Ireland (≥18 years, n
= 587)
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allowance

Employment Status
*Associated number of individuals who reported their employment status: Full-time = 161 individuals; Student = 57 individuals; Parttime = 50 individuals; Self-employed = 22 individual; Retired = 19 individuals; On disability allowance = 14 individuals; Homemaker
= 14 individuals; Unemployed = 9 individuals; Volunteer = 1 individuals; *Unspecified (did not answer) = 168 individuals

Figure 6.A.8: Employment status recorded by adults who reported to be FI in a
survey conducted between November 2019 and June 2020, in NI (≥18 years, n = 515)
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Percentage

Geographical location indicated by adults reporting to have Food Intolerance (FI)
in Ireland (n=587) and NI (n=515)
50%
45%
40%
35%
30%
25%
20%
15%
10%
5%
0%

47%

29%

24%

Urban

Rural

Unspecified*

Geographical Location
*Associated number of individuals who reported their living settlement: Urban = 278 individuals; Rural = 142 individuals;
*Unspecified (did not answer) = 167 individuals

Figure 6.A.9: Percentage of adults reporting to have FI in a survey conducted
between November 2019 and June 2020, living in urban and rural setting in Ireland
(≥18 years, n = 587)
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Unspecified*

Geographical Location
*Associated number of individuals who reported their living settlement: Urban = 222 individuals; Rural = 125 individuals;
*Unspecified (did not answer) = 168 individuals

Figure 6.A.10: Percentage of adults reporting to have FI in a survey conducted
between November 2019 and June 2020, living in urban and rural setting in NI (≥18
years, n = 515)

576

Monthly income range as an individual (after tax deductions) recorded by adults
reporting to have Food Intolerance (FI) in Ireland (n=587) and NI (n=515)
60%
50%

49%

47%

Percentage

40%
30%
20%
10%

4%

0%
Under 1,000 to 3,500

3,501 to 8,0001 or more

Unspecified*

Income range per month
*Associated number of individuals who reported their monthly income range (after tax deductions): Under 1,000 to 3,500 = 276
individuals; 3,501 to 8,0001 or more = 22 individuals; *Unspecified (did not answer) = 289 individuals

Figure 6.A.11: Percentage of monthly income range (after tax deductions) earned
by adults reporting to have FI in a survey conducted between November 2019 and
June 2020, in Ireland (≥18 years, n = 587)
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3,501 to 8,0001 or more

Unspecified*

Income range per month
*Associated number of individuals who reported their monthly income range (after tax deductions): Under 1,000 to 3,500 = 247
individuals; 3,501 to 8,0001 or more = 27 individuals; *Unspecified (did not answer) = 241 individuals

Figure 6.A.12: Percentage of monthly income range (after tax deductions) earned
by adults reporting to have FI in a survey conducted between November 2019 and
June 2020, in the NI (≥18 years, n = 515)
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Additional long-term illness, health problems, or disabilities other than food allergy
or intolerance reported by adults reporting to have Food Intolerance (FI) in Ireland
(n=587) and NI (n=515)
80%

72%

70%

Percentage
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50%
40%
27%

30%
20%
10%

1%

0%
No

Yes

Unspecified*

Long-term illness, health problems, or disabilities other than food allergy or
intolerance
*Associated number of individuals who reported to have additional long-term illness, health problems, or disabilities other than food
allergy or intolerance: No = 424 individuals; Yes = 161 individuals; *Unspecified (did not answer) = 2 individuals

Figure 6.A.13: Percentage of adults who reported to have FI and have additional
long-term illness, health problems, or disabilities (other than food allergy or
intolerance) in a survey conducted between November 2019 and June 2020, in
Ireland (≥18 years, n = 587)
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Long-term illness, health problems, or disabilities other than food allergy or
intolerance
*Associated number of individuals who reported to have additional long-term illness, health problems, or disabilities other than food
allergy or intolerance: No = 361 individuals; Yes = 152 individuals; *Unspecified (did not answer) = 2 individuals

Figure 6.A.14: Percentage of adults who reported to have FI and have additional
long-term illness, health problems, or disabilities (other than food allergy or
intolerance) in a survey conducted between November 2019 and June 2020, in NI
(≥18 years, n = 515)
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Private medical insurance reported by adults reporting to have FI in Ireland
(n=587) and NI (n=515)
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43%

40%

36%

Percentage
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Unspecified*

Private Medical Insurance
*Associated number of individuals who reported to have a private medical insurance: No = 254 individuals; Yes = 210 individua ls;
*Unspecified (did not answer): 123 individuals.

Figure 6.A.15: Percentage of adults reporting to have FI who indicated that they
pay for private medical insurance in a survey conducted between November 2019
and June 2020, in Ireland (≥18 years, n = 587)
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Unspecified*

Private Medical Insurance
*Associated number of individuals who reported to have a private medical insurance: No = 343 individuals; Yes = 59 individual s;
*Unspecified (did not answer) = 113 individuals

Figure 6.A.16: Percentage of adults reporting to have FI who indicated that they
pay for private medical insurance in a survey conducted between November 2019
and June 2020, in NI (≥18 years, n = 515)
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Percentage

Reported FI indicated by adults in Ireland (n=587)
Milk
Cereals containing gluten
Other Fruits
Peanuts
Sulphur dioxide and sulphites
Eggs
Crustaceans
Other nuts
Soy beans
Molluscs
Fish
Meat or poultry
Celery
Kiwi
Sesame seeds
Mustard
Lupins
Other Foods

57%
44%
17%
11%
9%
9%
7%
7%
6%
5%
5%
5%
3%
3%
2%
2%
2%
24%

0%

10%

20%

30%

40%

50%

60%

Food intolerances, Suspected, or Non-medically diagnosed food allergies
*Associated number of individuals who suffer from food intolerance to these foodstuffs: Milk = 333 individuals; Cereals containing
gluten = 259 individuals; Other Foods = 142 individuals; Other Fruits = 99 individuals; Peanut = 63 individuals; Sulphur dioxide and
sulphites = 54 individuals; Eggs = 53 individuals; Crustaceans = 40 individuals; Other nuts = 41 individuals; Soy beans = 38
individuals; Molluscs = 28 individuals; Fish = 28 individuals; Meat and poultry = 30 individuals; Celery = 17 individuals; Kiwi = 15
individuals; Sesame seeds = 14 individuals; Mustard = 10 individuals; Lupins = 9 individuals
**Breakdown of food intolerance to:
°Other nuts (n=51) = Nuts (*Unspecified, n=13); All tree nuts (n=7); Almonds (n=7); Cashew nuts (n=7); Hazelnuts (n=7); Walnut
(n=4); Pine Nut (n=3); Pistachio (n=3)
˟Other fruits (n=99) = Fruits (*Unspecified, n=18); Citrus fruit (*Unspecified, n=4; Orange, n=15; Grapefruit, n=2; Lemon, n=1 ;
Nectarine, n=1); Apple (n=18); Berries (*Unspecified, n=1; Strawberry, n=11; Cranberry, n=2; Blackcurrant, n=1; Pomegranate,
n=1; Raspberry, n=1); Tomato (n=15); Banana (n=14); Pineapple (n=6); Pear (n=4); Avocado (n=2); Cherry (n=2); Coconut (n=2);
Plum (n=2); Grape (n=1); Mango (n=1); Passion fruit (n=1); Passion fruit (n=1); Peach (n=1)
ˣˣOther Foods; see Figure 6.A.18 for the top 10 food intolerances to other foods

Figure 6.A.17: Food intolerances indicated by adults reporting to be FI in a survey
conducted between November 2019 and June 2020, in Ireland (≥18 years, n = 587)
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Top 10 most reported food intolerances to other foods indicated by adults reporting
FI in Ireland (n=587)
Onion

6%

Garlic

3%

Percentage

Mushroom

2%

Yeast

2%

Pepper

2%

Legumes

2%

Food Additives

1%

Potatoes

1%

Cabbage

1%

Broccoli

1%

0%

1%

2%

3%

4%

5%

6%

Food intolerances, Suspected, or Non-medically diagnosed food allergies
*Associated number of individuals who suffer from food intolerance to these foodstuffs: Onion = 33 individuals; Garlic = 20
individuals; Mushroom = 12 individuals; Yeast = 10 individuals; Pepper = 9 individuals; Legumes = 9 individuals; Food Additiv es
= 8 individuals; Cabbage = 7 individuals; Potatoes = 7 individuals; Broccoli = 6 individuals
Breakdown of food intolerances:
ˣFood Additives: Monosodium Glutamate (MSG) (n=5), Food Colourings (n=2); Sweeteners (n=1)
ˣˣLegumes: Peas (n=5); Chickpeas (n=3); Kidney beans (n=1); Lentils (n=1)

Figure 6.A.18: Top 10 most reported food intolerances to other foods as indicated
by adults reporting to be FI in a survey conducted between November 2019 and
June 2020, in Ireland (≥18 years, n = 587)
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Reported FI indicated by adults in NI (n=515)
Milk

59%

Cereals containing gluten

48%

Other Fruits

16%

Eggs

11%

Peanuts

8%

Percentage

Meat or poultry

7%

Other nuts

6%

Crustaceans

5%

Fish

5%

Sulphur dioxide and sulphites

4%

Molluscs

4%

Soy beans

4%

Kiwi

3%

Celery

3%

Sesame seeds

2%

Mustard

1%

Lupins

1%

Other Foods

24%

0%

10%

20%

30%

40%

50%

60%

70%

FI Adults
*Associated number of individuals who suffer from food intolerance to these foodstuffs: Milk = 306 individuals; Cereals containing
gluten = 245 individuals; Other Foods = 125 individuals; Other Fruits = 84 individuals; Eggs = 58 individuals; Peanut = 40 individuals;
Meat and poultry = 36 individuals; Other nuts = 33 individuals; Crustaceans = 26 individuals; Fish = 25 individuals; Sulphur dioxide
and sulphites = 22 individuals; Molluscs = 23 individuals; Soy beans = 21 individuals; Kiwi = 17 individuals; Celery = 18 individuals;
Sesame seeds = 11 individuals; Mustard = 6 individuals; Lupins = 4 individuals
**Breakdown of food intolerance to:
°Other nuts (n=36) = Nuts (unspecified, n=12); All tree nuts (n=5); Almond (n=8); Hazelnut (n=4); Brazil nut (n=2); Cashew nut
(n=2); Walnut (n=2); Pine nuts (n=1)
˟Other fruits (n=99) = Fruit (unspecified, n=7); Citrus fruits (unspecified, n=9; Orange, n=15; Lime, n=1); Banana (n=16); Berries
(*Unspecified, n=3; Strawberry, n=7; Raspberry, n=4; Blackcurrant, n=1; Cranberry, n=1); Tomatoes (n=15); Apple (n=9); Grapes
(n=5); Melon (n=3); Coconut (n=2); Mango (n=2); Peach (n=2); Pineapple (n=2); Avocado (n=1); Dragon fruit (n=1); Passionfruit
(n=1); Pear (n=1)
ˣˣOther Foods; see Figure 6.A.20 for the top 10 food intolerances to other foods

Figure 6.A.19: Reported food intolerances indicated by adults reporting to be FI in
a survey conducted between November 2019 and June 2020, in NI (≥18 years, n =
515)
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Top 10 most reported food intolerances to other foods indicated by adults reporting
to have Food Intolerance (FI) in the NI (n=515)
Onion

4%

Garlic

4%

Food Additives

3%

Percentage

Pepper

2%

Potatoes

2%

Mushroom

2%

Legumes

2%

Yeast

2%

Gravy

1%

Cocoa

1%

0%

1%

1%

2%

2%

3%

3%

4%

4%

5%

Food intolerances, Suspected, or Non-medically diagnosed food allergies
*Associated number of individuals who suffer from food intolerance to these foodstuffs: Onion = 22 individuals; Garlic = 22
individuals; Food Additives = 13 individuals; Pepper = 11 individuals; Mushroom = 10 individuals; Potatoes = 10 individuals;
Legumes = 9 individuals; Yeast = 8 individuals; Cocoa = 7 individuals; Gravy = 7 individuals
Breakdown of food intolerance to:
ˣFood Additives: Monosodium Glutamate (MSG) (n=4), Aspartame (n=3), Food colourings (n=4), Sugar alcohol (n=1), EDTA
additives (n=1)
ˣˣLegumes: Legumes (unspecified, n=1), Beans (n=3), Peas (n=3), Pulses (n=1)

Figure 6.A.20: Top 10 most reported food intolerances to other foods as indicated
by adults reporting to be FI in a survey conducted between November 2019 and
June 2020, in NI (≥18 years, n = 515)
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Additional gluten sensitivities reported by adults reporting to have FI in Ireland (n=587)
and NI (n=515)
250
211

Number of adults

200

150

131

100

69

50
0
Gluten sensitivity/non-coeliac gluten
sensitivity

Suspected wheat allergy (not
medically diagnosed)

Suspected coeliac disease (not
medically diagnosed)

Additional gluten sensitivities
*Associated number of individuals who reported additional gluten sensitivities: Gluten sensitivity/non-coeliac gluten sensitivity = 211
individuals (36%); Suspected wheat allergy (not medically diagnosed) = 131 individuals (22%); Suspected coeliac disease (not
medically diagnosed) = 69 individuals (12%)

Number of adults

Figure 6.A.21: Additional gluten sensitivities recorded by adults reporting to be FI
(to other foods) in a survey conducted between November 2019 and June 2020, in
Ireland (n=587)
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Gluten sensitivity/non-coeliac gluten
sensitivity

Suspected wheat allergy (not
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Suspected coeliac disease (not
medically diagnosed)

Additional gluten sensitivities
*Associated number of individuals who reported additional gluten sensitivities: Gluten sensitivity/non-coeliac gluten sensitivity = 183
individuals (36%); Suspected wheat allergy (not medically diagnosed) = 118 individuals (23%); Suspected coeliac disease (not
medically diagnosed) = 59 individuals (11%)

Figure 6.A.22: Additional gluten sensitivities recorded by adults reporting to be FI
(to other foods) in a survey conducted between November 2019 and June 2020, in
NI (n=515)
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Number of additional household members with food intolerance reported by adults
reporting to have Food Intolerance (FI) in Ireland (n=587) and NI (n=515)
1 household member
2 household members
3 plus household members

39%

41%

6%

Unspecified*

14%

*Associated number of individuals who reported number of household members with food intolerance: 1 household member (the
survey respondent) = 237 individuals; 2 household members = 82 individuals; 3 plus household members = 37 individuals;
*Unspecified (did not answer) = 231 individuals

Figure 6.A.23: Additional household members recorded as suffering with FI (other
than the adult survey respondent reporting to be FI) in a survey conducted between
November 2019 and June 2020, in Ireland (≥18 years, n = 587)
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1 household member
2 household members
35%

3 plus household members

Unspecified*
48%

3%

14%
*Associated number of individuals who reported number of household members with food intolerance: 1 household member (the
survey respondent) = 247 individuals; 2 household members = 72 individuals; 3 household members = 18 individuals; *Unspecified
(did not answer) = 178 individuals

Figure 6.A.24: Additional household members recorded as suffering with FI (other
than the adult survey respondent reporting to be FI) in a survey conducted between
November 2019 and June 2020, in NI (≥18 years, n = 515)
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Appendix 7: Supplementary Information on Direct, Indirect &
Intangible Costs
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Table 7.A.1. Breakdown of Additional (Incremental) Total Direct, Indirect and Total Costs (Direct & Indirect) in euro (€) associated
with being an adult (≥18 years) with food hypersensitivity (self-reported): MDFA (n=178; n=111), MDCD (n=609; n=173) and FI
(n=536; n=459) compared to non-food hypersensitive controls (n=531; n=204) in Ireland and Northern Ireland, respectively
(November 2019 – October 2020)
Ireland
NI
MDFA Adults
Visits to GP
Visits to
Consultant/Specialist
Visits to Nurse
Visits to Nurse (Outpatient
Clinic)
Visits to
Dietician/Nutritionist
Visits to Physiotherapist
Visits to Pharmacist
Visits to Other Health
Professionals
Visits to Alternative
Therapist
Total Cost of Medical
Visits & Alternative Visits
Travel to GP
Travel to
Consultant/Specialist
Travel to Nurse
Travel to Nurse (Outpatient
Clinic)
Travel to
Dietician/Nutritionist

71** (35, 106)

56** (26, 87)

Ireland
NI
MDCD Adults
Incremental Cost in Euro (€)
31* (7, 55)
50** (25, 76)

15 (-59, 90)

51 (-56, 158)

29 (-21, 79)

88* (16, 159)

-28 (-86, 31)

17 (-32, 67)

8 (-3, 20)

-15 (-14, 20)

3 (-5, 11)

12 (-18, 41)

2 (-6, 9)

-1 (-40, 42)

-6 (-29, 16)

12 (-13, 37)

-2 (-11, 7)

1 (-11, 12)

-7 (-25, 11)

15 (-8, 39)

-3 (-6, 1)

22 (-2, 46)

9** (5, 14)

26** (13, 39)

7 (-1, 16)

6 (-3, 15)

17 (-4, 37)
50 (-11, 111)

25 (-12, 62)
141* (15, 267)

18 (-3, 39)
-10 (-59, 38)

39* (4, 74)
59 (-7, 126)

-7 (-24, 10)
47 (-14, 109)

17 (-8, 43)
57 (-0, 115)

7 (-12, 25)

31* (2, 59)

-14** (-22, -6)

19 (-3, 41)

3 (-13, 20)

14* (2, 27)

19* (4, 35)

3 (-10, 15)

14** (1, 28)

2 (-10, 15)

19* (4, 35)

19* (2, 35)

178* (21, 335)

326* (72, 580)

78 (-27, 185)

296 **(130, 464)

79 (-45, 206)

189** (69, 315)

58** (29, 88)

141* (28, 253)

36** (18, 53)

63 (-10, 136)

63** (33, 91)

135** (67, 203)

3* (0, 7)

5 (-2, 12)

2* (0, 5)

2 (0, 5)

2 (-1, 5)

3 (-3, 8)

0 (-1, 1)

-34 (-68, 1)

1 (-2, 4)

-20 (-46, 7)

0 (-1, 1)

-19 (-39, 1)

-2 (-4, 1)

2 (-4, 8)

0 (-1, 2)

2 (-3, 6)

-1 (-3, 1)

4 (-2, 11)

0 (0, 0)

2 (-1, 5)

2* (0, 4)

4** (2, 6)

2 (-2, 6)

2 (0, 3)
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Ireland

NI
FI Adults

43** (14, 72)

45** (26, 63)

Travel to Pharmacist
Travel to Physiotherapist
Travel to Other Health
Professionals
Travel to Alternative
Therapist
Total Cost of Travel to
Medical & Alternative
Visits
Outpatient attendance
Emergency department
attendance without
subsequent admission to a
ward
Emergency department
attendance with subsequent
admission to a ward
Day Unit
Ambulance (Emergency
Department)
Ambulance (Hospital
Admission)
Total Cost of Hospital
Visits & Stays
Prescribed medicines
Over-the-counter medicines
Total Cost of Medication
Private Health Insurance
Total Food Cost
Total Direct Costs

15* (2,29)
-4 (-12, 3)

-11 (-39, 17)
3 (0, 6)

7* (0, 14)
-4 (-10, 2)

-19 (-44, 7)
8 (-2, 17)

8** (3, 13)
-4 (-10, 2)

29 (-65, 122)
1 (-1, 3)

0 (-3, 2)

2 (-1, 6)

-2* (-4, 0)

3 (-3, 10)

-1 (-3, 1)

1 (-2 3)

1** (0, 3)

1 (0, 1)

2** (1,3)

0 (-1, 1)

2** (1, 3)

22 (-3, 46)

71** (36, 109)

111 (-31, 251)

44** (22, 66)

43 (-49, 136)

71** (38, 103)

178** (44, 310)

6 (-81, 92)

184 (-69, 437)

16 (-29, 61)

158* (12, 305)

2 (-73, 77)

-31 (-126, 64)

14 (-16, 44)

53 (0, 107)

19 (-19, 57)

2 (-25, 28)

-1 (-22, 20)

20 (-1, 41)

371 (-122, 865)

134 (-223, 492)

-124** (-212, 36)

-139 (-316, 37)

-19 (-125, 86)

-5 (-143, 133)

-105 (-213, 2)

126** (46, 206)

154 (-37, 344)

144** (53, 236)

112 (-256, 480)

104** (45, 164)

3 (-1, 8)

1 (-6, 7)

8 (-7, 22)

0 (-7, 6)

4 (-7, 16)

-1 (-5, 3)

2 (-2, 5)

2 (-1, 5)

3 (-7, 13)

0 (0, 0)

-3** (-4, -1)

4* (0, 7)

291 (-245, 827)

500 (-115, 1,118)

76 (-178, 329)

165 (-122, 451)

95 (-335, 527)

91 (-112, 295)

11** (10, 13)
41* (9, 73)
52** (21, 84)
9 (-44, 63)
724**
(257,
1,191)
1,325**
(503,
2,150)

11** (9, 13)
8 (-4, 20)
19** (7, 31)
1 (-29, 32)

8** (6, 10)
-21 (-50, 9)
-13 (-42, 17)
95** (34, 156)
164/221 (-190,
518)
444/501 (-66,
957)

6** (4, 8)
0 (-8, 9)
6 (-2, 15)
-24 (-58, 9)

0 (0, 0)
1 (-27, 28)
1 (-27, 28)
22 (-43, 88)

0 (0, 0)
10** (2, 17)
10** (2, 17)
-10 (-32, 13)

370* (26, 713)

82 (-246, 411)

-20 (-267, 227)

856**
1,428)

350 (-275, 978)

438 (-2, 882)

25 (-289, 339)
982 (-102, 2,067)
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(284,

Time spent Food shopping
Time spent preparing food
Days missed from
Work/School/College
Lost Earning associated
with healthcare visits
Total Indirect Costs

57 (-93, 206)
-5 (-197, 188)

36 (-117, 188)
59 (-189, 307)

-23 (-114, 67)
6 (-164, 176)

15 (-140, 171)
203 (-63, 469)

-17 (-90, 57)
71 (-102, 243)

-41 (-142, 60)
-31 (-200, 137)

222 (-125, 569)

384 (86, 683)

0 (-217, 218)

486* (97, 876)

104 (-120, 328)

267** (-85, 449)

3 (-33, 39)

0 (-13, 14)

11 (-38, 60)

26* (1, 51)

-4 (-31, 23)

23* (1, 45)

277 (-184, 737)

479* (42, 916)

-6 (-347, 336)

154 (-175, 483)

218 (-78, 514)

Total Costs (Direct &
Indirect)
Number in group
Number in comparison
group

1,602**
2,652)
178

1,461*
2,730)
111

438/495 (-247,
1,126)
609

730**
1,262)
1,586**
2,500)
173

504 (-272, 1,282)

656 (68, 1,248)

536

459

531

204

531

204

531

(554,

204

(193,

*p <0.05 and ** p <0.01
**Table 7.A.2 shows these same figures in pounds (sterling)
Costs excluding/including a tax rebate on gluten-free foods claimed by 29% of MDCD adults in Ireland
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(-199,
(672,

Table 7.A.2. Breakdown of Additional (Incremental) Total Direct, Indirect and Total Costs (Direct & Indirect) in pounds sterling
(£) associated with being an adult (≥18 years) with food hypersensitivity (self-reported): MDFA (n=178; n=111), MDCD (n=609;
n=173) and FI (n=536; n=459) compared to non-food hypersensitive controls (n=531; n=204) Ireland and Northern Ireland,
respectively (November 2019 – October 2020)
Ireland
NI
MDFA Adults
Visits to GP
Visits to
Consultant/Specialist
Visits to Nurse
Visits to Nurse (Outpatient
Clinic)
Visits to
Dietician/Nutritionist
Visits to Physiotherapist
Visits to Pharmacist
Visits to Other Health
Professionals
Visits to Alternative
Therapist
Total Cost of Medical
Visits & Alternative
Visits
Travel to GP
Travel to
Consultant/Specialist
Travel to Nurse
Travel to Nurse (Outpatient
Clinic)

61** (30, 91)

48** (22, 75)

Ireland
NI
MDCD Adults
Incremental Cost in Pounds (£)
27* (6, 47)
43** (22, 65)

13 (-51, 77)

44 (-48, 136)

25 (-18, 68)

76* (14, 137)

-24 (-74, 27)

15 (-28, 58)

7 (-3, 17)

-13 (-12, 17)

3 (-4, 9)

10 (-15, 35)

2 (-5, 8)

-1 (-34, 36)

-5 (-25, 14)

10 (-11, 32)

-2 (-9, 6)

1 (-9, 10)

-6 (-22, 9)

13 (-7, 34)

-3 (-5, 1)

19(-2, 40)

8** (4, 12)

22** (11, 34)

6 (-1, 14)

5 (-3, 13)

15 (-3, 32)
43 (-9, 95)

22 (-10, 53)
121* (13, 230)

15 (-3, 34)
-9 (-51, 33)

34* (3, 64)
51 (-6, 108)

-6 (-21, 9)
40 (-12, 94)

15 (-7, 37)
49 (-0, 99)

6 (-10, 22)

27* (2, 51)

-12** (-19, -5)

16 (-3, 35)

3 (-11, 17)

12* (2, 23)

16* (3, 30)

3 (-9, 13)

12** (1, 24)

2 (-9, 13)

16* (3, 30)

16* (2, 30)

153* (18, 288)

281* (62, 499)

67 (-23, 159)

255** (112, 399)

68 (-39, 177)

163** (59, 271)

50** (25, 76)

121* (24, 218)

31** (15, 46)

54 (-9, 117)

54** (28, 78)

116** (58, 175)

3* (0, 6)

4 (-2, 10)

2* (0, 4)

2 (0, 4)

2 (-1, 4)

3 (-3, 7)

0 (-1, 1)

-29 (-58, 1)

1 (-2, 3)

-17 (-34, 6)

0 (-1, 1)

-16 (-34, 1)

-2 (-3, 1)

2 (-3, 7)

0 (-1, 2)

2 (-3, 5)

-1 (-3, 1)

3 (-2, 9)
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Ireland

NI
FI Adults

37** (12, 62)

39** (22, 54)

Travel to
Dietician/Nutritionist
Travel to Pharmacist
Travel to Physiotherapist
Travel to Other Health
Professionals
Travel to Alternative
Therapist
Total Cost of Travel to
Medical & Alternative
Visits
Outpatient attendance
Emergency department
attendance without
subsequent admission to a
ward
Emergency department
attendance with subsequent
admission to a ward
Day Unit
Ambulance (Emergency
Department)
Ambulance (Hospital
Admission)
Total Cost of Hospital
Visits & Stays
Prescribed medicines
Over-the-counter
medicines
Total Cost of Medication
Private Health Insurance

0 (0, 0)

2 (-1, 4)

2* (0, 3)

3** (2, 5)

2 (-2, 5)

2 (0, 3)

13* (2, 25)
-3 (-10, 3)

-9 (-34, 15)
3 (0, 5)

6* (0, 12)
-3 (-9, 2)

-16 (-38, 6)
7 (-2, 15)

6** (3, 11)
-3 (-10, 2)

25 (-56, 105)
1 (-1, 3)

0 (-3, 2)

2 (-1, 4)

-2* (-3, 0)

3 (-3, 9)

-1 (-3, 1)

1 (-2, 3)

1** (0, 3)

1 (0, 1)

2** (1,3)

0 (-1, 1)

2** (1, 3)

19 (-3, 40)

62** (31, 94)

97 (-27, 216)

38** (19, 57)

38 (-42, 117)

61** (33, 89)

154** (38, 267)

5 (-70, 79)

158 (-59, 376)

14 (-25, 52)

136* (10, 262)

2 (-63, 66)

-27 (-108, 55)

12 (-14, 38)

46 (0, 92)

16 (-16, 49)

2 (-22, 24)

-1 (-19, 17)

17 (-1, 35)

319 (-105, 744)

115 (-192, 423)

-107** (-182, 31)

-120 (-272, 32)

-16 (-108, 74)

-4 (-123, 114)

-90 (-183, 2)

108** (40, 177)

132 (-32, 296)

124** (46, 203)

96 (-220, 413)

89** (39, 141)

3 (-1, 7)

1 (-5, 6)

7 (-6, 19)

0 (-6, 5)

3 (-6, 14)

-1 (-4, 3)

2 (-2, 4)

2 (-1, 4)

3 (-6, 11)

0 (0, 0)

-3** (-3, -1)

3* (0, 6)

251 (-211, 711)

430 (-99, 961)

65 (-153, 283)

142 (-105, 388)

81 (-288, 453)

77 (-96, 254)

9** (9, 11)

9** (8, 11)

7** (5, 9)

5** (3, 7)

0 (0, 0)

0 (0, 0)

35* (8, 63)

7 (-3, 17)

-18 (-43, 8)

0 (-7, 8)

1 (-23, 24)

9** (2, 15)

44** (18, 72)
8 (-38, 54)

16** (6, 27)
1 (-25, 28)

-11 (-36, 15)
82** (29, 134)

5 (-2, 13)
-21 (-50, 8)

1 (-23, 24)
19 (-37, 76)

9** (2, 15)
-9 (-28, 11)
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Total Food Cost
Total Direct Costs
Time spent Food shopping
Time spent preparing food
Days missed from
Work/School/College
Lost Earning associated
with healthcare visits
Total Indirect Costs
Total Costs (Direct &
Indirect)
Number in group
Number in comparison
group

623**
(221,
1,024)
1,141**
(433,
1,849)
49 (-80, 177)
-4 (-169, 162)

31 (-101, 162)
51 (-163, 264)

141/190 (-163,
445)
382/431 (-57,
823)
-20 (-98, 58)
5 (-141, 151)

191 (-108, 489)

330 (74, 587)

0 (-187, 187)

418* (83, 753)

89 (-103, 282)

230** (-73, 386)

3 (-28, 34)

0 (-11, 12)

9 (-33, 55)

22* (1, 44)

-3 (-27, 20)

20* (1, 39)

239 (-158, 634)

412* (36, 788)

-5 (-298, 289)

132 (-151, 415)

188 (-67, 442)

1,380**
2,281)
178

1,259*
2,348)
111

377/426 (-212,
968)
609

628**
1,085)
1,365**
2,150)
173

433 (-234, 1,103)

565* (46, 849)

536

459

531

204

531

204

531

(476,

22 (-249, 292)
847 (-88, 1,778)

204

(166,

*p <0.05 and ** p<0.01
**Table 7.A.1 shows these same figures in in euro
Costs excluding/including tax rebate on gluten-free foods reported as claimed by 29% of MDCD Adults in Ireland
ˣ1 Euro in British Pounds is 0.86102 for 10/18/2019 (Exchange-Rates.Org)
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318* (22, 613)
737**
(244,
1,228)
13 (-120, 147)
175 (-54, 403)

(-171,
(578,

71 (-212, 353)

-17 (-230, 195)

301 (-237, 841)

377 (-2, 759)

-15 (-77, 49)
61 (-88, 209)

-35 (-122, 52)
-27 (-172, 118)

Table 7.A.3: Breakdown of Additional (Incremental) Total Direct, Indirect and Total Costs (Direct & Indirect) in euro (€) associated
with being a parent of children/adolescents (<18 years) with food hypersensitivity (self-reported): MDFA (n=173; n=147), MDCD
(n=148; n=60) and FI (n=56; n=51) compared to non-food hypersensitive controls (n=130; n=165) in Ireland and Northern Ireland,
respectively (November 2019 – October 2020)
Ireland
NI
MDFA Parental
Visits to GP
Visits to
Consultant/Specialist
Visits to Nurse
Visits to Nurse (Outpatient
Clinic)
Visits to
Dietician/Nutritionist
Visits to Physiotherapist
Visits to Pharmacist
Visits to Other Health
Professionals
Visits to Alternative
Therapist
Total Cost of Medical
Visits & Alternative Visits
Travel to GP
Travel to
Consultant/Specialist
Travel to Nurse
Travel to Nurse (Outpatient
Clinic)
Travel to
Dietician/Nutritionist

76** (30, 122)

85** (54, 116)

Ireland
NI
MDCD Parental
Incremental Cost in Euro (€)
35 (-11, 80)
45** (27, 62)

131** (47, 216)

118** (40, 197)

117** (48, 186)

147** (99, 195)

-12 (-96, 71)

64* (5, 123)

0 (-9, 9)

9 (-3, 21)

8* (0, 16)

14** (4, 24)

-2 (-13, 9)

2 (-10, 13)

3 (-5, 10)

32 (-8, 71)

5 (-3, 13)

20** (7, 33)

-3 (-11, 4)

-1 (-15, 13)

17** (6, 27)

59** (27, 92)

21** (14, 28)

52** (40, 63)

12* (3, 20)

15** (6, 23)

-13 (-37, 12)
148** (76, 220)

-1 (-10, 8)
102** (35, 169)

7 (-44, 59)
58 (-21, 136)

3 (-15, 22)
206** (76, 336)

-33* (-60, -6)
50 (-11, 112)

-8 (-20, 5)
76* (11, 141)

13 (-2, 28)

-20 (-39, 0)

-1 (-7, 5)

-1 (-19, 17)

-3* (-7, 0)

-13 (-34, 8)

11 (-5, 27)

7 (0, 15)

3 (-6, 12)

17 (-4, 37)

6* (1, 12)

14** (4, 25)

386** (192, 580)

391** (210, 574)

253** (74, 431)

503** (309, 696)

73 (-89, 233)

208** (75, 341)

-6 (-44, 32)

131* (28, 234)

13 (-41, 66)

21 (-19, 61)

9 (-39, 58)

35 (-26, 96)

7 (-1, 15)

4* (0, 8)

3* (0, 7)

3** (1, 5)

3 (-7, 14)

3 (-1, 7)

1 (-2, 4)

3* (0, 5)

0 (0, 1)

3** (1, 5)

-1 (-2, 0)

1 (-1, 2)

1 (-2, 4)

50 (-55, 156)

-1 (-4, 1)

28 (-1, 57)

-2* (-5, 0)

10 (-2, 22)

4 (0, 9)

41 (-22, 103)

4* (1, 8)

23** (8, 38)

2* (0, 4)

2** (1, 4)
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Ireland
NI
FI Parental
58* (13, 103)

59** (37, 80)

Travel to Pharmacist
Travel to Physiotherapist
Travel to Other Health
Professionals
Travel to Alternative
Therapist
Total Cost of Travel to
Medical & Alternative
Visits
Outpatient attendance
Emergency department
attendance without
subsequent admission to a
ward
Emergency department
attendance with subsequent
admission to a ward
Day Unit
Ambulance (Emergency
Department)
Ambulance (Hospital
Admission)
Total Cost of Hospital
Visits & Stays
Prescribed medicines
Over-the-counter medicines
Total Cost of Medication
Private Health Insurance
Total Food Cost

12 (-18, 42)
-3 (-6, 1)

61* (1, 120)
0 (-1, 0)

-5 (-12, 1)
0 (-3, 2)

324 (-42, 691)
3 (-2, 8)

-4 (-13, 6)
0 (-8, 8)

25* (5, 45)
0 (-1, 0)

3 (-1, 7)

-7 (-15, 1)

0 (-1, 2)

4 (-5, 14)

0 (-1, 0)

-5 (-13, 4)

4 (-2, 10)

3 (-1, 6)

0 (0, 1)

5 (-1, 10)

2 (-1, 4)

3** (1, 5)

23 (-42, 88)

286** (74, 497)

14 (-45, 74)

414* (-3, 834)

9 (-45, 64)

74* (3, 146)

82* (14, 150)

128** (49, 207)

4 (-47, 55)

124** (71, 177)

-42 (-96, 12)

19 (-41, 79)

130** (41, 219)

66* (2, 130)

8 (-22, 39)

16 (-4, 37)

23 (-18, 64)

30 (-14, 73)

150 (-130, 430)

193 (-137, 523)

105 (-46, 256)

18 (-131, 166)

-55 (-150, 39)

-101 (-215, 12)

175* (11, 338)

195** (90, 299)

50 (-70, 169)

139** (37, 240)

-35 (-154, 84)

29 (-25, 83)

4 (-2, 11)

0 (-7, 7)

0 (-2, 3)

0 (-7, 6)

4 (-4, 11)

0 (-7, 8)

1 (-3, 4)

13* (0, 25)

0 (-4, 4)

1 (-5, 6)

-1 (-3, 2)

5 (-2, 11)

167 (-64, 400)

298* (54, 538)

-106 (-307, 94)

-18 (-220, 183)

5** (3, 7)
54** (25, 83)
59** (30, 88)
48* (11, 84)

0 (0, 0)
24** (6, 42)
24** (6, 42)
32 (-57, 121)

0 (0, 0)
10 (0, 21)
10 (0, 21)
16* (1, 30)

549** (218, 880)

-160 (-352, 31)

47 (-37, 131)

Total Direct Costs

9** (5, 12)
14 (-5, 33)
23* (3, 42)
189** (55, 322)
257**/347
(168, 347)
903**/993
(467, 1,340)

1,871** (1,062,
2,677)

-128 (-545, 286)

337 (-10, 684)

23** (13, 33)
70** (43, 96)
93** (63, 121)
85 (-6, 176)

595*
(129,
1,061)
23** (16, 30)
11 (-2, 24)
34** (20, 49)
33** (10, 56)

-14 (-210, 181)

65 (-40, 169)

1,115**
1,750)

1,404**
2,128)

542** (136, 946)

(475,

(680,

595

Time spent Food shopping
Time spent preparing food
Days missed from
Work/School/College
Lost Earning associated
with healthcare visits
Total Indirect Costs
Total Direct & Indirect
Costs
Number in group
Number in comparison
group

-29 (-138, 79)

-61 (-218, 96)

64 (-53, 182)

8 (-173, 190)

59 (-93, 212)

-119 (-489, 251)

102 (-357, 561)

-83 (-370, 204)

-325* (-616, -34)

18 (-440, 475)

302** (121, 484)

142* (16, 269)

115 (-29, 259)

406* (60, 753)

98 (-37, 233)

167 (5, 329)

170** (49, 291)

56 (-51, 164)

34 (-8, 75)

7 (-13, 27)

23 (-13, 58)

15 (-21, 51)

324 (-200, 848)
1,439**
(537,
2,336)
173

239 (-332, 811)
1,643**
(608,
2,679)
147

130 (-284, 544)
1,033**/1,123
(318, 1,749)
148

96 (-428, 623)
1,967**
(973,
2,961)
60

198 (-409, 805)

-271 (-705, 164)

70 (-730, 866)

66 (-526, 659)

56

51

130

165

130

165

130

165

*p <0.05 and **p <0.01
**Table 7.A.4 shows these same figures in pounds (sterling)
Costs excluding/including tax rebate on gluten-free foods claimed by 30% of parents of MDCD children/adolescents in Ireland
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-71 (-264, 122)
-382** (-635, 128)

Table 7.A.4: Breakdown of Additional (Incremental) Total Direct, Indirect and Total Costs (Direct & Indirect) in pounds sterling
(£) associated with being a parent of children/adolescents (<18 years) with food hypersensitivity (self-reported): MDFA (n=173;
n=147), MDCD (n=148; n=60) and FI (n=56; n=51) compared to non-food hypersensitive controls (n=130; n=165) in Ireland and
Northern Ireland, respectively (November 2019 – October 2020)
Ireland
NI
MDFA Parental
Visits to GP
Visits to
Consultant/Specialist
Visits to Nurse
Visits to Nurse (Outpatient
Clinic)
Visits to
Dietician/Nutritionist
Visits to Physiotherapist
Visits to Pharmacist
Visits to Other Health
Professionals
Visits to Alternative
Therapist
Total Cost of Medical
Visits & Alternative Visits
Travel to GP
Travel to
Consultant/Specialist
Travel to Nurse
Travel to Nurse (Outpatient
Clinic)
Travel to
Dietician/Nutritionist

65** (26, 105)

73** (46, 100)

Ireland
NI
MDCD Parental
Incremental Cost in Pounds (£)
30 (-9, 69)
39** (23, 53)

113** (40, 186)

101** (40, 34)

101** (41, 160)

126** (85, 168)

-10 (-88, 61)

55* (4, 106)

0 (-8, 8)

9 (-8, 18)

7* (0, 14)

12** (3, 21)

-2 (-11, 8)

2 (-9, 11)

3 (-4, 9)

28 (-7, 61)

4 (-3, 11)

17** (6, 28)

-3 (-9, 3)

-1 (-13, 11)

15** (5, 23)

51** (23, 79)

18** (12, 24)

45** (34, 54)

10* (3, 17)

13** (5, 20)

-11 (-32, 10)
127** (65, 189)

-1 (-9, 7)
88** (30, 145)

6 (-38, 51)
50 (-18, 117)

3 (-13, 19)
177** (65, 289)

-28* (-52, -5)
43 (-9, 96)

-7 (-17, 4)
65* (9, 121)

11 (-2, 24)

-17 (-34, 0)

-1 (-6, 4)

-1 (-16, 15)

-3* (-6, 0)

-11 (-29, 7)

9 (-4, 23)

6 (0, 13)

3 (-5, 10)

15 (-3, 32)

5* (1, 10)

12** (3, 22)

338** (181, 494)

218** (64, 371)

433** (266, 599)

62 (-77, 200)

179** (65, 293)

113* (24, 201)

11 (-35, 57)

18 (-16, 52)

8 (-34, 50)

30 (-22, 83)

6 (-1, 13)

3* (0, 7)

3* (0, 6)

3** (1, 4)

3 (-6, 12)

3 (-1, 6)

1 (-2, 3)

3* (0, 4)

0 (0, 1)

3** (1, 4)

-1 (-2, 0)

1 (-1, 2)

1 (-2, 3)

43 (-47, 134)

-1 (-3, 1)

24 (-1, 49)

-2* (-4, 0)

9 (-2, 19)

3 (0, 8)

35 (-19, 89)

3* (1, 7)

20** (7, 33)

2* (0, 3)

2** (1, 3)

332**
(165,
499)
-5 (-38, 28)
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Ireland
NI
FI Parental
50* (11, 89)

51** (32, 69)

Travel to Pharmacist
Travel to Physiotherapist
Travel to Other Health
Professionals
Travel to Alternative
Therapist
Total Cost of Travel to
Medical & Alternative
Visits
Outpatient attendance
Emergency department
attendance without
subsequent admission to a
ward
Emergency department
attendance with subsequent
admission to a ward
Day Unit
Ambulance (Emergency
Department)
Ambulance (Hospital
Admission)
Total Cost of Hospital
Visits & Stays
Prescribed medicines
Over-the-counter medicines
Total Cost of Medication
Private Health Insurance
Total Food Cost

10 (-15, 36)
-3 (-5, 1)

52* (1, 103)
0 (-1, 0)

-4 (-10, 1)
0 (-3, 2)

277 (-36, 594)
3 (-2, 7)

-3 (-11, 5)
0 (-7, 7)

22* (4, 39)
0 (-1, 0)

3 (-1, 6)

-6 (-13, 1)

0 (-1, 2)

3 (-4, 12)

0 (-1, 0)

-4 (-11, 3)

3 (-2, 9)

3 (-1, 5)

0 (0, 1)

4 (-1, 9)

2 (-1, 3)

3** (1, 4)

20 (-36, 76)

246** (64, 427)

12 (-39, 64)

355* (-3, 717)

9 (-39, 55)

66* (3, 126)

71* (12, 129)

110** (42, 178)

3 (-40, 47)

107** (61, 152)

-36 (-83, 10)

16 (-35, 68)

112** (35, 188)

57* (2, 112)

7 (-19, 34)

14 (-3, 32)

20 (-15, 55)

26 (-12, 63)

129 (-112, 370)

166 (-118, 450)

90 (-40, 220)

15 (-113, 143)

-47 (-129, 34)

-87 (-185, 10)

151* (9, 291)

168** (77, 257)

43 (-60, 145)

120** (32, 206)

-30 (-132, 72)

25 (-22, 71)

3 (-2, 9)

0 (-6, 6)

0 (-2, 3)

0 (-6, 5)

3 (-3, 9)

0 (-6, 7)

1 (-3, 3)

11* (0, 22)

0 (-3, 3)

1 (-4, 5)

-1 (-3, 2)

4 (-2, 9)

512** (111, 912)

143 (-55, 344)

257* (46, 463)

-91 (-264, 81)

-16 (-189, 157)

20** (14, 26)
9 (-2, 21)
29** (17, 42)
28** (9, 48)

4** (3, 6)
46** (22, 71)
50** (26, 76)
41* (9, 72)

0 (0, 0)
21** (5, 36)
21** (5, 36)
28 (-49, 104)

0 (0, 0)
9 (0, 18)
9 (0, 18)
14* (1, 26)

-12 (-181, 156)

55 (-34, 145)

472** (187, 757)

-138 (-303, 27)

40 (-32, 113)

Total Direct Costs

959**
1,505)

1,208**
1,830)

8** (4, 10)
12 (-4, 28)
20* (3, 36)
163** (47, 277)
221**/298
(144, 298)
777**/854
(402, 1,152)

1,608**
2,302)

-109 (-469, 246)

292 (-9, 588)

466**
(117,
814)
20** (11, 28)
60** (37, 83)
80** (54, 104)
73 (-5, 151)

(409,

(585,

598

(913,

Time spent Food shopping
Time spent preparing food

-25 (-119, 68)

-52 (-187, 83)

55 (-46, 157)

7 (-149, 163)

51 (-80, 182)

-102 (-421, 216)

88 (-307, 482)

-71 (-318, 175)

-280* (-530, -29)

15 (-378, 409)

Days missed from
Work/School/College
Lost Earning associated with
healthcare visits
Total Indirect Costs
Total Direct & Indirect
Costs
Number in group
Number in comparison group

260**
416)

122* (14, 231)

99 (-25, 223)

349* (52, 648)

84 (-32, 200)

144 (4, 283)

146** (42, 250)

48 (-44, 141)

29 (-7, 65)

6 (-11, 23)

20 (-11, 50)

13 (-18, 44)

279 (-172, 729)
1,238** (462,
2,009)
173
130

206 (-286, 697)
1,414**
(413,
1,822)
147
165

112 (-244, 468)
889**/966
(273, 1,504)
148
130

82 (-368, 536)
1,690**
(837,
2,546)
60
165

170 (-352, 692)

-233 (-606, 141)

61 (628, 745)

59 (-452, 567)

56
130

51
165

(104,

*p <0.05 and **p <0.01
**Table 7.A.3 shows these same figures in euro
Costs excluding/including tax rebate on gluten-free foods reported as claimed by 30% of parents of MDCD children/adolescents in Ireland
ˣ1 Euro in British Pounds is 0.86102 for 10/18/2019 (Exchange-Rates.Org)
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-61 (-227, 105)
-329** (-546, 110)

Table 7.A.5 Breakdown of Additional (Incremental) Total Direct, Indirect and Total Costs (Direct & Indirect) in euro (€) associated
with being an adult (≥18 years) with food hypersensitivity (self-reported) including the outliers: MDFA (n=180 with 2 outliers;
n=111), MDCD (n=609; n=173) and FI (n=536; n=459) compared to non-food hypersensitive controls (n=531; n=204) in Ireland and
Northern Ireland, respectively (November 2019 – October 2020
Ireland
NI
MDFA Adults
Visits to GP
Visits to
Consultant/Specialist
Visits to Nurse
Visits to Nurse (Outpatient
Clinic)
Visits to
Dietician/Nutritionist
Visits to Physiotherapist
Visits to Pharmacist
Visits to Other Health
Professionals
Visits to Alternative
Therapist
Total Cost of Medical
Visits & Alternative Visits
Travel to GP
Travel to
Consultant/Specialist
Travel to Nurse
Travel to Nurse (Outpatient
Clinic)
Travel to
Dietician/Nutritionist

80** (41, 119)
34 (-47, 114)

56** (26, 87)

Ireland
NI
MDCD Adults
Incremental Cost in Euro (€)
31* (7, 55)
50** (25, 76)

51 (-56, 158)

29 (-21, 79)

88* (16, 159)

-28 (-86, 31)

17 (-32, 67)

11 (-3, 24)
-6 (-28, 16)

-15 (-14, 20)

3 (-5, 11)

12 (-18, 41)

2 (-6, 9)

-1 (-40, 42)

12 (-13, 37)

-2 (-11, 7)

1 (-11, 12)

-7 (-25, 11)

15 (-8, 39)

22 (-2, 46)

9** (5, 14)

26** (13, 39)

7 (-1, 16)

6 (-3, 15)

25 (-12, 62)
141* (15, 267)

18 (-3, 39)
-10 (-59, 38)

39* (4, 74)
59 (-7, 126)

-7 (-24, 10)
47 (-14, 109)

17 (-8, 43)
57 (-0, 115)

31* (2, 59)

-14** (-22, -6)

19 (-3, 41)

3 (-13, 20)

14* (2, 27)

3 (-10, 15)

14** (1, 28)

2 (-10, 15)

19* (4, 35)

19* (2, 35)

216* (46, 384)

326* (72, 580)

78 (-27, 185)

296 **(130, 464)

79 (-45, 206)

189** (69, 315)

67** (31, 103)
4* (0, 7)

141* (28, 253)

36** (18, 53)

63 (-10, 136)

63** (33, 91)

135** (67, 203)

5 (-2, 12)

2* (0, 5)

2 (0, 5)

2 (-1, 5)

3 (-3, 8)

0 (-1, 1)
-2 (-4, 1)

-34 (-68, 1)

1 (-2, 4)

-20 (-46, 7)

0 (-1, 1)

-19 (-39, 1)

2 (-4, 8)

0 (-1, 2)

2 (-3, 6)

-1 (-3, 1)

4 (-2, 11)

2 (-1, 5)

2* (0, 4)

4** (2, 6)

2 (-2, 6)

2 (0, 3)

4 (-8, 16)
16 (-4, 36)
50 (-10, 111)
7 (-12, 25)
20* (4, 35)

0 (-1, 1)
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Ireland

NI
FI Adults

43** (14, 72)

45** (26, 63)

Travel to Pharmacist
Travel to Physiotherapist
Travel to Other Health
Professionals
Travel to Alternative
Therapist
Total Cost of Travel to
Medical & Alternative
Visits
Outpatient attendance
Emergency department
attendance without
subsequent admission to a
ward
Emergency department
attendance with subsequent
admission to a ward
Day Unit
Ambulance (Emergency
Department)
Ambulance (Hospital
Admission)
Total Cost of Hospital
Visits & Stays
Prescribed medicines
Over-the-counter medicines
Total Cost of Medication
Private Health Insurance

15* (2,29)
-4 (-12, 3)
0 (-3, 2)

-11 (-39, 17)
3 (0, 6)

7* (0, 14)
-4 (-10, 2)

-19 (-44, 7)
8 (-2, 17)

8** (3, 13)
-4 (-10, 2)

29 (-65, 122)
1 (-1, 3)

2 (-1, 6)

-2* (-4, 0)

3 (-3, 10)

-1 (-3, 1)

1 (-2 3)

1 (0, 1)

2** (1,3)

0 (-1, 1)

2** (1, 3)

22 (-3, 46)

81** (39, 124)

111 (-31, 251)

44** (22, 66)

43 (-49, 136)

71** (38, 103)

178** (44, 310)

7 (-79, 94)

184 (-69, 437)

16 (-29, 61)

158* (12, 305)

2 (-73, 77)

-31 (-126, 64)

22 (-11, 55)

53 (0, 107)

19 (-19, 57)

2 (-25, 28)

-1 (-22, 20)

20 (-1, 41)

845 (-67, 1,757)

134 (-223, 492)

-124** (-212, 36)

-139 (-316, 37)

-19 (-125, 86)

-5 (-143, 133)

-83 (-198, 32)

126** (46, 206)

154 (-37, 344)

144** (53, 236)

112 (-256, 480)

104** (45, 164)

3 (-1, 8)

1 (-6, 7)

8 (-7, 22)

0 (-7, 6)

4 (-7, 16)

-1 (-5, 3)

1 (-2, 5)

2 (-1, 5)

3 (-7, 13)

0 (0, 0)

-3** (-4, -1)

4* (0, 7)

795 (-184, 1,777)

500 (-115, 1,118)

76 (-178, 329)

165 (-122, 451)

95 (-335, 527)

91 (-112, 295)

11** (10, 13)
41* (9, 72)
52** (20, 84)
11 (-42, 64)

11** (9, 13)
8 (-4, 20)
19** (7, 31)
1 (-29, 32)

8** (6, 10)
-21 (-50, 9)
-13 (-42, 17)
95** (34, 156)

6** (4, 8)
0 (-8, 9)
6 (-2, 15)
-24 (-58, 9)

0 (0, 0)
1 (-27, 28)
1 (-27, 28)
22 (-43, 88)

0 (0, 0)
10** (2, 17)
10** (2, 17)
-10 (-32, 13)

Total Food Cost

734**
1,200)

25 (-289, 339)

164/221 (-190,
518)

370* (26, 713)

82 (-246, 411)

-20 (-267, 227)

1** (0, 3)

(269,
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Total Direct Costs
Time spent Food shopping
Time spent preparing food
Days missed from
Work/School/College
Lost Earning associated
with healthcare visits
Total Indirect Costs
Total Costs (Direct &
Indirect)
Number in group
Number in comparison
group

1,889** (656,
3,123)
61 (-88, 210)
3 (-190, 195)

982 (-102,
2,067)
36 (-117, 188)
59 (-189, 307)

444/501 (-66,
957)
-23 (-114, 67)
6 (-164, 176)

856** (284,
1,428)
15 (-140, 171)
203 (-63, 469)

215 (-131, 562)

384 (86, 683)

0 (-217, 218)

3 (-33, 39)

0 (-13, 14)

11 (-38, 60)

282 (-179, 743)

479* (42, 916)

-6 (-347, 336)

2,171** (770,
3,573
180

1,461* (193,
2,730)
111

438/495 (-247,
1,126)
609

730**
(-199,
1,262)
1,586** (672,
2,500)
173

531

204

531

204

*p <0.05 and ** p <0.01
**Table 7.A.6 shows these same figures in pounds (sterling)
Costs excluding/including a tax rebate on gluten-free foods claimed by 29% of MDCD adults in Ireland
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350 (-275, 978)

438 (-2, 882)

-17 (-90, 57)
71 (-102, 243)

-41 (-142, 60)
-31 (-200, 137)

486* (97, 876)

104 (-120, 328)

267** (-85, 449)

26* (1, 51)

-4 (-31, 23)

23* (1, 45)

154 (-175, 483)

218 (-78, 514)

504 (-272,
1,282)
536
531

656 (68, 1,248)
459
204

Table 7.A.6. Breakdown of Additional (Incremental) Total Direct, Indirect and Total Costs (Direct & Indirect) in pounds sterling
(£) associated with being an adult (≥18 years) with food hypersensitivity (self-reported) including the outliers: MDFA (n=180 with 2
outliers; n=111), MDCD (n=609; n=173) and FI (n=536; n=459) compared to non-food hypersensitive controls (n=531; n=204)
Ireland and Northern Ireland, respectively (November 2019 – October 2020)
Ireland
NI
MDFA Adults
Visits to GP
Visits to
Consultant/Specialist
Visits to Nurse
Visits to Nurse (Outpatient
Clinic)
Visits to
Dietician/Nutritionist
Visits to Physiotherapist
Visits to Pharmacist
Visits to Other Health
Professionals
Visits to Alternative
Therapist
Total Cost of Medical
Visits & Alternative
Visits
Travel to GP
Travel to
Consultant/Specialist
Travel to Nurse
Travel to Nurse
(Outpatient Clinic)

69** (35, 102)
29 (-40, 98)

48** (22, 75)

Ireland
NI
MDCD Adults
Incremental Cost in Pounds (£)
27* (6, 47)
43** (22, 65)

44 (-48, 136)

25 (-18, 68)

76* (14, 137)

-24 (-74, 27)

15 (-28, 58)

9 (3, 21)
-5 (24, 14)

-13 (-12, 17)

3 (-4, 9)

10 (-15, 35)

2 (-5, 8)

-1 (-34, 36)

10 (-11, 32)

-2 (-9, 6)

1 (-9, 10)

-6 (-22, 9)

13 (-7, 34)

19(-2, 40)

8** (4, 12)

22** (11, 34)

6 (-1, 14)

5 (-3, 13)

22 (-10, 53)
121* (13, 230)

15 (-3, 34)
-9 (-51, 33)

34* (3, 64)
51 (-6, 108)

-6 (-21, 9)
40 (-12, 94)

15 (-7, 37)
49 (-0, 99)

27* (2, 51)

-12** (-19, -5)

16 (-3, 35)

3 (-11, 17)

12* (2, 23)

3 (-9, 13)

12** (1, 24)

2 (-9, 13)

16* (3, 30)

16* (2, 30)

185* (40, 330)

281* (62, 499)

67 (-23, 159)

255** (112, 399)

68 (-39, 177)

163** (59, 271)

58** (27, 89)
3* (0, 6)

121* (24, 218)

31** (15, 46)

54 (-9, 117)

54** (28, 78)

116** (58, 175)

4 (-2, 10)

2* (0, 4)

2 (0, 4)

2 (-1, 4)

3 (-3, 7)

0 (-1, 1)
-2 (-3, 1)

-29 (-58, 1)

1 (-2, 3)

-17 (-34, 6)

0 (-1, 1)

-16 (-34, 1)

2 (-3, 7)

0 (-1, 2)

2 (-3, 5)

-1 (-3, 1)

3 (-2, 9)

3 (-7, 14)
14 (-3, 31)
43 (-9, 95)
6 (-10, 22)
17 (3, 30)
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Ireland

NI
FI Adults

37** (12, 62)

39** (22, 54)

Travel to
Dietician/Nutritionist
Travel to Pharmacist
Travel to Physiotherapist
Travel to Other Health
Professionals
Travel to Alternative
Therapist
Total Cost of Travel to
Medical & Alternative
Visits
Outpatient attendance
Emergency department
attendance without
subsequent admission to a
ward
Emergency department
attendance with subsequent
admission to a ward
Day Unit
Ambulance (Emergency
Department)
Ambulance (Hospital
Admission)
Total Cost of Hospital
Visits & Stays
Prescribed medicines
Over-the-counter
medicines
Total Cost of Medication
Private Health Insurance

0 (-1, 1)

2 (-1, 4)

2* (0, 3)

3** (2, 5)

2 (-2, 5)

2 (0, 3)

-9 (-34, 15)
3 (0, 5)

6* (0, 12)
-3 (-9, 2)

-16 (-38, 6)
7 (-2, 15)

6** (3, 11)
-3 (-10, 2)

25 (-56, 105)
1 (-1, 3)

2 (-1, 4)

-2* (-3, 0)

3 (-3, 9)

-1 (-3, 1)

1 (-2, 3)

1 (0, 1)

2** (1,3)

0 (-1, 1)

2** (1, 3)

19 (-3, 40)

70** (34, 107)

97 (-27, 216)

38** (19, 57)

38 (-42, 117)

61** (33, 89)

154** (38, 267)

6 (-68, 81)

158 (-59, 376)

14 (-25, 52)

136* (10, 262)

2 (-63, 66)

-27 (-108, 55)

19 (-9, 47)

46 (0, 92)

16 (-16, 49)

2 (-22, 24)

-1 (-19, 17)

17 (-1, 35)

727 (-58, 1,511)

115 (-192, 423)

-107** (-182, 31)

-120 (-272, 32)

-16 (-108, 74)

-4 (-123, 114)

-71 (-170, 28)

108** (40, 177)

132 (-32, 296)

124** (46, 203)

96 (-220, 413)

89** (39, 141)

3 (-1, 7)

1 (-5, 6)

7 (-6, 19)

0 (-6, 5)

3 (-6, 14)

-1 (-4, 3)

1 (-2, 4)

2 (-1, 4)

3 (-6, 11)

0 (0, 0)

-3** (-3, -1)

3* (0, 6)

685 (-158, 1,528)

430 (-99, 961)

65 (-153, 283)

142 (-105, 388)

81 (-288, 453)

77 (-96, 254)

9** (9, 11)

9** (8, 11)

7** (5, 9)

5** (3, 7)

0 (0, 0)

0 (0, 0)

35* (8, 62)

7 (-3, 17)

-18 (-43, 8)

0 (-7, 8)

1 (-23, 24)

9** (2, 15)

44** (17, 72)
9 (-36, 55)

16** (6, 27)
1 (-25, 28)

-11 (-36, 15)
82** (29, 134)

5 (-2, 13)
-21 (-50, 8)

1 (-23, 24)
19 (-37, 76)

9** (2, 15)
-9 (-28, 11)

13* (2,25)
-3 (-10, 3)
0 (-3, 2)
1** (0, 3)
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Total Food Cost
Total Direct Costs
Time spent Food shopping
Time spent preparing food
Days missed from
Work/School/College
Lost Earning associated
with healthcare visits
Total Indirect Costs
Total Costs (Direct &
Indirect)
Number in group
Number in comparison
group

631**
(231,
1,032)
1,624** (564,
2,686)
52 (-76, 181)
3 (-163, 168)

31 (-101, 162)
51 (-163, 264)

141/190 (-163,
445)
382/431 (-57,
823)
-20 (-98, 58)
5 (-141, 151)

185 (-113, 483)

330 (74, 587)

0 (-187, 187)

418* (83, 753)

89 (-103, 282)

230** (-73, 386)

3 (-28, 34)

0 (-11, 12)

9 (-33, 55)

22* (1, 44)

-3 (-27, 20)

20* (1, 39)

243 (-154, 639)

412* (36, 788)

-5 (-298, 289)

132 (-151, 415)

188 (-67, 442)

1,867**
3,073
180

1,256*
2,348)
111

377/426 (-212,
968)
609

628**
1,085)
1,365**
2,150)
173

433 (-234, 1,103)

565* (46, 849)

536

459

531

204

531

204

531

(662,

22 (-249, 292)
847 (-88, 1,778)

204

(166,

*p <0.05 and ** p<0.01
**Table 7.A.5 shows these same figures in in euro
Costs excluding/including tax rebate on gluten-free foods reported as claimed by 29% of MDCD Adults in Ireland
ˣ1 Euro in British Pounds is 0.86102 for 10/18/2019 (Exchange-Rates.Org)
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318* (22, 613)
737** (244,
1,228)
13 (-120, 147)
175 (-54, 403)

(-171,
(578,

71 (-212, 353)

-17 (-230, 195)

301 (-237, 841)

377 (-2, 759)

-15 (-77, 49)
61 (-88, 209)

-35 (-122, 52)
-27 (-172, 118)

Table 7.A.7: Breakdown of Additional (Incremental) Total Direct, Indirect and Total Costs (Direct & Indirect) in euro (€) associated
with being a parent of children/adolescents (<18 years) with food hypersensitivity (self-reported) including the outlier: MDFA
(n=173; n=147), MDCD (n=148; n=60) and FI (n=56; n=52 with 1 outlier) compared to non-food hypersensitive controls (n=130;
n=165) in Ireland and Northern Ireland, respectively (November 2019 – October 2020)
Ireland
NI
MDFA Parental
Visits to GP
Visits to
Consultant/Specialist
Visits to Nurse
Visits to Nurse (Outpatient
Clinic)
Visits to
Dietician/Nutritionist
Visits to Physiotherapist
Visits to Pharmacist
Visits to Other Health
Professionals
Visits to Alternative
Therapist
Total Cost of Medical
Visits & Alternative Visits
Travel to GP
Travel to
Consultant/Specialist
Travel to Nurse
Travel to Nurse (Outpatient
Clinic)
Travel to
Dietician/Nutritionist

76** (30, 122)

85** (54, 116)

Ireland
NI
MDCD Parental
Incremental Cost in Euro (€)
35 (-11, 80)
45** (27, 62)

131** (47, 216)

118** (40, 197)

117** (48, 186)

147** (99, 195)

-12 (-96, 71)

0 (-9, 9)

9 (-3, 21)

8* (0, 16)

14** (4, 24)

-2 (-13, 9)

3 (-5, 10)

32 (-8, 71)

5 (-3, 13)

20** (7, 33)

-3 (-11, 4)

17** (6, 27)

59** (27, 92)

21** (14, 28)

52** (40, 63)

12* (3, 20)

-13 (-37, 12)
148** (76, 220)

-1 (-10, 8)
102** (35, 169)

7 (-44, 59)
58 (-21, 136)

3 (-15, 22)
206** (76, 336)

-33* (-60, -6)
50 (-11, 112)

13 (-2, 28)

-20 (-39, 0)

-1 (-7, 5)

-1 (-19, 17)

-3* (-7, 0)

11 (-5, 27)

7 (0, 15)

3 (-6, 12)

17 (-4, 37)

6* (1, 12)

386** (192, 580)

391** (210, 574)

253** (74, 431)

503** (309, 696)

73 (-89, 233)

291** (111, 469)

-6 (-44, 32)

131* (28, 234)

13 (-41, 66)

21 (-19, 61)

9 (-39, 58)

7 (-1, 15)

4* (0, 8)

3* (0, 7)

3** (1, 5)

3 (-7, 14)

32 (-28, 93)
5* (0, 9)

1 (-2, 4)

3* (0, 5)

0 (0, 1)

3** (1, 5)

-1 (-2, 0)

1 (-2, 4)

50 (-55, 156)

-1 (-4, 1)

28 (-1, 57)

-2* (-5, 0)

4 (0, 9)

41 (-22, 103)

4* (1, 8)

23** (8, 38)

2* (0, 4)
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Ireland
NI
FI Parental
58* (13, 103)

95** (41, 149)
91* (21, 161)
1 (-11, 12)
-2 (-16, 12)
22** (9, 35)
-4 (-17, 10)
86* (19, 153)
-12 (-34, 10)
14** (3, 25)

1 (-1, 2)
9 (-3, 21)
3** (1, 5)

Travel to Pharmacist
Travel to Physiotherapist
Travel to Other Health
Professionals
Travel to Alternative
Therapist
Total Cost of Travel to
Medical & Alternative
Visits
Outpatient attendance
Emergency department
attendance without
subsequent admission to a
ward
Emergency department
attendance with subsequent
admission to a ward
Day Unit
Ambulance (Emergency
Department)
Ambulance (Hospital
Admission)
Total Cost of Hospital
Visits & Stays
Prescribed medicines
Over-the-counter medicines
Total Cost of Medication
Private Health Insurance
Total Food Cost

12 (-18, 42)
-3 (-6, 1)

61* (1, 120)
0 (-1, 0)

-5 (-12, 1)
0 (-3, 2)

324 (-42, 691)
3 (-2, 8)

-4 (-13, 6)
0 (-8, 8)

3 (-1, 7)

-7 (-15, 1)

0 (-1, 2)

4 (-5, 14)

0 (-1, 0)

4 (-2, 10)

3 (-1, 6)

0 (0, 1)

5 (-1, 10)

2 (-1, 4)

23 (-42, 88)

286** (74, 497)

14 (-45, 74)

414* (-3, 834)

9 (-45, 64)

72* (1, 143)

82* (14, 150)

128** (49, 207)

4 (-47, 55)

124** (71, 177)

-42 (-96, 12)

110 (-32, 252)

130** (41, 219)

66* (2, 130)

8 (-22, 39)

16 (-4, 37)

23 (-18, 64)

129 (-16, 274)

150 (-130, 430)

193 (-137, 523)

105 (-46, 256)

18 (-131, 166)

-55 (-150, 39)

389 (-299, 1,077)

175* (11, 338)

195** (90, 299)

50 (-70, 169)

139** (37, 240)

-35 (-154, 84)

147 (-24, 318)

4 (-2, 11)

0 (-7, 7)

0 (-2, 3)

0 (-7, 6)

4 (-4, 11)

39 (-14, 93)

1 (-3, 4)

13* (0, 25)

0 (-4, 4)

1 (-5, 6)

-1 (-3, 2)

167 (-64, 400)

298* (54, 538)

-106 (-307, 94)

845 (-368, 2,058)

5** (3, 7)
54** (25, 83)
59** (30, 88)
48* (11, 84)

0 (0, 0)
24** (6, 42)
24** (6, 42)
32 (-57, 121)

549** (218, 880)

-160 (-352, 31)

0 (0, 0)
9 (-1, 20)
9 (-1, 20)
15* (1, 30)
44 (-40, 128)

Total Direct Costs

9** (5, 12)
14 (-5, 33)
23* (3, 42)
189** (55, 322)
257**/347
(168, 347)
903**/993
(467, 1,340)

1,871** (1,062,
2,677)

-128 (-545, 286)

23** (13, 33)
70** (43, 96)
93** (63, 121)
85 (-6, 176)

595*
(129,
1,061)
23** (16, 30)
11 (-2, 24)
34** (20, 49)
33** (10, 56)

-14 (-210, 181)

65 (-40, 169)

1,115**
1,750)

1,404**
2,128)

542** (136, 946)

(475,

(680,
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24* (4, 44)
0 (-1, 0)
-5 (-14, 4)
3** (1, 5)

31 (-5, 67)

1,276
2,628)

(-78,

Time spent Food shopping
Time spent preparing food
Days missed from
Work/School/College
Lost Earning associated
with healthcare visits
Total Indirect Costs
Total Direct & Indirect
Costs
Number in group
Number in comparison
group

-29 (-138, 79)

-61 (-218, 96)

64 (-53, 182)

8 (-173, 190)

59 (-93, 212)

-119 (-489, 251)

102 (-357, 561)

-83 (-370, 204)

-325* (-616, -34)

18 (-440, 475)

302** (121, 484)

142* (16, 269)

115 (-29, 259)

406* (60, 753)

98 (-37, 233)

147 (-14, 307)

170** (49, 291)

56 (-51, 164)

34 (-8, 75)

7 (-13, 27)

23 (-13, 58)

14 (-22, 49)

324 (-200, 848)
1,439**
(537,
2,336)
173

239 (-332, 811)
1,643**
(608,
2,679)
147

130 (-284, 544)
1,033**/1,123
(318, 1,749)
148

96 (-428, 623)
1,967**
(973,
2,961)
60

198 (-409, 805)

-299 (-733, 133)

70 (-730, 866)

977 (-426, 2,387)

56

52

130

165

130

165

130

165

*p <0.05 and **p <0.01
**Table 7.A.8 shows these same figures in pounds (sterling)
Costs excluding/including tax rebate on gluten-free foods claimed by 30% of parents of MDCD children/adolescents in Ireland
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-84 (-279, 110)
-376** (-626, 125)

Table 7.A.8: Breakdown of Additional (Incremental) Total Direct, Indirect and Total Costs (Direct & Indirect) in pounds sterling
(£) associated with being a parent of children/adolescents (<18 years) with food hypersensitivity (self-reported) including the outlier:
MDFA (n=173; n=147), MDCD (n=148; n=60) and FI (n=56; n=52 with 1 outlier) compared to non-food hypersensitive controls
(n=130; n=165) in Ireland and Northern Ireland, respectively (November 2019 – October 2020)
Ireland
NI
MDFA Parental
Visits to GP
Visits to
Consultant/Specialist
Visits to Nurse
Visits to Nurse (Outpatient
Clinic)
Visits to
Dietician/Nutritionist
Visits to Physiotherapist
Visits to Pharmacist
Visits to Other Health
Professionals
Visits to Alternative
Therapist
Total Cost of Medical
Visits & Alternative Visits
Travel to GP
Travel to
Consultant/Specialist
Travel to Nurse
Travel to Nurse (Outpatient
Clinic)
Travel to
Dietician/Nutritionist

65** (26, 105)

73** (46, 100)

Ireland
NI
MDCD Parental
Incremental Cost in Pounds (£)
30 (-9, 69)
39** (23, 53)

113** (40, 186)

101** (40, 34)

101** (41, 160)

126** (85, 168)

-10 (-88, 61)

0 (-8, 8)

9 (-8, 18)

7* (0, 14)

12** (3, 21)

-2 (-11, 8)

3 (-4, 9)

28 (-7, 61)

4 (-3, 11)

17** (6, 28)

-3 (-9, 3)

15** (5, 23)

51** (23, 79)

18** (12, 24)

45** (34, 54)

10* (3, 17)

-11 (-32, 10)
127** (65, 189)

-1 (-9, 7)
88** (30, 145)

6 (-38, 51)
50 (-18, 117)

3 (-13, 19)
177** (65, 289)

-28* (-52, -5)
43 (-9, 96)

11 (-2, 24)

-17 (-34, 0)

-1 (-6, 4)

-1 (-16, 15)

-3* (-6, 0)

9 (-4, 23)

6 (0, 13)

3 (-5, 10)

15 (-3, 32)

5* (1, 10)

338** (181, 494)

218** (64, 371)

433** (266, 599)

62 (-77, 200)

251** (95, 403)

113* (24, 201)

11 (-35, 57)

18 (-16, 52)

8 (-34, 50)

6 (-1, 13)

3* (0, 7)

3* (0, 6)

3** (1, 4)

3 (-6, 12)

28 (-24, 80)
4* (0, 8)

1 (-2, 3)

3* (0, 4)

0 (0, 1)

3** (1, 4)

-1 (-2, 0)

1 (-2, 3)

43 (-47, 134)

-1 (-3, 1)

24 (-1, 49)

-2* (-4, 0)

3 (0, 8)

35 (-19, 89)

3* (1, 7)

20** (7, 33)

2* (0, 3)

332**
(165,
499)
-5 (-38, 28)
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Ireland
NI
FI Parental
50* (11, 89)

82** (35, 128)
78* (30, 138)
1 (-9, 10)
-2 (-14, 10)
19** (8, 82)
-3 (-15, 9)
74* (16, 132)
-10 (-29, 9)
12** (3, 22)

1 (-1, 2)
8 (-3, 18)
3** (1, 4)

Travel to Pharmacist
Travel to Physiotherapist
Travel to Other Health
Professionals
Travel to Alternative
Therapist
Total Cost of Travel to
Medical & Alternative
Visits
Outpatient attendance
Emergency department
attendance without
subsequent admission to a
ward
Emergency department
attendance with subsequent
admission to a ward
Day Unit
Ambulance (Emergency
Department)
Ambulance (Hospital
Admission)
Total Cost of Hospital
Visits & Stays
Prescribed medicines
Over-the-counter medicines
Total Cost of Medication
Private Health Insurance
Total Food Cost

10 (-15, 36)
-3 (-5, 1)

52* (1, 103)
0 (-1, 0)

-4 (-10, 1)
0 (-3, 2)

277 (-36, 594)
3 (-2, 7)

-3 (-11, 5)
0 (-7, 7)

3 (-1, 6)

-6 (-13, 1)

0 (-1, 2)

3 (-4, 12)

0 (-1, 0)

3 (-2, 9)

3 (-1, 5)

0 (0, 1)

4 (-1, 9)

2 (-1, 3)

20 (-36, 76)

246** (64, 427)

12 (-39, 64)

355* (-3, 717)

9 (-39, 55)

64* (1, 123)

71* (12, 129)

110** (42, 178)

3 (-40, 47)

107** (61, 152)

-36 (-83, 10)

95 (-28, 217)

112** (35, 188)

57* (2, 112)

7 (-19, 34)

14 (-3, 32)

20 (-15, 55)

111 (-14, 236)

129 (-112, 370)

166 (-118, 450)

90 (-40, 220)

15 (-113, 143)

-47 (-129, 34)

335 (-257, 926)

151* (9, 291)

168** (77, 257)

43 (-60, 145)

120** (32, 206)

-30 (-132, 72)

3 (-2, 9)

0 (-6, 6)

0 (-2, 3)

0 (-6, 5)

3 (-3, 9)

126 (-21, 273)
34 (-12, 80)

1 (-3, 3)

11* (0, 22)

0 (-3, 3)

1 (-4, 5)

-1 (-3, 2)

512** (111, 912)

143 (-55, 344)

257* (46, 463)

-91 (-264, 81)

728 (-316, 1,770)

20** (14, 26)
9 (-2, 21)
29** (17, 42)
28** (9, 48)

4** (3, 6)
46** (22, 71)
50** (26, 76)
41* (9, 72)

0 (0, 0)
21** (5, 36)
21** (5, 36)
28 (-49, 104)

-12 (-181, 156)

55 (-34, 145)

472** (187, 757)

-138 (-303, 27)

0 (0, 0)
8 (-1, 17)
8 (-1, 17)
13* (1, 26)
38 (-34, 110)

Total Direct Costs

959** (409,
1,505)

1,208** (585,
1,830)

8** (4, 10)
12 (-4, 28)
20* (3, 36)
163** (47, 277)
221**/298
(144, 298)
777**/854
(402, 1,152)

1,608** (913,
2,302)

-109 (-469, 246)

466**
(117,
814)
20** (11, 28)
60** (37, 83)
80** (54, 104)
73 (-5, 151)
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21* (3, 38)
0 (-1, 0)
-4 (-12, 3)
3** (1, 4)

27 (-4, 58)

1,102 (-67,
2,260)

Time spent Food shopping
Time spent preparing food

-25 (-119, 68)

-52 (-187, 83)

55 (-46, 157)

7 (-149, 163)

51 (-80, 182)

-102 (-421, 216)

88 (-307, 482)

-71 (-318, 175)

-280* (-530, -29)

15 (-378, 409)

Days missed from
Work/School/College
Lost Earning associated with
healthcare visits
Total Indirect Costs
Total Direct & Indirect
Costs
Number in group
Number in comparison group

260**
416)

122* (14, 231)

99 (-25, 223)

349* (52, 648)

84 (-32, 200)

126 (-12, 264)

146** (42, 250)

48 (-44, 141)

29 (-7, 65)

6 (-11, 23)

20 (-11, 50)

12 (-19, 42)

279 (-172, 729)
1,238** (462,
2,009)
173
130

206 (-286, 697)
1,414** (413,
1,822)
147
165

112 (-244, 468)
889**/966
(273, 1,504)
148
130

82 (-368, 536)
1,690** (837,
2,546)
60
165

170 (-352, 692)

-257 (-630, 114)
847 (-366,
2,053)
52
165

(104,

*p <0.05 and **p <0.01
**Table 7.A.7 shows these same figures in euro
Costs excluding/including tax rebate on gluten-free foods reported as claimed by 30% of parents of MDCD children/adolescents in Ireland
ˣ1 Euro in British Pounds is 0.86102 for 10/18/2019 (Exchange-Rates.Org)
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61 (628, 745)
56
130

-72 (-240, 95)
-323** (-538, 108)

Table 7.A.9: Reported areas of life affected as a result of having a MDFA (self-reported) to sufferers (children (0 – 12 years) and
their families in Ireland (n = 218) and NI (n=145)
Ireland

NI

MDFA Child

No

Yes

Total

Percentage

Lower
CI

Upper
CI

No

Yes

Total

Percentage

Lower
CI

Upper
CI

Ability to eat out

22

97

119

82%

73%

88%

Ability to eat out

Affects the diet of all the family

24

95

119

80%

71%

87%

Time
for
shopping

18

87

105

83%

74%

90%

22

83

105

79%

70%

86%

Children’s parties

26

93

119

78%

70%

85%

Emotions

33

86

119

72%

63%

80%

Children’s parties

23

82

105

78%

69%

86%

Affects the diet of all
the family

27

78

105

74%

65%

82%

Travel

37

82

119

69%

60%

77%

Cost of food shopping

27

78

105

74%

65%

82%

Cost of food shopping

41

78

119

66%

Childcare arrangement

44

75

119

63%

56%

74%

Travel

37

68

105

65%

55%

74%

54%

72%

Family social life

38

67

105

64%

54%

73%

Family social life

44

75

119

Time for food shopping

45

74

119

63%

54%

72%

Emotions

40

65

105

62%

52%

71%

62%

53%

71%

Social life

49

56

105

53%

43%

63%

Social life

51

68

Social activities

55

64

119

57%

48%

66%

Childcare arrangement

52

53

105

50%

41%

60%

119

54%

44%

63%

Social activities

54

51

105

49%

39%

59%

Poor treatment in restaurants

56

63

119

53%

44%

62%

Effects on other family
members

55

50

105

48%

38%

58%

Assumption of being a fussy eater

66

53

119

45%

35%

54%

Poor treatment
restaurants

in

59

46

105

44%

34%

54%

Effects on other family members

67

52

119

44%

35%

53%

Assumption of being a
fussy eater

61

44

105

42%

32%

52%

Caring for family when unwell

70

49

119

41%

32%

51%

Social interaction

68

37

105

35%

26%

45%

Loss of time at work

72

47

119

39%

31%

49%

Caring for
when unwell

73

32

105

30%

22%

40%

Social interaction

73

46

119

39%

30%

48%

Household tasks

77

28

105

27%

19%

36%

Household tasks

78

41

119

34%

26%

44%

Loss of time at work

79

26

105

25%

17%

34%
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MDFA Child

food

family

Choice of job

85

34

119

29%

21%

38%

Relationship with my
partner

87

18

105

17%

10%

26%

Relationship with my partner

86

33

119

28%

20%

37%

Expanding my family

89

16

105

15%

9%

24%

Sports and hobbies

88

31

119

26%

18%

35%

Sports and hobbies

90

15

105

14%

8%

22%

Expanding my family

98

21

119

18%

11%

26%

Choice of job

92

13

105

12%

7%

20%

Public transport

108

11

119

9%

5%

16%

Public transport

99

6

105

6%

2%

12%

Change schools

115

4

119

3%

1%

8%

Change schools

103

2

105

2%

0%

7%

None of the above

119

2

121

2%

0%

6%

None of the above

105

1

106

1%

0%

5%
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Table 7.A.10: Reported areas of life affected as a result of having a MDCD (self-reported) to sufferers (children (0 – 12 years) and
their families in Ireland (n = 107) and NI (n=43)
Ireland

NI
No

Yes

Total

Percentage

Lower
CI

Upper
CI

Cost of food shopping

1

28

29

97%

82%

100%

Ability to eat out

2

27

29

93%

77%

99%

90%

Affects the diet of all the family

6

23

29

79%

60%

92%

89%

Children’s parties

7

22

29

76%

56%

90%

62%

83%

Time for food shopping

7

22

29

76%

56%

90%

67%

55%

77%

Emotions

8

21

29

72%

53%

87%

59%

47%

70%

Travel

8

21

29

72%

53%

87%

76

55%

43%

67%

Family social life

9

20

29

69%

49%

85%

76

53%

41%

64%

Poor treatment in restaurants

11

18

29

62%

42%

79%

40

76

53%

41%

64%

Social life

12

17

29

59%

39%

76%

38

76

50%

38%

62%

Social activities

14

15

29

52%

33%

71%

44

32

76

42%

31%

54%

Assumption of being a fussy
eater

15

14

29

48%

29%

67%

Household tasks

47

29

76

38%

27%

50%

Caring for family when unwell

16

13

29

45%

26%

64%

Assumption of being a fussy eater

52

24

76

32%

21%

43%

Household tasks

18

11

29

38%

21%

58%

Social interaction

56

20

76

26%

17%

38%

Effects on other family members

19

10

29

34%

18%

54%

Caring for family when unwell

59

17

76

22%

14%

33%

Loss of time at work

19

10

29

34%

18%

54%

Childcare arrangement

59

17

76

22%

14%

33%

Childcare arrangement

21

8

29

28%

13%

47%

Loss of time at work

63

13

76

17%

9%

27%

Social interaction

22

7

29

24%

10%

44%

Sports and hobbies

69

7

76

9%

4%

18%

Choice of job

23

6

29

21%

8%

40%

Relationship with my partner

70

6

76

8%

3%

16%

Sports and hobbies

24

5

29

17%

6%

36%

Expanding my family

72

4

76

5%

1%

13%

Relationship with my partner

26

3

29

10%

2%

27%

Choice of job

73

3

76

4%

1%

11%

Expanding my family

28

1

29

3%

0%

18%

Change schools

76

0

76

0%

0%

5%

Public transport

28

1

29

3%

0%

18%

MDCD Child

No

Yes

Total

Percentage

Lower CI

Upper CI

Cost of food shopping

1

75

76

99%

93%

100%

Ability to eat out

3

73

76

96%

89%

99%

Affects the diet of all the family

14

62

76

82%

71%

Children’s parties

15

61

76

80%

70%

Travel

20

56

76

74%

Time for food shopping

25

51

76

Emotions

31

45

76

Family social life

34

42

Poor treatment in restaurants

36

40

Social activities

36

Social life

38

Effects on other family members

MDCD Child
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None of the above

76

0

76

0%

0%

5%

Change schools

29

0

29

0%

0%

12%

Public transport

76

0

76

0%

0%

5%

None of the above

29

0

29

0%

0%

12%
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Table 7.A.11. Reported areas of life affected as a result of having a FI (self-reported) to sufferers (children (0 – 12 years) and their
families in Ireland (n = 47) and NI (n=44)
Ireland

NI
No

Yes

Total

Percentage

Lower
CI

Upper
CI

Cost of food shopping

2

29

31

94%

79%

99%

Ability to eat out

6

25

31

81%

63%

93%

74%

Affects the diet of all the family

6

25

31

81%

63%

93%

71%

Time for food shopping

8

23

31

74%

55%

88%

35%

71%

Children’s parties

13

18

31

58%

39%

75%

44%

26%

62%

Emotions

14

17

31

55%

36%

73%

44%

26%

62%

Effects on other family members

18

13

31

42%

25%

61%

32

38%

21%

56%

Social life

18

13

31

42%

25%

61%

32

34%

19%

53%

Travel

18

13

31

42%

25%

61%

11

32

34%

19%

53%

Assumption of being a fussy eater

19

12

31

39%

22%

58%

10

32

31%

16%

50%

Family social life

19

12

31

39%

22%

58%

23

9

32

28%

14%

47%

Social activities

21

10

31

32%

17%

51%

23

9

32

28%

14%

47%

Childcare arrangement

22

9

31

29%

14%

48%

Childcare arrangement

25

7

32

22%

9%

40%

Social interaction

22

9

31

29%

14%

48%

Social interaction

25

7

32

22%

9%

40%

Caring for family when unwell

23

8

31

26%

12%

45%

Loss of time at work

26

6

32

19%

7%

36%

Household tasks

23

8

31

26%

12%

45%

Caring for family when unwell

27

5

32

16%

5%

33%

Loss of time at work

23

8

31

26%

12%

45%

None of the above

32

6

38

16%

6%

31%

Poor treatment in restaurants

24

7

31

23%

10%

41%

Poor treatment in restaurants

28

4

32

12%

4%

29%

Relationship with my partner

25

6

31

19%

7%

37%

Choice of job

29

3

32

9%

2%

25%

Choice of job

27

4

31

13%

4%

30%

Relationship with my partner

29

3

32

9%

2%

25%

Sports and hobbies

28

3

31

10%

2%

26%

Expanding my family

30

2

32

6%

1%

21%

None of the above

31

3

34

9%

2%

24%

Public transport

31

1

32

3%

0%

16%

Expanding my family

30

1

31

3%

0%

17%

FI Child

No

Yes

Total

Percentage

Lower CI

Upper CI

Cost of food shopping

8

24

32

75%

57%

89%

Ability to eat out

12

20

32

62%

44%

79%

Emotions

14

18

32

56%

38%

Affects the diet of all the family

15

17

32

53%

35%

Assumption of being a fussy eater

15

17

32

53%

Children’s parties

18

14

32

Time for food shopping

18

14

32

Social life

20

12

Family social life

21

11

Household tasks

21

Travel

22

Effects on other family members
Social activities

FI Child
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Sports and hobbies

31

1

32

3%

0%

16%

Public transport

30

1

31

3%

0%

17%

Change schools

32

0

32

0%

0%

11%

Change schools

31

0

31

0%

0%

11%

617

Table 7.A.12. Reported areas of life affected as a result of having a MDFA (self-reported) to sufferers (adolescents (13 – 17 years)
and their families in Ireland (n =40) and NI (n=23)
Ireland
MDFA Adolescent

NI
No

Yes

Total

Percentage

Lower CI

Upper CI

Yes

Total

Percentage

Lower CI

Upper CI

Ability to eat out

3

16

19

84%

60%

97%

MDFA Adolescent
Affects the diet of all the family

1

16

17

94%

71%

100%

Emotions

5

14

19

74%

49%

91%

Ability to eat out

2

15

17

88%

64%

99%

Cost of food shopping

6

13

19

68%

43%

87%

Travel

3

14

17

82%

57%

96%

Travel

6

13

19

68%

43%

87%

Emotions

5

12

17

71%

44%

90%

Affects the diet of all the family

7

12

19

63%

38%

84%

Children’s parties

6

11

17

65%

38%

86%

Children’s parties

7

12

19

63%

38%

84%

Time for food shopping

6

11

17

65%

38%

86%

Time for food shopping

7

12

19

63%

38%

84%

Cost of food shopping

7

10

17

59%

33%

82%

Effects on other family members

8

11

19

58%

33%

80%

Social life

7

10

17

59%

33%

82%

Social activities

8

11

19

58%

33%

80%

Assumption of being a fussy eater

8

9

17

53%

28%

77%

Assumption of being a fussy eater

10

9

19

47%

24%

71%

Family social life

8

9

17

53%

28%

77%

Family social life

10

9

19

47%

24%

71%

Social activities

8

9

17

53%

28%

77%

Loss of time at work

10

9

19

47%

24%

71%

Social interaction

9

8

17

47%

23%

72%

Poor treatment in restaurants

10

9

19

47%

24%

71%

Childcare arrangement

10

7

17

41%

18%

67%

Household tasks

11

8

19

42%

20%

67%

Poor treatment in restaurants

11

6

17

35%

14%

62%

Social interaction

11

8

19

42%

20%

67%

Effects on other family members

13

4

17

24%

7%

50%

Social life

11

8

19

42%

20%

67%

Household tasks

13

4

17

24%

7%

50%

Caring for family when unwell

12

7

19

37%

16%

62%

Sports and hobbies

13

4

17

24%

7%

50%

Relationship with my partner

14

5

19

26%

9%

51%

Caring for family when unwell

14

3

17

18%

4%

43%

Sports and hobbies

14

5

19

26%

9%

51%

Loss of time at work

14

3

17

18%

4%

43%

Childcare arrangement

15

4

19

21%

6%

46%

Choice of job

15

2

17

12%

1%

36%

Choice of job

15

4

19

21%

6%

46%

Public transport

15

2

17

12%

1%

36%

Public transport

16

3

19

16%

3%

40%

None of the above

17

1

18

6%

0%

27%

Expanding my family

17

2

19

11%

1%

33%

Relationship with my partner

16

1

17

6%

0%

29%

None of the above

19

1

20

5%

0%

25%

Change schools

17

0

17

0%

0%

20%

618

No

Change schools

19

0

19

0%

0%

18%

Expanding my family

619

17

0

17

0%

0%

20%

Table 7.A.13: Reported areas of life affected as a result of having a MDCD (self-reported) to sufferers (adolescents (13 – 17 years)
and their families in Ireland (n = 44) and NI (n=23)
Ireland
MDCD Adolescent

NI
No

Yes

Total

Percentage

Lower CI

Upper CI

Cost of food shopping

0

32

32

100%

89%

100%

Ability to eat out

2

30

32

94%

79%

Time for food shopping

5

27

32

84%

67%

Affects the diet of all the family

7

25

32

78%

Travel

9

23

32

72%

Social activities

10

22

32

Social life

10

22

32

Family social life

11

21

Emotions

13

19

Poor treatment in restaurants

13

Children’s parties

16

Effects on other family members

MDCD Adolescent

Total

Percentage

Lower CI

Upper CI

Cost of food shopping

1

14

15

93%

68%

100%

99%

Ability to eat out

2

13

15

87%

60%

98%

95%

Time for food shopping

4

11

15

73%

45%

92%

60%

91%

Affects the diet of all the family

5

10

15

67%

38%

88%

53%

86%

Travel

5

10

15

67%

38%

88%

69%

50%

84%

Social activities

6

9

15

60%

32%

84%

69%

50%

84%

Social life

6

9

15

60%

32%

84%

32

66%

47%

81%

Children’s parties

7

8

15

53%

27%

79%

32

59%

41%

76%

Family social life

7

8

15

53%

27%

79%

19

32

59%

41%

76%

Poor treatment in restaurants

7

8

15

53%

27%

79%

16

32

50%

32%

68%

Assumption of being a fussy eater

8

7

15

47%

21%

73%

17

15

32

47%

29%

65%

Emotions

8

7

15

47%

21%

73%

Household tasks

18

14

32

44%

26%

62%

Social interaction

11

4

15

27%

8%

55%

Caring for family when unwell

20

12

32

38%

21%

56%

Caring for family when unwell

12

3

15

20%

4%

48%

Assumption of being a fussy eater

22

10

32

31%

16%

50%

Effects on other family members

12

3

15

20%

4%

48%

Loss of time at work

25

7

32

22%

9%

40%

Sports and hobbies

12

3

15

20%

4%

48%

Social interaction

25

7

32

22%

9%

40%

Household tasks

13

2

15

13%

2%

40%

Sports and hobbies

26

6

32

19%

7%

36%

Childcare arrangement

14

1

15

7%

0%

32%

Choice of job

29

3

32

9%

2%

25%

Change schools

15

0

15

0%

0%

22%

Childcare arrangement

30

2

32

6%

1%

21%

Choice of job

15

0

15

0%

0%

22%

Relationship with my partner

31

1

32

3%

0%

16%

Expanding my family

15

0

15

0%

0%

22%

Change schools

32

0

32

0%

0%

11%

Loss of time at work

15

0

15

0%

0%

22%

Expanding my family

32

0

32

0%

0%

11%

None of the above

15

0

15

0%

0%

22%

None of the above

32

0

32

0%

0%

11%

Public transport

15

0

15

0%

0%

22%

620

No

Yes

Public transport

32

0

32

0%

0%

11%

Relationship with my partner

621

15

0

15

0%

0%

22%

Table 7.A.14: Reported areas of life affected as a result of having a FI (self-reported) to sufferers (adolescents (13 – 17 years) and
their families in Ireland (n = 12) and NI (n=17)
Ireland
FI Adolescent

NI
No

Yes

Total

Percentage

Lower CI

Upper CI

Yes

Total

Percentage

Lower CI

Upper CI

Cost of food shopping

0

6

6

100%

54%

100%

NI FI Adolescent
Cost of food shopping

2

8

10

80%

44%

97%

Affects the diet of all the family

1

5

6

83%

36%

100%

Ability to eat out

3

7

10

70%

35%

93%

Ability to eat out

3

3

6

50%

12%

88%

Affects the diet of all the family

3

7

10

70%

35%

93%

Assumption of being a fussy eater

3

3

6

50%

12%

88%

Emotions

4

6

10

60%

26%

88%

Time for food shopping

3

3

6

50%

12%

88%

Effects on other family members

5

5

10

50%

19%

81%

Family social life

4

2

6

33%

4%

78%

Social interaction

5

5

10

50%

19%

81%

Household tasks

4

2

6

33%

4%

78%

Time for food shopping

5

5

10

50%

19%

81%

None of the above

6

3

9

33%

7%

70%

Assumption of being a fussy eater

6

4

10

40%

12%

74%

Social activities

4

2

6

33%

4%

78%

Caring for family when unwell

6

4

10

40%

12%

74%

Social interaction

4

2

6

33%

4%

78%

Social activities

6

4

10

40%

12%

74%

Children’s parties

5

1

6

17%

0%

64%

Social life

6

4

10

40%

12%

74%

Effects on other family members

5

1

6

17%

0%

64%

Family social life

7

3

10

30%

7%

65%

Emotions

5

1

6

17%

0%

64%

Sports and hobbies

7

3

10

30%

7%

65%

Poor treatment in restaurants

5

1

6

17%

0%

64%

Children’s parties

8

2

10

20%

3%

56%

Social life

5

1

6

17%

0%

64%

Household tasks

8

2

10

20%

3%

56%

Caring for family when unwell

6

0

6

0%

0%

46%

Loss of time at work

8

2

10

20%

3%

56%

Change schools

6

0

6

0%

0%

46%

Public transport

9

1

10

10%

0%

45%

Childcare arrangement

6

0

6

0%

0%

46%

Travel

9

1

10

10%

0%

45%

Choice of job

6

0

6

0%

0%

46%

None of the above

10

1

11

9%

0%

41%

Expanding my family

6

0

6

0%

0%

46%

Change schools

10

0

10

0%

0%

31%

Loss of time at work

6

0

6

0%

0%

46%

Childcare arrangement

10

0

10

0%

0%

31%

Public transport

6

0

6

0%

0%

46%

Choice of job

10

0

10

0%

0%

31%

Relationship with my partner

6

0

6

0%

0%

46%

Expanding my family

10

0

10

0%

0%

31%

Sports and hobbies

6

0

6

0%

0%

46%

Poor treatment in restaurants

10

0

10

0%

0%

31%

622

No

Travel

6

0

6

0%

0%

46%

Relationship with my partner

623

10

0

10

0%

0%

31%

Table 7.A.15: Reported areas of life affected as a result of having a MDFA (self-reported) to sufferers (adults ≥18 years) and their
families in Ireland (n = 194) and NI (n=124)
Ireland

NI
MDFA Adult

No

Yes

Total

Percentage

Lower
CI

Upper
CI

78%

Ability to eat out

17

66

83

80%

69%

88%

63%

79%

Affects the diet of all the family

18

65

83

78%

68%

87%

53%

70%

Cost of food shopping

22

61

83

73%

63%

83%

58%

49%

67%

Assumption of being a fussy
eater

23

60

83

72%

61%

82%

126

52%

43%

61%

Poor treatment in restaurants

28

55

83

66%

55%

76%

126

48%

39%

57%

Time for food shopping

29

54

83

65%

54%

75%

57

126

45%

36%

54%

Emotions

36

47

83

57%

45%

67%

56

126

44%

36%

54%

Travel

39

44

83

53%

42%

64%

82

44

126

35%

27%

44%

Effects on
members

46

37

83

45%

34%

56%

Social life

86

40

126

32%

24%

41%

Social life

48

35

83

42%

31%

54%

Family social life

89

37

126

29%

22%

38%

Family social life

49

34

83

41%

30%

52%

Work life

90

36

126

29%

21%

37%

Work life

55

28

83

34%

24%

45%

Loss of time at work

96

30

126

24%

17%

32%

Relationship with my partner

60

23

83

28%

18%

39%

Social activities

98

28

126

22%

15%

30%

Loss of time at work

62

21

83

25%

16%

36%

Relationship with my partner

100

26

126

21%

14%

29%

Social activities

65

18

83

22%

13%

32%

Choice of job

103

23

126

18%

12%

26%

Choice of job

66

17

83

20%

12%

31%

Household tasks

105

21

126

17%

11%

24%

Social interaction

67

16

83

19%

11%

29%

Social interaction

106

20

126

16%

10%

23%

Public transport

70

13

83

16%

9%

25%

Sports and hobbies

111

15

126

12%

7%

19%

Household tasks

72

11

83

13%

7%

22%

Public transport

115

11

126

9%

4%

15%

Caring for family when unwell

77

6

83

7%

3%

15%

Caring for family when unwell

120

6

126

5%

2%

10%

Sports and hobbies

77

6

83

7%

3%

15%

None of the above

126

7

133

5%

2%

11%

None of the above

83

4

87

5%

1%

11%

MDFA Adult

No

Yes

Total

Percentage

Lower CI

Upper CI

Ability to eat out

37

89

126

71%

62%

Assumption of being a fussy eater

36

90

126

71%

Affects the diet of all the family

48

78

126

62%

Cost of food shopping

53

73

126

Poor treatment in restaurants

60

66

Time for food shopping

66

60

Travel

69

Emotions

70

Effects on other family members

624

other

family

Childcare arrangement

121

5

126

4%

1%

9%

Childcare arrangement

80

3

83

4%

1%

10%

Expanding my family

124

2

126

2%

0%

6%

Change schools

81

2

83

2%

0%

8%

Change schools

125

1

126

1%

0%

4%

Expanding my family

81

2

83

2%

0%

8%

625

Table 7.A.16: Reported areas of life affected as a result of having a MDCD (self-reported) to sufferers (adults ≥18 years) and their
families in Ireland (n = 623) and NI (n= 195)
Ireland

NI
No

Yes

Total

Percentage

Lower
CI

Upper
CI

Cost of food shopping

7

141

148

95%

90%

98%

85%

Ability to eat out

27

121

148

82%

75%

88%

68%

Assumption of being a fussy
eater

48

100

148

68%

59%

75%

56%

66%

Time for food shopping

53

95

148

64%

56%

72%

61%

56%

65%

Poor treatment in restaurants

56

92

148

62%

54%

70%

59%

55%

64%

Travel

59

89

148

60%

52%

68%

437

59%

55%

64%

Affects the diet of all the family

67

81

148

55%

46%

63%

437

48%

43%

53%

Family social life

71

77

148

52%

44%

60%

206

437

47%

42%

52%

Social life

73

75

148

51%

42%

59%

187

437

43%

38%

48%

Emotions

74

74

148

50%

42%

58%

295

142

437

32%

28%

37%

Work life

89

59

148

40%

32%

48%

Effects on other family members

307

130

437

30%

25%

34%

Effects on other family members

105

43

148

29%

22%

37%

Household tasks

352

85

437

19%

16%

23%

Social activities

108

40

148

27%

20%

35%

Relationship with my partner

354

83

437

19%

15%

23%

Loss of time at work

118

30

148

20%

14%

28%

Loss of time at work

361

76

437

17%

14%

21%

Household tasks

122

26

148

18%

12%

25%

Social activities

361

76

437

17%

14%

21%

Relationship with my partner

122

26

148

18%

12%

25%

Social interaction

369

68

437

16%

12%

19%

Social interaction

122

26

148

18%

12%

25%

Caring for family when unwell

390

47

437

11%

8%

14%

Caring for family when unwell

131

17

148

11%

7%

18%

Sports and hobbies

409

28

437

6%

4%

9%

Sports and hobbies

131

17

148

11%

7%

18%

Choice of job

414

23

437

5%

3%

8%

Public transport

136

12

148

8%

4%

14%

Expanding my family

413

24

437

5%

4%

8%

Choice of job

137

11

148

7%

4%

13%

None of the above

437

12

449

3%

1%

5%

Expanding my family

142

6

148

4%

2%

9%

MDCD Adult

No

Yes

Total

Percentage

Lower CI

Upper CI

Cost of food shopping

19

418

437

96%

93%

97%

Ability to eat out

80

357

437

82%

78%

Assumption of being a fussy eater

159

278

437

64%

59%

Poor treatment in restaurants

170

267

437

61%

Time for food shopping

171

266

437

Affects the diet of all the family

177

260

437

Travel

177

260

Social life

228

209

Family social life

231

Emotions

250

Work life

MDCD Adult

626

Public transport

425

12

437

3%

1%

5%

Change schools

148

0

148

0%

0%

2%

Childcare arrangement

433

4

437

1%

0%

2%

Childcare arrangement

148

0

148

0%

0%

2%

Change schools

436

1

437

0%

0%

1%

None of the above

148

0

148

0%

0%

2%

627

Table 7.A.17: Reported areas of life affected as a result of having a FI (self-reported) to sufferers (adults≥18 years) and their families
in Ireland (n = 587) and NI (n= 515)
Ireland

NI
NI FI Adult

No

Yes

Total

Percentage

Lower
CI

Upper
CI

71%

Cost of food shopping

92

229

321

71%

66%

76%

56%

66%

Assumption of being a fussy
eater

119

202

321

63%

57%

68%

50%

45%

55%

Ability to eat out

129

192

321

60%

54%

65%

42%

37%

48%

Time for food shopping

157

164

321

51%

45%

57%

371

39%

34%

45%

Emotions

168

153

321

48%

42%

53%

371

37%

33%

43%

Affects the diet of all the
family

198

123

321

38%

33%

44%

114

371

31%

26%

36%

Poor treatment in restaurants

207

114

321

36%

30%

41%

102

371

27%

23%

32%

Social life

219

102

321

32%

27%

37%

284

87

371

23%

19%

28%

Travel

222

99

321

31%

26%

36%

286

85

371

23%

19%

28%

Family social life

227

94

321

29%

24%

35%

Relationship with my partner

304

67

371

18%

14%

22%

Relationship with my partner

247

74

321

23%

19%

28%

Work life

310

61

371

16%

13%

21%

Work life

250

71

321

22%

18%

27%

Loss of time at work

316

55

371

15%

11%

19%

Loss of time at work

263

58

321

18%

14%

23%

Social activities

316

55

371

15%

11%

19%

Social interaction

262

59

321

18%

14%

23%

Effects on other family members

321

50

371

13%

10%

17%

Effects on
members

265

56

321

17%

13%

22%

Household tasks

324

47

371

13%

9%

16%

Household tasks

276

45

321

14%

10%

18%

Social interaction

321

50

371

13%

10%

17%

Social activities

275

46

321

14%

11%

19%

None of the above

371

52

423

12%

9%

16%

Caring for family when unwell

280

41

321

13%

9%

17%

Sports and hobbies

342

29

371

8%

5%

11%

Sports and hobbies

287

34

321

11%

7%

14%

Caring for family when unwell

344

27

371

7%

5%

10%

Public transport

292

29

321

9%

6%

13%

Public transport

345

26

371

7%

5%

10%

None of the above

321

27

348

8%

5%

11%

FI Adult

No

Yes

Total

Percentage

Lower CI

Upper CI

Cost of food shopping

127

244

371

66%

61%

Assumption of being a fussy eater

143

228

371

61%

Ability to eat out

186

185

371

Time for food shopping

214

157

371

Affects the diet of all the family

225

146

Emotions

232

139

Poor treatment in restaurants

257

Social life

269

Family social life
Travel

628

other

family

Choice of job

347

24

371

6%

4%

9%

Choice of job

298

23

321

7%

5%

11%

Childcare arrangement

365

6

371

2%

1%

3%

Expanding my family

313

8

321

2%

1%

5%

Expanding my family

363

8

371

2%

1%

4%

Change schools

318

3

321

1%

0%

3%

Change schools

366

5

371

1%

0%

3%

Childcare arrangement

318

3

321

1%

0%

3%
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Appendix 8 – Priority Setting Interview Documents
8.1 Priority Setting Activity Participant Information Sheet

Priority Setting Activity: To examine the issues associated with living
with medically diagnosed food allergies and coeliac disease on the Island
of Ireland (Republic of Ireland and Northern Ireland)
What does this activity/project aim to achieve?
Safefood, Technological University Dublin (TU Dublin) and Queen’s University Belfast
are interested in examining issues associated with living with medically diagnosed food
allergies and coeliac disease on the Island of Ireland (Republic of Ireland and Northern
Ireland). The aim of this activity is to identify potential strategies and approaches, which
could be considered to improve the quality of life of medically diagnosed food allergy
and coeliac disease sufferers and families.
Who can participate in the phone interview?
You can participate if you are an adult (18 years of age and above) with medically
diagnosed food allergies or coeliac disease, or a parent/guardian of a child (under 18 years
of age) with medically diagnosed food allergies or coeliac disease. All participants must
be aged 18 years and older and living in the Republic of Ireland or Northern Ireland.
If I participate in this this activity/project what will I be required to do?
If you agree to participate in this activity, you will be invited to take part in a short
telephone interview to share your views on topics associated with your (or your child’s)
condition. Each interview is expected to take 30 minutes. Interviews will take place at
time and date which is convenient to each participant. The interviews will not be audio
recorded but the researcher will take notes during the phone call. Participants may stop
the interview at any time and/or continue the interview at a more convenient time.
Following the interview, participants will be asked to complete a short online survey (5
minutes). This is an anonymous survey. This will involve ranking the topics discussed
during the phone interview in the order that is most important to you.
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Each participant will receive a €25/£25 ‘One4All’ voucher for contributing to this study.
Your name and e-mail address will be asked in order to send you the voucher. Please
note, your survey responses will be stored separate to your personal data and it will not
be possible to link your personal details to your survey responses.
Do I have to participate in this activity/project?
Your participation is entirely voluntary, and you may withdraw from the activity/ies at
any time and for any reason, without having to give an explanation. Your data responses
from the interview may be withdrawn. However, your data responses to the priority
listing activities may not be withdrawn as these will be conducted anonymously via an
online survey. Please note only individuals who agree and understand the information on
this participant information sheet and are willing to give consent by completing a consent
form with a typed signature prior to the phone interview and priority listing activities will
be able to take part in this activity/project.
What will happen to the results of this study?
All data will be examined and summarised in the final report, to be submitted to Safefood.
All data collected will be treated in an anonymous manner. Therefore, all individuals’
contributions will be anonymous in the final report, and results may be presented at
conferences, in a peer reviewed journal and/or included in student reports. If you have
any concerns at any time during the study, you can contact the Researcher: Miss Eliza
Dimla, foodhypersens.research@tudublin.ie
How will the data be stored?
All data collected will be treated securely and confidentially under the Data Protection
Act 2018 (The Act 2018) and the General Data Protection Regulation (GDPR), and stored
electronically on a password-protected encrypted computers by the study team until the
report has been drafted for Safefood before being electronically deleted as required by
Technological University Dublin. The data will be accessible to the research team only.
The data protection and privacy policy for Technological University Dublin – City
Campus can be accessed here:
https://www.dit.ie/media/instituteofsecretary/dataprotection/Data-Protection-andPrivacy-Policy-v1.pdf

631

This study has received ethical approval from TU Dublin's Research Ethics Committee,
researchethics@TUDublin.ie and this approval has been affirmed by Queen’s University
Belfast, Faculty of Medicine, Health and Life Sciences Research Ethics Committee.
For further information about the study, please contact a member of the research team by
e-mail, or alternatively you can send us a message via our Facebook, or Twitter page
called Food Hypersensitivity Study:
Miss Eliza Dimla

Dr. Charlene McShane

Researcher, TU Dublin
Belfast

Researcher, Queen’s University

E-mail: foodhypersens.research@tudublin.ie

E-mail: XXX

Dr. Ciara Walsh
Lead Researcher, TU Dublin
E-mail: XXX
Food Hypersensitivity Study
https://www.facebook.com/pg/FoodHypersensitivityStudy/posts/?ref=page_internal
Food Hypersensitivity Study
https://mobile.twitter.com/food_study

Information Sheet for the Activity| Version 1.0 | 07/05/2020
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8.1.1 Priority Setting Activity Promotion Leaflet
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8.2 Consent Form

Priority Setting Activity: To examine the associated issues with living with medically
diagnosed food allergies and coeliac disease on the Island of Ireland (Republic of
Ireland and Northern Ireland)
Initial if appropriate

1. I confirm that I have been given and have read and understand the
[]
Information Leaflet for the above study.
I have had the opportunity to ask, and receive answers to any questions I may have
had.
2. I confirm that I am over 18 years of age.

[ ]

3. I understand that my participation is voluntary and that I am free to withdraw

[ ]

at any time, without giving any reason.

4. I agree to take part in the above study, inclusive of the procedures mentioned
in the Information Leaflet.

[ ]

5. I understand all data will be treated securely as described by the Data

[ ]

Protection Act 2018 (The Act 2018) and the General Data Protection
Regulation (GDPR) and stored appropriately as required by the University.

6. I am aware that the data I provide for this project will be shared with
the study team at TU Dublin, Queen’s University Belfast and Safefood.

[ ]

7. I understand that I will not be identifiable in any data published in relation to [
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]

this project.
8. I agree to take part in this project.

_______________________

[

___________

Name of Participant

_______________________

Date

_______________________

___________

Name of Researcher

]

Date

Signature

_____________________
Signature

Contact details for researchers:
Miss Eliza Dimla | email: foodhypersens.research@tudublin.ie| Telephone: XXX
Dr Ciara Walsh | email: XXX | Telephone: XXX
Dr Charlene McShane | email: XXX | Telephone: XXX

Consent form for the Activity | Version 1.0 | 07/05/2020
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8.3 Survey-style Interview Sheet
Priority Setting Activity - Phone Interview

Section A: Survey questions (5 questions)
This section includes your (or your child’s) demographics information (place of
residence, age and gender only), on whose behalf (parental), and the associated food
hypersensitivity (medically diagnosed food allergy/coeliac disease).
Section B: Discussion of each heading
The following headings will be reviewed by individual sufferers (medically diagnosed
food allergy and coeliac disease sufferers, or parents of sufferers):
1. Awareness and training regarding your (or your child’s) condition in an
educational setting
2. Public & food industry awareness and understanding of your (or your child’s)
condition
3. Cost and availability of medication & supplements to treat your (or your child’s)
condition
4. Accessing medical teams e.g. consultants, specialist nurses etc. for your (or your
child’s) condition
5. Dietetic support for your (or your child's) condition
6. Counselling/psychological services for sufferers and their families
7. Recognition of your (or your child’s) condition as a ‘disability’
8. Epi-pens to be available in all public spaces in case of emergency (similar to
automated external defibrillator, AED)

Each interview is expected to last about 30 minutes to discuss each of the 7 or 8 listed
headings in order. Please note the 8th heading will be considered by medically diagnosed
food allergy sufferers (or parents of sufferers) only.
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In this interview, each participant is asked to consider these headings individually with
regard to:
a) Associated issues for sufferers (and their families) and
b) Proposed future strategies, approaches and possible solutions
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Priority Setting Activity - Phone Interview (continued)

Section A: Survey questions

Date: ______

Survey Code: _________

1. Where is your place of residence?

□ Republic of Ireland
□ Northern Ireland
2. Please let us know on whose behalf you are undertaking this interview on:

□ On my behalf
□ On behalf of my child
3. Please confirm whether you (or your child) has one of the following:

□ Medically diagnosed food allergy
□ Medically diagnosed coeliac disease
4. What is your gender?

□ Male
□ Female
□ Other
□ Prefer not to say
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5. Which age category do you (or your child) belong to?

□ 0-5
□ 6 - 12
□ 13 - 17
□ 18 - 20
□ 21 - 29
□ 30 - 39
□ 40 - 49
□ 50 - 59
□ 60 or older
□ Prefer not to say
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Priority Setting Activity - Phone Interview

Section B: Discussion of each heading

Date: ______________

Survey Code: ____________
Heading 1: Awareness and training regarding your (or your child’s) condition in an
educational setting
Associated issues for sufferers (and their families)

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
Proposed future strategies, approaches and possible solutions

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
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Heading 2: Public & food industry awareness and understanding of your (or your child’s)
condition
Associated issues for sufferers (and their families)

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
Proposed future strategies, approaches and possible solutions

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
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Heading 3: Cost and availability of medication & supplements to treat your (or your
child’s) condition
Associated issues for sufferers (and their families)

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
Proposed future strategies, approaches and possible solutions

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
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Heading 4: Accessing medical teams e.g. consultants, specialist nurses etc. for your (or
your child’s) condition
Associated issues for sufferers (and their families)

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
Proposed future strategies, approaches and possible solutions

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
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Heading 5: Dietetic support for your (or your child's) condition
Associated issues for sufferers (and their families)

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
Proposed future strategies, approaches and possible solutions

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
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Heading 6: Counselling/psychological services for sufferers and their families
Associated issues for sufferers (and their families)

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
Proposed future strategies, approaches and possible solutions

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
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Heading 7: Recognition of your (or your child’s) condition as a ‘disability’
Associated issues for sufferers (and their families)

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
Proposed future strategies, approaches and possible solutions

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
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Heading 8: Epi-pens to be available in all public spaces in case of emergency (similar to
automated external defibrillator, AED)
Associated issues for sufferers (and their families)

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
Proposed future strategies, approaches and possible solutions

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
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8.4 Post-interview Priority List Surveys – Electronic Surveys
Post-interview Priority List Surveys – Electronic Surveys:
•
•

Post-interview Priority List Survey Link:
https://www.surveymonkey.com/r/TLF8LRV
Post-interview Priority List Voucher Survey Link (This voucher survey link
is a redirect from the main survey above) https://www.surveymonkey.com/r/K92F65R
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8.4.1 Participant Information Sheet for the Post-interview Priority List Survey
Safefood, Technological University Dublin (TU Dublin) and Queen’s University Belfast
are interested in examining issues associated with living with medically diagnosed food
allergies and coeliac disease on the island of Ireland (Republic of Ireland and Northern
Ireland).
In this short survey we will ask you to rank the topics discussed during the phone
interview in the order that is most important to you. This survey is anonymous and IP
(computer address) tracking has been switched off. This activity is expected to take about
5 minutes to complete. You can withdraw from this survey at any time by simply exiting
the webpage. As data collection is anonymous we will not be able to remove any data
provided.
Upon completion of the survey, you will be invited to enter your name and e-mail address
in order to send you a €25/£25 ‘One4All’ voucher as a token of appreciation for your
time. Please note, your survey responses will be stored separate to your personal data and
it will not be possible to link your personal details to your survey responses.
All data collected will be treated securely and confidentially under the Data Protection
Act 2018 (The Act 2018) and the General Data Protection Regulation (GDPR), and stored
electronically on a password-protected encrypted computers by the study team until the
report has been drafted for Safefood before being electronically deleted as required by
Technological University Dublin.
The data will be accessible to the research team only. The data protection and privacy
policy for Technological University Dublin – City Campus can be accessed
here:https://www.dit.ie/media/instituteofsecretary/dataprotection/Data-Protection-andPrivacy-Policy-v1.pdf

By taking part in this survey, you agree that you:
•
•
•

are 18 years of age and older,
understand the information presented above and
give consent to the information that you provide being used in this study

For further information about the study, please contact:
Miss Eliza Dimla
Researcher, TU Dublin
E-mail: foodhypersens.research@tudublin.ie
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8.4.2 Post-interview Priority List Survey for Medically Diagnosed Food Allergy or
Coeliac Disease Sufferers (and their Families) - Hard Copy Version
1. Where is your place of residence?
 Republic of Ireland
 Northern Ireland

2. Please let us know on whose behalf you are completing this priority list on:
 On my behalf
 On behalf of my child

3. Please state the age of the child if you are completing this on behalf of your child.






0-5
6 - 12
13 - 17
Prefer not to say
Not applicable

4. Please confirm whether you (or your child) has one of the following:
 Medically diagnosed coeliac disease
 Medically diagnosed food allergy
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Please skip to question 7, if you or your child does not have medically diagnosed coeliac
disease.

The following priority listing activities (question 5 and 6) can be completed by an adult
or a parent/guardian of a child with medically diagnosed coeliac disease.

5. Please prioritise each of the following headings and rank each of the heading in order
of priority i.e. with 1 being the most important and 7 being the least important to
you (and your family).

Headings

Please list the headings
in order of importance.

Awareness and training regarding your (or your child’s)
condition in an educational setting
Public & food industry awareness and understanding of
your (or your child’s) condition
Cost and availability of medication & supplements to treat
your (or your child’s) condition
Accessing medical teams e.g. consultants, specialist
nurses etc. to treat your (or your child’s) condition
Dietetic support for your (or your child's) condition
Counselling/psychological services for sufferers and their
families
Recognition of your (or your child’s) condition as a
‘disability’
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6. Please prioritise each of the following headings and rank each of the heading in terms
of what will be the easiest to solve, or implement, or which will be most easily
overcome vs which will be more difficult? i.e. with 7 being the most difficult to solve
and 1 being the most easiest to solve.

Headings

Please list the headings
by ease of solution.

Awareness and training regarding your (or your child’s)
condition in an educational setting
Public & food industry awareness and understanding of
your (or your child’s) condition
Cost and availability of medication & supplements to treat
your (or your child’s) condition
Accessing medical teams e.g. consultants, specialist nurses
etc. to treat your (or your child’s) condition
Dietetic support for your (or your child's) condition
Counselling/psychological services for sufferers and their
families
Recognition of your (or your child’s) condition as a
‘disability’
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Please skip to question 11, if you or your child does not have medically diagnosed
food allergy.
The following questions and priority listing activities (question 7 to 10) can be completed
by an adult or a parent/guardian of a child with medically diagnosed food allergy.
7. What type of foods have you or your child been medically diagnosed as allergic to?

Please specify:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________

8. What other additional food intolerances, suspected, non-medically diagnosed food
allergies do you or child have?

Please specify:

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
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9. Please prioritise each of the following headings and rank each of the heading in order
of priority i.e. with 1 being the most important and 8 being the least important to
you (and your family).

Headings

Please
list
the
headings in order of
importance.

Awareness and training regarding your (or your child’s)
condition in an educational setting
Public & food industry awareness and understanding of your
(or your child’s) condition
Cost and availability of medication & supplements to treat
your (or your child’s) condition

Accessing medical teams e.g. consultants, specialist nurses
etc. to treat your (or your child’s) condition
Dietetic support for your (or your child's) condition

Counselling/psychological services for sufferers and their
families
Recognition of your (or your child’s) condition as a
‘disability’

Epi-pens to be available in all public spaces in case of
emergency (similar to automated external defibrillator, AED)
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10. Please prioritise each of the following headings and rank each of the heading in terms
of what will be the easiest to solve, or implement, or which will be most easily
overcome vs which will be more difficult? i.e. with 8 being the most difficult to solve
and 1 being the most easiest to solve.

Headings

Please list the headings
by ease of solution.

Awareness and training regarding your (or your child’s)
condition in an educational setting
Public & food industry awareness and understanding of
your (or your child’s) condition
Cost and availability of medication & supplements to treat
your (or your child’s) condition
Accessing medical teams e.g. consultants, specialist nurses
etc. to treat your (or your child’s) condition
Dietetic support for your (or your child's) condition
Counselling/psychological services for sufferers and their
families
Recognition of your (or your child’s) condition as a
‘disability’
Epi-pens to be available in all public spaces in case of
emergency (similar to automated external defibrillator,
AED)

655

11. If you would like to receive one €25/£25 ‘One4All’ voucher, please enter your
name and e-mail address on this link:
https://www.surveymonkey.com/r/K92F65R
TU Dublin will securely store this data until the voucher has been sent out to the
participant. This data will not be shared with any third parties or used in a way other
than for the purpose it was provided and then will be destroyed. By providing your
name and address, you consent to TU Dublin processing your data in line with the
purpose specified above.

➔Name: _______________

➔E-mail Address: ________________________

Thank you for participating in our study.

Priority List Survey for the Activity via Phone Interviews | Version 1.0 | 07/05/2020
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Appendix 9 – Food Hypersensitivity and Control Surveys for Ireland
and Northern Ireland
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9.1 SAFEFOOD - FOOD HYPERSENSITIVITY QUESTIONNAIRES
Survey Link: https://safefood.mysurveyhosting.com/index.php/679263?lang=en
Participant Information Sheet
Adult Surveys
• Survey 1: Medically Diagnosed Food Allergy Survey – version for adults
• Survey 1a: Lottery Survey
• Survey 2: Medically Diagnosed Coeliac Disease Survey – version for adults
• Survey 2a: Lottery Survey
• Survey 3: Food Intolerance/s, Suspected, or Non-medically diagnosed Food
Allergy/ies Survey – version for adults
• Survey 3a: Lottery Survey
Parental Surveys
• Survey 4: Medically Diagnosed Food Allergy Survey – version for parents
• Survey 4a: Lottery Survey
• Survey 5: Medically Diagnosed Coeliac Disease Survey – version for parents
• Survey 5a: Lottery Survey
• Survey 6: Food Intolerance/s, Suspected, or Non-medically diagnosed Food
Allergy/ies Survey – version for parents
• Survey 6a: Lottery Survey
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9.1.1 Food Hypersensitivity Questionnaire Participant Information Sheet

Safefood, Technological University Dublin (TU Dublin) and Queen’s University Belfast
are researching the socio-economic costs associated with food hypersensitivities on the
Island of Ireland today. We are asking (i) adults with food hypersensitivities (e.g. food
allergies, food intolerances or coeliac disease), or (ii) parents of a child with food
hypersensitivities (e.g. food allergies, food intolerances or coeliac disease) to help us by
providing information in this survey.
This information will be used to make recommendations and potentially to develop
interventions. It is our hope that this study will provide much needed information, and
potentially inform policy, in this important area.
This survey will take between 10 to 15 minutes to complete. The survey should be
completed in the context of the respondent’s normal circumstances before these were
interrupted by the current Covid-19 crisis.
You will be asked questions regarding the monetary costs associated with living with a
food hypersensitivity, in addition to the overall effect that this condition has on you and
your family’s ‘quality of life’. You will also be given the opportunity to express your
views on what changes could be made to improve the standard of living of sufferers (and
their families) on the Island of Ireland.
Respondents must be resident in the Republic of Ireland or Northern Ireland.
Completed surveys will be entered into a prize draw (optional) for one of 5 x €100/£100
‘One4All’ vouchers and cannot be linked to any submitted survey data.
This survey is anonymous and cannot be traced back to any computer IP address. The
information from this survey will be stored electronically on a password-protected
encrypted computer at TU Dublin for 5 years before being electronically deleted. To learn
more, please visit: https://www.dit.ie/media/instituteofsecretary/dataprotection/DataProtection-and-Privacy-Policy-v1.pdf
By taking part in this survey, you agree that you:
• are 18 years of age and older,
• understand the information presented above and
• give consent to the information that you provide being used in this study
For further information about the study, please contact:
Miss Eliza Dimla
Researcher, TU Dublin
E-mail: C14710955@mytudublin.ie
Phone: XXX
Address: TU Dublin, Sackville Place, Dublin 1, D01 FH94
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1. This questionnaire can be completed by an adult or a parent/guardian of a child with a
food hypersensitivity (e.g. food allergies, food intolerances or coeliac disease). Please select
one and tick on whose behalf you are completing this survey on. This survey is to be
completed with regard to pre-COVID-19 situation.

□ On my behalf

□ On behalf of my child

2. Please confirm whether you or your child (whichever option you selected in Q1) has one
of the following:

□

Medically diagnosed Food Allergy (as diagnosed by a doctor/medical professional)
o If you or your child have a medically diagnosed food allergy/ies (based on a food
oral challenge, trial elimination diet, blood, or skin prick test) and if you or your
child have additional food intolerance/s, suspected, or non-medically diagnosed
food allergy/ies, or coeliac disease, please select this option

□

Medically diagnosed Coeliac Disease (as diagnosed by a doctor/medical professional)
o If you or your child have been medically diagnosed with coeliac disease, please
select this option

□

Food Intolerance/s, Suspected, or Non-medically diagnosed Food Allergy/ies
o If you or your child have a food intolerance/s, suspected, or non-medically
diagnosed food allergy/ies (which has not been medically diagnosed by a medical
professional), please select this option
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9.1.2 Safefood Food Hypersensitivity Questionnaires – Version for Adults
Survey 1: Medically Diagnosed Food Allergy Survey – version for adults
I. Your household and health. Please complete the following questions with regard
to pre-COVID-19 situation.
1. Where is your place of residence?

□ Republic of Ireland

□ Northern Ireland

2. In total, how many adults, adolescents and children live in your household?
Number of adults
(>18 years of age)

_____ male

_____ female

_____ male

_____ female

_____ male

_____ female

Number of adolescents
(13 – 17 years of age)
Number of children
(0 - 12 years of age)

3. Please state your age and gender.

You

Age

Male or female
(Enter M or F)

_____

_____
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4. What is your ethnic or cultural background?

□ Irish
□ British
□ Northern Irish
□ Irish Traveller
□ Any other White background
□ African
□ Any other Black background
□ Chinese
□ Any other Asian background
□ Other (including mixed background), please specify _________
5. Do you have one or more of the following:

□ Medically diagnosed food allergy/ies
□ Medically diagnosed coeliac disease
□ Food Intolerance/s, Suspected, or Non-medically diagnosed food allergy/ies
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6. At what age were you medically diagnosed with food allergy/ies by a doctor or medical
professional?
➔ Age of diagnosis _____

7. What type of foods have you been medically diagnosed as allergic to?
Additional food intolerance/s, suspected, or non-medically diagnosed food allergy/ies can be
noted. Please tick all that apply.
Medically diagnosed
Food intolerances,
food allergies
suspected, or nonmedically diagnosed
food allergies
1. Peanuts
2. Milk & dairy products
3. Eggs
4. Celery
5. Lupin
6. Mustard
7. Sesame seeds
8. Molluscs
9. Crustaceans
10. Soy beans
11. Sulphur dioxide and sulphites
12. Cereals containing gluten
(wheat, rye, barley, oats)
13. Fish
Please specify what type of fish

□
□
□
□
□
□
□
□
□
□
□

□
□
□
□
□
□
□
□
□
□
□

□

□

□

□

□

□

___________________________
14. Nuts
Please specify what type of nuts
___________________________
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15. Fruit
Please specify what type of fruit

□

□

□

□

___________________________
16. Meat or poultry
Please specify what type of
meat/poultry
___________________________

8. Please specify other types of foods that you have been medically diagnosed as allergic to.
Additional food intolerance/s, suspected, or non-medically diagnosed food allergy/ies can be
noted. If you do not have any other medically diagnosed food allergies, food intolerances,
suspected, or non-medically diagnosed food allergies, please skip to the next question.
Medically diagnosed
Food intolerances,
food allergies
suspected, or nonmedically diagnosed
food allergies

□
□
□
□
□
□
□
□
□
□

1. __________________________
2. __________________________
3. __________________________
4. __________________________
5. __________________________
6. __________________________
7. __________________________
8. __________________________
9. __________________________
10. __________________________
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□
□
□
□
□
□
□
□
□
□

9. Do you have one or more of the following:

□ Suspected coeliac disease (not medically diagnosed)
□ Gluten sensitivity/non-coeliac gluten sensitivity
□ Suspected wheat allergy (not medically diagnosed)
□ None of the above
10. Which test(s) have been performed on you to confirm the food allergy/ies?
You may tick more than one box.

□ Blood tests
□ Skin prick test
□ Food oral challenge
□ Trial elimination diet
□ Don’t know
□ Other, please specify _________
11. Do you know whether your food allergy is:
You may tick more than one box.

□ IgE-mediated
□ Non-IgE-mediated
□ Mixed IgE and non-IgE-mediated
□ Don’t know
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12. Where was the food allergy/ies diagnosed?
You may tick more than one box.

□ Family doctor (GP)
□ Consultant out-patient clinic
□ Following / during hospital admission
□ Can’t remember
□ Other, please specify _________
13. Please tick all the medicines that have been prescribed for you by a doctor for food
allergy/ies in the last 12 MONTHS.
List of prescribed medicines:

□

Adrenaline (epinephrine) auto-injectors

□

Antihistamines

□

Corticosteroids (prescribed to treat symptoms of food allergy)

□

Other, please specify
_________________
_________________
_________________

14. An anaphylactic reaction is a severe life-threatening allergic reaction.
In the last 12 months, have you ever had an anaphylactic reaction due to a food allergen/s?

□ Yes
□

No

➔ If yes, on how many occasions in the last 12 months: ________
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15. Including you, how many adults, adolescents and children live in your household that
are diagnosed by medically diagnosed food allergies, as far as you are aware?
Number of adults
(>18 years of age)

_____ male

_____ female

_____ male

_____ female

_____ male

_____ female

Number of adolescents
(13 – 17 years of age)
Number of children
(0 - 12 years of age)

16. At what age were you medically diagnosed with coeliac disease by a doctor or medical
professional? (This is an additional question based on Question 5. Please answer if you have
medically diagnosed coeliac disease.)
➔ Age of diagnosis _____

17. Which test(s) have been performed on you to confirm the coeliac disease?
You may tick more than one box. (This is an additional question based on Question 5. Please
answer if you have medically diagnosed coeliac disease.)

□ Blood tests
□ Gastrointestinal endoscopy and biopsy
□ Don’t know
□ Other, please specify _________
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18. Where was the coeliac disease diagnosed?
You may tick more than one box. (This is an additional question based on Question 5. Please
answer if you have medically diagnosed coeliac disease.)

□ Family doctor (GP)
□ Consultant out-patient clinic
□ Following / during hospital admission
□ Can’t remember
□ Other, please specify _________
19. Please tick all the medicines that have been prescribed for you by a doctor for coeliac
disease in the last 12 MONTHS. (This is an additional question based on Question 5. Please
answer if you have medically diagnosed coeliac disease.)
List of prescribed medicines:

□

Corticosteroids (prescribed to treat symptoms of coeliac disease)

□

Prescribed vitamins and supplements

□

Other, please specify
_________________
_________________
_________________

20. Do you have any long-term illness, health problems, or disabilities other than food
allergy or intolerance which limit your daily activities?

□ Yes
□ No
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21. Under each heading, please tick the ONE box that best describes your health TODAY.
MOBILITY

❑
❑
❑

I have no problems in walking about
I have some problems in walking about
I am confined to bed

SELF-CARE
I have no problems with self-care
I have some problems washing or dressing myself
I am unable to wash or dress myself

❑
❑
❑

USUAL ACTIVITIES (e.g. work, study, housework, family or leisure activities)
I have no problems with performing my usual activities
I have some problems with performing my usual activities
I am unable to perform my usual activities

❑
❑
❑

PAIN/DISCOMFORT

❑
❑
❑

I have no pain or discomfort
I have moderate pain or discomfort
I have extreme pain or discomfort

ANXIETY/DEPRESSION

❑
❑
❑

I am not anxious or depressed
I am moderately anxious or depressed
I am extremely anxious or depressed

© 1990 EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research
Foundation. UK (English) v2.1
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The best health
you can imagine
100

•

We would like to know how good or bad your health is TODAY.

95

•

This scale is numbered from 0 to 100.

90

•

100 means the best health you can imagine.

85

80

0 means the worst health you can imagine.
•

•

75

Please mark an X on the scale to indicate how your health is
TODAY.

70

Now, write the number you marked on the scale in the box below.

65
60
55
50
45

YOUR HEALTH TODAY =

40
35
30
25
20
15
10
5
0

The worst health
© 1990 EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research
you can
Foundation. UK (English) v2.1
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imagine

II. Cost of visits to health professionals (excluding hospital admissions). Please
complete the following cost questions with regard to pre-COVID-19 situation.
22. Approximately, how often did you visit any of the following health professionals for your
own health in the last 12 months? Please complete for any of the health professionals relevant
to you.
Approximate number
How many miles or
of visits over the last 12 kilometres did you travel to
months period?
get to most recent
appointment?
[1] Family doctor (GP)

[2] Consultants/Specialists

[3] Nurse

[4] Nurse at outpatient clinic

[5] Dietician/Nutritionist

[6] Physiotherapist

[7] Pharmacist

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

[8] Alternative therapist
Please specify
____________________

___
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___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

____________________

[9] Other health professionals
Please specify

23. When you attended your last appointment with these health professionals, how much
did you personally pay (if anything) for the consultation? Please exclude any payments
covered by private/health insurance.
Consultation fee of last appointment
(£)/(€)
[1] Family doctor (GP)

____

[2] Consultants/Specialists

____

[3] Nurse

____
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[4] Nurse at outpatient clinic

____

[5] Dietician/Nutritionist

____

[6] Physiotherapist

____

[7] Pharmacist

____

[8] Alternative therapist
Please specify
____________________

____

____________________

____

____________________

____

[9] Other health professionals
Please specify
____________________

____

____________________

____

____________________

____
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III. Hospital inpatient admissions in the last 12 MONTHS. Please complete the
following questions with regard to pre-COVID-19 situation.

24. How many times (if any) have you been admitted/attended hospital in the last 12 months?
If you have not been admitted nor attended a hospital in the last 12 months, please skip to the next
question.
Outpatient attendence Day Unit: often used
A&E attendance
Hospital admission
for tests that require
without subsequent
to a ward, possibly after
monitoring
admission to a ward
A&E attendance

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

How many times ____

How many times ____

How many times ____

How many times ____

Total number of nights ___
Did this result in a loss
of earnings for you?

Did this result in a loss
of earnings for you?

Did this result in a loss
of earnings for you?

Did this result in a loss of
earnings for you?

□ Yes
□ No

□ Yes
□ No

□ Yes
□ No

□ Yes
□ No

If so, how much?

If so, how much?

If so, how much?

If so, how much?

(£)/(€)_______

(£)/(€)_______

(£)/(€)_______

(£)/(€)_______

Did you require an
ambulance over the last
12 months?

Did you require an
ambulance over the last 12
months?

□ Yes
□ No

□ Yes
□ No

If so, how many times?

If so, how many times?

_______

_______

How much did the
ambulance cost?

How much did the
ambulance cost?
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(£)/(€) _______

(£)/(€) _______

25. Approximately, how much have you spent on medicines and food supplements for
yourself, in the last 12 months?
➔ Prescribed medicines? (£)/(€) ________
➔ Over-the-counter medicines? (£)/(€) ________
➔ Food supplements? (£)/(€) ________

26. Approximately, how much have you spent on gluten-free products in the last 12 months?
(This is an additional question based on Question 5. Please answer if you have medically
diagnosed coeliac disease.)
➔ Approximate cost of gluten-free food products (£)/(€) ________

27. Have you claimed tax relief on gluten-free products? (Applicable to the Republic of
Ireland respondents only. This is an additional question based on Question 5. Please answer
if you have medically diagnosed coeliac disease.)

□ Yes
□ No
➔ If yes, at what percentage of total cost did you receive? (%) _________

28. Do you have private/additional medical insurance?

□ Yes
□ No
➔ If yes, how much does your individual policy cost per year? (£)/(€) _________
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IV. Days off work, school or college. Please complete this question with regard to
pre-COVID-19 situation.
29. During the last 12 months, how many days (if any) have you taken off work, school or
college due to any illness?
➔ Total number of days off _________

V. Costs of living. Please complete the following cost questions with regard to preCOVID-19 situation.
30. On average, how much do you or your household spend EACH WEEK on food shopping
(excluding eating out)?
Please estimate the amount you spend on food shopping for yourself, by answering either
part (i) or (ii).
i) Total cost of household food shopping (£)/(€) _________
Approximate percentage (total cost) of household food shopping attributed to you (%) ______
ii) Total cost of your own food shopping (£)/(€) _________

31. On average, how much TIME do you spend EACH WEEK on shopping for food and
preparing food for yourself?
➔ Time spent shopping for food each week? ____ hours ____ minutes
➔ Time spent preparing for food each week? ____ hours ____ minutes

32. Over the PAST MONTH, approximately how many times did you consume food and
meals bought outside the home (e.g. including meals at work/school/college, canteen, café,
restaurants), and at what cost?
➔ Approximate number of times _________
➔ Approximate cost per time (£)/(€) _________
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VI. About you and your household. Please complete the following questions with
regard to pre-COVID-19 situation.
33. Please tell us which areas of daily life have been affected as a result of your food
allergy/ies. Please tick all that apply.

□ Childcare arrangement
□ Changed schools
□ The time it takes to complete my food shopping
□ The cost of my food shopping
□ Household tasks
□ Relationship with my partner
□ Effects on other siblings and family members
□ Affects the diet of all the family (food eliminated from house/change to overall family diet)
□ Ability to eat out/eat out as a family
□ Assumption of being a fussy eater
□ Poor treatment by some staff in restaurants
□ Expanding my family
□ Caring for family and children when unwell
□ Choice of job or career
□ Loss of time at work
□ Work life (team building, going to restaurants with workmates)
□ Emotions (anger, fear, anxiety, feeling left out and trauma)
□ Ability to use public transport
□ Social interaction
□ Social activities (e.g. going to school tours, theme parks)
□ Sports and hobbies
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□ Social life (e.g. going to parties)
□ Family social life (e.g. going to family parties, weddings, visiting family members)
□ Holidays/travel to foreign destinations
□ None of the above
Please feel free to elaborate or add to any of the above.
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________

34. Do you live in an urban or rural setting?

□ Urban
□ Rural
35. What is the highest level of education you have completed to date?

□ Primary Education or less
□ Intermediate/Junior/Group/Ordinary Levels/General Certificate of Secondary Education or
equivalent

□ Leaving Certificate/Advanced Levels/General Certificate of Education Advanced Level or
equivalent

□ Diploma/Certificate
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□ Primary degree/Bachelor’s degree
□ Postgraduate/Higher degree
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36. What is your employment status?
Please tick one box which best describes your current working status.

□
□
□
□
□
□
□
□
□
□
□
□

Part-time
Full-time
Self employed with employees
Self employed without employees
Unemployed and seeking work
Unemployed and not seeking work
Retired
Student
Homemaker
On disability allowance
Volunteer
Other, please specify
_________________
_________________
_________________

37. If you are in paid employment, on average how many hours do you work per week?

□ Not applicable
➔ Total number of hours per week? _______
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38. All the information that you provide will be completely anonymous and strictly
confidential.
What would be your total net income PER MONTH after tax and other deductions
e.g. Pay As You Earn, Pay Related Social Insurance and Pension Related Deduction
are taken out? Please tick one box only.
Per Month (£)/(€)
Total Net Income
Not applicable

□

Under 1,000

□

1,001 to under 1,500

□

1,501 to under 2,000

□

2,001 to under 2,500

□

2,501 to under 3,500

□

3,501 to under 4,000

□

4,001 to under 5,000

□

5,001 to under 6,500

□

6,501 to under 8,000

□

8,001 or more

□
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39. Please feel free to write suggestions or recommendations you believe would assist in
improving the quality of life of individuals with food allergy or intolerance on the Island of
Ireland today:
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________

Thank you very much for your co-operation!
1. Do you want to participate in our lottery for the chance to win one of 5 x €100/£100
‘One4All’ vouchers?

□ Yes
□ No
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Survey 1a: Lottery Survey
1. Please provide a contact email address to enter a lottery for the chance to win one of 5 x
€100/£100 ‘One4All’ vouchers. This email address will only be used to contact you in the
event that you are chosen as a winner. TU Dublin will securely store this data until the
winner has been randomly chosen and has claimed their prize. This data will not be shared
with any third parties or used in a way other than for the purpose it was provided and then
will be destroyed. By providing your email address, you consent to TU Dublin processing
your data in line with the purpose specified above.
➔ Email address: _______________

Thank you very much for your co-operation!
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Survey 2: Medically Diagnosed Coeliac Disease Survey – version for adults
I. Your household and health. Please complete the following questions with regard
to pre-COVID-19 situation.
1. Where is your place of residence?

□ Republic of Ireland

□ Northern Ireland

2. In total, how many adults, adolescents and children live in your household?
Number of adults
(>18 years of age)

_____ male

_____ female

_____ male

_____ female

_____ male

_____ female

Number of adolescents
(13 – 17 years of age)
Number of children
(0 - 12 years of age)

3. Please state your age and gender.
Age

You

_____
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Male or female
(Enter M or F)
_____

4. What is your ethnic or cultural background?

□ Irish
□ British
□ Northern Irish
□ Irish Traveller
□ Any other White background
□ African
□ Any other Black background
□ Chinese
□ Any other Asian background
□ Other (including mixed background), please specify _________
5. Do you have one or more of the following:

□ Medically diagnosed coeliac disease
□ Food Intolerance/s, Suspected, or Non-medically diagnosed food allergy/ies
6. At what age were you medically diagnosed with coeliac disease by a doctor or medical
professional?
➔ Age of diagnosis _____

7. Which test(s) have been performed on you to confirm the coeliac disease?
You may tick more than one box.

□ Blood tests
□ Gastrointestinal endoscopy and biopsy
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□ Don’t know
□ Other, please specify _________
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8. Where was the coeliac disease diagnosed?
You may tick more than one box.

□ Family doctor (GP)
□ Consultant out-patient clinic
□ Following / during hospital admission
□ Can’t remember
□ Other, please specify _________
9. Please tick all the medicines that have been prescribed for you by a doctor for coeliac
disease in the last 12 MONTHS.
List of prescribed medicines:

□

Corticosteroids (prescribed to treat symptoms of coeliac disease)

□

Prescribed vitamins and supplements

□

Other, please specify
_________________
_________________
_________________

10. Including you, how many adults, adolescents and children live in your household that
are diagnosed by medically diagnosed coeliac disease, as far as you are aware?
Number of adults
(>18 years of age)

_____ male

_____ female

_____ male

_____ female

_____ male

_____ female

Number of adolescents
(13 – 17 years of age)
Number of children
(0 - 12 years of age)
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11. What type of foods are you intolerant or allergic to but have not been medically
diagnosed by a medical professional? Please tick all that apply. (This is an additional
question based on Question 5. Please answer if you have food intolerance/s, suspected, or
non-medically diagnosed food allergy/ies.)
Food intolerances, suspected, or non-medically
diagnosed food allergies

□
□
□
□
□
□
□
□
□
□
□

1. Peanuts
2. Milk & dairy products
3. Eggs
4. Celery
5. Lupin
6. Mustard
7. Sesame seeds
8. Molluscs
9. Crustaceans
10. Soy beans
11. Sulphur dioxide and sulphites
12. Cereals containing gluten
(wheat, rye, barley, oats)
13. Fish
Please specify what type of fish

□
□

___________________________
14. Nuts
Please specify what type of nuts

□
___________________________
15. Fruit
Please specify what type of fruit

□
___________________________
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16. Meat or poultry
Please specify what type of
meat/poultry

□

___________________________

□

17. None of the above

12. Please specify other types of foods that you are intolerant or allergic to but have not been
medically diagnosed by a medical professional.
If you do not have any other food intolerances, suspected, or non-medically diagnosed food
allergies, please skip to the next question. (This is an additional question based on Question
5. Please answer if you have food intolerance/s, suspected, or non-medically diagnosed food
allergy/ies.)
Food intolerances, suspected, or non-medically
diagnosed food allergies

□
□
□
□
□
□
□
□
□
□

1. __________________________
2. __________________________
3. __________________________
4. __________________________
5. __________________________
6. __________________________
7. __________________________
8. __________________________
9. __________________________
10. __________________________

689

13. Do you have any long-term illness, health problems, or disabilities other than food
intolerance or allergy which limit your daily activities?

□ Yes
□ No
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14. Under each heading, please tick the ONE box that best describes your health TODAY.
MOBILITY

❑
❑
❑

I have no problems in walking about
I have some problems in walking about
I am confined to bed

SELF-CARE
I have no problems with self-care
I have some problems washing or dressing myself
I am unable to wash or dress myself

❑
❑
❑

USUAL ACTIVITIES (e.g. work, study, housework, family or leisure activities)
I have no problems with performing my usual activities
I have some problems with performing my usual activities
I am unable to perform my usual activities

❑
❑
❑

PAIN/DISCOMFORT

❑
❑
❑

I have no pain or discomfort
I have moderate pain or discomfort
I have extreme pain or discomfort

ANXIETY/DEPRESSION

❑
❑
❑

I am not anxious or depressed
I am moderately anxious or depressed
I am extremely anxious or depressed

© 1990 EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research
Foundation. UK (English) v2.1
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The best health
you can imagine
100

95

•

We would like to know how good or bad your health is TODAY.

•

This scale is numbered from 0 to 100.

•

100 means the best health you can imagine.

90
85

80

0 means the worst health you can imagine.
•

•

75

Please mark an X on the scale to indicate how your health is
TODAY.

70

Now, write the number you marked on the scale in the box below.

65
60
55
50
45

YOUR HEALTH TODAY =
40
35
30
25
20
15
10
5

The worst health
0

you can imagine

© 1990 EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research
Foundation. UK (English) v2.1
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II. Cost of visits to health professionals (excluding hospital admissions). Please
complete the following cost questions with regard to pre-COVID-19 situation.
15. Approximately, how often did you visit any of the following health professionals for your
own health in the last 12 months? Please complete for any of the health professionals relevant
to you.
Approximate number
How many miles or
of visits over the last 12 kilometres did you travel to
months period?
get to most recent
appointment?
[1] Family doctor (GP)

[2] Consultants/Specialists

[3] Nurse

[4] Nurse at outpatient clinic

[5] Dietician/Nutritionist

[6] Physiotherapist

[7] Pharmacist

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

[8] Alternative therapist
Please specify
____________________

___
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___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

____________________

[9] Other health professionals
Please specify

16. When you attended your last appointment with these health professionals, how much
did you personally pay (if anything) for the consultation? Please exclude any payments
covered by private/health insurance.
Consultation fee of last appointment
(£)/(€)
[1] Family doctor (GP)

____

[2] Consultants/Specialists

____

[3] Nurse

____
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[4] Nurse at outpatient clinic

____

[5] Dietician/Nutritionist

____

[6] Physiotherapist

____

[7] Pharmacist

____

[8] Alternative therapist
Please specify
____________________

____

____________________

____

____________________

____

[9] Other health professionals
Please specify
____________________

____

____________________

____

____________________

____
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III. Hospital inpatient admissions in the last 12 MONTHS. Please complete the
following questions with regard to pre-COVID-19 situation.

17. How many times (if any) have you been admitted/attended hospital in the last 12 months?
If you have not been admitted nor attended a hospital in the last 12 months, please skip to the next
question.
Outpatient attendence Day Unit: often used
A&E attendance
Hospital admission
for tests that require
without subsequent
to a ward, possibly after
monitoring
admission to a ward
A&E attendance

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

How many times ____

How many times ____

How many times ____

How many times ____

Total number of nights ___
Did this result in a loss
of earnings for you?

Did this result in a loss
of earnings for you?

Did this result in a loss
of earnings for you?

Did this result in a loss of
earnings for you?

□ Yes
□ No

□ Yes
□ No

□ Yes
□ No

□ Yes
□ No

If so, how much?

If so, how much?

If so, how much?

If so, how much?

(£)/(€)_______

(£)/(€)_______

(£)/(€)_______

(£)/(€)_______

Did you require an
ambulance over the last
12 months?

Did you require an
ambulance over the last 12
months?

□ Yes
□ No

□ Yes
□ No

If so, how many times?

If so, how many times?

_______

_______

How much did the
ambulance cost?

How much did the
ambulance cost?
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(£)/(€) _______

(£)/(€) _______

18. Approximately, how much have you spent on medicines and food supplements for
yourself, in the last 12 months?
➔ Prescribed medicines? (£)/(€) ________
➔ Over-the-counter medicines? (£)/(€) ________
➔ Food Supplements? (£)/(€) ________

19. Approximately, how much have you spent on gluten-free products in the last 12 months?
➔ Approximate cost of gluten-free food products (£)/(€) ________

20. Have you claimed tax relief on gluten-free products? (Applicable to the Republic of
Ireland respondents only.)

□ Yes
□ No
➔ If yes, at what percentage of total cost did you receive? (%) _________

21. Do you have private/additional medical insurance?

□ Yes
□ No
➔ If yes, how much does your individual policy cost per year? (£)/(€) _________
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IV. Days off work, school or college. Please complete this question with regard to
pre-COVID-19 situation.
22. During the last 12 months, how many days (if any) have you taken off work, school or
college due to any illness?
➔ Total number of days off _________
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V. Costs of living. Please complete the following cost questions with regard to preCOVID-19 situation.
23. On average, how much do you or your household spend EACH WEEK on food shopping
(excluding eating out)?
Please estimate the amount you spend on food shopping for yourself, by answering either
part (i) or (ii).
i) Total cost of household food shopping (£)/(€) _________
Approximate percentage (total cost) of household food shopping attributed to you (%) ______
ii) Total cost of your own food shopping (£)/(€) _________

24. On average, how much TIME do you spend EACH WEEK on shopping for food and
preparing food for yourself?
➔ Time spent shopping for food each week? ____ hours ____ minutes
➔ Time spent preparing for food each week? ____ hours ____ minutes

25. Over the PAST MONTH, approximately how many times did you consume food and
meals bought outside the home (e.g. including meals at work/school/college, canteen, café,
restaurants), and at what cost?
➔ Approximate number of times _________
➔ Approximate cost per time (£)/(€) _________
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VI. About you and your household. Please complete the following questions with
regard to pre-COVID-19 situation.
26. Please tell us which areas of daily life have been affected as a result of your coeliac
disease. Please tick all that apply.

□ Childcare arrangement
□ Changed schools
□ The time it takes to complete my food shopping
□ The cost of my food shopping
□ Household tasks
□ Relationship with my partner
□ Effects on other siblings and family members
□ Affects the diet of all the family (food eliminated from house/change to overall family diet)
□ Ability to eat out/eat out as a family
□ Assumption of being a fussy eater
□ Poor treatment by some staff in restaurants
□ Expanding my family
□ Caring for family and children when unwell
□ Choice of job or career
□ Loss of time at work
□ Work life (team building, going to restaurants with workmates)
□ Emotions (anger, fear, anxiety, feeling left out and trauma)
□ Ability to use public transport
□ Social interaction
□ Social activities (e.g. going to school tours, theme parks)
□ Sports and hobbies
□ Social life (e.g. going to parties)
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□ Family social life (e.g. going to family parties, weddings, visiting family members)
□ Holidays/travel to foreign destinations
□ None of the above
Please feel free to elaborate or add to any of the above.
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________

27. Do you live in an urban or rural setting?

□ Urban
□ Rural
28. What is the highest level of education you have completed to date?

□ Primary Education or less
□ Intermediate/Junior/Group/Ordinary Levels/General Certificate of Secondary Education or
equivalent

□ Leaving Certificate/Advanced Levels/General Certificate of Education Advanced Level or
equivalent

□ Diploma/Certificate
□ Primary degree/Bachelor’s degree
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□ Postgraduate/Higher degree
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29. What is your employment status?
Please tick one box which best describes your current working status.

□
□
□
□
□
□
□
□
□
□
□
□

Part-time
Full-time
Self employed with employees
Self employed without employees
Unemployed and seeking work
Unemployed and not seeking work
Retired
Student
Homemaker
On disability allowance
Volunteer
Other, please specify
_________________
_________________
_________________

30. If you are in paid employment, on average how many hours do you work per week?

□ Not applicable
➔ Total number of hours per week? _______
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31. All the information that you provide will be completely anonymous and strictly
confidential.
What would be your total net income PER MONTH after tax and other deductions
e.g. Pay As You Earn, Pay Related Social Insurance and Pension Related Deduction
are taken out? Please tick one box only.
Per Month (£)/(€)
Total Net Income
Not applicable

□

Under 1,000

□

1,001 to under 1,500

□

1,501 to under 2,000

□

2,001 to under 2,500

□

2,501 to under 3,500

□

3,501 to under 4,000

□

4,001 to under 5,000

□

5,001 to under 6,500

□

6,501 to under 8,000

□

8,001 or more

□
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32. Please feel free to write suggestions or recommendations you believe would assist in
improving the quality of life of individuals with food intolerance or allergy on the Island of
Ireland today:
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________

Thank you very much for your co-operation!
1. Do you want to participate in our lottery for the chance to win one of 5 x €100/£100
‘One4All’ vouchers?

□ Yes
□ No
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Survey 2a: Lottery Survey

1. Please provide a contact email address to enter a lottery for the chance to win one of 5 x
€100/£100 ‘One4All’ vouchers. This email address will only be used to contact you in the
event that you are chosen as a winner. TU Dublin will securely store this data until the
winner has been randomly chosen and has claimed their prize. This data will not be shared
with any third parties or used in a way other than for the purpose it was provided and then
will be destroyed. By providing your email address, you consent to TU Dublin processing
your data in line with the purpose specified above.
➔ Email address: _______________

Thank you very much for your co-operation!
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Survey 3: Food Intolerance/s, Suspected, or Non-medically diagnosed Food
Allergy/ies Survey – version for adults
I. Your household and health. Please complete the following questions with regard
to
pre-COVID-19 situation.
1. Where is your place of residence?

□ Republic of Ireland

□ Northern Ireland

2. In total, how many adults, adolescents and children live in your household?
Number of adults
(>18 years of age)

_____ male

_____ female

_____ male

_____ female

_____ male

_____ female

Number of adolescents
(13 – 17 years of age)
Number of children
(0 - 12 years of age)

3. Please state your age and gender.

You

Age

Male or female
(Enter M or F)

_____

_____
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4. What is your ethnic or cultural background?

□ Irish
□ Bristish
□ Northern Irish
□ Irish Traveller
□ Any other White background
□ African
□ Any other Black background
□ Chinese
□ Any other Asian background
□ Other (including mixed background), please specify _________
5. What type of foods are you intolerant or allergic to but have not been medically diagnosed
by a medical professional? Please tick all that apply.
Food intolerances, suspected, or non-medically
diagnosed food allergies

□
□
□
□
□
□
□
□
□
□
□

1. Peanuts
2. Milk & dairy products
3. Eggs
4. Celery
5. Lupin
6. Mustard
7. Sesame seeds
8. Molluscs
9. Crustaceans
10. Soy beans
11. Sulphur dioxide and sulphites
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12. Cereals containing gluten
(wheat, rye, barley, oats)
13. Fish
Please specify what type of fish

□
□

___________________________
14. Nuts
Please specify what type of nuts

□
___________________________
15. Fruit
Please specify what type of fruit

□
___________________________
16. Meat or poultry
Please specify what type of
meat/poultry

□

___________________________

□

17. None of the above

6. Please specify other types of foods that you are intolerant or allergic to but have not been
medically diagnosed by a medical professional. If you do not have any other food intolerances,
suspected, or non-medically diagnosed food allergies, please skip to the next question.
Food intolerances, suspected, or non-medically
diagnosed food allergies

□
□
□
□
□

1. __________________________
2. __________________________
3. __________________________
4. __________________________
5. __________________________
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□
□
□
□
□

6. __________________________
7. __________________________
8. __________________________
9. __________________________
10. __________________________
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7. Do you have one or more of the following:

□ Suspected coeliac disease (not medically diagnosed)
□ Gluten sensitivity/non-coeliac gluten sensitivity
□ Suspected wheat allergy (not medically diagnosed)
□ None of the above
8. Including you, how many adults, adolescents and children live in your household that are
food intolerant or allergic but have not been medically diagnosed by a medical professional,
as far as you are aware?
Number of adults
(>18 years of age)

_____ male

_____ female

_____ male

_____ female

_____ male

_____ female

Number of adolescents
(13 – 17 years of age)
Number of children
(0 - 12 years of age)

9. Do you have any long-term illness, health problems, or disabilities other than food
intolerance or allergy which limit your daily activities?

□ Yes
□ No
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10. Under each heading, please tick the ONE box that best describes your health TODAY.
MOBILITY

❑
❑
❑

I have no problems in walking about
I have some problems in walking about
I am confined to bed

SELF-CARE
I have no problems with self-care
I have some problems washing or dressing myself
I am unable to wash or dress myself

❑
❑
❑

USUAL ACTIVITIES (e.g. work, study, housework, family or leisure activities)
I have no problems with performing my usual activities
I have some problems with performing my usual activities
I am unable to perform my usual activities

❑
❑
❑

PAIN/DISCOMFORT

❑
❑
❑

I have no pain or discomfort
I have moderate pain or discomfort
I have extreme pain or discomfort

ANXIETY/DEPRESSION

❑
❑
❑

I am not anxious or depressed
I am moderately anxious or depressed
I am extremely anxious or depressed

© 1990 EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research
Foundation. UK (English) v2.1
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The best health
you can imagine
100

•

We would like to know how good or bad your health is TODAY.

•

This scale is numbered from 0 to 100.

•

100 means the best health you can imagine.

95
90
85

80

0 means the worst health you can imagine.
•
•

75

Please mark an X on the scale to indicate how your health is
TODAY.

70

Now, write the number you marked on the scale in the box below.

65
60
55
50
45

YOUR HEALTH TODAY =
40
35
30
25
20
15
10
5

The worst health

0

you can imagine

© 1990 EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research
Foundation. UK (English) v2.1

713

II. Cost of visits to health professionals (excluding hospital admissions). Please
complete the following cost questions with regard to pre-COVID-19 situation.
11. Approximately, how often did you visit any of the following health professionals for your
own health in the last 12 months? Please complete for any of the health professionals relevant
to you.
Approximate number
How many miles or
of visits over the last 12 kilometres did you travel to
months period?
get to most recent
appointment?
[1] Family doctor (GP)

[2] Consultants/Specialists

[3] Nurse

[4] Nurse at outpatient clinic

[5] Dietician/Nutritionist

[6] Physiotherapist

[7] Pharmacist

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

[8] Alternative therapist
Please specify
____________________

___
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___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

____________________

[9] Other health professionals
Please specify

12. When you attended your last appointment with these health professionals, how much
did you personally pay (if anything) for the consultation? Please exclude any payments
covered by private/health insurance.
Consultation fee of last appointment
(£)/(€)
[1] Family doctor (GP)

____

[2] Consultants/Specialists

____

[3] Nurse

____
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[4] Nurse at outpatient clinic

____

[5] Dietician/Nutritionist

____

[6] Physiotherapist

____

[7] Pharmacist

____

[8] Alternative therapist
Please specify
____________________

____

____________________

____

____________________

____

[9] Other health professionals
Please specify
____________________

____

____________________

____

____________________

____
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III. Hospital inpatient admissions in the last 12 MONTHS. Please complete the
following questions with regard to pre-COVID-19 situation.

13. How many times (if any) have you been admitted/attended hospital in the last 12 months?
If you have not been admitted nor attended a hospital in the last 12 months, please skip to the next question
Outpatient attendence Day Unit: often used
A&E attendance
Hospital admission
for tests that require
without subsequent
to a ward, possibly after
monitoring
admission to a ward
A&E attendance

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

How many times ____

How many times ____

How many times ____

How many times ____

Total number of nights ___
Did this result in a loss
of earnings for you?

Did this result in a loss
of earnings for you?

Did this result in a loss
of earnings for you?

Did this result in a loss of
earnings for you?

□ Yes
□ No

□ Yes
□ No

□ Yes
□ No

□ Yes
□ No

If so, how much?

If so, how much?

If so, how much?

If so, how much?

(£)/(€)_______

(£)/(€)_______

(£)/(€)_______

(£)/(€)_______

Did you require an
ambulance over the last
12 months?

Did you require an
ambulance over the last 12
months?

□ Yes
□ No

□ Yes
□ No

If so, how many times?

If so, how many times?

_______

_______

How much did the
ambulance cost?

How much did the
ambulance cost?

(£)/(€) _______

(£)/(€) _______
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14. Approximately, how much have you spent on medicines and food supplements for
yourself, in the last 12 months?
➔ Prescribed medicines? (£)/(€) ________
➔ Over-the-counter medicines? (£)/(€) ________
➔ Food supplements? (£)/(€) ________

15. Do you have private/additional medical insurance?

□ Yes
□ No
➔ If yes, how much does your individual policy cost per year? (£)/(€) _________

IV. Days off work, school or college. Please complete this question with regard to
pre-COVID-19 situation.
16. During the last 12 months, how many days (if any) have you taken off work, school or
college due to any illness?
➔ Total number of days off _________

V. Costs of living. Please complete the following cost questions with regard to preCOVID-19 situation.
17. On average, how much do you or your household spend EACH WEEK on food shopping
(excluding eating out)?
Please estimate the amount you spend on food shopping for yourself, by answering either
part (i) or (ii).
i) Total cost of household food shopping (£)/(€) _________
Approximate percentage (total cost) of household food shopping attributed to you (%) ______
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ii) Total cost of your own food shopping (£)/(€) _________
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18. On average, how much TIME do you spend EACH WEEK on shopping for food and
preparing food for yourself?
➔ Time spent shopping for food each week? ____ hours ____ minutes
➔ Time spent preparing for food each week? ____ hours ____ minutes

19. Over the PAST MONTH, approximately how many times did you consume food and
meals bought outside the home (e.g. including meals at work/school/college, canteen, café,
restaurants), and at what cost?
➔ Approximate number of times _________
➔ Approximate cost per time (£)/(€) _________
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VI. About you and your household. Please complete the following questions with
regard to pre-COVID-19 situation.
20. Please tell us which areas of daily life have been affected as a result of your food
intolerance/s, suspected, or non-medically diagnosed food allergy/ies. Please tick all that
apply.

□ Childcare arrangement
□ Changed schools
□ The time it takes to complete my food shopping
□ The cost of my food shopping
□ Household tasks
□ Relationship with my partner
□ Effects on other siblings and family members
□ Affects the diet of all the family (food eliminated from house/change to overall family diet)
□ Ability to eat out/eat out as a family
□ Assumption of being a fussy eater
□ Poor treatment by some staff in restaurants
□ Expanding my family
□ Caring for family and children when unwell
□ Choice of job or career
□ Loss of time at work
□ Work life (team building, going to restaurants with workmates)
□ Emotions (anger, fear, anxiety, feeling left out and trauma)
□ Ability to use public transport
□ Social interaction
□ Social activities (e.g. going to school tours, theme parks)
□ Sports and hobbies
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□ Social life (e.g. going to parties)
□ Family social life (e.g. going to family parties, weddings, visiting family members)
□ Holidays/travel to foreign destinations
□ None of the above

Please feel free to elaborate or add to any of the above.
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________

21. Do you live in an urban or rural setting?

□ Urban
□ Rural
22. What is the highest level of education you have completed to date?

□ Primary Education or less
□ Intermediate/Junior/Group/Ordinary Levels/General Certificate of Secondary Education or
equivalent

□ Leaving Certificate/Advanced Levels/General Certificate of Education Advanced Level or
equivalent

□ Diploma/Certificate
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□ Primary degree/Bachelor’s degree
□ Postgraduate/Higher degree
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23. What is your employment status?
Please tick one box which best describes your current working status.

□
□
□
□
□
□
□
□
□
□
□
□

Part-time
Full-time
Self employed with employees
Self employed without employees
Unemployed and seeking work
Unemployed and not seeking work
Retired
Student
Homemaker
On disability allowance
Volunteer
Other, please specify
_________________
_________________
_________________

24. If you are in paid employment, on average how many hours do you work per week?

□ Not applicable
➔ Total number of hours per week? _______
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25. All the information that you provide will be completely anonymous and strictly
confidential.
What would be your total net income PER MONTH after tax and other deductions
e.g. Pay As You Earn, Pay Related Social Insurance and Pension Related Deduction
are taken out? Please tick one box only.
Per Month (£)/(€)
Total Net Income
Not applicable

□

Under 1,000

□

1,001 to under 1,500

□

1,501 to under 2,000

□

2,001 to under 2,500

□

2,501 to under 3,500

□

3,501 to under 4,000

□

4,001 to under 5,000

□

5,001 to under 6,500

□

6,501 to under 8,000

□

8,001 or more

□
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26. Please feel free to write suggestions or recommendations you believe would assist in
improving the quality of life of individuals with food intolerance or allergy on the Island of
Ireland today:
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
Thank you very much for your co-operation!
1. Do you want to participate in our lottery for the chance to win one of 5 x €100/£100
‘One4All’ vouchers?

□ Yes
□ No
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Survey 3a: Lottery Survey

1. Please provide a contact email address to enter a lottery for the chance to win one of 5 x
€100/£100 ‘One4All’ vouchers. This email address will only be used to contact you in the
event that you are chosen as a winner. TU Dublin will securely store this data until the
winner has been randomly chosen and has claimed their prize. This data will not be shared
with any third parties or used in a way other than for the purpose it was provided and then
will be destroyed. By providing your email address, you consent to TU Dublin processing
your data in line with the purpose specified above.
➔ Email address: _______________

Thank you very much for your co-operation!
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9.1.3 Safefood Food Hypersensitivity Questionnaires – Version for Parents
Survey 4: Medically Diagnosed Food Allergy Survey – version for parents
I. Your household and child’s health. Please complete the following questions with
regard to pre-COVID-19 situation.
1. Where is your place of residence?

□ Republic of Ireland

□ Northern Ireland

2. In total, how many adults, adolescents and children live in your household?
Number of adults
(>18 years of age)

_____ male

_____ female

_____ male

_____ female

_____ male

_____ female

Number of adolescents
(13 – 17 years of age)
Number of children
(0 - 12 years of age)
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3. For each member of your household that have been medically or non-medically diagnosed
with food allergy/ies and coeliac disease, please state their relationship to you below.
Please tick all that apply.
Household
Gender
Relationship
Medically
Medical
Food
members
diagnosed food
ly
intolerance/s,
allergy/ies
diagnose suspected, or
d coeliac non-medically
disease
diagnosed
food
allergy/ies
Adult 1

_____

________

□

□

□

Adult 2

_____

________

□

□

□

Adult 3

_____

________

□

□

□

Adult 4

_____

________

□

□

□

Adult 5

_____

________

□

□

□

Child 1

Age
____

_____

________

□

□

□

Child 2

Age
____

_____

________

□

□

□

Child 3

Age
____

_____

________

□

□

□

Child 4

Age
____

_____

________

□

□

□

Child 5

Age
____

_____

________

□

□

□

4. Please complete for your child who has been medically diagnosed with a food allergy/ies
(or for the eldest child, if more than one child has been medically diagnosed with food
allergy/ies).
Age
Male or female
(Enter M or F)
_____

_____
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Please complete the rest of the survey for the medically diagnosed child (as
referred to Question 4).

5. What is the ethnic or cultural background of this child?

□ Irish
□ British
□ Northern Irish
□ Irish Traveller
□ Any other White background
□ African
□ Any other Black background
□ Chinese
□ Any other Asian background
□ Other (including mixed background), please specify _________
6. Does the child have one or more of the following:

□ Medically diagnosed food allergy/ies
□ Medically diagnosed coeliac disease
□ Food Intolerance/s, Suspected, or Non-medically diagnosed food allergy/ies
7. At what age was the child medically diagnosed with food allergy/ies by a doctor or medical
professional?
➔ Age of diagnosis _____
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8. What type of foods has the child been medically diagnosed as allergic to?
Additional food intolerance/s, suspected, or non-medically diagnosed food allergy/ies can be
noted. Please tick all that apply.
Medically diagnosed
Food intolerances,
food allergies
suspected, or nonmedically diagnosed
food allergies
1. Peanuts
2. Milk & dairy products
3. Eggs
4. Celery
5. Lupin
6. Mustard
7. Sesame seeds
8. Molluscs
9. Crustaceans
10. Soy beans
11. Sulphur dioxide and sulphites
12. Cereals containing gluten
(wheat, rye, barley, oats)
13. Fish
Please specify what type of fish

□
□
□
□
□
□
□
□
□
□
□

□
□
□
□
□
□
□
□
□
□
□

□

□

□

□

□

□

□

□

□

□

___________________________
14. Nuts
Please specify what type of nuts
___________________________
15. Fruit
Please specify what type of fruit
___________________________
16. Meat or poultry
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Please specify what type of
meat/poultry
___________________________
9. Please specify other types of foods that the child has been medically diagnosed as allergic
to? Additional food intolerance/s, suspected, or non-medically diagnosed food allergy/ies can
be noted. If you do not have any other medically diagnosed food allergies, food intolerances,
suspected, or non-medically diagnosed food allergies, please skip to the next question.
Medically diagnosed
Food intolerances,
food allergies
suspected, or nonmedically diagnosed
food allergies

□
□
□
□
□
□
□
□
□
□

1. __________________________
2. __________________________
3. __________________________
4. __________________________
5. __________________________
6. __________________________
7. __________________________
8. __________________________
9. __________________________
10. __________________________
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□
□
□
□
□
□
□
□
□
□

10. Does the child have one or more of the following:

□ Suspected coeliac disease (not medically diagnosed)
□ Gluten sensitivity/non-coeliac gluten sensitivity
□ Suspected wheat allergy (not medically diagnosed)
□ None of the above
11. Which test(s) have been performed on this child to confirm the food allergy/ies?
You may tick more than one box.

□ Blood tests
□ Skin prick test
□ Food oral challenge
□ Trial elimination diet
□ Don’t know
□ Other, please specify _________
12. Do you know whether this child’s food allergy is:
You may tick more than one box.

□ IgE-mediated
□ Non-IgE-mediated
□ Mixed IgE and non-IgE-mediated
□ Don’t know
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13. Where was the food allergy/ies diagnosed?
You may tick more than one box.

□ Family doctor (GP)
□ Consultant out-patient clinic
□ Following / during hospital admission
□ Can’t remember
□ Other, please specify _________
14. Please tick all the medicines that have been prescribed for this child by a doctor for food
allergy/ies in the last 12 MONTHS.
List of prescribed medicines:

□

Adrenaline (epinephrine) auto-injectors

□

Antihistamines

□

Corticosteroids (prescribed to treat symptoms of food allergy)

□

Other, please specify
_________________
_________________
_________________

15. An anaphylactic reaction is a severe life-threatening allergic reaction.
In the last 12 months, has this child ever had an anaphylactic reaction due to a food
allergen/s?

□ Yes
□

No

➔ If yes, on how many occasions in the last 12 months: ________
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16. At what age was the child medically diagnosed with coeliac disease by a doctor or medical
professional? (This is an additional question based on Question 6. Please answer if the child
has medically diagnosed coeliac disease.)
➔ Age of diagnosis _____

17. Which test(s) have been performed on this child to confirm the coeliac disease?
You may tick more than one box. (This is an additional question based on Question 6. Please
answer if the child has medically diagnosed coeliac disease.)

□ Blood tests
□ Gastrointestinal endoscopy and biopsy
□ Don’t know
□ Other, please specify _________
18. Where was the coeliac disease diagnosed?
You may tick more than one box. (This is an additional question based on Question 6. Please
answer if the child has medically diagnosed coeliac disease.)

□ Family doctor (GP)
□ Consultant out-patient clinic
□ Following / during hospital admission
□ Can’t remember
□ Other, please specify _________
19. Please tick all the medicines that have been prescribed for this child by a doctor for
coeliac disease in the last 12 MONTHS. (This is an additional question based on Question 6.
Please answer if the child has medically diagnosed coeliac disease.)
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List of prescribed medicines:

□

Corticosteroids (prescribed to treat symptoms of coeliac disease)

□

Prescribed vitamins and supplements

□

Other, please specify
_________________
_________________
_________________

20. Does this child have any long-term illness, health problems, or disabilities other than
food allergy or intolerance which limit their daily activities?

□ Yes
□ No
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21. Under each heading, please tick the ONE box that you think best describes the child’s
health TODAY.
MOBILITY (walking about)

❑
❑
❑

No problems walking about
Some problems walking about
A lot of problems walking about

LOOKING AFTER HIM/HERSELF
No problems washing or dressing him/herself
Some problems washing or dressing him/herself
A lot of problems washing or dressing him/herself

❑
❑
❑

DOING USUAL ACTIVITIES (for example: going to school, hobbies,
sports, playing, doing things with family or friends)
No problems doing his/her usual activities

❑

Some problems doing his/her usual activities

❑

A lot of problems doing his/her usual activities

❑

HAVING PAIN OR DISCOMFORT

❑
❑
❑

No pain or discomfort
Some pain or discomfort
A lot of pain or discomfort

FEELING WORRIED, SAD OR UNHAPPY

❑
❑
❑

Not worried, sad or unhappy
A bit worried, sad or unhappy
Very worried, sad or unhappy

© 2010 EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research
Foundation. UK (English) v2.1
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The best health
you can imagine
100

•

We would like to know how good or bad you think the child’s health
is TODAY.

95
90

•

This scale is numbered from 0 to 100.
85

•

100 means the best health you can imagine.

80

0 means the worst health you can imagine.
•

•

Please mark an X on the scale to indicate how you think the child’s

75

health is TODAY.

70

Now, write the number you marked on the scale in the box below.

65
60
55

50

THE CHILD’S HEALTH TODAY =

45
40

35
30
25

20
15
10
5

The worst health

0

you can imagine
© 2010 EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research
Foundation. UK (English) v2.1
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II. Cost of visits to health professionals (excluding hospital admissions). Please
complete the following cost questions with regard to pre-COVID-19 situation.
22. Approximately, how often did you visit any of the following health professionals for this
child’s health in the last 12 months? Please complete for any of the health professionals
relevant to your child.
Approximate number
How many miles or
of visits over the last 12 kilometres did you travel to
months period?
get to most recent
appointment?
[1] Family doctor (GP)

[2] Consultants/Specialists

[3] Nurse

[4] Nurse at outpatient clinic

[5] Dietician/Nutritionist

[6] Physiotherapist

[7] Pharmacist

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

[8] Alternative therapist
Please specify
____________________

___
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___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

____________________

[9] Other health professionals
Please specify

23. When you attended these health professionals for this child’s last appointment, how
much did you personally pay (if anything) for the consultation? Please exclude any payments
covered by private/health insurance.
Consultation fee of last appointment
(£)/(€)
[1] Family doctor (GP)

____

[2] Consultants/Specialists

____

[3] Nurse

____

740

[4] Nurse at outpatient clinic

____

[5] Dietician/Nutritionist

____

[6] Physiotherapist

____

[7] Pharmacist

____

[8] Alternative therapist
Please specify
____________________

____

____________________

____

____________________

____

[9] Other health professionals
Please specify
____________________

____

____________________

____

____________________

____
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III. Hospital inpatient admissions in the last 12 MONTHS. Please complete the
following questions with regard to pre-COVID-19 situation.

24. How many times (if any) has this child been admitted/attended hospital in the last 12 months?
If your child has not been admitted nor attended a hospital in the last 12 months, please skip to the nex
question.
Outpatient attendence Day Unit: often used
A&E attendance
Hospital admission
for tests that require
without subsequent
to a ward, possibly after
monitoring
admission to a ward
A&E attendance

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

How many times ____

How many times ____

How many times ____

How many times ____

Total number of nights ____
Did this result in a loss
of earnings for you or
partner/spouse?

Did this result in a loss Did this result in a loss
of earnings for you or of earnings for you or
partner/spouse?
partner/spouse?

Did this result in a loss of
earnings for you or
partner/spouse?

□ Yes
□ No

□ Yes
□ No

□ Yes
□ No

□ Yes
□ No

If so, how much?

If so, how much?

If so, how much?

If so, how much?

(£)/(€)_______

(£)/(€)_______

(£)/(€)_______

(£)/(€)_______

Did you require an
Did you require an
ambulance for this child ambulance for this child
over the last 12 months? over the last 12 months?

□ Yes
□ No

□ Yes
□ No

If so, how many times?
_______

If so, how many times?
_______

How much did the
ambulance cost?

How much did the
ambulance cost?
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(£)/(€) _______

(£)/(€) _______

25. Approximately, how much have you spent on this child’s medicines and food
supplements in the last 12 months?
➔ Prescribed medicines (£)/(€) ________
➔ Over-the-counter medicines (£)/(€) ________
➔ Food supplements (£)/(€) ________

26. Approximately, how much does your household spend on gluten-free products, in the
last 12 months? (This is an additional question based on Question 6. Please answer if the
child has medically diagnosed coeliac disease.)
➔ Approximate cost of gluten-free food products (£)/(€) ________

27. Have you claimed tax relief on gluten-free products? (Applicable to the Republic of
Ireland respondents only. This is an additional question based on Question 6. Please answer
if the child has medically diagnosed coeliac disease.)

□ Yes
□ No
➔ If yes, at what percentage of total cost did you receive? (%) _________
28. Does this child have private/additional medical insurance?
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□ Yes
□ No
➔ If yes, how much does the household policy cost per year? (£)/(€) _________

IV. Days off school or college. Please complete this question with regard to preCOVID-19 situation.
29. During the last 12 months, how many days (if any) has this child taken off school or
college due to any illness?
➔ Total number of days off _________

V. Costs of living. Please complete the following cost questions with regard to preCOVID-19 situation.
30. On average, how much does your household spend EACH WEEK on food shopping?
➔ Total cost (£)/(€) _________

31. On average, how much TIME does your household spend EACH WEEK on shopping
for food and preparing food?
➔ Time spent shopping for food each week? ____ hours ____ minutes
➔ Time spent preparing for food each week? ____ hours ____ minutes

32. Over the PAST MONTH, approximately how many times did your household consume
food and meals bought outside the home (e.g. including meals at work/school/college,
canteen, café, restaurants), and at what cost?
➔ Approximate number of times _________
➔ Approximate number of times (£)/(€) _________
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VI. About you and your household. Please complete the following questions with
regard to pre-COVID-19 situation.
33. Please tell us which areas of daily life have been affected as a result of this child’s food
allergy/ies. Please tick all that apply.

□ My childcare arrangement
□ They had to change schools
□ The time it takes to complete my food shopping
□ The cost of my food shopping
□ Household tasks
□ Relationship with my partner
□ Effects on other siblings and family members
□ Affects the diet of all the family (food eliminated from house/change to overall family diet)
□ Ability to eat out/eat out as a family
□ Assumption of being a fussy eater
□ Poor treatment by some staff in restaurants
□ Expanding my family
□ Caring for family and children when unwell
□ Choice of job or career
□ Loss of time at work
□ Emotions (anger, fear, anxiety, feeling left out and trauma)
□ Ability to use public transport
□ Going to children’s parties
□ Social interaction
□ Social activities (e.g. going to school tours, theme parks)
□ Sports and hobbies
□ Social life (e.g. going to parties)
□ Family social life (e.g. going to family parties, weddings, visiting family members)
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□ Holidays/travel to foreign destinations
□ None of the above

Please feel free to elaborate or add to any of the above.
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________

34. Do you live in an urban or rural setting?

□ Urban
□ Rural
35. What is the highest level of education you and your spouse/partner have completed to
date? Please tick one box for you and one for your spouse/partner which best describes your
level of education.
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You

Spouse/Partner

□ Not applicable (No spouse/partner)
□ Primary Education or less
□ Intermediate/Junior/Group/Ordinary
Levels/General Certificate of Secondary
Education or equivalent

□ Leaving Certificate/Advanced
Levels/General Certificate of Education
Advanced Level or equivalent

□ Diploma/Certificate
□ Primary degree/Bachelor’s degree
□ Postgraduate/Higher degree

□ Primary Education or less
□ Intermediate/Junior/Group/Ordinary
Levels/General Certificate of Secondary
Education or equivalent

□ Leaving Certificate/Advanced
Levels/General Certificate of Education
Advanced Level or equivalent

□ Diploma/Certificate
□ Primary degree/Bachelor’s degree
□ Postgraduate/Higher degree
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36. What is your and your spouse/partner’s employment status?
Please tick one box for you and one for your spouse/partner which best describes your
current working status.
You
Spouse/Partner

□ Not applicable (No spouse/partner)
□ Part-time
□ Full-time
□ Self employed with employees
□ Self employed without employees
□ Unemployed and seeking work
□ Unemployed and not seeking work
□ Retired
□ Student
□ Homemaker
□ On disability allowance
□ Volunteer
□ Other, please specify

□ Part-time
□ Full-time
□ Self employed with employees
□ Self employed without employees
□ Unemployed and seeking work
□ Unemployed and not seeking work
□ Retired
□ Student
□ Homemaker
□ On disability allowance
□ Volunteer
□ Other, please specify

________________
________________
________________

________________
________________
________________

37. If you are in paid employment, on average how many hours do you and your
spouse/partner work per week?
You
Spouse/Partner

□ Not applicable

□ Not applicable

➔ Total number of hours per week? _______

➔ Total number of hours per week? _______
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38. All the information that you provide will be completely anonymous and strictly
confidential.
Approximately, what would be the combined income of your household PER MONTH
after tax and other deductions e.g. Pay As You Earn, Pay Related Social Insurance
and Pension Related Deduction are taken out? Please tick one box only.
Per Month (£)/(€)
Combined Household Income
Not applicable

□

Under 1,000

□

1,001 to under 1,500

□

1,501 to under 2,000

□

2,001 to under 2,500

□

2,501 to under 3,500

□

3,501 to under 4,000

□

4,001 to under 5,000

□

5,001 to under 6,500

□

6,501 to under 8,000

□

8,001 or more

□
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39. Please feel free to write suggestions or recommendations you believe would assist in
improving the quality of life of families of children with food allergy or intolerance on the
Island of Ireland today:
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
Thank you very much for your co-operation!
1. Do you want to participate in our lottery for the chance to win one of 5 x €100/£100
‘One4All’ vouchers?

□ Yes
□ No
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Survey 4a: Lottery Survey

1. Please provide a contact email address to enter a lottery for the chance to win one of 5 x
€100/£100 ‘One4All’ vouchers. This email address will only be used to contact you in the
event that you are chosen as a winner. TU Dublin will securely store this data until the
winner has been randomly chosen and has claimed their prize. This data will not be shared
with any third parties or used in a way other than for the purpose it was provided and then
will be destroyed. By providing your email address, you consent to TU Dublin processing
your data in line with the purpose specified above.
➔ Email address: _______________

Thank you very much for your co-operation!
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Survey 5: Medically Diagnosed Coeliac Disease Survey – version for parents
I. Your household and child’s health. Please complete the following questions with
regard to pre-COVID-19 situation.
1. Where is your place of residence?

□ Republic of Ireland

□ Northern Ireland

2. In total, how many adults, adolescents and children live in your household?
Number of adults
(>18 years of age)

_____ male

_____ female

_____ male

_____ female

_____ male

_____ female

Number of adolescents
(13 – 17 years of age)
Number of children
(0 - 12 years of age)
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3. For each member of your household that have been medically or non-medically diagnosed
with food allergy/ies and coeliac disease, please state their relationship to you below.
Please tick all that apply.
Household
members

Gender

Relationship

Medically
diagnosed food
allergy/ies

Medically
diagnosed
coeliac disease

Food
intolerance/s,
suspected, or nonmedically
diagnosed food
allergy/ies

Adult 1

___
__

________

□

□

□

Adult 2

___
__

________

□

□

□

Adult 3

___
__

________

□

□

□

Adult 4

___
__

________

□

□

□

Adult 5

___
__

________

□

□

□

Child 1

Age
____

___
__

________

□

□

□

Child 2

Age
____

___
__

________

□

□

□

Child 3

Age
____

___
__

________

□

□

□

Child 4

Age
____

___
__

________

□

□

□

Child 5

Age
____

___
__

________

□

□

□

4. Please complete for your child who has been medically diagnosed with coeliac disease (or
for the eldest child, if more than one child has been medically diagnosed with coeliac
disease).
Age
Male or female
(Enter M or F)
_____

_____
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Please complete the rest of the survey for the medically diagnosed child (as referred
to Question 4).

5. What is the ethnic or cultural background of this child?

□ Irish
□ British
□ Northern Irish
□ Irish Traveller
□ Any other White background
□ African
□ Any other Black background
□ Chinese
□ Any other Asian background
□ Other (including mixed background), please specify _________
6. Does the child have one or more of the following:

□ Medically diagnosed coeliac disease
□ Food Intolerance/s, Suspected, or Non-medically diagnosed food allergy/ies
7. At what age was the child medically diagnosed with coeliac disease by a doctor or medical
professional?
➔ Age of diagnosis _____
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8. Which test(s) have been performed on this child to confirm the coeliac disease?
You may tick more than one box.

□ Blood tests
□ Gastrointestinal endoscopy and biopsy
□ Don’t know
□ Other, please specify _________
9. Where was the coeliac disease diagnosed?
You may tick more than one box.

□ Family doctor (GP)
□ Consultant out-patient clinic
□ Following / during hospital admission
□ Can’t remember
□ Other, please specify _________
10. Please tick all the medicines that have been prescribed for this child by a doctor for
coeliac disease in the last 12 MONTHS.
List of prescribed medicines:

□

Corticosteroids (prescribed to treat symptoms of coeliac disease)

□

Prescribed vitamins and supplements

□

Other, please specify
_________________
_________________
_________________
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11. What type of foods is this child intolerant or allergic to but has not been medically
diagnosed by a medical professional? Please tick all that apply. (This is an additional
question based on Question 6. Please answer if the child has food intolerance/s, suspected,
or non-medically diagnosed food allergy/ies.)
Food intolerances, suspected, or non-medically
diagnosed food allergies

□
□
□
□
□
□
□
□
□
□
□

1. Peanuts
2. Milk & dairy products
3. Eggs
4. Celery
5. Lupin
6. Mustard
7. Sesame seeds
8. Molluscs
9. Crustaceans
10. Soy beans
11. Sulphur dioxide and sulphites
12. Cereals containing gluten
(wheat, rye, barley, oats)
13. Fish
Please specify what type of fish

□
□

___________________________
14. Nuts
Please specify what type of nuts

□
___________________________
15. Fruit
Please specify what type of fruit

□
___________________________
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16. Meat or poultry
Please specify what type of
meat/poultry

□

___________________________

□

17. None of the above

12. Please specify other types of foods this child is intolerant or allergic to but has not been
medically diagnosed by a medical professional.
If the child does not have any other food intolerances, suspected, or non-medically diagnosed
food allergies, please skip to the next question.
(This is an additional question based on Question 6. Please answer if the child has food
intolerance/s, suspected, or non-medically diagnosed food allergy/ies.)
Food intolerances, suspected, or non-medically
diagnosed food allergies

□
□
□
□
□
□
□
□
□
□

1. __________________________
2. __________________________
3. __________________________
4. __________________________
5. __________________________
6. __________________________
7. __________________________
8. __________________________
9. __________________________
10. __________________________

13. Does this child have any long-term illness, health problems, or disabilities other than
food intolerance or allergy which limits their daily activities?

□ Yes
□ No
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14. Under each heading, please tick the ONE box that you think best describes the child’s
health TODAY.
MOBILITY (walking about)

❑
❑
❑

No problems walking about
Some problems walking about
A lot of problems walking about

LOOKING AFTER HIM/HERSELF
No problems washing or dressing him/herself
Some problems washing or dressing him/herself
A lot of problems washing or dressing him/herself

❑
❑
❑

DOING USUAL ACTIVITIES (for example: going to school, hobbies,
sports, playing, doing things with family or friends)
No problems doing his/her usual activities

❑

Some problems doing his/her usual activities

❑

A lot of problems doing his/her usual activities

❑

HAVING PAIN OR DISCOMFORT

❑
❑
❑

No pain or discomfort
Some pain or discomfort
A lot of pain or discomfort

FEELING WORRIED, SAD OR UNHAPPY

❑
❑
❑

Not worried, sad or unhappy
A bit worried, sad or unhappy
Very worried, sad or unhappy

© 2010 EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research
Foundation. UK (English) v2.1
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The best health
you can imagine
100

•

We would like to know how good or bad you think the child’s health
is TODAY.

95
90

•

This scale is numbered from 0 to 100.
85

•

100 means the best health you can imagine.

80

0 means the worst health you can imagine.
•

•

Please mark an X on the scale to indicate how you think the child’s

75

health is TODAY.

70

Now, write the number you marked on the scale in the box below.

65
60
55

50

THE CHILD’S HEALTH TODAY =

45
40

35
30
25

20
15
10
5

The worst health

0

you can imagine
© 2010 EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research
Foundation. UK (English) v2.1
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II. Cost of visits to health professionals (excluding hospital admissions). Please
complete the following cost questions with regard to pre-COVID-19 situation.
15. Approximately, how often did you visit any of the following health professionals for this
child’s health in the last 12 months? Please complete for any of the health professionals
relevant to your child.
Approximate number
How many miles or
of visits over the last 12 kilometres did you travel to
months period?
get to most recent
appointment?
[1] Family doctor (GP)

[2] Consultants/Specialists

[3] Nurse

[4] Nurse at outpatient clinic

[5] Dietician/Nutritionist

[6] Physiotherapist

[7] Pharmacist

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

[8] Alternative therapist
Please specify
____________________

___
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___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

____________________

[9] Other health professionals
Please specify

16. When you attended these health professionals for this child’s last appointment, how
much did you personally pay (if anything) for the consultation? Please exclude any payments
covered by private/health insurance.
Consultation fee of last appointment
(£)/(€)
[1] Family doctor (GP)

____

[2] Consultants/Specialists

____

[3] Nurse

____
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[4] Nurse at outpatient clinic

____

[5] Dietician/Nutritionist

____

[6] Physiotherapist

____

[7] Pharmacist

____

[8] Alternative therapist
Please specify
____________________

____

____________________

____

____________________

____

[9] Other health professionals
Please specify
____________________

____

____________________

____

____________________

____
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III. Hospital inpatient admissions in the last 12 MONTHS. Please complete the
following questions with regard to pre-COVID-19 situation.

17. How many times (if any) has this child been admitted/attended hospital in the last 12 months?
If your child has not been admitted nor attended a hospital in the last 12 months, please skip to the nex
question.
Outpatient attendence Day Unit: often used
A&E attendance
Hospital admission
for tests that require
without subsequent
to a ward, possibly after
monitoring
admission to a ward
A&E attendance

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

How many times ____

How many times ____

How many times ____

How many times ____

Total number of nights ____
Did this result in a loss
of earnings for you or
partner/spouse?

Did this result in a loss Did this result in a loss
of earnings for you or of earnings for you or
partner/spouse?
partner/spouse?

Did this result in a loss of
earnings for you or
partner/spouse?

□ Yes
□ No

□ Yes
□ No

□ Yes
□ No

□ Yes
□ No

If so, how much?

If so, how much?

If so, how much?

If so, how much?

(£)/(€)_______

(£)/(€)_______

(£)/(€)_______

(£)/(€)_______

Did you require an
Did you require an
ambulance for this child ambulance for this child
over the last 12 months? over the last 12 months?

□ Yes
□ No

□ Yes
□ No

If so, how many times?
_______

If so, how many times?
_______

How much did the
ambulance cost?

How much did the
ambulance cost?

(£)/(€) _______

(£)/(€) _______
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18. Approximately, how much have you spent on this child’s medicines and food
supplements in the last 12 months?
➔ Prescribed medicines (£)/(€) ________
➔ Over-the-counter medicines (£)/(€) ________
➔ Food supplements (£)/(€) ________

19. Approximately, how much does your household spend on gluten-free products, in the
last 12 months?
➔ Approximate cost of gluten-free food products (£)/(€) ________

20. Have you claimed tax relief on gluten-free products? (Applicable to the Republic of
Ireland respondents only.)

□ Yes
□ No
➔ If yes, at what percentage of total cost did you receive? (%) _________
21. Does this child have private/additional medical insurance?

□ Yes
□ No
➔ If yes, how much does the household policy cost per year? (£)/(€) _________

IV. Days off school or college. Please complete this question with regard to preCOVID-19 situation.
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22. During the last 12 months, how many days (if any) has this child taken off school or
college due to any illness?
➔ Total number of days off _________
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V. Costs of living. Please complete the following cost questions with regard to preCOVID-19 situation.
23. On average, how much does your household spend EACH WEEK on food shopping?
➔ Total cost (£)/(€) _________

24. On average, how much TIME does your household spend EACH WEEK on shopping
for food and preparing food?
➔ Time spent shopping for food each week? ____ hours ____ minutes
➔ Time spent preparing for food each week? ____ hours ____ minutes

25. Over the PAST MONTH, approximately how many times did your household consume
food and meals bought outside the home (e.g. including meals at work/school/college,
canteen, café, restaurants), and at what cost?
➔ Approximate number of times _________
➔ Approximate number of times (£)/(€) _________
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VI. About you and your household. Please complete the following questions with
regard to pre-COVID-19 situation.
26. Please tell us which areas of daily life have been affected as a result of this child’s coeliac
disease. Please tick all that apply.

□ My childcare arrangement
□ They had to change schools
□ The time it takes to complete my food shopping
□ The cost of my food shopping
□ Household tasks
□ Relationship with my partner
□ Effects on other siblings and family members
□ Affects the diet of all the family (food eliminated from house/change to overall family diet)
□ Ability to eat out/eat out as a family
□ Assumption of being a fussy eater
□ Poor treatment by some staff in restaurants
□ Expanding my family
□ Caring for family and children when unwell
□ Choice of job or career
□ Loss of time at work
□ Emotions (anger, fear, anxiety, feeling left out and trauma)
□ Ability to use public transport
□ Going to children’s parties
□ Social interaction
□ Social activities (e.g. going to school tours, theme parks)
□ Sports and hobbies
□ Social life (e.g. going to parties)
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□ Family social life (e.g. going to family parties, weddings, visiting family members)
□ Holidays/travel to foreign destinations
□ None of the above

Please feel free to elaborate or add to any of the above.
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________

27. Do you live in an urban or rural setting?

□ Urban
□ Rural
28. What is the highest level of education you and your spouse/partner have completed to
date? Please tick one box for you and one for your spouse/partner which best describes your
level of education.
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You

Spouse/Partner

□ Not applicable (No spouse/partner)
□ Primary Education or less
□ Intermediate/Junior/Group/Ordinary
Levels/General Certificate of Secondary
Education or equivalent

□ Leaving Certificate/Advanced
Levels/General Certificate of Education
Advanced Level or equivalent

□ Diploma/Certificate
□ Primary degree/Bachelor’s degree
□ Postgraduate/Higher degree

□ Primary Education or less
□ Intermediate/Junior/Group/Ordinary
Levels/General Certificate of Secondary
Education or equivalent

□ Leaving Certificate/Advanced
Levels/General Certificate of Education
Advanced Level or equivalent

□ Diploma/Certificate
□ Primary degree/Bachelor’s degree
□ Postgraduate/Higher degree
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29. What is your and your spouse/partner’s employment status?
Please tick one box for you and one for your spouse/partner which best describes your
current working status.
You
Spouse/Partner

□ Not applicable (No spouse/partner)
□ Part-time
□ Full-time
□ Self employed with employees
□ Self employed without employees
□ Unemployed and seeking work
□ Unemployed and not seeking work
□ Retired
□ Student
□ Homemaker
□ On disability allowance
□ Volunteer
□ Other, please specify

□ Part-time
□ Full-time
□ Self employed with employees
□ Self employed without employees
□ Unemployed and seeking work
□ Unemployed and not seeking work
□ Retired
□ Student
□ Homemaker
□ On disability allowance
□ Volunteer
□ Other, please specify

________________
________________
________________

________________
________________
________________

30. If you are in paid employment, on average how many hours do you and your
spouse/partner work per week?
You
Spouse/Partner

□ Not applicable

□ Not applicable

➔ Total number of hours per week? _______

➔ Total number of hours per week? _______
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31. All the information that you provide will be completely anonymous and strictly
confidential.
Approximately, what would be the combined income of your household PER MONTH
after tax and other deductions e.g. Pay As You Earn, Pay Related Social Insurance
and Pension Related Deduction are taken out? Please tick one box only.
Per Month (£)/(€)
Combined Household Income
Not applicable

□

Under 1,000

□

1,001 to under 1,500

□

1,501 to under 2,000

□

2,001 to under 2,500

□

2,501 to under 3,500

□

3,501 to under 4,000

□

4,001 to under 5,000

□

5,001 to under 6,500

□

6,501 to under 8,000

□

8,001 or more

□
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32. Please feel free to write suggestions or recommendations you believe would assist in
improving the quality of life of families of children with food intolerance or allergy on the
Island of Ireland today:
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________

Thank you very much for your co-operation!
1. Do you want to participate in our lottery for the chance to win one of 5 x €100/£100
‘One4All’ vouchers?

□ Yes
□ No
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Survey 5a: Lottery Survey

1. Please provide a contact email address to enter a lottery for the chance to win one of 5 x
€100/£100 ‘One4All’ vouchers. This email address will only be used to contact you in the
event that you are chosen as a winner. TU Dublin will securely store this data until the
winner has been randomly chosen and has claimed their prize. This data will not be shared
with any third parties or used in a way other than for the purpose it was provided and then
will be destroyed. By providing your email address, you consent to TU Dublin processing
your data in line with the purpose specified above.
➔ Email address: _______________

Thank you very much for your co-operation!
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Survey 6: Food Intolerance/s, Suspected, or Non-medically diagnosed Food
Allergy/ies Survey – version for parents
I. Your household and child’s health. Please complete the following questions with
regard to pre-COVID-19 situation.
1. Where is your place of residence?

□ Republic of Ireland

□ Northern Ireland

2. In total, how many adults, adolescents and children live in your household?
Number of adults
(>18 years of age)

_____ male

_____ female

_____ male

_____ female

_____ male

_____ female

Number of adolescents
(13 – 17 years of age)
Number of children
(0 - 12 years of age)
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3. For each member of your household that have been medically or non-medically diagnosed
with food allergy/ies and coeliac disease, please state their relationship to you below.
Please tick all that apply.
Household members

Gender

Relationship

Medically
diagnosed food
allergy/ies

Medically
diagnosed
coeliac disease

Food
intolerance/s,
suspected, or
non-medically
diagnosed food
allergy/ies

Adult 1

_____

________

□

□

□

Adult 2

_____

________

□

□

□

Adult 3

_____

________

□

□

□

Adult 4

_____

________

□

□

□

Adult 5

_____

________

□

□

□

Child 1

Age
____

_____

________

□

□

□

Child 2

Age
____

_____

________

□

□

□

Child 3

Age
____

_____

________

□

□

□

Child 4

Age
____

_____

________

□

□

□

Child 5

Age
____

_____

________

□

□

□

4. Please complete for your child who has food Intolerance/s, suspected, or non-medically
diagnosed food allergy/ies (or for the eldest child, if more than one child has food
Intolerance/s, suspected, or non-medically diagnosed food allergy/ies).
Age
Male or female
(Enter M or F)
_____

_____
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Please complete the rest of the survey for the child who has food Intolerance/s,
suspected, or non-medically diagnosed food allergy/ies (as referred to Question 4).

5. What is the ethnic or cultural background of this child?

□ Irish
□ British
□ Northern Irish
□ Irish Traveller
□ Any other White background
□ African
□ Any other Black background
□ Chinese
□ Any other Asian background
□ Other (including mixed background), please specify _________
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6. What type of foods is this child intolerant or allergic to but has not been medically
diagnosed by a medical professional? Please tick all that apply.
Food intolerances, suspected, or non-medically
diagnosed food allergies

□
□
□
□
□
□
□
□
□
□
□

1. Peanuts
2. Milk & dairy products
3. Eggs
4. Celery
5. Lupin
6. Mustard
7. Sesame seeds
8. Molluscs
9. Crustaceans
10. Soy beans
11. Sulphur dioxide and sulphites
12. Cereals containing gluten
(wheat, rye, barley, oats)
13. Fish
Please specify what type of fish

□
□

___________________________
14. Nuts
Please specify what type of nuts

□
___________________________
15. Fruit
Please specify what type of fruit

□
___________________________
16. Meat or poultry
Please specify what type of
meat/poultry

□
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___________________________

□

17. None of the above

7. Please specify other types of foods this child is intolerant or allergic to but has not been
medically diagnosed by a medical professional.
If the child does not have any other food intolerances, suspected, or non-medically diagnosed
food allergies, please skip to the next question.
Food intolerances, suspected, or non-medically
diagnosed food allergies

□
□
□
□
□
□
□
□
□
□

1. __________________________
2. __________________________
3. __________________________
4. __________________________
5. __________________________
6. __________________________
7. __________________________
8. __________________________
9. __________________________
10. __________________________

8. Does the child have one or more of the following:

□ Suspected coeliac disease (not medically diagnosed)
□ Gluten sensitivity/non-coeliac gluten sensitivity
□ Suspected wheat allergy (not medically diagnosed)
□ None of the above
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9. Does this child have any long-term illness, health problems, or disabilities other than food
intolerance or allergy which limit their daily activities?

□ Yes
□ No
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10. Under each heading, please tick the ONE box that you think best describes the child’s
health TODAY.
MOBILITY (walking about)

❑
❑
❑

No problems walking about
Some problems walking about
A lot of problems walking about

LOOKING AFTER HIM/HERSELF
No problems washing or dressing him/herself
Some problems washing or dressing him/herself
A lot of problems washing or dressing him/herself

❑
❑
❑

DOING USUAL ACTIVITIES (for example: going to school, hobbies,
sports, playing, doing things with family or friends)
No problems doing his/her usual activities

❑

Some problems doing his/her usual activities

❑

A lot of problems doing his/her usual activities

❑

HAVING PAIN OR DISCOMFORT

❑
❑
❑

No pain or discomfort
Some pain or discomfort
A lot of pain or discomfort

FEELING WORRIED, SAD OR UNHAPPY

❑
❑
❑

Not worried, sad or unhappy
A bit worried, sad or unhappy
Very worried, sad or unhappy

© 2010 EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research
Foundation. UK (English) v2.1
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The best health
you can imagine
100

•

We would like to know how good or bad you think the child’s health
is TODAY.

95
90

•

This scale is numbered from 0 to 100.
85

•

100 means the best health you can imagine.

80

0 means the worst health you can imagine.
•

•

Please mark an X on the scale to indicate how you think the child’s

75

health is TODAY.

70

Now, write the number you marked on the scale in the box below.

65
60
55

50

THE CHILD’S HEALTH TODAY =

45
40

35
30
25

20
15
10
5

The worst health

0

you can imagine
© 2010 EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research
Foundation. UK (English) v2.1
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II. Cost of visits to health professionals (excluding hospital admissions). Please
complete the following cost questions with regard to pre-COVID-19 situation.
11. Approximately, how often did you visit any of the following health professionals for this
child’s health in the last 12 months? Please complete for any of the health professionals
relevant to your child.
No. of visits over the
How many miles or
last 12 months period? kilometres did you travel to
get to most recent
appointment?
[1] Family doctor (GP)

[2] Consultants/Specialists

[3] Nurse

[4] Nurse at outpatient clinic

[5] Dietician/Nutritionist

[6] Physiotherapist

[7] Pharmacist

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

[8] Alternative therapist
Please specify
____________________

___
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___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

____________________

[9] Other health professionals
Please specify

12. When you attended these health professionals for this child’s last appointment, how
much did you personally pay (if anything) for the consultation? Please exclude any payments
covered by private/health insurance.
Consultation fee of last appointment
(£)/(€)
[1] Family doctor (GP)

____

[2] Consultants/Specialists

____

[3] Nurse

____
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[4] Nurse at outpatient clinic

____

[5] Dietician/Nutritionist

____

[6] Physiotherapist

____

[7] Pharmacist

____

[8] Alternative therapist
Please specify
____________________

____

____________________

____

____________________

____

[9] Other health professionals
Please specify
____________________

____

____________________

____

____________________

____
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III. Hospital inpatient admissions in the last 12 MONTHS. Please complete the
following questions with regard to pre-COVID-19 situation.

13. How many times (if any) has this child been admitted/attended hospital in the last 12 months?
If your child has not been admitted nor attended a hospital in the last 12 months, please skip to the nex
question.
Outpatient attendence Day Unit: often used
A&E attendance
Hospital admission
for tests that require
without subsequent
to a ward, possibly after
monitoring
admission to a ward
A&E attendance

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

How many times ____

How many times ____

How many times ____

How many times ____

Total number of nights ____
Did this result in a loss
of earnings for you or
partner/spouse?

Did this result in a loss Did this result in a loss
of earnings for you or of earnings for you or
partner/spouse?
partner/spouse?

Did this result in a loss of
earnings for you or
partner/spouse?

□ Yes
□ No

□ Yes
□ No

□ Yes
□ No

□ Yes
□ No

If so, how much?

If so, how much?

If so, how much?

If so, how much?

(£)/(€)_______

(£)/(€)_______

(£)/(€)_______

(£)/(€)_______

Did you require an
Did you require an
ambulance for this child ambulance for this child
over the last 12 months? over the last 12 months?

□ Yes
□ No

□ Yes
□ No

If so, how many times?
_______

If so, how many times?
_______

How much did the
ambulance cost?

How much did the
ambulance cost?

(£)/(€) _______

(£)/(€) _______
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14. Approximately, how much have you spent on this child’s medicines and food
supplements in the last 12 months?
➔ Prescribed medicines (£)/(€) ________
➔ Over-the-counter medicines (£)/(€) ________
➔ Food supplements (£)/(€) ________

15. Does this child have private/additional medical insurance?

□ Yes
□ No
➔ If yes, how much does the household policy cost per year? (£)/(€) _________

IV. Days off school or college. Please complete this question with regard to preCOVID-19 situation.
16. During the last 12 months, how many days (if any) has this child taken off school or
college due to any illness?
➔ Total number of days off _________
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V. Costs of living. Please complete the following cost questions with regard to preCOVID-19 situation.
17. On average, how much does your household spend EACH WEEK on food shopping?
➔ Total cost (£)/(€) _________

18. On average, how much TIME does your household spend EACH WEEK on shopping
for food and preparing food?
➔ Time spent shopping for food each week? ____ hours ____ minutes
➔ Time spent preparing for food each week? ____ hours ____ minutes

19. Over the PAST MONTH, approximately how many times did your household consume
food and meals bought outside the home (e.g. including meals at work/school/college,
canteen, café, restaurants), and at what cost?
➔ Approximate number of times _________
➔ Approximate number of times (£)/(€) _________
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VI. About you and your household. Please complete the following questions with
regard to pre-COVID-19 situation.
20. Please tell us which areas of daily life have been affected as a result of this child’s food
intolerance/s, suspected, or non-medically diagnosed food allergy/ies. Please tick all that
apply.

□ My childcare arrangement
□ They had to change schools
□ The time it takes to complete my food shopping
□ The cost of my food shopping
□ Household tasks
□ Relationship with my partner
□ Effects on other siblings and family members
□ Affects the diet of all the family (food eliminated from house/change to overall family diet)
□ Ability to eat out/eat out as a family
□ Assumption of being a fussy eater
□ Poor treatment by some staff in restaurants
□ Expanding my family
□ Caring for family and children when unwell
□ Choice of job or career
□ Loss of time at work
□ Emotions (anger, fear, anxiety, feeling left out and trauma)
□ Ability to use public transport
□ Going to children’s parties
□ Social interaction
□ Social activities (e.g. going to school tours, theme parks)
□ Sports and hobbies
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□ Social life (e.g. going to parties)
□ Family social life (e.g. going to family parties, weddings, visiting family members)
□ Holidays/travel to foreign destinations
□ None of the above
Please feel free to elaborate or add to any of the above.
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________

21. Do you live in an urban or rural setting?

□ Urban
□ Rural
22. What is the highest level of education you and your spouse/partner have completed to
date? Please tick one box for you and one for your spouse/partner which best describes your
level of education.
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You

Spouse/Partner

□ Not applicable (No spouse/partner)
□ Primary Education or less
□ Intermediate/Junior/Group/Ordinary
Levels/General Certificate of Secondary
Education or equivalent

□ Leaving Certificate/Advanced
Levels/General Certificate of Education
Advanced Level or equivalent

□ Diploma/Certificate
□ Primary degree/Bachelor’s degree
□ Postgraduate/Higher degree

□ Primary Education or less
□ Intermediate/Junior/Group/Ordinary
Levels/General Certificate of Secondary
Education or equivalent

□ Leaving Certificate/Advanced
Levels/General Certificate of Education
Advanced Level or equivalent

□ Diploma/Certificate
□ Primary degree/Bachelor’s degree
□ Postgraduate/Higher degree

23. What is your and your spouse/partner’s employment status?
Please tick one box for you and one for your spouse/partner which best describes your
current working status.
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You

Spouse/Partner

□ Not applicable (No spouse/partner)
□ Part-time
□ Full-time
□ Self employed with employees
□ Self employed without employees
□ Unemployed and seeking work
□ Unemployed and not seeking work
□ Retired
□ Student
□ Homemaker
□ On disability allowance
□ Volunteer
□ Other, please specify

□ Part-time
□ Full-time
□ Self employed with employees
□ Self employed without employees
□ Unemployed and seeking work
□ Unemployed and not seeking work
□ Retired
□ Student
□ Homemaker
□ On disability allowance
□ Volunteer
□ Other, please specify

________________
________________
________________

________________
________________
________________

24. If you are in paid employment, on average how many hours do you and your
spouse/partner work per week?
You
Spouse/Partner

□ Not applicable

□ Not applicable

➔ Total number of hours per week? _______

➔ Total number of hours per week? _______
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25. All the information that you provide will be completely anonymous and strictly
confidential.
Approximately, what would be the combined income of your household PER MONTH
after tax and other deductions e.g. Pay As You Earn, Pay Related Social Insurance
and Pension Related Deduction are taken out? Please tick one box only.
Per Month (£)/(€)
Combined Household Income
Not applicable

□

Under 1,000

□

1,001 to under 1,500

□

1,501 to under 2,000

□

2,001 to under 2,500

□

2,501 to under 3,500

□

3,501 to under 4,000

□

4,001 to under 5,000

□

5,001 to under 6,500

□

6,501 to under 8,000

□

8,001 or more

□
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26. Please feel free to write suggestions or recommendations you believe would assist in
improving the quality of life of families of children with food intolerance or allergy on the
Island of Ireland today:
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
Thank you very much for your co-operation!
1. Do you want to participate in our lottery for the chance to win one of 5 x €100/£100
‘One4All’ vouchers?

□ Yes
□ No
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Survey 6a: Lottery Survey

1. Please provide a contact email address to enter a lottery for the chance to win one of 5 x
€100/£100 ‘One4All’ vouchers. This email address will only be used to contact you in the
event that you are chosen as a winner. TU Dublin will securely store this data until the
winner has been randomly chosen and has claimed their prize. This data will not be shared
with any third parties or used in a way other than for the purpose it was provided and then
will be destroyed. By providing your email address, you consent to TU Dublin processing
your data in line with the purpose specified above.
➔ Email address: _______________

Thank you very much for your co-operation!
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9.2 SAFEFOOD COST OF LIVING AND HEALTH CARE
QUESTIONNAIRES (CONTROL SURVEYS)
Survey Link: https://safefood.mysurveyhosting.com/index.php/754917?lang=en
Participant Information Sheet
Adult Survey
•

Survey 1: Cost of Living and Health Care Survey – version for adults

•

Survey 1a: Lottery Survey

Parental Survey
•

Survey 2: Cost of Living and Health Care Survey – version for parents

•

Survey 2a: Lottery Survey

796

9.2.1 Cost of Living and Health Care Questionnaire Participant Information Sheet
Safefood, Technological University Dublin (TU Dublin) and Queen’s University Belfast
are researching the cost of living, health, and health care related expenses on the Island
of Ireland. We are looking for your assistance in completing this survey in order to obtain
much needed data on day-to-day living expenses for (i) adults, and (ii) children.
This survey will take between 8 to 10 minutes to complete and consists of 21 questions.
The survey should be completed in the context of the respondent’s normal
circumstances before these were interrupted by the current Covid-19 crisis.
Respondents must be resident in the Republic of Ireland or Northern Ireland.
Completed surveys will be entered into a prize draw (optional) for one of 5 x €100/£100
‘One4All’ vouchers and cannot be linked to any submitted survey data.
This survey is anonymous and cannot be traced back to any computer IP address. The
information from this survey will be stored electronically on a password-protected
encrypted computer at TU Dublin for 5 years before being electronically deleted. To learn
more, please visit: https://www.dit.ie/media/instituteofsecretary/dataprotection/DataProtection-and-Privacy-Policy-v1.pdf

By taking part in this survey, you agree that you:
• are 18 years of age and older,
• understand the information presented above and
• give consent to the information that you provide being used in this study

For further information about the study, please contact:
Miss Eliza Dimla
Researcher, TU Dublin
E-mail: C14710955@mytudublin.ie
Phone: XXX
Address: TU Dublin, Sackville Place, Dublin 1, D01 FH94
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1. This questionnaire can be completed by an adult or a parent/guardian of a child. Please
select one and tick on whose behalf you are completing this survey on. This survey is to be
completed with regard to pre-COVID-19 situation.

□ On my behalf

□ On behalf of my eldest child

2. Please confirm whether you or your eldest child (whichever option you selected in Q1) has
one of the following:
Please note if you choose one of the first three options, you will be directed to the food
hypersensitivity survey. You will be asked questions regarding the monetary costs associated
with living with a food hypersensitivity.

□ Medically diagnosed food allergy/ies (as diagnosed by a doctor/medical professional)
□ Medically diagnosed coeliac disease (as diagnosed by a doctor/medical professional)
□ Food intolerance/s, Suspected or Non-medically diagnosed food allergy/ies
□ None of the above
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Survey 1: Cost of Living and Health Care Survey – version for adults
I. Your household and health. Please complete the following questions with regard
to pre-COVID-19 situation.
1. Where is your place of residence?

□ Republic of Ireland

□ Northern Ireland

2. In total, how many adults, adolescents and children live in your household?
Number of adults
(>18 years of age)

_____ male

_____ female

_____ male

_____ female

_____ male

_____ female

Number of adolescents
(13 – 17 years of age)
Number of children
(0 - 12 years of age)

3. Please state your age and gender.

You

Age

Male or female
(Enter M or F)

_____

_____
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4. What is your ethnic or cultural background?

□ Irish
□ British
□ Northern Irish
□ Irish Traveller
□ Any other White background
□ African
□ Any other Black background
□ Chinese
□ Any other Asian background
□ Other (including mixed background), please specify _________
5. Do you have any long-term illness, health problems, or disabilities, which limit your daily
activities?

□ Yes
□ No
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6. Under each heading, please tick the ONE box that best describes your health TODAY.
MOBILITY

❑
❑
❑

I have no problems in walking about
I have some problems in walking about
I am confined to bed

SELF-CARE
I have no problems with self-care
I have some problems washing or dressing myself
I am unable to wash or dress myself

❑
❑
❑

USUAL ACTIVITIES (e.g. work, study, housework, family or leisure activities)
I have no problems with performing my usual activities
I have some problems with performing my usual activities
I am unable to perform my usual activities

❑
❑
❑

PAIN/DISCOMFORT

❑
❑
❑

I have no pain or discomfort
I have moderate pain or discomfort
I have extreme pain or discomfort

ANXIETY/DEPRESSION

❑
❑
❑

I am not anxious or depressed
I am moderately anxious or depressed
I am extremely anxious or depressed

© 1990 EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research
Foundation. UK (English) v2.1
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The best health
you can imagine
100

•

We would like to know how good or bad your health is TODAY.

95

•

This scale is numbered from 0 to 100.

90

•

100 means the best health you can imagine.

85

80

0 means the worst health you can imagine.
•

•

75

Please mark an X on the scale to indicate how your health is
TODAY.

70

Now, write the number you marked on the scale in the box below.

65
60
55
50
45

YOUR HEALTH TODAY =

40
35
30
25
20
15
10
5
0

The worst health

© 1990 EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research
Foundation. UK (English) v2.1

you can imagine
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II. Cost of visits to health professionals (excluding hospital admissions). Please
complete the following cost questions with regard to pre-COVID-19 situation.
7. Approximately, how often did you visit any of the following health professionals for your
own health in the last 12 months? Please complete for any of the health professionals relevant
to you.
Approximate number
How many miles or
of visits over the last 12 kilometres did you travel to
months period?
get to most recent
appointment?
[1] Family doctor (GP)

[2] Consultants/Specialists

[3] Nurse

[4] Nurse at outpatient clinic

[5] Dietician/Nutritionist

[6] Physiotherapist

[7] Pharmacist

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

[8] Alternative therapist
Please specify
____________________

___
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___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

____________________

[9] Other health professionals
Please specify

8. When you attended your last appointment with these health professionals, how much did
you personally pay (if anything) for the consultation? Please exclude any payments covered
by private/health insurance.
Consultation fee of last appointment
(£)/(€)
[1] Family doctor (GP)

____

[2] Consultants/Specialists

____

[3] Nurse

____
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[4] Nurse at outpatient clinic

____

[5] Dietician/Nutritionist

____

[6] Physiotherapist

____

[7] Pharmacist

____

[8] Alternative therapist
Please specify
____________________

____

____________________

____

____________________

____

[9] Other health professionals
Please specify
____________________

____

____________________

____

____________________

____
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III. Hospital inpatient admissions in the last 12 MONTHS. Please complete the
following questions with regard to pre-COVID-19 situation.

9. How many times (if any) have you been admitted/attended hospital in the last 12 months?
If you have not been admitted nor attended a hospital in the last 12 months, please skip to the next question
Outpatient attendence Day Unit: often used
A&E attendance
Hospital admission
for tests that require
without subsequent
to a ward, possibly after
monitoring
admission to a ward
A&E attendance

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

How many times ____

How many times ____

How many times ____

How many times ____

Total number of nights ___
Did this result in a loss
of earnings for you?

Did this result in a loss
of earnings for you?

Did this result in a loss
of earnings for you?

Did this result in a loss of
earnings for you?

□ Yes
□ No

□ Yes
□ No

□ Yes
□ No

□ Yes
□ No

If so, how much?

If so, how much?

If so, how much?

If so, how much?

(£)/(€)_______

(£)/(€)_______

(£)/(€)_______

(£)/(€)_______

Did you require an
ambulance over the last
12 months?

Did you require an
ambulance over the last 12
months?

□ Yes
□ No

□ Yes
□ No

If so, how many times?

If so, how many times?

_______

_______

How much did the
ambulance cost?

How much did the
ambulance cost?

(£)/(€) _______

(£)/(€) _______
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10. Approximately, how much have you spent on medicines and food supplements for
yourself, in the last 12 months?
➔ Prescribed medicines? (£)/(€) ________
➔ Over-the-counter medicines? (£)/(€) ________
➔ Food supplements? (£)/(€) ________

11. Do you have private/additional medical insurance?

□ Yes
□ No
➔ If yes, how much does your individual policy cost per year? (£)/(€) _________

IV. Days off work, school or college. Please complete this question with regard to
pre-COVID-19 situation.
12. During the last 12 months, how many days (if any) have you taken off work, school or
college due to any illness?
➔ Total number of days off _________

V. Costs of living. Please complete the following cost questions with regard to
pre-COVID-19 situation.
13. On average, how much do you or your household spend EACH WEEK on food shopping
(excluding eating out)?
Please estimate the amount you spend on food shopping for yourself, by answering either
part (i) or (ii).
i) Total cost of household food shopping (£)/(€) _________
Approximate percentage (total cost) of household food shopping attributed to you (%) ______
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ii) Total cost of your own food shopping (£)/(€) _________
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14. On average, how much TIME do you spend EACH WEEK on shopping for food and
preparing food for yourself?
➔ Time spent shopping for food each week? ____ hours ____ minutes
➔ Time spent preparing for food each week? ____ hours ____ minutes

15. Over the PAST MONTH, approximately how many times did you consume food and
meals bought outside the home (e.g. including meals at work/school/college, canteen, café,
restaurants), and at what cost?
➔ Approximate number of times _________
➔ Approximate cost per time (£)/(€) _________

VI. About you and your household. Please complete the following questions with
regard to pre-COVID-19 situation.
16. Do you live in an urban or rural setting?

□ Urban
□ Rural
17. What is the highest level of education you have completed to date?

□ Primary Education or less
□ Intermediate/Junior/Group/Ordinary Levels/General Certificate of Secondary Education or
equivalent

□ Leaving Certificate/Advanced Levels/General Certificate of Education Advanced Level or
equivalent

□ Diploma/Certificate
□ Primary degree/Bachelor’s degree
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□ Postgraduate/Higher degree
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18. What is your employment status?
Please tick one box which best describes your current working status.

□
□
□
□
□
□
□
□
□
□
□
□

Part-time
Full-time
Self employed with employees
Self employed without employees
Unemployed and seeking work
Unemployed and not seeking work
Retired
Student
Homemaker
On disability allowance
Volunteer
Other, please specify
_________________
_________________
_________________

19. If you are in paid employment, on average how many hours do you work per week?

□ Not applicable
➔ Total number of hours per week? _______
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20. All the information that you provide will be completely anonymous and strictly
confidential.
What would be your total net income PER MONTH after tax and other deductions
e.g. Pay As You Earn, Pay Related Social Insurance and Pension Related Deduction
are taken out? Please tick one box only.
Per Month (£)/(€)
Total Net Income
Not applicable

□

Under 1,000

□

1,001 to under 1,500

□

1,501 to under 2,000

□

2,001 to under 2,500

□

2,501 to under 3,500

□

3,501 to under 4,000

□

4,001 to under 5,000

□

5,001 to under 6,500

□

6,501 to under 8,000

□

8,001 or more

□
Thank you very much for your co-operation!

1. Do you want to participate in our lottery for the chance to win one of 5 x €100/£100
‘One4All’ vouchers?

□ Yes
□ No

812

Survey 1a: Lottery Survey
1. Please provide a contact email address to enter a lottery for the chance to win one of 5 x
€100/£100 ‘One4All’ vouchers. This email address will only be used to contact you in the
event that you are chosen as a winner. TU Dublin will securely store this data until the
winner has been randomly chosen and has claimed their prize. This data will not be shared
with any third parties or used in a way other than for the purpose it was provided and then
will be destroyed. By providing your email address, you consent to TU Dublin processing
your data in line with the purpose specified above.
➔ Email address: _______________

Thank you very much for your co-operation!
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Survey 2: Cost of Living and Health Care Survey – version for parents
I. Your household and child’s health. Please complete the following questions with
regard to pre-COVID-19 situation.
1. Where is your place of residence?

□ Republic of Ireland

□ Northern Ireland

2. In total, how many adults, adolescents and children live in your household?
Number of adults
(>18 years of age)

_____ male

_____ female

_____ male

_____ female

_____ male

_____ female

Number of adolescents
(13 – 17 years of age)
Number of children
(0 - 12 years of age)
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3. Do you, or any other member of your household have a food hypersensitivity e.g. food
allergy, food intolerance or coeliac disease?

□
□

Yes

No
➔ If yes, please complete the table for each member of your household that have a food
hypersensitivity below. Please tick all that apply.
Household members

Gender

Medically
diagnosed food
allergy/ies

Medically
diagnosed
coeliac disease

Food
intolerance/s,
suspected, or
non-medically
diagnosed
food
allergy/ies

Adult 1

_____

□

□

□

Adult 2

_____

□

□

□

Adult 3

_____

□

□

□

Adult 4

_____

□

□

□

Adult 5

_____

□

□

□

Child 1

Age
____

_____

□

□

□

Child 2

Age
____

_____

□

□

□

Child 3

Age
____

_____

□

□

□

Child 4

Age
____

_____

□

□

□

Child 5

Age
____

_____

□

□

□
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4. Please complete this for your eldest child.
Age

Eldest Child

Male or female
(Enter M or F)

_____

_____

5. What is the ethnic or cultural background of your eldest child?

□ Irish
□ British
□ Northern Irish
□ Irish Traveller
□ Any other White background
□ African
□ Any other Black background
□ Chinese
□ Any other Asian background
□ Other (including mixed background), please specify _________
6. Does the eldest child have any long-term illness, health problems, or disabilities which
limit their daily activities?

□ Yes
□ No
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7. Under each heading, please tick the ONE box that you think best describes the child’s
health TODAY.
MOBILITY (walking about)

❑
❑
❑

No problems walking about
Some problems walking about
A lot of problems walking about

LOOKING AFTER HIM/HERSELF
No problems washing or dressing him/herself
Some problems washing or dressing him/herself
A lot of problems washing or dressing him/herself

❑
❑
❑

DOING USUAL ACTIVITIES (for example: going to school, hobbies,
sports, playing, doing things with family or friends)
No problems doing his/her usual activities

❑

Some problems doing his/her usual activities

❑

A lot of problems doing his/her usual activities

❑

HAVING PAIN OR DISCOMFORT

❑
❑
❑

No pain or discomfort
Some pain or discomfort
A lot of pain or discomfort

FEELING WORRIED, SAD OR UNHAPPY

❑
❑
❑

Not worried, sad or unhappy
A bit worried, sad or unhappy
Very worried, sad or unhappy

© 2010 EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research
Foundation. UK (English) v2.1
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The best health
you can imagine
100

•

We would like to know how good or bad you think the child’s health
is TODAY.

95
90

•

This scale is numbered from 0 to 100.
85

•

100 means the best health you can imagine.

80

0 means the worst health you can imagine.
•

•

Please mark an X on the scale to indicate how you think the child’s

75

health is TODAY.

70

Now, write the number you marked on the scale in the box below.

65
60
55

50

THE CHILD’S HEALTH TODAY =

45
40

35
30
25

20
15
10
5

The worst health

0

you can imagine
© 2010 EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research
Foundation. UK (English) v2.1
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II. Cost of visits to health professionals (excluding hospital admissions). Please
complete the following cost questions with regard to pre-COVID-19 situation.
8. Approximately, how often did you visit any of the following health professionals for your
eldest child’s health in the last 12 months? Please complete for any of the health professionals
relevant to your child.
Approximate number
How many miles or
of visits over the last 12 kilometres did you travel to
months period?
get to most recent
appointment?
[1] Family doctor (GP)

[2] Consultants/Specialists

[3] Nurse

[4] Nurse at outpatient clinic

[5] Dietician/Nutritionist

[6] Physiotherapist

[7] Pharmacist

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

[8] Alternative therapist
Please specify
____________________

___
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___ miles or
___ km

___

___ miles or
___ km

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

___

___ miles or
___ km

____________________

____________________

[9] Other health professionals
Please specify

9. When you attended these health professionals for your eldest child’s last appointment,
how much did you personally pay (if anything) for the consultation? Please exclude any
payments covered by private/health insurance.
Consultation fee of last appointment
(£)/(€)
[1] Family doctor (GP)

____

[2] Consultants/Specialists

____

[3] Nurse

____
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[4] Nurse at outpatient clinic

____

[5] Dietician/Nutritionist

____

[6] Physiotherapist

____

[7] Pharmacist

____

[8] Alternative therapist
Please specify
____________________

____

____________________

____

____________________

____

[9] Other health professionals
Please specify
____________________

____

____________________

____

____________________

____
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III. Hospital inpatient admissions in the last 12 MONTHS. Please complete the
following questions with regard to pre-COVID-19 situation.

10. How many times (if any) has this child been admitted/attended hospital in the last 12 months?
If your child has not been admitted nor attended a hospital in the last 12 months, please skip to the nex
question.
Outpatient attendence Day Unit: often used
A&E attendance
Hospital admission
for tests that require
without subsequent
to a ward, possibly after
monitoring
admission to a ward
A&E attendance

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

□ Public hospital
□ Private hospital

How many times ____

How many times ____

How many times ____

How many times ____

Total number of nights ____
Did this result in a loss
of earnings for you or
partner/spouse?

Did this result in a loss Did this result in a loss
of earnings for you or of earnings for you or
partner/spouse?
partner/spouse?

Did this result in a loss of
earnings for you or
partner/spouse?

□ Yes
□ No

□ Yes
□ No

□ Yes
□ No

□ Yes
□ No

If so, how much?

If so, how much?

If so, how much?

If so, how much?

(£)/(€)_______

(£)/(€)_______

(£)/(€)_______

(£)/(€)_______

Did you require an
Did you require an
ambulance for this child ambulance for this child
over the last 12 months? over the last 12 months?

□ Yes
□ No

□ Yes
□ No

If so, how many times?
_______

If so, how many times?
_______

How much did the
ambulance cost?

How much did the
ambulance cost?

(£)/(€) _______

(£)/(€) _______
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11. Approximately, how much have you spent on medicines and food supplements for your
eldest child in the last 12 months?
➔ Prescribed medicines (£)/(€) ________
➔ Over-the-counter medicines (£)/(€) ________
➔ Food supplements (£)/(€) ________

12. Does the eldest child have private/additional medical insurance?

□ Yes
□ No
➔ If yes, how much does the household policy cost per year? (£)/(€) _________

IV. Days off school or college. Please complete this question with regard to
pre-COVID-19 situation.
13. During the last 12 months, how many days (if any) has the eldest child taken off school
or college due to any illness?
➔ Total number of days off _________

V. Costs of living. Please complete the following cost questions with regard to preCOVID-19 situation.
14. On average, how much does your household spend EACH WEEK on food shopping?
➔ Total cost (£)/(€) _________
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15. On average, how much TIME does your household spend EACH WEEK on shopping
for food and preparing food?
➔ Time spent shopping for food each week? ____ hours ____ minutes
➔ Time spent preparing for food each week? ____ hours ____ minutes

16. Over the PAST MONTH, approximately how many times did your household consume
food and meals bought outside the home (e.g. including meals at work/school/college,
canteen, café, restaurants), and at what cost?
➔ Approximate number of times _________
➔ Approximate number of times (£)/(€) _________

VI. About you and your household. Please complete the following questions with
regard to pre-COVID-19 situation.
17. Do you live in an urban or rural setting?

□ Urban
□ Rural
18. What is the highest level of education you and your spouse/partner have completed to
date? Please tick one box for you and one for your spouse/partner which best describes your
level of education.
You
Spouse/Partner

□ Not applicable (No spouse/partner)
□ Primary Education or less

□ Primary Education or less

□ Intermediate/Junior/Group/Ordinary

□ Intermediate/Junior/Group/Ordinary

Levels/General Certificate of Secondary
Education or equivalent
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Levels/General Certificate of Secondary
Education or equivalent

□ Leaving Certificate/Advanced

□ Leaving Certificate/Advanced

Levels/General Certificate of Education
Advanced Level or equivalent

Levels/General Certificate of Education
Advanced Level or equivalent

□ Diploma/Certificate

□ Diploma/Certificate

□ Primary degree/Bachelor’s degree

□ Primary degree/Bachelor’s degree

□ Postgraduate/Higher degree

□ Postgraduate/Higher degree
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19. What is your and your spouse/partner’s employment status?
Please tick one box for you and one for your spouse/partner which best describes your
current working status.
You
Spouse/Partner

□ Not applicable (No spouse/partner)
□ Part-time
□ Full-time
□ Self employed with employees
□ Self employed without employees
□ Unemployed and seeking work
□ Unemployed and not seeking work
□ Retired
□ Student
□ Homemaker
□ On disability allowance
□ Volunteer
□ Other, please specify

□ Part-time
□ Full-time
□ Self employed with employees
□ Self employed without employees
□ Unemployed and seeking work
□ Unemployed and not seeking work
□ Retired
□ Student
□ Homemaker
□ On disability allowance
□ Volunteer
□ Other, please specify

________________
________________
________________

________________
________________
________________

20. If you are in paid employment, on average how many hours do you and your
spouse/partner work per week?
You
Spouse/Partner

□ Not applicable

□ Not applicable

➔ Total number of hours per week? _______

➔ Total number of hours per week? _______
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21. All the information that you provide will be completely anonymous and strictly
confidential.
Approximately, what would be the combined income of your household PER MONTH
after tax and other deductions e.g. Pay As You Earn, Pay Related Social Insurance
and Pension Related Deduction are taken out? Please tick one box only.
Per Month (£)/(€)
Combined Household Income
Not applicable

□

Under 1,000

□

1,001 to under 1,500

□

1,501 to under 2,000

□

2,001 to under 2,500

□

2,501 to under 3,500

□

3,501 to under 4,000

□

4,001 to under 5,000

□

5,001 to under 6,500

□

6,501 to under 8,000

□

8,001 or more

□
Thank you very much for your co-operation!

1. Do you want to participate in our lottery for the chance to win one of 5 x €100/£100
‘One4All’ vouchers?

□ Yes
□ No
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Survey 2a: Lottery Survey

1. Please provide a contact email address to enter a lottery for the chance to win one of 5 x
€100/£100 ‘One4All’ vouchers. This email address will only be used to contact you in the
event that you are chosen as a winner. TU Dublin will securely store this data until the
winner has been randomly chosen and has claimed their prize. This data will not be shared
with any third parties or used in a way other than for the purpose it was provided and then
will be destroyed. By providing your email address, you consent to TU Dublin processing
your data in line with the purpose specified above.
➔ Email address: _______________

Thank you very much for your co-operation!
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10 List of Publications
10.1 Published SUREbyt video
– an educational video for
undergraduate students organised by Science Undergraduate Research
Experience (SURE) Network
SUREbyts is a project that is designed to help researchers and research students
disseminate their research to an audience of first-year and second-year undergraduate
students; and to support the integration of research into the early years of undergraduate
Science programmes. The SUREbyts project is being run by the Science Undergraduate
Research Experience (SURE) Network (SURE Network, 2021a).

The Science Undergraduate Research Experience (SURE) Network was established in
2016 by a community of Irish institutions interested in enhancing practice in
undergraduate research in the Sciences. The SURE Network aims to enhance practice
through dissemination of best practice, and implementation of workshops, conferences
and an undergraduate journal. The SURE Network is a disciplinary network and member
of the National Forum for the Enhancement of Teaching and Learning in Higher
Education (SURE Network, 2017).
I developed a SUREbyt video which was published on the 11th August 2021 in the SURE
Network website, and is available here: Eliza Dimla – Medically Diagnosed Food
Allergies – Teaching & Learning (sure-network.ie) (SURE Network, 2021b).

A SUREbyt video is a short video created by researchers and research students. In each
SUREbyt video, researchers will introduce themselves, and then pose a question and
presents possible solutions related to their research. When used in class for the fiirst or
second-year undergraduate students, students will be asked to reflect on the question and
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possible solutions before the researcher provides their opinion on the relative quality of
the solutions in the final part of the video (SURE Network, 2021a).
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10.2 Published Safefood report and media coverage - Publication with
Safefood in collaboration with researchers in TU Dublin, QUB,
Maynooth University, and NUI Galway
•

Safefood Commissioned Research: The Socioeconomic Cost of Food
Hypersensitivity on the island of Ireland; published in May 2022

•

The research examines for the first time the cost of living with a food
hypersensitivity (food allergy, food intolerance and coeliac disease) on the island
of Ireland. The research also looked at the non-monetary or ‘intangible’ costs
involved to determine how quality of life can be affected by a food
hypersensitivity.

•

The research was covered by various media platforms including radio stations and
newspapers; Newstalk, BBC radio, regional radio stations, the Irish Times, Irish
Examiner, and Belfast Telegraph.

Associated links:
➢ https://www.safefood.net/news/cost-allergy-Ireland
➢ https://www.safefood.net/news/cost-allergy-NI
➢ https://www.safefood.net/research/hypersensitivity
Full report:
➢ https://www.safefood.net/getattachment/69d04d2f-314d-44a6-9983be3ea09f9acc/safefood-2022-Economic-Cost-Hypersensitivity.pdf?lang=en-IE
Associated media coverage:
➢ Irish Times,28th of June 2022 - Cost of food allergies tops €1,600, new research
shows – The Irish Times
➢ Irish Examiner, 28th June 2022 - Coeliacs face extra costs of almost €1k a year
to buy gluten-free (irishexaminer.com)
➢ Irish News, 28 of June 2022 - New research reveals average cost of living with
food allergy is over £1,400 per year - The Irish News
➢ Belfast Telegraph, 28th of June 2022 - Cost of living: NI people with food
allergies forking out over £1,400 a year on average - BelfastTelegraph.co.uk
831

➢ Belfast Newsletter, 7th of July 2022 - Health: average cost of living with a food
allergy in NI is over £1,400 per year | Belfast Newsletter
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11 List of Employability Skills and Discipline Specific Skills Training
11 Employability Skills and Discipline Specific Skills Training
A total of three courses of the Employability Skills and Discipline Specific Skills training
were undertaken during the research work for this MPhil Programme. A total of 10
European Credit Transfer System (ECTS) were required for the MPhil Programme.
However, a total of 15 ECTS were completed as per Table 1.

Research Integrity, Research Information Retrieval and Literature Review Skills, and
Data visualisation courses were chosen and completed as per Table 1, to help undertake
the research project and learn new skills regarding information retrieval and graphical
representations (TU Dublin, 2020).

The Research Integrity course is designed to help graduate and early career researchers
to answer questions that will arise as they consider how to plan, carry out and report their
research with integrity, and to deal with the complex situations in which they may find
themselves. This course covered topics such as principle and responsibilities, designing,
conducting, reporting, and responsibilities to society with regard to carrying out a
research study.

The Research Information Retrieval and Literature Review Skills course is developed to
give structured guidance and support to postgraduate research students in the arts,
humanities, business, science and engineering fields, who are keen to develop their
research and put it into the public realm. This course focused on developing skills to
search and retrieve information successfully at a postgraduate level, use of electronic
resources and how to produce literature reviews with referencing.
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Data Visualisation explores the landscape of graphical methods for presenting the results
of scientific experiments. It presents the techniques of the R programming language used
to elicit the narrative behind complex datasets. Students will learn the fundamentals of
aesthetics, attributes, layers, and different options for graphical presentations.

Table 11: Completed European Credit Transfer System (ECTS)
SL

Name of Course

No.
01

Module

ECTS

No.
Data Visualisation

Total
ECTS

DATA

5

5

HXXX
02

Research Integrity

Type

Discipline
Specific

GRSO

5

1012
10
03

Research

GRSO

Information

1011

Employability

5
Specific

Retrieval and
Literature Review
Skills
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Total ECTS required

10

Total ECTS earnt

15
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